country,term,count
AL,ASTHENIA,1
AL,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
AL,COUGH,1
AL,EATING DISORDER,1
AL,FEBRILE NEUTROPENIA,1
AL,GENERAL PHYSICAL HEALTH DETERIORATION,1
AL,INFECTION,1
AL,OROPHARYNGEAL PAIN,1
AL,STREPTOCOCCAL URINARY TRACT INFECTION,1
DZ,CONSTIPATION,11
DZ,GASTROINTESTINAL DISORDER,11
DZ,NAUSEA,11
DZ,VOMITING,9
DZ,NEURALGIA,8
DZ,NEUROPATHY PERIPHERAL,8
DZ,EMBOLISM,6
DZ,ANAEMIA,5
DZ,DIARRHOEA,5
DZ,HYPERTENSION,5
DZ,LEUKOPENIA,3
DZ,THROMBOCYTOPENIA,3
DZ,DYSPNOEA,2
DZ,NEUTROPENIA,2
DZ,PAIN,2
DZ,AGITATION,1
DZ,ALOPECIA,1
DZ,ANXIETY DISORDER,1
DZ,ASTHENIA,1
DZ,BONE PAIN,1
DZ,DECUBITUS ULCER,1
DZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
DZ,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1
DZ,FACE OEDEMA,1
DZ,FACIAL PARALYSIS,1
DZ,FEMORAL NECK FRACTURE,1
DZ,HYPERSENSITIVITY,1
DZ,HYPOKINESIA,1
DZ,HYPOREFLEXIA,1
DZ,INFECTION,1
DZ,INTERSTITIAL LUNG DISEASE,1
DZ,ISCHAEMIC CEREBRAL INFARCTION,1
DZ,ISCHAEMIC STROKE,1
DZ,LUNG DISORDER,1
DZ,LUNG INFECTION,1
DZ,LYMPHADENOPATHY,1
DZ,MONOPLEGIA,1
DZ,MUCOSAL INFLAMMATION,1
DZ,MYOCARDIAL INFARCTION,1
DZ,NERVE COMPRESSION,1
DZ,OEDEMA,1
DZ,OVERDOSE,1
DZ,PALLOR,1
DZ,PARAESTHESIA,1
DZ,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
DZ,PHLEBITIS,1
DZ,PLASMACYTOMA,1
DZ,PLEURAL EFFUSION,1
DZ,PULMONARY VENO-OCCLUSIVE DISEASE,1
DZ,SOCIAL FEAR,1
DZ,THINKING ABNORMAL,1
DZ,TREATMENT FAILURE,1
DZ,URTICARIA,1
DZ,VERTIGO,1
DZ,VIITH NERVE PARALYSIS,1
AG,INJURY,1
AG,SUBARACHNOID HAEMATOMA,1
AG,SUBDURAL HAEMATOMA,1
AG,URINARY RETENTION,1
AR,THROMBOCYTOPENIA,13
AR,PNEUMONIA,9
AR,PYREXIA,8
AR,SEPTIC SHOCK,8
AR,NEUTROPENIA,7
AR,URINARY TRACT INFECTION,7
AR,FEBRILE NEUTROPENIA,6
AR,DEATH,5
AR,DIARRHOEA,5
AR,INFECTION,5
AR,LUNG DISORDER,5
AR,BRONCHOSPASM,4
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
AR,DEEP VEIN THROMBOSIS,4
AR,DISEASE PROGRESSION,4
AR,DRUG INEFFECTIVE,4
AR,FOETAL EXPOSURE DURING PREGNANCY,4
AR,HAEMATOTOXICITY,4
AR,HEADACHE,4
AR,HERPES ZOSTER,4
AR,MUCOSAL INFLAMMATION,4
AR,RESPIRATORY FAILURE,4
AR,ABORTION SPONTANEOUS,3
AR,ACUTE KIDNEY INJURY,3
AR,ANAEMIA,3
AR,BLOOD CREATININE INCREASED,3
AR,CELLULITIS,3
AR,DYSPNOEA,3
AR,FALL,3
AR,GASTROENTERITIS,3
AR,HYPOTENSION,3
AR,INFUSION RELATED REACTION,3
AR,NEPHROLITHIASIS,3
AR,SKIN NECROSIS,3
AR,THROMBOTIC MICROANGIOPATHY,3
AR,WHITE BLOOD CELL COUNT DECREASED,3
AR,ACUTE RESPIRATORY FAILURE,2
AR,ARTHRITIS,2
AR,ARTHROPATHY,2
AR,ASTHMA,2
AR,AUTOIMMUNE HEPATITIS,2
AR,BRONCHITIS,2
AR,CEREBROVASCULAR ACCIDENT,2
AR,CHOLECYSTITIS ACUTE,2
AR,CHOLELITHIASIS,2
AR,CONDITION AGGRAVATED,2
AR,COUGH,2
AR,ENTEROBACTER INFECTION,2
AR,EOSINOPHIL COUNT INCREASED,2
AR,EXPOSURE DURING PREGNANCY,2
AR,FLUID OVERLOAD,2
AR,FOOT DEFORMITY,2
AR,FOOT FRACTURE,2
AR,HAEMATOMA,2
AR,HEPATIC FIBROSIS,2
AR,HUMERUS FRACTURE,2
AR,HYPERBILIRUBINAEMIA,2
AR,HYPERCHOLESTEROLAEMIA,2
AR,HYPERTENSION,2
AR,HYPONATRAEMIA,2
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
AR,KLEBSIELLA INFECTION,2
AR,LEUKOCYTOSIS,2
AR,LOSS OF CONSCIOUSNESS,2
AR,MATERNAL EXPOSURE DURING PREGNANCY,2
AR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
AR,MYOCARDIAL INFARCTION,2
AR,OEDEMA PERIPHERAL,2
AR,PERICARDIAL EFFUSION,2
AR,PLEURAL EFFUSION,2
AR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
AR,PREGNANCY ON CONTRACEPTIVE,2
AR,PREMATURE BABY,2
AR,PRODUCT USE ISSUE,2
AR,PSORIASIS,2
AR,PULMONARY MASS,2
AR,PULMONARY OEDEMA,2
AR,RENAL DISORDER,2
AR,RENAL FAILURE,2
AR,RENAL FAILURE ACUTE,2
AR,RENAL IMPAIRMENT,2
AR,SKIN ULCER,2
AR,SYSTEMIC LUPUS ERYTHEMATOSUS,2
AR,TUBERCULOSIS,2
AR,UPPER LIMB FRACTURE,2
AR,VOMITING,2
AR,WHITE BLOOD CELL COUNT INCREASED,2
AR,ABDOMINAL DISCOMFORT,1
AR,ABDOMINAL PAIN,1
AR,ABORTION INDUCED,1
AR,ABSCESS LIMB,1
AR,ABSCESS NECK,1
AR,ACUTE MYOCARDIAL INFARCTION,1
AR,ADENOCARCINOMA PANCREAS,1
AR,ALANINE AMINOTRANSFERASE INCREASED,1
AR,AMOEBIASIS,1
AR,ANAPHYLACTIC REACTION,1
AR,ANASTOMOTIC ULCER HAEMORRHAGE,1
AR,ANKLE FRACTURE,1
AR,ANKYLOSING SPONDYLITIS,1
AR,ANTINUCLEAR ANTIBODY POSITIVE,1
AR,APPLICATION SITE PAIN,1
AR,ARTHRITIS BACTERIAL,1
AR,ARTHRITIS INFECTIVE,1
AR,ARTHROPOD BITE,1
AR,ASPARTATE AMINOTRANSFERASE INCREASED,1
AR,ASPERGILLUS INFECTION,1
AR,ASPIRATION,1
AR,ATYPICAL PNEUMONIA,1
AR,AUTOIMMUNE DISORDER,1
AR,BACK PAIN,1
AR,BACTERAEMIA,1
AR,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
AR,BIOPSY KIDNEY ABNORMAL,1
AR,BLISTER,1
AR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
AR,BLOOD BILIRUBIN INCREASED,1
AR,BLOOD CHOLESTEROL INCREASED,1
AR,BLOOD DISORDER,1
AR,BLOOD GLUCOSE INCREASED,1
AR,BLOOD IMMUNOGLOBULIN E INCREASED,1
AR,BONE MARROW TOXICITY,1
AR,BREAST FEEDING,1
AR,BRONCHIAL WALL THICKENING,1
AR,BRONCHIECTASIS,1
AR,BRONCHOPULMONARY ASPERGILLOSIS,1
AR,BURSITIS,1
AR,C-REACTIVE PROTEIN ABNORMAL,1
AR,CAESAREAN SECTION,1
AR,CALCULUS URINARY,1
AR,CANDIDA INFECTION,1
AR,CARDIAC ARREST,1
AR,CARDIAC FAILURE,1
AR,CARDIOPULMONARY FAILURE,1
AR,CARTILAGE ATROPHY,1
AR,CELLULITIS STAPHYLOCOCCAL,1
AR,CERVIX CARCINOMA STAGE 0,1
AR,CHEST PAIN,1
AR,CHILLS,1
AR,CHRONIC ALLOGRAFT NEPHROPATHY,1
AR,COLON CANCER METASTATIC,1
AR,CRITICAL ILLNESS MYOPATHY,1
AR,CRITICAL ILLNESS POLYNEUROPATHY,1
AR,CRYPTOCOCCOSIS,1
AR,CSF GLUCOSE DECREASED,1
AR,CYTOMEGALOVIRUS INFECTION,1
AR,DEHYDRATION,1
AR,DEPRESSION,1
AR,DERMATITIS EXFOLIATIVE,1
AR,DEVICE RELATED INFECTION,1
AR,DIFFUSE LARGE B-CELL LYMPHOMA,1
AR,DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY,1
AR,DIVERTICULITIS,1
AR,DRUG EFFECT DECREASED,1
AR,DRUG EFFECT INCOMPLETE,1
AR,DRUG INTOLERANCE,1
AR,DRY EYE,1
AR,DUODENAL ATRESIA,1
AR,DYSPEPSIA,1
AR,DYSPNOEA AT REST,1
AR,DYSURIA,1
AR,EAR HAEMORRHAGE,1
AR,EAR PAIN,1
AR,ENCAPSULATING PERITONEAL SCLEROSIS,1
AR,ENDODONTIC PROCEDURE,1
AR,ENTEROCOLITIS,1
AR,EOSINOPHILIA,1
AR,EPISTAXIS,1
AR,ERYSIPELAS,1
AR,ERYTHEMA,1
AR,FORCED EXPIRATORY VOLUME DECREASED,1
AR,FOREIGN BODY,1
AR,FUNGAL ENDOCARDITIS,1
AR,GAIT DISTURBANCE,1
AR,GASTROINTESTINAL DISORDER,1
AR,GASTROINTESTINAL HAEMORRHAGE,1
AR,GASTROINTESTINAL PERFORATION,1
AR,GASTROSTOMY,1
AR,GENERAL PHYSICAL HEALTH DETERIORATION,1
AR,GENERALISED TONIC-CLONIC SEIZURE,1
AR,GENITAL HERPES,1
AR,GINGIVAL BLEEDING,1
AR,HAEMATOCRIT DECREASED,1
AR,HAEMODIALYSIS,1
AR,HAEMOLYSIS,1
AR,HAEMORRHAGE,1
AR,HEART RATE INCREASED,1
AR,HEPARIN-INDUCED THROMBOCYTOPENIA,1
AR,HEPATIC FAILURE,1
AR,HERPES VIRUS INFECTION,1
AR,HISTIOCYTOSIS HAEMATOPHAGIC,1
AR,HYDRONEPHROSIS,1
AR,HYDROURETER,1
AR,HYPERTENSIVE CRISIS,1
AR,HYPERTRIGLYCERIDAEMIA,1
AR,HYPOGAMMAGLOBULINAEMIA,1
AR,HYPOKALAEMIA,1
AR,HYPOTHERMIA,1
AR,IGA NEPHROPATHY,1
AR,IMMOBILE,1
AR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
AR,IMPAIRED HEALING,1
AR,INFECTED LYMPHOCELE,1
AR,INFLAMMATION,1
AR,INFLUENZA,1
AR,INTERVERTEBRAL DISC PROTRUSION,1
AR,INTESTINAL PERFORATION,1
AR,JAUNDICE,1
AR,JAUNDICE NEONATAL,1
AR,JC VIRUS TEST POSITIVE,1
AR,JOINT EFFUSION,1
AR,KIDNEY FIBROSIS,1
AR,KIDNEY TRANSPLANT REJECTION,1
AR,LARGE INTESTINAL ULCER,1
AR,LARYNGITIS,1
AR,LEUKOPENIA,1
AR,LOCALISED INFECTION,1
AR,LOW BIRTH WEIGHT BABY,1
AR,LUNG ABSCESS,1
AR,LUNG INFECTION,1
AR,LUNG INFILTRATION,1
AR,LUPUS-LIKE SYNDROME,1
AR,LYMPHADENOPATHY,1
AR,LYMPHOCELE,1
AR,MALAISE,1
AR,MALIGNANT MELANOMA,1
AR,MALIGNANT NEOPLASM PROGRESSION,1
AR,MEDICAL INDUCTION OF COMA,1
AR,MELAENA,1
AR,MENINGITIS,1
AR,MENINGITIS MENINGOCOCCAL,1
AR,MENINGITIS TUBERCULOUS,1
AR,METASTASES TO BONE,1
AR,METASTASES TO LUNG,1
AR,MIGRAINE,1
AR,MOBILITY DECREASED,1
AR,MULTI-ORGAN DISORDER,1
AR,MULTI-ORGAN FAILURE,1
AR,MUSCULOSKELETAL DISORDER,1
AR,NASAL OBSTRUCTION,1
AR,NASOPHARYNGITIS,1
AR,NAUSEA,1
AR,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
AR,NEOPLASM PROGRESSION,1
AR,NEPHROPATHY TOXIC,1
AR,NIGHT SWEATS,1
AR,NODULE,1
AR,NONINFECTIVE SIALOADENITIS,1
AR,OEDEMA,1
AR,OROPHARYNGEAL PAIN,1
AR,OROPHARYNGEAL PLAQUE,1
AR,OSTEOARTHRITIS,1
AR,OSTEOPENIA,1
AR,OSTEOPOROSIS,1
AR,OTITIS EXTERNA,1
AR,PAIN,1
AR,PAIN IN EXTREMITY,1
AR,PARACOCCIDIOIDES INFECTION,1
AR,PARAESTHESIA,1
AR,PERIARTHRITIS,1
AR,PHARYNGEAL ERYTHEMA,1
AR,PHARYNGEAL ULCERATION,1
AR,PHARYNGITIS,1
AR,PHARYNGOTONSILLITIS,1
AR,PHOTOSENSITIVITY REACTION,1
AR,PLASMA CELL MYELOMA,1
AR,PLATELET COUNT DECREASED,1
AR,PLEOCYTOSIS,1
AR,PNEUMONIA CRYPTOCOCCAL,1
AR,PNEUMONITIS,1
AR,PNEUMONITIS CHEMICAL,1
AR,PNEUMOTHORAX,1
AR,POST PROCEDURAL INFECTION,1
AR,PREMATURE LABOUR,1
AR,PREMATURE RUPTURE OF MEMBRANES,1
AR,PRESCRIBED UNDERDOSE,1
AR,PROSTATE CANCER METASTATIC,1
AR,PROTEUS INFECTION,1
AR,PULMONARY CAVITATION,1
AR,PULMONARY EMBOLISM,1
AR,PULMONARY FIBROSIS,1
AR,PULMONARY HAEMORRHAGE,1
AR,PULMONARY HYPERTENSION,1
AR,PULMONARY HYPOPERFUSION,1
AR,PURPURA,1
AR,PYELONEPHRITIS,1
AR,PYELONEPHRITIS ACUTE,1
AR,RASH ERYTHEMATOUS,1
AR,RASH GENERALISED,1
AR,RASH MACULAR,1
AR,RASH PUSTULAR,1
AR,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,1
AR,RENAL TUBULAR ATROPHY,1
AR,RHEUMATOID ARTHRITIS,1
AR,SALPINGITIS,1
AR,SCOLIOSIS,1
AR,SEIZURE,1
AR,SENSORY LOSS,1
AR,SEPSIS,1
AR,SHOCK,1
AR,SINUSITIS,1
AR,SKIN CANCER,1
AR,SKIN PAPILLOMA,1
AR,SNORING,1
AR,SOFT TISSUE INFECTION,1
AR,SPINAL DISORDER,1
AR,STAPHYLOCOCCUS TEST,1
AR,SUBARACHNOID HAEMORRHAGE,1
AR,SUDDEN DEATH,1
AR,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,1
AR,SUPRAVENTRICULAR TACHYCARDIA,1
AR,SYNCOPE,1
AR,SYNOVITIS,1
AR,TELANGIECTASIA,1
AR,THROAT IRRITATION,1
AR,THROMBOSIS,1
AR,TRANSAMINASES INCREASED,1
AR,TRANSPLANT REJECTION,1
AR,TREATMENT FAILURE,1
AR,TUBULOINTERSTITIAL NEPHRITIS,1
AR,TYPE 2 DIABETES MELLITUS,1
AR,ULCER,1
AR,URINARY TRACT OBSTRUCTION,1
AR,URINARY TRACT STOMA COMPLICATION,1
AR,UROSEPSIS,1
AR,URTICARIA,1
AR,UTERINE CANCER,1
AR,UTERINE HAEMORRHAGE,1
AR,VARICELLA,1
AR,VIRAL INFECTION,1
AR,VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION,1
AR,WALKING AID USER,1
AR,WEIGHT INCREASED,1
AR,WHEEZING,1
AR,WOUND SECRETION,1
AM,MYOCARDIAL INFARCTION,2
AM,METASTASES TO CENTRAL NERVOUS SYSTEM,1
AM,METASTASES TO LUNG,1
AM,NERVOUS SYSTEM DISORDER,1
AU,DIARRHOEA,45
AU,DRUG INEFFECTIVE,41
AU,PYREXIA,40
AU,DYSPNOEA,36
AU,NAUSEA,30
AU,VOMITING,29
AU,ARTHRALGIA,28
AU,FATIGUE,28
AU,LOWER RESPIRATORY TRACT INFECTION,27
AU,FEBRILE NEUTROPENIA,26
AU,PAIN,26
AU,PNEUMONIA,25
AU,MALAISE,24
AU,FALL,22
AU,HEADACHE,22
AU,HYPERTENSION,22
AU,SEPSIS,22
AU,ANAEMIA,21
AU,DIZZINESS,20
AU,RASH,20
AU,BRADYCARDIA,19
AU,OSTEONECROSIS,19
AU,COUGH,16
AU,NEUTROPENIA,16
AU,PNEUMOCYSTIS JIROVECII PNEUMONIA,16
AU,WEIGHT INCREASED,16
AU,ASTHMA,15
AU,PAIN IN EXTREMITY,15
AU,RHEUMATOID ARTHRITIS,15
AU,URINARY TRACT INFECTION,15
AU,HYPOTENSION,14
AU,SQUAMOUS CELL CARCINOMA OF SKIN,14
AU,URTICARIA,14
AU,WEIGHT DECREASED,14
AU,CONDITION AGGRAVATED,13
AU,DEHYDRATION,13
AU,INSOMNIA,13
AU,INTENTIONAL OVERDOSE,13
AU,CHEST PAIN,12
AU,ACUTE MYELOID LEUKAEMIA,11
AU,ATRIAL FIBRILLATION,11
AU,BACK PAIN,11
AU,DEATH,11
AU,DEEP VEIN THROMBOSIS,11
AU,PRURITUS,11
AU,ACUTE KIDNEY INJURY,10
AU,APLASIA PURE RED CELL,10
AU,CELLULITIS,10
AU,CONTUSION,10
AU,DIABETES MELLITUS,10
AU,DRUG DEPENDENCE,10
AU,LETHARGY,10
AU,MUSCULAR WEAKNESS,10
AU,NEUROPATHY PERIPHERAL,10
AU,PLEURAL EFFUSION,10
AU,ARTHRITIS,9
AU,CEREBROVASCULAR ACCIDENT,9
AU,CHILLS,9
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,9
AU,MYOCARDIAL INFARCTION,9
AU,STAPHYLOCOCCAL INFECTION,9
AU,TOXICITY TO VARIOUS AGENTS,9
AU,UPPER RESPIRATORY TRACT INFECTION,9
AU,ABDOMINAL DISTENSION,8
AU,CATARACT,8
AU,DECREASED APPETITE,8
AU,ERYTHEMA,8
AU,GAIT DISTURBANCE,8
AU,GRAFT VERSUS HOST DISEASE,8
AU,INFECTION,8
AU,LIVER FUNCTION TEST ABNORMAL,8
AU,MUSCLE SPASMS,8
AU,MYALGIA,8
AU,OEDEMA PERIPHERAL,8
AU,OSTEOMYELITIS,8
AU,OSTEOPOROSIS,8
AU,PARVOVIRUS B19 INFECTION,8
AU,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,8
AU,PRODUCT USE ISSUE,8
AU,PULMONARY EMBOLISM,8
AU,RENAL IMPAIRMENT,8
AU,RESPIRATORY FAILURE,8
AU,ABDOMINAL DISCOMFORT,7
AU,ABDOMINAL PAIN,7
AU,ARTHROPATHY,7
AU,ASPARTATE AMINOTRANSFERASE INCREASED,7
AU,ASTHENIA,7
AU,CONFUSIONAL STATE,7
AU,DISEASE PROGRESSION,7
AU,DRUG DOSE OMISSION,7
AU,HAEMOGLOBIN DECREASED,7
AU,HYPERGLYCAEMIA,7
AU,HYPERHIDROSIS,7
AU,ILL-DEFINED DISORDER,7
AU,MALIGNANT NEOPLASM PROGRESSION,7
AU,OSTEOARTHRITIS,7
AU,PALPITATIONS,7
AU,PARAESTHESIA,7
AU,PERIPHERAL SWELLING,7
AU,RHODOCOCCUS INFECTION,7
AU,SCEDOSPORIUM INFECTION,7
AU,SKIN LESION,7
AU,TREATMENT FAILURE,7
AU,VIRAL INFECTION,7
AU,ALANINE AMINOTRANSFERASE INCREASED,6
AU,ALOPECIA,6
AU,BASAL CELL CARCINOMA,6
AU,BONE MARROW FAILURE,6
AU,CHEST DISCOMFORT,6
AU,COLITIS,6
AU,CROHN^S DISEASE,6
AU,CUSHING^S SYNDROME,6
AU,DEPRESSION,6
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,6
AU,LUNG INFECTION,6
AU,MIGRAINE,6
AU,NEPHROPATHY TOXIC,6
AU,OSTEOPENIA,6
AU,OVERDOSE,6
AU,PNEUMONITIS,6
AU,RASH PRURITIC,6
AU,SYNCOPE,6
AU,TREMOR,6
AU,WHEEZING,6
AU,ARTHRITIS BACTERIAL,5
AU,ASCITES,5
AU,BLOOD CREATININE INCREASED,5
AU,BONE DENSITY DECREASED,5
AU,BOWEN^S DISEASE,5
AU,C-REACTIVE PROTEIN INCREASED,5
AU,CARDIAC ARREST,5
AU,CARDIAC FAILURE,5
AU,CARDIAC FAILURE CONGESTIVE,5
AU,CONSTIPATION,5
AU,CUSHINGOID,5
AU,DISCOMFORT,5
AU,DRUG-INDUCED LIVER INJURY,5
AU,DYSARTHRIA,5
AU,DYSPHAGIA,5
AU,GASTROOESOPHAGEAL REFLUX DISEASE,5
AU,HEPATIC FAILURE,5
AU,IMPAIRED HEALING,5
AU,INFLUENZA,5
AU,INFLUENZA LIKE ILLNESS,5
AU,KIDNEY TRANSPLANT REJECTION,5
AU,LUNG DISORDER,5
AU,LYMPHADENOPATHY,5
AU,MEMORY IMPAIRMENT,5
AU,MOUTH ULCERATION,5
AU,MULTI-ORGAN FAILURE,5
AU,MYOPATHY,5
AU,NASOPHARYNGITIS,5
AU,NECK PAIN,5
AU,OBESITY,5
AU,PNEUMONIA ASPIRATION,5
AU,PRODUCTIVE COUGH,5
AU,RENAL FAILURE,5
AU,SEDATION,5
AU,STEROID WITHDRAWAL SYNDROME,5
AU,SWELLING,5
AU,VISION BLURRED,5
AU,ADRENAL INSUFFICIENCY,4
AU,ANKLE FRACTURE,4
AU,ANXIETY,4
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,4
AU,BLOOD GLUCOSE INCREASED,4
AU,BONE PAIN,4
AU,BRONCHIECTASIS,4
AU,BRONCHITIS,4
AU,CANDIDA OSTEOMYELITIS,4
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
AU,CONVULSION,4
AU,DELIRIUM,4
AU,DISEASE RECURRENCE,4
AU,DIVERTICULAR PERFORATION,4
AU,DIVERTICULITIS,4
AU,DRUG EFFECT DECREASED,4
AU,DRUG EFFECT INCOMPLETE,4
AU,DRUG LEVEL ABOVE THERAPEUTIC,4
AU,ELECTROCARDIOGRAM QT PROLONGED,4
AU,EXPOSURE DURING PREGNANCY,4
AU,FEELING ABNORMAL,4
AU,FOETAL EXPOSURE DURING PREGNANCY,4
AU,FUNGAL INFECTION,4
AU,HEMIPARESIS,4
AU,HYPOAESTHESIA,4
AU,HYPOXIA,4
AU,INTESTINAL OBSTRUCTION,4
AU,INTESTINAL PERFORATION,4
AU,JOINT SWELLING,4
AU,LYMPHADENOPATHY MEDIASTINAL,4
AU,MANIA,4
AU,METASTATIC MALIGNANT MELANOMA,4
AU,MOBILITY DECREASED,4
AU,MUSCULOSKELETAL CHEST PAIN,4
AU,MYCOBACTERIAL INFECTION,4
AU,NEUTROPENIC SEPSIS,4
AU,NIGHT SWEATS,4
AU,PAIN IN JAW,4
AU,PLASMA CELL MYELOMA,4
AU,PLATELET COUNT DECREASED,4
AU,PNEUMOTHORAX,4
AU,PREMATURE BABY,4
AU,PULMONARY TOXICITY,4
AU,RESPIRATORY TRACT INFECTION,4
AU,SEIZURE,4
AU,SEPTIC SHOCK,4
AU,SKIN CANCER,4
AU,SKIN EXFOLIATION,4
AU,SKIN ULCER,4
AU,SMALL INTESTINAL OBSTRUCTION,4
AU,SOMNOLENCE,4
AU,SPINAL FRACTURE,4
AU,SQUAMOUS CELL CARCINOMA,4
AU,STAPHYLOCOCCAL SEPSIS,4
AU,SWELLING FACE,4
AU,THROMBOSIS,4
AU,UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE,4
AU,VASCULITIS,4
AU,WHITE BLOOD CELL COUNT ABNORMAL,4
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,3
AU,ACUTE CORONARY SYNDROME,3
AU,ACUTE MYOCARDIAL INFARCTION,3
AU,AMNESIA,3
AU,ANGIOEDEMA,3
AU,APHASIA,3
AU,BALANCE DISORDER,3
AU,BLADDER CANCER,3
AU,BLOOD BILIRUBIN INCREASED,3
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,3
AU,BODY TEMPERATURE INCREASED,3
AU,BRAIN NEOPLASM,3
AU,BURNING SENSATION,3
AU,CANCER PAIN,3
AU,CARDIAC DISORDER,3
AU,CYTOMEGALOVIRUS INFECTION,3
AU,DEVICE RELATED INFECTION,3
AU,DIABETIC KETOACIDOSIS,3
AU,DIPLOPIA,3
AU,DUODENAL ULCER,3
AU,DYSPNOEA EXERTIONAL,3
AU,EYE SWELLING,3
AU,GASTROENTERITIS,3
AU,GASTROINTESTINAL DISORDER,3
AU,GENERAL PHYSICAL HEALTH DETERIORATION,3
AU,HAEMOGLOBIN ABNORMAL,3
AU,HAEMORRHAGE,3
AU,HEART RATE INCREASED,3
AU,HEPATIC CIRRHOSIS,3
AU,HEPATIC ENZYME INCREASED,3
AU,HEPATIC FUNCTION ABNORMAL,3
AU,HEPATITIS,3
AU,HEPATITIS B,3
AU,HEPATOTOXICITY,3
AU,HOT FLUSH,3
AU,HYPERSENSITIVITY,3
AU,HYPERTHYROIDISM,3
AU,HYPOALBUMINAEMIA,3
AU,HYPOCALCAEMIA,3
AU,HYPOKALAEMIA,3
AU,HYPONATRAEMIA,3
AU,HYPOPHOSPHATAEMIA,3
AU,IMMUNE SYSTEM DISORDER,3
AU,IMMUNODEFICIENCY,3
AU,INFUSION RELATED REACTION,3
AU,INJECTION SITE PAIN,3
AU,INTENTIONAL PRODUCT USE ISSUE,3
AU,INTERSTITIAL LUNG DISEASE,3
AU,INTERVERTEBRAL DISC DISORDER,3
AU,JOINT DISLOCATION,3
AU,KERATITIS FUNGAL,3
AU,LIGAMENT RUPTURE,3
AU,LISTERIA ENCEPHALITIS,3
AU,LIVER DISORDER,3
AU,LOCAL SWELLING,3
AU,LOCALISED INFECTION,3
AU,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,3
AU,LYMPHOCYTE COUNT DECREASED,3
AU,MALIGNANT MELANOMA,3
AU,MOVEMENT DISORDER,3
AU,MUSCLE TWITCHING,3
AU,MUSCULOSKELETAL PAIN,3
AU,MUSCULOSKELETAL STIFFNESS,3
AU,MYCOBACTERIUM CHELONAE INFECTION,3
AU,NEPHROLITHIASIS,3
AU,NEURALGIA,3
AU,ORAL HERPES,3
AU,OSTEOMYELITIS FUNGAL,3
AU,OSTEONECROSIS OF JAW,3
AU,PANCYTOPENIA,3
AU,PELVIC VENOUS THROMBOSIS,3
AU,PLATELET COUNT ABNORMAL,3
AU,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,3
AU,POSTOPERATIVE WOUND INFECTION,3
AU,PREMATURE DELIVERY,3
AU,PRODUCT QUALITY ISSUE,3
AU,PRODUCT USE IN UNAPPROVED INDICATION,3
AU,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
AU,PROSTATE CANCER,3
AU,PULMONARY ARTERY OCCLUSION,3
AU,PULMONARY HYPOPERFUSION,3
AU,PULMONARY MASS,3
AU,RASH ERYTHEMATOUS,3
AU,RASH GENERALISED,3
AU,RECTAL HAEMORRHAGE,3
AU,RENAL FAILURE ACUTE,3
AU,RESPIRATORY DISTRESS,3
AU,RHINORRHOEA,3
AU,SLEEP APNOEA SYNDROME,3
AU,SLEEP DISORDER,3
AU,STOMATITIS,3
AU,STRONGYLOIDIASIS,3
AU,SYSTEMIC LUPUS ERYTHEMATOSUS,3
AU,TENDON RUPTURE,3
AU,THROMBOCYTOPENIA,3
AU,TOOTHACHE,3
AU,TRANSAMINASES INCREASED,3
AU,TRANSPLANT REJECTION,3
AU,TUBULOINTERSTITIAL NEPHRITIS,3
AU,UNEVALUABLE EVENT,3
AU,UPPER GASTROINTESTINAL HAEMORRHAGE,3
AU,URINARY RETENTION,3
AU,UROSEPSIS,3
AU,VISUAL IMPAIRMENT,3
AU,WOUND INFECTION,3
AU,WRIST FRACTURE,3
AU,ABDOMINAL ADHESIONS,2
AU,ABNORMAL BEHAVIOUR,2
AU,ACTINIC KERATOSIS,2
AU,ACUTE RESPIRATORY FAILURE,2
AU,ANAL FISTULA,2
AU,ANAPHYLACTIC REACTION,2
AU,ANGIOCENTRIC LYMPHOMA,2
AU,APPENDICEAL ABSCESS,2
AU,ARRHYTHMIA,2
AU,ATAXIA,2
AU,ATRIAL TACHYCARDIA,2
AU,AUTOIMMUNE HEPATITIS,2
AU,AUTOIMMUNE PANCREATITIS,2
AU,BLADDER TRANSITIONAL CELL CARCINOMA,2
AU,BLINDNESS,2
AU,BLOOD CHOLESTEROL INCREASED,2
AU,BLOOD IRON DECREASED,2
AU,BLOOD PRESSURE ABNORMAL,2
AU,BLOOD PRESSURE DECREASED,2
AU,BONE DISORDER,2
AU,BRONCHIAL HYPERREACTIVITY,2
AU,BUNDLE BRANCH BLOCK RIGHT,2
AU,CARDIAC TAMPONADE,2
AU,CARDIOTOXICITY,2
AU,CARDIOVASCULAR SYMPTOM,2
AU,CATARACT OPERATION,2
AU,CHEST X-RAY ABNORMAL,2
AU,CHONDROCALCINOSIS PYROPHOSPHATE,2
AU,COGNITIVE DISORDER,2
AU,COLITIS ULCERATIVE,2
AU,COLON CANCER,2
AU,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
AU,CONCOMITANT DISEASE PROGRESSION,2
AU,CRYPTOCOCCOSIS,2
AU,CYTARABINE SYNDROME,2
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,2
AU,DEPRESSED MOOD,2
AU,DIFFUSE LARGE B-CELL LYMPHOMA,2
AU,DRUG INTOLERANCE,2
AU,DRUG LEVEL INCREASED,2
AU,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
AU,DRUG WITHDRAWAL SYNDROME,2
AU,DYSGEUSIA,2
AU,DYSURIA,2
AU,ECZEMA,2
AU,EJECTION FRACTION DECREASED,2
AU,ENCEPHALITIS,2
AU,ENDOPHTHALMITIS,2
AU,ENTERITIS,2
AU,EPISTAXIS,2
AU,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,2
AU,ERYTHEMA NODOSUM,2
AU,FAECAL INCONTINENCE,2
AU,FEELING HOT,2
AU,FEMUR FRACTURE,2
AU,FIBROMYALGIA,2
AU,FINE MOTOR SKILL DYSFUNCTION,2
AU,FLUID RETENTION,2
AU,FLUSHING,2
AU,FOREARM FRACTURE,2
AU,FUNGAL SKIN INFECTION,2
AU,GALLBLADDER DISORDER,2
AU,GASTRIC DISORDER,2
AU,GASTRITIS,2
AU,GASTROINTESTINAL HAEMORRHAGE,2
AU,GASTROINTESTINAL INFECTION,2
AU,GENERALISED OEDEMA,2
AU,GENITAL HERPES SIMPLEX,2
AU,GLOMERULAR FILTRATION RATE DECREASED,2
AU,GRANULOMA,2
AU,GRANULOMATOSIS WITH POLYANGIITIS,2
AU,GROWTH RETARDATION,2
AU,HAEMATOMA,2
AU,HALLUCINATION,2
AU,HEARING IMPAIRED,2
AU,HEART RATE IRREGULAR,2
AU,HEPATIC STEATOSIS,2
AU,HEPATITIS CHOLESTATIC,2
AU,HEPATOMEGALY,2
AU,HIATUS HERNIA,2
AU,HIP FRACTURE,2
AU,HISTIOCYTOSIS HAEMATOPHAGIC,2
AU,HISTOPLASMOSIS,2
AU,HYDRONEPHROSIS,2
AU,HYDROPS FOETALIS,2
AU,HYPERCALCAEMIA,2
AU,HYPERKALAEMIA,2
AU,HYPERLIPIDAEMIA,2
AU,HYPOPHAGIA,2
AU,HYPOTHYROIDISM,2
AU,ILEUS,2
AU,INCONTINENCE,2
AU,INFECTIVE EXACERBATION OF BRONCHIECTASIS,2
AU,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,2
AU,INFECTIVE MYOSITIS,2
AU,INFLAMMATORY MARKER INCREASED,2
AU,INGUINAL HERNIA,2
AU,INJECTION SITE ERYTHEMA,2
AU,INJECTION SITE SWELLING,2
AU,INTESTINAL STENOSIS,2
AU,IRON DEFICIENCY,2
AU,JOINT STIFFNESS,2
AU,KNEE ARTHROPLASTY,2
AU,KNEE OPERATION,2
AU,LACRIMATION INCREASED,2
AU,LARGE INTESTINE PERFORATION,2
AU,LEUKAEMIA RECURRENT,2
AU,LEUKOPENIA,2
AU,LIMB DISCOMFORT,2
AU,LISTERIA SEPSIS,2
AU,LUNG INFILTRATION,2
AU,LUNG NEOPLASM MALIGNANT,2
AU,LUPUS-LIKE SYNDROME,2
AU,MEDICATION ERROR,2
AU,MENINGITIS ASEPTIC,2
AU,MENTAL IMPAIRMENT,2
AU,MICROSPORIDIA INFECTION,2
AU,MITRAL VALVE INCOMPETENCE,2
AU,MUCOSAL INFLAMMATION,2
AU,MULTIPLE SCLEROSIS RELAPSE,2
AU,MUSCLE STRAIN,2
AU,MYASTHENIA GRAVIS CRISIS,2
AU,MYELODYSPLASTIC SYNDROME,2
AU,NECROTISING MYOSITIS,2
AU,NEOPLASM MALIGNANT,2
AU,NERVE COMPRESSION,2
AU,NERVOUS SYSTEM DISORDER,2
AU,NEUTROPENIC COLITIS,2
AU,NEUTROPHILIA,2
AU,NO ADVERSE EVENT,2
AU,NON-HODGKIN^S LYMPHOMA RECURRENT,2
AU,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
AU,OEDEMA,2
AU,ORAL CANDIDIASIS,2
AU,ORAL INFECTION,2
AU,OROPHARYNGEAL PAIN,2
AU,OXYGEN SATURATION DECREASED,2
AU,PANCREATIC FAILURE,2
AU,PELVIC PAIN,2
AU,PEPTIC ULCER,2
AU,PERIPHERAL COLDNESS,2
AU,PHARYNGEAL OEDEMA,2
AU,PHOTOPHOBIA,2
AU,PLASMABLASTIC LYMPHOMA,2
AU,PNEUMOCOCCAL SEPSIS,2
AU,PNEUMOCYSTIS JIROVECII INFECTION,2
AU,PNEUMONIA VIRAL,2
AU,POISONING DELIBERATE,2
AU,POLYARTHRITIS,2
AU,POLYMYALGIA RHEUMATICA,2
AU,PORTAL HYPERTENSION,2
AU,PROSTATE CANCER METASTATIC,2
AU,PSEUDOMONAS INFECTION,2
AU,PULMONARY ARTERIAL HYPERTENSION,2
AU,PULMONARY HAEMORRHAGE,2
AU,PYODERMA GANGRENOSUM,2
AU,RHEUMATOID NODULE,2
AU,ROSACEA,2
AU,SALMONELLOSIS,2
AU,SARCOIDOSIS,2
AU,SINUS DISORDER,2
AU,SKIN DISORDER,2
AU,SKIN REACTION,2
AU,SOCIAL AVOIDANT BEHAVIOUR,2
AU,SOFT TISSUE INFECTION,2
AU,SOFT TISSUE INJURY,2
AU,SPLEEN DISORDER,2
AU,SPLENIC INFARCTION,2
AU,STAPHYLOCOCCAL SKIN INFECTION,2
AU,STILLBIRTH,2
AU,STRESS,2
AU,SURGERY,2
AU,SYNOVIAL CYST,2
AU,SYNOVITIS,2
AU,SYSTOLIC HYPERTENSION,2
AU,TACHYCARDIA,2
AU,TEMPORAL ARTERITIS,2
AU,TEMPOROMANDIBULAR JOINT SYNDROME,2
AU,TETANY,2
AU,THERAPEUTIC RESPONSE SHORTENED,2
AU,THERAPY NON-RESPONDER,2
AU,THERMAL BURN,2
AU,THORACIC VERTEBRAL FRACTURE,2
AU,THROAT TIGHTNESS,2
AU,TOE AMPUTATION,2
AU,TOOTH EXTRACTION,2
AU,TOOTH INFECTION,2
AU,TYPE 2 DIABETES MELLITUS,2
AU,TYPE III IMMUNE COMPLEX MEDIATED REACTION,2
AU,UPPER LIMB FRACTURE,2
AU,URINARY INCONTINENCE,2
AU,UVEITIS,2
AU,VIITH NERVE PARALYSIS,2
AU,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
AU,VISUAL ACUITY REDUCED,2
AU,WEIGHT LOSS POOR,2
AU,WHITE BLOOD CELL COUNT DECREASED,2
AU,WOUND DEHISCENCE,2
AU,WOUND SECRETION,2
AU,ABASIA,1
AU,ABDOMINAL SEPSIS,1
AU,ABORTION INDUCED,1
AU,ABSCESS,1
AU,ABSCESS INTESTINAL,1
AU,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
AU,ACCIDENTAL OVERDOSE,1
AU,ACIDOSIS,1
AU,ACNE,1
AU,ACROMEGALY,1
AU,ACUTE GRAFT VERSUS HOST DISEASE,1
AU,ACUTE MYELOID LEUKAEMIA RECURRENT,1
AU,ACUTE PROMYELOCYTIC LEUKAEMIA,1
AU,ACUTE PULMONARY OEDEMA,1
AU,ACUTE RESPIRATORY DISTRESS SYNDROME,1
AU,ADDISON^S DISEASE,1
AU,ADENOVIRUS INFECTION,1
AU,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
AU,ADVERSE DRUG REACTION,1
AU,ALOPECIA AREATA,1
AU,ALVEOLAR PROTEINOSIS,1
AU,ANAEMIA OF CHRONIC DISEASE,1
AU,ANAL ABSCESS,1
AU,ANAL HAEMORRHAGE,1
AU,ANAL STENOSIS,1
AU,ANGINA PECTORIS,1
AU,ANISOCYTOSIS,1
AU,ANKLE OPERATION,1
AU,ANKYLOSING SPONDYLITIS,1
AU,ANORECTAL DISORDER,1
AU,ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE,1
AU,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,1
AU,ANTIBODY TEST POSITIVE,1
AU,AORTIC ANEURYSM,1
AU,APHAGIA,1
AU,APHTHOUS ULCER,1
AU,APPENDICITIS,1
AU,APPENDICITIS PERFORATED,1
AU,ARTERIAL HAEMORRHAGE,1
AU,ARTHRITIS FUNGAL,1
AU,ARTHRITIS INFECTIVE,1
AU,ARTHRODESIS,1
AU,ASPIRATION,1
AU,ASTHENOPIA,1
AU,ATELECTASIS,1
AU,ATRIAL FLUTTER,1
AU,ATRIOVENTRICULAR BLOCK,1
AU,ATRIOVENTRICULAR BLOCK COMPLETE,1
AU,ATYPICAL FEMUR FRACTURE,1
AU,ATYPICAL MYCOBACTERIAL INFECTION,1
AU,ATYPICAL PNEUMONIA,1
AU,AUTOIMMUNE COLITIS,1
AU,AUTOIMMUNE DISORDER,1
AU,AUTOIMMUNE HYPOTHYROIDISM,1
AU,B-CELL LYMPHOMA RECURRENT,1
AU,BACTERIAL INFECTION,1
AU,BACTERIAL PAROTITIS,1
AU,BACTERIAL SEPSIS,1
AU,BALANOPOSTHITIS,1
AU,BASEDOW^S DISEASE,1
AU,BASOSQUAMOUS CARCINOMA OF SKIN,1
AU,BEDRIDDEN,1
AU,BENIGN PROSTATIC HYPERPLASIA,1
AU,BENIGN SPLEEN TUMOUR,1
AU,BK VIRUS INFECTION,1
AU,BLEEDING TIME PROLONGED,1
AU,BLISTER,1
AU,BLISTER INFECTED,1
AU,BLOOD ALBUMIN DECREASED,1
AU,BLOOD CALCIUM DECREASED,1
AU,BLOOD CHLORIDE DECREASED,1
AU,BLOOD CREATINE INCREASED,1
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
AU,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
AU,BLOOD ELECTROLYTES ABNORMAL,1
AU,BLOOD LACTATE DEHYDROGENASE DECREASED,1
AU,BLOOD MAGNESIUM INCREASED,1
AU,BLOOD PHOSPHORUS INCREASED,1
AU,BLOOD POTASSIUM DECREASED,1
AU,BLOOD POTASSIUM INCREASED,1
AU,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
AU,BLOOD PRESSURE INCREASED,1
AU,BLOOD PRESSURE SYSTOLIC INCREASED,1
AU,BLOOD PRODUCT TRANSFUSION DEPENDENT,1
AU,BLOOD TEST ABNORMAL,1
AU,BLOOD THYROID STIMULATING HORMONE DECREASED,1
AU,BLOOD UREA INCREASED,1
AU,BLOOD URIC ACID INCREASED,1
AU,BODY MASS INDEX DECREASED,1
AU,BODY MASS INDEX INCREASED,1
AU,BONE EROSION,1
AU,BONE LESION,1
AU,BORRELIA TEST POSITIVE,1
AU,BOWEL MOVEMENT IRREGULARITY,1
AU,BRAIN MASS,1
AU,BRAIN NEOPLASM BENIGN,1
AU,BREAST CANCER,1
AU,BRONCHIOLITIS,1
AU,BRONCHOPULMONARY ASPERGILLOSIS,1
AU,BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC,1
AU,BRONCHOSPASM PARADOXICAL,1
AU,BUNDLE BRANCH BLOCK LEFT,1
AU,BURSITIS,1
AU,C-REACTIVE PROTEIN ABNORMAL,1
AU,CAESAREAN SECTION,1
AU,CALCINOSIS,1
AU,CANDIDA INFECTION,1
AU,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,1
AU,CARDIAC FAILURE ACUTE,1
AU,CARDIAC MURMUR,1
AU,CARDIAC VEIN PERFORATION,1
AU,CARDIOMEGALY,1
AU,CARDIOMYOPATHY,1
AU,CAROTID ARTERY STENOSIS,1
AU,CARPAL TUNNEL SYNDROME,1
AU,CARTILAGE INJURY,1
AU,CATHETER SITE ERYTHEMA,1
AU,CATHETER SITE HAEMORRHAGE,1
AU,CELLULITIS ORBITAL,1
AU,CENTRAL NERVOUS SYSTEM INFECTION,1
AU,CENTRAL NERVOUS SYSTEM LESION,1
AU,CENTRAL NERVOUS SYSTEM LUPUS,1
AU,CEREBRAL ISCHAEMIA,1
AU,CHLOROMA,1
AU,CHOLANGIOCARCINOMA,1
AU,CHOLECYSTECTOMY,1
AU,CHOLESTASIS,1
AU,CHRONIC ALLOGRAFT NEPHROPATHY,1
AU,CHRONIC GRAFT VERSUS HOST DISEASE,1
AU,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,1
AU,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,1
AU,CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT,1
AU,CHVOSTEK^S SIGN,1
AU,CIRCULATORY COLLAPSE,1
AU,CLAVICLE FRACTURE,1
AU,CLEFT PALATE,1
AU,CLOSTRIDIUM DIFFICILE COLITIS,1
AU,CLOSTRIDIUM TEST POSITIVE,1
AU,COLD SWEAT,1
AU,COLECTOMY,1
AU,COLONIC ABSCESS,1
AU,COLORECTAL CANCER METASTATIC,1
AU,COMPLICATIONS OF TRANSPLANTED LIVER,1
AU,COMPRESSION FRACTURE,1
AU,CONCOMITANT DISEASE AGGRAVATED,1
AU,CONGENITAL SYPHILITIC OSTEOCHONDRITIS,1
AU,COORDINATION ABNORMAL,1
AU,CORNEAL EPITHELIUM DEFECT,1
AU,CORNEAL INFILTRATES,1
AU,COSTOCHONDRITIS,1
AU,CRANIAL NERVE PALSIES MULTIPLE,1
AU,CUTANEOUS SARCOIDOSIS,1
AU,CYANOSIS,1
AU,CYST,1
AU,CYSTITIS,1
AU,CYTOMEGALOVIRUS CHORIORETINITIS,1
AU,CYTOMEGALOVIRUS VIRAEMIA,1
AU,DANDRUFF,1
AU,DEAFNESS,1
AU,DEFAECATION URGENCY,1
AU,DEMENTIA,1
AU,DEMENTIA ALZHEIMER^S TYPE,1
AU,DEMYELINATING POLYNEUROPATHY,1
AU,DENTAL CARIES,1
AU,DERMAL CYST,1
AU,DERMATITIS,1
AU,DERMATITIS CONTACT,1
AU,DEVICE DISLOCATION,1
AU,DIABETES MELLITUS INADEQUATE CONTROL,1
AU,DISSEMINATED CRYPTOCOCCOSIS,1
AU,DISTURBANCE IN ATTENTION,1
AU,DIVERTICULUM,1
AU,DRESSLER^S SYNDROME,1
AU,DRUG DISPENSING ERROR,1
AU,DRUG ERUPTION,1
AU,DRUG LEVEL BELOW THERAPEUTIC,1
AU,DRUG RESISTANCE,1
AU,DRY EYE,1
AU,DRY MOUTH,1
AU,DUODENITIS,1
AU,DYSPEPSIA,1
AU,DYSPRAXIA,1
AU,DYSTONIA,1
AU,EAR INFECTION,1
AU,EAR PAIN,1
AU,ECHINOCOCCIASIS,1
AU,EFFUSION,1
AU,EJECTION FRACTION,1
AU,ELECTROCARDIOGRAM CHANGE,1
AU,EMOTIONAL DISTRESS,1
AU,ENCEPHALITIS VIRAL,1
AU,ENTERAL NUTRITION,1
AU,ENTERITIS INFECTIOUS,1
AU,ENTEROCOCCAL INFECTION,1
AU,ENTEROCOLITIS,1
AU,ENTEROVIRUS INFECTION,1
AU,EOSINOPHILIC FASCIITIS,1
AU,EPSTEIN-BARR VIRAEMIA,1
AU,EPSTEIN-BARR VIRUS INFECTION,1
AU,ESCHERICHIA INFECTION,1
AU,ESCHERICHIA URINARY TRACT INFECTION,1
AU,EXCORIATION,1
AU,EXERCISE TOLERANCE DECREASED,1
AU,EXOSTOSIS,1
AU,EXPOSED BONE IN JAW,1
AU,EXTRADURAL ABSCESS,1
AU,EXTRASYSTOLES,1
AU,EYE DISORDER,1
AU,EYE INFECTION,1
AU,EYE INFLAMMATION,1
AU,EYE PRURITUS,1
AU,FACE OEDEMA,1
AU,FAECES DISCOLOURED,1
AU,FALSE POSITIVE INVESTIGATION RESULT,1
AU,FANCONI SYNDROME,1
AU,FAT NECROSIS,1
AU,FEMORAL NECK FRACTURE,1
AU,FISTULA,1
AU,FLUID OVERLOAD,1
AU,FOETAL DEATH,1
AU,FOETAL GROWTH RESTRICTION,1
AU,FOETAL MACROSOMIA,1
AU,FOETAL MONITORING ABNORMAL,1
AU,FOOT FRACTURE,1
AU,FOOT OPERATION,1
AU,FREQUENT BOWEL MOVEMENTS,1
AU,GALLBLADDER OPERATION,1
AU,GASTRIC DILATATION,1
AU,GASTROENTERITIS SALMONELLA,1
AU,GASTROINTESTINAL NEOPLASM,1
AU,GASTROINTESTINAL PAIN,1
AU,GASTROINTESTINAL PERFORATION,1
AU,GASTROINTESTINAL STOMA COMPLICATION,1
AU,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
AU,GENITAL HERPES,1
AU,GENITAL TRACT INFLAMMATION,1
AU,GINGIVAL PAIN,1
AU,GLAUCOMA,1
AU,GLUCOSE TOLERANCE IMPAIRED,1
AU,GRAFT COMPLICATION,1
AU,GRAFT VERSUS HOST DISEASE IN EYE,1
AU,GRAFT VERSUS HOST DISEASE IN LIVER,1
AU,GRAFT VERSUS HOST DISEASE IN LUNG,1
AU,GRAFT VERSUS HOST DISEASE IN SKIN,1
AU,GROIN ABSCESS,1
AU,HAEMATEMESIS,1
AU,HAEMATOCRIT DECREASED,1
AU,HAEMATOTOXICITY,1
AU,HAEMATURIA,1
AU,HAEMOPTYSIS,1
AU,HAEMORRHAGE INTRACRANIAL,1
AU,HEAD DISCOMFORT,1
AU,HEMIPLEGIA,1
AU,HEPATECTOMY,1
AU,HEPATIC ENCEPHALOPATHY,1
AU,HEPATIC NECROSIS,1
AU,HEPATIC STEATO-FIBROSIS,1
AU,HEPATOSPLENIC T-CELL LYMPHOMA,1
AU,HEPATOSPLENOMEGALY,1
AU,HERNIA,1
AU,HERPES SIMPLEX,1
AU,HERPES SIMPLEX PNEUMONIA,1
AU,HERPES VIRUS INFECTION,1
AU,HILAR LYMPHADENOPATHY,1
AU,HIP ARTHROPLASTY,1
AU,HODGKIN^S DISEASE,1
AU,HOSPITALISATION,1
AU,HUMERUS FRACTURE,1
AU,HYPERBILIRUBINAEMIA,1
AU,HYPERCHOLESTEROLAEMIA,1
AU,HYPERPHOSPHATAEMIA,1
AU,HYPERTENSIVE CRISIS,1
AU,HYPERTRIGLYCERIDAEMIA,1
AU,HYPOGAMMAGLOBULINAEMIA,1
AU,HYPOGLYCAEMIA,1
AU,HYPOKINESIA,1
AU,HYPOMAGNESAEMIA,1
AU,HYPOPITUITARISM,1
AU,HYPOPYON,1
AU,IDIOPATHIC ANGIOEDEMA,1
AU,IDIOPATHIC URTICARIA,1
AU,ILEAL FISTULA,1
AU,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
AU,IMMUNE THROMBOCYTOPENIC PURPURA,1
AU,IMMUNOSUPPRESSION,1
AU,IMPAIRED QUALITY OF LIFE,1
AU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
AU,INCORRECT DOSE ADMINISTERED,1
AU,INCORRECT PRODUCT STORAGE,1
AU,INFARCTION,1
AU,INFECTED SEROMA,1
AU,INFECTED SKIN ULCER,1
AU,INFLAMMATION,1
AU,INFLAMMATORY BOWEL DISEASE,1
AU,INFUSION SITE RASH,1
AU,INJECTION SITE PRURITUS,1
AU,INJECTION SITE RASH,1
AU,INJECTION SITE REACTION,1
AU,INTERVERTEBRAL DISC COMPRESSION,1
AU,INTERVERTEBRAL DISC DEGENERATION,1
AU,INTERVERTEBRAL DISCITIS,1
AU,INTESTINAL HAEMORRHAGE,1
AU,INTESTINAL OPERATION,1
AU,INTESTINAL RESECTION,1
AU,INTESTINAL ULCER,1
AU,INTRACRANIAL ANEURYSM,1
AU,INTRACRANIAL PRESSURE INCREASED,1
AU,INTRAVENTRICULAR HAEMORRHAGE,1
AU,INVESTIGATION,1
AU,IRRITABILITY,1
AU,ISCHAEMIC STROKE,1
AU,JOINT CREPITATION,1
AU,JOINT DISLOCATION REDUCTION,1
AU,JOINT EFFUSION,1
AU,JOINT INJURY,1
AU,JUVENILE IDIOPATHIC ARTHRITIS,1
AU,KERATOACANTHOMA,1
AU,KERATODERMA BLENORRHAGICA,1
AU,KIDNEY INFECTION,1
AU,KLEBSIELLA SEPSIS,1
AU,LABORATORY TEST ABNORMAL,1
AU,LACERATION,1
AU,LARGE GRANULAR LYMPHOCYTOSIS,1
AU,LEFT ATRIAL DILATATION,1
AU,LEFT VENTRICULAR DYSFUNCTION,1
AU,LEFT VENTRICULAR FAILURE,1
AU,LENTIGO MALIGNA,1
AU,LEUKAEMIA,1
AU,LEUKOENCEPHALOPATHY,1
AU,LIGAMENT SPRAIN,1
AU,LIMB OPERATION,1
AU,LIP SQUAMOUS CELL CARCINOMA,1
AU,LIP SWELLING,1
AU,LIPOSARCOMA,1
AU,LISTERIOSIS,1
AU,LOSS OF CONSCIOUSNESS,1
AU,LOW BIRTH WEIGHT BABY,1
AU,LOW DENSITY LIPOPROTEIN INCREASED,1
AU,LOWER EXTREMITY MASS,1
AU,LUMBAR RADICULOPATHY,1
AU,LUMBAR SPINAL STENOSIS,1
AU,LUMBAR VERTEBRAL FRACTURE,1
AU,LUNG CANCER METASTATIC,1
AU,LUNG CYST,1
AU,LUNG NEOPLASM,1
AU,LUPUS NEPHRITIS,1
AU,LYME DISEASE,1
AU,LYMPHADENECTOMY,1
AU,LYMPHADENITIS,1
AU,LYMPHOCELE,1
AU,LYMPHOCYTIC INFILTRATION,1
AU,LYMPHOCYTOSIS,1
AU,LYMPHOEDEMA,1
AU,LYMPHOPROLIFERATIVE DISORDER,1
AU,MALIGNANT PLEURAL EFFUSION,1
AU,MALNUTRITION,1
AU,MANTLE CELL LYMPHOMA,1
AU,MANTLE CELL LYMPHOMA RECURRENT,1
AU,MASTOIDITIS,1
AU,MATERNAL EXPOSURE DURING PREGNANCY,1
AU,MEDIASTINUM NEOPLASM,1
AU,MELAENA,1
AU,MELANOCYTIC NAEVUS,1
AU,MENTAL DISORDER,1
AU,MESOTHELIOMA,1
AU,METABOLIC ACIDOSIS,1
AU,METABOLIC ALKALOSIS,1
AU,METASTASES TO LARYNX,1
AU,METASTASES TO LIVER,1
AU,MONOCYTE COUNT INCREASED,1
AU,MONOCYTOSIS,1
AU,MONOPLEGIA,1
AU,MOOD ALTERED,1
AU,MOTOR DYSFUNCTION,1
AU,MUCORMYCOSIS,1
AU,MULTIPLE FRACTURES,1
AU,MUSCLE ATROPHY,1
AU,MUSCLE TIGHTNESS,1
AU,MYASTHENIA GRAVIS,1
AU,MYCOBACTERIUM TEST POSITIVE,1
AU,MYOCARDIAL ISCHAEMIA,1
AU,MYOSITIS,1
AU,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
AU,NASAL CONGESTION,1
AU,NASAL INFLAMMATION,1
AU,NASAL ULCER,1
AU,NEOPLASM,1
AU,NEPHROTIC SYNDROME,1
AU,NERVE INJURY,1
AU,NERVE ROOT COMPRESSION,1
AU,NEUROLOGICAL DECOMPENSATION,1
AU,NEUROSARCOIDOSIS,1
AU,NEUTROPHIL COUNT DECREASED,1
AU,NEUTROPHIL COUNT INCREASED,1
AU,NOCTURIA,1
AU,NODULE,1
AU,NON-SMALL CELL LUNG CANCER,1
AU,NOROVIRUS TEST POSITIVE,1
AU,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
AU,OBSTRUCTIVE UROPATHY,1
AU,OCULAR DISCOMFORT,1
AU,OEDEMA MUCOSAL,1
AU,OESOPHAGEAL INFECTION,1
AU,OESOPHAGEAL RUPTURE,1
AU,OESOPHAGITIS,1
AU,OESOPHAGITIS ULCERATIVE,1
AU,OPEN FRACTURE,1
AU,OPPORTUNISTIC INFECTION,1
AU,ORAL PUSTULE,1
AU,OSTEOMYELITIS BACTERIAL,1
AU,OSTEOPOROTIC FRACTURE,1
AU,OTITIS MEDIA ACUTE,1
AU,OTOTOXICITY,1
AU,OVARIAN CANCER STAGE II,1
AU,OVERWEIGHT,1
AU,PAIN OF SKIN,1
AU,PAINFUL DEFAECATION,1
AU,PALINDROMIC RHEUMATISM,1
AU,PALLOR,1
AU,PANCREATIC ATROPHY,1
AU,PANCREATITIS,1
AU,PANCREATITIS ACUTE,1
AU,PANNICULITIS LOBULAR,1
AU,PANOPHTHALMITIS,1
AU,PAPILLITIS,1
AU,PAPILLOEDEMA,1
AU,PARADOXICAL DRUG REACTION,1
AU,PARAESTHESIA ORAL,1
AU,PARAPROTEINAEMIA,1
AU,PARKINSON^S DISEASE,1
AU,PAROSMIA,1
AU,PARTIAL SEIZURES,1
AU,PATHOLOGICAL FRACTURE,1
AU,PELVIC NEOPLASM,1
AU,PERICARDIAL EFFUSION,1
AU,PERICARDIAL HAEMORRHAGE,1
AU,PERIPHERAL ARTERY STENOSIS,1
AU,PERIPHERAL MOTOR NEUROPATHY,1
AU,PERIPHERAL VASCULAR DISORDER,1
AU,PHARYNGEAL ULCERATION,1
AU,PHOTOSENSITIVITY REACTION,1
AU,PIGMENTATION DISORDER,1
AU,PITUITARY TUMOUR,1
AU,PITUITARY TUMOUR REMOVAL,1
AU,PLASMA CELL MYELOMA RECURRENT,1
AU,PLATELET COUNT INCREASED,1
AU,PLEURISY,1
AU,PLEURITIC PAIN,1
AU,PNEUMOCONIOSIS,1
AU,PNEUMONIA PNEUMOCOCCAL,1
AU,POLLAKIURIA,1
AU,POLYMENORRHOEA,1
AU,POLYP,1
AU,POST PROCEDURAL HAEMATOMA,1
AU,POST-TUSSIVE VOMITING,1
AU,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
AU,POSTOPERATIVE WOUND COMPLICATION,1
AU,PRE-ECLAMPSIA,1
AU,PREGNANCY,1
AU,PREGNANCY ON CONTRACEPTIVE,1
AU,PRIMARY HYPOGONADISM,1
AU,PRIMARY SEQUESTRUM,1
AU,PROCTALGIA,1
AU,PROSTATIC DISORDER,1
AU,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
AU,PROTEIN TOTAL DECREASED,1
AU,PROTEINURIA,1
AU,PRURIGO,1
AU,PRURITUS GENERALISED,1
AU,PSEUDOPOLYPOSIS,1
AU,PSORIASIS,1
AU,PSORIATIC ARTHROPATHY,1
AU,PULMONARY CONGESTION,1
AT,DEATH,71
AT,B-CELL LYMPHOMA RECURRENT,31
AT,DISEASE PROGRESSION,18
AT,FEBRILE NEUTROPENIA,17
AT,NEUTROPENIA,12
AT,INFECTION,10
AT,ANAEMIA,9
AT,THROMBOCYTOPENIA,7
AT,LEUKOPENIA,6
AT,ABDOMINAL PAIN,5
AT,C-REACTIVE PROTEIN INCREASED,5
AT,VOMITING,5
AT,PYREXIA,4
AT,RENAL FAILURE ACUTE,4
AT,ACUTE HEPATIC FAILURE,3
AT,BLOOD BILIRUBIN INCREASED,3
AT,BLOOD CREATININE INCREASED,3
AT,BONE MARROW TOXICITY,3
AT,CREATININE RENAL CLEARANCE DECREASED,3
AT,FLUID RETENTION,3
AT,HEPATOTOXICITY,3
AT,INFLUENZA,3
AT,PANCYTOPENIA,3
AT,PNEUMONIA,3
AT,RESPIRATORY FAILURE,3
AT,SEPTIC SHOCK,3
AT,ACUTE MYELOID LEUKAEMIA,2
AT,AGRANULOCYTOSIS,2
AT,BRONCHOSTENOSIS,2
AT,CARDIAC FAILURE,2
AT,CARDIOTOXICITY,2
AT,FEMORAL NECK FRACTURE,2
AT,GASTROINTESTINAL TOXICITY,2
AT,HYPERTRIGLYCERIDAEMIA,2
AT,MULTI-ORGAN FAILURE,2
AT,NASOPHARYNGITIS,2
AT,NAUSEA,2
AT,PARAESTHESIA,2
AT,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,2
AT,PULMONARY EMBOLISM,2
AT,PULMONARY MYCOSIS,2
AT,RECTAL CANCER METASTATIC,2
AT,SQUAMOUS CELL CARCINOMA OF SKIN,2
AT,SYNCOPE,2
AT,URINARY TRACT INFECTION,2
AT,ADVERSE EVENT,1
AT,ANGINA PECTORIS,1
AT,ATRIAL FLUTTER,1
AT,BLOOD SODIUM DECREASED,1
AT,BONE MARROW OEDEMA,1
AT,BREAST CANCER,1
AT,CACHEXIA,1
AT,CARDIOGENIC SHOCK,1
AT,CEREBRAL INFARCTION,1
AT,CIRCULATORY COLLAPSE,1
AT,CLOSTRIDIUM DIFFICILE INFECTION,1
AT,COUGH,1
AT,CYTOMEGALOVIRUS INFECTION,1
AT,DEEP VEIN THROMBOSIS,1
AT,DEVICE RELATED INFECTION,1
AT,DIARRHOEA,1
AT,DRUG INEFFECTIVE,1
AT,ENTEROCOLITIS,1
AT,ERYTHEMA,1
AT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
AT,GENERAL PHYSICAL HEALTH DETERIORATION,1
AT,GRAFT DYSFUNCTION,1
AT,HAEMATOMA,1
AT,HAEMORRHAGIC STROKE,1
AT,HEPATIC FAILURE,1
AT,HIP FRACTURE,1
AT,HYDRONEPHROSIS,1
AT,HYPERBILIRUBINAEMIA,1
AT,HYPERTENSIVE CRISIS,1
AT,HYPOKALAEMIA,1
AT,HYPONATRAEMIA,1
AT,INFESTATION,1
AT,INJECTION SITE REACTION,1
AT,LUNG TRANSPLANT REJECTION,1
AT,LYMPHANGIOSIS CARCINOMATOSA,1
AT,LYMPHOMA,1
AT,METASTASES TO LIVER,1
AT,MUCOSAL INFLAMMATION,1
AT,MUSCLE TIGHTNESS,1
AT,MYELODYSPLASTIC SYNDROME TRANSFORMATION,1
AT,MYOCARDIAL INFARCTION,1
AT,MYOCARDIAL ISCHAEMIA,1
AT,NEOPLASM RECURRENCE,1
AT,OBLITERATIVE BRONCHIOLITIS,1
AT,OSTEOARTHRITIS,1
AT,PANCREATIC ENZYMES INCREASED,1
AT,PITUITARY TUMOUR BENIGN,1
AT,POLYDIPSIA PSYCHOGENIC,1
AT,PRODUCT USE ISSUE,1
AT,PULMONARY VEIN STENOSIS,1
AT,RECTAL ULCER,1
AT,RENAL CANCER,1
AT,RENAL CELL CARCINOMA,1
AT,RENAL FAILURE CHRONIC,1
AT,RHINITIS,1
AT,RIB FRACTURE,1
AT,SEIZURE,1
AT,SEPSIS,1
AT,SKIN NECROSIS,1
AT,SYSTEMIC CANDIDA,1
AT,SYSTEMIC MYCOSIS,1
AT,TACHYCARDIA,1
AT,TENOSYNOVITIS,1
AT,TRANSAMINASES INCREASED,1
AT,TRANSITIONAL CELL CARCINOMA,1
AT,TRANSPLANT REJECTION,1
AT,URETERIC CANCER,1
AT,URETERIC STENOSIS,1
AT,URINARY RETENTION,1
AT,WHITE BLOOD CELL COUNT DECREASED,1
BD,ASCITES,1
BD,BLOOD PRESSURE DECREASED,1
BD,HEPATITIS B,1
BD,OBSTRUCTIVE AIRWAYS DISORDER,1
BD,PERIPHERAL EMBOLISM,1
BY,ACUTE HEPATIC FAILURE,1
BY,ACUTE KIDNEY INJURY,1
BY,ANASTOMOTIC STENOSIS,1
BY,CARDIAC ARREST,1
BY,CARDIAC FAILURE,1
BY,HEPATIC NECROSIS,1
BY,INFERIOR VENA CAVA STENOSIS,1
BY,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
BY,PULMONARY OEDEMA,1
BE,PYREXIA,21
BE,FEBRILE NEUTROPENIA,18
BE,NEUTROPENIC SEPSIS,17
BE,CYTOPENIA,16
BE,DEATH,12
BE,END STAGE RENAL DISEASE,12
BE,MALIGNANT NEOPLASM PROGRESSION,12
BE,STAPHYLOCOCCAL INFECTION,12
BE,TUBULOINTERSTITIAL NEPHRITIS,12
BE,CYTOKINE RELEASE SYNDROME,10
BE,DRUG INEFFECTIVE,10
BE,DIARRHOEA,9
BE,DEVICE RELATED INFECTION,8
BE,DIFFUSE LARGE B-CELL LYMPHOMA,8
BE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,8
BE,GLOMERULAR FILTRATION RATE DECREASED,8
BE,HIP FRACTURE,8
BE,KAPOSI^S SARCOMA,8
BE,NERVOUS SYSTEM DISORDER,8
BE,RENAL IMPAIRMENT,8
BE,ANAEMIA,7
BE,DECREASED APPETITE,7
BE,GENERAL PHYSICAL HEALTH DETERIORATION,7
BE,NEUTROPENIA,7
BE,PNEUMONIA,7
BE,GASTROINTESTINAL INFLAMMATION,6
BE,INTERVERTEBRAL DISCITIS,6
BE,METASTASES TO BONE MARROW,6
BE,METASTASES TO LIVER,6
BE,METASTASES TO LUNG,6
BE,METASTASES TO MUSCLE,6
BE,METASTASES TO RETROPERITONEUM,6
BE,METASTASES TO SPLEEN,6
BE,TOXICITY TO VARIOUS AGENTS,6
BE,VOMITING,6
BE,ABDOMINAL PAIN,5
BE,DEEP VEIN THROMBOSIS,5
BE,OSTEONECROSIS OF JAW,5
BE,PANCYTOPENIA,5
BE,PULMONARY EMBOLISM,5
BE,THROMBOCYTOPENIA,5
BE,TINNITUS,5
BE,CARDIAC ARREST,4
BE,CARDIAC FAILURE,4
BE,DISEASE PROGRESSION,4
BE,FALL,4
BE,FATIGUE,4
BE,HUMAN HERPESVIRUS 8 INFECTION,4
BE,KERATITIS,4
BE,PAIN,4
BE,RENAL FAILURE,4
BE,SMALL INTESTINAL OBSTRUCTION,4
BE,ASTHENIA,3
BE,DRUG INTOLERANCE,3
BE,DYSPEPSIA,3
BE,EMPYEMA,3
BE,HAEMATOTOXICITY,3
BE,HAEMATURIA,3
BE,HEADACHE,3
BE,HYPERTENSION,3
BE,HYPONATRAEMIA,3
BE,LEUKOPENIA,3
BE,MYOCARDIAL INFARCTION,3
BE,RESPIRATORY FAILURE,3
BE,SQUAMOUS CELL CARCINOMA OF SKIN,3
BE,ACUTE MYELOID LEUKAEMIA,2
BE,ADENOCARCINOMA OF COLON,2
BE,ATAXIA,2
BE,BACK PAIN,2
BE,BASAL CELL CARCINOMA,2
BE,BRONCHITIS,2
BE,CONSTIPATION,2
BE,CYSTITIS HAEMORRHAGIC,2
BE,DEPRESSION,2
BE,EPSTEIN-BARR VIRUS INFECTION,2
BE,ERYTHEMA,2
BE,FUNGAEMIA,2
BE,GASTROINTESTINAL DISORDER,2
BE,GLIOBLASTOMA MULTIFORME,2
BE,HEPATIC FAILURE,2
BE,HYDRONEPHROSIS,2
BE,HYPOKALAEMIA,2
BE,INFECTION,2
BE,MUCOSAL INFLAMMATION,2
BE,MUSCULOSKELETAL PAIN,2
BE,MYELODYSPLASTIC SYNDROME,2
BE,NAUSEA,2
BE,NEUROTOXICITY,2
BE,OEDEMA PERIPHERAL,2
BE,PARKINSON^S DISEASE,2
BE,PLATELET COUNT DECREASED,2
BE,PRODUCT USE IN UNAPPROVED INDICATION,2
BE,SINUSITIS,2
BE,SQUAMOUS CELL CARCINOMA,2
BE,UPPER GASTROINTESTINAL HAEMORRHAGE,2
BE,UPPER RESPIRATORY TRACT INFECTION,2
BE,URINARY TRACT INFECTION,2
BE,VISCERAL LEISHMANIASIS,2
BE,ABDOMINAL PAIN LOWER,1
BE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
BE,AMNESIA,1
BE,ANAL FISTULA,1
BE,ANAPHYLACTIC REACTION,1
BE,ANGINA PECTORIS,1
BE,ANGINA UNSTABLE,1
BE,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,1
BE,ANXIETY,1
BE,APHASIA,1
BE,ARRHYTHMIA,1
BE,ARTHRITIS,1
BE,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
BE,ASTHMA,1
BE,ATELECTASIS,1
BE,ATRIAL FIBRILLATION,1
BE,BACTERIAL INFECTION,1
BE,BLADDER TRANSITIONAL CELL CARCINOMA,1
BE,BLISTER,1
BE,BLOOD PRESSURE FLUCTUATION,1
BE,BONE MARROW TOXICITY,1
BE,BRONCHIECTASIS,1
BE,BRONCHOPULMONARY ASPERGILLOSIS,1
BE,CANDIDA INFECTION,1
BE,CATARACT,1
BE,CHEST DISCOMFORT,1
BE,CHEST PAIN,1
BE,CHOLECYSTITIS,1
BE,CHOLECYSTITIS CHRONIC,1
BE,CHOLELITHIASIS,1
BE,CHRONIC KIDNEY DISEASE,1
BE,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
BE,CHRONIC SINUSITIS,1
BE,COLITIS,1
BE,COLITIS ULCERATIVE,1
BE,CONCOMITANT DISEASE AGGRAVATED,1
BE,CONDITION AGGRAVATED,1
BE,CONFUSIONAL STATE,1
BE,CROHN^S DISEASE,1
BE,CYSTOID MACULAR OEDEMA,1
BE,CYTOMEGALOVIRUS INFECTION,1
BE,DEHYDRATION,1
BE,DIVERTICULAR PERFORATION,1
BE,DIVERTICULITIS,1
BE,DIZZINESS,1
BE,DRUG HYPERSENSITIVITY,1
BE,DRUG TOLERANCE DECREASED,1
BE,DYSARTHRIA,1
BE,DYSGEUSIA,1
BE,DYSPHAGIA,1
BE,DYSPNOEA,1
BE,DYSPNOEA EXERTIONAL,1
BE,ELECTROCARDIOGRAM QT PROLONGED,1
BE,EMOTIONAL DISORDER,1
BE,ENCEPHALITIS,1
BE,EPILEPSY,1
BE,EXOPHTHALMOS,1
BE,EYE INFECTION,1
BE,FACIAL PARESIS,1
BE,FISTULA,1
BE,GASTROENTERITIS,1
BE,GLIOBLASTOMA,1
BE,HAEMATOCHEZIA,1
BE,HAEMATOLOGICAL MALIGNANCY,1
BE,HAEMORRHOIDS,1
BE,HEPATOMEGALY,1
BE,HERPES ZOSTER,1
BE,HYPERGLYCAEMIA,1
BE,HYPERKALAEMIA,1
BE,HYPERNATRAEMIA,1
BE,HYPERTONIC BLADDER,1
BE,HYPOCALCAEMIA,1
BE,IMMOBILE,1
BE,IMPAIRED HEALING,1
BE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
BE,INFLAMMATION,1
BE,INJURY,1
BE,INVASIVE DUCTAL BREAST CARCINOMA,1
BE,ISCHAEMIC STROKE,1
BE,KERATOPATHY,1
BE,LARGE INTESTINAL STENOSIS,1
BE,LARGE INTESTINE PERFORATION,1
BE,LEISHMANIASIS,1
BE,LOWER EXTREMITY MASS,1
BE,LOWER RESPIRATORY TRACT INFECTION,1
BE,LUNG INFECTION,1
BE,LUNG NEOPLASM MALIGNANT,1
BE,LYMPHANGIOSIS CARCINOMATOSA,1
BE,LYMPHOPENIA,1
BE,MALAISE,1
BE,MENINGITIS,1
BE,MENINGITIS PNEUMOCOCCAL,1
BE,METASTATIC MALIGNANT MELANOMA,1
BE,MUCOCUTANEOUS LEISHMANIASIS,1
BE,MUSCLE SPASMS,1
BE,MYOCARDIAL ISCHAEMIA,1
BE,NASAL ABSCESS,1
BE,NEOPLASM PROGRESSION,1
BE,NERVOUSNESS,1
BE,NEUROPATHY PERIPHERAL,1
BE,NEUTROPENIC COLITIS,1
BE,NOCARDIOSIS,1
BE,NON-HODGKIN^S LYMPHOMA,1
BE,OEDEMA,1
BE,OEDEMA MOUTH,1
BE,ORTHOSTATIC TREMOR,1
BE,OSTEONECROSIS,1
BE,OTOTOXICITY,1
BE,PACKED RED BLOOD CELL TRANSFUSION,1
BE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
BE,PATHOGEN RESISTANCE,1
BE,PATHOLOGICAL FRACTURE,1
BE,PELVIC VENOUS THROMBOSIS,1
BE,PERIPHERAL SENSORY NEUROPATHY,1
BE,PHLEBITIS,1
BE,PHOTOSENSITIVITY REACTION,1
BE,PLASMA CELL MYELOMA,1
BE,PLASMA CELL MYELOMA RECURRENT,1
BE,PLASMACYTOMA,1
BE,PLEURAL EFFUSION,1
BE,PNEUMONITIS,1
BE,PNEUMOPERITONEUM,1
BE,PNEUMOTHORAX,1
BE,POLYARTHRITIS,1
BE,POLYNEUROPATHY,1
BE,POST PROCEDURAL PNEUMONIA,1
BE,PREMATURE MENOPAUSE,1
BE,PRODUCT USE ISSUE,1
BE,PROSTATE CANCER,1
BE,PROSTATE CANCER METASTATIC,1
BE,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
BE,PULMONARY ALVEOLAR HAEMORRHAGE,1
BE,PULMONARY FIBROSIS,1
BE,PURULENT DISCHARGE,1
BE,RASH MACULO-PAPULAR,1
BE,RECTAL ADENOCARCINOMA,1
BE,RECTAL CANCER METASTATIC,1
BE,RECTAL HAEMORRHAGE,1
BE,RESPIRATORY DISTRESS,1
BE,RESPIRATORY TRACT INFECTION,1
BE,RHABDOMYOLYSIS,1
BE,RHINORRHOEA,1
BE,SCEDOSPORIUM INFECTION,1
BE,SEBORRHOEIC KERATOSIS,1
BE,SECOND PRIMARY MALIGNANCY,1
BE,SEPSIS,1
BE,SEPTIC SHOCK,1
BE,SKIN LESION,1
BE,SLEEP APNOEA SYNDROME,1
BE,SPLENOMEGALY,1
BE,SUPRAVENTRICULAR TACHYARRHYTHMIA,1
BE,SYSTEMIC MYCOSIS,1
BE,T-CELL LYMPHOMA RECURRENT,1
BE,TENDON RUPTURE,1
BE,THERAPEUTIC RESPONSE UNEXPECTED,1
BE,TRACHEITIS,1
BE,TRANSAMINASES INCREASED,1
BE,ULCER HAEMORRHAGE,1
BE,UPPER LIMB FRACTURE,1
BE,URINARY RETENTION,1
BE,URINARY TRACT OBSTRUCTION,1
BE,VENTRICULAR TACHYARRHYTHMIA,1
BE,VERTIGO,1
BE,VIITH NERVE PARALYSIS,1
BO,GENERAL PHYSICAL HEALTH DETERIORATION,2
BO,MALIGNANT NEOPLASM PROGRESSION,2
BO,ACUTE LYMPHOCYTIC LEUKAEMIA,1
BO,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
BO,ANAEMIA,1
BO,BACK PAIN,1
BO,CENTRAL NERVOUS SYSTEM LEUKAEMIA,1
BO,EPSTEIN-BARR VIRUS INFECTION,1
BO,EXPOSURE DURING PREGNANCY,1
BO,FAECES DISCOLOURED,1
BO,INTERMITTENT CLAUDICATION,1
BO,LOSS OF CONSCIOUSNESS,1
BO,NEUTROPENIA,1
BO,NEUTROPHIL COUNT DECREASED,1
BO,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
BO,SYNCOPE,1
BO,THROMBOCYTOPENIA,1
BA,HYDRONEPHROSIS,1
BA,RECTAL HAEMORRHAGE,1
BA,URTICARIA,1
BR,PAIN,504
BR,ARTHRALGIA,464
BR,DRUG INEFFECTIVE,375
BR,PAIN IN EXTREMITY,356
BR,MALAISE,257
BR,WEIGHT DECREASED,244
BR,PYREXIA,242
BR,GAIT DISTURBANCE,241
BR,DYSPNOEA,240
BR,PNEUMONIA,240
BR,INFLUENZA,239
BR,URINARY TRACT INFECTION,229
BR,HEADACHE,219
BR,RHEUMATOID ARTHRITIS,217
BR,ASTHENIA,196
BR,FATIGUE,179
BR,PERIPHERAL SWELLING,177
BR,FALL,169
BR,HYPERTENSION,159
BR,NAUSEA,158
BR,SWELLING,157
BR,WEIGHT INCREASED,157
BR,DIARRHOEA,154
BR,VOMITING,149
BR,HYPERSENSITIVITY,141
BR,IMMUNODEFICIENCY,140
BR,ANAEMIA,138
BR,COUGH,130
BR,ARTHROPATHY,129
BR,DIZZINESS,128
BR,JOINT SWELLING,123
BR,OSTEOARTHRITIS,121
BR,BACK PAIN,119
BR,PRURITUS,119
BR,ABDOMINAL PAIN,113
BR,INJECTION SITE PAIN,112
BR,DIABETES MELLITUS,111
BR,INFECTION,106
BR,ABASIA,103
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,101
BR,ARTHRITIS,100
BR,DEPRESSION,98
BR,DRUG DOSE OMISSION,96
BR,ERYTHEMA,93
BR,DECREASED APPETITE,89
BR,BLOOD PRESSURE INCREASED,86
BR,FEELING ABNORMAL,86
BR,INJECTION SITE ERYTHEMA,83
BR,CHEST PAIN,81
BR,MEMORY IMPAIRMENT,79
BR,INFLAMMATION,77
BR,INSOMNIA,77
BR,TREMOR,76
BR,ABDOMINAL PAIN UPPER,75
BR,BLOOD CHOLESTEROL INCREASED,74
BR,SINUSITIS,73
BR,MOBILITY DECREASED,70
BR,SOMNOLENCE,67
BR,CATARACT,66
BR,HYPOAESTHESIA,66
BR,LUNG DISORDER,66
BR,DEATH,65
BR,ASTHMA,64
BR,MUSCULOSKELETAL STIFFNESS,63
BR,SYNCOPE,62
BR,INJECTION SITE PRURITUS,61
BR,HAEMORRHAGE,60
BR,CONDITION AGGRAVATED,59
BR,FOOT DEFORMITY,58
BR,OSTEOPOROSIS,58
BR,TUBERCULOSIS,58
BR,ALOPECIA,57
BR,MUSCULOSKELETAL PAIN,57
BR,NASOPHARYNGITIS,57
BR,PRODUCT USE ISSUE,57
BR,CARDIAC DISORDER,56
BR,DENGUE FEVER,56
BR,NEPHROLITHIASIS,56
BR,SEPSIS,56
BR,MUSCULAR WEAKNESS,55
BR,PARAESTHESIA,54
BR,ANXIETY,53
BR,CROHN^S DISEASE,53
BR,VISUAL IMPAIRMENT,53
BR,DYSPHONIA,52
BR,WOUND,52
BR,BEDRIDDEN,51
BR,HYPOTENSION,51
BR,SEPTIC SHOCK,51
BR,BONE PAIN,50
BR,SPINAL PAIN,49
BR,BONE DISORDER,47
BR,RENAL IMPAIRMENT,47
BR,INTERVERTEBRAL DISC PROTRUSION,46
BR,ARRHYTHMIA,45
BR,CHOLELITHIASIS,45
BR,LUNG INFECTION,45
BR,OROPHARYNGEAL PAIN,45
BR,THROMBOSIS,45
BR,BLOOD PRESSURE DECREASED,44
BR,FEELING HOT,44
BR,INFUSION RELATED REACTION,43
BR,OEDEMA PERIPHERAL,43
BR,DYSSTASIA,42
BR,HAND DEFORMITY,41
BR,CEREBROVASCULAR ACCIDENT,40
BR,RASH,40
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,40
BR,ABDOMINAL DISTENSION,39
BR,DEVICE MALFUNCTION,39
BR,HYPERHIDROSIS,39
BR,MUSCLE SPASMS,39
BR,SKIN DISCOLOURATION,39
BR,TACHYCARDIA,39
BR,GASTRITIS,38
BR,MYOCARDIAL INFARCTION,38
BR,BURNING SENSATION,37
BR,FEMUR FRACTURE,37
BR,NECK PAIN,37
BR,PLEURAL EFFUSION,37
BR,RENAL DISORDER,37
BR,THERAPEUTIC RESPONSE DECREASED,37
BR,DRUG HYPERSENSITIVITY,36
BR,PHARYNGITIS,36
BR,PLATELET COUNT DECREASED,36
BR,DECREASED IMMUNE RESPONSIVENESS,35
BR,EXPOSURE DURING PREGNANCY,35
BR,FINGER DEFORMITY,35
BR,LOCALISED INFECTION,35
BR,BLOOD CREATININE INCREASED,34
BR,BRONCHITIS,34
BR,LOCAL SWELLING,34
BR,NODULE,34
BR,SPINAL DISORDER,34
BR,BACTERIAL INFECTION,33
BR,BLISTER,33
BR,LIVER DISORDER,33
BR,NERVOUSNESS,33
BR,BLOOD PRESSURE FLUCTUATION,32
BR,FEBRILE NEUTROPENIA,32
BR,MOVEMENT DISORDER,32
BR,VIRAL INFECTION,32
BR,CYTOMEGALOVIRUS INFECTION,31
BR,GASTRIC DISORDER,31
BR,SPEECH DISORDER,31
BR,CHILLS,30
BR,CONFUSIONAL STATE,30
BR,DRY MOUTH,30
BR,LIMB INJURY,30
BR,BLOOD GLUCOSE INCREASED,29
BR,CARDIAC ARREST,29
BR,HERPES ZOSTER,29
BR,INFARCTION,29
BR,INJECTION SITE SWELLING,29
BR,PULMONARY EMBOLISM,29
BR,THROAT IRRITATION,29
BR,DRUG EFFECT INCOMPLETE,28
BR,ILL-DEFINED DISORDER,28
BR,PULMONARY OEDEMA,28
BR,RASH MACULAR,28
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,27
BR,LEUKOPENIA,27
BR,THROMBOCYTOPENIA,27
BR,DEHYDRATION,26
BR,ERYSIPELAS,26
BR,HEART RATE INCREASED,26
BR,INJECTION SITE DISCOLOURATION,26
BR,JOINT RANGE OF MOTION DECREASED,26
BR,PSORIASIS,26
BR,SWELLING FACE,26
BR,HAEMOGLOBIN DECREASED,25
BR,MASS,25
BR,RENAL FAILURE,25
BR,RESPIRATORY FAILURE,25
BR,UNEVALUABLE EVENT,25
BR,VISION BLURRED,25
BR,CYST,24
BR,GAIT INABILITY,24
BR,GASTROINTESTINAL DISORDER,24
BR,HYPOPHAGIA,24
BR,PROTEINURIA,24
BR,PRURITUS GENERALISED,24
BR,SEIZURE,24
BR,BLINDNESS,23
BR,BLOOD CHOLESTEROL ABNORMAL,23
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,23
BR,DISEASE PROGRESSION,23
BR,DISEASE RECURRENCE,23
BR,EATING DISORDER,23
BR,EMPHYSEMA,23
BR,FLUID RETENTION,23
BR,FUNGAL INFECTION,23
BR,HAEMATOCHEZIA,23
BR,INJECTION SITE HAEMATOMA,23
BR,JOINT STIFFNESS,23
BR,PALPITATIONS,23
BR,TENDON RUPTURE,23
BR,BLOOD TEST ABNORMAL,22
BR,CRYING,22
BR,DYSGEUSIA,22
BR,DYSPHAGIA,22
BR,FEEDING DISORDER,22
BR,FIBROMYALGIA,22
BR,FOOT FRACTURE,22
BR,LOWER LIMB FRACTURE,22
BR,MYALGIA,22
BR,PULMONARY MASS,22
BR,STRESS,22
BR,THYROID DISORDER,22
BR,WHEEZING,22
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,22
BR,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,21
BR,AMNESIA,21
BR,BALANCE DISORDER,21
BR,CARDIOMEGALY,21
BR,COLITIS,21
BR,COMA,21
BR,CONSTIPATION,21
BR,DEEP VEIN THROMBOSIS,21
BR,FEELING COLD,21
BR,LABYRINTHITIS,21
BR,MEDICATION ERROR,21
BR,NEUTROPENIA,21
BR,PULMONARY FIBROSIS,21
BR,RESPIRATORY DISORDER,21
BR,RETCHING,21
BR,VISUAL ACUITY REDUCED,21
BR,CARDIAC FAILURE,20
BR,DEPRESSED MOOD,20
BR,EYE DISORDER,20
BR,GASTROINTESTINAL INFECTION,20
BR,HEPATIC STEATOSIS,20
BR,HERPES VIRUS INFECTION,20
BR,HYPERGLYCAEMIA,20
BR,HYPOKINESIA,20
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,20
BR,ASTHMATIC CRISIS,19
BR,BLOOD PRESSURE ABNORMAL,19
BR,BODY HEIGHT DECREASED,19
BR,BONE EROSION,19
BR,CATARRH,19
BR,CHONDROPATHY,19
BR,COMPLICATIONS OF TRANSPLANTED KIDNEY,19
BR,DERMATITIS ALLERGIC,19
BR,DEVICE RELATED INFECTION,19
BR,INTESTINAL OBSTRUCTION,19
BR,PHAEHYPHOMYCOSIS,19
BR,RHINITIS,19
BR,SKIN EXFOLIATION,19
BR,EXOSTOSIS,18
BR,EYE PAIN,18
BR,GENERAL PHYSICAL HEALTH DETERIORATION,18
BR,GLAUCOMA,18
BR,HYPOTHYROIDISM,18
BR,IRIS ADHESIONS,18
BR,LIMB DEFORMITY,18
BR,NEUROPATHY PERIPHERAL,18
BR,OEDEMA,18
BR,PRODUCT AVAILABILITY ISSUE,18
BR,SKIN LESION,18
BR,SPINAL OSTEOARTHRITIS,18
BR,TENDONITIS,18
BR,THROAT TIGHTNESS,18
BR,VARICOSE VEIN,18
BR,ATROPHY,17
BR,BURSITIS,17
BR,DIVERTICULITIS,17
BR,DRUG EFFECT DECREASED,17
BR,DYSURIA,17
BR,GALLBLADDER DISORDER,17
BR,IMPAIRED HEALING,17
BR,INJECTION SITE WARMTH,17
BR,KIDNEY INFECTION,17
BR,LARYNGEAL OEDEMA,17
BR,POST PROCEDURAL COMPLICATION,17
BR,RENAL PAIN,17
BR,TINNITUS,17
BR,TOOTH DISORDER,17
BR,WHITE BLOOD CELL COUNT DECREASED,17
BR,ARTHRITIS INFECTIVE,16
BR,CELLULITIS,16
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,16
BR,DISSEMINATED TUBERCULOSIS,16
BR,DRY SKIN,16
BR,FURUNCLE,16
BR,HEAD DISCOMFORT,16
BR,HYPERKERATOSIS,16
BR,INCORRECT DOSE ADMINISTERED,16
BR,IRRITABILITY,16
BR,JOINT DISLOCATION,16
BR,JOINT EFFUSION,16
BR,MUSCULOSKELETAL DISORDER,16
BR,NEOPLASM,16
BR,POSTOPERATIVE WOUND INFECTION,16
BR,RHEUMATIC DISORDER,16
BR,SPINAL FRACTURE,16
BR,UPPER LIMB FRACTURE,16
BR,ACUTE KIDNEY INJURY,15
BR,DEAFNESS,15
BR,DYSENTERY,15
BR,GASTROINTESTINAL INFLAMMATION,15
BR,GASTROOESOPHAGEAL REFLUX DISEASE,15
BR,INJECTION SITE MASS,15
BR,KIDNEY TRANSPLANT REJECTION,15
BR,LOSS OF CONSCIOUSNESS,15
BR,OCULAR HYPERAEMIA,15
BR,PALLOR,15
BR,PRODUCT USE IN UNAPPROVED INDICATION,15
BR,RENAL TUBULAR NECROSIS,15
BR,ROAD TRAFFIC ACCIDENT,15
BR,SKIN DISORDER,15
BR,TOOTH INFECTION,15
BR,UMBILICAL HERNIA,15
BR,UNDERDOSE,15
BR,VENOUS OCCLUSION,15
BR,ACCIDENT,14
BR,ADVERSE EVENT,14
BR,ANKYLOSING SPONDYLITIS,14
BR,CHEST DISCOMFORT,14
BR,DEVICE DISLOCATION,14
BR,DISCOMFORT,14
BR,DYSPEPSIA,14
BR,EPISTAXIS,14
BR,FORMICATION,14
BR,HEPATITIS,14
BR,HIP ARTHROPLASTY,14
BR,JOINT INJURY,14
BR,KNEE ARTHROPLASTY,14
BR,KNEE DEFORMITY,14
BR,LABORATORY TEST ABNORMAL,14
BR,PANCREATITIS,14
BR,POST PROCEDURAL INFECTION,14
BR,RENAL TUBULAR ATROPHY,14
BR,SECRETION DISCHARGE,14
BR,UTERINE LEIOMYOMA,14
BR,UVEITIS,14
BR,ABORTION SPONTANEOUS,13
BR,ARTERIAL OCCLUSIVE DISEASE,13
BR,BLOOD TRIGLYCERIDES INCREASED,13
BR,CARDIOVASCULAR DISORDER,13
BR,DIARRHOEA HAEMORRHAGIC,13
BR,EAR PAIN,13
BR,EMOTIONAL DISORDER,13
BR,EYE SWELLING,13
BR,FEAR,13
BR,GENERALISED OEDEMA,13
BR,HAEMATOMA,13
BR,HEPATIC NEOPLASM,13
BR,HEPATOMEGALY,13
BR,HYPOACUSIS,13
BR,LEIOMYOMA,13
BR,LIGAMENT SPRAIN,13
BR,MENTAL DISORDER,13
BR,NERVOUS SYSTEM DISORDER,13
BR,NOSOCOMIAL INFECTION,13
BR,OXYGEN SATURATION DECREASED,13
BR,PANCYTOPENIA,13
BR,PARALYSIS,13
BR,RESPIRATORY TRACT INFECTION,13
BR,RIB FRACTURE,13
BR,SLUGGISHNESS,13
BR,URTICARIA,13
BR,VASCULITIS,13
BR,VITAMIN D DECREASED,13
BR,VITAMIN D DEFICIENCY,13
BR,CARTILAGE INJURY,12
BR,CHIKUNGUNYA VIRUS INFECTION,12
BR,CONJUNCTIVITIS,12
BR,DRUG PRESCRIBING ERROR,12
BR,DRUG-INDUCED LIVER INJURY,12
BR,EAR INFECTION,12
BR,FLATULENCE,12
BR,GASTROENTERITIS,12
BR,HEAD INJURY,12
BR,HYPERAEMIA,12
BR,INJECTION SITE HYPERSENSITIVITY,12
BR,KNEE OPERATION,12
BR,LEUKOCYTOSIS,12
BR,LIMB DISCOMFORT,12
BR,MUSCULOSKELETAL CHEST PAIN,12
BR,NEPHROPATHY TOXIC,12
BR,ORAL CANDIDIASIS,12
BR,OSTEOMYELITIS,12
BR,OSTEOPENIA,12
BR,PHARYNGEAL DISORDER,12
BR,PYELONEPHRITIS,12
BR,RESPIRATORY ARREST,12
BR,SKIN ULCER,12
BR,SURGERY,12
BR,ACCIDENTAL EXPOSURE TO PRODUCT,11
BR,ANKLE FRACTURE,11
BR,APHASIA,11
BR,BLOOD GLUCOSE ABNORMAL,11
BR,GRAFT LOSS,11
BR,HIP FRACTURE,11
BR,HOSPITALISATION,11
BR,IMMUNE SYSTEM DISORDER,11
BR,INJECTION SITE HAEMORRHAGE,11
BR,JOINT LOCK,11
BR,KIDNEY FIBROSIS,11
BR,MUCOCUTANEOUS LEISHMANIASIS,11
BR,MUSCLE RIGIDITY,11
BR,OBSTRUCTIVE AIRWAYS DISORDER,11
BR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,11
BR,PREMATURE DELIVERY,11
BR,PRODUCTIVE COUGH,11
BR,RASH ERYTHEMATOUS,11
BR,SLEEP DISORDER,11
BR,SPLENOMEGALY,11
BR,TOOTH FRACTURE,11
BR,ABDOMINAL HERNIA,10
BR,ABSCESS,10
BR,ACUTE RESPIRATORY FAILURE,10
BR,BLOOD GLUCOSE DECREASED,10
BR,CANDIDA INFECTION,10
BR,CARDIO-RESPIRATORY ARREST,10
BR,CONTUSION,10
BR,CYANOSIS,10
BR,DEFORMITY,10
BR,DIABETES MELLITUS INADEQUATE CONTROL,10
BR,DRUG INTOLERANCE,10
BR,DRY EYE,10
BR,FLUSHING,10
BR,HAEMOPTYSIS,10
BR,HAEMORRHOIDS,10
BR,HIATUS HERNIA,10
BR,HORMONE LEVEL ABNORMAL,10
BR,HYPERTENSIVE CRISIS,10
BR,HYPOGLYCAEMIA,10
BR,INCORRECT PRODUCT STORAGE,10
BR,INJECTION SITE INDURATION,10
BR,INTESTINAL PERFORATION,10
BR,LYMPHADENOPATHY,10
BR,PRODUCT QUALITY ISSUE,10
BR,PURULENT DISCHARGE,10
BR,RESPIRATORY DISTRESS,10
BR,RHINITIS ALLERGIC,10
BR,RHINORRHOEA,10
BR,SUICIDAL IDEATION,10
BR,SYNOVIAL CYST,10
BR,TACHYPNOEA,10
BR,URINARY INCONTINENCE,10
BR,UTERINE DISORDER,10
BR,APHONIA,9
BR,ASCITES,9
BR,BONE LOSS,9
BR,BONE MARROW DISORDER,9
BR,BONE MARROW FAILURE,9
BR,CARPAL TUNNEL SYNDROME,9
BR,CHOKING,9
BR,COLITIS ULCERATIVE,9
BR,CONVULSION,9
BR,DRUG RESISTANCE,9
BR,GASTROINTESTINAL HAEMORRHAGE,9
BR,GLUCOSE TOLERANCE IMPAIRED,9
BR,HAEMATURIA,9
BR,HAEMOLYSIS,9
BR,IMMUNOSUPPRESSION,9
BR,INTESTINAL HAEMORRHAGE,9
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,9
BR,MIGRAINE,9
BR,MOUTH ULCERATION,9
BR,MULTI-ORGAN FAILURE,9
BR,MUSCLE ATROPHY,9
BR,NEEDLE ISSUE,9
BR,OSTEONECROSIS,9
BR,OVARIAN CYST,9
BR,OVERDOSE,9
BR,PHARYNGEAL INFLAMMATION,9
BR,POLLAKIURIA,9
BR,PROCEDURAL PAIN,9
BR,RHEUMATOID FACTOR INCREASED,9
BR,SCIATICA,9
BR,SKIN HYPERTROPHY,9
BR,SKIN IRRITATION,9
BR,STOMATITIS,9
BR,THERAPEUTIC RESPONSE UNEXPECTED,9
BR,ULCER,9
BR,WHITE BLOOD CELL COUNT INCREASED,9
BR,AGITATION,8
BR,ANAPHYLACTIC SHOCK,8
BR,ARTHRITIS BACTERIAL,8
BR,BLOOD LACTATE DEHYDROGENASE INCREASED,8
BR,BREAST CANCER,8
BR,BRONCHOSPASM,8
BR,CHOLECYSTITIS,8
BR,CONCOMITANT DISEASE AGGRAVATED,8
BR,CORONARY ARTERY OCCLUSION,8
BR,DRUG ADMINISTRATION ERROR,8
BR,DRUG DEPENDENCE,8
BR,DRUG LEVEL INCREASED,8
BR,DYSPNOEA EXERTIONAL,8
BR,EYE INFLAMMATION,8
BR,FEELING OF DESPAIR,8
BR,FISTULA,8
BR,GENERALISED ERYTHEMA,8
BR,HAEMATEMESIS,8
BR,HALLUCINATION,8
BR,HEART RATE DECREASED,8
BR,HISTIOCYTOSIS HAEMATOPHAGIC,8
BR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,8
BR,INJECTION SITE REACTION,8
BR,INJURY,8
BR,INTERSTITIAL LUNG DISEASE,8
BR,INTESTINAL FISTULA,8
BR,ISCHAEMIC STROKE,8
BR,LIMB OPERATION,8
BR,MALNUTRITION,8
BR,MOTOR DYSFUNCTION,8
BR,MUCOSAL INFLAMMATION,8
BR,MULTIPLE SCLEROSIS RELAPSE,8
BR,ODYNOPHAGIA,8
BR,OESOPHAGITIS,8
BR,ORAL DISORDER,8
BR,ORAL PAIN,8
BR,PAIN IN JAW,8
BR,PATIENT-DEVICE INCOMPATIBILITY,8
BR,PERICARDIAL EFFUSION,8
BR,PERITONITIS,8
BR,PRURITUS ALLERGIC,8
BR,PULMONARY TUBERCULOSIS,8
BR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,8
BR,RHEUMATIC FEVER,8
BR,SENSORY DISTURBANCE,8
BR,SERUM FERRITIN INCREASED,8
BR,SKIN CANCER,8
BR,SKIN INFECTION,8
BR,SKIN MASS,8
BR,THROMBOTIC MICROANGIOPATHY,8
BR,VEIN DISORDER,8
BR,VERTIGO,8
BR,WRIST FRACTURE,8
BR,ABDOMINAL DISCOMFORT,7
BR,ALANINE AMINOTRANSFERASE INCREASED,7
BR,AMERICAN TRYPANOSOMIASIS,7
BR,ANGINA PECTORIS,7
BR,ANGIOPATHY,7
BR,APHTHOUS ULCER,7
BR,APPENDICITIS,7
BR,ASPHYXIA,7
BR,BREAST MASS,7
BR,BRONCHOPNEUMONIA,7
BR,C-REACTIVE PROTEIN INCREASED,7
BR,CUSHING^S SYNDROME,7
BR,CYSTITIS,7
BR,DEAFNESS UNILATERAL,7
BR,DELIRIUM,7
BR,DYSARTHRIA,7
BR,DYSKINESIA,7
BR,EMOTIONAL DISTRESS,7
BR,ENDOCARDITIS,7
BR,EPILEPSY,7
BR,EYE IRRITATION,7
BR,GRIP STRENGTH DECREASED,7
BR,GROIN PAIN,7
BR,HEARING IMPAIRED,7
BR,HEPATIC CIRRHOSIS,7
BR,HEPATITIS C,7
BR,HEPATOTOXICITY,7
BR,HYPERAESTHESIA,7
BR,INFLUENZA LIKE ILLNESS,7
BR,MATERNAL EXPOSURE DURING PREGNANCY,7
BR,MENISCUS INJURY,7
BR,MOUTH INJURY,7
BR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,7
BR,OBESITY,7
BR,ORAL HERPES,7
BR,PANIC DISORDER,7
BR,PELVIC FRACTURE,7
BR,PHARYNGEAL OEDEMA,7
BR,PNEUMONIA ASPIRATION,7
BR,PROCEDURAL COMPLICATION,7
BR,PRODUCT STORAGE ERROR,7
BR,PSORIATIC ARTHROPATHY,7
BR,PULMONARY HYPERTENSION,7
BR,PURULENCE,7
BR,SCAR,7
BR,TENDON DISORDER,7
BR,THYROID MASS,7
BR,TOOTH LOSS,7
BR,URINE OUTPUT DECREASED,7
BR,UTERINE HAEMORRHAGE,7
BR,WEIGHT LOSS POOR,7
BR,WOUND INFECTION,7
BR,ACUTE MYOCARDIAL INFARCTION,6
BR,ALLERGIC COUGH,6
BR,ANAL FISTULA,6
BR,ANTIPHOSPHOLIPID SYNDROME,6
BR,APPARENT DEATH,6
BR,ARTERIOSCLEROSIS CORONARY ARTERY,6
BR,AUTOIMMUNE DISORDER,6
BR,BACK DISORDER,6
BR,BASAL CELL CARCINOMA,6
BR,BLINDNESS UNILATERAL,6
BR,BLOOD IMMUNOGLOBULIN E INCREASED,6
BR,BLOOD POTASSIUM DECREASED,6
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,6
BR,CATARACT OPERATION,6
BR,CENTRAL NERVOUS SYSTEM LESION,6
BR,CHRONIC GASTRITIS,6
BR,COORDINATION ABNORMAL,6
BR,CUTANEOUS LEISHMANIASIS,6
BR,DEMENTIA ALZHEIMER^S TYPE,6
BR,DERMATITIS,6
BR,DIPLOPIA,6
BR,DISORIENTATION,6
BR,DRY THROAT,6
BR,ELBOW DEFORMITY,6
BR,FRACTURE,6
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,6
BR,GASTRIC HAEMORRHAGE,6
BR,HEMIPARESIS,6
BR,HYPERTHYROIDISM,6
BR,HYPOAESTHESIA ORAL,6
BR,HYPONATRAEMIA,6
BR,IMMOBILE,6
BR,INCISION SITE PAIN,6
BR,INJECTION SITE BRUISING,6
BR,INTENTIONAL PRODUCT MISUSE,6
BR,JUVENILE IDIOPATHIC ARTHRITIS,6
BR,LACRIMATION INCREASED,6
BR,LUNG NEOPLASM MALIGNANT,6
BR,LYMPHOMA,6
BR,MALIGNANT MELANOMA,6
BR,MEDICAL DEVICE COMPLICATION,6
BR,MENINGITIS,6
BR,NAIL DISORDER,6
BR,NASAL CONGESTION,6
BR,NECROSIS,6
BR,NEOPLASM MALIGNANT,6
BR,NEPHRITIS,6
BR,NIGHT SWEATS,6
BR,OSTEITIS,6
BR,OVERWEIGHT,6
BR,PNEUMONIA BACTERIAL,6
BR,POOR PERIPHERAL CIRCULATION,6
BR,PULMONARY ARTERIAL HYPERTENSION,6
BR,PULMONARY SEPSIS,6
BR,RED BLOOD CELL COUNT DECREASED,6
BR,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,6
BR,RHEUMATOID NODULE,6
BR,SCIATIC NERVE NEUROPATHY,6
BR,SJOGREN^S SYNDROME,6
BR,SKIN BURNING SENSATION,6
BR,SKIN FISSURES,6
BR,SKIN PLAQUE,6
BR,SUBCUTANEOUS ABSCESS,6
BR,SYNOVITIS,6
BR,THIRST,6
BR,TIBIA FRACTURE,6
BR,TOOTHACHE,6
BR,TRANSPLANT REJECTION,6
BR,URINARY TRACT INFECTION BACTERIAL,6
BR,VEIN RUPTURE,6
BR,WEIGHT FLUCTUATION,6
BR,WOUND SECRETION,6
BR,X-RAY ABNORMAL,6
BR,AGEUSIA,5
BR,ANAL HAEMORRHAGE,5
BR,ARTHRODESIS,5
BR,ARTHROPOD BITE,5
BR,ASPARTATE AMINOTRANSFERASE INCREASED,5
BR,BLADDER DISORDER,5
BR,BLOOD CREATININE ABNORMAL,5
BR,BLOOD DISORDER,5
BR,BLOOD GLUCOSE FLUCTUATION,5
BR,BREATH SOUNDS ABNORMAL,5
BR,BRONCHIECTASIS,5
BR,CARDIOGENIC SHOCK,5
BR,COAGULOPATHY,5
BR,COLD SWEAT,5
BR,DENTAL IMPLANTATION,5
BR,DERMATITIS PAPILLARIS CAPILLITII,5
BR,DEVICE BREAKAGE,5
BR,ENTERITIS INFECTIOUS,5
BR,EYE PRURITUS,5
BR,FACE INJURY,5
BR,FIBROSIS,5
BR,FLAVIVIRUS INFECTION,5
BR,FOETAL DEATH,5
BR,FOOD ALLERGY,5
BR,FULL BLOOD COUNT ABNORMAL,5
BR,GASTROINTESTINAL CARCINOMA,5
BR,HAEMORRHAGIC STROKE,5
BR,HEMIPLEGIA,5
BR,HERNIA,5
BR,HISTOPLASMOSIS DISSEMINATED,5
BR,HYPOTHERMIA,5
BR,HYPOVITAMINOSIS,5
BR,HYSTERECTOMY,5
BR,INSULIN-LIKE GROWTH FACTOR INCREASED,5
BR,INTESTINAL ULCER,5
BR,ISCHAEMIA,5
BR,LACERATION,5
BR,LIMB MASS,5
BR,LUNG HYPERINFLATION,5
BR,MACULAR OEDEMA,5
BR,METABOLIC ACIDOSIS,5
BR,MITRAL VALVE CALCIFICATION,5
BR,MUSCLE TWITCHING,5
BR,NO THERAPEUTIC RESPONSE,5
BR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,5
BR,OCULAR HYPERTENSION,5
BR,OCULAR VASCULAR DISORDER,5
BR,OESOPHAGEAL CANDIDIASIS,5
BR,OPPORTUNISTIC INFECTION,5
BR,PAPULE,5
BR,PELVIC PAIN,5
BR,PERIPHERAL COLDNESS,5
BR,PHLEBITIS,5
BR,PNEUMONITIS,5
BR,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,5
BR,PROSTATE CANCER,5
BR,PROSTATIC SPECIFIC ANTIGEN INCREASED,5
BR,PSYCHIATRIC SYMPTOM,5
BR,PULMONARY PAIN,5
BR,RENAL FAILURE ACUTE,5
BR,SENSITIVITY TO WEATHER CHANGE,5
BR,SENSORY LOSS,5
BR,SHOCK,5
BR,SKIN PAPILLOMA,5
BR,SNEEZING,5
BR,SPOROTRICHOSIS,5
BR,SUICIDE ATTEMPT,5
BR,THROMBOPHLEBITIS,5
BR,THYROID NEOPLASM,5
BR,TONGUE DISORDER,5
BR,TUBERCULIN TEST POSITIVE,5
BR,VAGINAL HAEMORRHAGE,5
BR,VENOUS THROMBOSIS,5
BR,VIRAL UPPER RESPIRATORY TRACT INFECTION,5
BR,ACNE,4
BR,ADRENAL INSUFFICIENCY,4
BR,ANGIOEDEMA,4
BR,ANIMAL SCRATCH,4
BR,ANKLE DEFORMITY,4
BR,AORTIC VALVE INCOMPETENCE,4
BR,APHAGIA,4
BR,ARTERIOSCLEROSIS,4
BR,ATRIAL FIBRILLATION,4
BR,BACK INJURY,4
BR,BLOOD CORTISOL DECREASED,4
BR,BLOOD GROWTH HORMONE INCREASED,4
BR,BLOOD UREA INCREASED,4
BR,BLOOD URIC ACID INCREASED,4
BR,BODY TEMPERATURE DECREASED,4
BR,BONE MARROW TOXICITY,4
BR,BONE NEOPLASM,4
BR,BRADYCARDIA,4
BR,BRAIN HERNIATION,4
BR,BRONCHITIS CHRONIC,4
BR,CACHEXIA,4
BR,CARDIAC VALVE DISEASE,4
BR,CATARACT SUBCAPSULAR,4
BR,CEREBRAL DISORDER,4
BR,CEREBRAL ISCHAEMIA,4
BR,CHEST X-RAY ABNORMAL,4
BR,CHROMATURIA,4
BR,CHRONIC KIDNEY DISEASE,4
BR,CHRONIC SINUSITIS,4
BR,COGNITIVE DISORDER,4
BR,COMPLICATION ASSOCIATED WITH DEVICE,4
BR,CORNEAL DISORDER,4
BR,CRYPTOCOCCOSIS,4
BR,CUTANEOUS TUBERCULOSIS,4
BR,DEMENTIA,4
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,4
BR,DERMATITIS BULLOUS,4
BR,DERMATITIS CONTACT,4
BR,DERMATOMYOSITIS,4
BR,DIZZINESS POSTURAL,4
BR,DYSLIPIDAEMIA,4
BR,EAR DISCOMFORT,4
BR,EMBOLISM,4
BR,EXTREMITY NECROSIS,4
BR,EYE ALLERGY,4
BR,FACE OEDEMA,4
BR,FISTULA DISCHARGE,4
BR,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,4
BR,FOOT OPERATION,4
BR,FREQUENT BOWEL MOVEMENTS,4
BR,FUNGAL SKIN INFECTION,4
BR,GASTRIC ULCER,4
BR,GASTRITIS EROSIVE,4
BR,GENERALISED TONIC-CLONIC SEIZURE,4
BR,GINGIVITIS,4
BR,HAEMATOCRIT DECREASED,4
BR,HAEMATOTOXICITY,4
BR,HAPTOGLOBIN DECREASED,4
BR,HELICOBACTER INFECTION,4
BR,HEPATIC CANCER,4
BR,HEPATIC INFECTION,4
BR,HEPATIC PAIN,4
BR,HEPATITIS B,4
BR,IGA NEPHROPATHY,4
BR,INCISION SITE COMPLICATION,4
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,4
BR,INFECTION REACTIVATION,4
BR,INGUINAL HERNIA,4
BR,INJECTION SITE NODULE,4
BR,INJECTION SITE OEDEMA,4
BR,INJECTION SITE PAPULE,4
BR,INJECTION SITE URTICARIA,4
BR,INTESTINAL POLYP,4
BR,INTESTINAL RESECTION,4
BR,JOINT WARMTH,4
BR,KLEBSIELLA INFECTION,4
BR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,4
BR,LETHARGY,4
BR,LIMB ASYMMETRY,4
BR,LIP OEDEMA,4
BR,LUNG INFILTRATION,4
BR,LUNG NEOPLASM,4
BR,MACULE,4
BR,MENORRHAGIA,4
BR,MENSTRUATION IRREGULAR,4
BR,MITRAL VALVE INCOMPETENCE,4
BR,MONOPLEGIA,4
BR,MOUTH SWELLING,4
BR,MUCOUS STOOLS,4
BR,MULTIPLE SCLEROSIS,4
BR,MYDRIASIS,4
BR,NAIL INFECTION,4
BR,NERVE COMPRESSION,4
BR,OCULAR ICTERUS,4
BR,OESOPHAGEAL DISORDER,4
BR,OLIGURIA,4
BR,ORAL MUCOSAL BLISTERING,4
BR,PANCREATITIS ACUTE,4
BR,PANIC ATTACK,4
BR,PAPILLOEDEMA,4
BR,PAPILLOMA VIRAL INFECTION,4
BR,PATHOGEN RESISTANCE,4
BR,PLASMA CELL MYELOMA,4
BR,POISONING,4
BR,POLYARTHRITIS,4
BR,POST PROCEDURAL INFLAMMATION,4
BR,POST TRANSPLANT DISTAL LIMB SYNDROME,4
BR,PREMATURE BABY,4
BR,PROCTALGIA,4
BR,PROCTITIS,4
BR,PROSTATIC DISORDER,4
BR,PULPITIS DENTAL,4
BR,PYELOCALIECTASIS,4
BR,RASH GENERALISED,4
BR,RENAL ARTERY STENOSIS,4
BR,RETINAL DETACHMENT,4
BR,ROTATOR CUFF SYNDROME,4
BR,SENSATION OF FOREIGN BODY,4
BR,SKIN ABRASION,4
BR,SKIN HAEMORRHAGE,4
BR,SKIN INJURY,4
BR,SKIN WOUND,4
BR,SPLEEN DISORDER,4
BR,SQUAMOUS CELL CARCINOMA,4
BR,STAPHYLOCOCCAL INFECTION,4
BR,SUTURE RELATED COMPLICATION,4
BR,SUTURE RUPTURE,4
BR,SWOLLEN TONGUE,4
BR,SYSTEMIC INFECTION,4
BR,TENDON INJURY,4
BR,THERAPEUTIC RESPONSE SHORTENED,4
BR,TOXICITY TO VARIOUS AGENTS,4
BR,TRANSAMINASES INCREASED,4
BR,TRANSFUSION,4
BR,TUBULOINTERSTITIAL NEPHRITIS,4
BR,UPPER EXTREMITY MASS,4
BR,URINARY RETENTION,4
BR,VIITH NERVE PARALYSIS,4
BR,VITAMIN B12 DEFICIENCY,4
BR,WHEELCHAIR USER,4
BR,WOUND COMPLICATION,4
BR,ZIKA VIRUS INFECTION,4
BR,ABDOMINAL ABSCESS,3
BR,ACUTE PULMONARY OEDEMA,3
BR,ADVERSE REACTION,3
BR,AGGRESSION,3
BR,ALANINE AMINOTRANSFERASE ABNORMAL,3
BR,ALLERGY TO CHEMICALS,3
BR,AMAUROSIS,3
BR,ANAL SQUAMOUS CELL CARCINOMA,3
BR,AORTIC ANEURYSM,3
BR,AORTIC DISORDER,3
BR,AORTIC STENOSIS,3
BR,APHTHOUS STOMATITIS,3
BR,APLASTIC ANAEMIA,3
BR,APPLICATION SITE ERYTHEMA,3
BR,APPLICATION SITE PAIN,3
BR,APPLICATION SITE PRURITUS,3
BR,ASPARTATE AMINOTRANSFERASE ABNORMAL,3
BR,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,3
BR,BLOOD PRESSURE SYSTOLIC INCREASED,3
BR,BLOOD SODIUM DECREASED,3
BR,BLOOD URINE PRESENT,3
BR,BODY MASS INDEX INCREASED,3
BR,BONE ATROPHY,3
BR,BONE DECALCIFICATION,3
BR,BONE DEFORMITY,3
BR,BONE DENSITY DECREASED,3
BR,BONE TUBERCULOSIS,3
BR,BRAIN ABSCESS,3
BR,BREAST DISORDER,3
BR,BUNION,3
BR,CAESAREAN SECTION,3
BR,CALCINOSIS,3
BR,CARDIAC MURMUR,3
BR,CEREBRAL HAEMORRHAGE,3
BR,CEREBRAL THROMBOSIS,3
BR,CERVIX CARCINOMA,3
BR,CHOKING SENSATION,3
BR,CHRONIC ALLOGRAFT NEPHROPATHY,3
BR,CNS VENTRICULITIS,3
BR,COCCYDYNIA,3
BR,CORONARY ARTERY DISEASE,3
BR,CREATININE RENAL CLEARANCE DECREASED,3
BR,DEAFNESS TRANSITORY,3
BR,DENTAL CARIES,3
BR,DEVICE ISSUE,3
BR,DIABETIC NEUROPATHY,3
BR,DRUG DISPENSING ERROR,3
BR,DRUG ERUPTION,3
BR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
BR,DUODENAL ULCER,3
BR,EAR DISORDER,3
BR,ELECTROLYTE IMBALANCE,3
BR,ENCEPHALITIS,3
BR,EOSINOPHILIA,3
BR,ESCHERICHIA URINARY TRACT INFECTION,3
BR,EXCORIATION,3
BR,EXTERNAL EAR INFLAMMATION,3
BR,EXTRASYSTOLES,3
BR,EYE HAEMORRHAGE,3
BR,EYE INFECTION,3
BR,EYE MOVEMENT DISORDER,3
BR,EYELID OEDEMA,3
BR,FACIAL PAIN,3
BR,FINGER AMPUTATION,3
BR,FISTULA INFLAMMATION,3
BR,FOETAL EXPOSURE DURING PREGNANCY,3
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,3
BR,GALLBLADDER PAIN,3
BR,GASTROINTESTINAL BACTERIAL INFECTION,3
BR,GASTROINTESTINAL MOTILITY DISORDER,3
BR,GASTROINTESTINAL NECROSIS,3
BR,GASTROINTESTINAL PAIN,3
BR,GENITAL CANDIDIASIS,3
BR,GENITAL HERPES,3
BR,GINGIVAL DISORDER,3
BR,GLOMERULONEPHRITIS,3
BR,GLOMERULOSCLEROSIS,3
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,3
BR,GOITRE,3
BR,GRAFT VERSUS HOST DISEASE,3
BR,H1N1 INFLUENZA,3
BR,HAEMATOCRIT ABNORMAL,3
BR,HAEMODIALYSIS,3
BR,HAEMOGLOBINURIA,3
BR,HAEMORRHAGIC ANAEMIA,3
BR,HEPATIC ENZYME ABNORMAL,3
BR,HEPATIC ENZYME INCREASED,3
BR,HEPATIC FUNCTION ABNORMAL,3
BR,HEPATOSPLENOMEGALY,3
BR,HOT FLUSH,3
BR,HUMAN POLYOMAVIRUS INFECTION,3
BR,HUMERUS FRACTURE,3
BR,HUNGER,3
BR,HYPERCALCAEMIA,3
BR,HYPERSOMNIA,3
BR,HYPOKALAEMIA,3
BR,HYPOTONIA,3
BR,ILEUS PARALYTIC,3
BR,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,3
BR,INCORRECT DRUG ADMINISTRATION RATE,3
BR,INCREASED BRONCHIAL SECRETION,3
BR,INFLAMMATION OF WOUND,3
BR,INJECTION SITE INFECTION,3
BR,INJECTION SITE RASH,3
BR,INJECTION SITE VESICLES,3
BR,INTENTIONAL PRODUCT USE ISSUE,3
BR,INTERNAL HAEMORRHAGE,3
BR,INTERVERTEBRAL DISCITIS,3
BR,INTESTINAL STENOSIS,3
BR,INTRAOCULAR PRESSURE INCREASED,3
BR,LACK OF INJECTION SITE ROTATION,3
BR,LARYNGITIS,3
BR,LEPROSY,3
BR,LEUKAEMIA,3
BR,LEUKOCYTURIA,3
BR,LIGAMENT RUPTURE,3
BR,LIP DRY,3
BR,LIPOMA,3
BR,LIVE BIRTH,3
BR,LOCALISED OEDEMA,3
BR,LOOSE TOOTH,3
BR,LUMBAR VERTEBRAL FRACTURE,3
BR,LUNG ADENOCARCINOMA,3
BR,LUNG CONSOLIDATION,3
BR,LUPUS-LIKE SYNDROME,3
BG,HEPATOSPLENOMEGALY,3
BG,EAR INFECTION,2
BG,NECROSIS,2
BG,ANAEMIA,1
BG,ARTHRALGIA,1
BG,GROIN PAIN,1
BG,HYPOALBUMINAEMIA,1
BG,METASTASES TO BONE,1
BG,NEUTROPENIA,1
BG,OEDEMA PERIPHERAL,1
BG,PAIN IN EXTREMITY,1
BG,PLEURAL EFFUSION,1
BG,PULMONARY EMBOLISM,1
BG,THROMBOCYTOPENIA,1
CA,DRUG INEFFECTIVE,3383
CA,RHEUMATOID ARTHRITIS,1950
CA,FATIGUE,1744
CA,PAIN,1691
CA,ARTHRALGIA,1522
CA,DYSPNOEA,1249
CA,NAUSEA,1169
CA,MALAISE,1146
CA,HEADACHE,985
CA,DIARRHOEA,984
CA,COUGH,983
CA,WEIGHT DECREASED,934
CA,PNEUMONIA,910
CA,NASOPHARYNGITIS,891
CA,JOINT SWELLING,879
CA,BLOOD PRESSURE INCREASED,844
CA,CONDITION AGGRAVATED,838
CA,PAIN IN EXTREMITY,805
CA,ASTHENIA,803
CA,PERIPHERAL SWELLING,746
CA,WEIGHT INCREASED,724
CA,VOMITING,708
CA,FALL,676
CA,ASTHMA,673
CA,RASH,668
CA,PYREXIA,666
CA,INFUSION RELATED REACTION,650
CA,INFECTION,601
CA,DIZZINESS,568
CA,ABDOMINAL PAIN,549
CA,BACK PAIN,521
CA,INFLUENZA,516
CA,HEART RATE INCREASED,510
CA,DRUG INTOLERANCE,505
CA,ABDOMINAL DISCOMFORT,500
CA,MUSCULOSKELETAL STIFFNESS,454
CA,GAIT DISTURBANCE,452
CA,HYPERTENSION,443
CA,DRUG EFFECT DECREASED,442
CA,SINUSITIS,437
CA,ALOPECIA,436
CA,ARTHROPATHY,435
CA,PRODUCTIVE COUGH,414
CA,DRUG HYPERSENSITIVITY,410
CA,SWELLING,410
CA,WHEEZING,405
CA,OROPHARYNGEAL PAIN,398
CA,ARTHRITIS,389
CA,TREATMENT FAILURE,387
CA,URINARY TRACT INFECTION,379
CA,HYPOTENSION,378
CA,CROHN^S DISEASE,370
CA,DEATH,370
CA,INSOMNIA,369
CA,LOWER RESPIRATORY TRACT INFECTION,366
CA,PRURITUS,357
CA,HYPERSENSITIVITY,342
CA,OXYGEN SATURATION DECREASED,340
CA,BRONCHITIS,333
CA,CHEST DISCOMFORT,328
CA,MUSCULOSKELETAL PAIN,321
CA,CONTUSION,315
CA,CHEST PAIN,309
CA,MOBILITY DECREASED,306
CA,HAEMOGLOBIN DECREASED,305
CA,ABDOMINAL PAIN UPPER,301
CA,HYPOAESTHESIA,291
CA,ANXIETY,290
CA,LUNG INFECTION,289
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,288
CA,URTICARIA,284
CA,COLITIS ULCERATIVE,280
CA,ERYTHEMA,273
CA,DECREASED APPETITE,271
CA,INFLAMMATION,269
CA,PRODUCT USE ISSUE,266
CA,DRUG EFFECT INCOMPLETE,264
CA,HERPES ZOSTER,259
CA,SYNOVITIS,256
CA,PEMPHIGUS,254
CA,NASAL CONGESTION,253
CA,OSTEOPOROSIS,251
CA,RHINORRHOEA,251
CA,HAEMATOCHEZIA,247
CA,DEPRESSION,245
CA,PARAESTHESIA,242
CA,FEELING ABNORMAL,241
CA,SEPSIS,238
CA,CHILLS,232
CA,HEPATIC ENZYME INCREASED,230
CA,BLOOD PRESSURE SYSTOLIC INCREASED,229
CA,DIABETES MELLITUS,229
CA,NEPHROLITHIASIS,217
CA,CATARACT,215
CA,STRESS,214
CA,HEART RATE DECREASED,213
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,213
CA,OEDEMA PERIPHERAL,213
CA,GENERAL PHYSICAL HEALTH DETERIORATION,210
CA,GASTROOESOPHAGEAL REFLUX DISEASE,204
CA,MUSCLE SPASMS,204
CA,MYALGIA,203
CA,KNEE ARTHROPLASTY,202
CA,SOMNOLENCE,201
CA,OSTEOARTHRITIS,197
CA,ANAEMIA,196
CA,BLOOD PRESSURE DECREASED,195
CA,BODY TEMPERATURE DECREASED,194
CA,BLOOD PRESSURE FLUCTUATION,191
CA,MYOCARDIAL INFARCTION,191
CA,THERAPEUTIC RESPONSE DECREASED,189
CA,DEHYDRATION,187
CA,GASTROINTESTINAL DISORDER,187
CA,LUNG DISORDER,187
CA,CLOSTRIDIUM DIFFICILE INFECTION,185
CA,MUSCULAR WEAKNESS,184
CA,WHITE BLOOD CELL COUNT DECREASED,183
CA,CYSTITIS,177
CA,FORCED EXPIRATORY VOLUME DECREASED,177
CA,INTERSTITIAL LUNG DISEASE,174
CA,GLOSSODYNIA,173
CA,DRUG DOSE OMISSION,172
CA,CELLULITIS,169
CA,THROMBOSIS,169
CA,DYSPNOEA EXERTIONAL,166
CA,NECK PAIN,166
CA,FREQUENT BOWEL MOVEMENTS,165
CA,PLATELET COUNT DECREASED,163
CA,SPUTUM DISCOLOURED,163
CA,WOUND,161
CA,SKIN ULCER,160
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,159
CA,LOCALISED INFECTION,159
CA,HYPERHIDROSIS,158
CA,PALPITATIONS,158
CA,INFLUENZA LIKE ILLNESS,156
CA,CONSTIPATION,155
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,155
CA,TREMOR,154
CA,DYSPEPSIA,153
CA,RESPIRATORY RATE INCREASED,153
CA,HAND DEFORMITY,151
CA,LOSS OF CONSCIOUSNESS,149
CA,INTESTINAL OBSTRUCTION,148
CA,OBSTRUCTIVE AIRWAYS DISORDER,147
CA,MIGRAINE,145
CA,RESPIRATORY DISORDER,145
CA,HAEMORRHAGE,143
CA,VISION BLURRED,143
CA,ATRIAL FIBRILLATION,139
CA,C-REACTIVE PROTEIN ABNORMAL,139
CA,FEBRILE NEUTROPENIA,139
CA,FOOT DEFORMITY,138
CA,C-REACTIVE PROTEIN INCREASED,137
CA,RESPIRATORY TRACT CONGESTION,137
CA,DYSPHONIA,131
CA,SWELLING FACE,131
CA,DISEASE PROGRESSION,129
CA,RENAL IMPAIRMENT,129
CA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,128
CA,VIRAL INFECTION,128
CA,ABDOMINAL DISTENSION,127
CA,BLOOD GLUCOSE INCREASED,127
CA,JOINT STIFFNESS,126
CA,IMPAIRED HEALING,125
CA,UPPER RESPIRATORY TRACT INFECTION,124
CA,LYMPHADENOPATHY,123
CA,NEUROPATHY PERIPHERAL,122
CA,SLEEP DISORDER,122
CA,FIBROMYALGIA,121
CA,RECTAL HAEMORRHAGE,121
CA,IMPAIRED WORK ABILITY,119
CA,HIP ARTHROPLASTY,117
CA,INJECTION SITE PAIN,115
CA,BURNING SENSATION,112
CA,WHITE BLOOD CELL COUNT INCREASED,112
CA,LIMB INJURY,109
CA,HOSPITALISATION,108
CA,PULMONARY OEDEMA,108
CA,BLOOD CHOLESTEROL INCREASED,107
CA,BLOOD CREATININE INCREASED,107
CA,CEREBROVASCULAR ACCIDENT,107
CA,PSORIASIS,107
CA,BLOOD PRESSURE DIASTOLIC DECREASED,106
CA,EYE DISORDER,106
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,105
CA,FEELING HOT,105
CA,CARDIAC DISORDER,104
CA,THROAT IRRITATION,104
CA,HOT FLUSH,103
CA,SYNCOPE,103
CA,TACHYCARDIA,103
CA,BODY TEMPERATURE INCREASED,102
CA,NEOPLASM MALIGNANT,102
CA,SENSITIVITY TO WEATHER CHANGE,102
CA,CONFUSIONAL STATE,101
CA,PULMONARY EMBOLISM,100
CA,SURGERY,100
CA,EAR INFECTION,98
CA,EPISTAXIS,98
CA,FEMUR FRACTURE,98
CA,CONTRAINDICATED PRODUCT ADMINISTERED,95
CA,DISABILITY,95
CA,DYSPHAGIA,95
CA,MUSCULOSKELETAL DISORDER,95
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,95
CA,EXPOSURE DURING PREGNANCY,94
CA,LACERATION,94
CA,NEUTROPENIA,94
CA,SEPTIC SHOCK,94
CA,ORAL HERPES,93
CA,DRY MOUTH,92
CA,ILL-DEFINED DISORDER,92
CA,RASH PRURITIC,92
CA,RIB FRACTURE,92
CA,JOINT INJURY,91
CA,DIVERTICULITIS,90
CA,PULMONARY FIBROSIS,90
CA,RENAL FAILURE,90
CA,SINUS CONGESTION,90
CA,ALANINE AMINOTRANSFERASE INCREASED,89
CA,SCIATICA,89
CA,ANAPHYLACTIC REACTION,88
CA,BASAL CELL CARCINOMA,88
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,87
CA,EYE PAIN,86
CA,MATERNAL EXPOSURE DURING PREGNANCY,86
CA,CARDIAC FAILURE CONGESTIVE,84
CA,CARPAL TUNNEL SYNDROME,84
CA,FLUSHING,84
CA,LOCAL SWELLING,84
CA,RENAL DISORDER,84
CA,SKIN LESION,84
CA,STOMATITIS,84
CA,DRY EYE,83
CA,GASTROENTERITIS VIRAL,83
CA,HIP FRACTURE,83
CA,FOOT FRACTURE,82
CA,HEART RATE IRREGULAR,82
CA,RESPIRATORY FAILURE,82
CA,DISCOMFORT,81
CA,EAR PAIN,81
CA,INJECTION SITE ERYTHEMA,81
CA,INJECTION SITE REACTION,81
CA,POOR VENOUS ACCESS,81
CA,TOOTH INFECTION,81
CA,VISUAL IMPAIRMENT,81
CA,GASTRIC DISORDER,80
CA,LIVER FUNCTION TEST INCREASED,80
CA,ADVERSE EVENT,79
CA,CHOLELITHIASIS,79
CA,PULMONARY MASS,79
CA,ROAD TRAFFIC ACCIDENT,79
CA,BALANCE DISORDER,78
CA,INCORRECT DOSE ADMINISTERED,78
CA,MOUTH ULCERATION,78
CA,SKIN DISCOLOURATION,78
CA,COLITIS,77
CA,KIDNEY INFECTION,77
CA,RESPIRATORY TRACT INFECTION,77
CA,BLOOD PRESSURE DIASTOLIC INCREASED,76
CA,MEMORY IMPAIRMENT,76
CA,ACNE,75
CA,BONE PAIN,75
CA,FUNGAL INFECTION,75
CA,ASPARTATE AMINOTRANSFERASE INCREASED,74
CA,BREATH SOUNDS ABNORMAL,74
CA,CYST,74
CA,HERNIA,74
CA,PSORIATIC ARTHROPATHY,74
CA,HYPOVENTILATION,73
CA,PANCYTOPENIA,73
CA,TYPE 2 DIABETES MELLITUS,73
CA,BLISTER,72
CA,GASTROENTERITIS,72
CA,INJECTION SITE BRUISING,72
CA,LIMB DISCOMFORT,72
CA,TOXICITY TO VARIOUS AGENTS,71
CA,RHEUMATOID NODULE,70
CA,ADRENAL INSUFFICIENCY,69
CA,NODULE,69
CA,PLEURAL EFFUSION,69
CA,POST PROCEDURAL INFECTION,69
CA,PULMONARY CONGESTION,69
CA,TOOTH DISORDER,69
CA,UPPER LIMB FRACTURE,69
CA,ABASIA,68
CA,BACTERIAL INFECTION,68
CA,BONE DISORDER,68
CA,MIDDLE INSOMNIA,68
CA,THROMBOCYTOPENIA,68
CA,ABSCESS,67
CA,ADVERSE DRUG REACTION,67
CA,CANDIDA INFECTION,67
CA,COMA,67
CA,DEEP VEIN THROMBOSIS,67
CA,OEDEMA,67
CA,PAIN IN JAW,67
CA,PRURITUS GENERALISED,67
CA,SEASONAL ALLERGY,67
CA,VERTIGO,67
CA,ULCER,66
CA,GLAUCOMA,65
CA,PNEUMONITIS,65
CA,DRY SKIN,64
CA,LIVER FUNCTION TEST ABNORMAL,64
CA,NERVE INJURY,64
CA,OCULAR HYPERAEMIA,64
CA,PNEUMONIA ASPIRATION,64
CA,RALES,64
CA,BONE DENSITY DECREASED,63
CA,POST PROCEDURAL COMPLICATION,63
CA,SLEEP APNOEA SYNDROME,63
CA,BREAST CANCER,62
CA,ECZEMA,62
CA,LOWER LIMB FRACTURE,62
CA,MOVEMENT DISORDER,62
CA,RASH ERYTHEMATOUS,62
CA,DEPRESSED MOOD,61
CA,EYE SWELLING,61
CA,FLATULENCE,61
CA,MASS,61
CA,LUNG NEOPLASM MALIGNANT,60
CA,MALIGNANT MELANOMA,60
CA,PERICARDITIS,60
CA,SEIZURE,60
CA,TOOTH ABSCESS,60
CA,EYE INFECTION,59
CA,JOINT RANGE OF MOTION DECREASED,59
CA,PHARYNGEAL OEDEMA,59
CA,POLLAKIURIA,59
CA,AMNESIA,58
CA,ORAL CANDIDIASIS,58
CA,VASCULITIS,58
CA,ABORTION SPONTANEOUS,57
CA,DRUG ERUPTION,57
CA,INTESTINAL RESECTION,57
CA,OSTEOMYELITIS,57
CA,PANCREATITIS,57
CA,PROSTATE CANCER,57
CA,SECRETION DISCHARGE,57
CA,SNEEZING,57
CA,DIARRHOEA HAEMORRHAGIC,56
CA,FLUID RETENTION,56
CA,HAEMOPTYSIS,56
CA,SKIN CANCER,56
CA,SPINAL FRACTURE,56
CA,WEIGHT FLUCTUATION,56
CA,BLOOD IRON DECREASED,55
CA,GASTROINTESTINAL HAEMORRHAGE,55
CA,HYPOTHYROIDISM,55
CA,LABORATORY TEST ABNORMAL,55
CA,PALLOR,55
CA,CRYING,54
CA,OBESITY,54
CA,SINUS DISORDER,54
CA,BLOOD POTASSIUM DECREASED,53
CA,BLOOD URINE PRESENT,53
CA,HEPATOTOXICITY,53
CA,SKIN DISORDER,53
CA,BEDRIDDEN,52
CA,BONE EROSION,52
CA,COLECTOMY,52
CA,EYE HAEMORRHAGE,52
CA,ANGIOEDEMA,51
CA,ANKLE FRACTURE,51
CA,BURSITIS,51
CA,DYSURIA,51
CA,INJECTION SITE SWELLING,51
CA,RASH GENERALISED,51
CA,BACK DISORDER,50
CA,BLOOD COUNT ABNORMAL,50
CA,MENINGITIS TUBERCULOUS,50
CA,MUSCULOSKELETAL DISCOMFORT,50
CA,NERVOUSNESS,50
CA,NIGHT SWEATS,50
CA,THROAT TIGHTNESS,50
CA,HYPOPHAGIA,49
CA,RED BLOOD CELL COUNT DECREASED,49
CA,STAPHYLOCOCCAL INFECTION,49
CA,TENDERNESS,49
CA,ACUTE HEPATIC FAILURE,48
CA,GAIT INABILITY,48
CA,HAEMATOMA,48
CA,IMMUNODEFICIENCY,48
CA,INTERVERTEBRAL DISC PROTRUSION,48
CA,PHARYNGITIS,48
CA,PULMONARY FUNCTION TEST DECREASED,48
CA,SMALL INTESTINAL OBSTRUCTION,48
CA,TOOTH FRACTURE,48
CA,CLOSTRIDIUM DIFFICILE COLITIS,47
CA,FRACTURE,47
CA,HYPERCALCAEMIA,47
CA,LOWER RESPIRATORY TRACT CONGESTION,47
CA,OSTEOPENIA,47
CA,PANNICULITIS,47
CA,PRODUCT USE IN UNAPPROVED INDICATION,47
CA,SPINAL COLUMN STENOSIS,47
CA,ANGINA PECTORIS,46
CA,BLOOD MAGNESIUM DECREASED,46
CA,BLOOD PRESSURE ABNORMAL,46
CA,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,46
CA,EMPHYSEMA,46
CA,IMMOBILE,46
CA,LIVER DISORDER,46
CA,MALIGNANT NEOPLASM PROGRESSION,46
CA,POOR QUALITY SLEEP,46
CA,SYNOVIAL CYST,46
CA,THYROID DISORDER,46
CA,UNEVALUABLE EVENT,46
CA,WRIST FRACTURE,46
CA,DYSGEUSIA,45
CA,PHOTOPHOBIA,45
CA,RHEUMATOID FACTOR POSITIVE,45
CA,THERAPY NON-RESPONDER,45
CA,TRANSIENT ISCHAEMIC ATTACK,45
CA,APHONIA,44
CA,BLOOD IMMUNOGLOBULIN E INCREASED,44
CA,CREPITATIONS,44
CA,HEPATIC CIRRHOSIS,44
CA,LEUKOPENIA,44
CA,MUSCLE STRAIN,44
CA,SPINAL DISORDER,44
CA,WALKING AID USER,44
CA,WOUND INFECTION,44
CA,BACK INJURY,43
CA,BLOOD PARATHYROID HORMONE DECREASED,43
CA,BLOOD TEST ABNORMAL,43
CA,DEFORMITY,43
CA,GINGIVAL BLEEDING,43
CA,IMMUNE SYSTEM DISORDER,43
CA,JOINT EFFUSION,43
CA,LACRIMATION INCREASED,43
CA,SCAR,43
CA,ACUTE KIDNEY INJURY,42
CA,BRONCHOSPASM,42
CA,FISTULA,42
CA,GASTRIC ULCER,42
CA,NEURALGIA,42
CA,SUICIDAL IDEATION,42
CA,CARDIAC FAILURE,41
CA,DRUG RESISTANCE,41
CA,FINGER DEFORMITY,41
CA,HEART RATE ABNORMAL,41
CA,PNEUMOTHORAX,41
CA,RESPIRATORY DISTRESS,41
CA,SKIN EXFOLIATION,41
CA,SPEECH DISORDER,41
CA,TINNITUS,41
CA,ABDOMINAL PAIN LOWER,40
CA,ARRHYTHMIA,40
CA,DRUG DEPENDENCE,40
CA,HEAD INJURY,40
CA,HYPOACUSIS,40
CA,TOOTHACHE,40
CA,BRONCHIECTASIS,39
CA,DISEASE RECURRENCE,39
CA,EMOTIONAL DISORDER,39
CA,LYMPHOMA,39
CA,ROTATOR CUFF SYNDROME,39
CA,SWOLLEN TONGUE,39
CA,ANAPHYLACTIC SHOCK,38
CA,GALLBLADDER DISORDER,38
CA,LETHARGY,38
CA,PROCEDURAL PAIN,38
CA,HIATUS HERNIA,37
CA,HYPOKINESIA,37
CA,INJURY,37
CA,INTESTINAL PERFORATION,37
CA,MUSCULOSKELETAL CHEST PAIN,37
CA,RENAL PAIN,37
CA,FLANK PAIN,36
CA,GRANULOMATOSIS WITH POLYANGIITIS,36
CA,INTESTINAL STENOSIS,36
CA,JAUNDICE,36
CA,PHOTOSENSITIVITY REACTION,36
CA,RHINITIS,36
CA,ARTHRITIS INFECTIVE,35
CA,BLINDNESS,35
CA,BODY HEIGHT BELOW NORMAL,35
CA,CARDIAC ARREST,35
CA,DECREASED ACTIVITY,35
CA,DENTAL CARIES,35
CA,DRY THROAT,35
CA,FEELING COLD,35
CA,LIP SWELLING,35
CA,MENTAL DISORDER,35
CA,NECK MASS,35
CA,NEUTROPHIL COUNT INCREASED,35
CA,RED CELL DISTRIBUTION WIDTH INCREASED,35
CA,SQUAMOUS CELL CARCINOMA,35
CA,GASTROINTESTINAL INFECTION,34
CA,HEPATIC FAILURE,34
CA,HYPOXIA,34
CA,IRRITABILITY,34
CA,MOOD SWINGS,34
CA,MULTI-ORGAN FAILURE,34
CA,MUSCLE TWITCHING,34
CA,POLYP,34
CA,QUALITY OF LIFE DECREASED,34
CA,ATELECTASIS,33
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,33
CA,DRUG-INDUCED LIVER INJURY,33
CA,EYE IRRITATION,33
CA,GASTROINTESTINAL INFLAMMATION,33
CA,GOUT,33
CA,IRRITABLE BOWEL SYNDROME,33
CA,LARYNGITIS,33
CA,MULTIPLE SCLEROSIS,33
CA,OVERDOSE,33
CA,POSTOPERATIVE WOUND INFECTION,33
CA,SKIN ATROPHY,33
CA,BACTERAEMIA,32
CA,BLOOD GLUCOSE DECREASED,32
CA,MYCOBACTERIUM CHELONAE INFECTION,32
CA,PELVIC FRACTURE,32
CA,PLATELET COUNT INCREASED,32
CA,URINARY INCONTINENCE,32
CA,B-CELL LYMPHOMA RECURRENT,31
CA,BRONCHOPULMONARY ASPERGILLOSIS,31
CA,EATING DISORDER,31
CA,EMOTIONAL DISTRESS,31
CA,FINE MOTOR SKILL DYSFUNCTION,31
CA,HAEMATOCRIT DECREASED,31
CA,HEPATIC ENZYME ABNORMAL,31
CA,HUMAN ANTICHIMERIC ANTIBODY POSITIVE,31
CA,INJECTION SITE HAEMORRHAGE,31
CA,KNEE OPERATION,31
CA,LIGAMENT SPRAIN,31
CA,NEUTROPHIL COUNT DECREASED,31
CA,ORAL PAIN,31
CA,PARALYSIS,31
CA,PHARYNGITIS STREPTOCOCCAL,31
CA,PNEUMOCYSTIS JIROVECII PNEUMONIA,31
CA,SKIN NECROSIS,31
CA,ANAL ABSCESS,30
CA,ASPERGILLUS INFECTION,30
CA,CONCOMITANT DISEASE AGGRAVATED,30
CA,DEAFNESS NEUROSENSORY,30
CA,DELIRIUM,30
CA,DYSSTASIA,30
CA,FEEDING DISORDER,30
CA,HAEMORRHOIDS,30
CA,HEPATIC STEATOSIS,30
CA,HEPATITIS,30
CA,HEPATITIS B REACTIVATION,30
CA,HYPOAESTHESIA ORAL,30
CA,INJECTION SITE PRURITUS,30
CA,INTERVERTEBRAL DISC DEGENERATION,30
CA,PROSTATIC SPECIFIC ANTIGEN INCREASED,30
CA,SKIN INFECTION,30
CA,UPPER-AIRWAY COUGH SYNDROME,30
CA,VISUAL ACUITY REDUCED,30
CA,APHASIA,29
CA,BLOOD PRESSURE SYSTOLIC DECREASED,29
CA,CYTOMEGALOVIRUS INFECTION,29
CA,EPIGASTRIC DISCOMFORT,29
CA,EYE PRURITUS,29
CA,GRANULOMA SKIN,29
CA,INJECTION SITE EXTRAVASATION,29
CA,LIMB DEFORMITY,29
CA,LUPUS-LIKE SYNDROME,29
CA,MUSCLE ATROPHY,29
CA,SQUAMOUS CELL CARCINOMA OF SKIN,29
CA,TENDON RUPTURE,29
CA,TENDONITIS,29
CA,WRIST DEFORMITY,29
CA,APHTHOUS ULCER,28
CA,CONJUNCTIVITIS,28
CA,DISTURBANCE IN ATTENTION,28
CA,FAECES DISCOLOURED,28
CA,HALLUCINATION,28
CA,ILEOSTOMY,28
CA,IMMUNE THROMBOCYTOPENIC PURPURA,28
CA,PERICARDIAL EFFUSION,28
CA,PRESYNCOPE,28
CA,RASH MACULAR,28
CA,SJOGREN^S SYNDROME,28
CA,SKIN HAEMORRHAGE,28
CA,UVEITIS,28
CA,BLOOD ALBUMIN DECREASED,27
CA,COGNITIVE DISORDER,27
CA,CORONARY ARTERY OCCLUSION,27
CA,ENTERITIS,27
CA,FEAR OF INJECTION,27
CA,FORCED VITAL CAPACITY DECREASED,27
CA,FURUNCLE,27
CA,HAEMOLYSIS,27
CA,HEAD DISCOMFORT,27
CA,MEDICATION ERROR,27
CA,PLEURAL FIBROSIS,27
CA,PRESBYACUSIS,27
CA,SCAB,27
CA,TRANSAMINASES INCREASED,27
CA,AGITATION,26
CA,EAR DISCOMFORT,26
CA,HAEMATURIA,26
CA,HYPERGLYCAEMIA,26
CA,LYMPHADENITIS,26
CA,NASAL POLYPS,26
CA,POLYARTHRITIS,26
CA,PRERENAL FAILURE,26
CA,RESTLESSNESS,26
CA,SENSORY LOSS,26
CA,SKIN PAPILLOMA,26
CA,STRESS FRACTURE,26
CA,THERAPY PARTIAL RESPONDER,26
CA,VAGINAL HAEMORRHAGE,26
CA,WHEELCHAIR USER,26
CA,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,25
CA,ARTHRODESIS,25
CA,BLADDER DISORDER,25
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,25
CA,CEREBRAL HAEMORRHAGE,25
CA,CYANOSIS,25
CA,FEELING JITTERY,25
CA,HYPOGLYCAEMIA,25
CA,JOINT DESTRUCTION,25
CA,JOINT DISLOCATION,25
CA,LYMPHOCYTE COUNT DECREASED,25
CA,NERVE COMPRESSION,25
CA,PLASMA CELL MYELOMA,25
CA,PREGNANCY,25
CA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,25
CA,TOOTH EXTRACTION,25
CA,WOUND SECRETION,25
CA,ACCIDENT,24
CA,ANAL FISTULA,24
CA,BILE DUCT OBSTRUCTION,24
CA,CYTOMEGALOVIRUS CHORIORETINITIS,24
CA,DERMATITIS ALLERGIC,24
CA,EXERCISE TOLERANCE DECREASED,24
CA,FOETAL EXPOSURE DURING PREGNANCY,24
CA,HUMAN HERPESVIRUS 6 INFECTION,24
CA,INCREASED TENDENCY TO BRUISE,24
CA,INTERNATIONAL NORMALISED RATIO FLUCTUATION,24
CA,INTERNATIONAL NORMALISED RATIO INCREASED,24
CA,IRON DEFICIENCY,24
CA,LIMB OPERATION,24
CA,OSTEONECROSIS,24
CA,PLEURISY,24
CA,RENAL FAILURE ACUTE,24
CA,RESPIRATORY ARREST,24
CA,SHOULDER ARTHROPLASTY,24
CA,SKIN FISSURES,24
CA,SPINAL PAIN,24
CA,SPLENOMEGALY,24
CA,THYROID NEOPLASM,24
CA,URINARY RETENTION,24
CA,URINE ABNORMALITY,24
CA,ANGER,23
CA,APPENDICITIS,23
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,23
CA,BLOOD POTASSIUM INCREASED,23
CA,BLOOD SODIUM DECREASED,23
CA,BONE MARROW FAILURE,23
CA,CATARACT OPERATION,23
CA,CYTOMEGALOVIRUS VIRAEMIA,23
CA,DEVICE RELATED INFECTION,23
CA,GRIP STRENGTH DECREASED,23
CA,HAND FRACTURE,23
CA,INTENTIONAL PRODUCT MISUSE,23
CA,JUVENILE IDIOPATHIC ARTHRITIS,23
CA,NEOPLASM,23
CA,PARAINFLUENZAE VIRUS INFECTION,23
CA,RHONCHI,23
CA,SPINAL COMPRESSION FRACTURE,23
CA,UNDERDOSE,23
CA,CARDIOVASCULAR DISORDER,22
CA,COMPRESSION FRACTURE,22
CA,DIFFUSE LARGE B-CELL LYMPHOMA,22
CA,EOSINOPHIL COUNT INCREASED,22
CA,FAECES SOFT,22
CA,HEPATITIS B,22
CA,INCREASED BRONCHIAL SECRETION,22
CA,INCREASED UPPER AIRWAY SECRETION,22
CA,MONOCYTE COUNT INCREASED,22
CA,NON-HODGKIN^S LYMPHOMA,22
CA,OESOPHAGEAL CANDIDIASIS,22
CA,OSTEONECROSIS OF JAW,22
CA,PNEUMATOSIS INTESTINALIS,22
CA,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,22
CA,PROCTALGIA,22
CA,PULMONARY HYPERTENSION,22
CA,RHINOVIRUS INFECTION,22
CA,SCOLIOSIS,22
CA,TUBERCULOSIS,22
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,22
CA,ACUTE MYOCARDIAL INFARCTION,21
CA,ASCITES,21
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,21
CA,BLOOD DISORDER,21
CA,BONE DENSITY ABNORMAL,21
CA,BRADYCARDIA,21
CA,BRAIN NEOPLASM,21
CA,CHOKING,21
CA,CONVULSION,21
CA,DIPLOPIA,21
CA,EYE DISCHARGE,21
CA,GASTROINTESTINAL PAIN,21
CA,GRAFT VERSUS HOST DISEASE,21
CA,NERVOUS SYSTEM DISORDER,21
CA,PULMONARY FUNCTION TEST ABNORMAL,21
CA,PULMONARY HAEMORRHAGE,21
CA,SKIN REACTION,21
CA,URINARY TRACT DISORDER,21
CA,ACTINIC KERATOSIS,20
CA,ARTHRITIS BACTERIAL,20
CA,ARTHROPOD BITE,20
CA,CHROMATURIA,20
CA,DISORIENTATION,20
CA,EYE OPERATION,20
CA,FACIAL PAIN,20
CA,FOOD ALLERGY,20
CA,FOOD POISONING,20
CA,FOOT OPERATION,20
CA,GASTRIC INFECTION,20
CA,INJECTION SITE RASH,20
CA,INTERNAL HAEMORRHAGE,20
CA,INTERVERTEBRAL DISC DISORDER,20
CA,MUCOUS STOOLS,20
CA,MULTIPLE FRACTURES,20
CA,PANIC ATTACK,20
CA,PLEURITIC PAIN,20
CA,PSEUDOMONAS INFECTION,20
CA,PSYCHIATRIC SYMPTOM,20
CA,PULMONARY THROMBOSIS,20
CA,REMISSION NOT ACHIEVED,20
CA,SKIN BURNING SENSATION,20
CA,TENDON DISORDER,20
CA,THERAPEUTIC RESPONSE SHORTENED,20
CA,UTERINE LEIOMYOMA,20
CA,ABSCESS INTESTINAL,19
CA,ANKLE DEFORMITY,19
CA,ANTINUCLEAR ANTIBODY POSITIVE,19
CA,BLOOD BILIRUBIN INCREASED,19
CA,BLOOD GLUCOSE ABNORMAL,19
CA,CONCUSSION,19
CA,CUSHING^S SYNDROME,19
CA,DEVICE DISLOCATION,19
CA,DIABETES MELLITUS INADEQUATE CONTROL,19
CA,ENTEROBACTER INFECTION,19
CA,EXOSTOSIS,19
CA,HAEMOGLOBIN ABNORMAL,19
CA,HUMAN BOCAVIRUS INFECTION,19
CA,HYPERSOMNIA,19
CA,HYPONATRAEMIA,19
CA,NO THERAPEUTIC RESPONSE,19
CA,PREMATURE DELIVERY,19
CA,PROSTATE CANCER METASTATIC,19
CA,PSEUDOMONAL SEPSIS,19
CA,SCLERODERMA,19
CA,SCRATCH,19
CA,SKIN WARM,19
CA,TENOSYNOVITIS,19
CA,THERMAL BURN,19
CA,URINE OUTPUT DECREASED,19
CA,ABDOMINAL ABSCESS,18
CA,COLON CANCER,18
CA,CUSHINGOID,18
CA,DIVERTICULUM,18
CA,DIZZINESS POSTURAL,18
CA,ELECTROLYTE IMBALANCE,18
CA,EOSINOPHILIA,18
CA,FRUSTRATION TOLERANCE DECREASED,18
CA,GINGIVAL PAIN,18
CA,HIP SURGERY,18
CA,INCORRECT DOSAGE ADMINISTERED,18
CA,INJECTION SITE HYPERSENSITIVITY,18
CA,IRITIS,18
CA,MENORRHAGIA,18
CA,MICTURITION URGENCY,18
CA,ORGANISING PNEUMONIA,18
CA,PREMATURE BABY,18
CA,SKIN ABRASION,18
CA,SOLAR LENTIGO,18
CA,TEMPERATURE INTOLERANCE,18
CA,THROMBOCYTOSIS,18
CA,TREATMENT NONCOMPLIANCE,18
CA,TUBERCULIN TEST POSITIVE,18
CA,UMBILICAL HERNIA,18
CA,VEIN DISORDER,18
CA,VIRAEMIA,18
CA,ABDOMINAL ADHESIONS,17
CA,ACUTE MYELOID LEUKAEMIA,17
CA,ADJUSTMENT DISORDER WITH DEPRESSED MOOD,17
CA,AUTOIMMUNE DISORDER,17
CA,CARDIAC VALVE DISEASE,17
CA,CORONA VIRUS INFECTION,17
CA,CYTOPENIA,17
CA,DISSEMINATED INTRAVASCULAR COAGULATION,17
CA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,17
CA,ECCHYMOSIS,17
CA,ERYTHEMA NODOSUM,17
CA,INCISION SITE INFECTION,17
CA,INTERVERTEBRAL DISC COMPRESSION,17
CA,INTERVERTEBRAL DISC SPACE NARROWING,17
CA,MULTIPLE ALLERGIES,17
CA,MUSCLE DISORDER,17
CA,MUSCLE SPASTICITY,17
CA,OBSTRUCTION,17
CA,PRODUCT QUALITY ISSUE,17
CA,RAYNAUD^S PHENOMENON,17
CA,RESPIRATORY RATE DECREASED,17
CA,SCLERITIS,17
CA,SKIN PLAQUE,17
CA,THIRST,17
CA,TRANSFUSION,17
CA,URINE ODOUR ABNORMAL,17
CA,ABDOMINAL TENDERNESS,16
CA,ABNORMAL FAECES,16
CA,ANIMAL BITE,16
CA,ARTERIAL OCCLUSIVE DISEASE,16
CA,CEREBRAL DISORDER,16
CA,CHRONIC SINUSITIS,16
CA,COLD SWEAT,16
CA,DEAFNESS,16
CA,DERMATITIS,16
CA,FEELING DRUNK,16
CA,GLOMERULAR FILTRATION RATE DECREASED,16
CA,HAEMORRHAGE INTRACRANIAL,16
CA,HYPOKALAEMIA,16
CA,INFUSION SITE EXTRAVASATION,16
CA,INTENTIONAL PRODUCT USE ISSUE,16
CA,NO ADVERSE EVENT,16
CA,OSTEOPOROTIC FRACTURE,16
CA,OVARIAN CYST,16
CA,PHLEBITIS,16
CA,PHOTODERMATOSIS,16
CA,PLEURAL THICKENING,16
CA,PNEUMONIA VIRAL,16
CA,POST PROCEDURAL HAEMORRHAGE,16
CA,PROTEINURIA,16
CA,PULMONARY PAIN,16
CA,SARCOIDOSIS,16
CA,SINUS HEADACHE,16
CA,SINUS PAIN,16
CA,SKIN MASS,16
CA,SPINAL OPERATION,16
CA,VENOUS THROMBOSIS,16
CA,WRIST SURGERY,16
CA,ABSCESS LIMB,15
CA,BLADDER CANCER,15
CA,BLINDNESS UNILATERAL,15
CA,CARDIOMYOPATHY,15
CA,CYSTIC FIBROSIS,15
CA,DEFAECATION URGENCY,15
CA,DRUG EFFECT DELAYED,15
CA,EAR PRURITUS,15
CA,ENCEPHALITIS,15
CA,EYE INFLAMMATION,15
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,15
CA,GASTRIC HAEMORRHAGE,15
CA,GROIN PAIN,15
CA,HAEMATEMESIS,15
CA,HERPES VIRUS INFECTION,15
CA,HYPOPNOEA,15
CA,ILEAL STENOSIS,15
CA,IMMUNOSUPPRESSION,15
CA,INFLAMMATORY BOWEL DISEASE,15
CA,INFUSION SITE ERYTHEMA,15
CA,INTRAOCULAR PRESSURE INCREASED,15
CA,NECK DEFORMITY,15
CA,NOROVIRUS TEST POSITIVE,15
CA,ORTHOSTATIC HYPOTENSION,15
CA,PAINFUL RESPIRATION,15
CA,PELVIC PAIN,15
CA,PERIPHERAL COLDNESS,15
CA,PURULENT DISCHARGE,15
CA,PYELONEPHRITIS,15
CA,RENAL CYST,15
CA,RETINAL DETACHMENT,15
CA,SPINAL OSTEOARTHRITIS,15
CA,SUPRAVENTRICULAR TACHYCARDIA,15
CA,THERAPEUTIC REACTION TIME DECREASED,15
CA,UPPER RESPIRATORY TRACT CONGESTION,15
CA,ACQUIRED HAEMOPHILIA,14
CA,ACUTE RESPIRATORY DISTRESS SYNDROME,14
CA,ANAL INCONTINENCE,14
CA,AORTIC ANEURYSM,14
CA,APATHY,14
CA,ASTHMATIC CRISIS,14
CA,AUTOIMMUNE HAEMOLYTIC ANAEMIA,14
CA,BLOOD CALCIUM DECREASED,14
CA,BLOOD PRESSURE SYSTOLIC ABNORMAL,14
CA,BONE SWELLING,14
CA,BRONCHIAL DISORDER,14
CA,BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC,14
CA,CHOLECYSTECTOMY,14
CA,CYSTITIS BACTERIAL,14
CA,DIFFUSE ALVEOLAR DAMAGE,14
CA,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,14
CA,DRUG SPECIFIC ANTIBODY PRESENT,14
CA,DYSPNOEA AT REST,14
CA,FACE OEDEMA,14
CA,GOITRE,14
CA,HEPATOMEGALY,14
CA,HERPES SIMPLEX,14
CA,HYPERAESTHESIA,14
CA,INCORRECT ROUTE OF DRUG ADMINISTRATION,14
CA,INCREASED APPETITE,14
CA,INFECTED SKIN ULCER,14
CA,LIGAMENT RUPTURE,14
CA,LIP ULCERATION,14
CA,LOOSE BODY IN JOINT,14
CA,LYMPHADENECTOMY,14
CA,MELAENA,14
CA,MELANOCYTIC NAEVUS,14
CA,MENINGITIS,14
CA,MUSCLE RUPTURE,14
CA,NASAL DISCHARGE DISCOLOURATION,14
CA,PANCREATIC CARCINOMA,14
CA,PARAESTHESIA ORAL,14
CA,PERFUME SENSITIVITY,14
CA,PETECHIAE,14
CA,PSYCHOTIC DISORDER,14
CA,RESTLESS LEGS SYNDROME,14
CA,RESTRICTIVE PULMONARY DISEASE,14
CA,RETCHING,14
CA,RHABDOMYOLYSIS,14
CA,SHOCK,14
CA,SKIN IRRITATION,14
CA,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,14
CA,SPINAL FUSION SURGERY,14
CA,TEMPORAL ARTERITIS,14
CA,TOTAL LUNG CAPACITY DECREASED,14
CA,UROSEPSIS,14
CA,VAGINAL INFECTION,14
CA,ABSCESS BACTERIAL,13
CA,ADVERSE REACTION,13
CA,ANKLE OPERATION,13
CA,ANKYLOSING SPONDYLITIS,13
CA,ANTIBODY TEST POSITIVE,13
CA,ARTERIOVENOUS FISTULA OCCLUSION,13
CA,BLOODY DISCHARGE,13
CA,BREAST PAIN,13
CA,CARTILAGE INJURY,13
CA,CHOLANGITIS,13
CA,COLECTOMY TOTAL,13
CA,DYSARTHRIA,13
CA,EPSTEIN-BARR VIRUS INFECTION,13
CA,EXCORIATION,13
CA,EXTRASYSTOLES,13
CA,FEAR,13
CA,GENERALISED TONIC-CLONIC SEIZURE,13
CA,HEMIPARESIS,13
CA,HEPATIC FUNCTION ABNORMAL,13
CA,HUMERUS FRACTURE,13
CA,IMPAIRED QUALITY OF LIFE,13
CA,LYMPH NODE PAIN,13
CA,MALNUTRITION,13
CA,MENISCUS INJURY,13
CA,MOOD ALTERED,13
CA,MOUTH HAEMORRHAGE,13
CA,MUSCLE TIGHTNESS,13
CA,MYASTHENIA GRAVIS,13
CA,MYCOBACTERIUM AVIUM COMPLEX INFECTION,13
CA,MYOCARDITIS,13
CA,ODYNOPHAGIA,13
CA,ORAL INFECTION,13
CA,PAIN OF SKIN,13
CA,PARANASAL SINUS DISCOMFORT,13
CA,POST PROCEDURAL DISCHARGE,13
CA,PROSTATIC DISORDER,13
CA,PYODERMA GANGRENOSUM,13
CA,RESPIRATORY TRACT INFLAMMATION,13
CA,THINKING ABNORMAL,13
CA,TOE OPERATION,13
CA,WOUND DEHISCENCE,13
CA,X-RAY ABNORMAL,13
CA,AGEUSIA,12
CA,ANEURYSM,12
CA,ANOSMIA,12
CA,APPENDICECTOMY,12
CA,CARDIAC MURMUR,12
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,12
CA,DEVICE BREAKAGE,12
CA,DRUG PRESCRIBING ERROR,12
CA,DUST ALLERGY,12
CA,EPILEPSY,12
CA,FUNGAL SKIN INFECTION,12
CA,H1N1 INFLUENZA,12
CA,HYPERCHOLESTEROLAEMIA,12
CA,HYPERKALAEMIA,12
CA,HYPERTHYROIDISM,12
CA,HYSTERECTOMY,12
CA,INFECTION SUSCEPTIBILITY INCREASED,12
CA,INFLAMMATORY MARKER INCREASED,12
CA,INFUSION SITE PAIN,12
CA,INJECTION SITE DISCOLOURATION,12
CA,INTESTINAL POLYP,12
CA,LARGE INTESTINE PERFORATION,12
CA,LIVER INJURY,12
CA,MANIA,12
CA,METASTASES TO BONE,12
CA,MYELODYSPLASTIC SYNDROME,12
CA,MYOPATHY,12
CA,NAIL DISORDER,12
CL,DRUG INEFFECTIVE,22
CL,VOMITING,15
CL,DIARRHOEA,14
CL,PAIN,12
CL,PNEUMONIA,12
CL,ARTHRALGIA,9
CL,ARTHRITIS,9
CL,FALL,9
CL,MALAISE,9
CL,SWELLING,9
CL,URINARY TRACT INFECTION,9
CL,ANAEMIA,8
CL,INFLAMMATION,8
CL,NASOPHARYNGITIS,8
CL,PYREXIA,8
CL,RESPIRATORY FAILURE,8
CL,DIZZINESS,7
CL,DYSPNOEA,7
CL,SEPTIC SHOCK,7
CL,ABDOMINAL PAIN,6
CL,GASTRITIS,6
CL,HEADACHE,6
CL,NAUSEA,6
CL,VARICELLA ZOSTER VIRUS INFECTION,6
CL,ARTHROPATHY,5
CL,ASTHENIA,5
CL,ERYTHEMA,5
CL,FATIGUE,5
CL,HAEMATOCHEZIA,5
CL,MUSCULAR WEAKNESS,5
CL,PAIN IN EXTREMITY,5
CL,PERIPHERAL SWELLING,5
CL,SEPSIS,5
CL,ACUTE MYELOID LEUKAEMIA,4
CL,BACK PAIN,4
CL,DECREASED APPETITE,4
CL,DEPRESSION,4
CL,IMMUNE SYSTEM DISORDER,4
CL,MUSCULOSKELETAL PAIN,4
CL,NEUTROPENIA,4
CL,PLASMABLASTIC LYMPHOMA,4
CL,PRODUCT USE ISSUE,4
CL,RASH,4
CL,WEIGHT DECREASED,4
CL,ABDOMINAL PAIN UPPER,3
CL,ASTHMA,3
CL,BLOOD CREATININE INCREASED,3
CL,BRONCHITIS,3
CL,BURNING SENSATION,3
CL,CHOKING SENSATION,3
CL,CHOLESTASIS,3
CL,COLITIS,3
CL,CROHN^S DISEASE,3
CL,DRUG DOSE OMISSION,3
CL,DRUG EFFECT INCOMPLETE,3
CL,FOETAL EXPOSURE DURING PREGNANCY,3
CL,FOOD ALLERGY,3
CL,GENERAL PHYSICAL HEALTH DETERIORATION,3
CL,HERPES ZOSTER,3
CL,HYPERTENSION,3
CL,HYPERTENSIVE CRISIS,3
CL,IMMUNODEFICIENCY,3
CL,INSOMNIA,3
CL,JOINT SWELLING,3
CL,MYALGIA,3
CL,POST PROCEDURAL HAEMORRHAGE,3
CL,PREMATURE BABY,3
CL,PROTEINURIA,3
CL,PRURITUS,3
CL,RENAL IMPAIRMENT,3
CL,SYSTEMIC LUPUS ERYTHEMATOSUS,3
CL,VERTIGO,3
CL,WHITE BLOOD CELL COUNT DECREASED,3
CL,ALANINE AMINOTRANSFERASE INCREASED,2
CL,ANAPHYLACTIC REACTION,2
CL,APGAR SCORE LOW,2
CL,ASPARTATE AMINOTRANSFERASE INCREASED,2
CL,ASTHMATIC CRISIS,2
CL,AZOTAEMIA,2
CL,BLOOD TEST ABNORMAL,2
CL,BLOOD UREA INCREASED,2
CL,BONE PAIN,2
CL,CARDIAC FAILURE,2
CL,CATARACT,2
CL,COLITIS ULCERATIVE,2
CL,CONSTIPATION,2
CL,DEATH,2
CL,DEEP VEIN THROMBOSIS,2
CL,DEHYDRATION,2
CL,DERMATITIS ALLERGIC,2
CL,DIABETES MELLITUS,2
CL,DISORIENTATION,2
CL,ENCEPHALITIS,2
CL,FEELING ABNORMAL,2
CL,FOETAL DISTRESS SYNDROME,2
CL,FRACTURED COCCYX,2
CL,GAIT DISTURBANCE,2
CL,HAND DEFORMITY,2
CL,HEPATIC FAILURE,2
CL,HEPATITIS,2
CL,HERNIA,2
CL,HIP FRACTURE,2
CL,HISTIOCYTOSIS HAEMATOPHAGIC,2
CL,HYDRONEPHROSIS,2
CL,HYPOTENSION,2
CL,INFECTION,2
CL,INFLUENZA,2
CL,INTERVERTEBRAL DISC PROTRUSION,2
CL,INTESTINAL OBSTRUCTION,2
CL,INTESTINAL PERFORATION,2
CL,JAUNDICE,2
CL,KIDNEY TRANSPLANT REJECTION,2
CL,LIMB OPERATION,2
CL,LOW BIRTH WEIGHT BABY,2
CL,MEDICATION ERROR,2
CL,METABOLIC ACIDOSIS,2
CL,MUSCLE SPASMS,2
CL,MUSCULOSKELETAL STIFFNESS,2
CL,MYOCARDIAL INFARCTION,2
CL,MYOSITIS,2
CL,OCULAR HYPERAEMIA,2
CL,OSTEOPOROSIS,2
CL,PARAESTHESIA,2
CL,POSTOPERATIVE WOUND INFECTION,2
CL,PULMONARY EMBOLISM,2
CL,PULMONARY MASS,2
CL,RESPIRATORY DISTRESS,2
CL,RHEUMATOID ARTHRITIS,2
CL,SINUSITIS,2
CL,STRESS,2
CL,TACHYCARDIA,2
CL,THROMBOSIS,2
CL,TRANSAMINASES INCREASED,2
CL,TREMOR,2
CL,UROSEPSIS,2
CL,ABDOMINAL ABSCESS,1
CL,ABDOMINAL WALL ABSCESS,1
CL,ABDOMINAL WOUND DEHISCENCE,1
CL,ABSCESS LIMB,1
CL,ACUTE ABDOMEN,1
CL,ACUTE KIDNEY INJURY,1
CL,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
CL,ACUTE PULMONARY OEDEMA,1
CL,ACUTE RESPIRATORY DISTRESS SYNDROME,1
CL,ACUTE RESPIRATORY FAILURE,1
CL,ADENOIDAL DISORDER,1
CL,ADNEXA UTERI CYST,1
CL,ALLERGIC OEDEMA,1
CL,ALOPECIA,1
CL,ALTERED STATE OF CONSCIOUSNESS,1
CL,AMENORRHOEA,1
CL,AMNESIA,1
CL,AMNIOTIC FLUID VOLUME INCREASED,1
CL,ANAL ABSCESS,1
CL,ANAL HAEMORRHAGE,1
CL,ANAL PROLAPSE,1
CL,ANGIOEDEMA,1
CL,APHONIA,1
CL,APPENDIX DISORDER,1
CL,ARRHYTHMIA,1
CL,ARTERIOSCLEROSIS,1
CL,ARTERIOSPASM CORONARY,1
CL,ARTHRITIS BACTERIAL,1
CL,ARTHRITIS INFECTIVE,1
CL,ASCITES,1
CL,ASPHYXIA,1
CL,ASPIRATION,1
CL,AUTOIMMUNE HEPATITIS,1
CL,BACTERIAL TRANSLOCATION,1
CL,BENIGN NEOPLASM OF THYROID GLAND,1
CL,BLINDNESS,1
CL,BLOOD CHOLESTEROL INCREASED,1
CL,BLOOD CREATININE DECREASED,1
CL,BLOOD GASES ABNORMAL,1
CL,BLOOD GLUCOSE INCREASED,1
CL,BLOOD PRESSURE ABNORMAL,1
CL,BLOOD PRESSURE INCREASED,1
CL,BLOOD URINE PRESENT,1
CL,BONE MARROW FAILURE,1
CL,BRAIN DEATH,1
CL,BRAIN NEOPLASM,1
CL,BRAIN NEOPLASM BENIGN,1
CL,BREAST MASS,1
CL,BREAST PAIN,1
CL,BREECH DELIVERY,1
CL,BREECH PRESENTATION,1
CL,BRONCHIOLOALVEOLAR CARCINOMA,1
CL,BRONCHOSPASM,1
CL,BURSA DISORDER,1
CL,C-REACTIVE PROTEIN INCREASED,1
CL,CALCULUS BLADDER,1
CL,CAMPYLOBACTER INFECTION,1
CL,CANDIDA INFECTION,1
CL,CARDIAC DISORDER,1
CL,CARDIO-RESPIRATORY ARREST,1
CL,CERVIX HAEMATOMA UTERINE,1
CL,CHEMICAL PERITONITIS,1
CL,CHILLS,1
CL,CHOLECYSTITIS ACUTE,1
CL,CHOLELITHIASIS,1
CL,CHRONIC ALLOGRAFT NEPHROPATHY,1
CL,COMBINED IMMUNODEFICIENCY,1
CL,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
CL,CONTUSION,1
CL,CORONARY ARTERY BYPASS,1
CL,CORONARY ARTERY DISEASE,1
CL,CORONARY ARTERY OCCLUSION,1
CL,COUGH,1
CL,CREATININE RENAL CLEARANCE DECREASED,1
CL,CRYING,1
CL,CRYPTOCOCCOSIS,1
CL,CUSHINGOID,1
CL,CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION,1
CL,CYTOMEGALOVIRUS INFECTION,1
CL,DELAYED GRAFT FUNCTION,1
CL,DEPRESSED MOOD,1
CL,DERMATITIS,1
CL,DEVICE ISSUE,1
CL,DEVICE RELATED INFECTION,1
CL,DIABETIC COMA,1
CL,DIABETIC KETOACIDOSIS,1
CL,DIARRHOEA HAEMORRHAGIC,1
CL,DISCOMFORT,1
CL,DISEASE PROGRESSION,1
CL,DIVERTICULITIS,1
CL,DIVERTICULUM,1
CL,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
CL,DRUG LEVEL INCREASED,1
CL,DRUG PRESCRIBING ERROR,1
CL,DRUG-INDUCED LIVER INJURY,1
CL,DYSPHAGIA,1
CL,DYSSTASIA,1
CL,DYSURIA,1
CL,EAR PAIN,1
CL,EATING DISORDER,1
CL,ELBOW DEFORMITY,1
CL,ELECTRIC SHOCK,1
CL,EMPHYSEMATOUS CYSTITIS,1
CL,ENDOMETRIOSIS,1
CL,ENDOMETRITIS,1
CL,ENERGY INCREASED,1
CL,ENTEROBACTER TEST POSITIVE,1
CL,ENTEROCOLITIS,1
CL,EPICONDYLITIS,1
CL,EPILEPSY,1
CL,EPISCLERITIS,1
CL,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,1
CL,EPSTEIN-BARR VIRUS INFECTION,1
CL,EPSTEIN-BARR VIRUS TEST POSITIVE,1
CL,EUPHORIC MOOD,1
CL,EXPOSURE DURING PREGNANCY,1
CL,FAECAL CALPROTECTIN ABNORMAL,1
CL,FAECALOMA,1
CL,FEBRILE NEUTROPENIA,1
CL,FEELING HOT,1
CL,FLUID RETENTION,1
CL,FOOD INTOLERANCE,1
CL,FOOT DEFORMITY,1
CL,FOOT FRACTURE,1
CL,FOOT OPERATION,1
CL,FREQUENT BOWEL MOVEMENTS,1
CL,FUNGAL PERITONITIS,1
CL,GASTRIC HAEMORRHAGE,1
CL,GASTRITIS EROSIVE,1
CL,GASTROENTERITIS,1
CL,GASTROINTESTINAL INFECTION,1
CL,GASTROINTESTINAL INFLAMMATION,1
CL,GASTROINTESTINAL NECROSIS,1
CL,GASTROINTESTINAL SOUNDS ABNORMAL,1
CL,HAEMATOCRIT DECREASED,1
CL,HAEMATOMA,1
CL,HAEMORRHAGE,1
CL,HAEMORRHOIDS,1
CL,HAIR GROWTH ABNORMAL,1
CL,HALLUCINATION,1
CL,HEART RATE DECREASED,1
CL,HEART RATE NORMAL,1
CL,HEMIPLEGIA,1
CL,HEPATOTOXICITY,1
CL,HOSPITALISATION,1
CL,HYPERCAPNIA,1
CL,HYPERGLYCAEMIA,1
CL,HYPERHIDROSIS,1
CL,HYPERSENSITIVITY,1
CL,HYPOAESTHESIA,1
CL,HYPOALBUMINAEMIA,1
CL,HYPOGAMMAGLOBULINAEMIA,1
CL,HYPOPHAGIA,1
CL,HYPOXIA,1
CL,ILEUS PARALYTIC,1
CL,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
CL,IMPLANTABLE DEFIBRILLATOR INSERTION,1
CL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CL,INCREASED BRONCHIAL SECRETION,1
CL,INFECTION IN AN IMMUNOCOMPROMISED HOST,1
CL,INJECTION SITE PAIN,1
CL,INTENTIONAL PRODUCT USE ISSUE,1
CL,INTERSTITIAL LUNG DISEASE,1
CL,INTESTINAL HAEMORRHAGE,1
CL,JOINT DESTRUCTION,1
CL,JOINT DISLOCATION,1
CL,JOINT EFFUSION,1
CL,JUVENILE PSORIATIC ARTHRITIS,1
CL,KELOID SCAR,1
CL,KIDNEY FIBROSIS,1
CL,LARYNGITIS,1
CL,LEUKOCYTOSIS,1
CL,LEUKOPENIA,1
CL,LIGAMENT SPRAIN,1
CL,LIVE BIRTH,1
CL,LOSS OF CONSCIOUSNESS,1
CL,LUMBAR RADICULOPATHY,1
CL,LUNG DISORDER,1
CL,LUNG PERFORATION,1
CL,LUPUS NEPHRITIS,1
CL,LYMPHADENOPATHY,1
CL,LYMPHOCELE,1
CL,LYMPHOMA,1
CL,MALARIA,1
CL,MALNUTRITION,1
CL,MATERNAL EXPOSURE DURING PREGNANCY,1
CL,MECONIUM IN AMNIOTIC FLUID,1
CL,MEMORY IMPAIRMENT,1
CL,MENINGITIS,1
CL,MENSTRUATION IRREGULAR,1
CL,MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS,1
CL,METASTASES TO LIVER,1
CL,MOTOR DYSFUNCTION,1
CL,MUSCLE ATROPHY,1
CL,MUSCLE FIBROSIS,1
CL,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
CL,MYOMECTOMY,1
CL,NASAL CONGESTION,1
CL,NASAL POLYPS,1
CL,NECK PAIN,1
CL,NEPHRITIS ALLERGIC,1
CL,NEPHROLITHIASIS,1
CL,NEPHROPATHY TOXIC,1
CL,NEPHROSTOMY,1
CL,NEUTROPHIL COUNT DECREASED,1
CL,NODULE,1
CL,OBSTRUCTIVE AIRWAYS DISORDER,1
CL,OEDEMA PERIPHERAL,1
CL,OESOPHAGEAL CANDIDIASIS,1
CL,ORAL HERPES,1
CL,OSTEONECROSIS OF JAW,1
CL,OXYGEN SATURATION DECREASED,1
CL,OXYGEN SATURATION NORMAL,1
CL,PAIN OF SKIN,1
CL,PANCREATIC NECROSIS,1
CL,PANCREATITIS,1
CL,PERITONEAL DISORDER,1
CL,PERITONITIS,1
CL,PHARYNGITIS,1
CL,PLATELET COUNT DECREASED,1
CL,PLEURAL EFFUSION,1
CL,PNEUMONIA ASPIRATION,1
CL,PNEUMONIA BACTERIAL,1
CL,PNEUMONIA KLEBSIELLA,1
CL,PNEUMONITIS,1
CL,POLYDIPSIA,1
CL,POLYMERASE CHAIN REACTION,1
CL,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,1
CL,POLYURIA,1
CL,POST PROCEDURAL COMPLICATION,1
CL,POST PROCEDURAL INFECTION,1
CL,POSTURE ABNORMAL,1
CL,PREMATURE DELIVERY,1
CL,PREMATURE RUPTURE OF MEMBRANES,1
CL,PRESYNCOPE,1
CL,PROCEDURAL COMPLICATION,1
CL,PROCEDURAL INTESTINAL PERFORATION,1
CL,PROCEDURAL PAIN,1
CL,PRODUCT USE IN UNAPPROVED INDICATION,1
CL,PRODUCT USED FOR UNKNOWN INDICATION,1
CL,PRURITUS GENERALISED,1
CL,PULMONARY FIBROSIS,1
CL,PULMONARY HYPERTENSION,1
CL,PULMONARY OEDEMA,1
CL,PYELONEPHRITIS ACUTE,1
CL,PYRAMIDAL TRACT SYNDROME,1
CL,RASH MACULAR,1
CL,RECALL PHENOMENON,1
CL,RECTAL HAEMORRHAGE,1
CL,RECTAL POLYP,1
CL,RED BLOOD CELL COUNT DECREASED,1
CL,RENAL CANCER RECURRENT,1
CL,RENAL CYST,1
CL,RENAL FAILURE,1
CL,RENAL INJURY,1
CL,RENAL TUBULAR NECROSIS,1
CL,RESPIRATORY DISORDER,1
CL,RESPIRATORY TRACT INFECTION,1
CL,RESPIRATORY TRACT INFECTION VIRAL,1
CL,RETINAL INJURY,1
CL,RETROPERITONEAL MASS,1
CL,RHINITIS,1
CL,RHINOVIRUS INFECTION,1
CL,RIB FRACTURE,1
CL,SENSORY DISTURBANCE,1
CL,SKIN DISCOLOURATION,1
CL,SKIN DISORDER,1
CL,SKIN INFECTION,1
CL,SKIN WARM,1
CL,SLEEP APNOEA SYNDROME,1
CL,SLUGGISHNESS,1
CL,SOMNOLENCE,1
CL,SPINAL DEFORMITY,1
CL,SPLENOMEGALY,1
CL,STERNAL FRACTURE,1
CL,STEVENS-JOHNSON SYNDROME,1
CL,STOMA SITE PAIN,1
CL,STRIDOR,1
CL,SUICIDAL IDEATION,1
CL,SUPERINFECTION,1
CL,SUPERINFECTION BACTERIAL,1
CL,SWELLING FACE,1
CL,SYNOVIAL CYST,1
CL,SYNOVIAL FLUID ANALYSIS ABNORMAL,1
CL,SYNOVITIS,1
CL,TACHYARRHYTHMIA,1
CL,THERAPEUTIC RESPONSE DECREASED,1
CL,THERAPY NON-RESPONDER,1
CL,THIRST,1
CL,THROMBOCYTOPENIA,1
CL,THROMBOCYTOSIS,1
CL,THROMBOPHLEBITIS,1
CL,THYMOMA,1
CL,THYROID HORMONES INCREASED,1
CL,TONGUE DISORDER,1
CL,TONSILLITIS,1
CL,TOOTH DISORDER,1
CL,TOOTH INJURY,1
CL,TOXOCARIASIS,1
CL,TUBULOINTERSTITIAL NEPHRITIS,1
CL,TYPE 1 DIABETES MELLITUS,1
CL,ULTRASOUND ABDOMEN ABNORMAL,1
CL,UNDERWEIGHT,1
CL,UPPER RESPIRATORY TRACT INFECTION,1
CL,URINARY TRACT INFECTION BACTERIAL,1
CL,URINARY TRACT INFLAMMATION,1
CL,URINE OUTPUT DECREASED,1
CL,URTICARIA,1
CL,UTERINE LEIOMYOMA,1
CL,UVEITIS,1
CL,VARICELLA,1
CL,VENA CAVA THROMBOSIS,1
CL,VIITH NERVE PARALYSIS,1
CL,VIRAL INFECTION,1
CL,WALKING DISTANCE TEST NORMAL,1
CL,WHITE BLOOD CELL COUNT INCREASED,1
CL,WRIST FRACTURE,1
CN,LYMPHOCYTE COUNT DECREASED,97
CN,HAEMOGLOBIN DECREASED,91
CN,PYREXIA,79
CN,BLOOD GLUCOSE INCREASED,71
CN,NEUTROPHIL COUNT INCREASED,71
CN,BLOOD UREA INCREASED,65
CN,BONE MARROW FAILURE,63
CN,WHITE BLOOD CELL COUNT INCREASED,60
CN,BLOOD CREATININE INCREASED,59
CN,PNEUMONIA,58
CN,DIARRHOEA,57
CN,LUNG INFECTION,57
CN,INTERSTITIAL LUNG DISEASE,48
CN,INCISION SITE PAIN,47
CN,ANAEMIA,44
CN,PLATELET COUNT DECREASED,43
CN,ALANINE AMINOTRANSFERASE INCREASED,42
CN,RED BLOOD CELLS URINE POSITIVE,41
CN,RESPIRATORY FAILURE,40
CN,PROTEIN URINE PRESENT,39
CN,LUNG DISORDER,37
CN,IATROGENIC INJURY,36
CN,PNEUMOCYSTIS JIROVECII PNEUMONIA,35
CN,DEATH,34
CN,C-REACTIVE PROTEIN INCREASED,31
CN,HYPERBILIRUBINAEMIA,31
CN,THROMBOCYTOPENIA,31
CN,TRAUMATIC LUNG INJURY,29
CN,DRUG INEFFECTIVE,28
CN,HEPATIC FUNCTION ABNORMAL,28
CN,INFECTION,28
CN,NEUTROPENIA,28
CN,SEPSIS,27
CN,URINARY TRACT INFECTION,26
CN,OESOPHAGEAL CANDIDIASIS,24
CN,BLOOD ALBUMIN DECREASED,23
CN,COUGH,23
CN,DIABETES MELLITUS,23
CN,FEBRILE NEUTROPENIA,23
CN,NEUROTOXICITY,23
CN,CANDIDA INFECTION,22
CN,DECREASED APPETITE,22
CN,ASPARTATE AMINOTRANSFERASE INCREASED,21
CN,BLOOD TRIGLYCERIDES INCREASED,21
CN,DISEASE PROGRESSION,21
CN,LEUKOPENIA,21
CN,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,21
CN,CARDIAC FAILURE,20
CN,DISEASE RECURRENCE,20
CN,LYMPHOPENIA,20
CN,PULMONARY TUBERCULOSIS,20
CN,COMPLICATIONS OF TRANSPLANTED KIDNEY,19
CN,FATIGUE,19
CN,NAUSEA,19
CN,WHITE BLOOD CELL COUNT DECREASED,19
CN,ABDOMINAL DISTENSION,18
CN,HYPOALBUMINAEMIA,18
CN,HYPOKALAEMIA,18
CN,KIDNEY TRANSPLANT REJECTION,18
CN,BLOOD CHOLESTEROL INCREASED,17
CN,RENAL IMPAIRMENT,17
CN,VOMITING,17
CN,CHEST DISCOMFORT,16
CN,DYSPNOEA,16
CN,MULTI-ORGAN FAILURE,16
CN,PROCEDURAL PAIN,16
CN,PULMONARY TOXICITY,16
CN,RASH,16
CN,RENAL TUBULAR ACIDOSIS,16
CN,HYPERKALAEMIA,15
CN,PRODUCT USE IN UNAPPROVED INDICATION,15
CN,ABDOMINAL PAIN,14
CN,BILIRUBIN CONJUGATED INCREASED,14
CN,CYTOMEGALOVIRUS INFECTION,14
CN,DRUG-INDUCED LIVER INJURY,14
CN,FUNGAL INFECTION,14
CN,GASTROINTESTINAL DISORDER,14
CN,OVERDOSE,14
CN,PROTEINURIA,14
CN,TOXICITY TO VARIOUS AGENTS,14
CN,UPPER RESPIRATORY TRACT INFECTION,14
CN,HEPATITIS B,13
CN,LOW DENSITY LIPOPROTEIN INCREASED,13
CN,NASOPHARYNGITIS,13
CN,ASPERGILLUS INFECTION,12
CN,ASTHENIA,12
CN,BLOOD BILIRUBIN INCREASED,12
CN,CONSTIPATION,12
CN,HYPERLIPIDAEMIA,12
CN,ACUTE RESPIRATORY DISTRESS SYNDROME,11
CN,CONDITION AGGRAVATED,11
CN,GASTRIC PERFORATION,11
CN,HEPATITIS,11
CN,HIGH DENSITY LIPOPROTEIN DECREASED,11
CN,HYPERTENSION,11
CN,TRANSPLANT REJECTION,11
CN,ACUTE RESPIRATORY FAILURE,10
CN,AGRANULOCYTOSIS,10
CN,COMA,10
CN,FUNGAL OESOPHAGITIS,10
CN,HYDRONEPHROSIS,10
CN,LISTERIOSIS,10
CN,LIVER INJURY,10
CN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,10
CN,PRODUCTIVE COUGH,10
CN,RENAL FAILURE,10
CN,BLOOD URINE PRESENT,9
CN,DYSURIA,9
CN,HAEMATOCHEZIA,9
CN,HAEMATURIA,9
CN,NEUROPATHY PERIPHERAL,9
CN,OSTEOPOROSIS,9
CN,PLEURAL EFFUSION,9
CN,PNEUMONITIS,9
CN,SEPTIC SHOCK,9
CN,SURGERY,9
CN,CHRONIC MYELOID LEUKAEMIA,8
CN,EPILEPSY,8
CN,HEADACHE,8
CN,HEPATITIS B REACTIVATION,8
CN,HERPES ZOSTER,8
CN,OSTEONECROSIS,8
CN,URINE OUTPUT DECREASED,8
CN,WOUND COMPLICATION,8
CN,ACUTE KIDNEY INJURY,7
CN,ACUTE MYOCARDIAL INFARCTION,7
CN,ARRHYTHMIA,7
CN,ATRIAL FIBRILLATION,7
CN,DIZZINESS,7
CN,ERYTHEMA,7
CN,EXPOSURE DURING PREGNANCY,7
CN,HEPATIC ENCEPHALOPATHY,7
CN,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,7
CN,JAUNDICE,7
CN,LUNG NEOPLASM MALIGNANT,7
CN,LYMPHOMA,7
CN,PAIN,7
CN,PAIN IN EXTREMITY,7
CN,BLADDER CANCER,6
CN,BLOOD URIC ACID INCREASED,6
CN,BRONCHOPULMONARY ASPERGILLOSIS,6
CN,CHRONIC KIDNEY DISEASE,6
CN,CUSHING^S SYNDROME,6
CN,DELAYED GRAFT FUNCTION,6
CN,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,6
CN,GASTROINTESTINAL HAEMORRHAGE,6
CN,GLOMERULAR FILTRATION RATE DECREASED,6
CN,HEPATIC FAILURE,6
CN,HYPOAESTHESIA,6
CN,HYPONATRAEMIA,6
CN,HYPOTENSION,6
CN,INFUSION RELATED REACTION,6
CN,MUCORMYCOSIS,6
CN,NEPHROPATHY TOXIC,6
CN,OEDEMA PERIPHERAL,6
CN,PLASMA CELL MYELOMA,6
CN,PNEUMONIA KLEBSIELLA,6
CN,PRURITUS,6
CN,RENAL FAILURE ACUTE,6
CN,SHOCK,6
CN,THROMBOSIS,6
CN,URETERIC STENOSIS,6
CN,ASCITES,5
CN,ATELECTASIS,5
CN,BACK PAIN,5
CN,BLOOD PRESSURE DECREASED,5
CN,CEREBRAL HAEMORRHAGE,5
CN,CONVULSION,5
CN,EPSTEIN-BARR VIRUS INFECTION,5
CN,GASTRIC HAEMORRHAGE,5
CN,HEPATIC CANCER,5
CN,HERPES SIMPLEX,5
CN,HIGH DENSITY LIPOPROTEIN INCREASED,5
CN,HYPERGLYCAEMIA,5
CN,HYPERURICAEMIA,5
CN,IMMUNE THROMBOCYTOPENIC PURPURA,5
CN,IMPAIRED HEALING,5
CN,KLEBSIELLA INFECTION,5
CN,LIVER DISORDER,5
CN,LYMPHADENOPATHY,5
CN,MOUTH ULCERATION,5
CN,MUCOSAL INFLAMMATION,5
CN,MULTIPLE-DRUG RESISTANCE,5
CN,NEPHROLITHIASIS,5
CN,OEDEMA,5
CN,OROPHARYNGEAL PAIN,5
CN,PANCREATITIS ACUTE,5
CN,PNEUMOCYSTIS JIROVECII INFECTION,5
CN,PRODUCT USE ISSUE,5
CN,RENAL CANCER,5
CN,SKIN INFECTION,5
CN,TRANSAMINASES INCREASED,5
CN,TREATMENT FAILURE,5
CN,TUBERCULOSIS,5
CN,TUMOUR LYSIS SYNDROME,5
CN,URINE ANALYSIS ABNORMAL,5
CN,ABDOMINAL PAIN UPPER,4
CN,ABORTION SPONTANEOUS,4
CN,ACUTE GRAFT VERSUS HOST DISEASE,4
CN,ACUTE HEPATIC FAILURE,4
CN,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,4
CN,ALOPECIA,4
CN,BLOOD CREATININE DECREASED,4
CN,BODY TEMPERATURE INCREASED,4
CN,CARDIAC ARREST,4
CN,CLOSTRIDIUM DIFFICILE INFECTION,4
CN,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,4
CN,GASTRITIS EROSIVE,4
CN,GRANULOCYTOPENIA,4
CN,HAEMATEMESIS,4
CN,HAEMORRHAGE,4
CN,HAEMORRHOIDS,4
CN,HEPATIC STEATOSIS,4
CN,HYPERCHLORAEMIA,4
CN,HYPERSENSITIVITY,4
CN,HYPOCALCAEMIA,4
CN,HYPOPROTEINAEMIA,4
CN,LIVER FUNCTION TEST ABNORMAL,4
CN,LOSS OF CONSCIOUSNESS,4
CN,MENINGITIS,4
CN,METABOLIC ACIDOSIS,4
CN,METABOLIC DISORDER,4
CN,MUSCULOSKELETAL PAIN,4
CN,NEOPLASM RECURRENCE,4
CN,NEPHROTIC SYNDROME,4
CN,OPTIC ATROPHY,4
CN,OPTIC ISCHAEMIC NEUROPATHY,4
CN,PALPITATIONS,4
CN,PANCYTOPENIA,4
CN,PAPULE,4
CN,PARVOVIRUS INFECTION,4
CN,PATHOGEN RESISTANCE,4
CN,PERICARDIAL EFFUSION,4
CN,PLATELET COUNT INCREASED,4
CN,POLLAKIURIA,4
CN,RENAL ARTERY STENOSIS,4
CN,RENAL INJURY,4
CN,RESPIRATORY TRACT INFECTION,4
CN,SEIZURE,4
CN,SLEEP DISORDER,4
CN,SOMNOLENCE,4
CN,TRANSITIONAL CELL CARCINOMA,4
CN,VISION BLURRED,4
CN,WEIGHT INCREASED,4
CN,ABDOMINAL DISCOMFORT,3
CN,ACUTE HEPATITIS B,3
CN,ALTERED STATE OF CONSCIOUSNESS,3
CN,ANAL ABSCESS,3
CN,ANGINA PECTORIS,3
CN,APLASIA PURE RED CELL,3
CN,ARTHRALGIA,3
CN,ASTHMA,3
CN,AUTOIMMUNE HEPATITIS,3
CN,BENIGN PROSTATIC HYPERPLASIA,3
CN,BK VIRUS INFECTION,3
CN,BLOOD LACTATE DEHYDROGENASE INCREASED,3
CN,BREAST MASS,3
CN,CACHEXIA,3
CN,CEREBRAL INFARCTION,3
CN,CHEST PAIN,3
CN,CHILLS,3
CN,CHRONIC GRAFT VERSUS HOST DISEASE,3
CN,CIRCULATORY COLLAPSE,3
CN,COAGULOPATHY,3
CN,COLITIS,3
CN,DEEP VEIN THROMBOSIS,3
CN,DRUG HYPERSENSITIVITY,3
CN,DRUG LEVEL INCREASED,3
CN,DRY MOUTH,3
CN,DYSPEPSIA,3
CN,DYSPHAGIA,3
CN,EFFUSION,3
CN,ESCHERICHIA SEPSIS,3
CN,FRACTURE,3
CN,GASTROOESOPHAGEAL REFLUX DISEASE,3
CN,GRAFT VERSUS HOST DISEASE,3
CN,GRANULOCYTE COUNT DECREASED,3
CN,HAEMOPTYSIS,3
CN,HEPATIC ENZYME INCREASED,3
CN,HYPERHIDROSIS,3
CN,HYPERPARATHYROIDISM SECONDARY,3
CN,HYPOTONIA,3
CN,ILEUS,3
CN,INCISION SITE HAEMORRHAGE,3
CN,INTESTINAL OBSTRUCTION,3
CN,LOCAL SWELLING,3
CN,MALAISE,3
CN,MALIGNANT NEOPLASM OF RENAL PELVIS,3
CN,MALIGNANT NEOPLASM PROGRESSION,3
CN,MENTAL DISORDER,3
CN,MICTURITION URGENCY,3
CN,NEOPLASM,3
CN,NEOPLASM MALIGNANT,3
CN,NEOPLASM PROGRESSION,3
CN,NEUTROPHIL COUNT DECREASED,3
CN,OXYGEN SATURATION DECREASED,3
CN,PERIPHERAL SWELLING,3
CN,PNEUMONIA FUNGAL,3
CN,PRIMARY MYELOFIBROSIS,3
CN,PROSTATIC SPECIFIC ANTIGEN INCREASED,3
CN,PUPILLARY REFLEX IMPAIRED,3
CN,RECTAL ADENOCARCINOMA,3
CN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
CN,RED BLOOD CELLS URINE,3
CN,RENAL CYST,3
CN,STAPHYLOCOCCAL INFECTION,3
CN,TOXIC SHOCK SYNDROME,3
CN,TRANSPLANT FAILURE,3
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,3
CN,UTERINE HAEMORRHAGE,3
CN,VIRAL INFECTION,3
CN,WEIGHT DECREASED,3
CN,ABDOMINAL PAIN LOWER,2
CN,ACANTHOMA,2
CN,ACINETOBACTER INFECTION,2
CN,ACINETOBACTER TEST POSITIVE,2
CN,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
CN,ACUTE LEFT VENTRICULAR FAILURE,2
CN,ACUTE MYELOID LEUKAEMIA,2
CN,ANAL FISSURE,2
CN,ANAL SQUAMOUS CELL CARCINOMA,2
CN,ARTERIAL RUPTURE,2
CN,ARTERIOSCLEROSIS,2
CN,ARTHRITIS BACTERIAL,2
CN,ASPARTATE AMINOTRANSFERASE DECREASED,2
CN,ASPHYXIA,2
CN,ATROPHY,2
CN,AUTOMATISM EPILEPTIC,2
CN,BLINDNESS TRANSIENT,2
CN,BLOOD ALBUMIN INCREASED,2
CN,BLOOD FIBRINOGEN DECREASED,2
CN,BLOOD GLUCOSE DECREASED,2
CN,BLOOD POTASSIUM DECREASED,2
CN,BLOOD POTASSIUM INCREASED,2
CN,BLOOD PRESSURE INCREASED,2
CN,BONE PAIN,2
CN,BONE TUBERCULOSIS,2
CN,BREATH SOUNDS ABNORMAL,2
CN,BRONCHIECTASIS,2
CN,CARDIAC DISORDER,2
CN,CARDIAC HYPERTROPHY,2
CN,CARDIAC MURMUR,2
CN,CARDIOTOXICITY,2
CN,CELLULITIS,2
CN,CHLOROMA,2
CN,CHOLANGITIS SCLEROSING,2
CN,CHRONIC HEPATITIS C,2
CN,CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER,2
CN,CLAVICLE FRACTURE,2
CN,CONFUSIONAL STATE,2
CN,CORONARY ARTERY DISEASE,2
CN,CROHN^S DISEASE,2
CN,CUSHINGOID,2
CN,CYTOKINE RELEASE SYNDROME,2
CN,DENTAL CARIES,2
CN,DERMATITIS,2
CN,DERMATITIS EXFOLIATIVE,2
CN,DIFFUSE LARGE B-CELL LYMPHOMA STAGE II,2
CN,DISSEMINATED INTRAVASCULAR COAGULATION,2
CN,DISSEMINATED TUBERCULOSIS,2
CN,DRUG INTOLERANCE,2
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CN,DYSPHONIA,2
CN,ENDOCARDITIS,2
CN,ENTERITIS INFECTIOUS,2
CN,EPISTAXIS,2
CN,ESCHERICHIA INFECTION,2
CN,EYE HAEMORRHAGE,2
CN,FLATULENCE,2
CN,FOETAL EXPOSURE DURING PREGNANCY,2
CN,FREQUENT BOWEL MOVEMENTS,2
CN,FULL BLOOD COUNT DECREASED,2
CN,FUNGAEMIA,2
CN,GASTRIC CANCER,2
CN,GASTRIC ULCER,2
CN,GASTROINTESTINAL TOXICITY,2
CN,GENERAL PHYSICAL HEALTH DETERIORATION,2
CN,GINGIVAL BLEEDING,2
CN,GLAUCOMA,2
CN,GLUCOSE TOLERANCE IMPAIRED,2
CN,GUILLAIN-BARRE SYNDROME,2
CN,HAEMATOTOXICITY,2
CN,HAEMORRHAGIC CEREBRAL INFARCTION,2
CN,HEART RATE INCREASED,2
CN,HEPATIC CIRRHOSIS,2
CN,HEPATITIS C,2
CN,HEPATOCELLULAR CARCINOMA,2
CN,HEPATORENAL SYNDROME,2
CN,HISTIOCYTOSIS HAEMATOPHAGIC,2
CN,HYDROTHORAX,2
CN,HYPERCALCAEMIA,2
CN,HYPOGAMMAGLOBULINAEMIA,2
CN,HYPOHIDROSIS,2
CN,HYPOTHYROIDISM,2
CN,ILL-DEFINED DISORDER,2
CN,INCREASED APPETITE,2
CN,INSOMNIA,2
CN,IRON DEFICIENCY ANAEMIA,2
CN,JOINT SWELLING,2
CN,KAPOSI^S VARICELLIFORM ERUPTION,2
CN,KIDNEY FIBROSIS,2
CN,KIDNEY INFECTION,2
CN,KLEBSIELLA BACTERAEMIA,2
CN,KOUNIS SYNDROME,2
CN,LEUKAEMIA,2
CN,LEUKOENCEPHALOPATHY,2
CN,LIVER TRANSPLANT REJECTION,2
CN,LOW BIRTH WEIGHT BABY,2
CN,LOW DENSITY LIPOPROTEIN DECREASED,2
CN,LUPUS-LIKE SYNDROME,2
CN,LYMPHOCYTE COUNT INCREASED,2
CN,MALIGNANT MELANOMA,2
CN,MANIA,2
CN,MATERNAL EXPOSURE DURING PREGNANCY,2
CN,MEMORY IMPAIRMENT,2
CN,MENINGITIS CRYPTOCOCCAL,2
CN,MENSTRUATION IRREGULAR,2
CN,MENTAL IMPAIRMENT,2
CN,METASTASES TO LIVER,2
CN,MITRAL VALVE INCOMPETENCE,2
CN,MYALGIA,2
CN,MYOCARDIAL INFARCTION,2
CN,MYOPATHY,2
CN,NECROSIS,2
CN,NEONATAL ASPHYXIA,2
CN,NEPHROGENIC ANAEMIA,2
CN,OPTIC NEURITIS,2
CN,PARATHYROID TUMOUR BENIGN,2
CN,PERICARDIAL FIBROSIS,2
CN,PERITONITIS,2
CN,PETECHIAE,2
CN,PNEUMONIA CYTOMEGALOVIRAL,2
CN,PNEUMONIA STAPHYLOCOCCAL,2
CN,POSTOPERATIVE WOUND INFECTION,2
CN,PREMATURE BABY,2
CN,PROCALCITONIN INCREASED,2
CN,PROCTALGIA,2
CN,PROSTATE CANCER METASTATIC,2
CN,PSEUDOMEMBRANOUS COLITIS,2
CN,PULMONARY FIBROSIS,2
CN,PULMONARY HAEMORRHAGE,2
CN,PULMONARY MYCOSIS,2
CN,PULPITIS DENTAL,2
CN,RASH MACULO-PAPULAR,2
CN,RECURRENT CANCER,2
CN,REGURGITATION,2
CN,RENAL DISORDER,2
CN,RENAL FAILURE CHRONIC,2
CN,RENAL HYPERTENSION,2
CN,RENAL NEOPLASM,2
CN,RENAL TUBERCULOSIS,2
CN,RENAL TUBULAR ATROPHY,2
CN,RENAL TUBULAR DISORDER,2
CN,RESPIRATORY ARREST,2
CN,RESPIRATORY RATE INCREASED,2
CN,RESPIRATORY TRACT INFECTION FUNGAL,2
CN,RESTLESSNESS,2
CN,RHEUMATOID ARTHRITIS,2
CN,RHINORRHOEA,2
CN,RIGHT VENTRICULAR FAILURE,2
CN,SCAB,2
CN,SERUM FERRITIN INCREASED,2
CN,SINUS BRADYCARDIA,2
CN,SINUS TACHYCARDIA,2
CN,SINUSITIS,2
CN,SKIN EXFOLIATION,2
CN,SKIN LESION,2
CN,SKIN MASS,2
CN,SOFT TISSUE HAEMORRHAGE,2
CN,SQUAMOUS CELL CARCINOMA OF THE TONGUE,2
CN,SUDDEN CARDIAC DEATH,2
CN,SUPERIOR SAGITTAL SINUS THROMBOSIS,2
CN,SWELLING FACE,2
CN,SYSTEMIC LUPUS ERYTHEMATOSUS,2
CN,TEMPORAL LOBE EPILEPSY,2
CN,TENDERNESS,2
CN,TENDON LAXITY,2
CN,TENDON RUPTURE,2
CN,THERAPEUTIC RESPONSE DECREASED,2
CN,THERAPY NON-RESPONDER,2
CN,THROAT IRRITATION,2
CN,THROMBOCYTOSIS,2
CN,TONIC CLONIC MOVEMENTS,2
CN,URETERAL NEOPLASM,2
CN,URETERIC CANCER,2
CN,URETERIC OBSTRUCTION,2
CN,URETEROLITHIASIS,2
CN,URINARY RETENTION,2
CN,VAGINAL HAEMORRHAGE,2
CN,VARICELLA,2
CN,VISUAL ACUITY REDUCED,2
CN,ABDOMINAL INFECTION,1
CN,ABDOMINAL TENDERNESS,1
CN,ABNORMAL FAECES,1
CN,ABORTION INDUCED,1
CN,ABORTION LATE,1
CN,ACID BASE BALANCE ABNORMAL,1
CN,ACINETOBACTER BACTERAEMIA,1
CN,ACNE,1
CN,ACQUIRED HAEMOPHILIA,1
CN,ACTIVITIES OF DAILY LIVING IMPAIRED,1
CN,ACUTE CORONARY SYNDROME,1
CN,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,1
CN,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
CN,ACUTE LYMPHOCYTIC LEUKAEMIA,1
CN,ACUTE PROMYELOCYTIC LEUKAEMIA,1
CN,ADENOCARCINOMA GASTRIC,1
CN,ADENOCARCINOMA OF COLON,1
CN,AGITATION,1
CN,ALANINE AMINOTRANSFERASE DECREASED,1
CN,AMNIOTIC CAVITY INFECTION,1
CN,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
CN,ANAL FUNGAL INFECTION,1
CN,ANAPHYLACTIC REACTION,1
CN,ANAPHYLACTIC SHOCK,1
CN,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,1
CN,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES RECURRENT,1
CN,ANAPLASTIC LARGE-CELL LYMPHOMA,1
CN,ANGIOCENTRIC LYMPHOMA,1
CN,ANGIOPATHY,1
CN,ANKYLOSING SPONDYLITIS,1
CN,ANOSMIA,1
CN,APLASTIC ANAEMIA,1
CN,APOPTOSIS,1
CN,APPENDICEAL ABSCESS,1
CN,APPENDICITIS,1
CN,ARTERIOSCLEROSIS CORONARY ARTERY,1
CN,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
CN,AUTONOMIC NEUROPATHY,1
CN,B-LYMPHOCYTE COUNT DECREASED,1
CN,BACTERAEMIA,1
CN,BACTERIAL INFECTION,1
CN,BACTERIAL SEPSIS,1
CN,BACTERIAL TEST POSITIVE,1
CN,BENIGN HYDATIDIFORM MOLE,1
CN,BILE DUCT OBSTRUCTION,1
CN,BILIARY CIRRHOSIS,1
CN,BLADDER NEOPLASM,1
CN,BLADDER TRANSITIONAL CELL CARCINOMA,1
CN,BLINDNESS,1
CN,BLISTER,1
CN,BLOOD BILIRUBIN DECREASED,1
CN,BLOOD BLISTER,1
CN,BLOOD CALCIUM DECREASED,1
CN,BLOOD CHOLESTEROL DECREASED,1
CN,BLOOD CREATINE INCREASED,1
CN,BLOOD ELECTROLYTES ABNORMAL,1
CN,BLOOD FIBRINOGEN INCREASED,1
CN,BLOOD IMMUNOGLOBULIN A DECREASED,1
CN,BLOOD IMMUNOGLOBULIN G DECREASED,1
CN,BLOOD IMMUNOGLOBULIN G INCREASED,1
CN,BLOOD OESTROGEN DECREASED,1
CN,BLOOD OESTROGEN INCREASED,1
CN,BLOOD PHOSPHORUS DECREASED,1
CN,BLOOD TESTOSTERONE DECREASED,1
CN,BLOOD TRIGLYCERIDES DECREASED,1
CN,BLOOD UREA DECREASED,1
CN,BLOODY DISCHARGE,1
CN,BRAIN DEATH,1
CN,BRAIN INJURY,1
CN,BRAIN NATRIURETIC PEPTIDE INCREASED,1
CN,BRAIN OEDEMA,1
CN,BRAIN STEM STROKE,1
CN,BREECH PRESENTATION,1
CN,BRONCHOSPASM,1
CN,BUNDLE BRANCH BLOCK RIGHT,1
CN,BURKITT^S LYMPHOMA,1
CN,BURNING SENSATION,1
CN,C-REACTIVE PROTEIN DECREASED,1
CN,CARDIAC AMYLOIDOSIS,1
CN,CARDIAC DISCOMFORT,1
CN,CARDIAC FAILURE ACUTE,1
CN,CARDIAC FAILURE CHRONIC,1
CN,CARDIAC FAILURE CONGESTIVE,1
CN,CARDIAC NEOPLASM UNSPECIFIED,1
CN,CARDIAC SEPTAL HYPERTROPHY,1
CN,CARDIO-RESPIRATORY ARREST,1
CN,CARDIOGENIC SHOCK,1
CN,CARDIOMYOPATHY,1
CN,CARDIOVASCULAR DISORDER,1
CN,CATARACT,1
CN,CELL-MEDIATED IMMUNE DEFICIENCY,1
CN,CELLULITIS GANGRENOUS,1
CN,CEREBELLAR INFARCTION,1
CN,CEREBRAL ARTERY EMBOLISM,1
CN,CEREBRAL ATROPHY,1
CN,CEREBRAL DISORDER,1
CN,CEREBROVASCULAR ACCIDENT,1
CN,CEREBROVASCULAR INSUFFICIENCY,1
CN,CHEST X-RAY ABNORMAL,1
CN,CHOLECYSTITIS ACUTE,1
CN,CHOLESTASIS,1
CN,CHOLESTEROSIS,1
CN,CHRONIC GASTRITIS,1
CN,CHRONIC HEPATITIS,1
CN,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
CN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
CN,CLEAR CELL RENAL CELL CARCINOMA,1
CN,CLOSTRIDIUM DIFFICILE COLITIS,1
CN,COLON CANCER,1
CN,COMPLICATIONS OF TRANSPLANT SURGERY,1
CN,COMPLICATIONS OF TRANSPLANTED LUNG,1
CN,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
CN,CONJUNCTIVAL HYPERAEMIA,1
CN,CONTUSION,1
CN,COXSACKIE VIRUS TEST POSITIVE,1
CN,CRANIAL NERVE DISORDER,1
CN,CRYPTOCOCCOSIS,1
CN,CYANOSIS,1
CN,CYSTATIN C INCREASED,1
CN,CYSTIC LUNG DISEASE,1
CN,CYSTITIS,1
CN,DEFIANT BEHAVIOUR,1
CN,DELIRIUM,1
CN,DEPRESSION,1
CN,DEPRESSIVE SYMPTOM,1
CN,DEVELOPMENTAL DELAY,1
CN,DEVICE LEAKAGE,1
CN,DEVICE MALFUNCTION,1
CN,DIABETES INSIPIDUS,1
CN,DIABETES MELLITUS INADEQUATE CONTROL,1
CN,DIABETIC KETOACIDOSIS,1
CN,DIASTOLIC DYSFUNCTION,1
CN,DIFFUSE LARGE B-CELL LYMPHOMA,1
CN,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1
CN,DOUBLE STRANDED DNA ANTIBODY POSITIVE,1
CN,DRUG EFFECT INCOMPLETE,1
CN,DRUG ERUPTION,1
CN,DRUG RESISTANCE,1
CN,DRUG USE DISORDER,1
CN,DRY EYE,1
CN,DRY THROAT,1
CN,DYSARTHRIA,1
CN,DYSCHEZIA,1
CN,DYSFUNCTIONAL UTERINE BLEEDING,1
CN,ECCHYMOSIS,1
CN,ECZEMA,1
CN,EJECTION FRACTION DECREASED,1
CN,ELECTROCARDIOGRAM ABNORMAL,1
CN,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
CN,EMPHYSEMA,1
CN,ENCEPHALITIS,1
CN,ENCEPHALOMALACIA,1
CN,ENCEPHALOPATHY,1
CN,END STAGE RENAL DISEASE,1
CN,ENDOTOXIC SHOCK,1
CN,ENTERITIS,1
CN,ENTEROBACTER BACTERAEMIA,1
CN,ENTEROBACTER PNEUMONIA,1
CN,ENTEROCOCCAL BACTERAEMIA,1
CN,ENTEROVIRUS TEST POSITIVE,1
CN,EPICONDYLITIS,1
CN,EPIDERMOLYSIS BULLOSA,1
CN,EPIDIDYMAL DISORDER,1
CN,EPIDIDYMITIS,1
CN,EPILEPTIC AURA,1
CN,ERECTILE DYSFUNCTION,1
CN,ERUCTATION,1
CN,EXOSTOSIS,1
CN,EXTRADURAL HAEMATOMA,1
CN,EXTRAPULMONARY TUBERCULOSIS,1
CN,EXTREMITY NECROSIS,1
CN,EYE DISORDER,1
CN,EYELID PTOSIS,1
CN,FACE OEDEMA,1
CN,FACTOR VIII INHIBITION,1
CN,FALL,1
CN,FASCIOLIASIS,1
CN,FEAR,1
CN,FIBRIN D DIMER INCREASED,1
CN,FISTULA,1
CN,FLANK PAIN,1
CN,FUNCTIONAL GASTROINTESTINAL DISORDER,1
CN,FUNGAL TEST POSITIVE,1
CN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CN,GASTRIC POLYPS,1
CN,GASTRITIS,1
CN,GASTROENTERITIS,1
CN,GASTROENTERITIS ESCHERICHIA COLI,1
CN,GASTROINTESTINAL HYPOMOTILITY,1
CN,GASTROINTESTINAL INFECTION,1
CN,GASTROINTESTINAL MOTILITY DISORDER,1
CN,GASTROINTESTINAL MUCOSAL DISORDER,1
CN,GASTROINTESTINAL PAIN,1
CN,GASTROINTESTINAL PERFORATION,1
CN,GASTROINTESTINAL ULCER,1
CN,GASTROINTESTINAL ULCER HAEMORRHAGE,1
CN,GASTROINTESTINAL WALL THICKENING,1
CN,GENERALISED ERYTHEMA,1
CN,GENERALISED OEDEMA,1
CN,GENERALISED TONIC-CLONIC SEIZURE,1
CN,GENITAL PAIN,1
CN,GINGIVAL EROSION,1
CN,GINGIVAL HYPERPLASIA,1
CN,GINGIVAL PAIN,1
CN,GINGIVAL SWELLING,1
CN,GINGIVITIS,1
CN,GOUTY ARTHRITIS,1
CN,GRAFT COMPLICATION,1
CN,GRAFT VERSUS HOST DISEASE IN SKIN,1
CN,H1N1 INFLUENZA,1
CN,HAEMANGIOMA OF LIVER,1
CN,HAEMODYNAMIC INSTABILITY,1
CN,HAEMOGLOBIN INCREASED,1
CN,HAEMOLYTIC ANAEMIA,1
CN,HAEMORRHAGE INTRACRANIAL,1
CN,HAIR GROWTH ABNORMAL,1
CN,HALLUCINATION_ AUDITORY,1
CN,HEART RATE DECREASED,1
CN,HEART TRANSPLANT REJECTION,1
CN,HELICOBACTER INFECTION,1
CN,HEMIPARESIS,1
CN,HENOCH-SCHONLEIN PURPURA NEPHRITIS,1
CN,HEPATIC CANCER RECURRENT,1
CN,HEPATIC CYST,1
CN,HEPATIC NECROSIS,1
CN,HEPATITIS B DNA INCREASED,1
CN,HEPATITIS B SURFACE ANTIBODY POSITIVE,1
CN,HEPATITIS D,1
CN,HEPATITIS FULMINANT,1
CN,HEPATITIS INFECTIOUS,1
CN,HEPATOBILIARY DISEASE,1
CN,HEPATOCELLULAR INJURY,1
CN,HEPATORENAL FAILURE,1
CN,HERPES VIRUS INFECTION,1
CN,HIATUS HERNIA,1
CN,HIPPOCAMPAL SCLEROSIS,1
CN,HUNGER,1
CN,HYPEROXALURIA,1
CN,HYPERPYREXIA,1
CN,HYPERTRICHOSIS,1
CN,HYPOCHLORAEMIA,1
CN,HYPOFIBRINOGENAEMIA,1
CN,HYPOGLYCAEMIA,1
CN,HYPOGLYCAEMIA NEONATAL,1
CN,HYPOTHALAMO-PITUITARY DISORDER,1
CN,HYPOURICAEMIA,1
CN,HYPOVOLAEMIC SHOCK,1
CN,IDIOPATHIC THROMBOCYTOPENIC PURPURA,1
CN,IGA NEPHROPATHY,1
CN,ILEAL STENOSIS,1
CN,ILEAL ULCER,1
CN,ILLUSION,1
CN,IMMUNODEFICIENCY,1
CN,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
CN,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
CN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CN,INCISION SITE EROSION,1
CN,INFANTILE SPASMS,1
CN,INTERVERTEBRAL DISC PROTRUSION,1
CN,INTESTINAL HAEMORRHAGE,1
CN,INTESTINAL PERFORATION,1
CN,INTESTINAL TUBERCULOSIS,1
CN,INTRA-ABDOMINAL FLUID COLLECTION,1
CN,INTRACRANIAL PRESSURE INCREASED,1
CN,INVASIVE DUCTAL BREAST CARCINOMA,1
CN,IRON METABOLISM DISORDER,1
CN,IRRITABILITY,1
CN,JARISCH-HERXHEIMER REACTION,1
CN,KIDNEY ENLARGEMENT,1
CN,KLEBSIELLA TEST POSITIVE,1
CN,LACUNAR INFARCTION,1
CN,LANGERHANS^ CELL HISTIOCYTOSIS,1
CN,LARYNGEAL OEDEMA,1
CN,LATENT TUBERCULOSIS,1
CN,LDL/HDL RATIO INCREASED,1
CN,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,1
CN,LEFT VENTRICULAR DYSFUNCTION,1
CN,LEFT VENTRICULAR ENLARGEMENT,1
CN,LEFT VENTRICULAR HYPERTROPHY,1
CN,LEPROSY,1
CN,LEUKAEMIC LYMPHOMA,1
CN,LEUKOCYTOSIS,1
CN,LICHEN PLANUS,1
CN,LIGAMENT SPRAIN,1
CN,LIGHT CHAIN DISEASE,1
CN,LIMBAL SWELLING,1
CN,LIP EROSION,1
CN,LIPIDS INCREASED,1
CN,LISTERIA SEPSIS,1
CN,LOWER GASTROINTESTINAL HAEMORRHAGE,1
CN,LOWER LIMB FRACTURE,1
CN,LOWER RESPIRATORY TRACT INFECTION FUNGAL,1
CN,LUMBAR VERTEBRAL FRACTURE,1
CN,LUNG ADENOCARCINOMA,1
CN,LUNG INFILTRATION,1
CN,LUPUS ENCEPHALITIS,1
CN,LUPUS NEPHRITIS,1
CN,LYMPH NODE CALCIFICATION,1
CN,LYMPHOCYTIC LEUKAEMIA,1
CN,LYMPHORRHOEA,1
CN,MALNUTRITION,1
CN,MARROW HYPERPLASIA,1
CN,MASTICATION DISORDER,1
CN,MASTOIDITIS,1
CN,MEASLES,1
CN,MEDICATION ERROR,1
CN,MELAENA,1
CN,MENINGITIS TUBERCULOUS,1
CN,MENINGITIS VIRAL,1
CN,MENORRHAGIA,1
CN,MENTAL STATUS CHANGES,1
CN,MESENTERIC VEIN THROMBOSIS,1
CN,METABOLIC SYNDROME,1
CN,METASTASES TO LYMPH NODES,1
CN,MICROSCOPIC POLYANGIITIS,1
CN,MICROSPORUM INFECTION,1
CN,MITRAL VALVE PROLAPSE,1
CN,MUCOCUTANEOUS HAEMORRHAGE,1
CN,MUCOSAL NECROSIS,1
CN,MULTI-ORGAN DISORDER,1
CN,MUSCLE SPASMS,1
CN,MUSCLE TWITCHING,1
CN,MUSCULAR WEAKNESS,1
CN,MUSCULOSKELETAL DISCOMFORT,1
CN,MUSCULOSKELETAL DISORDER,1
CN,MYASTHENIA GRAVIS,1
CN,MYCOBACTERIUM AVIUM COMPLEX INFECTION,1
CN,MYOCARDIAL ISCHAEMIA,1
CN,NASAL OBSTRUCTION,1
CN,NASOPHARYNGEAL CANCER,1
CN,NATURAL KILLER CELL COUNT DECREASED,1
CN,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
CN,NERVE INJURY,1
CN,NERVOUS SYSTEM DISORDER,1
CN,NERVOUSNESS,1
CN,NEURODERMATITIS,1
CN,NEUTROPENIC INFECTION,1
CN,NIGHT SWEATS,1
CN,NOCARDIOSIS,1
CN,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
CN,OBSTRUCTION,1
CN,OCULAR DISCOMFORT,1
CN,OEDEMA MUCOSAL,1
CN,OEDEMATOUS KIDNEY,1
CN,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
CN,OLIGURIA,1
CN,OPPORTUNISTIC INFECTION,1
CN,OPTIC DISC DISORDER,1
CN,OPTIC NERVE INJURY,1
CN,ORAL MUCOSA EROSION,1
CN,ORCHIDECTOMY,1
CN,ORGAN FAILURE,1
CN,OSTEOARTHRITIS,1
CN,OSTEOMYELITIS,1
CN,OSTEOMYELITIS ACUTE,1
CN,OTITIS EXTERNA,1
CN,PAIN IN JAW,1
CN,PALATAL DISORDER,1
CN,PANCREATITIS,1
CN,PANNICULITIS,1
CN,PAPILLOEDEMA,1
CN,PARAESTHESIA,1
CN,PARAGONIMIASIS,1
CN,PARALYSIS,1
CN,PARTIAL SEIZURES,1
CN,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,1
CN,PARURESIS,1
CN,PARVOVIRUS B19 INFECTION,1
CN,PEMPHIGUS,1
CN,PEPTIC ULCER,1
CN,PERICARDIAL CALCIFICATION,1
CN,PERICARDITIS,1
CN,PERICARDITIS TUBERCULOUS,1
CN,PERINEPHRIC ABSCESS,1
CN,PERINEPHRIC EFFUSION,1
CN,PERITONSILLITIS,1
CN,PHARYNGITIS,1
CN,PITUITARY-DEPENDENT CUSHING^S SYNDROME,1
CN,PLASMABLASTIC LYMPHOMA,1
CN,PLASMACYTOMA,1
CN,PNEUMOMEDIASTINUM,1
CN,PNEUMONIA BACTERIAL,1
CN,PNEUMOTHORAX,1
CN,PNEUMOVIRUS TEST POSITIVE,1
CN,POLYNEUROPATHY,1
CN,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,1
CN,POLYSEROSITIS,1
CN,POOR QUALITY SLEEP,1
CN,POOR SUCKING REFLEX,1
CN,POST PROCEDURAL INFECTION,1
CN,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
CN,POSTOPERATIVE WOUND COMPLICATION,1
CN,PREMATURE DELIVERY,1
CN,PREMATURE LABOUR,1
CN,PRESCRIBED OVERDOSE,1
CN,PRODUCT LABEL ISSUE,1
CN,PRODUCT PHYSICAL ISSUE,1
CN,PROPIONIBACTERIUM INFECTION,1
CN,PROSTATITIS,1
CN,PROTHROMBIN TIME PROLONGED,1
CN,PRURITUS GENERALISED,1
CN,PSEUDOMONAL BACTERAEMIA,1
CN,PSEUDOMONAL SEPSIS,1
CN,PSEUDOMONAS INFECTION,1
CN,PSORIASIS,1
CN,PULMONARY ARTERIAL HYPERTENSION,1
CN,PULMONARY BULLA,1
CN,PULMONARY CONGESTION,1
CN,PULMONARY EMBOLISM,1
CN,PULMONARY MASS,1
CN,PUPILLARY LIGHT REFLEX TESTS ABNORMAL,1
CN,PURPURA,1
CN,PURULENT DISCHARGE,1
CN,PYELONEPHRITIS,1
CN,PYLORIC STENOSIS,1
CN,RADIATION PNEUMONITIS,1
CN,RASH GENERALISED,1
CN,RASH VESICULAR,1
CN,REBOUND EFFECT,1
CN,RED BLOOD CELL COUNT DECREASED,1
CN,REFLEXES ABNORMAL,1
CN,REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS,1
CN,REFUSAL OF TREATMENT BY PATIENT,1
CN,RENAL ANEURYSM,1
CN,RENAL ARTERIOSCLEROSIS,1
CN,RENAL ARTERY THROMBOSIS,1
CN,RENAL GRAFT INFECTION,1
CN,RENAL HAEMATOMA,1
CN,RENAL HAEMORRHAGE,1
CN,RENAL HYPOPLASIA,1
CN,RENAL INFARCT,1
CN,RENAL MASS,1
CN,RENAL PAIN,1
CN,RENAL TUBULAR DYSFUNCTION,1
CN,RENAL TUBULAR NECROSIS,1
CN,RESPIRATORY ACIDOSIS,1
CN,RESPIRATORY DISTRESS,1
CN,RESPIRATORY TRACT HAEMORRHAGE,1
CN,RETINAL DETACHMENT,1
CN,RETINAL HAEMORRHAGE,1
CN,RETINAL VASCULAR DISORDER,1
CN,RIGHT ATRIAL ENLARGEMENT,1
CN,RIGHT VENTRICULAR ENLARGEMENT,1
CN,SCHIZOPHRENIA,1
CN,SCLEREMA,1
CN,SCROTAL SWELLING,1
CN,SECOND PRIMARY MALIGNANCY,1
CN,SECONDARY AMYLOIDOSIS,1
CN,SECONDARY HYPOTHYROIDISM,1
CN,SERUM SICKNESS,1
CN,SHOCK HAEMORRHAGIC,1
CN,SKIN CANCER,1
CN,SKIN DISCOLOURATION,1
CN,SKIN DISORDER,1
CN,SKIN HAEMORRHAGE,1
CN,SKIN HYPERPIGMENTATION,1
CN,SKIN PLAQUE,1
CN,SOFT TISSUE SWELLING,1
CN,SPINAL COMPRESSION FRACTURE,1
CN,SPINAL FRACTURE,1
CN,SPUTUM CULTURE POSITIVE,1
CN,SQUAMOUS CELL CARCINOMA,1
CN,STAPHYLOCOCCAL BACTERAEMIA,1
CN,STAPHYLOCOCCAL SEPSIS,1
CN,STARING,1
CN,STEM CELL TRANSPLANT,1
CN,STENOTROPHOMONAS INFECTION,1
CN,STROKE IN EVOLUTION,1
CN,STRONGYLOIDIASIS,1
CN,SUBCUTANEOUS EMPHYSEMA,1
CN,SUICIDAL IDEATION,1
CN,SUPRAVENTRICULAR EXTRASYSTOLES,1
CN,SUSPECTED COUNTERFEIT PRODUCT,1
CN,SWELLING,1
CN,SYSTEMIC BACTERIAL INFECTION,1
CN,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
CN,T-CELL LYMPHOMA,1
CN,TACHYPNOEA,1
CN,TAENIASIS,1
CN,TEMPERATURE INTOLERANCE,1
CN,TERATOMA,1
CN,THERAPEUTIC RESPONSE UNEXPECTED,1
CN,THERAPY CESSATION,1
CN,THROMBOCYTOPENIC PURPURA,1
CN,THYROID NEOPLASM,1
CN,THYROXINE DECREASED,1
CN,TOOTHACHE,1
CN,TOXIC EPIDERMAL NECROLYSIS,1
CN,TREMOR,1
CN,TRI-IODOTHYRONINE DECREASED,1
CN,TRICUSPID VALVE INCOMPETENCE,1
CN,TROPONIN T INCREASED,1
CN,TUBERCULOUS PLEURISY,1
CN,TUBULOINTERSTITIAL NEPHRITIS,1
CN,TUMOUR RUPTURE,1
CN,TYPE 2 DIABETES MELLITUS,1
CN,UNDERDOSE,1
CN,URETERIC ANASTOMOSIS COMPLICATION,1
CN,URETERIC CANCER RECURRENT,1
CN,URETERIC FISTULA,1
CN,URETHRAL HAEMORRHAGE,1
CN,URETHRAL INJURY,1
CN,URETHRAL PAIN,1
CN,URINARY BLADDER HAEMORRHAGE,1
CN,URINARY INCONTINENCE,1
CN,URINARY TRACT NEOPLASM,1
CN,URINARY TRACT PAIN,1
CO,PLATELET COUNT DECREASED,12
CO,PYREXIA,12
CO,DIZZINESS,11
CO,DYSPNOEA,11
CO,URINARY TRACT INFECTION,11
CO,MALAISE,9
CO,PAIN,9
CO,DEATH,7
CO,FALL,7
CO,FATIGUE,7
CO,HEADACHE,7
CO,NAUSEA,7
CO,ASTHENIA,6
CO,ARTHRALGIA,5
CO,COUGH,5
CO,CUSHING^S SYNDROME,5
CO,DECREASED APPETITE,5
CO,DIARRHOEA,5
CO,MALACOPLAKIA VESICAE,5
CO,PAIN IN EXTREMITY,5
CO,PNEUMONIA,5
CO,VOMITING,5
CO,WEIGHT DECREASED,5
CO,ANAEMIA,4
CO,COMPLICATIONS OF TRANSPLANTED KIDNEY,4
CO,CONTUSION,4
CO,DISORIENTATION,4
CO,PETECHIAE,4
CO,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
CO,TUBULOINTERSTITIAL NEPHRITIS,4
CO,ABDOMINAL PAIN,3
CO,BACK PAIN,3
CO,CARDIO-RESPIRATORY ARREST,3
CO,CELLULITIS,3
CO,DRUG INEFFECTIVE,3
CO,ESCHERICHIA INFECTION,3
CO,GINGIVAL BLEEDING,3
CO,IMMUNOSUPPRESSION,3
CO,IRIDOCYCLITIS,3
CO,MUSCULOSKELETAL CHEST PAIN,3
CO,MYOPATHY,3
CO,OEDEMA,3
CO,PERIPHERAL SWELLING,3
CO,PRODUCT USE IN UNAPPROVED INDICATION,3
CO,BACTERIAL INFECTION,2
CO,BLISTER,2
CO,BLOOD URINE PRESENT,2
CO,BRONCHITIS,2
CO,CATARACT,2
CO,CEREBRAL HAEMORRHAGE,2
CO,CHOKING SENSATION,2
CO,CONDITION AGGRAVATED,2
CO,CRYING,2
CO,CUSHINGOID,2
CO,CYANOSIS,2
CO,DEPRESSION,2
CO,DERMATITIS,2
CO,DRUG DOSE OMISSION,2
CO,EPISTAXIS,2
CO,ERYTHEMA,2
CO,GAIT DISTURBANCE,2
CO,GENERAL PHYSICAL HEALTH DETERIORATION,2
CO,HAEMORRHAGE,2
CO,HEPATOSPLENOMEGALY,2
CO,HERPES VIRUS INFECTION,2
CO,HERPES ZOSTER,2
CO,HYPOKALAEMIA,2
CO,INFLUENZA,2
CO,MANIA,2
CO,MATERNAL EXPOSURE DURING PREGNANCY,2
CO,METHAEMOGLOBINAEMIA,2
CO,MIGRAINE,2
CO,MOUTH HAEMORRHAGE,2
CO,MUCORMYCOSIS,2
CO,MULTI-ORGAN FAILURE,2
CO,NEUROLOGICAL DECOMPENSATION,2
CO,OEDEMA PERIPHERAL,2
CO,PLEURAL EFFUSION,2
CO,PRE-ECLAMPSIA,2
CO,PRODUCTIVE COUGH,2
CO,PSORIASIS,2
CO,RASH,2
CO,RESPIRATORY ARREST,2
CO,SEIZURE,2
CO,SEPSIS,2
CO,SKIN INFECTION,2
CO,SPINAL PAIN,2
CO,SWELLING,2
CO,THROAT IRRITATION,2
CO,THROMBOCYTOPENIA,2
CO,THROMBOSIS,2
CO,VAGINAL HAEMORRHAGE,2
CO,VARICOSE ULCERATION,2
CO,WHITE BLOOD CELL COUNT INCREASED,2
CO,ABASIA,1
CO,ABORTION SPONTANEOUS,1
CO,ABSCESS,1
CO,ABSCESS RUPTURE,1
CO,ACNE,1
CO,ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED,1
CO,ACTIVITIES OF DAILY LIVING IMPAIRED,1
CO,ACUTE MYOCARDIAL INFARCTION,1
CO,ACUTE RESPIRATORY FAILURE,1
CO,ADVERSE DRUG REACTION,1
CO,AMYLASE INCREASED,1
CO,ANAEMIA MACROCYTIC,1
CO,ANGINA UNSTABLE,1
CO,ANXIETY,1
CO,APHTHOUS ULCER,1
CO,APLASTIC ANAEMIA,1
CO,ARRHYTHMIA,1
CO,ARTERIAL RUPTURE,1
CO,ARTHROPATHY,1
CO,ASPARTATE AMINOTRANSFERASE INCREASED,1
CO,ASPHYXIA,1
CO,ASTHMA,1
CO,ASTHMATIC CRISIS,1
CO,ATRIOVENTRICULAR BLOCK,1
CO,ATRIOVENTRICULAR BLOCK COMPLETE,1
CO,AUTOIMMUNE HEPATITIS,1
CO,BACTERAEMIA,1
CO,BALANCE DISORDER,1
CO,BENIGN PROSTATIC HYPERPLASIA,1
CO,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CO,BLOOD CREATININE INCREASED,1
CO,BLOOD GLUCOSE INCREASED,1
CO,BLOOD PRESSURE DECREASED,1
CO,BONE PAIN,1
CO,BREATH SOUNDS ABNORMAL,1
CO,BRONCHOSPASM,1
CO,BURNING SENSATION,1
CO,BURSITIS,1
CO,CARDIAC ARREST,1
CO,CARDIAC DISORDER,1
CO,CARDIAC FAILURE,1
CO,CARDIOGENIC SHOCK,1
CO,CARDIOTOXICITY,1
CO,CHEST DISCOMFORT,1
CO,CHEST PAIN,1
CO,CHOKING,1
CO,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
CO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
CO,COLITIS ULCERATIVE,1
CO,COMA,1
CO,CONCOMITANT DISEASE PROGRESSION,1
CO,CONSTIPATION,1
CO,CORNEAL DISORDER,1
CO,CUTANEOUS VASCULITIS,1
CO,CYST,1
CO,CYSTITIS,1
CO,DEAFNESS,1
CO,DEPRESSED MOOD,1
CO,DISCOMFORT,1
CO,DISEASE COMPLICATION,1
CO,DISEASE RECURRENCE,1
CO,DRUG DISPENSING ERROR,1
CO,DRY SKIN,1
CO,DRY THROAT,1
CO,DYSSTASIA,1
CO,EATING DISORDER,1
CO,ECLAMPSIA,1
CO,ENCEPHALITIS,1
CO,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,1
CO,EROSIVE OESOPHAGITIS,1
CO,ERYSIPELAS,1
CO,ERYTHEMA NODOSUM,1
CO,ESCHERICHIA URINARY TRACT INFECTION,1
CO,EXTRAPYRAMIDAL DISORDER,1
CO,FACE OEDEMA,1
CO,FACIAL PAIN,1
CO,FEEDING DISORDER,1
CO,FEELING ABNORMAL,1
CO,FEELING HOT,1
CO,FEMUR FRACTURE,1
CO,FLUID RETENTION,1
CO,FOOT FRACTURE,1
CO,FUNGAL PERITONITIS,1
CO,GASTRODUODENITIS,1
CO,GASTROINTESTINAL DISORDER,1
CO,GASTROINTESTINAL PAIN,1
CO,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
CO,GENERALISED OEDEMA,1
CO,GINGIVAL ABSCESS,1
CO,GINGIVAL PAIN,1
CO,GINGIVAL SWELLING,1
CO,GLAUCOMA,1
CO,GRANULOMATOUS LIVER DISEASE,1
CO,HAEMOGLOBIN ABNORMAL,1
CO,HAEMOGLOBIN DECREASED,1
CO,HAEMOLYTIC URAEMIC SYNDROME,1
CO,HAEMOPTYSIS,1
CO,HAEMORRHOIDS,1
CO,HEAD INJURY,1
CO,HEAT STROKE,1
CO,HEPATIC STEATOSIS,1
CO,HEPATITIS B,1
CO,HISTOPLASMOSIS,1
CO,HYPERHIDROSIS,1
CO,HYPERSENSITIVITY,1
CO,HYPERSPLENISM,1
CO,HYPERTENSION,1
CO,HYPOAESTHESIA,1
CO,HYPOKINESIA,1
CO,HYPOTENSION,1
CO,IMMUNODEFICIENCY,1
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CO,INCOHERENT,1
CO,INCONTINENCE,1
CO,INCORRECT DOSE ADMINISTERED,1
CO,INFARCTION,1
CO,INFECTED SKIN ULCER,1
CO,INFECTION,1
CO,INFLAMMATION,1
CO,INFLUENZA LIKE ILLNESS,1
CO,INJECTION SITE PAIN,1
CO,INJURY,1
CO,INSOMNIA,1
CO,INTESTINAL PERFORATION,1
CO,KIDNEY INFECTION,1
CO,KLEBSIELLA INFECTION,1
CO,LEUKAEMIA,1
CO,LIGAMENT SPRAIN,1
CO,LIP BLISTER,1
CO,LUNG DISORDER,1
CO,LUNG INFECTION,1
CO,LYMPHADENOPATHY,1
CO,MALIGNANT NEOPLASM PROGRESSION,1
CO,MALNUTRITION,1
CO,MENINGITIS CRYPTOCOCCAL,1
CO,MENSTRUAL DISORDER,1
CO,METASTASES TO LUNG,1
CO,METASTASES TO LYMPH NODES,1
CO,METASTASES TO RETROPERITONEUM,1
CO,METASTASES TO THE MEDIASTINUM,1
CO,MOBILITY DECREASED,1
CO,MOOD ALTERED,1
CO,MUSCLE OEDEMA,1
CO,MUSCULAR WEAKNESS,1
CO,MYOSITIS,1
CO,NECROSIS,1
CO,NEOPLASM MALIGNANT,1
CO,NEPHROLITHIASIS,1
CO,NERVOUSNESS,1
CO,NORMAL NEWBORN,1
CO,OPPORTUNISTIC INFECTION,1
CO,ORAL MUCOSAL BLISTERING,1
CO,ORAL PAIN,1
CO,OROPHARYNGEAL PAIN,1
CO,OSTEOSARCOMA,1
CO,OVARIAN CYST RUPTURED,1
CO,PALLOR,1
CO,PANCYTOPENIA,1
CO,PAPULE,1
CO,PARAESTHESIA,1
CO,PEAU D^ORANGE,1
CO,PERIHEPATIC ABSCESS,1
CO,PERIPHERAL SENSORY NEUROPATHY,1
CO,PHLEBITIS,1
CO,PLATELET COUNT ABNORMAL,1
CO,PLATELET COUNT INCREASED,1
CO,PLATELET DISORDER,1
CO,PNEUMONIA BACTERIAL,1
CO,PNEUMONITIS,1
CO,POLYARTHRITIS,1
CO,POLYNEUROPATHY,1
CO,PROCEDURAL PAIN,1
CO,PROCTALGIA,1
CO,PROSTATE CANCER METASTATIC,1
CO,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
CO,PSORIATIC ARTHROPATHY,1
CO,PSYCHIATRIC SYMPTOM,1
CO,PULMONARY MASS,1
CO,PULMONARY OEDEMA,1
CO,PULMONARY TUBERCULOSIS,1
CO,RENAL DISORDER,1
CO,RENAL FAILURE,1
CO,RENAL TRANSPLANT,1
CO,RESPIRATORY DISTRESS,1
CO,RESPIRATORY FAILURE,1
CO,RHINITIS,1
CO,RHINORRHOEA,1
CO,SECRETION DISCHARGE,1
CO,SENSE OF OPPRESSION,1
CO,SEPTIC SHOCK,1
CO,SKIN DISCOLOURATION,1
CO,SKIN EXFOLIATION,1
CO,SKIN LESION,1
CO,SKIN MASS,1
CO,SKIN PLAQUE,1
CO,SKIN ULCER,1
CO,SKULL FRACTURE,1
CO,SLEEP DISORDER,1
CO,SOMNOLENCE,1
CO,SPEECH DISORDER,1
CO,STRONGYLOIDIASIS,1
CO,SYNOVITIS,1
CO,TACHYCARDIA,1
CO,TAKAYASU^S ARTERITIS,1
CO,TEMPERATURE INTOLERANCE,1
CO,TENDERNESS,1
CO,THERAPEUTIC RESPONSE DECREASED,1
CO,THROMBOPHLEBITIS SEPTIC,1
CO,THROMBOTIC MICROANGIOPATHY,1
CO,TONSILLITIS,1
CO,TOOTH ABSCESS,1
CO,TOXICITY TO VARIOUS AGENTS,1
CO,TREMOR,1
CO,TUBERCULIN TEST POSITIVE,1
CO,TUMOUR RUPTURE,1
CO,UNEVALUABLE EVENT,1
CO,UTERINE LEIOMYOMA,1
CO,UVEITIS,1
CO,VASCULITIS,1
CO,VERTIGO,1
CO,VISUAL ACUITY REDUCED,1
CO,WHEEZING,1
CO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
CO,YELLOW SKIN,1
CO,ZYGOMYCOSIS,1
CG,DRUG RESISTANCE,1
CR,THROMBOSIS,3
CR,DIARRHOEA,2
CR,DIZZINESS,2
CR,HAEMOGLOBIN DECREASED,2
CR,ABDOMINAL DISTENSION,1
CR,ACUTE KIDNEY INJURY,1
CR,ACUTE MYOCARDIAL INFARCTION,1
CR,ADENOCARCINOMA OF COLON,1
CR,AMPUTATION,1
CR,ARTERIAL INSUFFICIENCY,1
CR,ASCITES,1
CR,ASPARTATE AMINOTRANSFERASE INCREASED,1
CR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CR,BLOOD CHOLESTEROL INCREASED,1
CR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CR,BLOOD TRIGLYCERIDES INCREASED,1
CR,BLOOD UREA INCREASED,1
CR,BODY HEIGHT DECREASED,1
CR,CHRONIC GASTRITIS,1
CR,CHRONIC HEPATIC FAILURE,1
CR,COLORECTAL CANCER METASTATIC,1
CR,CYST,1
CR,DANDRUFF,1
CR,DEAFNESS,1
CR,DECREASED APPETITE,1
CR,DRUG INEFFECTIVE,1
CR,DYSPHAGIA,1
CR,DYSPNOEA,1
CR,ENDOMETRIOSIS,1
CR,EXPOSURE DURING PREGNANCY,1
CR,FAECES DISCOLOURED,1
CR,FALL,1
CR,FURUNCLE,1
CR,GAIT DISTURBANCE,1
CR,GASTRIC ULCER,1
CR,GASTRIC ULCER HAEMORRHAGE,1
CR,GASTRIC ULCER PERFORATION,1
CR,GENERAL PHYSICAL HEALTH DETERIORATION,1
CR,HAEMATEMESIS,1
CR,HAEMATOCHEZIA,1
CR,HAEMATOCRIT DECREASED,1
CR,HAEMORRHOIDS,1
CR,HELICOBACTER INFECTION,1
CR,HEPATIC CANCER,1
CR,HIGH DENSITY LIPOPROTEIN DECREASED,1
CR,HYPERAEMIA,1
CR,HYPOAESTHESIA,1
CR,INTENTIONAL PRODUCT USE ISSUE,1
CR,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,1
CR,LEUKOENCEPHALOPATHY,1
CR,LYMPHOCYTE PERCENTAGE INCREASED,1
CR,MALAISE,1
CR,MALIGNANT MELANOMA,1
CR,METASTASES TO LIVER,1
CR,METASTASES TO LUNG,1
CR,MOBILITY DECREASED,1
CR,MONOCYTE PERCENTAGE INCREASED,1
CR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CR,MUSCLE ATROPHY,1
CR,MUSCLE SPASMS,1
CR,MYALGIA,1
CR,NAUSEA,1
CR,NECK PAIN,1
CR,OCCULT BLOOD POSITIVE,1
CR,OSTEONECROSIS,1
CR,PAIN IN EXTREMITY,1
CR,PLEURAL EFFUSION,1
CR,PNEUMONIA,1
CR,PRURITUS,1
CR,RENAL FAILURE,1
CR,RIB FRACTURE,1
CR,SEIZURE,1
CR,SINUSITIS,1
CR,SPINAL CORD COMPRESSION,1
CR,SPINAL FRACTURE,1
CR,SUBCUTANEOUS ABSCESS,1
CR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
CR,TOOTH ABSCESS,1
CR,TRANSPLANT REJECTION,1
CR,URINARY TRACT INFECTION,1
CR,UROSEPSIS,1
CR,VOMITING,1
CR,WEIGHT DECREASED,1
CR,WHITE BLOOD CELL COUNT DECREASED,1
CI,MUCORMYCOSIS,2
CI,DELIRIUM,1
CI,HALLUCINATION,1
CI,INSOMNIA,1
HR,PYREXIA,8
HR,ABDOMINAL PAIN,4
HR,ANAEMIA,4
HR,BONE EROSION,4
HR,CARDIOMYOPATHY,4
HR,DIFFUSE LARGE B-CELL LYMPHOMA,4
HR,GASTROINTESTINAL HAEMORRHAGE,4
HR,HEPATIC ENZYME INCREASED,4
HR,HISTIOCYTOSIS HAEMATOPHAGIC,4
HR,INFUSION RELATED REACTION,4
HR,MOBILITY DECREASED,4
HR,NEUTROPENIA,4
HR,POLYARTHRITIS,4
HR,SUICIDE ATTEMPT,4
HR,THROMBOCYTOPENIA,4
HR,VISCERAL LEISHMANIASIS,4
HR,CYSTITIS HAEMORRHAGIC,3
HR,FEBRILE NEUTROPENIA,3
HR,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,3
HR,ASPERGILLUS INFECTION,2
HR,BRONCHOPULMONARY ASPERGILLOSIS,2
HR,CEREBRAL INFARCTION,2
HR,CONDITION AGGRAVATED,2
HR,EYE OEDEMA,2
HR,EYE SWELLING,2
HR,GENERAL PHYSICAL HEALTH DETERIORATION,2
HR,HEPATIC LESION,2
HR,HEPATOTOXICITY,2
HR,HYPOVOLAEMIC SHOCK,2
HR,LEUKOPENIA,2
HR,LIVER INJURY,2
HR,LOWER GASTROINTESTINAL HAEMORRHAGE,2
HR,PERFORMANCE STATUS DECREASED,2
HR,POLYNEUROPATHY,2
HR,PRODUCT USE ISSUE,2
HR,RESPIRATORY TRACT INFECTION,2
HR,RHEUMATOID ARTHRITIS,2
HR,SKIN LESION,2
HR,THYROIDITIS,2
HR,TINEA INFECTION,2
HR,TRANSAMINASES INCREASED,2
HR,VENOUS THROMBOSIS,2
HR,ACUTE RESPIRATORY FAILURE,1
HR,AGITATION,1
HR,APLASTIC ANAEMIA,1
HR,BASAL CELL CARCINOMA,1
HR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
HR,BLOOD CREATININE INCREASED,1
HR,BLOOD PRESSURE INCREASED,1
HR,BLOOD UREA INCREASED,1
HR,BRADYCARDIA,1
HR,BRONCHIAL OBSTRUCTION,1
HR,BRONCHOSPASM,1
HR,C-REACTIVE PROTEIN INCREASED,1
HR,CHOLELITHIASIS,1
HR,CLOSTRIDIUM DIFFICILE INFECTION,1
HR,COLITIS ULCERATIVE,1
HR,COMPLEMENT FACTOR C3 DECREASED,1
HR,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
HR,COUGH,1
HR,CYTOMEGALOVIRUS INFECTION,1
HR,CYTOMEGALOVIRUS TEST POSITIVE,1
HR,CYTOMEGALOVIRUS VIRAEMIA,1
HR,DEATH,1
HR,DEVICE TOXICITY,1
HR,DIABETES MELLITUS,1
HR,DIVERTICULUM,1
HR,DRUG HYPERSENSITIVITY,1
HR,DRUG INEFFECTIVE,1
HR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
HR,DYSLIPIDAEMIA,1
HR,DYSPNOEA,1
HR,ENTEROBACTER INFECTION,1
HR,ENTEROCOLITIS,1
HR,EOSINOPHILIA,1
HR,EPSTEIN-BARR VIRAEMIA,1
HR,FACE OEDEMA,1
HR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
HR,GASTROENTERITIS,1
HR,GASTROOESOPHAGEAL REFLUX DISEASE,1
HR,GRAFT VERSUS HOST DISEASE,1
HR,HAEMATOCHEZIA,1
HR,HAEMOTHORAX,1
HR,HEADACHE,1
HR,HEPATIC STEATOSIS,1
HR,HEPATITIS,1
HR,HEPATITIS B,1
HR,HEPATITIS B REACTIVATION,1
HR,HEPATOMEGALY,1
HR,HERPES ZOSTER,1
HR,HYPERCOAGULATION,1
HR,HYPERLIPIDAEMIA,1
HR,HYPERSENSITIVITY,1
HR,HYPOPROTEINAEMIA,1
HR,HYPOTENSION,1
HR,HYPOTONIA,1
HR,INAPPROPRIATE PRESCRIBING,1
HR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
HR,INFECTION,1
HR,INFLUENZA LIKE ILLNESS,1
HR,IRRITABILITY,1
HR,KIDNEY TRANSPLANT REJECTION,1
HR,LEFT VENTRICULAR DYSFUNCTION,1
HR,LEFT VENTRICULAR HYPERTROPHY,1
HR,LEUKOCYTOSIS,1
HR,LUNG INFILTRATION,1
HR,LYMPHADENOPATHY,1
HR,LYMPHOCYTOSIS,1
HR,MALAISE,1
HR,MONONEURITIS,1
HR,MUSCULAR WEAKNESS,1
HR,MYASTHENIA GRAVIS,1
HR,NASAL SEPTUM ULCERATION,1
HR,NASOPHARYNGITIS,1
HR,NEPHROLITHIASIS,1
HR,NEUTROPENIC COLITIS,1
HR,NOSOCOMIAL INFECTION,1
HR,OESOPHAGEAL CANDIDIASIS,1
HR,OXYGEN SATURATION DECREASED,1
HR,PALLOR,1
HR,PLEURAL EFFUSION,1
HR,PNEUMOCOCCAL SEPSIS,1
HR,PNEUMONIA,1
HR,PNEUMONIA PNEUMOCOCCAL,1
HR,PRODUCT USE IN UNAPPROVED INDICATION,1
HR,PUPILS UNEQUAL,1
HR,RASH GENERALISED,1
HR,RENAL FUNCTION TEST ABNORMAL,1
HR,RESPIRATORY FAILURE,1
HR,RHINORRHOEA,1
HR,SEPSIS,1
HR,SINUSITIS,1
HR,SPLENOMEGALY,1
HR,STAPHYLOCOCCAL SEPSIS,1
HR,TACHYCARDIA,1
HR,TACHYPNOEA,1
HR,THYMOMA,1
HR,TREATMENT NONCOMPLIANCE,1
HR,TRICHOPHYTOSIS,1
HR,UPPER RESPIRATORY TRACT INFECTION,1
HR,VASCULAR HEADACHE,1
HR,WHEEZING,1
HR,WHITE BLOOD CELL COUNT DECREASED,1
CU,CRYPTOCOCCOSIS,1
CU,DECREASED APPETITE,1
CU,DISORIENTATION,1
CU,ENCEPHALITIS,1
CU,HEADACHE,1
CU,PSYCHOMOTOR HYPERACTIVITY,1
CU,VOMITING,1
CY,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CY,BLOOD CREATININE INCREASED,1
CY,BLOOD UREA INCREASED,1
CY,CHOLECYSTITIS,1
CY,DEEP VEIN THROMBOSIS,1
CY,DYSPNOEA,1
CY,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CY,HAEMOGLOBIN DECREASED,1
CY,OEDEMA PERIPHERAL,1
CY,PNEUMONITIS,1
CY,PYREXIA,1
CY,RESPIRATORY FAILURE,1
CZ,NEUTROPENIA,23
CZ,OSTEOPOROSIS,18
CZ,PERIPHERAL SENSORY NEUROPATHY,18
CZ,DIABETES MELLITUS,17
CZ,HERPES ZOSTER,16
CZ,ANAEMIA,15
CZ,FEBRILE NEUTROPENIA,15
CZ,PANCYTOPENIA,14
CZ,PNEUMONIA,13
CZ,SEPSIS,10
CZ,DIARRHOEA,9
CZ,DRUG INEFFECTIVE,9
CZ,DYSPNOEA,9
CZ,HAEMATOTOXICITY,9
CZ,POLYNEUROPATHY,9
CZ,THROMBOCYTOPENIA,9
CZ,CARDIAC FAILURE,8
CZ,LEUKOPENIA,8
CZ,DEATH,7
CZ,DEEP VEIN THROMBOSIS,7
CZ,FATIGUE,7
CZ,INFECTION,7
CZ,NAUSEA,7
CZ,NEUROPATHY PERIPHERAL,7
CZ,OSTEONECROSIS,7
CZ,PNEUMONITIS,7
CZ,PYREXIA,7
CZ,SPINAL CORD COMPRESSION,7
CZ,AMENORRHOEA,6
CZ,BODY HEIGHT DECREASED,6
CZ,LIVER DISORDER,6
CZ,PNEUMOCYSTIS JIROVECII PNEUMONIA,6
CZ,ACUTE HEPATIC FAILURE,5
CZ,ACUTE MYELOID LEUKAEMIA,5
CZ,ARRHYTHMIA,5
CZ,ASTHENIA,5
CZ,BRONCHOPNEUMONIA,5
CZ,BRONCHOPULMONARY ASPERGILLOSIS,5
CZ,DEHYDRATION,5
CZ,DEPRESSION,5
CZ,DYSPEPSIA,5
CZ,INTERVERTEBRAL DISCITIS,5
CZ,PULMONARY EMBOLISM,5
CZ,SALMONELLA SEPSIS,5
CZ,SEPTIC SHOCK,5
CZ,SPINAL PAIN,5
CZ,ARTHRALGIA,4
CZ,ATRIAL FIBRILLATION,4
CZ,DISEASE PROGRESSION,4
CZ,GASTROINTESTINAL DISORDER,4
CZ,GASTROINTESTINAL TOXICITY,4
CZ,GENERAL PHYSICAL HEALTH DETERIORATION,4
CZ,HEPATITIS B,4
CZ,INFUSION RELATED REACTION,4
CZ,OSTEOPOROTIC FRACTURE,4
CZ,RENAL FAILURE,4
CZ,RESPIRATORY TRACT INFECTION,4
CZ,SPINAL COMPRESSION FRACTURE,4
CZ,URINARY TRACT INFECTION,4
CZ,VOMITING,4
CZ,ADENOCARCINOMA GASTRIC,3
CZ,C-REACTIVE PROTEIN INCREASED,3
CZ,CELLULITIS,3
CZ,CEREBROVASCULAR ACCIDENT,3
CZ,CIRCULATORY COLLAPSE,3
CZ,CLOSTRIDIUM DIFFICILE INFECTION,3
CZ,COMPRESSION FRACTURE,3
CZ,CUSHINGOID,3
CZ,CUSHING^S SYNDROME,3
CZ,FUNGAL SKIN INFECTION,3
CZ,HAEMATOSPERMIA,3
CZ,HAEMATURIA,3
CZ,HEPATORENAL FAILURE,3
CZ,HODGKIN^S DISEASE,3
CZ,HYPERTENSION,3
CZ,HYPONATRAEMIA,3
CZ,MEGACOLON,3
CZ,MUCOSAL INFLAMMATION,3
CZ,MYOCARDIAL INFARCTION,3
CZ,MYOPATHY,3
CZ,OPTIC NEUROPATHY,3
CZ,PARAESTHESIA,3
CZ,PRODUCT USE ISSUE,3
CZ,RASH,3
CZ,RASH GENERALISED,3
CZ,RESPIRATORY FAILURE,3
CZ,SARCOPENIA,3
CZ,THROMBOSIS,3
CZ,WEIGHT INCREASED,3
CZ,ACUTE MONOCYTIC LEUKAEMIA,2
CZ,ALANINE AMINOTRANSFERASE INCREASED,2
CZ,ALTERED STATE OF CONSCIOUSNESS,2
CZ,AMNESIA,2
CZ,ATYPICAL PNEUMONIA,2
CZ,BACILLARY ANGIOMATOSIS,2
CZ,BACK PAIN,2
CZ,BLOOD CREATININE INCREASED,2
CZ,CARDIAC AMYLOIDOSIS,2
CZ,CARDIAC ARREST,2
CZ,CENTRAL NERVOUS SYSTEM LYMPHOMA,2
CZ,CEREBRAL HAEMORRHAGE,2
CZ,CONDITION AGGRAVATED,2
CZ,DIABETIC METABOLIC DECOMPENSATION,2
CZ,GENE MUTATION,2
CZ,HAEMATOMA,2
CZ,HAEMOPTYSIS,2
CZ,HYPERPARATHYROIDISM SECONDARY,2
CZ,HYPERSENSITIVITY,2
CZ,HYPERURICAEMIA,2
CZ,HYPOKALAEMIA,2
CZ,HYPOTENSION,2
CZ,ILEUS,2
CZ,INSOMNIA,2
CZ,KYPHOSIS,2
CZ,LEUKAEMIA RECURRENT,2
CZ,LEUKOCYTOSIS,2
CZ,LIVER FUNCTION TEST INCREASED,2
CZ,LUMBAR VERTEBRAL FRACTURE,2
CZ,LUNG INFECTION,2
CZ,MALAISE,2
CZ,MULTIPLE SCLEROSIS,2
CZ,MUSCULAR WEAKNESS,2
CZ,NEURALGIA,2
CZ,NEUROTOXICITY,2
CZ,NEUTROPENIC INFECTION,2
CZ,ONYCHOLYSIS,2
CZ,OPTIC NEURITIS,2
CZ,OSTEOPENIA,2
CZ,PALPITATIONS,2
CZ,PARAPARESIS,2
CZ,PERIPHERAL SWELLING,2
CZ,PLASMA CELL MYELOMA,2
CZ,PLATELET COUNT DECREASED,2
CZ,PORTAL VEIN THROMBOSIS,2
CZ,PRODUCT USE IN UNAPPROVED INDICATION,2
CZ,PROTEINURIA,2
CZ,PULMONARY OEDEMA,2
CZ,RENAL IMPAIRMENT,2
CZ,SINUS TACHYCARDIA,2
CZ,SINUSITIS,2
CZ,SPINAL FRACTURE,2
CZ,SUDDEN DEATH,2
CZ,TACHYCARDIA,2
CZ,TRANSPLANT FAILURE,2
CZ,TUMOUR LYSIS SYNDROME,2
CZ,VASCULITIS,2
CZ,VITAMIN D ABNORMAL,2
CZ,ABDOMINAL PAIN,1
CZ,ABORTION SPONTANEOUS,1
CZ,ABSCESS,1
CZ,ACUTE KIDNEY INJURY,1
CZ,ACUTE RESPIRATORY FAILURE,1
CZ,ACUTE TONSILLITIS,1
CZ,ADENOCARCINOMA OF COLON,1
CZ,AGRANULOCYTOSIS,1
CZ,ALVEOLITIS,1
CZ,ANKYLOSING SPONDYLITIS,1
CZ,ANTIBODY TEST POSITIVE,1
CZ,APHTHOUS STOMATITIS,1
CZ,AREFLEXIA,1
CZ,ARTERIOSCLEROSIS CORONARY ARTERY,1
CZ,ASPARTATE AMINOTRANSFERASE INCREASED,1
CZ,ASPERGILLUS INFECTION,1
CZ,AUTOIMMUNE DISORDER,1
CZ,AUTOIMMUNE HEPATITIS,1
CZ,B-CELL LYMPHOMA,1
CZ,BARTONELLA TEST POSITIVE,1
CZ,BLADDER TAMPONADE,1
CZ,BLIGHTED OVUM,1
CZ,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CZ,BLOOD PARATHYROID HORMONE INCREASED,1
CZ,BODY HEIGHT ABNORMAL,1
CZ,BONE FORMATION DECREASED,1
CZ,BONE MARROW FAILURE,1
CZ,BONE MARROW OEDEMA,1
CZ,BONE PAIN,1
CZ,BREAST CANCER,1
CZ,BREAST CANCER FEMALE,1
CZ,BRONCHIAL CARCINOMA,1
CZ,BRONCHITIS,1
CZ,BURNING SENSATION,1
CZ,BURSITIS,1
CZ,CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT,1
CZ,CARDIAC SEPTAL HYPERTROPHY,1
CZ,CARDIOPULMONARY FAILURE,1
CZ,CARDIOTOXICITY,1
CZ,CARDIOVASCULAR DISORDER,1
CZ,CENTRAL VENOUS CATHETERISATION,1
CZ,CEREBRAL ISCHAEMIA,1
CZ,CERVIX DISORDER,1
CZ,CERVIX INFLAMMATION,1
CZ,CHEST DISCOMFORT,1
CZ,CHEST PAIN,1
CZ,CHOLANGIOCARCINOMA,1
CZ,CHOLANGITIS,1
CZ,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
CZ,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
CZ,CLOSTRIDIUM COLITIS,1
CZ,COAGULOPATHY,1
CZ,COLITIS,1
CZ,COLITIS ULCERATIVE,1
CZ,COMPLETED SUICIDE,1
CZ,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
CZ,COMPLICATIONS OF TRANSPLANTED LIVER,1
CZ,CONJUNCTIVITIS,1
CZ,CONSTIPATION,1
CZ,CREUTZFELDT-JAKOB DISEASE,1
CZ,CYSTITIS,1
CZ,CYTOMEGALOVIRUS INFECTION,1
CZ,CYTOPENIA,1
CZ,DECREASED APPETITE,1
CZ,DECUBITUS ULCER,1
CZ,DELIRIUM,1
CZ,DEVICE RELATED SEPSIS,1
CZ,DIZZINESS,1
CZ,DRUG EFFECT INCOMPLETE,1
CZ,DRUG LEVEL INCREASED,1
CZ,DRUG PRESCRIBING ERROR,1
CZ,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
CZ,DRUG SPECIFIC ANTIBODY PRESENT,1
CZ,DRUG-INDUCED LIVER INJURY,1
CZ,DYSPNOEA EXERTIONAL,1
CZ,EATING DISORDER,1
CZ,EMBOLISM,1
CZ,ENCEPHALITIS VIRAL,1
CZ,ENDOMETRIAL ADENOCARCINOMA,1
CZ,ENDOMETRIAL CANCER,1
CZ,ENTEROBACTER INFECTION,1
CZ,ERYSIPELAS,1
CZ,ERYTHEMA,1
CZ,ERYTHEMA NODOSUM,1
CZ,EXOPHTHALMOS,1
CZ,EXPOSURE DURING PREGNANCY,1
CZ,FALL,1
CZ,FEMORAL NECK FRACTURE,1
CZ,FLUID RETENTION,1
CZ,FLUSHING,1
CZ,FOETAL DEATH,1
CZ,FUNGAL INFECTION,1
CZ,GAIT DISTURBANCE,1
CZ,GASTROENTERITIS SALMONELLA,1
CZ,GASTROINTESTINAL INFECTION,1
CZ,GASTROINTESTINAL INFLAMMATION,1
CZ,GENERALISED ERYTHEMA,1
CZ,GLIOMA,1
CZ,GLOMERULAR FILTRATION RATE DECREASED,1
CZ,HAEMANGIOMA OF SKIN,1
CZ,HAEMORRHOIDS,1
CZ,HEPATIC ENZYME INCREASED,1
CZ,HEPATIC FAILURE,1
CZ,HEPATIC LESION,1
CZ,HERPES ZOSTER DISSEMINATED,1
CZ,HORDEOLUM,1
CZ,HUMAN HERPESVIRUS 8 INFECTION,1
CZ,HYPERKERATOSIS,1
CZ,HYPERPARATHYROIDISM,1
CZ,HYPOTHYROIDISM,1
CZ,ILEUS PARALYTIC,1
CZ,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
CZ,INFLUENZA LIKE ILLNESS,1
CZ,INTERVERTEBRAL DISC COMPRESSION,1
CZ,INTESTINAL HAEMORRHAGE,1
CZ,INVASIVE DUCTAL BREAST CARCINOMA,1
CZ,JOINT SWELLING,1
CZ,KAPOSI^S SARCOMA,1
CZ,KIDNEY TRANSPLANT REJECTION,1
CZ,LEUKAEMIC INFILTRATION,1
CZ,LOWER GASTROINTESTINAL HAEMORRHAGE,1
CZ,LOWER RESPIRATORY TRACT INFECTION,1
CZ,LUNG CANCER METASTATIC,1
CZ,LUNG NEOPLASM MALIGNANT,1
CZ,LYMPHADENOPATHY,1
CZ,LYMPHOMA,1
CZ,LYMPHOPENIA,1
CZ,MALIGNANT FIBROUS HISTIOCYTOMA RECURRENT,1
CZ,MALIGNANT MELANOMA,1
CZ,MALIGNANT NEOPLASM PROGRESSION,1
CZ,MALNUTRITION,1
CZ,MATERNAL EXPOSURE DURING PREGNANCY,1
CZ,MENINGIOMA,1
CZ,METASTASIS,1
CZ,METASTATIC MALIGNANT MELANOMA,1
CZ,METRORRHAGIA,1
CZ,MUCOSAL TOXICITY,1
CZ,MULTI-ORGAN FAILURE,1
CZ,MYALGIA,1
CZ,MYELODYSPLASTIC SYNDROME,1
CZ,MYOFASCIAL PAIN SYNDROME,1
CZ,NEPHROLITHIASIS,1
CZ,NEUTROPENIC COLITIS,1
CZ,NEUTROPHIL COUNT DECREASED,1
CZ,OEDEMA PERIPHERAL,1
CZ,OESOPHAGEAL CANDIDIASIS,1
CZ,OLIGURIA,1
CZ,ORAL CANDIDIASIS,1
CZ,ORTHOSTATIC HYPOTENSION,1
CZ,OSTEOARTHRITIS,1
CZ,OSTEOMYELITIS,1
CZ,OXYGEN SATURATION DECREASED,1
CZ,PAIN,1
CZ,PAIN IN EXTREMITY,1
CZ,PANCREATIC CARCINOMA METASTATIC,1
CZ,PATHOLOGICAL FRACTURE,1
CZ,PETECHIAE,1
CZ,PHOTOSENSITIVITY REACTION,1
CZ,PLEURAL EFFUSION,1
CZ,PNEUMOCYSTIS JIROVECI PNEUMONIA,1
CZ,PNEUMONIA KLEBSIELLA,1
CZ,PNEUMONIA STAPHYLOCOCCAL,1
CZ,POEMS SYNDROME,1
CZ,PROSTATE CANCER,1
CZ,PSOAS ABSCESS,1
CZ,PULMONARY CONGESTION,1
CZ,PULMONARY HYPERTENSION,1
CZ,PULMONARY TOXICITY,1
CZ,PULMONARY TUBERCULOSIS,1
CZ,PYELONEPHRITIS,1
CZ,QUALITY OF LIFE DECREASED,1
CZ,REBOUND EFFECT,1
CZ,RECURRENT CANCER,1
CZ,RENAL CANCER,1
CZ,RENAL CELL CARCINOMA,1
CZ,RESORPTION BONE INCREASED,1
CZ,RESPIRATORY DISORDER,1
CZ,RETROPERITONEAL LYMPHADENOPATHY,1
CZ,SALMONELLOSIS,1
CZ,SKIN DISORDER,1
CZ,SKIN HAEMORRHAGE,1
CZ,SKIN LESION,1
CZ,SKIN MASS,1
CZ,SMALL INTESTINAL PERFORATION,1
CZ,SOMNOLENCE,1
CZ,SPINAL DISORDER,1
CZ,SQUAMOUS CELL CARCINOMA,1
CZ,STILL^S DISEASE,1
CZ,STOMATITIS,1
CZ,SUPERINFECTION,1
CZ,SYNCOPE,1
CZ,SYNOVITIS,1
CZ,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CZ,THERAPEUTIC PRODUCT INEFFECTIVE,1
CZ,THERAPEUTIC RESPONSE DECREASED,1
CZ,THERMOHYPERAESTHESIA,1
CZ,THORACIC VERTEBRAL FRACTURE,1
CZ,THROMBOPHLEBITIS,1
CZ,TINNITUS,1
CZ,TRANSPLANT DYSFUNCTION,1
CZ,TRANSPLANT REJECTION,1
CZ,TYPE 1 DIABETES MELLITUS,1
CZ,UPPER RESPIRATORY TRACT INFECTION,1
CZ,URTICARIA,1
CZ,UVEITIS,1
CZ,VAGINAL HAEMORRHAGE,1
CZ,VENTRICULAR FLUTTER,1
CZ,VERTIGO,1
CZ,VISUAL ACUITY REDUCED,1
CZ,VULVOVAGINITIS,1
DK,FEBRILE NEUTROPENIA,17
DK,DIARRHOEA,16
DK,WEIGHT DECREASED,15
DK,DEHYDRATION,14
DK,PYREXIA,13
DK,PNEUMONIA,10
DK,RHABDOMYOLYSIS,10
DK,ACUTE KIDNEY INJURY,9
DK,TROPONIN T INCREASED,7
DK,ANAEMIA,6
DK,CARDIAC ARREST,6
DK,SEPSIS,6
DK,STOMATITIS,6
DK,VOMITING,6
DK,ASCITES,5
DK,ATRIAL FIBRILLATION,5
DK,CROHN^S DISEASE,5
DK,CYTOMEGALOVIRUS INFECTION,5
DK,FATIGUE,5
DK,MALABSORPTION,5
DK,ABDOMINAL PAIN UPPER,4
DK,FALL,4
DK,INFECTION,4
DK,MALAISE,4
DK,PRODUCT USE IN UNAPPROVED INDICATION,4
DK,PULMONARY EMBOLISM,4
DK,UPPER RESPIRATORY TRACT INFECTION,4
DK,BACK PAIN,3
DK,CENTRAL NERVOUS SYSTEM LYMPHOMA,3
DK,DIZZINESS,3
DK,ORAL CANDIDIASIS,3
DK,PERIPHERAL SENSORY NEUROPATHY,3
DK,SEPTIC SHOCK,3
DK,THROMBOSIS,3
DK,TUMOUR LYSIS SYNDROME,3
DK,ABDOMINAL PAIN,2
DK,ACUTE MYOCARDIAL INFARCTION,2
DK,ALANINE AMINOTRANSFERASE INCREASED,2
DK,ARRHYTHMIA,2
DK,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
DK,AUTOIMMUNE HEPATITIS,2
DK,BONE DENSITY DECREASED,2
DK,BUNDLE BRANCH BLOCK RIGHT,2
DK,CARDIOMEGALY,2
DK,COLITIS,2
DK,COLITIS ULCERATIVE,2
DK,CONFUSIONAL STATE,2
DK,DEATH,2
DK,DEEP VEIN THROMBOSIS,2
DK,DIFFUSE LARGE B-CELL LYMPHOMA,2
DK,DRUG INEFFECTIVE,2
DK,DYSPNOEA EXERTIONAL,2
DK,ELECTROCARDIOGRAM QT PROLONGED,2
DK,GASTRIC ULCER HAEMORRHAGE,2
DK,GASTROINTESTINAL STOMA COMPLICATION,2
DK,GENERAL PHYSICAL HEALTH DETERIORATION,2
DK,HAEMOGLOBIN DECREASED,2
DK,HEADACHE,2
DK,HUMAN HERPESVIRUS 6 INFECTION,2
DK,HYPERKALAEMIA,2
DK,HYPOGAMMAGLOBULINAEMIA,2
DK,HYPOKALAEMIA,2
DK,INTERSTITIAL LUNG DISEASE,2
DK,KLEBSIELLA INFECTION,2
DK,MUSCLE RUPTURE,2
DK,NAUSEA,2
DK,NEUTROPENIA,2
DK,NON-HODGKIN^S LYMPHOMA,2
DK,OSTEONECROSIS OF JAW,2
DK,PAIN,2
DK,PLEURAL EFFUSION,2
DK,PNEUMOTHORAX,2
DK,PRODUCT USE ISSUE,2
DK,RESPIRATORY FAILURE,2
DK,SPINAL FRACTURE,2
DK,SQUAMOUS CELL CARCINOMA OF SKIN,2
DK,TENDON RUPTURE,2
DK,TENDONITIS,2
DK,TOXICITY TO VARIOUS AGENTS,2
DK,WHITE BLOOD CELL COUNT DECREASED,2
DK,ABDOMINAL ADHESIONS,1
DK,ABDOMINAL CAVITY DRAINAGE,1
DK,ABDOMINAL OPERATION,1
DK,ABDOMINAL WOUND DEHISCENCE,1
DK,ABSCESS,1
DK,ADENOCARCINOMA OF COLON,1
DK,ANAL ABSCESS,1
DK,APHASIA,1
DK,ARTHRALGIA,1
DK,ASTHENIA,1
DK,ATRIOVENTRICULAR BLOCK,1
DK,ATYPICAL PNEUMONIA,1
DK,BILE DUCT STENOSIS,1
DK,BLOOD LACTIC ACID INCREASED,1
DK,BLOOD TEST ABNORMAL,1
DK,BUNDLE BRANCH BLOCK LEFT,1
DK,C-REACTIVE PROTEIN INCREASED,1
DK,CANDIDA INFECTION,1
DK,CARDIAC FAILURE,1
DK,CARDIAC PACEMAKER INSERTION,1
DK,CARDIOVASCULAR DISORDER,1
DK,CAUDA EQUINA SYNDROME,1
DK,CHEST DISCOMFORT,1
DK,CHEST PAIN,1
DK,CHOLANGITIS,1
DK,CHOLANGITIS SCLEROSING,1
DK,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
DK,COLECTOMY,1
DK,COLITIS MICROSCOPIC,1
DK,CONSTIPATION,1
DK,CONTRAST MEDIA ALLERGY,1
DK,COUGH,1
DK,CYSTITIS,1
DK,DEAFNESS TRAUMATIC,1
DK,DEPRESSIVE SYMPTOM,1
DK,DIABETES MELLITUS,1
DK,DISSEMINATED INTRAVASCULAR COAGULATION,1
DK,DIVERTICULITIS,1
DK,DRUG ABUSE,1
DK,DRUG RESISTANCE,1
DK,DUODENAL ULCER,1
DK,DYSPNOEA,1
DK,EJECTION FRACTION DECREASED,1
DK,ENCEPHALITIS,1
DK,ENCEPHALOPATHY,1
DK,ENDOTRACHEAL INTUBATION,1
DK,EPISCLERITIS,1
DK,EPSTEIN-BARR VIRAEMIA,1
DK,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,1
DK,EXPOSED BONE IN JAW,1
DK,FASCIAL RUPTURE,1
DK,FEELING OF BODY TEMPERATURE CHANGE,1
DK,FIBROMYALGIA,1
DK,GALLBLADDER ENLARGEMENT,1
DK,GASTRIC HAEMORRHAGE,1
DK,GASTRIC PERFORATION,1
DK,GASTRITIS,1
DK,GASTROINTESTINAL DISORDER,1
DK,GASTROINTESTINAL HAEMORRHAGE,1
DK,GLAUCOMA,1
DK,HEMIPLEGIA,1
DK,HEPATITIS D,1
DK,HERPES VIRUS INFECTION,1
DK,HISTIOCYTOSIS HAEMATOPHAGIC,1
DK,HUMERUS FRACTURE,1
DK,HYPERCALCAEMIA,1
DK,HYPERGLYCAEMIA,1
DK,HYPOMAGNESAEMIA,1
DK,ILEUS,1
DK,INCISIONAL HERNIA,1
DK,INFUSION RELATED REACTION,1
DK,JAUNDICE,1
DK,LEFT VENTRICULAR DYSFUNCTION,1
DK,LEUKOCYTOSIS,1
DK,LOSS OF CONSCIOUSNESS,1
DK,LYMPHOPENIA,1
DK,MALLORY-WEISS SYNDROME,1
DK,MANTLE CELL LYMPHOMA,1
DK,MELANOCYTIC NAEVUS,1
DK,METASTASES TO PERITONEUM,1
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DK,MYELODYSPLASTIC SYNDROME,1
DK,MYOPATHY TOXIC,1
DK,NECK PAIN,1
DK,NEUROTOXICITY,1
DK,NEUTROPENIC COLITIS,1
DK,NEUTROPENIC SEPSIS,1
DK,NON-HODGKIN^S LYMPHOMA RECURRENT,1
DK,NON-SMALL CELL LUNG CANCER STAGE IIIB,1
DK,NUTRITIONAL CONDITION ABNORMAL,1
DK,OEDEMA PERIPHERAL,1
DK,ORAL FUNGAL INFECTION,1
DK,ORAL INFECTION,1
DK,ORGAN FAILURE,1
DK,PAPILLARY THYROID CANCER,1
DK,PARAPARESIS,1
DK,PLEOCYTOSIS,1
DK,POLLAKIURIA,1
DK,POLYURIA,1
DK,PSEUDOPOLYP,1
DK,RADIATION NECROSIS,1
DK,RENAL IMPAIRMENT,1
DK,RESUSCITATION,1
DK,SENSORY LOSS,1
DK,SEQUESTRECTOMY,1
DK,SKIN DISORDER,1
DK,SKIN INFECTION,1
DK,SKIN LESION,1
DK,STOMA OBSTRUCTION,1
DK,SUBARACHNOID HAEMORRHAGE,1
DK,SUPERINFECTION,1
DK,SURGICAL SKIN TEAR,1
DK,SWELLING,1
DK,SYMPTOM MASKED,1
DK,SYNCOPE,1
DK,T-CELL LYMPHOMA,1
DK,THERAPEUTIC RESPONSE UNEXPECTED,1
DK,THIRST,1
DK,UNEVALUABLE EVENT,1
DK,URINARY INCONTINENCE,1
DK,URINARY TRACT INFECTION,1
DK,VISION BLURRED,1
DK,WOUND HAEMORRHAGE,1
DO,ANAEMIA,2
DO,ARTHRALGIA,2
DO,ASTHENIA,2
DO,DEHYDRATION,2
DO,DYSURIA,2
DO,FREQUENT BOWEL MOVEMENTS,2
DO,HYPERGLYCAEMIA,2
DO,OSTEOARTHRITIS,2
DO,POST PROCEDURAL COMPLICATION,2
DO,PULMONARY OEDEMA,2
DO,URINARY TRACT INFECTION,2
DO,VISION BLURRED,2
DO,ABDOMINAL DISCOMFORT,1
DO,ABDOMINAL DISTENSION,1
DO,ABDOMINAL HERNIA,1
DO,ABDOMINAL PAIN,1
DO,ABORTION SPONTANEOUS,1
DO,ACUTE CORONARY SYNDROME,1
DO,ACUTE KIDNEY INJURY,1
DO,AMOEBIASIS,1
DO,ANAL FISSURE,1
DO,AXILLARY MASS,1
DO,BACK PAIN,1
DO,BLOOD PRESSURE ABNORMAL,1
DO,BONE MARROW TOXICITY,1
DO,BREAST DISCOMFORT,1
DO,BREATH SOUNDS ABNORMAL,1
DO,CHEST PAIN,1
DO,COLITIS ULCERATIVE,1
DO,DIABETES MELLITUS,1
DO,DIARRHOEA,1
DO,DIZZINESS,1
DO,DRUG EFFECT INCOMPLETE,1
DO,DYSSTASIA,1
DO,EXPOSURE DURING PREGNANCY,1
DO,FALL,1
DO,FATIGUE,1
DO,FOETAL DEATH,1
DO,GAIT DISTURBANCE,1
DO,GALLBLADDER NECROSIS,1
DO,GALLBLADDER OEDEMA,1
DO,GASTRITIS,1
DO,GASTROINTESTINAL HAEMORRHAGE,1
DO,GASTROINTESTINAL OEDEMA,1
DO,GLAUCOMA,1
DO,HAEMATOCHEZIA,1
DO,HELICOBACTER INFECTION,1
DO,HYPERHIDROSIS,1
DO,HYPOACUSIS,1
DO,HYPOTENSION,1
DO,INFLUENZA,1
DO,INSOMNIA,1
DO,INTERSTITIAL LUNG DISEASE,1
DO,JOINT RANGE OF MOTION DECREASED,1
DO,JOINT SWELLING,1
DO,JOINT WARMTH,1
DO,KIDNEY ENLARGEMENT,1
DO,LIPOMA,1
DO,LIVER DISORDER,1
DO,MENIERE^S DISEASE,1
DO,MOBILITY DECREASED,1
DO,MUCOUS STOOLS,1
DO,NAUSEA,1
DO,NODULE,1
DO,OEDEMA MUCOSAL,1
DO,PAIN,1
DO,PAINFUL DEFAECATION,1
DO,PELVIC PAIN,1
DO,PNEUMONIA,1
DO,POLYDIPSIA,1
DO,POLYURIA,1
DO,PROCTALGIA,1
DO,PRURITUS,1
DO,PSYCHIATRIC SYMPTOM,1
DO,RASH ERYTHEMATOUS,1
DO,RECTAL ABSCESS,1
DO,RECTAL HAEMORRHAGE,1
DO,RECTAL PROLAPSE,1
DO,RESPIRATORY DISTRESS,1
DO,SENSORY LOSS,1
DO,SKIN REACTION,1
DO,STRIDOR,1
DO,SWELLING,1
DO,THYROID MASS,1
DO,UPPER LIMB FRACTURE,1
DO,VAGINAL HAEMORRHAGE,1
DO,VERTIGO,1
DO,VIRAL INFECTION,1
DO,VISUAL IMPAIRMENT,1
DO,VOMITING,1
DO,WEIGHT DECREASED,1
EC,CEREBRAL HAEMORRHAGE,3
EC,BONE MARROW FAILURE,2
EC,DRUG INEFFECTIVE,2
EC,GINGIVAL BLEEDING,2
EC,MULTI-ORGAN FAILURE,2
EC,PAIN,2
EC,PETECHIAE,2
EC,PLATELET COUNT DECREASED,2
EC,PNEUMONIA,2
EC,PYREXIA,2
EC,RENAL DISORDER,2
EC,ABDOMINAL PAIN,1
EC,ABORTION,1
EC,ACINETOBACTER TEST POSITIVE,1
EC,ANEURYSM,1
EC,ARTHRALGIA,1
EC,ARTHROPATHY,1
EC,ASTHENIA,1
EC,ASTHMATIC CRISIS,1
EC,BLOOD GLUCOSE INCREASED,1
EC,BLOOD PRESSURE FLUCTUATION,1
EC,BRADYCARDIA,1
EC,BRAIN ABSCESS,1
EC,CARDIAC ARREST,1
EC,DECREASED APPETITE,1
EC,DENGUE FEVER,1
EC,DIARRHOEA,1
EC,DISEASE PROGRESSION,1
EC,DYSGEUSIA,1
EC,DYSPNOEA,1
EC,DYSURIA,1
EC,EXPOSURE DURING PREGNANCY,1
EC,FACE OEDEMA,1
EC,FATIGUE,1
EC,GASTRIC HAEMORRHAGE,1
EC,HAEMATEMESIS,1
EC,HAEMATOCRIT DECREASED,1
EC,HAEMORRHAGE,1
EC,HYPOAESTHESIA,1
EC,IMMUNE SYSTEM DISORDER,1
EC,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
EC,INFECTION,1
EC,INFLUENZA,1
EC,KIDNEY INFECTION,1
EC,LYMPHADENOPATHY,1
EC,LYMPHOEDEMA,1
EC,MITRAL VALVE CALCIFICATION,1
EC,MOUTH ULCERATION,1
EC,MUSCULAR WEAKNESS,1
EC,MYASTHENIC SYNDROME,1
EC,MYOCARDIAL INFARCTION,1
EC,NECK PAIN,1
EC,NEOPLASM PROGRESSION,1
EC,NONINFECTIVE GINGIVITIS,1
EC,OEDEMA PERIPHERAL,1
EC,ORAL CANDIDIASIS,1
EC,PALLOR,1
EC,PERITONITIS,1
EC,PLATELET COUNT ABNORMAL,1
EC,PLEURAL EFFUSION,1
EC,PNEUMONIA STAPHYLOCOCCAL,1
EC,PNEUMOTHORAX,1
EC,POSTOPERATIVE WOUND INFECTION,1
EC,PROCEDURAL PAIN,1
EC,PRODUCT USE ISSUE,1
EC,PROTEINURIA,1
EC,RED BLOOD CELL COUNT DECREASED,1
EC,RENAL FAILURE,1
EC,RENAL TRANSPLANT,1
EC,RESPIRATORY FAILURE,1
EC,RESPIRATORY TRACT INFECTION BACTERIAL,1
EC,SEIZURE,1
EC,SEPTIC SHOCK,1
EC,STARVATION,1
EC,SYNCOPE,1
EC,SYSTEMIC LUPUS ERYTHEMATOSUS,1
EC,THROMBOCYTOPENIA,1
EC,THROMBOCYTOSIS,1
EC,THROMBOSIS,1
EC,TRICUSPID VALVE INCOMPETENCE,1
EC,TROPICAL SPASTIC PARESIS,1
EG,SEPSIS,6
EG,DEATH,4
EG,ALOPECIA,3
EG,HEPATOTOXICITY,3
EG,NO THERAPEUTIC RESPONSE,3
EG,PNEUMATOSIS INTESTINALIS,3
EG,CARDIOTOXICITY,2
EG,CHEST PAIN,2
EG,COMA,2
EG,FEBRILE NEUTROPENIA,2
EG,NEUTROPENIA,2
EG,THROMBOSIS,2
EG,ACUTE HEPATIC FAILURE,1
EG,ACUTE KIDNEY INJURY,1
EG,ANAEMIA,1
EG,APPENDICITIS,1
EG,ARRHYTHMIA,1
EG,BLOOD BILIRUBIN INCREASED,1
EG,BLOOD CHOLESTEROL INCREASED,1
EG,BONE INFARCTION,1
EG,CALCINOSIS,1
EG,CARDIOMEGALY,1
EG,CEREBRAL INFARCTION,1
EG,CHRONIC ALLOGRAFT NEPHROPATHY,1
EG,CONVULSION,1
EG,CUTANEOUS LEISHMANIASIS,1
EG,DEAFNESS UNILATERAL,1
EG,DEEP VEIN THROMBOSIS,1
EG,DYSPNOEA,1
EG,EJECTION FRACTION DECREASED,1
EG,FEELING HOT,1
EG,GASTROOESOPHAGEAL REFLUX DISEASE,1
EG,HEART RATE INCREASED,1
EG,HISTOLOGY ABNORMAL,1
EG,HYPERTENSION,1
EG,HYPOAESTHESIA,1
EG,INFECTION,1
EG,INTUSSUSCEPTION,1
EG,LYMPH GLAND INFECTION,1
EG,NON-HODGKIN^S LYMPHOMA,1
EG,OROPHARYNGEAL PAIN,1
EG,OSTEONECROSIS,1
EG,OSTEOPENIA,1
EG,PANCREATIC DISORDER,1
EG,PAPILLARY MUSCLE RUPTURE,1
EG,PARAPARESIS,1
EG,PATHOLOGICAL FRACTURE,1
EG,PLATELET COUNT INCREASED,1
EG,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
EG,PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA RECURRENT,1
EG,PRODUCT USE ISSUE,1
EG,PULMONARY CALCIFICATION,1
EG,PULMONARY TOXICITY,1
EG,PYREXIA,1
EG,REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA,1
EG,RENAL FAILURE,1
EG,RICHTER^S SYNDROME,1
EG,TRANSAMINASES INCREASED,1
EG,TREATMENT FAILURE,1
EG,TUMOUR LYSIS SYNDROME,1
EG,WARM TYPE HAEMOLYTIC ANAEMIA,1
SV,CARDIAC DISORDER,1
SV,INTERSTITIAL LUNG DISEASE,1
SV,VENTRICULAR FIBRILLATION,1
EE,BLOOD CREATININE INCREASED,1
EE,RENAL FAILURE,1
EE,SEPSIS,1
SZ,MYOCARDIAL ISCHAEMIA,1
SZ,RASH MACULO-PAPULAR,1
SZ,RENAL FAILURE ACUTE,1
SZ,RESPIRATORY FAILURE,1
FO,BACK PAIN,1
FO,DIZZINESS,1
FO,FALL,1
FO,LACERATION,1
FO,LOSS OF CONSCIOUSNESS,1
FO,MUSCLE SPASMS,1
FI,OSTEONECROSIS OF JAW,5
FI,PNEUMONIA,3
FI,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
FI,ARTHRALGIA,2
FI,CROHN^S DISEASE,2
FI,DRUG INEFFECTIVE,2
FI,DYSPNOEA,2
FI,ERYTHEMA,2
FI,EXPOSURE DURING PREGNANCY,2
FI,GENERAL PHYSICAL HEALTH DETERIORATION,2
FI,INFECTION,2
FI,JOINT SWELLING,2
FI,MALIGNANT NEOPLASM PROGRESSION,2
FI,MUSCULOSKELETAL STIFFNESS,2
FI,PAIN IN EXTREMITY,2
FI,RASH,2
FI,ABDOMINAL PAIN,1
FI,ABSCESS,1
FI,ACUTE MYELOID LEUKAEMIA,1
FI,ADENOCARCINOMA,1
FI,ADRENAL INSUFFICIENCY,1
FI,ANAEMIA,1
FI,ANGINA PECTORIS,1
FI,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
FI,ARTHRITIS INFECTIVE,1
FI,ATONIC URINARY BLADDER,1
FI,ATRIAL FIBRILLATION,1
FI,BACK PAIN,1
FI,BLOOD CREATINE INCREASED,1
FI,BLOOD GLUCOSE ABNORMAL,1
FI,BLOOD PRESSURE DECREASED,1
FI,BREAST CANCER,1
FI,BURNING SENSATION,1
FI,C-REACTIVE PROTEIN INCREASED,1
FI,CAMPYLOBACTER GASTROENTERITIS,1
FI,CARDIAC FAILURE,1
FI,CHOLECYSTITIS ACUTE,1
FI,CIRCULATORY COLLAPSE,1
FI,CLOSTRIDIUM DIFFICILE COLITIS,1
FI,CLOSTRIDIUM DIFFICILE INFECTION,1
FI,COLITIS,1
FI,CYSTITIS HAEMORRHAGIC,1
FI,DELUSION,1
FI,DISEASE PROGRESSION,1
FI,DRUG RESISTANCE,1
FI,DYSLIPIDAEMIA,1
FI,ENDOCARDITIS,1
FI,ESCHERICHIA SEPSIS,1
FI,FEBRILE NEUTROPENIA,1
FI,FEELING ABNORMAL,1
FI,FISTULA,1
FI,FLUSHING,1
FI,FUNGAL INFECTION,1
FI,GASTROINTESTINAL TOXICITY,1
FI,GENERALISED TONIC-CLONIC SEIZURE,1
FI,GLOMERULAR FILTRATION RATE DECREASED,1
FI,HEART RATE INCREASED,1
FI,HEPATIC ENZYME INCREASED,1
FI,HERPES VIRUS INFECTION,1
FI,HYPERPARATHYROIDISM SECONDARY,1
FI,HYPERTENSION,1
FI,HYPERVENTILATION,1
FI,HYPONATRAEMIA,1
FI,HYPOPHYSITIS,1
FI,IMMUNE THROMBOCYTOPENIC PURPURA,1
FI,INCOHERENT,1
FI,INJECTION SITE ERYTHEMA,1
FI,JOINT STIFFNESS,1
FI,KIDNEY FIBROSIS,1
FI,LEFT VENTRICULAR DYSFUNCTION,1
FI,LEUKOPENIA,1
FI,LOWER LIMB FRACTURE,1
FI,LYMPHOMA TRANSFORMATION,1
FI,METASTASES TO LUNG,1
FI,METASTASES TO SKIN,1
FI,MUSCULOSKELETAL PAIN,1
FI,MYELODYSPLASTIC SYNDROME,1
FI,MYOCARDIAL INFARCTION,1
FI,NEONATAL LUPUS ERYTHEMATOSUS,1
FI,NEPHROGENIC ANAEMIA,1
FI,NEUTROPENIA,1
FI,NEUTROPENIC INFECTION,1
FI,NEUTROPENIC SEPSIS,1
FI,OSTEOARTHRITIS,1
FI,OSTEOMYELITIS,1
FI,OSTEONECROSIS,1
FI,OSTEOPOROSIS,1
FI,OXYGEN SATURATION DECREASED,1
FI,PAIN,1
FI,PANCREATIC CARCINOMA,1
FI,PATHOLOGICAL FRACTURE,1
FI,PERICARDITIS,1
FI,PLASMA CELL MYELOMA,1
FI,PRODUCT USE ISSUE,1
FI,PROSTATE CANCER,1
FI,PSEUDOMONAL SEPSIS,1
FI,PULMONARY EMBOLISM,1
FI,PYREXIA,1
FI,RASH VESICULAR,1
FI,RECURRENT CANCER,1
FI,ROAD TRAFFIC ACCIDENT,1
FI,ROTATOR CUFF SYNDROME,1
FI,SEIZURE,1
FI,SEPSIS,1
FI,SKIN ATROPHY,1
FI,SKIN CANCER,1
FI,SKIN LESION,1
FI,SKIN REACTION,1
FI,SPINAL COMPRESSION FRACTURE,1
FI,STREPTOCOCCAL SEPSIS,1
FI,SWELLING,1
FI,SWELLING FACE,1
FI,SYNOVITIS,1
FI,THROAT IRRITATION,1
FI,THROMBOCYTOPENIA,1
FI,TINEA VERSICOLOUR,1
FI,TOOTH EXTRACTION,1
FI,TRANSIENT ISCHAEMIC ATTACK,1
FI,TUBULOINTERSTITIAL NEPHRITIS,1
FI,URINARY TRACT INFECTION,1
FI,URTICARIA,1
FI,VERTIGO,1
FR,ACUTE KIDNEY INJURY,123
FR,THROMBOCYTOPENIA,113
FR,PYREXIA,111
FR,NEUTROPENIA,105
FR,DIARRHOEA,94
FR,SEPTIC SHOCK,91
FR,ANAEMIA,84
FR,FEBRILE BONE MARROW APLASIA,83
FR,DEATH,82
FR,FEBRILE NEUTROPENIA,81
FR,SEPSIS,75
FR,DRUG INEFFECTIVE,72
FR,PLASMA CELL MYELOMA,71
FR,INFECTION,69
FR,DYSPNOEA,67
FR,HEPATOCELLULAR INJURY,65
FR,HYPOTENSION,62
FR,GENERAL PHYSICAL HEALTH DETERIORATION,61
FR,VOMITING,60
FR,RENAL FAILURE,58
FR,ASTHENIA,49
FR,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,49
FR,TOXICITY TO VARIOUS AGENTS,48
FR,PNEUMONIA,47
FR,CARDIAC FAILURE,46
FR,ABDOMINAL PAIN,44
FR,CONDITION AGGRAVATED,44
FR,LUNG DISORDER,44
FR,CHOLESTASIS,43
FR,PRODUCT USE IN UNAPPROVED INDICATION,43
FR,DISEASE RECURRENCE,42
FR,PANCYTOPENIA,42
FR,NAUSEA,38
FR,AGRANULOCYTOSIS,37
FR,HYPERTENSION,37
FR,HYPOFIBRINOGENAEMIA,37
FR,OVERDOSE,37
FR,LEUKOPENIA,36
FR,DEEP VEIN THROMBOSIS,35
FR,LYMPHOPENIA,35
FR,RENAL FAILURE ACUTE,35
FR,PULMONARY EMBOLISM,34
FR,HEADACHE,33
FR,MUCOSAL INFLAMMATION,33
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,33
FR,DIABETES MELLITUS,32
FR,FALL,32
FR,ATRIAL FIBRILLATION,31
FR,EXPOSURE DURING PREGNANCY,31
FR,FOETAL EXPOSURE DURING PREGNANCY,31
FR,ACUTE MYELOID LEUKAEMIA,30
FR,CYTOMEGALOVIRUS INFECTION,30
FR,HEPATITIS,30
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,30
FR,PRURITUS,30
FR,TREATMENT FAILURE,29
FR,WEIGHT DECREASED,29
FR,CONFUSIONAL STATE,28
FR,DEHYDRATION,28
FR,HYPONATRAEMIA,28
FR,MYELODYSPLASTIC SYNDROME,28
FR,RASH,28
FR,DECREASED APPETITE,27
FR,DISEASE PROGRESSION,27
FR,HYPOKALAEMIA,27
FR,INTERSTITIAL LUNG DISEASE,27
FR,LUNG INFECTION,27
FR,PRODUCT USE ISSUE,27
FR,FATIGUE,26
FR,NEUROPATHY PERIPHERAL,26
FR,RENAL IMPAIRMENT,26
FR,CARDIOGENIC SHOCK,25
FR,MALAISE,25
FR,RESPIRATORY DISTRESS,25
FR,CARDIO-RESPIRATORY ARREST,24
FR,KIDNEY TRANSPLANT REJECTION,24
FR,ARTHRALGIA,23
FR,BLINDNESS,23
FR,BONE MARROW FAILURE,23
FR,SOMNOLENCE,23
FR,CYTOMEGALOVIRUS CHORIORETINITIS,22
FR,MYALGIA,22
FR,URINARY TRACT INFECTION,22
FR,BRONCHITIS,21
FR,DYSPHAGIA,21
FR,ERYTHEMA,21
FR,HYPERBILIRUBINAEMIA,21
FR,INFLAMMATION,20
FR,MALIGNANT NEOPLASM PROGRESSION,20
FR,RESPIRATORY FAILURE,20
FR,ALANINE AMINOTRANSFERASE INCREASED,19
FR,CRYPTOSPORIDIOSIS INFECTION,19
FR,HAEMATOTOXICITY,19
FR,HAEMORRHAGE,19
FR,MATERNAL EXPOSURE DURING PREGNANCY,19
FR,MYOCARDIAL INFARCTION,19
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,19
FR,TRANSPLANT REJECTION,19
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,18
FR,CARDIAC ARREST,18
FR,COLITIS,18
FR,HYPERKALAEMIA,18
FR,METABOLIC ACIDOSIS,18
FR,PREMATURE DELIVERY,18
FR,RECTAL HAEMORRHAGE,18
FR,BACK PAIN,17
FR,ENCEPHALOPATHY,17
FR,OEDEMA PERIPHERAL,17
FR,PARAESTHESIA,17
FR,PHAEHYPHOMYCOSIS,17
FR,PLEURAL EFFUSION,17
FR,ESCHERICHIA SEPSIS,16
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,16
FR,GASTROINTESTINAL HAEMORRHAGE,16
FR,HYPERTHERMIA,16
FR,HYPOGLYCAEMIA,16
FR,PERITONITIS,16
FR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,16
FR,SUPRAVENTRICULAR TACHYCARDIA,16
FR,TOXIC SKIN ERUPTION,16
FR,ACUTE CORONARY SYNDROME,15
FR,ANURIA,15
FR,CHEST PAIN,15
FR,ERYSIPELAS,15
FR,OSTEONECROSIS OF JAW,15
FR,PREMATURE BABY,15
FR,TOXIC EPIDERMAL NECROLYSIS,15
FR,ARTHRITIS,14
FR,BASAL CELL CARCINOMA,14
FR,CELLULITIS,14
FR,CONSTIPATION,14
FR,COUGH,14
FR,EPSTEIN-BARR VIRUS INFECTION,14
FR,FOETAL DEATH,14
FR,FUNGAL INFECTION,14
FR,HAEMATURIA,14
FR,MALNUTRITION,14
FR,PLASMACYTOMA,14
FR,TACHYCARDIA,14
FR,ANAEMIA MACROCYTIC,13
FR,APLASIA,13
FR,CARDIAC FAILURE ACUTE,13
FR,CEREBRAL VENOUS THROMBOSIS,13
FR,COAGULOPATHY,13
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,13
FR,EJECTION FRACTION DECREASED,13
FR,HERPES ZOSTER,13
FR,HODGKIN^S DISEASE,13
FR,INTERNATIONAL NORMALISED RATIO INCREASED,13
FR,JAUNDICE,13
FR,LYMPHADENOPATHY,13
FR,NEOPLASM MALIGNANT,13
FR,PERIPHERAL SENSORY NEUROPATHY,13
FR,PULMONARY MASS,13
FR,RASH MACULO-PAPULAR,13
FR,RENAL FAILURE CHRONIC,13
FR,ABORTION SPONTANEOUS,12
FR,ACUTE PULMONARY OEDEMA,12
FR,COMA,12
FR,DISSEMINATED INTRAVASCULAR COAGULATION,12
FR,DRUG RESISTANCE,12
FR,GASTROINTESTINAL DISORDER,12
FR,HYPOGAMMAGLOBULINAEMIA,12
FR,ISOSPORIASIS,12
FR,KAPOSI^S SARCOMA,12
FR,KIDNEY FIBROSIS,12
FR,MUSCULAR WEAKNESS,12
FR,OEDEMA,12
FR,PANCREATITIS ACUTE,12
FR,PURPURA,12
FR,TUBERCULOSIS,12
FR,ASPERGILLUS INFECTION,11
FR,B-CELL LYMPHOMA,11
FR,BRAIN ABSCESS,11
FR,CARDIAC DISORDER,11
FR,CHILLS,11
FR,DIFFUSE LARGE B-CELL LYMPHOMA,11
FR,DIZZINESS,11
FR,ESCHERICHIA INFECTION,11
FR,FACIAL PARALYSIS,11
FR,HEPATITIS VIRAL,11
FR,HYPERSENSITIVITY,11
FR,HYPOXIA,11
FR,INTESTINAL PERFORATION,11
FR,ISCHAEMIC STROKE,11
FR,MELAENA,11
FR,MULTI-ORGAN FAILURE,11
FR,PAIN,11
FR,PNEUMONIA PSEUDOMONAL,11
FR,SECOND PRIMARY MALIGNANCY,11
FR,SHOCK HAEMORRHAGIC,11
FR,SYNCOPE,11
FR,TUMOUR LYSIS SYNDROME,11
FR,ARRHYTHMIA,10
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,10
FR,COMPLICATIONS OF TRANSPLANTED KIDNEY,10
FR,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,10
FR,HEPATIC ENZYME INCREASED,10
FR,HEPATIC FAILURE,10
FR,HISTIOCYTOSIS HAEMATOPHAGIC,10
FR,HYPERGLYCAEMIA,10
FR,LEUKOCYTOSIS,10
FR,SINUS BRADYCARDIA,10
FR,URTICARIA,10
FR,ABDOMINAL PAIN UPPER,9
FR,ACUTE RESPIRATORY FAILURE,9
FR,BACTERIAL INFECTION,9
FR,BLOOD CREATININE INCREASED,9
FR,BRONCHOPULMONARY ASPERGILLOSIS,9
FR,CLOSTRIDIUM DIFFICILE INFECTION,9
FR,CROHN^S DISEASE,9
FR,CRYPTOCOCCOSIS,9
FR,ENCEPHALITIS,9
FR,EOSINOPHILIA,9
FR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,9
FR,INFUSION RELATED REACTION,9
FR,MENINGITIS ASEPTIC,9
FR,NOCARDIOSIS,9
FR,PAIN IN EXTREMITY,9
FR,PNEUMONITIS,9
FR,PULMONARY OEDEMA,9
FR,STOMATITIS,9
FR,THERAPEUTIC RESPONSE DECREASED,9
FR,TRANSAMINASES INCREASED,9
FR,VISCERAL LEISHMANIASIS,9
FR,WEIGHT INCREASED,9
FR,ADENOCARCINOMA OF COLON,8
FR,ADVERSE EVENT,8
FR,ALOPECIA,8
FR,ANAPHYLACTIC SHOCK,8
FR,ARTHRITIS BACTERIAL,8
FR,ASCITES,8
FR,BREAST CANCER,8
FR,C-REACTIVE PROTEIN INCREASED,8
FR,CANDIDA INFECTION,8
FR,CEREBROVASCULAR ACCIDENT,8
FR,DEVICE RELATED INFECTION,8
FR,DIVERTICULAR PERFORATION,8
FR,DRUG-INDUCED LIVER INJURY,8
FR,FUNGAL SKIN INFECTION,8
FR,GLOMERULOSCLEROSIS,8
FR,GUILLAIN-BARRE SYNDROME,8
FR,HAEMATOMA,8
FR,HAEMOLYTIC ANAEMIA,8
FR,HYPOVOLAEMIC SHOCK,8
FR,MUSCLE SPASMS,8
FR,NEONATAL RESPIRATORY DISTRESS SYNDROME,8
FR,NEUROTOXICITY,8
FR,PANCREATITIS,8
FR,PERICARDITIS,8
FR,POTENTIATING DRUG INTERACTION,8
FR,PROSTATE CANCER,8
FR,PULMONARY TOXICITY,8
FR,SEIZURE,8
FR,SKIN INFECTION,8
FR,SKIN LESION,8
FR,SPLENOMEGALY,8
FR,STAPHYLOCOCCAL SEPSIS,8
FR,TOXOPLASMOSIS,8
FR,ABSCESS,7
FR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,7
FR,ANXIETY,7
FR,ASPARTATE AMINOTRANSFERASE INCREASED,7
FR,BACTERIAL SEPSIS,7
FR,CARDIOMYOPATHY,7
FR,CARDIOTOXICITY,7
FR,DIABETES MELLITUS INADEQUATE CONTROL,7
FR,ENTEROBACTER SEPSIS,7
FR,EPILEPSY,7
FR,ESCHERICHIA URINARY TRACT INFECTION,7
FR,GAIT DISTURBANCE,7
FR,GASTRIC ULCER,7
FR,GASTROENTERITIS,7
FR,HAEMARTHROSIS,7
FR,HAEMOGLOBIN DECREASED,7
FR,HUMAN HERPESVIRUS 8 INFECTION,7
FR,HYPERLEUKOCYTOSIS,7
FR,HYPOCALCAEMIA,7
FR,INTESTINAL OBSTRUCTION,7
FR,LIVER DISORDER,7
FR,MALIGNANT MELANOMA,7
FR,MYOCARDITIS,7
FR,OSTEITIS,7
FR,PNEUMOCYSTIS JIROVECII INFECTION,7
FR,POLYNEUROPATHY,7
FR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,7
FR,PULMONARY FIBROSIS,7
FR,RENAL TRANSPLANT FAILURE,7
FR,SHOCK,7
FR,SINUS NODE DYSFUNCTION,7
FR,SUBDURAL HAEMATOMA,7
FR,TENOSYNOVITIS,7
FR,THROMBOSIS,7
FR,THROMBOTIC MICROANGIOPATHY,7
FR,TREMOR,7
FR,VENTRICULAR FIBRILLATION,7
FR,VERTIGO,7
FR,AGITATION,6
FR,ALTERED STATE OF CONSCIOUSNESS,6
FR,ATRIOVENTRICULAR BLOCK,6
FR,BK VIRUS INFECTION,6
FR,BLOOD BILIRUBIN INCREASED,6
FR,CARDIAC FAILURE CONGESTIVE,6
FR,CELL DEATH,6
FR,CEREBRAL THROMBOSIS,6
FR,CHEST DISCOMFORT,6
FR,COLITIS ULCERATIVE,6
FR,COMPLETED SUICIDE,6
FR,CONGENITAL CYTOMEGALOVIRUS INFECTION,6
FR,CYSTITIS,6
FR,DISORIENTATION,6
FR,DISSEMINATED LARGE CELL LYMPHOMA,6
FR,DIVERTICULITIS,6
FR,DRUG DEPENDENCE,6
FR,DYSPEPSIA,6
FR,ENDOCARDITIS,6
FR,ENTEROCOCCAL INFECTION,6
FR,FACE OEDEMA,6
FR,GASTROINTESTINAL TOXICITY,6
FR,GENERAL PHYSICAL CONDITION ABNORMAL,6
FR,HAEMATEMESIS,6
FR,HEPATIC ENCEPHALOPATHY,6
FR,HEPATOMEGALY,6
FR,IMMUNE-MEDIATED NECROTISING MYOPATHY,6
FR,INFECTIOUS COLITIS,6
FR,INTESTINAL ISCHAEMIA,6
FR,LIPASE INCREASED,6
FR,LOSS OF CONSCIOUSNESS,6
FR,LUNG NEOPLASM MALIGNANT,6
FR,LYMPHOMA,6
FR,MOUTH ULCERATION,6
FR,MUCORMYCOSIS,6
FR,NEPHROPATHY TOXIC,6
FR,NERVOUS SYSTEM DISORDER,6
FR,OESOPHAGITIS,6
FR,ORF,6
FR,ORTHOSTATIC HYPOTENSION,6
FR,OSTEOARTHRITIS,6
FR,PERICARDIAL EFFUSION,6
FR,PHLEBITIS,6
FR,PLASMA CELL MYELOMA RECURRENT,6
FR,PLATELET COUNT DECREASED,6
FR,PNEUMONIA CYTOMEGALOVIRAL,6
FR,PNEUMOPERITONEUM,6
FR,PSEUDOMONAS INFECTION,6
FR,PSORIASIS,6
FR,PYELONEPHRITIS ACUTE,6
FR,PYOPNEUMOTHORAX,6
FR,QUADRIPARESIS,6
FR,RASH MACULAR,6
FR,RECURRENT CANCER,6
FR,RHEUMATOID NODULE,6
FR,SINUSITIS,6
FR,SQUAMOUS CELL CARCINOMA OF SKIN,6
FR,SUBILEUS,6
FR,TINNITUS,6
FR,ACUTE LEUKAEMIA,5
FR,ANGIOEDEMA,5
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
FR,BRAIN OEDEMA,5
FR,BRONCHIECTASIS,5
FR,BRONCHOSPASM,5
FR,CAMPYLOBACTER GASTROENTERITIS,5
FR,CENTRAL NERVOUS SYSTEM LYMPHOMA,5
FR,CHORIORETINOPATHY,5
FR,COGNITIVE DISORDER,5
FR,CONGENITAL TOXOPLASMOSIS,5
FR,CYSTITIS HAEMORRHAGIC,5
FR,DEPRESSION,5
FR,DERMATITIS BULLOUS,5
FR,DRUG INTOLERANCE,5
FR,ELECTROCARDIOGRAM QT PROLONGED,5
FR,EPISTAXIS,5
FR,GROIN ABSCESS,5
FR,HAEMOPTYSIS,5
FR,HEART TRANSPLANT REJECTION,5
FR,HEPATIC FUNCTION ABNORMAL,5
FR,HEPATOCELLULAR CARCINOMA,5
FR,HYPERCREATININAEMIA,5
FR,HYPERLIPIDAEMIA,5
FR,HYPOPHOSPHATAEMIA,5
FR,HYPOVOLAEMIA,5
FR,ILEUS PARALYTIC,5
FR,IMPAIRED HEALING,5
FR,INTRACRANIAL PRESSURE INCREASED,5
FR,LIVER TRANSPLANT REJECTION,5
FR,LUNG ABSCESS,5
FR,LUNG ADENOCARCINOMA,5
FR,LYMPHOCYTOSIS,5
FR,METASTATIC MALIGNANT MELANOMA,5
FR,MOTOR DYSFUNCTION,5
FR,NEPHROTIC SYNDROME,5
FR,ORGANISING PNEUMONIA,5
FR,OSTEOPOROSIS,5
FR,PALPITATIONS,5
FR,PERIPHERAL SENSORIMOTOR NEUROPATHY,5
FR,PETECHIAE,5
FR,PHARYNGITIS,5
FR,PLEURISY,5
FR,PNEUMONIA ASPIRATION,5
FR,PRODUCTIVE COUGH,5
FR,PROSTATIC SPECIFIC ANTIGEN INCREASED,5
FR,PROTHROMBIN LEVEL DECREASED,5
FR,RECTAL ADENOCARCINOMA,5
FR,RETINAL DETACHMENT,5
FR,RETROPERITONEAL FIBROSIS,5
FR,RHABDOMYOLYSIS,5
FR,RHEUMATOID ARTHRITIS,5
FR,SECONDARY IMMUNODEFICIENCY,5
FR,SEGMENTED HYALINISING VASCULITIS,5
FR,SKIN TOXICITY,5
FR,THROMBOTIC THROMBOCYTOPENIC PURPURA,5
FR,VISUAL IMPAIRMENT,5
FR,ABNORMAL BEHAVIOUR,4
FR,ANAPHYLACTIC REACTION,4
FR,ANGINA PECTORIS,4
FR,ANGIOPATHY,4
FR,ANGLE CLOSURE GLAUCOMA,4
FR,AORTIC THROMBOSIS,4
FR,APHASIA,4
FR,APLASTIC ANAEMIA,4
FR,ATAXIA,4
FR,BLINDNESS UNILATERAL,4
FR,BLOOD HIV RNA INCREASED,4
FR,BONE PAIN,4
FR,CATARACT,4
FR,CEREBRAL TOXOPLASMOSIS,4
FR,CEREBRAL VENTRICLE DILATATION,4
FR,CHOLANGIOCARCINOMA,4
FR,CHRONIC ALLOGRAFT NEPHROPATHY,4
FR,CHRONIC KIDNEY DISEASE,4
FR,COAGULATION FACTOR V LEVEL DECREASED,4
FR,COLONIC ABSCESS,4
FR,CONJUNCTIVITIS,4
FR,CONVULSION,4
FR,DIABETIC METABOLIC DECOMPENSATION,4
FR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
FR,DRUG LEVEL INCREASED,4
FR,DRY MOUTH,4
FR,ECZEMA,4
FR,EMBOLISM,4
FR,EMPHYSEMATOUS CYSTITIS,4
FR,ENTERITIS,4
FR,EPSTEIN-BARR VIRUS TEST POSITIVE,4
FR,ESCHERICHIA BACTERAEMIA,4
FR,ESCHERICHIA PYELONEPHRITIS,4
FR,FLUSHING,4
FR,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,4
FR,FOETAL GROWTH RESTRICTION,4
FR,FOETAL HEART RATE ABNORMAL,4
FR,HEPATIC INFARCTION,4
FR,HEPATIC STEATOSIS,4
FR,HEPATITIS ACUTE,4
FR,HEPATITIS B,4
FR,HEPATITIS FULMINANT,4
FR,HEPATOTOXICITY,4
FR,HERPES SIMPLEX,4
FR,HYPERCALCAEMIA,4
FR,HYPERNATRAEMIA,4
FR,HYPOACUSIS,4
FR,HYPOTHERMIA,4
FR,IMMUNE THROMBOCYTOPENIC PURPURA,4
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
FR,INSOMNIA,4
FR,INTENTIONAL OVERDOSE,4
FR,INTENTIONAL PRODUCT MISUSE,4
FR,INTRACARDIAC THROMBUS,4
FR,JC VIRUS INFECTION,4
FR,KLEBSIELLA INFECTION,4
FR,LACTIC ACIDOSIS,4
FR,LARGE INTESTINE PERFORATION,4
FR,LEUKAEMIA,4
FR,MENINGITIS ENTEROCOCCAL,4
FR,METABOLIC SYNDROME,4
FR,METASTASES TO LIVER,4
FR,MIXED LIVER INJURY,4
FR,MUSCLE HAEMORRHAGE,4
FR,NECK PAIN,4
FR,NEOPLASM PROGRESSION,4
FR,NEPHROPATHY,4
FR,NEURALGIA,4
FR,NEUTROPHIL COUNT INCREASED,4
FR,NO THERAPEUTIC RESPONSE,4
FR,ORAL CANDIDIASIS,4
FR,PANCREATIC CYST,4
FR,PANCREATITIS NECROTISING,4
FR,PNEUMONIA VIRAL,4
FR,PNEUMOTHORAX,4
FR,PRE-ECLAMPSIA,4
FR,PRETERM PREMATURE RUPTURE OF MEMBRANES,4
FR,PSEUDOMONAL SEPSIS,4
FR,PULMONARY ALVEOLAR HAEMORRHAGE,4
FR,RASH ERYTHEMATOUS,4
FR,REBOUND EFFECT,4
FR,RENAL INFARCT,4
FR,RENAL TUBULAR NECROSIS,4
FR,RESPIRATORY TRACT INFECTION,4
FR,ROTATOR CUFF SYNDROME,4
FR,SINOATRIAL BLOCK,4
FR,SKIN ULCER,4
FR,SMALL INTESTINAL OBSTRUCTION,4
FR,SPLENIC INFARCTION,4
FR,SQUAMOUS CELL CARCINOMA,4
FR,STATUS EPILEPTICUS,4
FR,STRONGYLOIDIASIS,4
FR,SUBCUTANEOUS ABSCESS,4
FR,SUDDEN DEATH,4
FR,SWELLING,4
FR,T-CELL LYMPHOMA,4
FR,TOOTH ABSCESS,4
FR,TORSADE DE POINTES,4
FR,TULARAEMIA,4
FR,ULCER,4
FR,UNRESPONSIVE TO STIMULI,4
FR,URINARY RETENTION,4
FR,VASCULITIS,4
FR,ABDOMINAL PAIN LOWER,3
FR,ABORTION INDUCED,3
FR,ABSCESS LIMB,3
FR,ACTINOMYCOTIC PULMONARY INFECTION,3
FR,ACUTE MYELOMONOCYTIC LEUKAEMIA,3
FR,ALVEOLITIS,3
FR,ANAL ABSCESS,3
FR,APOPTOTIC COLONOPATHY,3
FR,ARTERIAL THROMBOSIS,3
FR,ATRIAL FLUTTER,3
FR,AUTOIMMUNE HAEMOLYTIC ANAEMIA,3
FR,BACTERAEMIA,3
FR,BALANCE DISORDER,3
FR,BLOOD CREATININE ABNORMAL,3
FR,BONE DISORDER,3
FR,BRADYCARDIA,3
FR,BRADYCARDIA FOETAL,3
FR,BRONCHIAL OBSTRUCTION,3
FR,BURNING SENSATION,3
FR,CALCULUS URINARY,3
FR,CENTRAL NERVOUS SYSTEM LESION,3
FR,CEREBELLAR SYNDROME,3
FR,CEREBRAL ASPERGILLOSIS,3
FR,CEREBRAL FUNGAL INFECTION,3
FR,CHOLANGITIS,3
FR,CHROMOBLASTOMYCOSIS,3
FR,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,3
FR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
FR,CITROBACTER INFECTION,3
FR,CLOSTRIDIUM COLITIS,3
FR,COLITIS ISCHAEMIC,3
FR,CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY,3
FR,CORONARY ARTERY OCCLUSION,3
FR,CREATININE RENAL CLEARANCE ABNORMAL,3
FR,CUTANEOUS LUPUS ERYTHEMATOSUS,3
FR,CYTOMEGALOVIRUS TEST POSITIVE,3
FR,CYTOPENIA,3
FR,DEPRESSED LEVEL OF CONSCIOUSNESS,3
FR,DERMATITIS,3
FR,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,3
FR,DIVERTICULUM INTESTINAL,3
FR,DRUG DISPENSING ERROR,3
FR,DYSARTHRIA,3
FR,DYSCHROMATOPSIA,3
FR,DYSKINESIA,3
FR,DYSLIPIDAEMIA,3
FR,DYSPHONIA,3
FR,DYSPNOEA EXERTIONAL,3
FR,ECCHYMOSIS,3
FR,ERYTHEMA MULTIFORME,3
FR,FEMUR FRACTURE,3
FR,FLUID OVERLOAD,3
FR,FRACTURE,3
FR,FUNGAEMIA,3
FR,FUNGAL PERITONITIS,3
FR,FUSARIUM INFECTION,3
FR,GASTROENTERITIS CRYPTOSPORIDIAL,3
FR,GASTROINTESTINAL NECROSIS,3
FR,GASTROINTESTINAL PERFORATION,3
FR,GASTROOESOPHAGEAL REFLUX DISEASE,3
FR,GENERALISED OEDEMA,3
FR,GRAFT VERSUS HOST DISEASE,3
FR,HAEMATOMA INFECTION,3
FR,HAEMOGLOBIN ABNORMAL,3
FR,HEPATITIS CHOLESTATIC,3
FR,HEPATOSPLENOMEGALY,3
FR,HIATUS HERNIA,3
FR,HODGKIN^S DISEASE RECURRENT,3
FR,HOSPITALISATION,3
FR,HOT FLUSH,3
FR,HYPERAMMONAEMIA,3
FR,HYPERHIDROSIS,3
FR,HYPERTRIGLYCERIDAEMIA,3
FR,HYPOAESTHESIA,3
FR,HYPOALBUMINAEMIA,3
FR,IMMUNODEFICIENCY,3
FR,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,3
FR,INCORRECT DOSE ADMINISTERED,3
FR,INFLUENZA,3
FR,INTENTIONAL PRODUCT USE ISSUE,3
FR,JAUNDICE CHOLESTATIC,3
FR,JAW FRACTURE,3
FR,JOINT EFFUSION,3
FR,LIGHT CHAIN DISEASE,3
FR,LIPOMATOSIS,3
FR,LIVER FUNCTION TEST ABNORMAL,3
FR,LOW BIRTH WEIGHT BABY,3
FR,LYMPHOPROLIFERATIVE DISORDER,3
FR,MACULOPATHY,3
FR,MENINGITIS CRYPTOCOCCAL,3
FR,MENINGITIS HAEMOPHILUS,3
FR,METABOLIC DISORDER,3
FR,METASTASES TO CENTRAL NERVOUS SYSTEM,3
FR,METASTASES TO MENINGES,3
FR,MICROCYTIC ANAEMIA,3
FR,MYOCLONUS,3
FR,MYOPATHY,3
FR,NECROTISING HERPETIC RETINOPATHY,3
FR,NEUTROPHIL COUNT DECREASED,3
FR,NO ADVERSE EVENT,3
FR,NON-HODGKIN^S LYMPHOMA,3
FR,NORMAL NEWBORN,3
FR,NOSOCOMIAL INFECTION,3
FR,OESOPHAGEAL CARCINOMA,3
FR,OESOPHAGEAL PAIN,3
FR,OLIGOHYDRAMNIOS,3
FR,OLIGURIA,3
FR,OPHTHALMIC HERPES ZOSTER,3
FR,OROPHARYNGEAL PAIN,3
FR,OSTEOMALACIA,3
FR,OSTEOMYELITIS,3
FR,OSTEOPOROTIC FRACTURE,3
FR,OXYGEN SATURATION DECREASED,3
FR,PACHYMENINGITIS,3
FR,PACKED RED BLOOD CELL TRANSFUSION,3
FR,PAIN IN JAW,3
FR,PARAPOX VIRUS INFECTION,3
FR,PARESIS,3
FR,PARTIAL SEIZURES,3
FR,PERFORATION,3
FR,PERIPHERAL MOTOR NEUROPATHY,3
FR,PERITONEAL DISORDER,3
FR,PERITONEAL HAEMORRHAGE,3
FR,PNEUMONIA PNEUMOCOCCAL,3
FR,PORTAL HYPERTENSION,3
FR,PROSTATITIS,3
FR,PSYCHOMOTOR SKILLS IMPAIRED,3
FR,PULMONARY TUBERCULOSIS,3
FR,PURULENT DISCHARGE,3
FR,PYELOCALIECTASIS,3
FR,PYELONEPHRITIS,3
FR,RASH MORBILLIFORM,3
FR,RENAL TUBULAR DISORDER,3
FR,RESPIRATORY TRACT INFECTION FUNGAL,3
FR,RETROPERITONEAL HAEMATOMA,3
FR,RIB FRACTURE,3
FR,SARCOIDOSIS,3
FR,SKIN DISCOLOURATION,3
FR,SKIN DISORDER,3
FR,SKIN GRAFT REJECTION,3
FR,SKIN MASS,3
FR,SPINAL COMPRESSION FRACTURE,3
FR,SPINAL FRACTURE,3
FR,SUBARACHNOID HAEMORRHAGE,3
FR,SYSTEMIC CANDIDA,3
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,3
FR,TENDONITIS,3
FR,THINKING ABNORMAL,3
FR,THROMBOCYTOSIS,3
FR,THROMBOPHLEBITIS,3
FR,TYPE 2 DIABETES MELLITUS,3
FR,UPPER RESPIRATORY TRACT INFECTION,3
FR,URINARY TRACT INFECTION ENTEROCOCCAL,3
FR,URINOMA,3
FR,VASCULAR PSEUDOANEURYSM RUPTURED,3
FR,VENOUS THROMBOSIS,3
FR,VIRAL INFECTION,3
FR,VISUAL FIELD DEFECT,3
FR,WHITE BLOOD CELL DISORDER,3
FR,ABDOMINAL SEPSIS,2
FR,ACCIDENTAL OVERDOSE,2
FR,ACNE FULMINANS,2
FR,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
FR,ACUTE GRAFT VERSUS HOST DISEASE,2
FR,ACUTE LYMPHOCYTIC LEUKAEMIA,2
FR,ACUTE MYOCARDIAL INFARCTION,2
FR,ADMINISTRATION SITE REACTION,2
FR,ADRENAL INSUFFICIENCY,2
FR,ALTERNARIA INFECTION,2
FR,ALVEOLITIS ALLERGIC,2
FR,ANAEMIA HAEMOLYTIC AUTOIMMUNE,2
FR,ANAEMIA NEONATAL,2
FR,ANAL CANDIDIASIS,2
FR,ANAL PRURITUS,2
FR,ANGIOCENTRIC LYMPHOMA,2
FR,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,2
FR,ANKYLOSING SPONDYLITIS,2
FR,APHTHOUS STOMATITIS,2
FR,ARTERIOSCLEROSIS,2
FR,ARTERIOSPASM CORONARY,2
FR,ARTERIOVENOUS FISTULA,2
FR,ARTHROPATHY,2
FR,ASTHMA,2
FR,ATELECTASIS,2
FR,ATRIAL THROMBOSIS,2
FR,ATRIOVENTRICULAR BLOCK COMPLETE,2
FR,AUTOIMMUNE HEPATITIS,2
FR,AUTOIMMUNE NEUTROPENIA,2
FR,AUTONOMIC NERVOUS SYSTEM IMBALANCE,2
FR,AUTONOMIC NEUROPATHY,2
FR,AXONAL NEUROPATHY,2
FR,AZOOSPERMIA,2
FR,BICYTOPENIA,2
FR,BLINDNESS TRANSIENT,2
FR,BLOOD ALBUMIN DECREASED,2
FR,BLOOD BILIRUBIN ABNORMAL,2
FR,BLOOD DISORDER,2
FR,BLOOD LACTATE DEHYDROGENASE INCREASED,2
FR,BLOOD POTASSIUM DECREASED,2
FR,BLOOD POTASSIUM INCREASED,2
FR,BOWEN^S DISEASE,2
FR,BRADYARRHYTHMIA,2
FR,BREAST NEOPLASM,2
FR,BRONCHIAL DISORDER,2
FR,BRONCHIOLITIS,2
FR,BRONCHOPNEUMONIA,2
FR,BUNDLE BRANCH BLOCK LEFT,2
FR,CANDIDA SEPSIS,2
FR,CARDIAC TAMPONADE,2
FR,CARPAL TUNNEL SYNDROME,2
FR,CEREBELLAR ATAXIA,2
FR,CHOLANGITIS SCLEROSING,2
FR,CHOLELITHIASIS,2
FR,CHONDROCALCINOSIS,2
FR,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
FR,CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT,2
FR,CHRONIC RESPIRATORY FAILURE,2
FR,CIRCULATORY COLLAPSE,2
FR,CLOSTRIDIUM DIFFICILE COLITIS,2
FR,COLON CANCER,2
FR,COLON NEOPLASM,2
FR,CONCOMITANT DISEASE AGGRAVATED,2
FR,CONGENITAL HAND MALFORMATION,2
FR,CONGENITAL HYDROCEPHALUS,2
FR,CONGENITAL NOSE MALFORMATION,2
FR,CONGESTIVE CARDIOMYOPATHY,2
FR,CONNECTIVE TISSUE DISORDER,2
FR,CORONARY ARTERY STENOSIS,2
FR,CREPITATIONS,2
FR,CUSHING^S SYNDROME,2
FR,DEAFNESS,2
FR,DERMO-HYPODERMITIS,2
FR,DEVICE RELATED SEPSIS,2
FR,DIAPHRAGMATIC PARALYSIS,2
FR,DILATATION VENTRICULAR,2
FR,DONOR SPECIFIC ANTIBODY PRESENT,2
FR,DRUG EFFECT INCOMPLETE,2
FR,DRUG ERUPTION,2
FR,DRUG HYPERSENSITIVITY,2
FR,DRUG LEVEL ABOVE THERAPEUTIC,2
FR,DRUG LEVEL BELOW THERAPEUTIC,2
FR,DRUG LEVEL DECREASED,2
FR,DRUG WITHDRAWAL SYNDROME,2
FR,DYSGEUSIA,2
FR,EAR INFECTION,2
FR,EMPHYSEMA,2
FR,ENDOMETRIAL ADENOCARCINOMA,2
FR,ENTEROBACTER INFECTION,2
FR,ENTEROCOLITIS,2
FR,ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA,2
FR,EOSINOPHILIC FASCIITIS,2
FR,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,2
FR,EPSTEIN-BARR VIRUS ANTIBODY,2
FR,EXTRA DOSE ADMINISTERED,2
FR,EXTRAPYRAMIDAL DISORDER,2
FR,EXTRAVASATION,2
FR,EYE PAIN,2
FR,FEELING ABNORMAL,2
FR,FISTULA,2
FR,FLANK PAIN,2
FR,FOETAL DISTRESS SYNDROME,2
FR,GASTRITIS,2
FR,GASTROENTERITIS NOROVIRUS,2
FR,GASTROENTERITIS VIRAL,2
FR,GASTROINTESTINAL FUNGAL INFECTION,2
FR,GASTROINTESTINAL WALL THICKENING,2
FR,GLAUCOMA,2
FR,GLUCOSE TOLERANCE IMPAIRED,2
FR,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,2
FR,GRAFT VERSUS HOST DISEASE IN SKIN,2
FR,GRANULOCYTES ABNORMAL,2
FR,GROWTH RETARDATION,2
FR,HAEMODYNAMIC INSTABILITY,2
FR,HAEMORRHAGE URINARY TRACT,2
FR,HAEMORRHAGIC STROKE,2
FR,HALLUCINATION,2
FR,HALLUCINATION_ VISUAL,2
FR,HENOCH-SCHONLEIN PURPURA,2
FR,HEPATIC CANCER,2
FR,HEPATIC CIRRHOSIS,2
FR,HEPATIC NECROSIS,2
FR,HEPATITIS E,2
FR,HEPATORENAL SYNDROME,2
FR,HERPES VIRUS INFECTION,2
FR,HICCUPS,2
FR,HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA RECURRENT,2
FR,HYDROCEPHALUS,2
FR,HYDRONEPHROSIS,2
FR,HYPERTENSIVE CRISIS,2
FR,HYPERTRICHOSIS,2
FR,HYPERTROPHIC CARDIOMYOPATHY,2
FR,HYPERURICAEMIA,2
FR,HYPOMAGNESAEMIA,2
FR,HYPOVENTILATION,2
FR,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,2
FR,INFUSION SITE EXTRAVASATION,2
FR,INFUSION SITE PAIN,2
FR,INGUINAL HERNIA,2
FR,INJURY,2
FR,IRON DEFICIENCY ANAEMIA,2
FR,JC VIRUS CSF TEST POSITIVE,2
FR,JEJUNAL PERFORATION,2
FR,JOINT DISLOCATION,2
FR,JOINT MICROHAEMORRHAGE,2
FR,KLEBSIELLA SEPSIS,2
FR,KNEE ARTHROPLASTY,2
FR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
FR,LACRIMATION INCREASED,2
FR,LEGIONELLA INFECTION,2
FR,LIMB REDUCTION DEFECT,2
FR,LIPODYSTROPHY ACQUIRED,2
FR,LISTERIOSIS,2
FR,LIVEDO RETICULARIS,2
FR,LUNG INFILTRATION,2
FR,LUPUS-LIKE SYNDROME,2
FR,LYMPHADENOPATHY MEDIASTINAL,2
FR,LYMPHANGITIS,2
FR,LYMPHOCYTE COUNT ABNORMAL,2
FR,LYMPHOCYTE COUNT INCREASED,2
FR,MANTLE CELL LYMPHOMA RECURRENT,2
FR,MEASLES,2
FR,METABOLIC ENCEPHALOPATHY,2
FR,METAMORPHOPSIA,2
FR,METASTASES TO SPINE,2
FR,METASTASIS,2
FR,METASTATIC BRONCHIAL CARCINOMA,2
FR,MICROSPORIDIA INFECTION,2
FR,MIGRAINE,2
FR,MITOCHONDRIAL TOXICITY,2
FR,MUCOCUTANEOUS ULCERATION,2
FR,MUSCULOSKELETAL DISORDER,2
FR,MUSCULOSKELETAL PAIN,2
FR,MUSCULOSKELETAL STIFFNESS,2
FR,MYELOMA CAST NEPHROPATHY,2
FR,NASOPHARYNGITIS,2
FR,NEOPLASM PROSTATE,2
FR,NEUROGENIC BLADDER,2
FR,NEUROLOGICAL DECOMPENSATION,2
FR,NEUROLOGICAL SYMPTOM,2
FR,NEUTROPENIC INFECTION,2
FR,NODULE,2
FR,OBLITERATIVE BRONCHIOLITIS,2
FR,ODYNOPHAGIA,2
FR,OPTIC NEURITIS,2
FR,ORAL HERPES,2
FR,ORTHOPNOEA,2
FR,OSTEONECROSIS,2
FR,OSTEOPENIA,2
FR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
FR,PAPULE,2
FR,PARAPLEGIA,2
FR,PATHOGEN RESISTANCE,2
FR,PATHOLOGICAL FRACTURE,2
FR,PELIOSIS HEPATIS,2
FR,PERIPHERAL COLDNESS,2
FR,PERIPHERAL ISCHAEMIA,2
FR,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,2
FR,PERITONITIS BACTERIAL,2
FR,PHOTOSENSITIVITY REACTION,2
FR,PLATELET DISORDER,2
FR,PNEUMONIA BACTERIAL,2
FR,PNEUMONIA CRYPTOCOCCAL,2
FR,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,2
FR,PORTAL VEIN PHLEBITIS,2
FR,POST LUMBAR PUNCTURE SYNDROME,2
FR,PREMATURE LABOUR,2
FR,PRESYNCOPE,2
FR,PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT,2
FR,PROSTATE CANCER RECURRENT,2
FR,PRURITUS GENERALISED,2
FR,PSORIATIC ARTHROPATHY,2
FR,PULMONARY ARTERIAL HYPERTENSION,2
FR,PULMONARY SEPSIS,2
FR,RECTAL CANCER,2
FR,RENAL ARTERY STENOSIS,2
FR,RENAL CELL CARCINOMA,2
FR,RENAL GRAFT INFECTION,2
FR,RENAL TUBULAR ATROPHY,2
FR,RESPIRATORY ACIDOSIS,2
FR,RESTLESS LEGS SYNDROME,2
FR,RETINOPATHY,2
FR,SCLERODERMA,2
FR,SCLERODERMA RENAL CRISIS,2
FR,SINUS TACHYCARDIA,2
FR,SKIN CANCER,2
FR,SKIN HYPERPIGMENTATION,2
FR,SLUGGISHNESS,2
FR,SMALL INTESTINAL PERFORATION,2
FR,SMOOTH MUSCLE CELL NEOPLASM,2
FR,SPEECH DISORDER,2
FR,SPINAL CORD COMPRESSION,2
FR,SPINAL CORD INFECTION,2
FR,SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX,2
FR,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,2
FR,STAPHYLOCOCCAL INFECTION,2
FR,STENOTROPHOMONAS INFECTION,2
FR,SUFFOCATION FEELING,2
FR,SUICIDE ATTEMPT,2
FR,SUPERIOR MESENTERIC ARTERY SYNDROME,2
FR,SYSTEMIC SCLEROSIS,2
FR,TENDON DISORDER,2
FR,TENDON RUPTURE,2
FR,THERAPEUTIC RESPONSE UNEXPECTED,2
FR,THERAPY RESPONDER,2
FR,TONGUE OEDEMA,2
FR,TONSILLITIS,2
FR,TOOTH INFECTION,2
FR,TOXIC SHOCK SYNDROME,2
FR,TOXIC SHOCK SYNDROME STREPTOCOCCAL,2
FR,TRANSAMINASES ABNORMAL,2
FR,TRANSIENT ISCHAEMIC ATTACK,2
FR,TREATMENT NONCOMPLIANCE,2
FR,TROPONIN INCREASED,2
FR,TROPONIN T INCREASED,2
FR,TUBULOINTERSTITIAL NEPHRITIS,2
FR,TYPE 1 DIABETES MELLITUS,2
FR,TYPE IV HYPERSENSITIVITY REACTION,2
FR,URINARY TRACT DISORDER,2
FR,URINARY TRACT INFECTION STAPHYLOCOCCAL,2
FR,VENA CAVA THROMBOSIS,2
FR,VENTRICULAR ENLARGEMENT,2
FR,VENTRICULAR HYPOKINESIA,2
FR,VIRAL LOAD INCREASED,2
FR,VISUAL ACUITY REDUCED,2
FR,VITH NERVE PARALYSIS,2
FR,WALKING DISABILITY,2
FR,WHEEZING,2
FR,WHITE BLOOD CELL COUNT ABNORMAL,2
FR,WHITE BLOOD CELL COUNT DECREASED,2
FR,WOUND EVISCERATION,2
FR,5Q MINUS SYNDROME,1
FR,ABDOMINAL ABSCESS,1
FR,ABDOMINAL ADHESIONS,1
FR,ABDOMINAL COMPARTMENT SYNDROME,1
FR,ABDOMINAL DISCOMFORT,1
FR,ABDOMINAL DISTENSION,1
FR,ABDOMINAL HERNIA,1
FR,ABDOMINAL LYMPHADENOPATHY,1
FR,ABDOMINAL MASS,1
FR,ABDOMINAL RIGIDITY,1
FR,ABDOMINAL TENDERNESS,1
FR,ABDOMINAL WALL HAEMATOMA,1
FR,ABNORMAL SENSATION IN EYE,1
FR,ABSCESS BACTERIAL,1
FR,ACQUIRED HAEMOPHILIA,1
FR,ACTINOMYCOSIS,1
FR,ACUTE PHOSPHATE NEPHROPATHY,1
FR,ACUTE PRERENAL FAILURE,1
FR,ACUTE TONSILLITIS,1
FR,ADAMTS13 ACTIVITY ABNORMAL,1
FR,ADENOCARCINOMA,1
FR,ADENOCARCINOMA GASTRIC,1
FR,ADENOCARCINOMA OF THE CERVIX,1
FR,ADENOCARCINOMA PANCREAS,1
FR,ADENOVIRUS INFECTION,1
FR,ADULT FAILURE TO THRIVE,1
FR,ADVERSE DRUG REACTION,1
FR,AGEUSIA,1
FR,ALLERGIC GRANULOMATOUS ANGIITIS,1
FR,ALOPECIA UNIVERSALIS,1
FR,ALVEOLAR LUNG DISEASE,1
FR,AMAUROSIS FUGAX,1
FR,AMNESIA,1
FR,AMPUTATION,1
FR,AMYLASE INCREASED,1
FR,AMYLOIDOSIS,1
FR,ANAL CANCER,1
FR,ANAL FISSURE,1
FR,ANAL FISTULA,1
FR,ANAL INCONTINENCE,1
FR,ANAPHYLACTOID REACTION,1
FR,ANASTOMOTIC HAEMORRHAGE,1
FR,ANEURYSM REPAIR,1
FR,ANGIODERMATITIS,1
FR,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT,1
FR,ANGIOPLASTY,1
FR,ANTI-SS-A ANTIBODY POSITIVE,1
FR,ANTIBIOTIC THERAPY,1
FR,ANTIMITOCHONDRIAL ANTIBODY POSITIVE,1
FR,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,1
FR,ANTINUCLEAR ANTIBODY POSITIVE,1
FR,ANTIPHOSPHOLIPID SYNDROME,1
GE,ABORTION SPONTANEOUS INCOMPLETE,2
GE,ANAEMIA,2
GE,DECREASED APPETITE,1
GE,EXPOSURE DURING PREGNANCY,1
GE,FATIGUE,1
GE,GASTROINTESTINAL HAEMORRHAGE,1
GE,HAEMORRHAGE IN PREGNANCY,1
GE,INFUSION RELATED REACTION,1
GE,LEUKOPENIA,1
GE,MATERNAL EXPOSURE DURING PREGNANCY,1
GE,NEPHROPATHY TOXIC,1
GE,PANCYTOPENIA,1
GE,PERIPHERAL SENSORY NEUROPATHY,1
GE,PNEUMONIA,1
GE,POST ABORTION HAEMORRHAGE,1
GE,PROSTATE CANCER,1
GE,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
GE,PULMONARY EMBOLISM,1
GE,SQUAMOUS CELL CARCINOMA OF SKIN,1
GE,UPPER RESPIRATORY TRACT INFECTION,1
DE,GENERAL PHYSICAL HEALTH DETERIORATION,80
DE,LEUKOPENIA,76
DE,THROMBOCYTOPENIA,68
DE,PYREXIA,67
DE,NEUTROPENIC INFECTION,65
DE,PNEUMONIA,64
DE,FEBRILE NEUTROPENIA,62
DE,ANAEMIA,53
DE,INFECTION,51
DE,PULMONARY EMBOLISM,43
DE,DEATH,42
DE,SEPSIS,42
DE,TOXICITY TO VARIOUS AGENTS,41
DE,NEUTROPENIA,40
DE,NAUSEA,39
DE,FATIGUE,37
DE,DIARRHOEA,35
DE,DRUG INEFFECTIVE,34
DE,VOMITING,34
DE,BACK PAIN,24
DE,DEHYDRATION,23
DE,PRODUCT USE IN UNAPPROVED INDICATION,22
DE,DYSPNOEA,21
DE,FALL,21
DE,FOETAL EXPOSURE DURING PREGNANCY,21
DE,ASTHENIA,20
DE,HYPOKALAEMIA,20
DE,MUCOSAL INFLAMMATION,20
DE,NO ADVERSE EVENT,20
DE,ATRIAL FIBRILLATION,19
DE,SEPTIC SHOCK,19
DE,ASPERGILLUS INFECTION,18
DE,PERIPHERAL SENSORY NEUROPATHY,18
DE,URINARY TRACT INFECTION,18
DE,BACTERIAL INFECTION,17
DE,C-REACTIVE PROTEIN INCREASED,17
DE,HAEMOGLOBIN DECREASED,17
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,17
DE,PANCYTOPENIA,17
DE,RASH,17
DE,CARDIAC FAILURE,16
DE,ABDOMINAL PAIN,15
DE,ACUTE KIDNEY INJURY,15
DE,HERPES SIMPLEX,15
DE,HISTIOCYTOSIS HAEMATOPHAGIC,15
DE,HYPERTENSION,15
DE,OEDEMA PERIPHERAL,15
DE,RESPIRATORY FAILURE,15
DE,WEIGHT DECREASED,15
DE,BLOOD CREATININE INCREASED,14
DE,COLITIS,14
DE,COLITIS ULCERATIVE,14
DE,HYPONATRAEMIA,14
DE,PAIN,14
DE,RENAL FAILURE,14
DE,STOMATITIS,14
DE,SYNCOPE,14
DE,VERTIGO,14
DE,ACUTE MYELOID LEUKAEMIA,13
DE,FUNGAL INFECTION,13
DE,HEADACHE,13
DE,PREMATURE BABY,13
DE,CONDITION AGGRAVATED,12
DE,DECREASED APPETITE,12
DE,DISEASE PROGRESSION,12
DE,DRUG-INDUCED LIVER INJURY,12
DE,EXPOSURE DURING PREGNANCY,12
DE,KIDNEY TRANSPLANT REJECTION,12
DE,LIVER DISORDER,12
DE,MYELODYSPLASTIC SYNDROME,12
DE,CONSTIPATION,11
DE,DIZZINESS,11
DE,LYMPHADENOPATHY,11
DE,MALIGNANT NEOPLASM PROGRESSION,11
DE,MATERNAL EXPOSURE BEFORE PREGNANCY,11
DE,SPINAL FRACTURE,11
DE,ACUTE HEPATIC FAILURE,10
DE,COUGH,10
DE,CUSHING^S SYNDROME,10
DE,CYTOMEGALOVIRUS INFECTION,10
DE,DEPRESSION,10
DE,DISEASE RECURRENCE,10
DE,DYSPHAGIA,10
DE,EMBOLISM,10
DE,FEBRILE INFECTION,10
DE,INTERSTITIAL LUNG DISEASE,10
DE,MATERNAL EXPOSURE DURING PREGNANCY,10
DE,PNEUMONIA LEGIONELLA,10
DE,ARRHYTHMIA,9
DE,BRONCHITIS,9
DE,CARDIAC DISORDER,9
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,9
DE,CROHN^S DISEASE,9
DE,EXPOSURE VIA FATHER,9
DE,GASTROENTERITIS,9
DE,GASTROINTESTINAL HAEMORRHAGE,9
DE,HAEMATOTOXICITY,9
DE,HYPOTENSION,9
DE,LUMBAR VERTEBRAL FRACTURE,9
DE,MALIGNANT MELANOMA,9
DE,MULTI-ORGAN FAILURE,9
DE,PLASMA CELL MYELOMA,9
DE,PNEUMONIA ASPIRATION,9
DE,POLYNEUROPATHY,9
DE,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,9
DE,PREMATURE DELIVERY,9
DE,ARTHRALGIA,8
DE,BONE PAIN,8
DE,BRONCHIOLITIS,8
DE,CIRCULATORY COLLAPSE,8
DE,DIABETES MELLITUS,8
DE,GRAFT VERSUS HOST DISEASE,8
DE,HEPATIC ENCEPHALOPATHY,8
DE,HYPERSENSITIVITY,8
DE,HYPOSPADIAS,8
DE,LEUKOCYTOSIS,8
DE,LUNG INFILTRATION,8
DE,NEUROPATHY PERIPHERAL,8
DE,NEUTROPENIC SEPSIS,8
DE,PANCREATITIS ACUTE,8
DE,PARAESTHESIA,8
DE,RED BLOOD CELL COUNT DECREASED,8
DE,UROSEPSIS,8
DE,WHIPPLE^S DISEASE,8
DE,ANAPHYLACTIC REACTION,7
DE,BONE MARROW FAILURE,7
DE,CEREBROVASCULAR ACCIDENT,7
DE,CONFUSIONAL STATE,7
DE,CONGENITAL SKIN DIMPLES,7
DE,DEEP VEIN THROMBOSIS,7
DE,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,7
DE,HYPOAESTHESIA,7
DE,HYPOGAMMAGLOBULINAEMIA,7
DE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,7
DE,LUNG INFECTION,7
DE,NEOPLASM,7
DE,NEOPLASM MALIGNANT,7
DE,NON-HODGKIN^S LYMPHOMA,7
DE,ORAL CANDIDIASIS,7
DE,OSTEONECROSIS OF JAW,7
DE,PLEURAL EFFUSION,7
DE,PRODUCT CONTAMINATION MICROBIAL,7
DE,PRURITUS,7
DE,RENAL IMPAIRMENT,7
DE,ALANINE AMINOTRANSFERASE INCREASED,6
DE,ATELECTASIS,6
DE,CEREBRAL ISCHAEMIA,6
DE,CHEST PAIN,6
DE,DIVERTICULITIS,6
DE,DRUG INTOLERANCE,6
DE,ENTERITIS,6
DE,EPILEPSY,6
DE,FACIAL PARESIS,6
DE,GASTROINTESTINAL DISORDER,6
DE,HAEMORRHAGE,6
DE,HYPERGLYCAEMIA,6
DE,HYPERTHYROIDISM,6
DE,ILEUS,6
DE,IMPAIRED HEALING,6
DE,LYMPHOMA,6
DE,METASTASES TO LIVER,6
DE,MITRAL VALVE DISEASE,6
DE,NERVOUS SYSTEM DISORDER,6
DE,PAIN IN EXTREMITY,6
DE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,6
DE,PERICARDIAL EFFUSION,6
DE,PLATELET COUNT DECREASED,6
DE,PNEUMOTHORAX,6
DE,PRODUCT USE ISSUE,6
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,6
DE,PYELONEPHRITIS,6
DE,UPPER RESPIRATORY TRACT INFECTION,6
DE,ABDOMINAL PAIN UPPER,5
DE,ACUTE MYOCARDIAL INFARCTION,5
DE,ADVERSE EVENT,5
DE,ANXIETY,5
DE,ASCITES,5
DE,ATYPICAL PNEUMONIA,5
DE,BACTERIAL DISEASE CARRIER,5
DE,BASAL CELL CARCINOMA,5
DE,CANDIDA INFECTION,5
DE,DERMATITIS ALLERGIC,5
DE,GAIT DISTURBANCE,5
DE,GASTROINTESTINAL INFLAMMATION,5
DE,GRAFT LOSS,5
DE,HEPATIC FAILURE,5
DE,HEPATITIS,5
DE,HERPES ZOSTER,5
DE,HYPERTENSIVE CRISIS,5
DE,IMMUNOSUPPRESSION,5
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
DE,LEUKAEMIA RECURRENT,5
DE,LYMPHOPENIA,5
DE,MENINGITIS,5
DE,MITRAL VALVE INCOMPETENCE,5
DE,OSTEONECROSIS,5
DE,OSTEOPOROSIS,5
DE,PNEUMONIA CYTOMEGALOVIRAL,5
DE,PNEUMONIA FUNGAL,5
DE,RENAL FAILURE ACUTE,5
DE,RESTLESSNESS,5
DE,SLEEP DISORDER,5
DE,TREMOR,5
DE,TYPE 1 DIABETES MELLITUS,5
DE,ABSCESS LIMB,4
DE,ASPARTATE AMINOTRANSFERASE INCREASED,4
DE,ATRIAL SEPTAL DEFECT,4
DE,B-CELL LYMPHOMA,4
DE,BLISTER,4
DE,BLOOD BILIRUBIN INCREASED,4
DE,BLOOD GLUCOSE INCREASED,4
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,4
DE,CARDIOMYOPATHY,4
DE,CENTRAL NERVOUS SYSTEM LESION,4
DE,CEREBRAL ASPERGILLOSIS,4
DE,CEREBRAL HAEMORRHAGE,4
DE,CHOLECYSTITIS,4
DE,CONTRAINDICATED PRODUCT ADMINISTERED,4
DE,CYSTITIS,4
DE,DIVERTICULAR PERFORATION,4
DE,DYSPNOEA EXERTIONAL,4
DE,EOSINOPHILIA,4
DE,FIBRIN D DIMER INCREASED,4
DE,GASTRITIS,4
DE,GENERAL PHYSICAL CONDITION ABNORMAL,4
DE,HAEMATOMA,4
DE,HAEMOLYTIC ANAEMIA,4
DE,HYDRONEPHROSIS,4
DE,HYPERHIDROSIS,4
DE,HYPOAESTHESIA ORAL,4
DE,INFUSION RELATED REACTION,4
DE,INSOMNIA,4
DE,LOSS OF CONSCIOUSNESS,4
DE,LUNG DISORDER,4
DE,LYMPHOCELE,4
DE,MUSCULAR WEAKNESS,4
DE,MYALGIA,4
DE,MYOCARDIAL INFARCTION,4
DE,NASOPHARYNGITIS,4
DE,NOCARDIOSIS,4
DE,OSTEOARTHRITIS,4
DE,OVERDOSE,4
DE,PAIN OF SKIN,4
DE,PARESIS CRANIAL NERVE,4
DE,PARTIAL SEIZURES,4
DE,PERIPHERAL MOTOR NEUROPATHY,4
DE,PERIPHERAL SWELLING,4
DE,PERITONITIS,4
DE,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
DE,PROSTATE CANCER,4
DE,PROSTATIC SPECIFIC ANTIGEN INCREASED,4
DE,PRURITUS GENERALISED,4
DE,PSYCHOTIC DISORDER,4
DE,RALES,4
DE,RENAL DISORDER,4
DE,RESPIRATORY TRACT INFECTION,4
DE,SEROMA,4
DE,SINUS TACHYCARDIA,4
DE,SKIN DISORDER,4
DE,SMALL INTESTINAL PERFORATION,4
DE,SOMNOLENCE,4
DE,SUBILEUS,4
DE,THALAMIC INFARCTION,4
DE,THROMBOSIS,4
DE,TOXIC EPIDERMAL NECROLYSIS,4
DE,URTICARIA,4
DE,VENTRICULAR SEPTAL DEFECT,4
DE,WHITE BLOOD CELL COUNT INCREASED,4
DE,WOUND DEHISCENCE,4
DE,ALOPECIA,3
DE,ANAEMIA OF MALIGNANT DISEASE,3
DE,AORTIC ANEURYSM,3
DE,BLINDNESS UNILATERAL,3
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,3
DE,BLOOD GLUCOSE ABNORMAL,3
DE,BLOOD POTASSIUM INCREASED,3
DE,BRAIN ABSCESS,3
DE,BRAIN OEDEMA,3
DE,BRONCHIAL CARCINOMA,3
DE,BRONCHOSCOPY ABNORMAL,3
DE,CACHEXIA,3
DE,CARDIOTOXICITY,3
DE,CATARACT CONGENITAL,3
DE,CHEST DISCOMFORT,3
DE,CHOLESTASIS,3
DE,COMPRESSION FRACTURE,3
DE,CONGESTIVE CARDIOMYOPATHY,3
DE,CONVULSION,3
DE,CORONARY ARTERY DISEASE,3
DE,CYTOKINE RELEASE SYNDROME,3
DE,DELIRIUM,3
DE,DEPRESSED MOOD,3
DE,DEVICE DISLOCATION,3
DE,DEVICE RELATED INFECTION,3
DE,DIARRHOEA HAEMORRHAGIC,3
DE,DIFFUSE LARGE B-CELL LYMPHOMA,3
DE,DRUG HYPERSENSITIVITY,3
DE,DYSURIA,3
DE,ENCEPHALITIS,3
DE,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,3
DE,ERYTHEMA,3
DE,ESCHERICHIA SEPSIS,3
DE,ESCHERICHIA URINARY TRACT INFECTION,3
DE,FEMUR FRACTURE,3
DE,FLUID RETENTION,3
DE,GASTRIC ULCER,3
DE,GASTROINTESTINAL INFECTION,3
DE,GESTATIONAL DIABETES,3
DE,GRANULOMA,3
DE,H1N1 INFLUENZA,3
DE,HAEMATURIA,3
DE,HAEMORRHAGE INTRACRANIAL,3
DE,HAEMORRHOIDS,3
DE,HALLUCINATION,3
DE,HERPES VIRUS INFECTION,3
DE,HODGKIN^S DISEASE,3
DE,HYDROCELE,3
DE,ILEUS PARALYTIC,3
DE,INGUINAL HERNIA,3
DE,INTESTINAL PROLAPSE,3
DE,IRRITABILITY,3
DE,JUVENILE IDIOPATHIC ARTHRITIS,3
DE,LIVER FUNCTION TEST ABNORMAL,3
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,3
DE,NECROTISING RETINITIS,3
DE,NEONATAL RESPIRATORY DISTRESS SYNDROME,3
DE,NEUROTOXICITY,3
DE,NEUTROPHIL COUNT INCREASED,3
DE,NEUTROPHILIA,3
DE,OEDEMA,3
DE,OESOPHAGEAL CANDIDIASIS,3
DE,OPTIC NEURITIS,3
DE,PALPITATIONS,3
DE,PANCREATIC CARCINOMA,3
DE,PANCREATITIS,3
DE,PATENT DUCTUS ARTERIOSUS,3
DE,PHLEBITIS,3
DE,PNEUMONIA INFLUENZAL,3
DE,PNEUMONITIS,3
DE,PRERENAL FAILURE,3
DE,PROCEDURAL COMPLICATION,3
DE,PROSTATE CANCER METASTATIC,3
DE,PULMONARY FIBROSIS,3
DE,PULMONARY OEDEMA,3
DE,RECTAL STENOSIS,3
DE,RECURRENT CANCER,3
DE,RHEUMATOID ARTHRITIS,3
DE,RIGHT VENTRICULAR FAILURE,3
DE,SEIZURE,3
DE,SKIN TOXICITY,3
DE,SMALL FOR DATES BABY,3
DE,SPEECH DISORDER,3
DE,SPINAL PAIN,3
DE,STAPHYLOCOCCAL SEPSIS,3
DE,STATUS EPILEPTICUS,3
DE,SWELLING FACE,3
DE,TACHYARRHYTHMIA,3
DE,TACHYCARDIA,3
DE,TRACHEITIS,3
DE,TRANSAMINASES INCREASED,3
DE,TREATMENT FAILURE,3
DE,UPPER LIMB FRACTURE,3
DE,VAGINAL HAEMORRHAGE,3
DE,VAGUS NERVE DISORDER,3
DE,WEIGHT INCREASED,3
DE,WHITE BLOOD CELL COUNT DECREASED,3
DE,ABDOMINAL HERNIA,2
DE,ABSCESS,2
DE,ACUTE ABDOMEN,2
DE,ACUTE CORONARY SYNDROME,2
DE,ACUTE GRAFT VERSUS HOST DISEASE,2
DE,ACUTE RESPIRATORY DISTRESS SYNDROME,2
DE,ACUTE RESPIRATORY FAILURE,2
DE,ADENOCARCINOMA OF COLON,2
DE,AMYLOIDOSIS,2
DE,AMYOTROPHIC LATERAL SCLEROSIS,2
DE,ANAPHYLACTIC SHOCK,2
DE,ANGIOEDEMA,2
DE,ATRIAL FLUTTER,2
DE,AUTOIMMUNE HEPATITIS,2
DE,BACTERIAL SEPSIS,2
DE,BETA 2 MICROGLOBULIN INCREASED,2
DE,BLOOD ALBUMIN DECREASED,2
DE,BLOOD CORTISOL DECREASED,2
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
DE,BLOOD PRESSURE DECREASED,2
DE,BLOOD URIC ACID INCREASED,2
DE,BONE MARROW DISORDER,2
DE,BONE MARROW RETICULIN FIBROSIS,2
DE,BRACHYCEPHALY,2
DE,BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC,2
DE,CAESAREAN SECTION,2
DE,CARDIAC ARREST,2
DE,CARDIOVASCULAR DISORDER,2
DE,CELLULITIS,2
DE,CEREBRAL HYPOPERFUSION,2
DE,CLOSTRIDIUM DIFFICILE INFECTION,2
DE,COGNITIVE DISORDER,2
DE,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
DE,CORONARY ARTERY STENOSIS,2
DE,CYTOMEGALOVIRUS COLITIS,2
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,2
DE,DEPRESSION SUICIDAL,2
DE,DIABETIC GASTROPARESIS,2
DE,DIABETIC NEPHROPATHY,2
DE,DISORIENTATION,2
DE,DISTURBANCE IN ATTENTION,2
DE,DRUG DEPENDENCE,2
DE,DRUG EFFECT DECREASED,2
DE,EAR DISORDER,2
DE,EJECTION FRACTION ABNORMAL,2
DE,ELECTROCARDIOGRAM T WAVE INVERSION,2
DE,EPISTAXIS,2
DE,ERYSIPELAS,2
DE,EXTERNAL AUDITORY CANAL ATRESIA,2
DE,EXTRASYSTOLES,2
DE,FACIAL BONES FRACTURE,2
DE,FEELING ABNORMAL,2
DE,FREQUENT BOWEL MOVEMENTS,2
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
DE,GASTROENTERITIS NOROVIRUS,2
DE,GENERAL SYMPTOM,2
DE,GLAUCOMA,2
DE,GLOMERULONEPHRITIS,2
DE,GOUT,2
DE,GRAFT VERSUS HOST DISEASE IN SKIN,2
DE,HAEMANGIOMA,2
DE,HAEMATOCHEZIA,2
DE,HAEMATOCRIT INCREASED,2
DE,HAEMOLYSIS,2
DE,HEPATIC CONGESTION,2
DE,HEPATIC STEATOSIS,2
DE,HEPATOTOXICITY,2
DE,HERPES SIMPLEX SEPSIS,2
DE,HIP ARTHROPLASTY,2
DE,HYPERKALAEMIA,2
DE,HYPERTELORISM OF ORBIT,2
DE,HYPOPLASTIC LEFT HEART SYNDROME,2
DE,HYPOTONIA NEONATAL,2
DE,HYSTERECTOMY,2
DE,ILEAL STENOSIS,2
DE,IMMUNODEFICIENCY,2
DE,IMMUNOGLOBULINS DECREASED,2
DE,INCISIONAL HERNIA,2
DE,INCORRECT DOSE ADMINISTERED,2
DE,INFLAMMATION,2
DE,INFLUENZA,2
DE,INTESTINAL HAEMORRHAGE,2
DE,INTESTINAL OBSTRUCTION,2
DE,JOINT CONTRACTURE,2
DE,LACERATION,2
DE,LARGE INTESTINE PERFORATION,2
DE,LEFT VENTRICULAR FAILURE,2
DE,LIGHT CHAIN ANALYSIS INCREASED,2
DE,LIP SWELLING,2
DE,LIVER ABSCESS,2
DE,LOW BIRTH WEIGHT BABY,2
DE,LYMPHOCYTE COUNT DECREASED,2
DE,MALABSORPTION,2
DE,MALAISE,2
DE,MANTLE CELL LYMPHOMA RECURRENT,2
DE,MATERNAL DRUGS AFFECTING FOETUS,2
DE,MECONIUM IN AMNIOTIC FLUID,2
DE,MENISCUS INJURY,2
DE,MENTAL DISORDER,2
DE,METASTASES TO LUNG,2
DE,METASTASIS,2
DE,MICROTIA,2
DE,MYELOFIBROSIS,2
DE,MYELOID LEUKAEMIA,2
DE,MYELOPROLIFERATIVE NEOPLASM,2
DE,MYOSITIS,2
DE,NASAL DISORDER,2
DE,NEPHROSCLEROSIS,2
DE,NEUTROPHIL COUNT DECREASED,2
DE,OEDEMA MOUTH,2
DE,OESOPHAGEAL ATRESIA,2
DE,OLIGOHYDRAMNIOS,2
DE,ORAL PAIN,2
DE,OROPHARYNGEAL PAIN,2
DE,OSTEOSYNTHESIS,2
DE,PANIC ATTACK,2
DE,PANIC DISORDER WITHOUT AGORAPHOBIA,2
DE,PARKINSONISM,2
DE,PATHOLOGICAL FRACTURE,2
DE,PENETRATING AORTIC ULCER,2
DE,PERFORMANCE STATUS DECREASED,2
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
DE,PETECHIAE,2
DE,PHARYNGEAL DISORDER,2
DE,PLATELET COUNT INCREASED,2
DE,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,2
DE,POLYSEROSITIS,2
DE,POLYURIA,2
DE,PORTAL FIBROSIS,2
DE,PREGNANCY,2
DE,PREMATURE RUPTURE OF MEMBRANES,2
DE,PROTEIN TOTAL DECREASED,2
DE,PROTEINURIA,2
DE,PSEUDARTHROSIS,2
DE,PSEUDOMEMBRANOUS COLITIS,2
DE,PSEUDOMONAS INFECTION,2
DE,PSORIASIS,2
DE,PULMONARY ARTERIAL PRESSURE INCREASED,2
DE,PULMONARY INFARCTION,2
DE,PULMONARY THROMBOSIS,2
DE,PULMONARY TOXICITY,2
DE,RASH PUSTULAR,2
DE,RENAL FUNCTION TEST ABNORMAL,2
DE,RENAL TUBULAR DISORDER,2
DE,RENAL TUBULAR NECROSIS,2
DE,RESPIRATORY DISORDER,2
DE,RESPIRATORY DISTRESS,2
DE,RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS,2
DE,RETINAL DETACHMENT,2
DE,RETROGNATHIA,2
DE,ROAD TRAFFIC ACCIDENT,2
DE,ROSS SYNDROME,2
DE,SCIATICA,2
DE,SECOND PRIMARY MALIGNANCY,2
DE,SHOCK,2
DE,SHOCK HAEMORRHAGIC,2
DE,SKIN FISSURES,2
DE,SKIN MASS,2
DE,SKIN ULCER,2
DE,SPLENOMEGALY,2
DE,STAPHYLOCOCCAL INFECTION,2
DE,STREPTOCOCCAL INFECTION,2
DE,SUBARACHNOID HAEMORRHAGE,2
DE,SYSTEMIC CANDIDA,2
DE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
DE,TALIPES,2
DE,TEMPORAL ARTERITIS,2
DE,TENDON DISORDER,2
DE,TENSION,2
DE,THROMBOPHLEBITIS,2
DE,THROMBOSIS IN DEVICE,2
DE,TOOTH LOSS,2
DE,TOXIC NEUROPATHY,2
DE,TRANSIENT ISCHAEMIC ATTACK,2
DE,TRANSPLANT FAILURE,2
DE,TRANSPLANT REJECTION,2
DE,TRICUSPID VALVE INCOMPETENCE,2
DE,TUMOUR FLARE,2
DE,URETERIC STENOSIS,2
DE,VENOOCCLUSIVE LIVER DISEASE,2
DE,VENOUS THROMBOSIS LIMB,2
DE,VENTRICULAR FIBRILLATION,2
DE,VIRAL INFECTION,2
DE,VISCERAL LEISHMANIASIS,2
DE,VITAMIN D DEFICIENCY,2
DE,VOCAL CORD PARALYSIS,2
DE,WOUND INFECTION,2
DE,5Q MINUS SYNDROME,1
DE,ABASIA,1
DE,ABDOMINAL ABSCESS,1
DE,ABDOMINAL DISCOMFORT,1
DE,ABDOMINAL INFECTION,1
DE,ABDOMINAL PAIN LOWER,1
DE,ABDOMINAL WALL HAEMATOMA,1
DE,ABNORMAL FAECES,1
DE,ABORTION INDUCED,1
DE,ABORTION SPONTANEOUS,1
DE,ABSCESS RUPTURE,1
DE,ACCELERATED HYPERTENSION,1
DE,ACNE,1
DE,ACUTE HEPATITIS C,1
DE,ACUTE LYMPHOCYTIC LEUKAEMIA,1
DE,ACUTE MYELOID LEUKAEMIA RECURRENT,1
DE,ADENOVIRUS INFECTION,1
DE,ADRENAL ADENOMA,1
DE,ADVERSE DRUG REACTION,1
DE,AGGRESSION,1
DE,AGITATION,1
DE,AKINESIA,1
DE,ALCOHOLISM,1
DE,ALPHA 1 GLOBULIN INCREASED,1
DE,ALPHA 2 GLOBULIN INCREASED,1
DE,ALTERED STATE OF CONSCIOUSNESS,1
DE,ALVEOLITIS,1
DE,AMAUROSIS,1
DE,AMAUROSIS FUGAX,1
DE,AMENORRHOEA,1
DE,AMNIOTIC CAVITY INFECTION,1
DE,ANAL FISTULA,1
DE,ANAL HAEMORRHAGE,1
DE,ANAL ULCER,1
DE,ANGINA PECTORIS,1
DE,ANGINA UNSTABLE,1
DE,ANGIOPATHY,1
DE,ANGIOPLASTY,1
DE,ANGIOSARCOMA,1
DE,ANHEDONIA,1
DE,ANTITHROMBIN III DECREASED,1
DE,ANURIA,1
DE,AORTA HYPOPLASIA,1
DE,AORTIC VALVE INCOMPETENCE,1
DE,APATHY,1
DE,APHASIA,1
DE,APPENDICITIS,1
DE,APPENDICITIS PERFORATED,1
DE,AREFLEXIA,1
DE,ARTERIAL DISORDER,1
DE,ARTHRITIS BACTERIAL,1
DE,ARTHRODESIS,1
DE,ARTHROPATHY,1
DE,ARTHROPOD BITE,1
DE,ARTHROPOD STING,1
DE,ASPERGILLOSIS,1
DE,ASPIRATION,1
DE,ASPLENIA,1
DE,ATAXIA TELANGIECTASIA,1
DE,ATRIOVENTRICULAR BLOCK COMPLETE,1
DE,AUTOIMMUNE COLITIS,1
DE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
DE,AUTOIMMUNE THYROIDITIS,1
DE,AZOOSPERMIA,1
DE,B-CELL LYMPHOMA RECURRENT,1
DE,B-LYMPHOCYTE COUNT DECREASED,1
DE,BACTERIAL TEST POSITIVE,1
DE,BENIGN NEOPLASM,1
DE,BENIGN PROSTATIC HYPERPLASIA,1
DE,BETA GLOBULIN DECREASED,1
DE,BICYTOPENIA,1
DE,BILE DUCT STONE,1
DE,BILIARY ISCHAEMIA,1
DE,BILIRUBIN CONJUGATED INCREASED,1
DE,BK VIRUS INFECTION,1
DE,BLAST CELL CRISIS,1
DE,BLINDNESS,1
DE,BLOOD BILIRUBIN DECREASED,1
DE,BLOOD CALCIUM DECREASED,1
DE,BLOOD ELECTROLYTES DECREASED,1
DE,BLOOD FIBRINOGEN DECREASED,1
DE,BLOOD GLUCOSE FLUCTUATION,1
DE,BLOOD IMMUNOGLOBULIN A DECREASED,1
DE,BLOOD IMMUNOGLOBULIN G DECREASED,1
DE,BLOOD IMMUNOGLOBULIN G INCREASED,1
DE,BLOOD IMMUNOGLOBULIN M DECREASED,1
DE,BLOOD IRON DECREASED,1
DE,BLOOD MAGNESIUM DECREASED,1
DE,BLOOD SODIUM DECREASED,1
DE,BLOOD TEST ABNORMAL,1
DE,BLOOD TRIGLYCERIDES INCREASED,1
DE,BLOOD UREA INCREASED,1
DE,BLOOD ZINC DECREASED,1
DE,BONE MARROW NECROSIS,1
DE,BONE MARROW OEDEMA,1
DE,BONE MARROW TUMOUR CELL INFILTRATION,1
DE,BRAIN HERNIATION,1
DE,BRAIN MALFORMATION,1
DE,BRAIN STEM SYNDROME,1
DE,BREAST CANCER METASTATIC,1
DE,BREAST FEEDING,1
DE,BREECH PRESENTATION,1
DE,BRONCHOPNEUMONIA,1
DE,BRONCHOPULMONARY ASPERGILLOSIS,1
DE,BRONCHOSPASM,1
DE,BURKITT^S LYMPHOMA,1
DE,C-REACTIVE PROTEIN DECREASED,1
DE,CALCIPHYLAXIS,1
DE,CAMPTODACTYLY CONGENITAL,1
DE,CAMPYLOBACTER INFECTION,1
DE,CANDIDA PNEUMONIA,1
DE,CANDIDA SEPSIS,1
DE,CAPILLARY LEAK SYNDROME,1
DE,CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT,1
DE,CARDIAC FAILURE ACUTE,1
DE,CARDIAC FAILURE CHRONIC,1
DE,CARDIAC FIBRILLATION,1
DE,CARDIAC FLUTTER,1
DE,CARDIOVASCULAR INSUFFICIENCY,1
DE,CATARACT,1
DE,CATATONIA,1
DE,CATHETER SITE ERYTHEMA,1
DE,CD4 LYMPHOCYTES DECREASED,1
DE,CD4/CD8 RATIO DECREASED,1
DE,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
DE,CEREBELLAR INFARCTION,1
DE,CEREBRAL INFARCTION,1
DE,CEREBRAL MICROANGIOPATHY,1
DE,CHOLANGITIS INFECTIVE,1
DE,CHOLANGITIS SCLEROSING,1
DE,CHROMATURIA,1
DE,CHRONIC GASTRITIS,1
DE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
DE,CHRONIC MYELOID LEUKAEMIA,1
DE,CLINODACTYLY,1
DE,CLOSTRIDIAL INFECTION,1
DE,CLOSTRIDIUM DIFFICILE COLITIS,1
DE,CLOSTRIDIUM DIFFICILE SEPSIS,1
DE,CLOSTRIDIUM TEST POSITIVE,1
DE,COAGULOPATHY,1
DE,COLOBOMA,1
DE,COLON CANCER,1
DE,COLORECTAL CANCER,1
DE,CONCUSSION,1
DE,CONGENITAL ANOMALY,1
DE,CONGENITAL ANOMALY IN OFFSPRING,1
DE,CONGENITAL CYSTIC KIDNEY DISEASE,1
DE,CONGENITAL RENAL DISORDER,1
DE,CONJUNCTIVAL HAEMORRHAGE,1
DE,CONTUSION,1
DE,COORDINATION ABNORMAL,1
DE,CORONARY ARTERY EMBOLISM,1
DE,CORONARY NO-REFLOW PHENOMENON,1
DE,CRANIOFACIAL DEFORMITY,1
DE,CREATININE RENAL CLEARANCE DECREASED,1
DE,CUSHINGOID,1
DE,CYST,1
DE,CYTOMEGALOVIRUS ENTERITIS,1
DE,CYTOMEGALOVIRUS HEPATITIS,1
DE,CYTOMEGALOVIRUS SYNDROME,1
DE,CYTOMEGALOVIRUS VIRAEMIA,1
DE,CYTOPENIA,1
DE,DEAFNESS,1
DE,DEAFNESS TRAUMATIC,1
DE,DEMYELINATION,1
DE,DERMATITIS,1
DE,DERMATITIS ATOPIC,1
DE,DEVELOPMENTAL HIP DYSPLASIA,1
DE,DEVICE BREAKAGE,1
DE,DEVICE ISSUE,1
DE,DEVICE OCCLUSION,1
DE,DIABETES INSIPIDUS,1
DE,DISSEMINATED INTRAVASCULAR COAGULATION,1
DE,DISSEMINATED TUBERCULOSIS,1
DE,DIVERTICULUM,1
DE,DIZZINESS POSTURAL,1
DE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
DE,DRUG EFFECT INCOMPLETE,1
DE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
DE,DRUG WITHDRAWAL SYNDROME,1
DE,DRY SKIN,1
DE,DUODENAL PERFORATION,1
DE,DYSAESTHESIA,1
DE,DYSARTHRIA,1
DE,DYSGEUSIA,1
DE,DYSPHEMIA,1
DE,EAR CONGESTION,1
DE,EAR INFECTION,1
DE,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,1
DE,ECLAMPSIA,1
DE,ECZEMA,1
DE,EJECTION FRACTION DECREASED,1
DE,ELECTROCARDIOGRAM QT PROLONGED,1
DE,ELECTROLYTE IMBALANCE,1
DE,EMOTIONAL DISORDER,1
DE,EMOTIONAL DISTRESS,1
DE,EMPYEMA,1
DE,ENDOCARDITIS,1
DE,ENTERITIS INFECTIOUS,1
DE,ENTEROCOLITIS,1
DE,ENTEROCOLITIS HAEMORRHAGIC,1
DE,ENTEROCOLITIS INFECTIOUS,1
DE,EOSINOPHIL PERCENTAGE INCREASED,1
DE,EPIDERMOLYSIS,1
DE,EPIGASTRIC DISCOMFORT,1
DE,EPSTEIN-BARR VIRAEMIA,1
DE,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,1
DE,EPSTEIN-BARR VIRUS INFECTION,1
DE,ERECTILE DYSFUNCTION,1
DE,EXOSTOSIS,1
DE,EXPOSURE DURING BREAST FEEDING,1
DE,EYE DISORDER,1
DE,EYE SWELLING,1
DE,EYELID OEDEMA,1
DE,FACIAL ASYMMETRY,1
DE,FAECAL INCONTINENCE,1
DE,FAECALOMA,1
DE,FAILURE TO THRIVE,1
DE,FEAR,1
DE,FEELING HOT,1
DE,FEMORAL NECK FRACTURE,1
DE,FIBROUS HISTIOCYTOMA,1
DE,FISTULA,1
DE,FLATULENCE,1
DE,FLUSHING,1
DE,FOETAL DEATH,1
DE,FOOT FRACTURE,1
DE,FRACTURE,1
DE,GALLBLADDER DISORDER,1
DE,GANGRENE,1
DE,GASTRIC DISORDER,1
DE,GASTRIC MUCOSAL HYPERTROPHY,1
DE,GASTRIC ULCER HAEMORRHAGE,1
DE,GASTRIC ULCER PERFORATION,1
DE,GASTRITIS EROSIVE,1
DE,GASTROINTESTINAL CARCINOMA,1
DE,GASTROINTESTINAL INJURY,1
DE,GASTROINTESTINAL NECROSIS,1
DE,GASTROINTESTINAL OEDEMA,1
DE,GASTROINTESTINAL PERFORATION,1
DE,GASTROINTESTINAL TOXICITY,1
DE,GASTROOESOPHAGEAL REFLUX DISEASE,1
DE,GENERALISED OEDEMA,1
DE,GENERALISED TONIC-CLONIC SEIZURE,1
DE,GENITAL ABSCESS,1
DE,GENITAL HERPES SIMPLEX,1
DE,GILBERT^S SYNDROME,1
DE,GLOMERULAR FILTRATION RATE DECREASED,1
DE,GLOMERULONEPHRITIS MEMBRANOUS,1
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
DE,GOITRE,1
DE,GRAFT VERSUS HOST DISEASE IN LIVER,1
DE,GROIN ABSCESS,1
DE,GROIN PAIN,1
DE,HAEMANGIOMA OF LIVER,1
DE,HAEMATEMESIS,1
DE,HAEMATOCRIT DECREASED,1
DE,HAEMOGLOBIN INCREASED,1
DE,HAEMOLYTIC URAEMIC SYNDROME,1
DE,HAEMORRHAGIC ANAEMIA,1
DE,HAEMORRHAGIC ASCITES,1
DE,HAIR GROWTH ABNORMAL,1
DE,HAND FRACTURE,1
DE,HAPTOGLOBIN DECREASED,1
DE,HEART INJURY,1
DE,HEART RATE INCREASED,1
DE,HEART RATE IRREGULAR,1
DE,HEART VALVE INCOMPETENCE,1
DE,HELICOBACTER GASTRITIS,1
DE,HEMIANOPIA HOMONYMOUS,1
DE,HEPARIN-INDUCED THROMBOCYTOPENIA,1
DE,HEPATIC MASS,1
DE,HEPATITIS ACUTE,1
DE,HEPATITIS C,1
DE,HEPATITIS E,1
DE,HEPATITIS FULMINANT,1
DE,HEPATOMEGALY,1
DE,HEPATOSPLENOMEGALY,1
DE,HERPES SIMPLEX ENCEPHALITIS,1
DE,HIATUS HERNIA,1
DE,HICCUPS,1
DE,HIP FRACTURE,1
DE,HODGKIN^S DISEASE NODULAR SCLEROSIS STAGE IV,1
DE,HOT FLUSH,1
DE,HUMERUS FRACTURE,1
DE,HYPERBILIRUBINAEMIA,1
DE,HYPERCAPNIA,1
DE,HYPERCHOLESTEROLAEMIA,1
DE,HYPERFERRITINAEMIA,1
DE,HYPERPARATHYROIDISM SECONDARY,1
DE,HYPERSOMNIA,1
DE,HYPERVENTILATION,1
DE,HYPERVOLAEMIA,1
DE,HYPOCALCAEMIA,1
DE,HYPOFIBRINOGENAEMIA,1
DE,HYPOGONADISM,1
DE,HYPOKINESIA,1
DE,HYPOMAGNESAEMIA,1
DE,HYPOPNOEA,1
DE,HYPOTHERMIA,1
DE,HYPOTHYROIDISM,1
DE,HYPOTONIA,1
DE,ILL-DEFINED DISORDER,1
DE,ILLUSION,1
DE,IMMUNE-MEDIATED HEPATITIS,1
DE,IMMUNODEFICIENCY CONGENITAL,1
DE,IMMUNOGLOBULIN G4 RELATED SCLEROSING DISEASE,1
DE,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
DE,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
DE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
DE,INCISION SITE ABSCESS,1
DE,INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION,1
DE,INFANTILE APNOEA,1
DE,INFECTION IN AN IMMUNOCOMPROMISED HOST,1
DE,INFECTION REACTIVATION,1
DE,INFERTILITY,1
DE,INFESTATION,1
DE,INFLAMMATORY MARKER INCREASED,1
DE,INNER EAR DISORDER,1
DE,INTENTIONAL DRUG MISUSE,1
DE,INTENTIONAL PRODUCT MISUSE,1
DE,INTENTIONAL PRODUCT USE ISSUE,1
DE,INTERLEUKIN LEVEL INCREASED,1
DE,INTERNATIONAL NORMALISED RATIO INCREASED,1
DE,INTERVERTEBRAL DISC PROTRUSION,1
DE,INTERVERTEBRAL DISCITIS,1
DE,INTESTINAL PERFORATION,1
DE,INTRACRANIAL ANEURYSM,1
DE,INTRACRANIAL PRESSURE INCREASED,1
DE,INTRAOCULAR PRESSURE INCREASED,1
DE,IRON DEFICIENCY,1
DE,ISCHAEMIA,1
DE,ISCHAEMIC CEREBRAL INFARCTION,1
DE,JC VIRUS INFECTION,1
DE,JEJUNAL PERFORATION,1
DE,JOINT INJURY,1
DE,JOINT STIFFNESS,1
DE,JOINT SWELLING,1
DE,KNEE OPERATION,1
DE,LABILE BLOOD PRESSURE,1
DE,LACTIC ACIDOSIS,1
DE,LACTOSE INTOLERANCE,1
DE,LANGERHANS^ CELL HISTIOCYTOSIS,1
DE,LARGE INTESTINAL STENOSIS,1
DE,LARGE INTESTINE POLYP,1
DE,LARYNGITIS BACTERIAL,1
DE,LARYNGITIS FUNGAL,1
DE,LEFT VENTRICULAR DYSFUNCTION,1
DE,LEGIONELLA INFECTION,1
DE,LEUKOENCEPHALOPATHY,1
DE,LIGAMENT RUPTURE,1
DE,LIP INJURY,1
DE,LIPASE INCREASED,1
DE,LISTLESS,1
DE,LIVER INJURY,1
DE,LOCAL SWELLING,1
DE,LOCALISED OEDEMA,1
DE,LUMBAR SPINAL STENOSIS,1
DE,LUNG ABSCESS,1
DE,LUNG CANCER METASTATIC,1
DE,LUNG NEOPLASM MALIGNANT,1
DE,LUNG TRANSPLANT REJECTION,1
DE,LYMPHATIC DISORDER,1
DE,LYMPHOMA AIDS RELATED,1
DE,MACULOPATHY,1
DE,MALIGNANT ASCITES,1
DE,MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED,1
DE,MELANOCYTIC NAEVUS,1
DE,MENOPAUSAL SYMPTOMS,1
DE,MESENTERIC ARTERIAL OCCLUSION,1
DE,METABOLIC ACIDOSIS,1
DE,METAPNEUMOVIRUS INFECTION,1
DE,METASTASES TO BONE,1
DE,METASTASES TO PERITONEUM,1
DE,METASTASES TO SOFT TISSUE,1
DE,METASTATIC MALIGNANT MELANOMA,1
DE,MICROANGIOPATHY,1
DE,MICROGNATHIA,1
DE,MICTURITION FREQUENCY DECREASED,1
DE,MITRAL VALVE ATRESIA,1
DE,MONOCLONAL GAMMOPATHY,1
DE,MONOCYTE COUNT INCREASED,1
DE,MONOPARESIS,1
DE,MOOD ALTERED,1
DE,MUCOSAL EROSION,1
DE,MUCOUS MEMBRANE DISORDER,1
DE,MULTIPLE FRACTURES,1
DE,MUSCLE HYPERTROPHY,1
DE,MUSCLE RIGIDITY,1
DE,MUSCLE SPASMS,1
DE,MUSCLE TWITCHING,1
DE,MUSCULOSKELETAL DISORDER,1
DE,MUSCULOSKELETAL PAIN,1
DE,MUSCULOSKELETAL STIFFNESS,1
DE,MUTISM,1
DE,MYOCARDITIS,1
DE,MYOCARDITIS INFECTIOUS,1
DE,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
DE,NAIL BED INFECTION,1
DE,NASAL DISCHARGE DISCOLOURATION,1
DE,NECK PAIN,1
DE,NECROSIS,1
DE,NECROTISING FASCIITIS,1
DE,NEOPLASM PROGRESSION,1
DE,NEOPLASM RECURRENCE,1
DE,NEPHRITIS,1
DE,NEPHROPATHY,1
DE,NEPHROPATHY TOXIC,1
DE,NERVE ROOT LESION,1
DE,NEUROBORRELIOSIS,1
DE,NEUROENDOCRINE CARCINOMA,1
DE,NEUROLOGICAL DECOMPENSATION,1
DE,NEUROLOGICAL SYMPTOM,1
DE,NIGHT SWEATS,1
DE,NIKOLSKY^S SIGN,1
DE,NO THERAPEUTIC RESPONSE,1
DE,NODULE,1
DE,NON-SMALL CELL LUNG CANCER,1
DE,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
DE,NOSOCOMIAL INFECTION,1
DE,NUTRITIONAL CONDITION ABNORMAL,1
DE,NYSTAGMUS,1
DE,OCULAR ICTERUS,1
DE,ODYNOPHAGIA,1
DE,OLFACTORY NERVE AGENESIS,1
DE,OLFACTORY NERVE DISORDER,1
DE,OLIGURIA,1
DE,ONYCHOLYSIS,1
DE,ORAL HERPES,1
DE,ORGANISING PNEUMONIA,1
DE,OROPHARYNGEAL CANCER,1
DE,OSTEOCHONDROSIS,1
DE,OSTEOMYELITIS,1
DE,OSTEOPENIA,1
DE,PACKED RED BLOOD CELL TRANSFUSION,1
DE,PANCREATIC CARCINOMA RECURRENT,1
DE,PANCREATIC DISORDER,1
DE,PANCREATIC ENZYMES INCREASED,1
DE,PANCREATIC INSUFFICIENCY,1
DE,PANCREATIC NEOPLASM,1
DE,PANIC DISORDER,1
DE,PAPILLOEDEMA,1
DE,PARVOVIRUS B19 INFECTION,1
DE,PELVIC PAIN,1
DE,PELVIC VENOUS THROMBOSIS,1
GH,ANAEMIA,1
GH,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1
GH,ULCER,1
GR,DISEASE RECURRENCE,10
GR,ANAEMIA,7
GR,DRUG INEFFECTIVE,7
GR,FEBRILE NEUTROPENIA,7
GR,HEPATITIS B,5
GR,CONDITION AGGRAVATED,4
GR,NECROTISING COLITIS,4
GR,NEUTROPENIA,4
GR,PROTEINURIA,4
GR,ENDOTHELIAL DYSFUNCTION,3
GR,HEPATITIS B REACTIVATION,3
GR,HYPERAMMONAEMIC ENCEPHALOPATHY,3
GR,LEUKOPENIA,3
GR,LOWER RESPIRATORY TRACT INFECTION,3
GR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
GR,PYREXIA,3
GR,SKIN ULCER,3
GR,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,2
GR,ARTHRALGIA,2
GR,ASTHENIA,2
GR,BACTERIAL SEPSIS,2
GR,COUGH,2
GR,DEATH,2
GR,DISEASE PROGRESSION,2
GR,DUODENAL ULCER,2
GR,EPSTEIN-BARR VIRUS INFECTION,2
GR,FATIGUE,2
GR,GASTROINTESTINAL HAEMORRHAGE,2
GR,HAEMOLYSIS,2
GR,HEADACHE,2
GR,HIATUS HERNIA,2
GR,HYPERSENSITIVITY,2
GR,INFECTION,2
GR,LUPUS NEPHRITIS,2
GR,NEOPLASM MALIGNANT,2
GR,OEDEMA,2
GR,OEDEMA PERIPHERAL,2
GR,OSTEONECROSIS,2
GR,PLEURAL EFFUSION,2
GR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
GR,PSEUDOMONAL SEPSIS,2
GR,SERRATIA SEPSIS,2
GR,VASCULITIS,2
GR,VOMITING,2
GR,WEIGHT INCREASED,2
GR,ABDOMINAL PAIN,1
GR,ACUTE KIDNEY INJURY,1
GR,ALANINE AMINOTRANSFERASE INCREASED,1
GR,AMMONIA INCREASED,1
GR,ANAPHYLACTIC REACTION,1
GR,ANISOCYTOSIS,1
GR,ANXIETY,1
GR,ARRHYTHMIA,1
GR,ASCITES,1
GR,ATRIAL FIBRILLATION,1
GR,B-CELL LYMPHOMA,1
GR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
GR,BLOOD PRESSURE INCREASED,1
GR,BONE MARROW LEUKAEMIC CELL INFILTRATION,1
GR,BONE PAIN,1
GR,BREAST CANCER IN SITU,1
GR,BREATH SOUNDS ABNORMAL,1
GR,BURNING SENSATION,1
GR,BUTTERFLY RASH,1
GR,C-REACTIVE PROTEIN INCREASED,1
GR,CATARACT,1
GR,CEREBRAL ASPERGILLOSIS,1
GR,CEREBRAL TOXOPLASMOSIS,1
GR,CHEST PAIN,1
GR,CHRONIC SPONTANEOUS URTICARIA,1
GR,COMPLEMENT FACTOR INCREASED,1
GR,CONSTIPATION,1
GR,CONTUSION,1
GR,CUSHING^S SYNDROME,1
GR,CYSTITIS,1
GR,DECREASED APPETITE,1
GR,DEEP VEIN THROMBOSIS,1
GR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
GR,DIABETIC KETOACIDOSIS,1
GR,DIARRHOEA,1
GR,DIASTOLIC DYSFUNCTION,1
GR,DRESSLER^S SYNDROME,1
GR,DRUG DEPENDENCE,1
GR,DRUG ERUPTION,1
GR,DRUG HYPERSENSITIVITY,1
GR,DRUG RESISTANCE,1
GR,DYSPEPSIA,1
GR,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
GR,EMBOLIC STROKE,1
GR,ENDOMETRIAL CANCER,1
GR,EPISTAXIS,1
GR,ERYTHEMA,1
GR,FEBRILE INFECTION,1
GR,FOOD POISONING,1
GR,FUNGAL INFECTION,1
GR,GENERAL PHYSICAL HEALTH DETERIORATION,1
GR,GINGIVAL BLEEDING,1
GR,GLOMERULONEPHRITIS,1
GR,GOUT,1
GR,H1N1 INFLUENZA,1
GR,HAEMATOCRIT DECREASED,1
GR,HAEMATURIA,1
GR,HAEMOGLOBIN DECREASED,1
GR,HEMIPARESIS,1
GR,HEPATOSPLENOMEGALY,1
GR,HORMONE LEVEL ABNORMAL,1
GR,HYPERGLYCAEMIA,1
GR,HYPERNATRAEMIA,1
GR,HYPERTENSION,1
GR,HYPOAESTHESIA,1
GR,HYPOCHROMASIA,1
GR,HYPOGAMMAGLOBULINAEMIA,1
GR,HYPOKALAEMIA,1
GR,HYPONATRAEMIA,1
GR,HYPOTENSION,1
GR,ILEAL STENOSIS,1
GR,ILEUS,1
GR,ILEUS PARALYTIC,1
GR,IMMUNOGLOBULINS INCREASED,1
GR,INFUSION RELATED REACTION,1
GR,ISCHAEMIC STROKE,1
GR,LIVER DISORDER,1
GR,LUNG INFECTION,1
GR,LUNG INFILTRATION,1
GR,LYMPHOCYTIC INFILTRATION,1
GR,MALAISE,1
GR,MATERNAL EXPOSURE DURING DELIVERY,1
GR,MATERNAL EXPOSURE DURING PREGNANCY,1
GR,MELAENA,1
GR,MENINGITIS LISTERIA,1
GR,METABOLIC ACIDOSIS,1
GR,MICROCYTOSIS,1
GR,MOUTH ULCERATION,1
GR,MUSCULAR WEAKNESS,1
GR,MUSCULOSKELETAL STIFFNESS,1
GR,MYELODYSPLASTIC SYNDROME,1
GR,NASOPHARYNGITIS,1
GR,NAUSEA,1
GR,NECROTISING RETINITIS,1
GR,NEPHROPATHY TOXIC,1
GR,NEUROTOXICITY,1
GR,NEUTROPENIC COLITIS,1
GR,NO THERAPEUTIC RESPONSE,1
GR,NON-HODGKIN^S LYMPHOMA,1
GR,NON-HODGKIN^S LYMPHOMA RECURRENT,1
GR,NORMAL NEWBORN,1
GR,OESOPHAGITIS,1
GR,OMPHALORRHEXIS,1
GR,ORAL MUCOSA EROSION,1
GR,OSTEONECROSIS OF JAW,1
GR,OSTEOPOROSIS,1
GR,PAIN,1
GR,PANCYTOPENIA,1
GR,PERICARDITIS CONSTRICTIVE,1
GR,PLASMA CELL MYELOMA,1
GR,PLATELET COUNT INCREASED,1
GR,PLEURITIC PAIN,1
GR,PNEUMONIA,1
GR,PREMATURE DELIVERY,1
GR,PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA,1
GR,PRODUCT USE IN UNAPPROVED INDICATION,1
GR,PRODUCTIVE COUGH,1
GR,PULMONARY ARTERIAL HYPERTENSION,1
GR,PULMONARY HAEMORRHAGE,1
GR,PULMONARY MASS,1
GR,PYOMYOSITIS,1
GR,RASH,1
GR,RASH ERYTHEMATOUS,1
GR,RASH MACULO-PAPULAR,1
GR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
GR,RENAL IMPAIRMENT,1
GR,RESPIRATORY DISORDER,1
GR,RESPIRATORY TRACT INFECTION,1
GR,SCIATICA,1
GR,SEPTIC SHOCK,1
GR,SINUS DISORDER,1
GR,SMALL INTESTINAL OBSTRUCTION,1
GR,SOMNOLENCE,1
GR,SQUAMOUS CELL CARCINOMA OF THE CERVIX,1
GR,SQUAMOUS CELL CARCINOMA OF THE VAGINA,1
GR,STEROID WITHDRAWAL SYNDROME,1
GR,SUPRAVENTRICULAR EXTRASYSTOLES,1
GR,SYNCOPE,1
GR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
GR,THALASSAEMIA TRAIT,1
GR,THROMBOCYTOPENIA,1
GR,TOXICITY TO VARIOUS AGENTS,1
GR,TRANSFERRIN DECREASED,1
GR,TUBERCULOSIS,1
GR,URINARY SEDIMENT PRESENT,1
GR,VENTRICULAR EXTRASYSTOLES,1
GR,VIRAL RASH,1
GR,WHEEZING,1
GT,HEPATIC STEATOSIS,2
GT,PERICARDIAL EFFUSION,2
GT,SERUM FERRITIN INCREASED,2
GT,ABDOMINAL PAIN,1
GT,ABDOMINAL PAIN UPPER,1
GT,ARTHRALGIA,1
GT,BACK PAIN,1
GT,COLITIS,1
GT,CONJUNCTIVITIS,1
GT,DIARRHOEA,1
GT,DISCOMFORT,1
GT,ERYTHEMA OF EYELID,1
GT,ESCHERICHIA INFECTION,1
GT,EYE INFECTION,1
GT,EYE IRRITATION,1
GT,FAECES DISCOLOURED,1
GT,FEEDING DISORDER,1
GT,GASTRITIS,1
GT,HEPATIC FIBROSIS,1
GT,IRIDOTOMY,1
GT,LIVER DISORDER,1
GT,LUNG NEOPLASM MALIGNANT,1
GT,MALAISE,1
GT,MENTAL IMPAIRMENT,1
GT,MUSCULOSKELETAL PAIN,1
GT,NAIL DISORDER,1
GT,OROPHARYNGEAL CANDIDIASIS,1
GT,PAIN,1
GT,PAIN IN EXTREMITY,1
GT,PERIPHERAL SWELLING,1
GT,PNEUMONIA,1
GT,PRODUCT USE ISSUE,1
GT,PYREXIA,1
GT,SOMNOLENCE,1
GT,URINARY TRACT DISORDER,1
GT,URINARY TRACT INFECTION,1
GT,WEIGHT DECREASED,1
HT,AIDS RELATED COMPLICATION,1
HT,HYPOGLYCAEMIA,1
HT,MALNUTRITION,1
HN,ABASIA,1
HN,COUGH,1
HN,DEATH,1
HN,DECREASED APPETITE,1
HN,DEPRESSION,1
HN,DIZZINESS,1
HN,EPISTAXIS,1
HN,INFLUENZA,1
HN,INJECTION SITE ERYTHEMA,1
HN,INTRACRANIAL PRESSURE INCREASED,1
HN,LUNG INFECTION,1
HN,MENORRHAGIA,1
HN,MOOD ALTERED,1
HN,MOUTH HAEMORRHAGE,1
HN,MUSCLE SPASMS,1
HN,PIGMENTATION DISORDER,1
HN,PLATELET COUNT DECREASED,1
HN,PLEURAL EFFUSION,1
HN,PYREXIA,1
HN,VAGINAL HAEMORRHAGE,1
HN,VOMITING,1
HN,WEIGHT DECREASED,1
HK,ACUTE KIDNEY INJURY,2
HK,NEPHROPATHY TOXIC,2
HK,NEUROTOXICITY,2
HK,PNEUMONIA,2
HK,PRODUCT CONTAMINATION,2
HK,PSEUDOMONAS INFECTION,2
HK,PULMONARY TUBERCULOSIS,2
HK,RESPIRATORY DISTRESS,2
HK,RESPIRATORY FAILURE,2
HK,TOXICITY TO VARIOUS AGENTS,2
HK,ABDOMINAL DISCOMFORT,1
HK,ACUTE MYOCARDIAL INFARCTION,1
HK,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
HK,BLOOD CREATININE INCREASED,1
HK,CHEST PAIN,1
HK,FEBRILE NEUTROPENIA,1
HK,GLAUCOMA,1
HK,HYPERGLYCAEMIA,1
HK,LUNG ABSCESS,1
HK,PLATELET COUNT DECREASED,1
HK,PNEUMONIA ESCHERICHIA,1
HK,RENAL FAILURE ACUTE,1
HK,RENAL IMPAIRMENT,1
HK,SEPSIS,1
HK,SHOCK,1
HK,TROPONIN INCREASED,1
HU,FEBRILE NEUTROPENIA,4
HU,ANAEMIA,2
HU,DEEP VEIN THROMBOSIS,2
HU,LUNG ADENOCARCINOMA,2
HU,NEUTROPENIA,2
HU,PNEUMONIA,2
HU,PRODUCT USE IN UNAPPROVED INDICATION,2
HU,PYREXIA,2
HU,ABDOMINAL PAIN,1
HU,ACUTE KIDNEY INJURY,1
HU,ACUTE MYOCARDIAL INFARCTION,1
HU,ACUTE RESPIRATORY DISTRESS SYNDROME,1
HU,BONE MARROW FAILURE,1
HU,BRONCHIAL CARCINOMA,1
HU,CIRCULATORY COLLAPSE,1
HU,CLOSTRIDIAL INFECTION,1
HU,COLON CANCER,1
HU,CONSTIPATION,1
HU,DEVICE RELATED INFECTION,1
HU,DYSLIPIDAEMIA,1
HU,ENCEPHALOMALACIA,1
HU,FATIGUE,1
HU,GASTRIC PERFORATION,1
HU,GASTROENTERITIS,1
HU,HAEMORRHAGE INTRACRANIAL,1
HU,HYDROTHORAX,1
HU,HYPERSENSITIVITY,1
HU,HYPERVOLAEMIA,1
HU,INFLUENZA,1
HU,LUNG INFILTRATION,1
HU,LYMPHOMA,1
HU,MYCOSIS FUNGOIDES RECURRENT,1
HU,NEUTROPENIC INFECTION,1
HU,PLASMA CELL MYELOMA,1
HU,PLEURAL EFFUSION,1
HU,PRODUCT USE ISSUE,1
HU,PULMONARY EMBOLISM,1
HU,PULMONARY OEDEMA,1
HU,RASH,1
HU,RENAL CANCER,1
HU,RESTRICTIVE PULMONARY DISEASE,1
HU,SKIN ULCER,1
HU,SYNCOPE,1
HU,THROMBOCYTOPENIA,1
HU,URINARY RETENTION,1
HU,URINARY TRACT INFECTION,1
IN,FEBRILE NEUTROPENIA,15
IN,KIDNEY TRANSPLANT REJECTION,13
IN,SEPSIS,12
IN,DEATH,11
IN,SEPTIC SHOCK,9
IN,CARDIOTOXICITY,7
IN,PRODUCT USE IN UNAPPROVED INDICATION,7
IN,ASTHENIA,5
IN,DRUG INEFFECTIVE,5
IN,ELECTROCARDIOGRAM ST-T CHANGE,5
IN,PNEUMONIA,5
IN,THERAPEUTIC RESPONSE DECREASED,5
IN,DIARRHOEA,4
IN,LOW CARDIAC OUTPUT SYNDROME,4
IN,NEUROPATHY PERIPHERAL,4
IN,RHABDOMYOLYSIS,4
IN,ACUTE RESPIRATORY DISTRESS SYNDROME,3
IN,ANAEMIA,3
IN,LEUKOPENIA,3
IN,MUCOSAL INFLAMMATION,3
IN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
IN,MYOGLOBINURIA,3
IN,PNEUMONITIS,3
IN,PRODUCT USE ISSUE,3
IN,PYREXIA,3
IN,SEIZURE,3
IN,ASTHMA,2
IN,BLINDNESS,2
IN,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
IN,CONGESTIVE CARDIOMYOPATHY,2
IN,CYTOMEGALOVIRUS VIRAEMIA,2
IN,DECREASED APPETITE,2
IN,DEEP VEIN THROMBOSIS,2
IN,DIFFUSE LARGE B-CELL LYMPHOMA,2
IN,DYSPNOEA,2
IN,EXPOSURE DURING PREGNANCY,2
IN,FOETAL DISTRESS SYNDROME,2
IN,HERPES ZOSTER,2
IN,HOSPITALISATION,2
IN,HYPOXIA,2
IN,INFUSION RELATED REACTION,2
IN,INTESTINAL PERFORATION,2
IN,LIVER ABSCESS,2
IN,MUCORMYCOSIS,2
IN,NECROTISING HERPETIC RETINOPATHY,2
IN,NEUTROPENIA,2
IN,PANCREATITIS ACUTE,2
IN,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
IN,PREMATURE BABY,2
IN,PULMONARY TUBERCULOSIS,2
IN,RENAL FAILURE ACUTE,2
IN,RENAL LIPOMATOSIS,2
IN,TRANSPLANT REJECTION,2
IN,TUBERCULOSIS,2
IN,URINARY TRACT INFECTION,2
IN,VOMITING,2
IN,ABDOMINAL DISTENSION,1
IN,ABDOMINAL MASS,1
IN,ABDOMINAL PAIN,1
IN,ABDOMINAL PAIN UPPER,1
IN,ACUTE KIDNEY INJURY,1
IN,ACUTE MYELOID LEUKAEMIA,1
IN,ANXIETY,1
IN,BLASTOMYCOSIS,1
IN,BLOOD CREATININE ABNORMAL,1
IN,BLOOD CREATININE INCREASED,1
IN,BLOOD IRON DECREASED,1
IN,CARDIO-RESPIRATORY ARREST,1
IN,CAVERNOUS SINUS THROMBOSIS,1
IN,CELLULITIS,1
IN,CELLULITIS ORBITAL,1
IN,CHRONIC KIDNEY DISEASE,1
IN,CONVULSION,1
IN,CYTOMEGALOVIRUS INFECTION,1
IN,CYTOTOXIC OEDEMA,1
IN,DEMYELINATION,1
IN,DIABETES MELLITUS INADEQUATE CONTROL,1
IN,DIABETIC NEPHROPATHY,1
IN,DISEASE COMPLICATION,1
IN,DISSEMINATED TUBERCULOSIS,1
IN,DYSPHONIA,1
IN,EJECTION FRACTION DECREASED,1
IN,EXTRAPULMONARY TUBERCULOSIS,1
IN,FOETAL EXPOSURE DURING PREGNANCY,1
IN,FUNGAL INFECTION,1
IN,GENERAL PHYSICAL HEALTH DETERIORATION,1
IN,GRAFT COMPLICATION,1
IN,GYNAECOMASTIA,1
IN,HAEMATURIA,1
IN,HAEMOGLOBIN DECREASED,1
IN,HAEMORRHAGE INTRACRANIAL,1
IN,HEART RATE DECREASED,1
IN,HEMIPARESIS,1
IN,HYPERGLYCAEMIA,1
IN,HYPERSENSITIVITY,1
IN,HYPERTENSIVE HEART DISEASE,1
IN,HYPONATRAEMIA,1
IN,ILEUS,1
IN,INFECTION,1
IN,INFECTIVE ANEURYSM,1
IN,INFUSION SITE EXTRAVASATION,1
IN,INTERCAPILLARY GLOMERULOSCLEROSIS,1
IN,INTERSTITIAL LUNG DISEASE,1
IN,INTERVERTEBRAL DISC DEGENERATION,1
IN,INTRACRANIAL PRESSURE INCREASED,1
IN,JOINT STIFFNESS,1
IN,KIDNEY FIBROSIS,1
IN,KLEBSIELLA INFECTION,1
IN,LEFT VENTRICULAR DYSFUNCTION,1
IN,LIVE BIRTH,1
IN,LOSS OF CONSCIOUSNESS,1
IN,LOW BIRTH WEIGHT BABY,1
IN,LOWER RESPIRATORY TRACT CONGESTION,1
IN,LOWER RESPIRATORY TRACT INFECTION,1
IN,MALAISE,1
IN,MALIGNANT NEOPLASM PROGRESSION,1
IN,MENINGITIS CRYPTOCOCCAL,1
IN,MOUTH ULCERATION,1
IN,MULTI-ORGAN FAILURE,1
IN,MYOPATHY,1
IN,NASOPHARYNGITIS,1
IN,OEDEMA PERIPHERAL,1
IN,OSTEONECROSIS,1
IN,PAIN,1
IN,PALMAR ERYTHEMA,1
IN,PANCREATITIS NECROTISING,1
IN,PANCYTOPENIA,1
IN,PAROTITIS,1
IN,PHARYNGITIS,1
IN,PLASMA CELL MYELOMA,1
IN,PLEURAL EFFUSION,1
IN,PNEUMONIA ASPIRATION,1
IN,PNEUMONIA KLEBSIELLA,1
IN,PREMATURE RUPTURE OF MEMBRANES,1
IN,PRODUCT QUALITY ISSUE,1
IN,PULMONARY EMBOLISM,1
IN,PULMONARY OEDEMA,1
IN,PYELONEPHRITIS,1
IN,RENAL ARTERY ARTERIOSCLEROSIS,1
IN,RENAL TUBULAR ATROPHY,1
IN,RENAL TUBULAR DISORDER,1
IN,RESPIRATORY DISTRESS,1
IN,RESPIRATORY TRACT INFECTION,1
IN,SKIN TOXICITY,1
IN,SOMNOLENCE,1
IN,SPINAL PAIN,1
IN,STOMATITIS,1
IN,STRESS URINARY INCONTINENCE,1
IN,SUBARACHNOID HAEMORRHAGE,1
IN,SYSTEMIC CANDIDA,1
IN,THROMBOCYTOPENIA,1
IN,THROMBOTIC MICROANGIOPATHY,1
IN,TOXICITY TO VARIOUS AGENTS,1
IN,TRANSPLANT DYSFUNCTION,1
IN,VIRAL INFECTION,1
IN,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
IN,VITAMIN B12 DECREASED,1
IN,WALDENSTROM^S MACROGLOBULINAEMIA,1
ID,DEATH,59
ID,GENERAL PHYSICAL HEALTH DETERIORATION,4
ID,PNEUMOTHORAX SPONTANEOUS,4
ID,DECREASED APPETITE,3
ID,BRONCHOPNEUMONIA,2
ID,DISEASE PROGRESSION,2
ID,DYSPNOEA,2
ID,LOSS OF CONSCIOUSNESS,2
ID,MELAENA,2
ID,THROMBOCYTOPENIA,2
ID,ACUTE HEPATIC FAILURE,1
ID,ANAEMIA,1
ID,DELIRIUM,1
ID,DIARRHOEA,1
ID,DISEASE RECURRENCE,1
ID,DIZZINESS,1
ID,DRUG INEFFECTIVE,1
ID,FEBRILE NEUTROPENIA,1
ID,GASTRITIS,1
ID,GASTRITIS EROSIVE,1
ID,GASTROINTESTINAL PERFORATION,1
ID,HAEMATEMESIS,1
ID,HEPATIC ENCEPHALOPATHY,1
ID,HICCUPS,1
ID,HYDRONEPHROSIS,1
ID,HYPOALBUMINAEMIA,1
ID,HYPOKALAEMIA,1
ID,HYPONATRAEMIA,1
ID,LUNG DISORDER,1
ID,METASTASES TO LUNG,1
ID,NEOPLASM,1
ID,NEUTROPENIA,1
ID,NON-HODGKIN^S LYMPHOMA,1
ID,PERFORMANCE STATUS DECREASED,1
ID,PERIPHERAL VENOUS DISEASE,1
ID,PHLEBITIS,1
ID,PNEUMONIA,1
ID,PULMONARY OEDEMA,1
ID,PYREXIA,1
ID,SEPTIC SHOCK,1
ID,TACHYCARDIA,1
ID,TACHYPNOEA,1
ID,TREATMENT NONCOMPLIANCE,1
ID,VISUAL IMPAIRMENT,1
ID,WHITE BLOOD CELL COUNT DECREASED,1
IR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,5
IR,ANAEMIA,4
IR,ASPERGILLUS INFECTION,3
IR,DEATH,3
IR,FOETAL EXPOSURE DURING PREGNANCY,3
IR,HAEMOLYSIS NEONATAL,3
IR,LOW BIRTH WEIGHT BABY,3
IR,PREMATURE BABY,3
IR,DRUG INEFFECTIVE,2
IR,EOSINOPHILIA,2
IR,INTESTINAL PERFORATION,2
IR,JUGULAR VEIN THROMBOSIS,2
IR,PANCYTOPENIA,2
IR,PYREXIA,2
IR,SEPSIS,2
IR,SEPTIC SHOCK,2
IR,TOXICITY TO VARIOUS AGENTS,2
IR,ABASIA,1
IR,ABDOMINAL DISTENSION,1
IR,ABDOMINAL PAIN,1
IR,ACUTE LYMPHOCYTIC LEUKAEMIA,1
IR,ALANINE AMINOTRANSFERASE ABNORMAL,1
IR,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
IR,BACK PAIN,1
IR,BLOOD CREATININE INCREASED,1
IR,CHOLESTASIS,1
IR,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
IR,CONSTIPATION,1
IR,CONVULSION,1
IR,CUSHINGOID,1
IR,DERMATITIS BULLOUS,1
IR,EXPOSURE DURING PREGNANCY,1
IR,FOETAL GROWTH RESTRICTION,1
IR,FUNGAL INFECTION,1
IR,GLOMERULONEPHRITIS PROLIFERATIVE,1
IR,HEMIANOPIA HOMONYMOUS,1
IR,HEPATIC ENZYME ABNORMAL,1
IR,HEPATOSPLENOMEGALY,1
IR,HODGKIN^S DISEASE RECURRENT,1
IR,HYPERTRICHOSIS,1
IR,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
IR,INFECTION,1
IR,INTERVERTEBRAL DISCITIS,1
IR,JAUNDICE,1
IR,MARROW HYPERPLASIA,1
IR,METASTASES TO BREAST,1
IR,MICROCYTIC ANAEMIA,1
IR,NECK PAIN,1
IR,NEUTROPENIA,1
IR,NO THERAPEUTIC RESPONSE,1
IR,OSTEOMYELITIS FUNGAL,1
IR,PAIN IN JAW,1
IR,PALLOR,1
IR,PANCREATITIS,1
IR,PARAESTHESIA,1
IR,PARAPLEGIA,1
IR,PERITONITIS,1
IR,PHOTOSENSITIVITY REACTION,1
IR,PORPHYRIA NON-ACUTE,1
IR,PREMATURE DELIVERY,1
IR,PRODUCT USE IN UNAPPROVED INDICATION,1
IR,PRODUCT USE ISSUE,1
IR,PROTEINURIA,1
IR,SCAB,1
IR,SKIN EROSION,1
IR,SKIN LESION,1
IR,SMALL INTESTINAL PERFORATION,1
IR,SPINAL COMPRESSION FRACTURE,1
IR,SPLENOMEGALY,1
IR,T-CELL TYPE ACUTE LEUKAEMIA,1
IR,THROMBOCYTOPENIA,1
IR,TRANSPLANT REJECTION,1
IQ,CONTUSION,1
IQ,DRUG INEFFECTIVE,1
IQ,FATIGUE,1
IQ,INFECTION,1
IQ,PANCYTOPENIA,1
IQ,PYREXIA,1
IQ,SKIN LESION,1
IQ,THROMBOCYTOPENIA,1
IE,DIARRHOEA,4
IE,DRUG INEFFECTIVE,4
IE,DEHYDRATION,3
IE,CATARACT CONGENITAL,2
IE,CONDITION AGGRAVATED,2
IE,COUGH,2
IE,FATIGUE,2
IE,HAEMATURIA,2
IE,MALAISE,2
IE,PLATELET COUNT DECREASED,2
IE,RASH,2
IE,RESPIRATORY FAILURE,2
IE,RHEUMATOID ARTHRITIS,2
IE,ABDOMINAL PAIN,1
IE,ACUTE KIDNEY INJURY,1
IE,ANTINUCLEAR ANTIBODY POSITIVE,1
IE,AORTIC VALVE REPAIR,1
IE,APPENDICEAL ABSCESS,1
IE,APPENDICITIS PERFORATED,1
IE,ASTHENIA,1
IE,BLADDER TRANSITIONAL CELL CARCINOMA,1
IE,BLOOD GLUCOSE DECREASED,1
IE,BLOOD POTASSIUM INCREASED,1
IE,BLOOD SODIUM INCREASED,1
IE,BONE MARROW FAILURE,1
IE,CELLULITIS,1
IE,CHILLS,1
IE,COLITIS,1
IE,CONTUSION,1
IE,DECREASED APPETITE,1
IE,DEVICE OCCLUSION,1
IE,DOUBLE STRANDED DNA ANTIBODY POSITIVE,1
IE,DRUG EFFECT DECREASED,1
IE,DYSPHAGIA,1
IE,EXPOSURE DURING PREGNANCY,1
IE,FEBRILE NEUTROPENIA,1
IE,FOETAL EXPOSURE DURING PREGNANCY,1
IE,FORMICATION,1
IE,GENERAL PHYSICAL HEALTH DETERIORATION,1
IE,GENERALISED TONIC-CLONIC SEIZURE,1
IE,GROIN INFECTION,1
IE,HAEMOGLOBIN ABNORMAL,1
IE,HAEMOGLOBIN DECREASED,1
IE,HAEMORRHAGE,1
IE,HEPATIC FAILURE,1
IE,HYPOAESTHESIA,1
IE,HYPOGLYCAEMIA,1
IE,HYPONATRAEMIA,1
IE,HYPOTENSION,1
IE,HYPOTHERMIA,1
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IE,INFLAMMATORY BOWEL DISEASE,1
IE,INFLUENZA,1
IE,JOINT STIFFNESS,1
IE,LOWER RESPIRATORY TRACT INFECTION,1
IE,LYMPHADENOPATHY,1
IE,LYMPHOMA,1
IE,METASTASES TO SPINE,1
IE,METHAEMOGLOBINAEMIA,1
IE,MUCOSAL INFLAMMATION,1
IE,MYASTHENIA GRAVIS CRISIS,1
IE,NAUSEA,1
IE,NERVE ROOT COMPRESSION,1
IE,NEUROPATHY PERIPHERAL,1
IE,NEUTROPENIA,1
IE,NEUTROPENIC SEPSIS,1
IE,NEUTROPHIL COUNT INCREASED,1
IE,NO ADVERSE EVENT,1
IE,OEDEMA PERIPHERAL,1
IE,OROPHARYNGEAL PAIN,1
IE,PAIN IN EXTREMITY,1
IE,PANNICULITIS,1
IE,PATENT DUCTUS ARTERIOSUS,1
IE,PELVIC ABSCESS,1
IE,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
IE,POST PROCEDURAL CONTUSION,1
IE,PRURITUS,1
IE,PULMONARY EMBOLISM,1
IE,PULMONARY FIBROSIS,1
IE,PURPURA,1
IE,PYREXIA,1
IE,SCRATCH,1
IE,SEPSIS,1
IE,SKIN PLAQUE,1
IE,SKIN ULCER,1
IE,SOMNOLENCE,1
IE,SPINAL CORD COMPRESSION,1
IE,STEVENS-JOHNSON SYNDROME,1
IE,THROMBOSIS IN DEVICE,1
IE,TOXIC EPIDERMAL NECROLYSIS,1
IE,TYPE IV HYPERSENSITIVITY REACTION,1
IE,UPPER RESPIRATORY TRACT INFECTION,1
IE,UROSEPSIS,1
IE,VOMITING,1
IE,WEIGHT DECREASED,1
IE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
IL,PYREXIA,29
IL,DYSPNOEA,25
IL,DIARRHOEA,23
IL,PNEUMONIA,20
IL,TOXICITY TO VARIOUS AGENTS,20
IL,ABDOMINAL PAIN,18
IL,ASTHENIA,18
IL,RENAL FAILURE,18
IL,PNEUMONITIS,17
IL,NEUTROPENIA,16
IL,PAIN,16
IL,PANCYTOPENIA,16
IL,DRUG INEFFECTIVE,14
IL,SEPSIS,14
IL,VOMITING,14
IL,ARTHRALGIA,12
IL,NAUSEA,12
IL,DEATH,11
IL,DIZZINESS,11
IL,KLEBSIELLA INFECTION,11
IL,PNEUMOCYSTIS JIROVECII PNEUMONIA,11
IL,FATIGUE,10
IL,HEADACHE,10
IL,RASH,10
IL,LEUKOPENIA,9
IL,PLASMACYTOMA,9
IL,PULMONARY EMBOLISM,9
IL,WEIGHT DECREASED,9
IL,BACK PAIN,8
IL,CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION,8
IL,DEEP VEIN THROMBOSIS,8
IL,MYOPATHY,8
IL,THROMBOCYTOPENIA,8
IL,CHEST PAIN,7
IL,DERMATOPHYTOSIS,7
IL,MUCOSAL INFLAMMATION,7
IL,MYALGIA,7
IL,PAIN IN EXTREMITY,7
IL,URINARY TRACT INFECTION,7
IL,ANAEMIA,6
IL,CONDITION AGGRAVATED,6
IL,CROHN^S DISEASE,6
IL,DECREASED APPETITE,6
IL,FALL,6
IL,GAIT DISTURBANCE,6
IL,GENERAL PHYSICAL HEALTH DETERIORATION,6
IL,HEPATOTOXICITY,6
IL,HYPOGAMMAGLOBULINAEMIA,6
IL,INTERSTITIAL LUNG DISEASE,6
IL,LUNG INFILTRATION,6
IL,MUSCULOSKELETAL PAIN,6
IL,ONYCHOMYCOSIS,6
IL,PERIPHERAL SWELLING,6
IL,ASTHMA,5
IL,ATRIAL FIBRILLATION,5
IL,BLOOD PRESSURE INCREASED,5
IL,BREAST CANCER,5
IL,COUGH,5
IL,DIABETES MELLITUS,5
IL,DISEASE PROGRESSION,5
IL,FEBRILE NEUTROPENIA,5
IL,FEELING ABNORMAL,5
IL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
IL,INFECTION,5
IL,OSTEOPOROTIC FRACTURE,5
IL,PLEURAL EFFUSION,5
IL,PRODUCT USE ISSUE,5
IL,RESPIRATORY FAILURE,5
IL,RESPIRATORY TRACT INFECTION,5
IL,ABDOMINAL DISTENSION,4
IL,ARTHRITIS,4
IL,BACTERAEMIA,4
IL,CONSTIPATION,4
IL,DECREASED ACTIVITY,4
IL,HAEMOGLOBIN DECREASED,4
IL,HYPERSENSITIVITY,4
IL,HYPERTENSION,4
IL,HYPONATRAEMIA,4
IL,INFLUENZA,4
IL,INTESTINAL OBSTRUCTION,4
IL,MALAISE,4
IL,MUSCULAR WEAKNESS,4
IL,NEPHROPATHY TOXIC,4
IL,OEDEMA,4
IL,OEDEMA PERIPHERAL,4
IL,OXYGEN SATURATION DECREASED,4
IL,PANCREATITIS,4
IL,PLASMA CELL MYELOMA,4
IL,RADIATION MUCOSITIS,4
IL,RENAL IMPAIRMENT,4
IL,SWELLING FACE,4
IL,WEIGHT INCREASED,4
IL,ACUTE KIDNEY INJURY,3
IL,BACTERIAL INFECTION,3
IL,BLOOD ALBUMIN DECREASED,3
IL,BLOOD CREATININE INCREASED,3
IL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
IL,COMA,3
IL,DEPRESSION,3
IL,DRUG EFFECT INCOMPLETE,3
IL,DYSPHAGIA,3
IL,DYSURIA,3
IL,ERYTHEMA,3
IL,GLOSSODYNIA,3
IL,HAEMOPTYSIS,3
IL,HEART RATE INCREASED,3
IL,HEPATIC ENZYME INCREASED,3
IL,HUMERUS FRACTURE,3
IL,HYPOALBUMINAEMIA,3
IL,HYPOTENSION,3
IL,INFLAMMATORY MARKER INCREASED,3
IL,INJECTION SITE PAIN,3
IL,INTERNATIONAL NORMALISED RATIO INCREASED,3
IL,JOINT SWELLING,3
IL,JUVENILE IDIOPATHIC ARTHRITIS,3
IL,LOSS OF CONSCIOUSNESS,3
IL,MALIGNANT MELANOMA,3
IL,MULTI-ORGAN FAILURE,3
IL,MUSCULOSKELETAL CHEST PAIN,3
IL,ORAL PAIN,3
IL,PALLOR,3
IL,PERICARDIAL EFFUSION,3
IL,PRODUCT USE IN UNAPPROVED INDICATION,3
IL,PROTEINURIA,3
IL,PULMONARY HYPERTENSION,3
IL,RESPIRATORY DISORDER,3
IL,STOMATITIS,3
IL,SYNCOPE,3
IL,VISION BLURRED,3
IL,WHITE BLOOD CELL COUNT DECREASED,3
IL,ACQUIRED HAEMOPHILIA,2
IL,ACUTE MYELOID LEUKAEMIA,2
IL,ALANINE AMINOTRANSFERASE INCREASED,2
IL,ANGIOEDEMA,2
IL,ARTERIAL THROMBOSIS,2
IL,ASPARTATE AMINOTRANSFERASE INCREASED,2
IL,AUTOIMMUNE HEPATITIS,2
IL,BALANCE DISORDER,2
IL,BK VIRUS INFECTION,2
IL,BLOOD COUNT ABNORMAL,2
IL,BLOOD LACTATE DEHYDROGENASE INCREASED,2
IL,BLOOD PRESSURE ABNORMAL,2
IL,BLOOD PRESSURE DECREASED,2
IL,BRONCHITIS,2
IL,BRONCHOSPASM,2
IL,BURNING SENSATION,2
IL,BURSITIS,2
IL,C-REACTIVE PROTEIN INCREASED,2
IL,CARDIAC ARREST,2
IL,CARDIAC FAILURE,2
IL,CARDIAC FAILURE CONGESTIVE,2
IL,CATARACT,2
IL,CEREBROVASCULAR ACCIDENT,2
IL,CHOKING SENSATION,2
IL,CLOSTRIDIAL INFECTION,2
IL,COGNITIVE DISORDER,2
IL,COLITIS ULCERATIVE,2
IL,CUSHING^S SYNDROME,2
IL,CYTOMEGALOVIRUS INFECTION,2
IL,DECUBITUS ULCER,2
IL,DIABETIC KETOACIDOSIS,2
IL,DIARRHOEA HAEMORRHAGIC,2
IL,DRUG EFFECT DECREASED,2
IL,DRUG LEVEL DECREASED,2
IL,DRUG LEVEL INCREASED,2
IL,DRY SKIN,2
IL,ENCEPHALOPATHY,2
IL,FREQUENT BOWEL MOVEMENTS,2
IL,HAEMORRHAGE,2
IL,HAEMORRHAGE INTRACRANIAL,2
IL,HEAD DISCOMFORT,2
IL,HYPERSENSITIVITY VASCULITIS,2
IL,HYPOKALAEMIA,2
IL,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
IL,INFLAMMATION,2
IL,INSOMNIA,2
IL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
IL,LEUKOCYTOSIS,2
IL,LUNG DISORDER,2
IL,LYMPHOPENIA,2
IL,MAJOR DEPRESSION,2
IL,MENTAL DISORDER,2
IL,MUCORMYCOSIS,2
IL,MUSCULOSKELETAL STIFFNESS,2
IL,NEUROPATHY PERIPHERAL,2
IL,OROPHARYNGEAL PAIN,2
IL,OSTEONECROSIS OF JAW,2
IL,PALPITATIONS,2
IL,PARAESTHESIA,2
IL,PATHOLOGICAL FRACTURE,2
IL,PLATELET COUNT ABNORMAL,2
IL,PNEUMONIA ASPIRATION,2
IL,POST PROCEDURAL INFECTION,2
IL,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,2
IL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
IL,PROCTALGIA,2
IL,PRODUCTIVE COUGH,2
IL,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
IL,PRURITUS,2
IL,PULMONARY CONGESTION,2
IL,PULMONARY OEDEMA,2
IL,RASH PUSTULAR,2
IL,RESPIRATORY ARREST,2
IL,SEIZURE,2
IL,SENSORY DISTURBANCE,2
IL,SEPTIC SHOCK,2
IL,SKIN HAEMORRHAGE,2
IL,SKIN MASS,2
IL,SOMNOLENCE,2
IL,THERAPEUTIC RESPONSE DECREASED,2
IL,TINNITUS,2
IL,TRANSPLANT REJECTION,2
IL,TREATMENT FAILURE,2
IL,URTICARIA,2
IL,VARICELLA,2
IL,VERTIGO,2
IL,ABASIA,1
IL,ABDOMINAL DISCOMFORT,1
IL,ABDOMINAL PAIN UPPER,1
IL,ABDOMINAL TENDERNESS,1
IL,ABSCESS INTESTINAL,1
IL,ACIDOSIS,1
IL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
IL,ACUTE MYOCARDIAL INFARCTION,1
IL,ACUTE RESPIRATORY FAILURE,1
IL,ADENOCARCINOMA GASTRIC,1
IL,ADENOCARCINOMA OF COLON,1
IL,AGEUSIA,1
IL,AMNESIA,1
IL,AMYLASE INCREASED,1
IL,ANAL FISSURE,1
IL,ANAL INFLAMMATION,1
IL,ANAPHYLACTIC SHOCK,1
IL,ANGINA UNSTABLE,1
IL,ANKYLOSING SPONDYLITIS,1
IL,APHASIA,1
IL,ASCITES,1
IL,ASPERGILLUS INFECTION,1
IL,ATELECTASIS,1
IL,ATYPICAL PNEUMONIA,1
IL,AUTOIMMUNE DISORDER,1
IL,AUTOIMMUNE PANCREATITIS,1
IL,AUTOINFLAMMATORY DISEASE,1
IL,B-CELL LYMPHOMA,1
IL,BACK INJURY,1
IL,BEDRIDDEN,1
IL,BENIGN INTRACRANIAL HYPERTENSION,1
IL,BILIARY CIRRHOSIS PRIMARY,1
IL,BLADDER PAPILLOMA,1
IL,BLINDNESS,1
IL,BLINDNESS UNILATERAL,1
IL,BLISTER,1
IL,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IL,BLOOD CALCIUM DECREASED,1
IL,BLOOD CORTISOL DECREASED,1
IL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IL,BLOOD CREATININE DECREASED,1
IL,BLOOD GLUCOSE DECREASED,1
IL,BLOOD GLUCOSE FLUCTUATION,1
IL,BLOOD GLUCOSE INCREASED,1
IL,BLOOD LACTATE DEHYDROGENASE DECREASED,1
IL,BLOOD MAGNESIUM DECREASED,1
IL,BLOOD POTASSIUM DECREASED,1
IL,BLOOD SODIUM DECREASED,1
IL,BLOOD TEST ABNORMAL,1
IL,BLOOD THYROID STIMULATING HORMONE,1
IL,BLOOD THYROID STIMULATING HORMONE INCREASED,1
IL,BLOOD URINE PRESENT,1
IL,BODY TINEA,1
IL,BONE EROSION,1
IL,BONE PAIN,1
IL,BRAIN OEDEMA,1
IL,C-REACTIVE PROTEIN ABNORMAL,1
IL,CACHEXIA,1
IL,CALCIUM DEFICIENCY,1
IL,CAMPYLOBACTER TEST POSITIVE,1
IL,CARDIAC DISORDER,1
IL,CATHETER SITE PAIN,1
IL,CEREBRAL ATROPHY,1
IL,CEREBRAL ISCHAEMIA,1
IL,CERVIX CARCINOMA,1
IL,CHILLS,1
IL,CHOLANGITIS,1
IL,CHROMATURIA,1
IL,CHRONIC KIDNEY DISEASE,1
IL,CHRONIC SPONTANEOUS URTICARIA,1
IL,CITROBACTER TEST POSITIVE,1
IL,COAGULOPATHY,1
IL,COLITIS,1
IL,COMPRESSION FRACTURE,1
IL,CONCOMITANT DISEASE AGGRAVATED,1
IL,CONFUSIONAL STATE,1
IL,CONTUSION,1
IL,CONVULSION,1
IL,COOMBS POSITIVE HAEMOLYTIC ANAEMIA,1
IL,CREPITATIONS,1
IL,CYSTITIS KLEBSIELLA,1
IL,DEHYDRATION,1
IL,DEMYELINATING POLYNEUROPATHY,1
IL,DERMATITIS CONTACT,1
IL,DEVELOPMENTAL DELAY,1
IL,DISCOMFORT,1
IL,DISSEMINATED INTRAVASCULAR COAGULATION,1
IL,DRUG HYPERSENSITIVITY,1
IL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
IL,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
IL,DRUG SPECIFIC ANTIBODY,1
IL,DRY MOUTH,1
IL,DYSARTHRIA,1
IL,DYSPEPSIA,1
IL,DYSPHEMIA,1
IL,DYSPHONIA,1
IL,DYSPNOEA EXERTIONAL,1
IL,DYSSTASIA,1
IL,EAR HAEMORRHAGE,1
IL,ELECTROCARDIOGRAM QT PROLONGED,1
IL,EMBOLISM,1
IL,ENDOMETRIAL CANCER,1
IL,ENDOMETRIAL CANCER METASTATIC,1
IL,ENDOTRACHEAL INTUBATION,1
IL,EPIDIDYMITIS,1
IL,ESCHERICHIA INFECTION,1
IL,ESCHERICHIA URINARY TRACT INFECTION,1
IL,EXOPHTHALMOS,1
IL,EXPOSURE DURING PREGNANCY,1
IL,EXTRA DOSE ADMINISTERED,1
IL,EYE IRRITATION,1
IL,FACIAL PARALYSIS,1
IL,FAILURE TO THRIVE,1
IL,FEELING COLD,1
IL,FEELING HOT,1
IL,FEMUR FRACTURE,1
IL,FLATULENCE,1
IL,FLUSHING,1
IL,FUNGAL INFECTION,1
IL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
IL,GASTRIC DISORDER,1
IL,GASTRODUODENAL ULCER,1
IL,GASTROENTERITIS,1
IL,GASTROINTESTINAL INFLAMMATION,1
IL,GASTROINTESTINAL OBSTRUCTION,1
IL,GASTROINTESTINAL PAIN,1
IL,GASTROINTESTINAL PERFORATION,1
IL,GASTROINTESTINAL SOUNDS ABNORMAL,1
IL,GENERAL SYMPTOM,1
IL,GINGIVAL BLEEDING,1
IL,GINGIVAL PAIN,1
IL,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
IL,GRAFT VERSUS HOST DISEASE IN SKIN,1
IL,GRANULOCYTOPENIA,1
IL,HAEMATOCHEZIA,1
IL,HAEMATOMA,1
IL,HAEMATOTOXICITY,1
IL,HAEMATURIA,1
IL,HAEMOPHILIA,1
IL,HAEMORRHOIDAL HAEMORRHAGE,1
IL,HAEMORRHOIDS,1
IL,HAIR COLOUR CHANGES,1
IL,HEART RATE IRREGULAR,1
IL,HEPATOCELLULAR CARCINOMA,1
IL,HEPATOSPLENOMEGALY,1
IL,HERPES ZOSTER,1
IL,HIDRADENITIS,1
IL,HOSPITALISATION,1
IL,HYDROCEPHALUS,1
IL,HYDRONEPHROSIS,1
IL,HYPERAMMONAEMIC ENCEPHALOPATHY,1
IL,HYPERCALCAEMIA,1
IL,HYPERHIDROSIS,1
IL,HYPERKALAEMIA,1
IL,HYPERNATRIURIA,1
IL,HYPERSOMNIA,1
IL,HYPOCALCAEMIA,1
IL,HYPOGLYCAEMIA,1
IL,HYPOPNOEA,1
IL,HYPOTHYROIDISM,1
IL,HYSTEROSALPINGO-OOPHORECTOMY,1
IL,IDIOPATHIC PULMONARY FIBROSIS,1
IL,IMMUNODEFICIENCY,1
IL,IMMUNOGLOBULINS DECREASED,1
IL,INAPPROPRIATE AFFECT,1
IL,INFERTILITY,1
IL,INFLAMMATORY BOWEL DISEASE,1
IL,INFUSION RELATED REACTION,1
IL,INJECTION SITE HAEMATOMA,1
IL,INJECTION SITE INJURY,1
IL,INJECTION SITE NODULE,1
IL,INNER EAR INFLAMMATION,1
IL,INTENTIONAL PRODUCT MISUSE,1
IL,INTENTIONAL PRODUCT USE ISSUE,1
IL,ISCHAEMIC STROKE,1
IL,KAPOSI^S SARCOMA,1
IL,LACUNAR INFARCTION,1
IL,LIVER FUNCTION TEST ABNORMAL,1
IL,LIVER FUNCTION TEST INCREASED,1
IL,LOCAL SWELLING,1
IL,LOCALISED OEDEMA,1
IL,LUMBAR VERTEBRAL FRACTURE,1
IL,LUPUS NEPHRITIS,1
IL,LUPUS PNEUMONITIS,1
IL,LYMPHADENOPATHY,1
IL,LYMPHOMA,1
IL,MALIGNANT NEOPLASM PROGRESSION,1
IL,MALNUTRITION,1
IL,MANTLE CELL LYMPHOMA,1
IL,MECHANICAL VENTILATION,1
IL,MELAENA,1
IL,MENINGITIS,1
IL,MENINGITIS HAEMOPHILUS,1
IL,METASTATIC RENAL CELL CARCINOMA,1
IL,MICROCYTIC ANAEMIA,1
IL,MICROSPORUM INFECTION,1
IL,MOBILITY DECREASED,1
IL,MOOD SWINGS,1
IL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
IL,MUSCLE NECROSIS,1
IL,MUSCULOSKELETAL DISCOMFORT,1
IL,MYCOPLASMA INFECTION,1
IL,MYCOSIS FUNGOIDES,1
IL,MYELODYSPLASTIC SYNDROME,1
IL,MYELODYSPLASTIC SYNDROME TRANSFORMATION,1
IL,MYOCARDIAL INFARCTION,1
IL,NASOPHARYNGITIS,1
IL,NECK PAIN,1
IL,NEOPLASM MALIGNANT,1
IL,NEPHROLITHIASIS,1
IL,NEURALGIA,1
IL,NEUTROPHIL COUNT DECREASED,1
IL,NODULAR REGENERATIVE HYPERPLASIA,1
IL,NON-SMALL CELL LUNG CANCER,1
IL,NORMOCYTIC ANAEMIA,1
IL,NYSTAGMUS,1
IL,OBESITY,1
IL,OBSTRUCTION,1
IL,OESOPHAGEAL ACHALASIA,1
IL,OESOPHAGEAL PERFORATION,1
IL,ONYCHALGIA,1
IL,OPTIC NEUROPATHY,1
IL,ORAL CANDIDIASIS,1
IL,ORAL DISCOMFORT,1
IL,ORTHOSTATIC HYPOTENSION,1
IL,OSTEOARTHRITIS,1
IL,OSTEOMYELITIS FUNGAL,1
IL,OTITIS MEDIA ACUTE,1
IL,OVARIAN CYST,1
IL,OVERDOSE,1
IL,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
IL,PANCREATITIS RELAPSING,1
IL,PANNICULITIS,1
IL,PAPILLARY THYROID CANCER,1
IL,PAPILLOEDEMA,1
IL,PARALYSIS,1
IL,PARTIAL SEIZURES,1
IL,PATHOGEN RESISTANCE,1
IL,PELVIC PAIN,1
IL,PERINEAL PAIN,1
IL,PERITONITIS,1
IL,PHARYNGEAL INFLAMMATION,1
IL,PLASMA CELL MYELOMA RECURRENT,1
IL,PLATELET COUNT DECREASED,1
IL,PLEUROPERICARDITIS,1
IL,PNEUMONIA CYTOMEGALOVIRAL,1
IL,PNEUMONIA PNEUMOCOCCAL,1
IL,POLYNEUROPATHY,1
IL,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,1
IL,PORTAL VEIN THROMBOSIS,1
IL,POST HERPETIC NEURALGIA,1
IL,POST PROCEDURAL SEPSIS,1
IL,PRE-ECLAMPSIA,1
IL,PROCTITIS,1
IL,PRODUCT AVAILABILITY ISSUE,1
IL,PRODUCT QUALITY ISSUE,1
IL,PROSTATE CANCER,1
IL,PSORIASIS,1
IL,PSORIATIC ARTHROPATHY,1
IL,PSYCHOTIC DISORDER,1
IL,PULMONARY FUNCTION TEST ABNORMAL,1
IL,PULMONARY MASS,1
IL,PULMONARY TOXICITY,1
IL,PULMONARY VENO-OCCLUSIVE DISEASE,1
IL,PYODERMA GANGRENOSUM,1
IL,RECTAL HAEMORRHAGE,1
IL,RED BLOOD CELL SCHISTOCYTES PRESENT,1
IL,REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS,1
IL,RENAL CYST,1
IL,RENAL INJURY,1
IL,RENAL TUBULAR DISORDER,1
IL,RENAL TUBULAR NECROSIS,1
IL,RESPIRATORY DISTRESS,1
IL,RESTLESSNESS,1
IL,RETINAL SCAR,1
IL,RETINITIS,1
IL,RETINOPATHY,1
IL,RHEUMATOID ARTHRITIS,1
IL,SARCOPENIA,1
IL,SEBORRHOEIC KERATOSIS,1
IL,SERRATIA BACTERAEMIA,1
IL,SHOCK,1
IL,SINUSITIS,1
IL,SKIN ATROPHY,1
IL,SKIN CANCER,1
IL,SKIN DISCOLOURATION,1
IL,SKIN EXFOLIATION,1
IL,SKIN LESION,1
IL,SKIN NECROSIS,1
IL,SKIN ULCER,1
IL,SLEEP DISORDER,1
IL,SMALL CELL LUNG CANCER,1
IL,SMALL INTESTINAL PERFORATION,1
IL,SOFT TISSUE MASS,1
IL,SPINAL DISORDER,1
IL,SPINAL FRACTURE,1
IL,SPINAL PAIN,1
IL,SPLENIC RUPTURE,1
IL,SPLENOMEGALY,1
IL,SPONDYLITIS,1
IL,SQUAMOUS CELL CARCINOMA OF LUNG,1
IL,SQUAMOUS CELL CARCINOMA OF SKIN,1
IL,STAPHYLOCOCCAL INFECTION,1
IL,STAPHYLOCOCCAL SEPSIS,1
IL,STAPHYLOCOCCUS TEST POSITIVE,1
IL,STATUS EPILEPTICUS,1
IL,STENT PLACEMENT,1
IL,STUPOR,1
IL,SUBCUTANEOUS HAEMATOMA,1
IL,SUDDEN DEATH,1
IL,SUICIDAL IDEATION,1
IL,SUICIDE ATTEMPT,1
IL,SUPERIOR VENA CAVA SYNDROME,1
IL,SUPRAVENTRICULAR TACHYCARDIA,1
IL,SWELLING,1
IL,SYSTEMIC CANDIDA,1
IL,TACHYCARDIA,1
IL,TENDON RUPTURE,1
IL,THERAPEUTIC RESPONSE UNEXPECTED,1
IL,THROMBOSIS,1
IL,THYROID FUNCTION TEST ABNORMAL,1
IL,THYROIDECTOMY,1
IL,THYROXINE DECREASED,1
IL,TOOTH DISORDER,1
IL,TOOTH INFECTION,1
IL,TRANSAMINASES INCREASED,1
IL,TRANSIENT ISCHAEMIC ATTACK,1
IL,TRANSVERSE SINUS THROMBOSIS,1
IL,TRAUMATIC INTRACRANIAL HAEMORRHAGE,1
IL,TREATMENT NONCOMPLIANCE,1
IL,TUMOUR LYSIS SYNDROME,1
IL,UNDERDOSE,1
IL,UPPER RESPIRATORY TRACT INFECTION,1
IL,URINARY INCONTINENCE,1
IL,URINARY TRACT INFECTION BACTERIAL,1
IL,UTERINE DILATION AND CURETTAGE,1
IL,UTERINE MASS,1
IL,UTERINE RUPTURE,1
IL,UVEITIS,1
IL,VASCULITIS,1
IL,VENTRICULAR ARRHYTHMIA,1
IL,VENTRICULAR TACHYCARDIA,1
IL,VIITH NERVE PARALYSIS,1
IL,VIRAEMIA,1
IL,VIRAL INFECTION,1
IL,VISUAL ACUITY REDUCED,1
IL,WHEEZING,1
IT,NEUTROPENIA,129
IT,DISEASE PROGRESSION,115
IT,PYREXIA,99
IT,ANAEMIA,96
IT,THROMBOCYTOPENIA,94
IT,DRUG INEFFECTIVE,81
IT,PNEUMONIA,73
IT,FEBRILE NEUTROPENIA,71
IT,DEATH,68
IT,DIARRHOEA,54
IT,DYSPNOEA,52
IT,INFECTION,51
IT,MYELODYSPLASTIC SYNDROME,51
IT,SEPSIS,48
IT,LEUKOPENIA,45
IT,SECONDARY IMMUNODEFICIENCY,45
IT,CONDITION AGGRAVATED,44
IT,HEPATOTOXICITY,44
IT,FATIGUE,41
IT,RESPIRATORY FAILURE,41
IT,VOMITING,40
IT,TOXICITY TO VARIOUS AGENTS,39
IT,HYPERTENSION,37
IT,NEUROPATHY PERIPHERAL,37
IT,ASTHENIA,36
IT,PULMONARY EMBOLISM,35
IT,NAUSEA,34
IT,ABDOMINAL PAIN,33
IT,KAPOSI^S SARCOMA,32
IT,HYPOTENSION,31
IT,MUCOSAL INFLAMMATION,31
IT,CYTOMEGALOVIRUS INFECTION,30
IT,OSTEONECROSIS OF JAW,30
IT,ALANINE AMINOTRANSFERASE INCREASED,29
IT,CONSTIPATION,29
IT,DRUG RESISTANCE,29
IT,NEUROTOXICITY,29
IT,CARDIAC FAILURE,28
IT,SEPTIC SHOCK,28
IT,TRANSPLANT REJECTION,28
IT,EXPOSURE DURING PREGNANCY,27
IT,HAEMATOTOXICITY,27
IT,NON-HODGKIN^S LYMPHOMA RECURRENT,27
IT,ATRIAL FIBRILLATION,26
IT,PAIN,26
IT,PREMATURE DELIVERY,26
IT,PRODUCT USE IN UNAPPROVED INDICATION,26
IT,PREMATURE BABY,25
IT,RASH,25
IT,RENAL IMPAIRMENT,25
IT,DEEP VEIN THROMBOSIS,24
IT,MATERNAL EXPOSURE DURING PREGNANCY,24
IT,PANCYTOPENIA,24
IT,RENAL FAILURE,24
IT,CONFUSIONAL STATE,23
IT,ACUTE KIDNEY INJURY,22
IT,BLOOD CREATININE INCREASED,22
IT,MALIGNANT NEOPLASM PROGRESSION,22
IT,NEPHROPATHY TOXIC,22
IT,SECOND PRIMARY MALIGNANCY,22
IT,PRODUCT USE ISSUE,21
IT,FOETAL EXPOSURE DURING PREGNANCY,20
IT,HEPATITIS B REACTIVATION,20
IT,INTERSTITIAL LUNG DISEASE,20
IT,NON-HODGKIN^S LYMPHOMA,20
IT,PLEURAL EFFUSION,20
IT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,20
IT,GASTROINTESTINAL DISORDER,19
IT,HERPES ZOSTER,19
IT,PLATELET COUNT DECREASED,19
IT,VENOOCCLUSIVE LIVER DISEASE,19
IT,COUGH,18
IT,HYPERPYREXIA,18
IT,OSTEONECROSIS,18
IT,ANXIETY,17
IT,ARRHYTHMIA,17
IT,ASPARTATE AMINOTRANSFERASE INCREASED,17
IT,BASAL CELL CARCINOMA,17
IT,INSOMNIA,17
IT,PLASMA CELL MYELOMA,17
IT,PRURITUS,17
IT,CARDIAC DISORDER,16
IT,COMA,16
IT,DISEASE RECURRENCE,16
IT,ERYTHEMA,16
IT,HEADACHE,16
IT,HYPERTRANSAMINASAEMIA,16
IT,MULTI-ORGAN FAILURE,16
IT,PULMONARY OEDEMA,16
IT,WEIGHT DECREASED,16
IT,BRONCHOPULMONARY ASPERGILLOSIS,15
IT,CARDIOTOXICITY,15
IT,TREATMENT FAILURE,15
IT,ACUTE MYELOID LEUKAEMIA,14
IT,EMBOLISM,14
IT,HYPOKALAEMIA,14
IT,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,14
IT,OEDEMA PERIPHERAL,14
IT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,14
IT,ADVERSE EVENT,13
IT,CEREBROVASCULAR ACCIDENT,13
IT,DIZZINESS,13
IT,ESCHERICHIA URINARY TRACT INFECTION,13
IT,HAEMORRHAGE,13
IT,INTESTINAL PERFORATION,13
IT,LOW BIRTH WEIGHT BABY,13
IT,LUPUS NEPHRITIS,13
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,13
IT,PROSTATE CANCER,13
IT,SKIN TOXICITY,13
IT,SYNCOPE,13
IT,URINARY TRACT INFECTION,13
IT,WEIGHT INCREASED,13
IT,ASCITES,12
IT,BRONCHITIS,12
IT,CHILLS,12
IT,DIABETES MELLITUS,12
IT,GENERAL PHYSICAL HEALTH DETERIORATION,12
IT,MYOCARDIAL INFARCTION,12
IT,OSTEOPOROSIS,12
IT,PERIPHERAL SENSORY NEUROPATHY,12
IT,PNEUMONITIS,12
IT,TUMOUR LYSIS SYNDROME,12
IT,VISUAL IMPAIRMENT,12
IT,APLASIA,11
IT,AUTOIMMUNE HAEMOLYTIC ANAEMIA,11
IT,BLISTER,11
IT,BONE MARROW FAILURE,11
IT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,11
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,11
IT,HEPATITIS C RNA INCREASED,11
IT,HYPERGLYCAEMIA,11
IT,HYPOKINESIA,11
IT,MITRAL VALVE DISEASE,11
IT,PALPITATIONS,11
IT,RASH ERYTHEMATOUS,11
IT,THERAPY RESPONDER,11
IT,TREMOR,11
IT,BACK PAIN,10
IT,CEREBRAL HAEMORRHAGE,10
IT,HAEMATURIA,10
IT,HAEMOGLOBIN DECREASED,10
IT,HEPATIC CIRRHOSIS,10
IT,HEPATIC ENZYME INCREASED,10
IT,IMMUNOSUPPRESSION,10
IT,LEFT VENTRICULAR DYSFUNCTION,10
IT,LYMPHOPENIA,10
IT,MUSCULOSKELETAL PAIN,10
IT,MYALGIA,10
IT,SEIZURE,10
IT,ABORTION SPONTANEOUS,9
IT,ACUTE MYOCARDIAL INFARCTION,9
IT,ANGINA PECTORIS,9
IT,BRAIN ABSCESS,9
IT,CEREBRAL TOXOPLASMOSIS,9
IT,DEHYDRATION,9
IT,DIFFUSE LARGE B-CELL LYMPHOMA,9
IT,EPISTAXIS,9
IT,GAIT DISTURBANCE,9
IT,HEPATIC FAILURE,9
IT,HYPERTENSIVE CRISIS,9
IT,MALAISE,9
IT,METASTASIS,9
IT,MYCOBACTERIAL INFECTION,9
IT,PORTAL HYPERTENSION,9
IT,PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT,9
IT,SYSTEMIC CANDIDA,9
IT,TRANSAMINASES INCREASED,9
IT,URTICARIA,9
IT,AGITATION,8
IT,CARDIAC ARREST,8
IT,CARDIOVASCULAR DISORDER,8
IT,DECREASED APPETITE,8
IT,DRUG INTOLERANCE,8
IT,ELECTROLYTE IMBALANCE,8
IT,GROWTH RETARDATION,8
IT,HYPERBILIRUBINAEMIA,8
IT,HYPONATRAEMIA,8
IT,INTRACRANIAL PRESSURE INCREASED,8
IT,KLEBSIELLA INFECTION,8
IT,LACTIC ACIDOSIS,8
IT,LISTERIOSIS,8
IT,LIVER INJURY,8
IT,MORPHOEA,8
IT,MYOCARDIAL ISCHAEMIA,8
IT,NEOPLASM MALIGNANT,8
IT,NEURALGIA,8
IT,NOCARDIOSIS,8
IT,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,8
IT,PULMONARY MASS,8
IT,RESPIRATORY DISORDER,8
IT,SEROTONIN SYNDROME,8
IT,SKIN LESION,8
IT,SOPOR,8
IT,STOMATITIS,8
IT,THERAPEUTIC RESPONSE DECREASED,8
IT,UPPER RESPIRATORY TRACT INFECTION,8
IT,ACINETOBACTER INFECTION,7
IT,AGGRESSION,7
IT,ARTHRALGIA,7
IT,BACTERAEMIA,7
IT,BLOOD BILIRUBIN INCREASED,7
IT,BREAST CANCER,7
IT,DISORIENTATION,7
IT,DRUG-INDUCED LIVER INJURY,7
IT,EJECTION FRACTION DECREASED,7
IT,ERYTHROPENIA,7
IT,FLUID RETENTION,7
IT,GASTROINTESTINAL HAEMORRHAGE,7
IT,HAEMOLYSIS,7
IT,HEMIPARESIS,7
IT,HEPATITIS ACUTE,7
IT,IDIOPATHIC PULMONARY FIBROSIS,7
IT,ILEUS PARALYTIC,7
IT,LOSS OF CONSCIOUSNESS,7
IT,LUNG NEOPLASM MALIGNANT,7
IT,MYOSITIS,7
IT,OEDEMA,7
IT,OLIGURIA,7
IT,OSTEOPENIA,7
IT,PNEUMONIA LEGIONELLA,7
IT,PORPHYRIA NON-ACUTE,7
IT,PRESCRIBED UNDERDOSE,7
IT,SPHINGOMONAS PAUCIMOBILIS INFECTION,7
IT,SPINAL FRACTURE,7
IT,STAPHYLOCOCCAL INFECTION,7
IT,SUDDEN DEATH,7
IT,VENOUS THROMBOSIS,7
IT,ABDOMINAL PAIN UPPER,6
IT,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,6
IT,ACUTE RESPIRATORY FAILURE,6
IT,ASPERGILLUS INFECTION,6
IT,BONE PAIN,6
IT,BREATH SOUNDS ABNORMAL,6
IT,CARDIOGENIC SHOCK,6
IT,CEREBROVASCULAR DISORDER,6
IT,CHOLESTASIS,6
IT,DELIRIUM,6
IT,DRUG LEVEL INCREASED,6
IT,DYSPHAGIA,6
IT,ENCEPHALITIS,6
IT,ENTEROCOCCAL INFECTION,6
IT,EXPOSED BONE IN JAW,6
IT,GASTRITIS EROSIVE,6
IT,GENERALISED OEDEMA,6
IT,HYPERHIDROSIS,6
IT,HYPERSENSITIVITY,6
IT,INFUSION RELATED REACTION,6
IT,LEUKOCYTOSIS,6
IT,LISTERIA ENCEPHALITIS,6
IT,LIVER TENDERNESS,6
IT,LUMBAR VERTEBRAL FRACTURE,6
IT,LUNG INFECTION,6
IT,METABOLIC DISORDER,6
IT,MYOCARDITIS,6
IT,NO THERAPEUTIC RESPONSE,6
IT,ORAL CANDIDIASIS,6
IT,OVARIAN FAILURE,6
IT,PHARYNGITIS,6
IT,PLASMACYTOMA,6
IT,PLEUROPERICARDITIS,6
IT,RECTAL HAEMORRHAGE,6
IT,RENAL FAILURE ACUTE,6
IT,RENAL INJURY,6
IT,RESPIRATORY DISTRESS,6
IT,RHINITIS,6
IT,SALMONELLA SEPSIS,6
IT,SEPSIS SYNDROME,6
IT,SOMNOLENCE,6
IT,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,6
IT,THERAPY NON-RESPONDER,6
IT,THROMBOTIC THROMBOCYTOPENIC PURPURA,6
IT,VIRAL INFECTION,6
IT,ACCIDENTAL OVERDOSE,5
IT,ACUTE CORONARY SYNDROME,5
IT,ACUTE LYMPHOCYTIC LEUKAEMIA,5
IT,ARTERIOVENOUS FISTULA,5
IT,ARTHRITIS,5
IT,BLINDNESS,5
IT,CANDIDA INFECTION,5
IT,CATARRH,5
IT,CEREBRAL ISCHAEMIA,5
IT,CHROMOSOMAL MUTATION,5
IT,CHRONIC GASTRITIS,5
IT,DEPRESSION,5
IT,ENCEPHALITIS AUTOIMMUNE,5
IT,ENCEPHALOPATHY,5
IT,ENTEROCOLITIS,5
IT,EPSTEIN-BARR VIRUS INFECTION,5
IT,GASTROINTESTINAL TOXICITY,5
IT,GLIOBLASTOMA,5
IT,HAEMOLYTIC URAEMIC SYNDROME,5
IT,HEPATITIS B,5
IT,HEPATITIS C,5
IT,HEPATOCELLULAR CARCINOMA,5
IT,HEPATOCELLULAR INJURY,5
IT,HYPOCALCAEMIA,5
IT,IRON DEFICIENCY,5
IT,LYMPHADENOPATHY,5
IT,LYMPHANGITIS,5
IT,MENINGITIS LISTERIA,5
IT,METABOLIC ACIDOSIS,5
IT,MUSCLE SPASMS,5
IT,MUSCULOSKELETAL DISORDER,5
IT,NERVOUS SYSTEM DISORDER,5
IT,NEUROLOGICAL SYMPTOM,5
IT,OBESITY,5
IT,OEDEMA MOUTH,5
IT,OESOPHAGEAL CANDIDIASIS,5
IT,PARAESTHESIA,5
IT,PERICARDIAL EFFUSION,5
IT,PHLEBITIS,5
IT,PNEUMATOSIS INTESTINALIS,5
IT,POLYP,5
IT,PULMONARY TUBERCULOSIS,5
IT,RHEUMATOID ARTHRITIS,5
IT,SELF INJURIOUS BEHAVIOUR,5
IT,SENSORY DISTURBANCE,5
IT,SKIN EXFOLIATION,5
IT,SUBCUTANEOUS EMPHYSEMA,5
IT,TAKAYASU^S ARTERITIS,5
IT,TOXIC EPIDERMAL NECROLYSIS,5
IT,VASCULAR PARKINSONISM,5
IT,VISCERAL LEISHMANIASIS,5
IT,ABNORMAL BEHAVIOUR,4
IT,ACQUIRED APPARENT MINERALOCORTICOID EXCESS,4
IT,ACUTE RESPIRATORY DISTRESS SYNDROME,4
IT,ALOPECIA,4
IT,ANTISYNTHETASE SYNDROME,4
IT,APATHY,4
IT,ATAXIA,4
IT,B-CELL LYMPHOMA RECURRENT,4
IT,BARRETT^S OESOPHAGUS,4
IT,BLOOD LACTATE DEHYDROGENASE INCREASED,4
IT,BODY MASS INDEX INCREASED,4
IT,C-REACTIVE PROTEIN INCREASED,4
IT,CATARACT,4
IT,CHOLECYSTITIS ACUTE,4
IT,CHOLELITHIASIS,4
IT,CHRONIC KIDNEY DISEASE,4
IT,COAGULOPATHY,4
IT,COGNITIVE DISORDER,4
IT,COLON CANCER,4
IT,CONGESTIVE CARDIOMYOPATHY,4
IT,CONTRAINDICATED PRODUCT ADMINISTERED,4
IT,CROHN^S DISEASE,4
IT,CYTOPENIA,4
IT,DEPRESSED MOOD,4
IT,DISSEMINATED INTRAVASCULAR COAGULATION,4
IT,ENDOCARDITIS,4
IT,EYE PAIN,4
IT,GASTRIC DISORDER,4
IT,GRAFT VERSUS HOST DISEASE,4
IT,HEPATITIS,4
IT,HEPATITIS E,4
IT,HEPATOMEGALY,4
IT,HERPES SIMPLEX ENCEPHALITIS,4
IT,HODGKIN^S DISEASE,4
IT,HYDROCEPHALUS,4
IT,HYPOGLYCAEMIA,4
IT,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,4
IT,IMMUNE THROMBOCYTOPENIC PURPURA,4
IT,IMPULSIVE BEHAVIOUR,4
IT,INFLUENZA,4
IT,IRRITABILITY,4
IT,LEISHMANIASIS,4
IT,LIVER TRANSPLANT REJECTION,4
IT,LUNG DISORDER,4
IT,MASTICATION DISORDER,4
IT,MYOPATHY,4
IT,NEOPLASM PROGRESSION,4
IT,NEPHROLITHIASIS,4
IT,NEUROFIBROMATOSIS,4
IT,OESOPHAGEAL ULCER,4
IT,PAIN IN EXTREMITY,4
IT,PANCREATITIS,4
IT,PANCREATITIS ACUTE,4
IT,POLYPECTOMY,4
IT,PRE-ECLAMPSIA,4
IT,PSORIASIS,4
IT,PULMONARY ARTERIAL HYPERTENSION,4
IT,PULMONARY FUNCTION TEST DECREASED,4
IT,RASH MACULO-PAPULAR,4
IT,RED BLOOD CELL COUNT DECREASED,4
IT,RETINAL DETACHMENT,4
IT,TACHYCARDIA,4
IT,THROMBOPHLEBITIS,4
IT,TUBERCULOSIS,4
IT,VASCULITIS,4
IT,VERTIGO,4
IT,VISUAL ACUITY REDUCED,4
IT,VULVOVAGINITIS TRICHOMONAL,4
IT,ACUTE GRAFT VERSUS HOST DISEASE,3
IT,ACUTE MOTOR-SENSORY AXONAL NEUROPATHY,3
IT,ADVERSE DRUG REACTION,3
IT,ALTERED STATE OF CONSCIOUSNESS,3
IT,AMYLASE INCREASED,3
IT,ANAPHYLACTIC REACTION,3
IT,ANGIOPATHY,3
IT,ANURIA,3
IT,ARTERIAL THROMBOSIS,3
IT,ARTERIAL WALL HYPERTROPHY,3
IT,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,3
IT,B-LYMPHOCYTE COUNT DECREASED,3
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,3
IT,BRADYCARDIA,3
IT,CAESAREAN SECTION,3
IT,CAROTID ARTERY STENOSIS,3
IT,CELLULITIS,3
IT,CENTRAL NERVOUS SYSTEM LESION,3
IT,CHEST PAIN,3
IT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
IT,COLITIS,3
IT,CONVULSION,3
IT,CYTOMEGALOVIRUS TEST POSITIVE,3
IT,DEMYELINATING POLYNEUROPATHY,3
IT,DIARRHOEA HAEMORRHAGIC,3
IT,DIVERTICULAR PERFORATION,3
IT,DIVERTICULITIS,3
IT,DRUG ABUSE,3
IT,DRUG EFFECT INCOMPLETE,3
IT,DRUG PRESCRIBING ERROR,3
IT,DUODENAL ULCER,3
IT,DYSARTHRIA,3
IT,DYSKINESIA,3
IT,ENTERITIS,3
IT,FALL,3
IT,FRACTURE,3
IT,GASTRIC CANCER,3
IT,GASTRIC ULCER HAEMORRHAGE,3
IT,GASTRITIS,3
IT,GASTROENTERITIS,3
IT,GASTROINTESTINAL MUCOSA HYPERAEMIA,3
IT,GESTATIONAL HYPERTENSION,3
IT,HAEMATEMESIS,3
IT,HAEMOLYTIC ANAEMIA,3
IT,HALLUCINATION_ VISUAL,3
IT,HEART TRANSPLANT REJECTION,3
IT,HEPATIC FUNCTION ABNORMAL,3
IT,HISTIOCYTOSIS HAEMATOPHAGIC,3
IT,HYPERGAMMAGLOBULINAEMIA,3
IT,HYPOPHONESIS,3
IT,HYPOTHYROIDISM,3
IT,HYPOXIA,3
IT,INCORRECT DOSE ADMINISTERED,3
IT,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
IT,INTESTINAL OBSTRUCTION,3
IT,JAUNDICE,3
IT,KLEBSIELLA SEPSIS,3
IT,LARYNGOSPASM,3
IT,LEFT ATRIAL DILATATION,3
IT,LIVE BIRTH,3
IT,LIVER FUNCTION TEST ABNORMAL,3
IT,LUNG ADENOCARCINOMA,3
IT,LUNG NEOPLASM,3
IT,LYMPHOMA,3
IT,MALIGNANT MELANOMA,3
IT,MANTLE CELL LYMPHOMA,3
IT,MENINGITIS,3
IT,MENTAL DISORDER,3
IT,MENTAL STATUS CHANGES,3
IT,METAPNEUMOVIRUS INFECTION,3
IT,MUCOCUTANEOUS LEISHMANIASIS,3
IT,MULTIPLE SCLEROSIS RELAPSE,3
IT,MUSCULAR WEAKNESS,3
IT,MUSCULOSKELETAL STIFFNESS,3
IT,MYASTHENIA GRAVIS CRISIS,3
IT,NASAL CAVITY CANCER,3
IT,NECROSIS,3
IT,ODYNOPHAGIA,3
IT,OPTIC NEURITIS,3
IT,ORAL DISORDER,3
IT,ORAL PAIN,3
IT,OSTEOMYELITIS,3
IT,OXYGEN SATURATION DECREASED,3
IT,PALATAL SWELLING,3
IT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,3
IT,PANCREATIC CARCINOMA,3
IT,PEMPHIGUS,3
IT,PERIPHERAL ISCHAEMIA,3
IT,PERIPHERAL MOTOR NEUROPATHY,3
IT,PLASMA CELL MYELOMA RECURRENT,3
IT,PLASMABLASTIC LYMPHOMA,3
IT,PNEUMONIA ASPIRATION,3
IT,PNEUMONIA PNEUMOCOCCAL,3
IT,PNEUMOPERITONEUM,3
IT,PROCEDURAL COMPLICATION,3
IT,PROSTATE CANCER METASTATIC,3
IT,PROTEINURIA,3
IT,PSEUDOMONAL SEPSIS,3
IT,PSYCHOMOTOR HYPERACTIVITY,3
IT,PSYCHOTIC DISORDER,3
IT,PULMONARY TOXICITY,3
IT,SCLERODERMA-LIKE REACTION,3
IT,SCROTAL ABSCESS,3
IT,SINUS BRADYCARDIA,3
IT,SINUS TACHYCARDIA,3
IT,SKIN DISORDER,3
IT,SPEECH DISORDER,3
IT,SPINAL PAIN,3
IT,SPLENOMEGALY,3
IT,SQUAMOUS CELL CARCINOMA,3
IT,STATUS EPILEPTICUS,3
IT,SYSTOLIC DYSFUNCTION,3
IT,TENDONITIS,3
IT,THORACIC VERTEBRAL FRACTURE,3
IT,THROMBOSIS,3
IT,THYROID DISORDER,3
IT,TINNITUS,3
IT,TRANSIENT ISCHAEMIC ATTACK,3
IT,TRANSPLANT DYSFUNCTION,3
IT,TRISMUS,3
IT,TROPONIN INCREASED,3
IT,VARICELLA,3
IT,VASCULITIS NECROTISING,3
IT,VASOPLEGIA SYNDROME,3
IT,VENOOCCLUSIVE DISEASE,3
IT,WHITE BLOOD CELL COUNT DECREASED,3
IT,ABDOMINAL ABSCESS,2
IT,ABDOMINAL DISCOMFORT,2
IT,ABSCESS,2
IT,ABSCESS JAW,2
IT,ABSCESS ORAL,2
IT,ACTINOMYCOSIS,2
IT,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,2
IT,ACUTE HEPATIC FAILURE,2
IT,ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME,2
IT,ACUTE PULMONARY OEDEMA,2
IT,ADENOCARCINOMA OF COLON,2
IT,AEROMONA INFECTION,2
IT,ALCOHOL ABUSE,2
IT,ALVEOLITIS,2
IT,AMNESTIC DISORDER,2
IT,ANAEMIA HAEMOLYTIC AUTOIMMUNE,2
IT,ANAEMIA MACROCYTIC,2
IT,ANAPHYLACTIC SHOCK,2
IT,ANTIPHOSPHOLIPID SYNDROME,2
IT,APRAXIA,2
IT,AREFLEXIA,2
IT,ATRIAL FLUTTER,2
IT,ATRIOVENTRICULAR BLOCK,2
IT,B-CELL LYMPHOMA,2
IT,BACTERIAL INFECTION,2
IT,BACTERIAL SEPSIS,2
IT,BALANCE DISORDER,2
IT,BEHCET^S SYNDROME,2
IT,BENIGN INTRACRANIAL HYPERTENSION,2
IT,BILIRUBIN CONJUGATED INCREASED,2
IT,BLADDER CANCER,2
IT,BLOOD CHOLESTEROL INCREASED,2
IT,BLOOD GLUCOSE INCREASED,2
IT,BLOOD PARATHYROID HORMONE INCREASED,2
IT,BLOOD PRESSURE DECREASED,2
IT,BLOOD TEST ABNORMAL,2
IT,BLOOD TRIGLYCERIDES INCREASED,2
IT,BODY TEMPERATURE INCREASED,2
IT,BONE DISORDER,2
IT,BONE MARROW TOXICITY,2
IT,BORDETELLA INFECTION,2
IT,BRAIN HERNIATION,2
IT,BRAIN OEDEMA,2
IT,BRAIN STEM HAEMORRHAGE,2
IT,BRONCHIOLITIS,2
IT,BRONCHOSPASM,2
IT,BURKHOLDERIA CEPACIA COMPLEX SEPSIS,2
IT,CAROTID ARTERY THROMBOSIS,2
IT,CENTRAL NERVOUS SYSTEM INFECTION,2
IT,CENTRAL NERVOUS SYSTEM LYMPHOMA,2
IT,CEREBRAL ASPERGILLOSIS,2
IT,CEREBRAL HAEMATOMA,2
IT,CHORIORETINITIS,2
IT,CLOSTRIDIUM DIFFICILE INFECTION,2
IT,COLD SWEAT,2
IT,COLITIS ULCERATIVE,2
IT,COLORECTAL CANCER,2
IT,COMPLEX PARTIAL SEIZURES,2
IT,CORONARY ARTERY STENOSIS,2
IT,CORONARY ARTERY THROMBOSIS,2
IT,CRYOGLOBULINAEMIA,2
IT,CUSHINGOID,2
IT,CYANOSIS,2
IT,CYSTITIS HAEMORRHAGIC,2
IT,DEMENTIA,2
IT,DERMATOMYOSITIS,2
IT,DEVICE RELATED INFECTION,2
IT,DIABETIC FOOT,2
IT,DIABETIC METABOLIC DECOMPENSATION,2
IT,DIPLOPIA,2
IT,DISSOCIATION,2
IT,DROP ATTACKS,2
IT,DRUG DOSE OMISSION,2
IT,DRUG LEVEL ABOVE THERAPEUTIC,2
IT,DUODENAL STENOSIS,2
IT,DYSPNOEA AT REST,2
IT,DYSPNOEA EXERTIONAL,2
IT,DYSSTASIA,2
IT,ELECTROENCEPHALOGRAM ABNORMAL,2
IT,ENCEPHALOMYELITIS,2
IT,EPILEPSY,2
IT,EROSIVE DUODENITIS,2
IT,ESCHERICHIA SEPSIS,2
IT,EXTRAVASATION,2
IT,FACE OEDEMA,2
IT,FOETAL GROWTH RESTRICTION,2
IT,GASTRIC ULCER,2
IT,GASTROINTESTINAL PERFORATION,2
IT,GASTROSPLENIC FISTULA,2
IT,GENITAL ABSCESS,2
IT,GLAUCOMA,2
IT,GLOMERULAR FILTRATION RATE DECREASED,2
IT,GRAND MAL CONVULSION,2
IT,GRANULOCYTOPENIA,2
IT,GUILLAIN-BARRE SYNDROME,2
IT,H1N1 INFLUENZA,2
IT,HAEMOPTYSIS,2
IT,HAEMORRHAGE URINARY TRACT,2
IT,HAEMOTHORAX,2
IT,HEART RATE INCREASED,2
IT,HEMIPLEGIA,2
IT,HEPATIC ENCEPHALOPATHY,2
IT,HEPATIC NECROSIS,2
IT,HEPATIC STEATOSIS,2
IT,HEPATITIS CHOLESTATIC,2
IT,HEPATITIS FULMINANT,2
IT,HERPES ZOSTER INFECTION NEUROLOGICAL,2
IT,HIGH DENSITY LIPOPROTEIN INCREASED,2
IT,HODGKIN^S DISEASE RECURRENT,2
IT,HOT FLUSH,2
IT,HUMAN HERPESVIRUS 8 INFECTION,2
IT,HYDRONEPHROSIS,2
IT,HYPERCALCAEMIA,2
IT,HYPERTENSIVE HEART DISEASE,2
IT,HYPERTRIGLYCERIDAEMIA,2
IT,HYPOCAPNIA,2
IT,HYPOGAMMAGLOBULINAEMIA,2
IT,HYPOPHYSITIS,2
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
IT,INFECTION REACTIVATION,2
IT,INFLAMMATION,2
IT,INFLAMMATORY BOWEL DISEASE,2
IT,INJURY,2
IT,INTENTIONAL PRODUCT USE ISSUE,2
IT,INTESTINAL HAEMORRHAGE,2
IT,INTESTINAL INFARCTION,2
IT,INVASIVE DUCTAL BREAST CARCINOMA,2
IT,ISCHAEMIC STROKE,2
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
IT,LARGE INTESTINAL OBSTRUCTION,2
IT,LEGIONELLA INFECTION,2
IT,LIPASE INCREASED,2
IT,LIVER DISORDER,2
IT,LIVER TRANSPLANT,2
IT,LUNG INFILTRATION,2
IT,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,2
IT,MATERNAL EXPOSURE BEFORE PREGNANCY,2
IT,MEDICATION ERROR,2
IT,MEMORY IMPAIRMENT,2
IT,MESOTHELIOMA,2
IT,METASTASES TO BONE,2
IT,METASTASES TO LIVER,2
IT,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,2
IT,MICROSCOPIC POLYANGIITIS,2
IT,MITRAL VALVE INCOMPETENCE,2
IT,MONOCLONAL B-CELL LYMPHOCYTOSIS,2
IT,MOTOR DYSFUNCTION,2
IT,MULTIPLE FRACTURES,2
IT,NEONATAL RESPIRATORY DISTRESS SYNDROME,2
IT,NEOPLASM,2
IT,NEPHROTIC SYNDROME,2
IT,NERVOUSNESS,2
IT,NEUROENDOCRINE CARCINOMA OF THE SKIN,2
IT,NEUROLOGICAL DECOMPENSATION,2
IT,NEUTROPHIL COUNT DECREASED,2
IT,NON-HODGKIN^S LYMPHOMA REFRACTORY,2
IT,OESOPHAGEAL STENOSIS,2
IT,OESOPHAGEAL ULCER HAEMORRHAGE,2
IT,OESOPHAGITIS,2
IT,ORAL HERPES,2
IT,ORAL MUCOSAL ERYTHEMA,2
IT,OROPHARYNGEAL PAIN,2
IT,OSTEOARTHRITIS,2
IT,PALLOR,2
IT,PAPILLOEDEMA,2
IT,PARKINSONISM,2
IT,PARTIAL SEIZURES,2
IT,PATHOGEN RESISTANCE,2
IT,PETECHIAE,2
IT,PHOTOPHOBIA,2
IT,PHOTOSENSITIVITY REACTION,2
IT,PLASMA CELL LEUKAEMIA,2
IT,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
IT,PNEUMONIA BACTERIAL,2
IT,PNEUMONIA CYTOMEGALOVIRAL,2
IT,PNEUMONIA KLEBSIELLA,2
IT,PNEUMORETROPERITONEUM,2
IT,POLYCYTHAEMIA,2
IT,POLYNEUROPATHY,2
IT,POST PROCEDURAL COMPLICATION,2
IT,PREMATURE LABOUR,2
IT,PREMATURE RUPTURE OF MEMBRANES,2
IT,PRESYNCOPE,2
IT,PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA,2
IT,PRODUCT MEASURED POTENCY ISSUE,2
IT,PRODUCTIVE COUGH,2
IT,PSEUDOMONAS INFECTION,2
IT,PSORIATIC ARTHROPATHY,2
IT,PULMONARY MYCOSIS,2
IT,PURULENT DISCHARGE,2
IT,RECTAL ADENOCARCINOMA,2
IT,RECTAL TENESMUS,2
IT,RENAL CANCER,2
IT,RENAL DISORDER,2
IT,RESPIRATORY TRACT INFECTION,2
IT,RHABDOMYOLYSIS,2
IT,RHODOCOCCUS INFECTION,2
IT,ROAD TRAFFIC ACCIDENT,2
IT,SELF-MEDICATION,2
IT,SHOCK HAEMORRHAGIC,2
IT,SINUSITIS,2
IT,SKIN CANCER,2
IT,SKIN HAEMORRHAGE,2
IT,SPINAL COMPRESSION FRACTURE,2
IT,SQUAMOUS CELL CARCINOMA OF SKIN,2
IT,STAPHYLOCOCCAL SEPSIS,2
IT,STEREOTYPY,2
IT,STREPTOCOCCAL SEPSIS,2
IT,STRESS CARDIOMYOPATHY,2
IT,SUBARACHNOID HAEMORRHAGE,2
IT,SUBCUTANEOUS HAEMATOMA,2
IT,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,2
IT,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,2
IT,SUPRAVENTRICULAR TACHYCARDIA,2
IT,SWELLING,2
IT,TACHYPNOEA,2
IT,THROMBOCYTOSIS,2
IT,TONSIL CANCER,2
IT,TOXIC SKIN ERUPTION,2
IT,TRANSFUSION,2
IT,TRAUMATIC LUNG INJURY,2
IT,TREATMENT NONCOMPLIANCE,2
IT,TROPONIN T INCREASED,2
IT,TUBULOINTERSTITIAL NEPHRITIS,2
IT,ULCER,2
IT,UNDERDOSE,2
IT,URINARY RETENTION,2
IT,UVEITIS,2
IT,VANISHING BILE DUCT SYNDROME,2
IT,VARICELLA ZOSTER VIRUS INFECTION,2
IT,VASOGENIC CEREBRAL OEDEMA,2
IT,VISION BLURRED,2
IT,VISUAL FIELD DEFECT,2
IT,WALKING DISABILITY,2
IT,WHITE BLOOD CELL COUNT INCREASED,2
IT,ABASIA,1
IT,ABNORMAL WEIGHT GAIN,1
IT,ABSCESS BACTERIAL,1
IT,ABSCESS INTESTINAL,1
IT,ABSCESS LIMB,1
IT,ACIDOSIS,1
IT,ACNE,1
IT,ACQUIRED BRONCHIAL CYST,1
IT,ACQUIRED GENE MUTATION,1
IT,ACQUIRED HAEMOPHILIA,1
IT,ACTINIC CHEILITIS,1
IT,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,1
IT,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
IT,ACUTE LEUKAEMIA,1
IT,ACUTE MYELOID LEUKAEMIA RECURRENT,1
IT,ADENOCARCINOMA GASTRIC,1
IT,ADENOCARCINOMA PANCREAS,1
IT,ADRENAL INSUFFICIENCY,1
IT,AEROMONAS INFECTION,1
IT,AFFECT LABILITY,1
IT,AFFECTIVE DISORDER,1
IT,AGEUSIA,1
IT,AGRANULOCYTOSIS,1
IT,ALKALOSIS,1
IT,ALLODYNIA,1
IT,ALOPECIA SCARRING,1
IT,AMMONIA INCREASED,1
IT,AMNESIA,1
IT,AMOEBIC DYSENTERY,1
IT,AMYLOIDOSIS,1
IT,ANGINA UNSTABLE,1
IT,ANGIOSARCOMA,1
IT,ANTEROGRADE AMNESIA,1
IT,ANTISOCIAL BEHAVIOUR,1
IT,AORTIC ANEURYSM RUPTURE,1
IT,AORTIC DISSECTION,1
IT,AORTIC VALVE INCOMPETENCE,1
IT,APGAR SCORE LOW,1
IT,APHASIA,1
IT,APHTHOUS STOMATITIS,1
IT,ASPIRATION,1
IT,ASPIRATION PLEURAL CAVITY,1
IT,ASPIRATION TRACHEAL,1
IT,ASTHMATIC CRISIS,1
IT,ASTRINGENT THERAPY,1
IT,ATELECTASIS,1
IT,ATRIOVENTRICULAR CONDUCTION TIME SHORTENED,1
IT,ATROPHY,1
IT,ATYPICAL FEMUR FRACTURE,1
IT,AUTOIMMUNE HEPATITIS,1
IT,BACILLUS BACTERAEMIA,1
IT,BACTEROIDES INFECTION,1
IT,BENIGN PROSTATIC HYPERPLASIA,1
IT,BILE DUCT STONE,1
IT,BILIARY CIRRHOSIS PRIMARY,1
IT,BILOMA,1
IT,BIOPSY BONE MARROW,1
IT,BIPHASIC MESOTHELIOMA,1
IT,BLADDER TRANSITIONAL CELL CARCINOMA,1
IT,BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0,1
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IT,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
IT,BLOOD FIBRINOGEN INCREASED,1
IT,BLOOD IMMUNOGLOBULIN E ABNORMAL,1
IT,BLOOD IMMUNOGLOBULIN E INCREASED,1
IT,BLOOD MAGNESIUM DECREASED,1
IT,BLOOD PHOSPHORUS DECREASED,1
IT,BLOOD POTASSIUM DECREASED,1
IT,BLOOD PRESSURE INCREASED,1
IT,BLOOD PRODUCT TRANSFUSION DEPENDENT,1
IT,BLOOD UREA INCREASED,1
IT,BLOOD URIC ACID INCREASED,1
IT,BLOODY DISCHARGE,1
IT,BONE EROSION,1
IT,BONE LESION,1
IT,BONE SWELLING,1
IT,BREAST CANCER METASTATIC,1
IT,BREAST CANCER STAGE II,1
IT,BREECH PRESENTATION,1
IT,BRONCHIAL DISORDER,1
IT,BRONCHIAL OBSTRUCTION,1
IT,BRONCHOPNEUMONIA,1
IT,BUNDLE BRANCH BLOCK LEFT,1
IT,BURKITT^S LYMPHOMA,1
IT,BURNING SENSATION,1
IT,BUTTOCK INJURY,1
IT,CACHEXIA,1
IT,CANCER IN REMISSION,1
IT,CANDIDA PNEUMONIA,1
IT,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,1
IT,CARDIAC FAILURE CHRONIC,1
IT,CARDIAC FAILURE CONGESTIVE,1
IT,CARDIAC VALVE VEGETATION,1
IT,CARDIAC VENTRICULAR THROMBOSIS,1
IT,CARDIO-RESPIRATORY ARREST,1
IT,CARDIOPULMONARY FAILURE,1
IT,CATARACT SUBCAPSULAR,1
IT,CATHETER SITE INFECTION,1
IT,CAUDA EQUINA SYNDROME,1
IT,CD4 LYMPHOCYTES DECREASED,1
IT,CD8 LYMPHOCYTES DECREASED,1
IT,CENTRAL NERVOUS SYSTEM NECROSIS,1
IT,CEREBELLAR HAEMORRHAGE,1
IT,CEREBRAL ATROPHY,1
IT,CHEST DISCOMFORT,1
IT,CHOLANGIOCARCINOMA,1
IT,CHOLESTASIS OF PREGNANCY,1
IT,CHORIORETINOPATHY,1
IT,CHOROIDITIS,1
IT,CHROMATURIA,1
IT,CHRONIC GRAFT VERSUS HOST DISEASE,1
IT,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
IT,CHRONIC MYELOID LEUKAEMIA,1
IT,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
IT,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
IT,CHYLOTHORAX,1
IT,CLEAR CELL RENAL CELL CARCINOMA,1
IT,CLOSTRIDIAL INFECTION,1
IT,CLUSTER HEADACHE,1
IT,COLECTOMY,1
IT,COLITIS ISCHAEMIC,1
IT,COLON NEOPLASM,1
IT,COLONIC STENOSIS,1
IT,COMA SCALE ABNORMAL,1
IT,COMPLEMENT FACTOR C4 DECREASED,1
IT,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
IT,CONCOMITANT DISEASE AGGRAVATED,1
IT,CONGENITAL THROMBOCYTE DISORDER,1
IT,CONJUNCTIVAL HAEMORRHAGE,1
IT,CONJUNCTIVAL HYPERAEMIA,1
IT,CONVULSION NEONATAL,1
IT,COXSACKIE MYOCARDITIS,1
IT,CRANIAL NERVE PALSIES MULTIPLE,1
IT,CRANIOCEREBRAL INJURY,1
IT,CSF GLUCOSE ABNORMAL,1
IT,CSF PROTEIN INCREASED,1
IT,CYTOKINE RELEASE SYNDROME,1
IT,CYTOMEGALOVIRUS COLITIS,1
IT,DEAFNESS,1
IT,DEBRIDEMENT,1
IT,DECUBITUS ULCER,1
IT,DELAYED PUBERTY,1
IT,DERMATITIS BULLOUS,1
IT,DERMATITIS PSORIASIFORM,1
IT,DERMO-HYPODERMITIS,1
IT,DIALYSIS,1
IT,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1
IT,DISSEMINATED TUBERCULOSIS,1
IT,DIVERTICULUM INTESTINAL,1
IT,DOUBLE STRANDED DNA ANTIBODY POSITIVE,1
IT,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
IT,DRUG ADMINISTRATION ERROR,1
IT,DRUG EFFECT DECREASED,1
IT,DRUG LEVEL BELOW THERAPEUTIC,1
IT,DRY SKIN,1
IT,DUODENAL ULCER HAEMORRHAGE,1
IT,DYSAESTHESIA,1
IT,DYSPEPSIA,1
IT,EMBOLISM VENOUS,1
IT,EMPHYSEMA,1
IT,END STAGE RENAL DISEASE,1
IT,ENDOCARDITIS BACTERIAL,1
IT,ENDOCRINE DISORDER,1
IT,ENDOMETRIAL CANCER,1
IT,ENDOPHTHALMITIS,1
IT,ENTEROCOCCAL SEPSIS,1
IT,ENTEROCOLITIS INFECTIOUS,1
IT,ENTEROVIRUS TEST POSITIVE,1
IT,EOSINOPHILIA,1
IT,EOSINOPHILIC COLITIS,1
IT,ERYSIPELAS,1
IT,ERYTHEMA MULTIFORME,1
IT,ERYTHEMA NODOSUM,1
IT,ERYTHRODERMIC PSORIASIS,1
IT,ESCHERICHIA TEST POSITIVE,1
IT,EXCESSIVE GRANULATION TISSUE,1
IT,EXOPHTHALMOS,1
IT,EXTENSOR PLANTAR RESPONSE,1
IT,EXTRAPYRAMIDAL DISORDER,1
IT,EYE INFLAMMATION,1
IT,EYELID PTOSIS,1
IT,FACIAL PAIN,1
IT,FAECAL VOMITING,1
IT,FAECES DISCOLOURED,1
IT,FAT EMBOLISM,1
IT,FEELING COLD,1
IT,FEMORAL NECK FRACTURE,1
IT,FIBROSARCOMA,1
IT,FISTULA,1
IT,FLUSHING,1
IT,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
IT,FOETAL DEATH,1
IT,FOETAL DISTRESS SYNDROME,1
IT,FOETAL EXPOSURE DURING DELIVERY,1
IT,FOLLICLE CENTRE LYMPHOMA_ FOLLICULAR GRADE I_ II_ III REFRACTORY,1
IT,FOLLICULITIS,1
IT,FULL BLOOD COUNT DECREASED,1
IT,GALLBLADDER CANCER,1
IT,GASTRIC HAEMORRHAGE,1
IT,GASTRIC MUCOSA ERYTHEMA,1
IT,GASTRIC MUCOSAL LESION,1
IT,GASTRIC STENOSIS,1
IT,GASTROINTESTINAL CARCINOMA,1
IT,GASTROINTESTINAL INFECTION,1
IT,GASTROINTESTINAL NECROSIS,1
IT,GASTROINTESTINAL OEDEMA,1
IT,GASTROSTOMY TUBE REMOVAL,1
IT,GAZE PALSY,1
IT,GENE MUTATION,1
IT,GENERAL SYMPTOM,1
IT,GIANT CELL EPULIS,1
IT,GINGIVAL BLEEDING,1
IT,GLIOBLASTOMA MULTIFORME,1
IT,GLIOSIS,1
IT,GLUCOSE TOLERANCE DECREASED,1
IT,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
IT,GRAFT LOSS,1
IT,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
IT,GRAFT VERSUS HOST DISEASE IN LIVER,1
IT,GRANULOMA ANNULARE,1
IT,HAEMANGIOMA OF LIVER,1
IT,HAEMATOMA,1
IT,HAEMODIALYSIS,1
IT,HAEMODYNAMIC INSTABILITY,1
IT,HAEMOGLOBINAEMIA,1
IT,HAEMOPHILUS INFECTION,1
IT,HAEMORRHAGE IN PREGNANCY,1
IT,HAEMORRHAGE INTRACRANIAL,1
IT,HAEMORRHAGIC ANAEMIA,1
IT,HAEMORRHAGIC STROKE,1
IT,HALLUCINATION,1
IT,HAPTOGLOBIN DECREASED,1
IT,HELLP SYNDROME,1
IT,HEPATIC CYST,1
IT,HEPATIC NEOPLASM,1
IT,HEPATIC RUPTURE,1
IT,HEPATITIS C VIRUS TEST POSITIVE,1
IT,HEPATITIS TOXIC,1
IT,HERPES VIRUS INFECTION,1
IT,HIDRADENITIS,1
IT,HISTOLOGY ABNORMAL,1
IT,HOMICIDE,1
IT,HORMONE-REFRACTORY PROSTATE CANCER,1
IT,HYDROCELE,1
IT,HYPERAEMIA,1
JM,DEATH,1
JM,EMPHYSEMA,1
JM,PULMONARY OEDEMA,1
JP,HEPATITIS B,31
JP,FEBRILE NEUTROPENIA,26
JP,NEUTROPENIA,25
JP,INTERSTITIAL LUNG DISEASE,20
JP,THROMBOCYTOPENIA,18
JP,LEUKOPENIA,17
JP,DISEASE PROGRESSION,15
JP,DRUG INEFFECTIVE,14
JP,PRODUCT USE ISSUE,14
JP,SEPSIS,14
JP,ANAEMIA,13
JP,INFECTION,13
JP,HEPATOTOXICITY,12
JP,PNEUMONIA,12
JP,DEATH,11
JP,PYREXIA,11
JP,CYTOMEGALOVIRUS INFECTION,10
JP,NEUROPATHY PERIPHERAL,10
JP,DIFFUSE LARGE B-CELL LYMPHOMA,9
JP,EPSTEIN-BARR VIRUS INFECTION,9
JP,PLATELET COUNT DECREASED,9
JP,PLEURAL EFFUSION,9
JP,WHITE BLOOD CELL COUNT DECREASED,9
JP,HEPATIC FAILURE,8
JP,HEPATIC FUNCTION ABNORMAL,8
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,8
JP,PRODUCT USE IN UNAPPROVED INDICATION,8
JP,CARDIAC FAILURE,7
JP,CONDITION AGGRAVATED,7
JP,CONSTIPATION,7
JP,PANCYTOPENIA,7
JP,RENAL IMPAIRMENT,7
JP,RESPIRATORY FAILURE,7
JP,SEPTIC SHOCK,7
JP,ASCITES,6
JP,BACK PAIN,6
JP,BONE MARROW FAILURE,6
JP,HAEMOGLOBIN DECREASED,6
JP,HEPATITIS,6
JP,HEPATITIS C RNA INCREASED,6
JP,ACUTE MYELOID LEUKAEMIA,5
JP,ACUTE RESPIRATORY DISTRESS SYNDROME,5
JP,DIARRHOEA,5
JP,HYPONATRAEMIA,5
JP,METASTASES TO BONE,5
JP,MYELODYSPLASTIC SYNDROME,5
JP,PNEUMOCYSTIS JIROVECI PNEUMONIA,5
JP,PNEUMONIA BACTERIAL,5
JP,RASH,5
JP,ALANINE AMINOTRANSFERASE INCREASED,4
JP,ASPARTATE AMINOTRANSFERASE INCREASED,4
JP,ASTHMA,4
JP,COMA,4
JP,DISSEMINATED INTRAVASCULAR COAGULATION,4
JP,EPIDURAL LIPOMATOSIS,4
JP,FATIGUE,4
JP,GENERAL PHYSICAL HEALTH DETERIORATION,4
JP,HEPATITIS CHOLESTATIC,4
JP,HERPES ZOSTER,4
JP,HIPPOCAMPAL SCLEROSIS,4
JP,HYPERGLYCAEMIA,4
JP,MALIGNANT NEOPLASM PROGRESSION,4
JP,METASTASES TO LIVER,4
JP,NAUSEA,4
JP,OEDEMA PERIPHERAL,4
JP,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
JP,TEMPORAL LOBE EPILEPSY,4
JP,BLOOD GLUCOSE INCREASED,3
JP,C-REACTIVE PROTEIN INCREASED,3
JP,CARDIAC DISORDER,3
JP,COLON CANCER,3
JP,DYSPNOEA,3
JP,ENCEPHALOPATHY,3
JP,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,3
JP,GAIT DISTURBANCE,3
JP,GASTRIC CANCER,3
JP,GASTRIC ULCER,3
JP,HAEMATOTOXICITY,3
JP,HODGKIN^S DISEASE,3
JP,HYDRONEPHROSIS,3
JP,HYPERCALCAEMIA,3
JP,HYPOAESTHESIA,3
JP,INFUSION RELATED REACTION,3
JP,JAUNDICE,3
JP,LUNG ADENOCARCINOMA,3
JP,LYMPHOPENIA,3
JP,MELAENA,3
JP,METASTASES TO LYMPH NODES,3
JP,MUSCULAR WEAKNESS,3
JP,NEPHROLITHIASIS,3
JP,SECOND PRIMARY MALIGNANCY,3
JP,TOXICITY TO VARIOUS AGENTS,3
JP,TRICHOSPORON INFECTION,3
JP,VENOOCCLUSIVE LIVER DISEASE,3
JP,VOMITING,3
JP,ACUTE GRAFT VERSUS HOST DISEASE,2
JP,ACUTE KIDNEY INJURY,2
JP,ACUTE LYMPHOCYTIC LEUKAEMIA,2
JP,ACUTE PROMYELOCYTIC LEUKAEMIA,2
JP,ACUTE RESPIRATORY FAILURE,2
JP,ADULT T-CELL LYMPHOMA/LEUKAEMIA,2
JP,ADVERSE EVENT,2
JP,ANAPHYLACTOID REACTION,2
JP,APLASIA PURE RED CELL,2
JP,ARTHRITIS INFECTIVE,2
JP,ATELECTASIS,2
JP,ATRIAL FIBRILLATION,2
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,2
JP,BRADYCARDIA,2
JP,BRAIN HERNIATION,2
JP,BRONCHITIS,2
JP,CD4 LYMPHOCYTES DECREASED,2
JP,CELLULITIS,2
JP,CENTRAL NERVOUS SYSTEM LYMPHOMA,2
JP,CEREBRAL INFARCTION,2
JP,CHILLS,2
JP,COAGULOPATHY,2
JP,COLORECTAL CANCER,2
JP,CONVULSION,2
JP,CYTOMEGALOVIRUS COLITIS,2
JP,CYTOMEGALOVIRUS VIRAEMIA,2
JP,DECREASED APPETITE,2
JP,DEEP VEIN THROMBOSIS,2
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,2
JP,DEPRESSION,2
JP,DEVICE RELATED INFECTION,2
JP,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
JP,DRUG LEVEL INCREASED,2
JP,DRUG RESISTANCE,2
JP,ELECTROLYTE IMBALANCE,2
JP,EMBOLISM,2
JP,EPISTAXIS,2
JP,FEELING ABNORMAL,2
JP,FUNGAL INFECTION,2
JP,GASTRIC HAEMORRHAGE,2
JP,GASTROINTESTINAL DISORDER,2
JP,GASTROINTESTINAL HAEMORRHAGE,2
JP,GRAND MAL CONVULSION,2
JP,HAEMATOCHEZIA,2
JP,HAEMATURIA,2
JP,HAEMORRHAGE INTRACRANIAL,2
JP,HAIR FOLLICLE TUMOUR BENIGN,2
JP,HEPATIC CIRRHOSIS,2
JP,HEPATITIS B REACTIVATION,2
JP,HEPATITIS C,2
JP,HERPES ZOSTER DISSEMINATED,2
JP,HYPOGLYCAEMIA,2
JP,HYPOTENSION,2
JP,ILEAL PERFORATION,2
JP,ILEUS,2
JP,ILEUS PARALYTIC,2
JP,INTESTINAL PERFORATION,2
JP,LARGE INTESTINE PERFORATION,2
JP,LIVER DISORDER,2
JP,LUNG ADENOCARCINOMA STAGE IV,2
JP,LUNG INFECTION,2
JP,LUNG NEOPLASM MALIGNANT,2
JP,LYMPHOMA,2
JP,MALAISE,2
JP,METASTASES TO LUNG,2
JP,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
JP,NECROSIS,2
JP,NEPHROPATHY TOXIC,2
JP,NEPHROTIC SYNDROME,2
JP,NEUTROPENIC INFECTION,2
JP,NEUTROPHIL COUNT DECREASED,2
JP,OSTEONECROSIS OF JAW,2
JP,PANCREATIC CARCINOMA,2
JP,PARALYSIS,2
JP,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,2
JP,PERITONEAL TUBERCULOSIS,2
JP,PERITONSILLAR ABSCESS,2
JP,PNEUMONIA ASPIRATION,2
JP,PNEUMONIA PNEUMOCOCCAL,2
JP,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,2
JP,PRODUCTIVE COUGH,2
JP,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
JP,PROSTATE CANCER,2
JP,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
JP,PROTEINURIA,2
JP,PULMONARY MYCOSIS,2
JP,SKIN CANCER METASTATIC,2
JP,SKIN LESION,2
JP,SKIN NECROSIS,2
JP,SPINAL COMPRESSION FRACTURE,2
JP,STOMATITIS,2
JP,SUBILEUS,2
JP,SYNCOPE,2
JP,THERAPEUTIC RESPONSE DECREASED,2
JP,URETEROLITHIASIS,2
JP,VANISHING BILE DUCT SYNDROME,2
JP,WEIGHT DECREASED,2
JP,WHITE BLOOD CELL COUNT INCREASED,2
JP,ABDOMINAL DISTENSION,1
JP,ABDOMINAL PAIN,1
JP,ABDOMINAL PAIN UPPER,1
JP,ABSCESS,1
JP,ACQUIRED HAEMOPHILIA,1
JP,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
JP,ACUTE CORONARY SYNDROME,1
JP,ACUTE DISSEMINATED ENCEPHALOMYELITIS,1
JP,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
JP,ACUTE HEPATIC FAILURE,1
JP,ACUTE HEPATITIS B,1
JP,ACUTE MEGAKARYOCYTIC LEUKAEMIA,1
JP,ADAMTS13 ACTIVITY ABNORMAL,1
JP,ADENOCARCINOMA GASTRIC,1
JP,ADENOCARCINOMA OF COLON,1
JP,ADRENAL INSUFFICIENCY,1
JP,ADVERSE REACTION,1
JP,AEROMONA INFECTION,1
JP,ALANINE AMINOTRANSFERASE ABNORMAL,1
JP,ALOPECIA,1
JP,ALTERED STATE OF CONSCIOUSNESS,1
JP,ANAPHYLACTIC REACTION,1
JP,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,1
JP,ANTI-GANGLIOSIDE ANTIBODY,1
JP,AORTIC ANEURYSM,1
JP,AREFLEXIA,1
JP,ARRHYTHMIA SUPRAVENTRICULAR,1
JP,ARTHRALGIA,1
JP,ARTHRITIS,1
JP,ARTICULAR CALCIFICATION,1
JP,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
JP,ASTHENIA,1
JP,AUTOIMMUNE NEUROPATHY,1
JP,AUTOIMMUNE PANCYTOPENIA,1
JP,B-CELL LYMPHOMA,1
JP,B-LYMPHOCYTE COUNT DECREASED,1
JP,BACTERIAL INFECTION,1
JP,BACTERIAL PROSTATITIS,1
JP,BACTERIAL SEPSIS,1
JP,BILE DUCT CANCER RECURRENT,1
JP,BILE DUCT STONE,1
JP,BLAST CELL COUNT INCREASED,1
JP,BLINDNESS,1
JP,BLOOD ALBUMIN DECREASED,1
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,1
JP,BLOOD BILIRUBIN INCREASED,1
JP,BLOOD CORTICOTROPHIN DECREASED,1
JP,BLOOD CORTISOL DECREASED,1
JP,BLOOD CREATININE INCREASED,1
JP,BLOOD FIBRINOGEN DECREASED,1
JP,BLOOD PARATHYROID HORMONE INCREASED,1
JP,BLOOD PRESSURE INCREASED,1
JP,BLOOD SODIUM DECREASED,1
JP,BONE DISORDER,1
JP,BONE LESION,1
JP,BONE PAIN,1
JP,BRAIN NATRIURETIC PEPTIDE INCREASED,1
JP,BREAST CANCER,1
JP,BRONCHIECTASIS,1
JP,BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC,1
JP,BUNDLE BRANCH BLOCK,1
JP,CALCIPHYLAXIS,1
JP,CANDIDA INFECTION,1
JP,CANDIDIASIS,1
JP,CARCINOEMBRYONIC ANTIGEN INCREASED,1
JP,CARDIOMEGALY,1
JP,CARDIOMYOPATHY,1
JP,CARDIOTOXICITY,1
JP,CELL MARKER INCREASED,1
JP,CHOLECYSTITIS,1
JP,CHOLECYSTITIS ACUTE,1
JP,CHOLELITHIASIS,1
JP,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
JP,CHRONIC RESPIRATORY FAILURE,1
JP,CIRCULATORY COLLAPSE,1
JP,COLITIS,1
JP,CONJUNCTIVAL HAEMORRHAGE,1
JP,CONJUNCTIVAL PALLOR,1
JP,CORTISOL DECREASED,1
JP,COUGH,1
JP,CYSTITIS,1
JP,CYSTITIS HAEMORRHAGIC,1
JP,CYTOMEGALOVIRUS CHORIORETINITIS,1
JP,CYTOMEGALOVIRUS ENTERITIS,1
JP,CYTOMEGALOVIRUS ENTEROCOLITIS,1
JP,CYTOMEGALOVIRUS GASTROENTERITIS,1
JP,DELIRIUM,1
JP,DERMATOMYOSITIS,1
JP,DIABETES MELLITUS,1
JP,DIALYSIS,1
JP,DIFFUSE ALVEOLAR DAMAGE,1
JP,DISEASE RECURRENCE,1
JP,DISLOCATION OF VERTEBRA,1
JP,DISSEMINATED TUBERCULOSIS,1
JP,DROWNING,1
JP,DRUG HYPERSENSITIVITY,1
JP,DRUG-INDUCED LIVER INJURY,1
JP,DYSKINESIA,1
JP,DYSPNOEA EXERTIONAL,1
JP,ECZEMA ASTEATOTIC,1
JP,EFFUSION,1
JP,EJECTION FRACTION DECREASED,1
JP,ENTERITIS,1
JP,EOSINOPHILIA,1
JP,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,1
JP,ERYTHEMA MULTIFORME,1
JP,EXPOSED BONE IN JAW,1
JP,FACE OEDEMA,1
JP,FASCIITIS,1
JP,FEMORAL NECK FRACTURE,1
JP,FEMUR FRACTURE,1
JP,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
JP,FOOD INTERACTION,1
JP,GASTRIC ADENOMA,1
JP,GASTRITIS EROSIVE,1
JP,GASTROENTERITIS,1
JP,GASTROINTESTINAL NECROSIS,1
JP,GASTROINTESTINAL TOXICITY,1
JP,GINGIVAL BLEEDING,1
JP,GINGIVAL ERYTHEMA,1
JP,GINGIVITIS,1
JP,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
JP,GRAFT VERSUS HOST DISEASE,1
JP,HAEMATEMESIS,1
JP,HAEMATOCRIT DECREASED,1
JP,HAEMATOMA,1
JP,HAEMOLYTIC URAEMIC SYNDROME,1
JP,HAEMORRHAGE,1
JP,HAEMORRHAGE SUBCUTANEOUS,1
JP,HAEMORRHOIDS,1
JP,HAEMOSIDEROSIS,1
JP,HEAD DISCOMFORT,1
JP,HEART RATE INCREASED,1
JP,HELICOBACTER INFECTION,1
JP,HEPATIC ENCEPHALOPATHY,1
JP,HEPATIC ENZYME INCREASED,1
JP,HEPATITIS ACUTE,1
JP,HEPATITIS B DNA INCREASED,1
JP,HEPATITIS FULMINANT,1
JP,HEPATOBILIARY DISEASE,1
JP,HEPATOCELLULAR CARCINOMA,1
JP,HEPATOMEGALY,1
JP,HERPES SIMPLEX,1
JP,HYPERBILIRUBINAEMIA,1
JP,HYPERHIDROSIS,1
JP,HYPERPHOSPHATAEMIA,1
JP,HYPERSENSITIVITY,1
JP,HYPERSENSITIVITY VASCULITIS,1
JP,HYPERTENSION,1
JP,HYPERTENSIVE CARDIOMEGALY,1
JP,HYPERTHYROIDISM,1
JP,HYPOALBUMINAEMIA,1
JP,HYPOCALCAEMIA,1
JP,HYPOGAMMAGLOBULINAEMIA,1
JP,HYPOKALAEMIA,1
JP,HYPOPHOSPHATAEMIA,1
JP,HYPOPITUITARISM,1
JP,HYPOXIA,1
JP,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
JP,IMMUNE THROMBOCYTOPENIC PURPURA,1
JP,IMMUNE-MEDIATED HEPATITIS,1
JP,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
JP,IMMUNOSUPPRESSION,1
JP,IMPETIGO,1
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
JP,INFUSION SITE DISCOLOURATION,1
JP,INFUSION SITE ERYTHEMA,1
JP,INFUSION SITE NECROSIS,1
JP,INFUSION SITE PAIN,1
JP,INTERNATIONAL NORMALISED RATIO INCREASED,1
JP,INTRACRANIAL HYPOTENSION,1
JP,JC VIRUS INFECTION,1
JP,KIDNEY TRANSPLANT REJECTION,1
JP,KLEBSIELLA INFECTION,1
JP,LARYNGEAL NEOPLASM,1
JP,LARYNX IRRITATION,1
JP,LEFT VENTRICULAR DYSFUNCTION,1
JP,LEUKAEMIA,1
JP,LEUKOCYTOSIS,1
JP,LIVER FUNCTION TEST ABNORMAL,1
JP,LOSS OF CONSCIOUSNESS,1
JP,LOWER GASTROINTESTINAL HAEMORRHAGE,1
JP,LUNG ABSCESS,1
JP,LUPUS NEPHRITIS,1
JP,LUPUS-LIKE SYNDROME,1
JP,LYMPHOCYTE COUNT DECREASED,1
JP,LYMPHOCYTIC INFILTRATION,1
JP,LYMPHOPROLIFERATIVE DISORDER,1
JP,MANTLE CELL LYMPHOMA,1
JP,MATERNAL EXPOSURE DURING DELIVERY,1
JP,MATERNAL EXPOSURE DURING PREGNANCY,1
JP,MENINGITIS CRYPTOCOCCAL,1
JP,MESENTERIC HAEMORRHAGE,1
JP,METASTASES TO PELVIS,1
JP,METASTASES TO THORAX,1
JP,MITRAL VALVE INCOMPETENCE,1
JP,MONOPLEGIA,1
JP,MOVEMENT DISORDER,1
JP,MUCOSAL INFLAMMATION,1
JP,MUSCULOSKELETAL PAIN,1
JP,NASOPHARYNGITIS,1
JP,NATURAL KILLER CELL COUNT DECREASED,1
JP,NEPHRITIS,1
JP,NEPHROGENIC ANAEMIA,1
JP,NEPHROPATHY,1
JP,NEPHROSCLEROSIS,1
JP,NODULE,1
JP,NON-SMALL CELL LUNG CANCER,1
JP,OBSTRUCTIVE AIRWAYS DISORDER,1
JP,OCULAR FISTULA,1
JP,OESOPHAGEAL DISORDER,1
JP,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
JP,OESOPHAGITIS,1
JP,ORTHOSTATIC HYPOTENSION,1
JP,OSTEOMALACIA,1
JP,OSTEOMYELITIS,1
JP,OXYGEN SATURATION DECREASED,1
JP,PAIN,1
JP,PAIN IN JAW,1
JP,PARACENTESIS,1
JP,PERICARDIAL EFFUSION,1
JP,PERICARDITIS CONSTRICTIVE,1
JP,PERIODONTITIS,1
JP,PERIPHERAL ARTERY ANEURYSM,1
JP,PERIPHERAL MOTOR NEUROPATHY,1
JP,PERIPHERAL SWELLING,1
JP,PHARYNGEAL OEDEMA,1
JP,PHARYNGITIS,1
JP,PLASMAPHERESIS,1
JP,PLATELET TRANSFUSION,1
JP,PNEUMATOSIS INTESTINALIS,1
JP,PNEUMONIA ADENOVIRAL,1
JP,PNEUMONIA KLEBSIELLA,1
JP,PNEUMONIA STAPHYLOCOCCAL,1
JP,PNEUMONITIS,1
JP,PNEUMOTHORAX,1
JP,POLYMYOSITIS,1
JP,POST PROCEDURAL SEPSIS,1
JP,PREMATURE RUPTURE OF MEMBRANES,1
JP,PRESCRIBED UNDERDOSE,1
JP,PROTHROMBIN TIME PROLONGED,1
JP,PRURITUS,1
JP,PULMONARY CONGESTION,1
JP,PULMONARY EMBOLISM,1
JP,PULMONARY HAEMORRHAGE,1
JP,PULMONARY TUBERCULOSIS,1
JP,PURPURA,1
JP,PURULENT DISCHARGE,1
JP,PYELONEPHRITIS,1
JP,RASH GENERALISED,1
JP,RECTAL ULCER,1
JP,RED BLOOD CELL COUNT DECREASED,1
JP,RED BLOOD CELL SCHISTOCYTES PRESENT,1
JP,RENAL DISORDER,1
JP,RENAL FAILURE,1
JP,RENAL FAILURE CHRONIC,1
JP,RENAL SALT-WASTING SYNDROME,1
JP,RENAL TUBULAR DYSFUNCTION,1
JP,RESPIRATORY ARREST,1
JP,RESPIRATORY DISORDER,1
JP,RHEUMATOID LUNG,1
JP,RIGHT VENTRICULAR FAILURE,1
JP,SCLERODERMA RENAL CRISIS,1
JP,SEASONAL ALLERGY,1
JP,SERUM SICKNESS,1
JP,SHOCK HAEMORRHAGIC,1
JP,SKIN HYPERTROPHY,1
JP,SKIN ULCER,1
JP,SMALL INTESTINAL PERFORATION,1
JP,SOMNOLENCE,1
JP,SPLENIC RUPTURE,1
JP,SQUAMOUS CELL CARCINOMA OF LUNG,1
JP,STREPTOCOCCAL INFECTION,1
JP,STUPOR,1
JP,SUBARACHNOID HAEMORRHAGE,1
JP,SUDDEN DEATH,1
JP,SUICIDE ATTEMPT,1
JP,SURFACTANT PROTEIN INCREASED,1
JP,SWELLING,1
JP,SWELLING FACE,1
JP,T-LYMPHOCYTE COUNT DECREASED,1
JP,TACHYCARDIA,1
JP,TELANGIECTASIA,1
JP,TEMPERATURE INTOLERANCE,1
JP,TENDERNESS,1
JP,THROMBOSIS,1
JP,THROMBOTIC MICROANGIOPATHY,1
JP,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
JP,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
JP,TREATMENT FAILURE,1
JP,TREATMENT NONCOMPLIANCE,1
JP,TREMOR,1
JP,TRICUSPID VALVE INCOMPETENCE,1
JP,TUBERCULOSIS,1
JP,UPPER RESPIRATORY TRACT INFLAMMATION,1
JP,UROSEPSIS,1
JP,VARICELLA,1
JP,VASCULAR PAIN,1
JP,VASOGENIC CEREBRAL OEDEMA,1
JP,VIRAL LOAD INCREASED,1
JP,VISUAL ACUITY REDUCED,1
JP,WALKING DISABILITY,1
JP,YERSINIA SEPSIS,1
JP,ZYGOMYCOSIS,1
JO,DEATH,1
JO,IMMUNOSUPPRESSION,1
JO,LEGIONELLA INFECTION,1
JO,PNEUMONIA LEGIONELLA,1
KZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
KZ,PANCYTOPENIA,1
KE,ANAEMIA,4
KE,MENINGITIS CRYPTOCOCCAL,3
KE,ACUTE KIDNEY INJURY,2
KE,BLOOD CREATININE INCREASED,2
KE,DEATH,2
KE,RENAL FAILURE ACUTE,2
KE,URINE OUTPUT DECREASED,2
KE,WEIGHT INCREASED,2
KE,PNEUMONIA,1
KE,VOMITING,1
KP,EMBOLISM ARTERIAL,2
KP,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
KP,ACUTE PROMYELOCYTIC LEUKAEMIA,1
KP,CARDIAC ARREST,1
KP,CEREBRAL INFARCTION,1
KP,DEATH,1
KP,DERMATITIS BULLOUS,1
KP,NEUROPATHY PERIPHERAL,1
KP,RASH,1
KP,SEPSIS,1
KP,SUDDEN DEATH,1
KP,TOXIC SKIN ERUPTION,1
KP,TOXICITY TO VARIOUS AGENTS,1
KP,VENTRICULAR FIBRILLATION,1
KR,DISEASE PROGRESSION,57
KR,VENOUS THROMBOSIS,37
KR,DEATH,35
KR,FEBRILE NEUTROPENIA,21
KR,PNEUMONIA,18
KR,NEUTROPENIA,12
KR,ARTERIAL THROMBOSIS,11
KR,T-CELL LYMPHOMA RECURRENT,10
KR,PRODUCT USE ISSUE,9
KR,TOXICITY TO VARIOUS AGENTS,8
KR,ANAEMIA,7
KR,PYREXIA,7
KR,THROMBOCYTOPENIA,7
KR,TUMOUR LYSIS SYNDROME,7
KR,ASTHENIA,6
KR,DECREASED APPETITE,6
KR,NAUSEA,6
KR,SEPTIC SHOCK,6
KR,VOMITING,6
KR,ADVERSE EVENT,5
KR,DIARRHOEA,5
KR,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,4
KR,ATYPICAL FEMUR FRACTURE,4
KR,B-CELL LYMPHOMA RECURRENT,4
KR,CONSTIPATION,4
KR,CYTOMEGALOVIRUS INFECTION,4
KR,DELIRIUM,4
KR,DRUG EFFECT INCOMPLETE,4
KR,DRUG INEFFECTIVE,4
KR,HEPATIC FAILURE,4
KR,NEUROPATHY PERIPHERAL,4
KR,NEUTROPHIL COUNT DECREASED,4
KR,PNEUMONITIS,4
KR,UPPER RESPIRATORY TRACT INFECTION,4
KR,URINARY TRACT INFECTION,4
KR,ACUTE MYELOID LEUKAEMIA,3
KR,ALANINE AMINOTRANSFERASE INCREASED,3
KR,BACTERAEMIA,3
KR,BLOOD LACTATE DEHYDROGENASE INCREASED,3
KR,BRONCHOPULMONARY ASPERGILLOSIS,3
KR,CEREBRAL ASPERGILLOSIS,3
KR,COLITIS,3
KR,COOMBS DIRECT TEST POSITIVE,3
KR,COUGH,3
KR,DYSPNOEA,3
KR,HAEMOGLOBIN DECREASED,3
KR,HEPATOTOXICITY,3
KR,HERPES ZOSTER,3
KR,INFECTION,3
KR,LABORATORY TEST ABNORMAL,3
KR,PANCYTOPENIA,3
KR,SEPSIS,3
KR,SERUM FERRITIN INCREASED,3
KR,SOMNOLENCE,3
KR,TOTAL COMPLEMENT ACTIVITY DECREASED,3
KR,ACUTE MYOCARDIAL INFARCTION,2
KR,ACUTE RESPIRATORY DISTRESS SYNDROME,2
KR,BACK PAIN,2
KR,BASAL CELL CARCINOMA,2
KR,CARDIAC DISORDER,2
KR,CARDIAC FAILURE,2
KR,CELLULITIS,2
KR,COLON CANCER,2
KR,DYSPEPSIA,2
KR,FATIGUE,2
KR,FOETAL DISTRESS SYNDROME,2
KR,FOETAL EXPOSURE DURING PREGNANCY,2
KR,FUNGAEMIA,2
KR,GASTRIC CANCER,2
KR,GASTROENTERITIS,2
KR,GENERAL PHYSICAL HEALTH DETERIORATION,2
KR,HAEMOPTYSIS,2
KR,HEPATITIS B,2
KR,HYPOALBUMINAEMIA,2
KR,INSOMNIA,2
KR,JAUNDICE,2
KR,MATERNAL EXPOSURE DURING PREGNANCY,2
KR,MENINGITIS BACTERIAL,2
KR,METASTASES TO LYMPH NODES,2
KR,MUCOSAL INFLAMMATION,2
KR,MYELODYSPLASTIC SYNDROME,2
KR,MYELOPROLIFERATIVE NEOPLASM,2
KR,NASOPHARYNGEAL CANCER,2
KR,PAIN,2
KR,PANCREATIC CARCINOMA,2
KR,PAPILLARY THYROID CANCER,2
KR,PERIPHERAL SENSORY NEUROPATHY,2
KR,PRODUCT USE IN UNAPPROVED INDICATION,2
KR,PRODUCTIVE COUGH,2
KR,PROSTATE CANCER,2
KR,PULMONARY EMBOLISM,2
KR,PULMONARY FIBROSIS,2
KR,PULMONARY TUBERCULOSIS,2
KR,RECTAL CANCER STAGE II,2
KR,RESPIRATORY FAILURE,2
KR,RETICULOCYTE COUNT INCREASED,2
KR,RETICULOCYTE PERCENTAGE INCREASED,2
KR,STOMATITIS,2
KR,TRANSITIONAL CELL CARCINOMA,2
KR,TREMOR,2
KR,ABDOMINAL INFECTION,1
KR,ABDOMINAL PAIN,1
KR,ABDOMINAL PAIN UPPER,1
KR,ABDOMINAL SEPSIS,1
KR,ACNE,1
KR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
KR,ACUTE HEPATIC FAILURE,1
KR,ACUTE LUNG INJURY,1
KR,ACUTE RESPIRATORY FAILURE,1
KR,APPENDICITIS,1
KR,ARTHRALGIA,1
KR,ASPHYXIA,1
KR,ATRIAL FIBRILLATION,1
KR,ATYPICAL PNEUMONIA,1
KR,AZOTAEMIA,1
KR,BACTERIAL INFECTION,1
KR,BILIARY TRACT INFECTION,1
KR,BLISTER,1
KR,BLOOD ERYTHROPOIETIN INCREASED,1
KR,BONE MARROW FAILURE,1
KR,BRAIN NEOPLASM,1
KR,BURNING SENSATION,1
KR,CARDIAC DISCOMFORT,1
KR,CARDIOMYOPATHY,1
KR,CEREBRAL DISORDER,1
KR,CEREBRAL HAEMORRHAGE,1
KR,CHEST PAIN,1
KR,CHILLS,1
KR,CHRONIC GASTRITIS,1
KR,CLOSTRIDIUM DIFFICILE COLITIS,1
KR,CONDITION AGGRAVATED,1
KR,CUSHINGOID,1
KR,CYSTITIS HAEMORRHAGIC,1
KR,DERMATITIS,1
KR,DEVICE FAILURE,1
KR,DEVICE RELATED INFECTION,1
KR,DIFFUSE PANBRONCHIOLITIS,1
KR,DISSEMINATED CYTOMEGALOVIRAL INFECTION,1
KR,DIZZINESS,1
KR,DRUG INTOLERANCE,1
KR,DRUG-INDUCED LIVER INJURY,1
KR,DRY MOUTH,1
KR,ELECTROLYTE IMBALANCE,1
KR,ENDOCARDITIS,1
KR,ENOPHTHALMOS,1
KR,ENTEROCOLITIS,1
KR,EYE MOVEMENT DISORDER,1
KR,FLUID RETENTION,1
KR,FRACTURE NONUNION,1
KR,FUNGAL INFECTION,1
KR,GASTRIC HAEMORRHAGE,1
KR,GASTRIC PERFORATION,1
KR,GASTROINTESTINAL TOXICITY,1
KR,HAEMATOCHEZIA,1
KR,HAEMORRHAGE INTRACRANIAL,1
KR,HEADACHE,1
KR,HEPATITIS,1
KR,HEPATITIS A,1
KR,HEPATITIS C,1
KR,HEPATITIS VIRAL,1
KR,HISTIOCYTOSIS HAEMATOPHAGIC,1
KR,HIV ANTIBODY POSITIVE,1
KR,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
KR,HYPERSENSITIVITY,1
KR,HYPERTENSION,1
KR,HYPOAESTHESIA,1
KR,HYPOKALAEMIA,1
KR,HYPONATRAEMIA,1
KR,HYPOPHAGIA,1
KR,HYPOPHOSPHATAEMIA,1
KR,HYPOXIA,1
KR,IDIOPATHIC PULMONARY FIBROSIS,1
KR,ILL-DEFINED DISORDER,1
KR,IMMUNOGLOBULIN G4 RELATED DISEASE,1
KR,INFECTIOUS COLITIS,1
KR,INFECTIVE SPONDYLITIS,1
KR,INFUSION RELATED REACTION,1
KR,INTERSTITIAL LUNG DISEASE,1
KR,INTESTINAL FISTULA,1
KR,LACTIC ACIDOSIS,1
KR,LEUKOPENIA,1
KR,LIVER FUNCTION TEST INCREASED,1
KR,LOWER RESPIRATORY TRACT INFECTION,1
KR,LUNG DISORDER,1
KR,LYMPHADENOPATHY,1
KR,MENINGITIS VIRAL,1
KR,METABOLIC ACIDOSIS,1
KR,METABOLIC ENCEPHALOPATHY,1
KR,METASTASES TO CENTRAL NERVOUS SYSTEM,1
KR,METASTASIS,1
KR,MULTI-ORGAN FAILURE,1
KR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
KR,MUSCULAR WEAKNESS,1
KR,MYOCLONUS,1
KR,NEUROTOXICITY,1
KR,OEDEMA PERIPHERAL,1
KR,OESOPHAGEAL RUPTURE,1
KR,OSTEONECROSIS,1
KR,OTITIS MEDIA,1
KR,PAIN IN EXTREMITY,1
KR,PANCREATIC CYST RUPTURE,1
KR,PANCREATITIS,1
KR,PATENT DUCTUS ARTERIOSUS,1
KR,PERINEAL ERYTHEMA,1
KR,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
KR,PERITONEAL TUBERCULOSIS,1
KR,PERITONITIS,1
KR,PERITONITIS BACTERIAL,1
KR,PLASMA CELL MYELOMA,1
KR,PNEUMOCYSTIS JIROVECI PNEUMONIA,1
KR,PNEUMONIA FUNGAL,1
KR,PNEUMOTHORAX,1
KR,PREMATURE BABY,1
KR,PREMATURE DELIVERY,1
KR,PREMATURE LABOUR,1
KR,PROSTATE CANCER METASTATIC,1
KR,PYELONEPHRITIS ACUTE,1
KR,RASH,1
KR,RASH ERYTHEMATOUS,1
KR,RASH MACULO-PAPULAR,1
KR,RENAL INJURY,1
KR,RENAL TUBULAR INJURY,1
KR,RESPIRATORY ARREST,1
KR,RHABDOMYOLYSIS,1
KR,SEIZURE,1
KR,SINUS NODE DYSFUNCTION,1
KR,SKIN INFECTION,1
KR,SKIN LESION,1
KR,SKIN PLAQUE,1
KR,SOFT TISSUE INFECTION,1
KR,STATUS EPILEPTICUS,1
KR,SYNCOPE,1
KR,TENOSYNOVITIS,1
KR,TOOTH INFECTION,1
KR,TREATMENT FAILURE,1
KR,TUBERCULOSIS,1
KR,TUMOUR HAEMORRHAGE,1
KR,WEIGHT DECREASED,1
KR,WEIGHT INCREASED,1
LB,PYREXIA,8
LB,ANAEMIA,6
LB,FATIGUE,5
LB,STOMATITIS,5
LB,ARTHRITIS BACTERIAL,4
LB,BLOOD CREATININE INCREASED,4
LB,COUGH,4
LB,INFECTION,4
LB,SALMONELLA BACTERAEMIA,4
LB,TACHYCARDIA,4
LB,ARTHRALGIA,3
LB,DEATH,3
LB,HYPOTENSION,3
LB,INFLUENZA,3
LB,INTESTINAL OBSTRUCTION,3
LB,MUCORMYCOSIS,3
LB,NAUSEA,3
LB,NEUROPATHY PERIPHERAL,3
LB,NEUTROPENIA,3
LB,OEDEMA,3
LB,SEPTIC SHOCK,3
LB,TREMOR,3
LB,WEIGHT INCREASED,3
LB,ABDOMINAL PAIN,2
LB,ALOPECIA,2
LB,ANXIETY,2
LB,ATRIAL FIBRILLATION,2
LB,BACK PAIN,2
LB,C-REACTIVE PROTEIN INCREASED,2
LB,CANDIDA INFECTION,2
LB,CONSTIPATION,2
LB,DIARRHOEA,2
LB,DYSPNOEA,2
LB,ERYTHEMA,2
LB,FLUID RETENTION,2
LB,FOOD INTERACTION,2
LB,GANGRENE,2
LB,HAEMOGLOBIN DECREASED,2
LB,HEADACHE,2
LB,HEPATIC FAILURE,2
LB,HEPATITIS FULMINANT,2
LB,HYPERTENSION,2
LB,HYPONATRAEMIA,2
LB,INCORRECT DOSE ADMINISTERED,2
LB,LETHARGY,2
LB,MENINGITIS LISTERIA,2
LB,MUSCLE SPASMS,2
LB,MYALGIA,2
LB,MYELODYSPLASTIC SYNDROME,2
LB,NEUTROPHIL COUNT INCREASED,2
LB,OSTEOMYELITIS,2
LB,PAIN,2
LB,PAIN IN EXTREMITY,2
LB,PANCYTOPENIA,2
LB,RECTAL HAEMORRHAGE,2
LB,RENAL FAILURE,2
LB,STAPHYLOCOCCAL INFECTION,2
LB,TENDON RUPTURE,2
LB,THROMBOCYTOPENIA,2
LB,TOXICITY TO VARIOUS AGENTS,2
LB,URINARY TRACT INFECTION,2
LB,VITAMIN D DEFICIENCY,2
LB,ABDOMINAL DISTENSION,1
LB,ABDOMINAL PAIN UPPER,1
LB,ABSCESS,1
LB,ABSCESS BACTERIAL,1
LB,ACUTE HEPATIC FAILURE,1
LB,ACUTE MYELOID LEUKAEMIA,1
LB,ACUTE RESPIRATORY DISTRESS SYNDROME,1
LB,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
LB,ANGINA PECTORIS,1
LB,ARRHYTHMIA,1
LB,ASTHENIA,1
LB,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
LB,BLOOD BILIRUBIN INCREASED,1
LB,BLOOD CHOLESTEROL INCREASED,1
LB,BLOOD CREATINE INCREASED,1
LB,BLOOD IRON DECREASED,1
LB,BLOOD POTASSIUM DECREASED,1
LB,BLOOD PRESSURE INCREASED,1
LB,BLOOD URIC ACID INCREASED,1
LB,BONE PAIN,1
LB,BREAST PAIN,1
LB,BREAST ULCERATION,1
LB,CARDIAC DISORDER,1
LB,CARDIAC FAILURE,1
LB,CEREBRAL HAEMORRHAGE,1
LB,CEREBROVASCULAR ACCIDENT,1
LB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
LB,CLONUS,1
LB,COLECTOMY,1
LB,COLECTOMY TOTAL,1
LB,COLITIS ULCERATIVE,1
LB,COMPLICATION OF PREGNANCY,1
LB,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
LB,CONJUNCTIVAL HAEMORRHAGE,1
LB,CYTOGENETIC ANALYSIS ABNORMAL,1
LB,CYTOMEGALOVIRUS INFECTION,1
LB,CYTOMEGALOVIRUS PANCREATITIS,1
LB,DEHYDRATION,1
LB,DIARRHOEA HAEMORRHAGIC,1
LB,DISEASE PROGRESSION,1
LB,DIVERTICULUM,1
LB,DIZZINESS,1
LB,DRUG INEFFECTIVE,1
LB,DRUG RESISTANCE,1
LB,DRY SKIN,1
LB,DYSLIPIDAEMIA,1
LB,DYSPNOEA EXERTIONAL,1
LB,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,1
LB,ESCHERICHIA INFECTION,1
LB,EXTREMITY NECROSIS,1
LB,EYE SWELLING,1
LB,FEBRILE NEUTROPENIA,1
LB,GASTRIC DISORDER,1
LB,GASTROINTESTINAL INFECTION,1
LB,GASTROINTESTINAL INFLAMMATION,1
LB,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
LB,GLAUCOMA,1
LB,GLOMERULONEPHRITIS MEMBRANOUS,1
LB,GRAFT VERSUS HOST DISEASE IN SKIN,1
LB,GRAND MAL CONVULSION,1
LB,GRANULOMA SKIN,1
LB,HAEMATURIA,1
LB,HERPES VIRUS INFECTION,1
LB,HOT FLUSH,1
LB,HYPERGLYCAEMIA,1
LB,HYPERHIDROSIS,1
LB,HYPERPHOSPHATAEMIA,1
LB,HYPERTRIGLYCERIDAEMIA,1
LB,HYPOKINESIA,1
LB,HYPOTONIA,1
LB,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
LB,IMMUNOSUPPRESSION,1
LB,INFECTIVE ANEURYSM,1
LB,INFLUENZA LIKE ILLNESS,1
LB,INFUSION SITE PAIN,1
LB,INFUSION SITE REACTION,1
LB,INTENTIONAL PRODUCT MISUSE,1
LB,INTERSTITIAL LUNG DISEASE,1
LB,INTERVERTEBRAL DISC PROTRUSION,1
LB,INTESTINAL ISCHAEMIA,1
LB,INTESTINAL STENOSIS,1
LB,INTRAOCULAR PRESSURE INCREASED,1
LB,INVESTIGATION,1
LB,JOINT RANGE OF MOTION DECREASED,1
LB,JOINT STIFFNESS,1
LB,KLEBSIELLA INFECTION,1
LB,LEUKOPENIA,1
LB,LIPOMA,1
LB,LOSS OF CONSCIOUSNESS,1
LB,LYMPHOMA,1
LB,LYMPHOPENIA,1
LB,MALARIA,1
LB,MEMORY IMPAIRMENT,1
LB,MENORRHAGIA,1
LB,MENSTRUATION DELAYED,1
LB,METASTATIC GASTRIC CANCER,1
LB,MICROALBUMINURIA,1
LB,MOUTH HAEMORRHAGE,1
LB,MOUTH ULCERATION,1
LB,MYOCARDIAL INFARCTION,1
LB,NAIL DISORDER,1
LB,NEOPLASM,1
LB,NEPHROPATHY TOXIC,1
LB,NIGHT SWEATS,1
LB,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
LB,OCULAR HYPERAEMIA,1
LB,OCULAR HYPERTENSION,1
LB,OCULAR SARCOIDOSIS,1
LB,OEDEMA PERIPHERAL,1
LB,ONYCHOCLASIS,1
LB,ORAL ADMINISTRATION COMPLICATION,1
LB,ORAL DISORDER,1
LB,ORAL MUCOSAL ERYTHEMA,1
LB,ORAL PAIN,1
LB,ORGAN FAILURE,1
LB,OSTEONECROSIS,1
LB,OSTEOPOROSIS,1
LB,OVARIAN CYST,1
LB,OXYGEN SATURATION DECREASED,1
LB,PALLOR,1
LB,PALPITATIONS,1
LB,PETECHIAE,1
LB,PLASMA CELL MYELOMA,1
LB,PNEUMOCYSTIS JIROVECII INFECTION,1
LB,PNEUMONIA,1
LB,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
LB,PULMONARY EMBOLISM,1
LB,PULMONARY MASS,1
LB,PULMONARY OEDEMA,1
LB,RASH,1
LB,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
LB,RENAL TUBULAR DISORDER,1
LB,SACROILIITIS,1
LB,SLEEP DISORDER,1
LB,SMALL INTESTINAL PERFORATION,1
LB,SPEECH DISORDER,1
LB,SPLENOMEGALY,1
LB,SQUAMOUS CELL CARCINOMA OF SKIN,1
LB,STOMATITIS NECROTISING,1
LB,SUBCUTANEOUS ABSCESS,1
LB,SUPERINFECTION,1
LB,TENDERNESS,1
LB,THERAPEUTIC RESPONSE DECREASED,1
LB,TONGUE EXFOLIATION,1
LB,TONGUE INJURY,1
LB,TOXIC ENCEPHALOPATHY,1
LB,TRANSPLANT DYSFUNCTION,1
LB,VARICELLA,1
LB,VITAMIN D DECREASED,1
LB,WEIGHT DECREASED,1
LB,WOUND,1
LY,ACUTE RESPIRATORY DISTRESS SYNDROME,1
LY,LOWER RESPIRATORY TRACT INFECTION,1
LY,UPPER RESPIRATORY TRACT CONGESTION,1
LT,PYREXIA,4
LT,ARTHRITIS,3
LT,TUBERCULOSIS,3
LT,ASPERGILLOMA,2
LT,BONE MARROW TOXICITY,2
LT,ARTHRALGIA,1
LT,ARTHRITIS BACTERIAL,1
LT,DRUG INEFFECTIVE,1
LU,CHEST PAIN,1
LU,PARAESTHESIA,1
LU,RESPIRATORY DISORDER,1
MK,IMMUNE THROMBOCYTOPENIC PURPURA,2
MK,HERPES VIRUS INFECTION,1
MK,OESOPHAGITIS HAEMORRHAGIC,1
MY,PNEUMONIA,4
MY,NEUTROPENIA,3
MY,SEPSIS,2
MY,ABDOMINAL DISTENSION,1
MY,ASTHENIA,1
MY,BACTERAEMIA,1
MY,CARDIAC ARREST,1
MY,DEATH,1
MY,DIARRHOEA,1
MY,DIPLOPIA,1
MY,DYSPNOEA,1
MY,DYSURIA,1
MY,ENTEROVESICAL FISTULA,1
MY,GASTROENTERITIS,1
MY,INCORRECT DOSE ADMINISTERED,1
MY,LEUKOPENIA,1
MY,LYMPHADENOPATHY,1
MY,MULTI-ORGAN FAILURE,1
MY,MYOCARDIAL ISCHAEMIA,1
MY,NAUSEA,1
MY,NEUTROPENIC SEPSIS,1
MY,PYREXIA,1
MY,RETCHING,1
MY,SEPTIC SHOCK,1
MY,STRONGYLOIDIASIS,1
MY,THROMBOCYTOPENIA,1
MY,THROMBOSIS,1
MY,UROSEPSIS,1
MY,VENOUS THROMBOSIS LIMB,1
MY,VOMITING,1
MY,WHITE BLOOD CELL COUNT DECREASED,1
MQ,B-CELL LYMPHOMA,1
MQ,DISTURBANCE IN ATTENTION,1
MQ,DRUG INEFFECTIVE,1
MQ,FEBRILE NEUTROPENIA,1
MQ,FUNGAL INFECTION,1
MQ,HEADACHE,1
MQ,IMMUNODEFICIENCY,1
MQ,SKIN DISCOLOURATION,1
MQ,SKIN HAEMORRHAGE,1
MQ,SKIN LESION,1
MQ,SKIN ULCER,1
MX,FEBRILE NEUTROPENIA,28
MX,PNEUMONIA,25
MX,DIARRHOEA,20
MX,NEUTROPENIA,17
MX,HEADACHE,15
MX,DRUG INEFFECTIVE,14
MX,TOXICITY TO VARIOUS AGENTS,14
MX,ARTHRALGIA,13
MX,ASTHENIA,13
MX,COUGH,13
MX,FATIGUE,13
MX,URINARY TRACT INFECTION,12
MX,ANAEMIA,11
MX,EXPOSURE DURING PREGNANCY,11
MX,GAIT DISTURBANCE,11
MX,NAUSEA,11
MX,VOMITING,11
MX,DYSPNOEA,10
MX,EXTRAPULMONARY TUBERCULOSIS,10
MX,PYREXIA,10
MX,SEPTIC SHOCK,10
MX,DISEASE PROGRESSION,9
MX,FALL,9
MX,INFECTION,9
MX,ABDOMINAL PAIN UPPER,8
MX,DEATH,8
MX,DECREASED APPETITE,8
MX,INFLUENZA,8
MX,PAIN,8
MX,TACHYCARDIA,8
MX,WEIGHT DECREASED,8
MX,ABDOMINAL PAIN,7
MX,DEPRESSION,7
MX,DIZZINESS,7
MX,HYPERTENSION,7
MX,INFLAMMATION,7
MX,PRODUCT USE ISSUE,7
MX,THROMBOCYTOPENIA,7
MX,ABORTION SPONTANEOUS,6
MX,ANXIETY,6
MX,CONDITION AGGRAVATED,6
MX,ERYTHEMA,6
MX,INSOMNIA,6
MX,MATERNAL EXPOSURE DURING PREGNANCY,6
MX,MUCORMYCOSIS,6
MX,ORAL CANDIDIASIS,6
MX,PAIN IN EXTREMITY,6
MX,RESPIRATORY FAILURE,6
MX,SEPSIS,6
MX,WEIGHT INCREASED,6
MX,WHITE BLOOD CELL COUNT DECREASED,6
MX,BACK PAIN,5
MX,CARDIO-RESPIRATORY ARREST,5
MX,CONSTIPATION,5
MX,GASTRITIS,5
MX,GENERAL PHYSICAL HEALTH DETERIORATION,5
MX,HAEMOGLOBIN DECREASED,5
MX,HEPATIC FUNCTION ABNORMAL,5
MX,MUCOSAL INFLAMMATION,5
MX,MUSCULAR WEAKNESS,5
MX,PLATELET COUNT DECREASED,5
MX,PRURITUS,5
MX,RASH,5
MX,RENAL FAILURE,5
MX,STOMATITIS,5
MX,ACUTE RESPIRATORY DISTRESS SYNDROME,4
MX,ARRHYTHMIA,4
MX,BONE PAIN,4
MX,CEREBRAL HAEMORRHAGE,4
MX,DEHYDRATION,4
MX,DEPRESSED MOOD,4
MX,FEELING ABNORMAL,4
MX,FEELING HOT,4
MX,FOETAL DEATH,4
MX,FOETAL EXPOSURE DURING PREGNANCY,4
MX,GASTROINTESTINAL HAEMORRHAGE,4
MX,HAEMOPTYSIS,4
MX,HYPERGLYCAEMIA,4
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
MX,MALAISE,4
MX,MEDICATION ERROR,4
MX,MOBILITY DECREASED,4
MX,MYCOBACTERIAL INFECTION,4
MX,OEDEMA PERIPHERAL,4
MX,PENICILLIUM INFECTION,4
MX,PHARYNGITIS,4
MX,PREMATURE BABY,4
MX,PULMONARY FIBROSIS,4
MX,SEIZURE,4
MX,STRESS,4
MX,TREMOR,4
MX,VITAMIN B12 ABNORMAL,4
MX,ABDOMINAL DISCOMFORT,3
MX,ABDOMINAL DISTENSION,3
MX,ASTHMA,3
MX,BLOOD UREA INCREASED,3
MX,BURNING SENSATION,3
MX,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
MX,COCCIDIOIDOMYCOSIS,3
MX,COMPLICATIONS OF TRANSPLANTED KIDNEY,3
MX,DERMATITIS ATOPIC,3
MX,DISORIENTATION,3
MX,DRY SKIN,3
MX,FEELING OF DESPAIR,3
MX,GASTROENTERITIS,3
MX,GASTROINTESTINAL DISORDER,3
MX,GENERALISED OEDEMA,3
MX,GRANULOCYTOPENIA,3
MX,HALLUCINATION_ VISUAL,3
MX,HYPERHIDROSIS,3
MX,HYPOPHAGIA,3
MX,HYPOTENSION,3
MX,IMMUNODEFICIENCY,3
MX,LIMB DISCOMFORT,3
MX,MALNUTRITION,3
MX,MEMORY IMPAIRMENT,3
MX,MUSCLE RIGIDITY,3
MX,MUSCULOSKELETAL STIFFNESS,3
MX,NASAL CONGESTION,3
MX,NUTRITIONAL CONDITION ABNORMAL,3
MX,OROPHARYNGEAL PAIN,3
MX,OSTEOPOROSIS,3
MX,PALLOR,3
MX,PANCYTOPENIA,3
MX,PARAESTHESIA,3
MX,PERIPHERAL SWELLING,3
MX,PLATELET COUNT ABNORMAL,3
MX,PLEURAL EFFUSION,3
MX,PRODUCTIVE COUGH,3
MX,RENAL FAILURE ACUTE,3
MX,RESPIRATORY DISTRESS,3
MX,SWELLING,3
MX,SYSTEMIC LUPUS ERYTHEMATOSUS,3
MX,THROAT IRRITATION,3
MX,THROMBOSIS,3
MX,TRANSFUSION,3
MX,TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM,3
MX,VISION BLURRED,3
MX,ABSCESS,2
MX,ACNE FULMINANS,2
MX,AGGRESSION,2
MX,ANGER,2
MX,ARTHRITIS,2
MX,ASPARTATE AMINOTRANSFERASE INCREASED,2
MX,ASPHYXIA,2
MX,ATRIAL FIBRILLATION,2
MX,BLOOD CREATININE INCREASED,2
MX,BLOOD DISORDER,2
MX,BLOOD GLUCOSE INCREASED,2
MX,BONE MARROW FAILURE,2
MX,BRONCHIECTASIS,2
MX,BURKHOLDERIA CEPACIA COMPLEX INFECTION,2
MX,CANDIDA INFECTION,2
MX,CARDIAC ARREST,2
MX,CARDIAC FAILURE CONGESTIVE,2
MX,CATARACT,2
MX,CEREBRAL ATROPHY,2
MX,CEREBRAL ISCHAEMIA,2
MX,CHEST PAIN,2
MX,CHOLECYSTITIS,2
MX,CHOLELITHIASIS,2
MX,COLITIS,2
MX,CONCOMITANT DISEASE AGGRAVATED,2
MX,CONTUSION,2
MX,CUSHING^S SYNDROME,2
MX,DIABETES MELLITUS,2
MX,DIABETIC KETOACIDOSIS,2
MX,DISEASE RECURRENCE,2
MX,DISSEMINATED INTRAVASCULAR COAGULATION,2
MX,DRUG DOSE OMISSION,2
MX,DRUG EFFECT INCOMPLETE,2
MX,DRUG INTOLERANCE,2
MX,DYSPHAGIA,2
MX,DYSPNOEA EXERTIONAL,2
MX,DYSSTASIA,2
MX,EAR PAIN,2
MX,EMOTIONAL DISORDER,2
MX,ESCHERICHIA INFECTION,2
MX,EYE PAIN,2
MX,FEELING COLD,2
MX,FOOD ALLERGY,2
MX,GASTRIC DISORDER,2
MX,H1N1 INFLUENZA,2
MX,HAEMATOMA,2
MX,HAEMATOTOXICITY,2
MX,HAEMORRHAGE,2
MX,HEPATIC STEATOSIS,2
MX,HERPES VIRUS INFECTION,2
MX,HIP FRACTURE,2
MX,HOT FLUSH,2
MX,HYPERSOMNIA,2
MX,HYPERTENSIVE CRISIS,2
MX,HYPOKALAEMIA,2
MX,HYPONATRAEMIA,2
MX,HYPOTHERMIA,2
MX,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
MX,INCOHERENT,2
MX,INTENTIONAL PRODUCT MISUSE,2
MX,INTENTIONAL PRODUCT USE ISSUE,2
MX,INTESTINAL OBSTRUCTION,2
MX,IRRITABILITY,2
MX,IRRITABLE BOWEL SYNDROME,2
MX,JAUNDICE,2
MX,JOINT SWELLING,2
MX,LEUKOPENIA,2
MX,LIVER INJURY,2
MX,LOSS OF CONSCIOUSNESS,2
MX,LOW BIRTH WEIGHT BABY,2
MX,LUNG DISORDER,2
MX,LUNG INFECTION,2
MX,LYMPHADENOPATHY,2
MX,LYMPHOCYTE COUNT DECREASED,2
MX,MALIGNANT NEOPLASM PROGRESSION,2
MX,MASS,2
MX,MENINGITIS TUBERCULOUS,2
MX,MENTAL IMPAIRMENT,2
MX,METABOLIC ACIDOSIS,2
MX,METASTASES TO CENTRAL NERVOUS SYSTEM,2
MX,MOUTH ULCERATION,2
MX,MUCOSAL ATROPHY,2
MX,MULTIPLE DRUG THERAPY,2
MX,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
MX,MULTIPLE SCLEROSIS RELAPSE,2
MX,MUSCLE SPASMS,2
MX,MUSCULOSKELETAL DISORDER,2
MX,NEOPLASM,2
MX,NEOPLASM PROGRESSION,2
MX,NERVOUS SYSTEM DISORDER,2
MX,NEUROLOGICAL DECOMPENSATION,2
MX,NEUROLOGICAL INFECTION,2
MX,NEUROPATHY PERIPHERAL,2
MX,NOCARDIOSIS,2
MX,ORAL DISORDER,2
MX,ORAL PAIN,2
MX,OVERDOSE,2
MX,PAIN OF SKIN,2
MX,PALPABLE PURPURA,2
MX,PEMPHIGUS,2
MX,PNEUMOCYSTIS JIROVECII INFECTION,2
MX,PNEUMONITIS,2
MX,PREMATURE DELIVERY,2
MX,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
MX,PSYCHOTIC DISORDER,2
MX,PULMONARY ARTERIAL HYPERTENSION,2
MX,PULMONARY EMBOLISM,2
MX,PULMONARY OEDEMA,2
MX,RASH GENERALISED,2
MX,RESPIRATORY TRACT INFECTION,2
MX,RESTLESSNESS,2
MX,RHINITIS ALLERGIC,2
MX,SKIN DISCOLOURATION,2
MX,SKIN EXFOLIATION,2
MX,SKIN LESION,2
MX,SKIN SWELLING,2
MX,SOMNOLENCE,2
MX,SPEECH DISORDER,2
MX,STEROID THERAPY,2
MX,STILLBIRTH,2
MX,SWELLING FACE,2
MX,TAKAYASU^S ARTERITIS,2
MX,TENDON RUPTURE,2
MX,THERAPEUTIC RESPONSE DECREASED,2
MX,THROAT TIGHTNESS,2
MX,THROMBOCYTOPENIC PURPURA,2
MX,THYROID FUNCTION TEST ABNORMAL,2
MX,TRANSPLANT REJECTION,2
MX,TREATMENT NONCOMPLIANCE,2
MX,TYPE 2 DIABETES MELLITUS,2
MX,URTICARIA,2
MX,VASCULITIS,2
MX,VISUAL ACUITY REDUCED,2
MX,WHITE BLOOD CELL COUNT INCREASED,2
MX,ABDOMINAL SEPSIS,1
MX,ABNORMAL BEHAVIOUR,1
MX,ABORTION INDUCED,1
MX,ACID FAST BACILLI INFECTION,1
MX,ACID PEPTIC DISEASE,1
MX,ACIDOSIS,1
MX,ACNE,1
MX,ACUTE GRAFT VERSUS HOST DISEASE,1
MX,ACUTE KIDNEY INJURY,1
MX,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
MX,ACUTE MYELOID LEUKAEMIA RECURRENT,1
MX,ACUTE MYOCARDIAL INFARCTION,1
MX,ACUTE RESPIRATORY FAILURE,1
MX,ACUTE SINUSITIS,1
MX,ADRENAL SUPPRESSION,1
MX,AFFECT LABILITY,1
MX,AGEUSIA,1
MX,AGITATION,1
MX,AIR EMBOLISM,1
MX,ALANINE AMINOTRANSFERASE INCREASED,1
MX,ALOPECIA,1
MX,ALVEOLITIS ALLERGIC,1
MX,AMAUROSIS,1
MX,ANAL HAEMORRHAGE,1
MX,ANAPHYLACTIC REACTION,1
MX,ANGIOEDEMA,1
MX,ANHEDONIA,1
MX,ANIMAL BITE,1
MX,ANTEROGRADE AMNESIA,1
MX,ANTICOAGULATION DRUG LEVEL INCREASED,1
MX,ANURIA,1
MX,APATHY,1
MX,APLASTIC ANAEMIA,1
MX,APPENDICITIS,1
MX,APPLICATION SITE SWELLING,1
MX,ARACHNOID CYST,1
MX,ARTHROPATHY,1
MX,ATOPY,1
MX,ATRIOVENTRICULAR BLOCK COMPLETE,1
MX,ATYPICAL PNEUMONIA,1
MX,AZOTAEMIA,1
MX,BACTERAEMIA,1
MX,BACTERIAL INFECTION,1
MX,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
MX,BLEPHAROSPASM,1
MX,BLINDNESS,1
MX,BLINDNESS TRANSIENT,1
MX,BLISTER,1
MX,BLOOD ALKALINE PHOSPHATASE INCREASED,1
MX,BLOOD BICARBONATE DECREASED,1
MX,BLOOD BILIRUBIN INCREASED,1
MX,BLOOD CALCIUM DECREASED,1
MX,BLOOD CHOLESTEROL INCREASED,1
MX,BLOOD CREATINE INCREASED,1
MX,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
MX,BLOOD CULTURE POSITIVE,1
MX,BLOOD GLUCOSE DECREASED,1
MX,BLOOD GROWTH HORMONE INCREASED,1
MX,BLOOD OSMOLARITY INCREASED,1
MX,BLOOD PRESSURE DECREASED,1
MX,BLOOD TRIGLYCERIDES INCREASED,1
MX,BLOOD URIC ACID INCREASED,1
MX,BODY TEMPERATURE INCREASED,1
MX,BONE DENSITY DECREASED,1
MX,BONE DISORDER,1
MX,BONE MARROW DISORDER,1
MX,BONE MARROW TOXICITY,1
MX,BRADYARRHYTHMIA,1
MX,BRADYCARDIA,1
MX,BRADYKINESIA,1
MX,BRADYPHRENIA,1
MX,BRAIN HERNIATION,1
MX,BRAIN INJURY,1
MX,BRAIN OEDEMA,1
MX,BREAST CANCER,1
MX,BREAST MASS,1
MX,BRONCHIOLITIS,1
MX,BRONCHOSPASM,1
MX,BURNING MOUTH SYNDROME,1
MX,BURSITIS INFECTIVE,1
MX,CACHEXIA,1
MX,CAPILLARY LEAK SYNDROME,1
MX,CARDIAC DISORDER,1
MX,CARDIAC FAILURE,1
MX,CARDIOVASCULAR DISORDER,1
MX,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
MX,CEREBRAL INFARCTION,1
MX,CEREBROVASCULAR ACCIDENT,1
MX,CHEST DISCOMFORT,1
MX,CHILLS,1
MX,CHONDROPATHY,1
MX,CHRONIC ALLOGRAFT NEPHROPATHY,1
MX,CHRONIC GRAFT VERSUS HOST DISEASE,1
MX,CHRONIC KIDNEY DISEASE,1
MX,CLOSTRIDIUM DIFFICILE INFECTION,1
MX,COLITIS ULCERATIVE,1
MX,COMPLEX PARTIAL SEIZURES,1
MX,CONCOMITANT DISEASE PROGRESSION,1
MX,CONFUSIONAL STATE,1
MX,CONGENITAL ANOMALY,1
MX,CONGESTIVE CARDIOMYOPATHY,1
MX,CRANIOCEREBRAL INJURY,1
MX,CREATININE RENAL CLEARANCE DECREASED,1
MX,CRYPTOCOCCOSIS,1
MX,CUTANEOUS TUBERCULOSIS,1
MX,CYANOSIS,1
MX,CYTOGENETIC ANALYSIS ABNORMAL,1
MX,CYTOMEGALOVIRUS INFECTION,1
MX,CYTOPENIA,1
MX,DECREASED IMMUNE RESPONSIVENESS,1
MX,DECREASED INTEREST,1
MX,DEMENTIA,1
MX,DEMYELINATION,1
MX,DENTAL CARIES,1
MX,DERMATITIS,1
MX,DIPLOPIA,1
MX,DISSEMINATED TUBERCULOSIS,1
MX,DRUG ADMINISTRATION ERROR,1
MX,DRUG DEPENDENCE,1
MX,DRUG HYPERSENSITIVITY,1
MX,DRUG LEVEL BELOW THERAPEUTIC,1
MX,DRUG LEVEL DECREASED,1
MX,DRUG RESISTANCE,1
MX,DRY MOUTH,1
MX,DYSGRAPHIA,1
MX,DYSKINESIA,1
MX,DYSPEPSIA,1
MX,DYSPHONIA,1
MX,DYSPNOEA AT REST,1
MX,DYSURIA,1
MX,EAR DISCOMFORT,1
MX,EAR PRURITUS,1
MX,EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY WITH BURST-SUPPRESSION,1
MX,EARLY SATIETY,1
MX,EATING DISORDER,1
MX,ELECTROLYTE IMBALANCE,1
MX,EMBOLISM,1
MX,EMOTIONAL DISTRESS,1
MX,ENTERITIS,1
MX,ENTEROCOCCAL INFECTION,1
MX,ENTEROCOLITIS INFECTIOUS,1
MX,EPILEPSY,1
MX,EPISTAXIS,1
MX,ESCHERICHIA TEST POSITIVE,1
MX,EVANS SYNDROME,1
MX,EXPIRED PRODUCT ADMINISTERED,1
MX,EYE ABSCESS,1
MX,EYE SWELLING,1
MX,EYELID PTOSIS,1
MX,FACE OEDEMA,1
MX,FAECAL VOLUME INCREASED,1
MX,FEEDING DISORDER,1
MX,FLATULENCE,1
MX,FLUID OVERLOAD,1
MX,FLUID RETENTION,1
MX,FLUSHING,1
MX,FOETAL GROWTH RESTRICTION,1
MX,FRACTURE DISPLACEMENT,1
MX,FRUSTRATION TOLERANCE DECREASED,1
MX,FUNGAL INFECTION,1
MX,GALLBLADDER POLYP,1
MX,GASTRIC INFECTION,1
MX,GASTRIC ULCER,1
MX,GASTROINTESTINAL INFLAMMATION,1
MX,GASTROINTESTINAL PAIN,1
MX,GASTROOESOPHAGEAL REFLUX DISEASE,1
MX,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
MX,GENERALISED ERYTHEMA,1
MX,GENERALISED TONIC-CLONIC SEIZURE,1
MX,GINGIVAL BLEEDING,1
MX,GINGIVAL ULCERATION,1
MX,GLOMUS TUMOUR,1
MX,GOITRE,1
MX,GRAFT VERSUS HOST DISEASE,1
MX,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
MX,GRAFT VERSUS HOST DISEASE IN SKIN,1
MX,GRANULOMA,1
MX,GRANULOMATOSIS WITH POLYANGIITIS,1
MX,HAEMATOCHEZIA,1
MX,HAEMODYNAMIC INSTABILITY,1
MX,HAEMOGLOBIN INCREASED,1
MX,HAEMOLYTIC ANAEMIA,1
MX,HAEMORRHAGIC ANAEMIA,1
MX,HAEMORRHAGIC CEREBRAL INFARCTION,1
MX,HAEMORRHOIDAL HAEMORRHAGE,1
MX,HAEMORRHOIDS,1
MX,HAEMOTHORAX,1
MX,HALLUCINATION,1
MX,HALLUCINATION_ AUDITORY,1
MX,HEAD DEFORMITY,1
MX,HEAD INJURY,1
MX,HEART RATE INCREASED,1
MX,HELICOBACTER GASTRITIS,1
MX,HEMIANOPIA,1
MX,HEMIPARESIS,1
MX,HEPATIC CIRRHOSIS,1
MX,HEPATIC CYST,1
MX,HEPATIC FAILURE,1
MX,HEPATITIS,1
MX,HEPATITIS A,1
MX,HEPATITIS C,1
MX,HEPATOBILIARY DISEASE,1
MX,HEPATOTOXICITY,1
MX,HIGH DENSITY LIPOPROTEIN INCREASED,1
MX,HIRSUTISM,1
MX,HISTIOCYTOSIS HAEMATOPHAGIC,1
MX,HODGKIN^S DISEASE,1
MX,HUMERUS FRACTURE,1
MX,HUNGER,1
MX,HYPERAMYLASAEMIA,1
MX,HYPERBILIRUBINAEMIA,1
MX,HYPERCAPNIA,1
MX,HYPERLIPASAEMIA,1
MX,HYPERSENSITIVITY,1
MX,HYPERTHYROIDISM,1
MX,HYPERTRIGLYCERIDAEMIA,1
MX,HYPOAESTHESIA,1
MX,HYPOAESTHESIA ORAL,1
MX,HYPOALBUMINAEMIA,1
MX,HYPOCALCAEMIA,1
MX,HYPOMAGNESAEMIA,1
MX,HYPOTHYROIDISM,1
MX,HYPOXIA,1
MX,ILEUS,1
MX,IMMINENT ABORTION,1
MX,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
MX,INCORRECT DRUG ADMINISTRATION DURATION,1
MX,INCREASED APPETITE,1
MX,INFUSION RELATED REACTION,1
MX,INFUSION SITE HAEMATOMA,1
MX,INGUINAL HERNIA,1
MX,INJECTION SITE PAIN,1
MX,INTERSTITIAL LUNG DISEASE,1
MX,INTESTINAL DILATATION,1
MX,INTESTINAL PERFORATION,1
MX,INTRA-ABDOMINAL FLUID COLLECTION,1
MX,INTRAOCULAR PRESSURE INCREASED,1
MX,JOINT CREPITATION,1
MX,JOINT EFFUSION,1
MX,JOINT STIFFNESS,1
MX,KETONURIA,1
MX,KIDNEY INFECTION,1
MX,KIDNEY TRANSPLANT REJECTION,1
MX,KNEE DEFORMITY,1
MX,LACERATION,1
MX,LARGE INTESTINE PERFORATION,1
MX,LEUKAEMIA MONOCYTIC,1
MX,LEUKOCYTOSIS,1
MX,LIGAMENT SPRAIN,1
MX,LIP DRY,1
MX,LIP SWELLING,1
MX,LIPASE INCREASED,1
MX,LIVER FUNCTION TEST ABNORMAL,1
MX,LIVER TRANSPLANT REJECTION,1
MX,LOOSE TOOTH,1
MX,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,1
MX,LUNG CYST,1
MX,LUNG NEOPLASM MALIGNANT,1
MX,LYMPHOMA,1
MX,LYMPHOPENIA,1
MX,LYMPHOPROLIFERATIVE DISORDER,1
MX,MAJOR DEPRESSION,1
MX,MALLORY-WEISS SYNDROME,1
MX,MATERNAL DRUGS AFFECTING FOETUS,1
MX,MELAENA,1
MX,MELANOCYTIC NAEVUS,1
MX,MENTAL DISORDER,1
MX,METASTASES TO LUNG,1
MX,MICROANGIOPATHY,1
MX,MIGRAINE,1
MX,MILLER FISHER SYNDROME,1
MX,MOOD ALTERED,1
MX,MOUTH HAEMORRHAGE,1
MX,MOVEMENT DISORDER,1
MX,MULTIPLE SCLEROSIS,1
MX,MUSCLE INJURY,1
MX,MUSCULOSKELETAL PAIN,1
MX,MYALGIA,1
MX,MYASTHENIA GRAVIS,1
MX,NEOPLASM MALIGNANT,1
MX,NEPHROLITHIASIS,1
MX,NERVOUSNESS,1
MX,NEURALGIA,1
MX,NEUROBLASTOMA,1
MX,NEUROPSYCHIATRIC SYMPTOMS,1
MX,NEUTROPHIL COUNT DECREASED,1
MX,NIGHTMARE,1
MX,NODULE,1
MX,NON-HODGKIN^S LYMPHOMA RECURRENT,1
MX,NOSOCOMIAL INFECTION,1
MX,OCULAR HYPERAEMIA,1
MX,OEDEMA,1
MX,OESOPHAGEAL DISORDER,1
MX,OLIGURIA,1
MX,OPTIC ISCHAEMIC NEUROPATHY,1
MX,ORAL DISCOMFORT,1
MX,ORAL INFECTION,1
MX,OSTEONECROSIS,1
MX,OVERLAP SYNDROME,1
MX,OVERWEIGHT,1
MX,PACKED RED BLOOD CELL TRANSFUSION,1
MX,PALPITATIONS,1
MX,PANCREATITIS,1
MX,PANCREATITIS ACUTE,1
MX,PAPILLARY THYROID CANCER,1
MX,PAPILLOMA,1
MX,PARALYSIS,1
MX,PARATHYROID DISORDER,1
MX,PARESIS,1
MX,PARTIAL SEIZURES,1
MX,PATERNAL EXPOSURE TIMING UNSPECIFIED,1
MX,PEAU D^ORANGE,1
MX,PELVIC INFLAMMATORY DISEASE,1
MX,PELVIC PAIN,1
MX,PEPTIC ULCER,1
MX,PERFORMANCE STATUS DECREASED,1
MX,PERITONEAL TUBERCULOSIS,1
MX,PERSONALITY DISORDER,1
MX,PHARYNGEAL MASS,1
MX,PHARYNGEAL OEDEMA,1
MX,PHARYNGEAL ULCERATION,1
MX,PHARYNGOTONSILLITIS,1
MX,PHLEBITIS,1
MX,PITUITARY TUMOUR BENIGN,1
MX,PLACENTAL DISORDER,1
MX,PLEURITIC PAIN,1
MX,PNEUMOCYSTIS JIROVECI PNEUMONIA,1
MX,PNEUMONIA BACTERIAL,1
MX,PNEUMONIA PSEUDOMONAL,1
MX,PNEUMOTHORAX,1
MX,POLYARTHRITIS,1
MX,POST-TRAUMATIC HEADACHE,1
MX,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
MX,POSTICTAL STATE,1
MX,PREGNANCY ON CONTRACEPTIVE,1
MX,PRESCRIBED OVERDOSE,1
MX,PRODUCT QUALITY ISSUE,1
MX,PRODUCT SUBSTITUTION ISSUE,1
MX,PRODUCT USE IN UNAPPROVED INDICATION,1
MX,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
MX,PROSTATE CANCER,1
MX,PROSTATE CANCER METASTATIC,1
MX,PROTEIN C INCREASED,1
MX,PROTEIN URINE PRESENT,1
MX,PRURITUS GENERALISED,1
MX,PSEUDOMONAS INFECTION,1
MX,PSORIASIS,1
MX,PSYCHOTIC BEHAVIOUR,1
MX,PULMONARY HAEMORRHAGE,1
MX,PULMONARY MASS,1
MX,PYODERMA,1
MX,PYODERMA GANGRENOSUM,1
MX,RASH ERYTHEMATOUS,1
MX,RASH MACULAR,1
MX,RASH PRURITIC,1
MX,RECTAL HAEMORRHAGE,1
MX,RENAL DISORDER,1
MX,RENAL IMPAIRMENT,1
MX,RENAL PAIN,1
MX,RENAL TRANSPLANT,1
MX,RENAL TUBULAR NECROSIS,1
MX,RESPIRATORY ARREST,1
MX,RESPIRATORY DISORDER,1
MX,RETINAL DETACHMENT,1
MX,RETINOPATHY,1
MX,RHODOCOCCUS INFECTION,1
MX,RIB DEFORMITY,1
MX,RIB FRACTURE,1
MX,RIGHT VENTRICULAR FAILURE,1
MX,SCAB,1
MX,SCLERITIS,1
MX,SCOLIOSIS,1
MX,SECOND PRIMARY MALIGNANCY,1
MX,SENILE DEMENTIA,1
MX,SENSORY DISTURBANCE,1
MX,SEROSITIS,1
MX,SHOCK,1
MX,SILENT MYOCARDIAL INFARCTION,1
MX,SINUSITIS,1
MX,SJOGREN^S SYNDROME,1
MX,SKIN BURNING SENSATION,1
MX,SKIN DISORDER,1
MX,SKIN HAEMORRHAGE,1
MX,SKIN INFECTION,1
MX,SKIN REACTION,1
MX,SKIN ULCER,1
MX,SOPOR,1
MX,SPINAL OPERATION,1
MX,SQUAMOUS CELL CARCINOMA,1
MX,STATUS EPILEPTICUS,1
MX,STENOSIS,1
MX,STRESS AT WORK,1
MX,SUDDEN VISUAL LOSS,1
MX,SUFFOCATION FEELING,1
MX,SUPERFICIAL VEIN PROMINENCE,1
MX,SURGERY,1
MX,TACHYPNOEA,1
MX,TEMPERATURE REGULATION DISORDER,1
MX,TENDONITIS,1
MX,TENSION,1
MX,THERAPEUTIC RESPONSE UNEXPECTED,1
MX,THERMAL BURN,1
MX,THROMBOCYTOSIS,1
MX,THROMBOPHLEBITIS,1
MX,THROMBOSIS MESENTERIC VESSEL,1
MX,THROMBOTIC MICROANGIOPATHY,1
MX,THYROIDITIS,1
MX,TONGUE ULCERATION,1
MX,TONSILLAR INFLAMMATION,1
MX,TOOTH ABSCESS,1
MX,TOXIC EPIDERMAL NECROLYSIS,1
MX,TOXIC LEUKOENCEPHALOPATHY,1
MX,TRANSIENT ISCHAEMIC ATTACK,1
MX,TUBERCULOSIS,1
MX,TUBERCULOSIS LIVER,1
MX,TUBULOINTERSTITIAL NEPHRITIS,1
MX,UNDERDOSE,1
MX,UNDERWEIGHT,1
MX,UNEVALUABLE EVENT,1
MX,UNRESPONSIVE TO STIMULI,1
MX,UPPER GASTROINTESTINAL HAEMORRHAGE,1
MX,UPPER RESPIRATORY TRACT INFECTION,1
MX,URETHRAL OBSTRUCTION,1
MX,URINARY NITROGEN INCREASED,1
MX,URINARY TRACT INFECTION FUNGAL,1
MX,URINE OUTPUT DECREASED,1
MX,VAGINAL INFECTION,1
MX,VARICELLA,1
MX,VARICOSE VEIN,1
MX,VASCULAR GRAFT THROMBOSIS,1
MX,VENOUS OCCLUSION,1
MX,VENOUS THROMBOSIS,1
MX,VENOUS THROMBOSIS LIMB,1
MX,VIRAL INFECTION,1
MX,VIROLOGIC FAILURE,1
MX,VISUAL IMPAIRMENT,1
MX,WOUND DEHISCENCE,1
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
MD,FEMUR FRACTURE,1
MD,OSTEONECROSIS,1
MD,OSTEOPOROSIS,1
ME,AGRANULOCYTOSIS,1
ME,DISORIENTATION,1
ME,FATIGUE,1
ME,LEUKOPENIA,1
ME,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
ME,SOPOR,1
ME,SPEECH DISORDER,1
ME,URINARY INCONTINENCE,1
MA,TOXICITY TO VARIOUS AGENTS,6
MA,INTERSTITIAL LUNG DISEASE,2
MA,SOMNOLENCE,2
MA,ANAPHYLACTIC SHOCK,1
MA,APATHY,1
MA,CHEST X-RAY ABNORMAL,1
MA,COMA,1
MA,CONDITION AGGRAVATED,1
MA,COUGH,1
MA,CRANIAL NERVE PARALYSIS,1
MA,CRYPTOCOCCOSIS,1
MA,DEATH,1
MA,DISORIENTATION,1
MA,DISSEMINATED CRYPTOCOCCOSIS,1
MA,DISSEMINATED INTRAVASCULAR COAGULATION,1
MA,DYSPNOEA,1
MA,DYSPNOEA EXERTIONAL,1
MA,EOSINOPHILIA,1
MA,FATIGUE,1
MA,FLUSHING,1
MA,GENERAL PHYSICAL HEALTH DETERIORATION,1
MA,HEPATITIS C,1
MA,HEPATOCELLULAR INJURY,1
MA,HYPOTENSION,1
MA,INFECTION,1
MA,ISCHAEMIC STROKE,1
MA,LOSS OF CONSCIOUSNESS,1
MA,NODULE,1
MA,PAIN,1
MA,POLYNEUROPATHY,1
MA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
MA,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
MA,PSYCHOMOTOR RETARDATION,1
MA,RALES,1
MA,SCIATICA,1
MA,SEPTIC SHOCK,1
MA,SPIROMETRY ABNORMAL,1
MA,SUPERINFECTION,1
MA,TENDERNESS,1
MA,TRANSPLANT REJECTION,1
NR,ANXIETY,1
NR,CROHN^S DISEASE,1
NR,DEVICE DIFFICULT TO USE,1
NR,FEAR OF INJECTION,1
NR,GASTROINTESTINAL OBSTRUCTION,1
NR,INJECTION SITE PAIN,1
NR,PAIN,1
NL,PNEUMONIA,52
NL,PYREXIA,50
NL,DYSPNOEA,32
NL,FEBRILE NEUTROPENIA,30
NL,DISEASE PROGRESSION,29
NL,INFECTION,29
NL,DIARRHOEA,27
NL,DRUG INEFFECTIVE,27
NL,DEATH,25
NL,PULMONARY EMBOLISM,25
NL,SEPSIS,25
NL,RESPIRATORY FAILURE,24
NL,MALAISE,22
NL,NAUSEA,22
NL,HISTOPLASMOSIS DISSEMINATED,21
NL,CARDIAC FAILURE,20
NL,ABDOMINAL PAIN,18
NL,URINARY TRACT INFECTION,17
NL,FATIGUE,16
NL,RENAL FAILURE,16
NL,CONDITION AGGRAVATED,15
NL,CONFUSIONAL STATE,15
NL,HEPATIC ENZYME INCREASED,15
NL,ANAEMIA,14
NL,MUCOSAL INFLAMMATION,14
NL,MULTI-ORGAN FAILURE,14
NL,WEIGHT DECREASED,14
NL,ABNORMAL BEHAVIOUR,13
NL,CROHN^S DISEASE,13
NL,VOMITING,13
NL,ANXIETY,12
NL,ATRIAL FIBRILLATION,12
NL,BACK PAIN,12
NL,PAIN,12
NL,CEREBRAL VENOUS THROMBOSIS,11
NL,DEHYDRATION,11
NL,HAEMOGLOBIN DECREASED,11
NL,THROMBOCYTOPENIA,11
NL,VISUAL IMPAIRMENT,11
NL,GENERAL PHYSICAL HEALTH DETERIORATION,10
NL,HEADACHE,10
NL,LUNG INFECTION,10
NL,NEUTROPENIA,10
NL,PRURITUS,10
NL,PSYCHIATRIC SYMPTOM,10
NL,VARICELLA ZOSTER VIRUS INFECTION,10
NL,DEEP VEIN THROMBOSIS,9
NL,DIZZINESS,9
NL,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,9
NL,HEPATIC NECROSIS,9
NL,BASAL CELL CARCINOMA,8
NL,COUGH,8
NL,DELUSION,8
NL,GASTROINTESTINAL DISORDER,8
NL,HAEMORRHAGE,8
NL,HYPOTENSION,8
NL,OESOPHAGEAL HAEMORRHAGE,8
NL,RENAL IMPAIRMENT,8
NL,SYNCOPE,8
NL,UROSEPSIS,8
NL,ABDOMINAL ABSCESS,7
NL,ACUTE MYELOID LEUKAEMIA,7
NL,AKATHISIA,7
NL,ALOPECIA,7
NL,ASTHMA,7
NL,CEREBRAL HAEMORRHAGE,7
NL,CHEST PAIN,7
NL,DIABETES MELLITUS,7
NL,HEPATIC FAILURE,7
NL,MALIGNANT NEOPLASM PROGRESSION,7
NL,MENTAL DISORDER,7
NL,MENTAL STATUS CHANGES,7
NL,OSTEONECROSIS,7
NL,PROSTATE CANCER METASTATIC,7
NL,PSEUDOMONAS INFECTION,7
NL,SEPTIC SHOCK,7
NL,SWELLING,7
NL,TERMINAL STATE,7
NL,UPPER RESPIRATORY TRACT INFECTION,7
NL,CUSHING^S SYNDROME,6
NL,DEPRESSED LEVEL OF CONSCIOUSNESS,6
NL,DISEASE RECURRENCE,6
NL,EYE DISORDER,6
NL,HYPERTENSION,6
NL,ILEUS,6
NL,INFLUENZA,6
NL,MYCOBACTERIAL INFECTION,6
NL,MYOCARDIAL INFARCTION,6
NL,PAIN IN EXTREMITY,6
NL,PANCYTOPENIA,6
NL,PLASMA CELL MYELOMA,6
NL,PRODUCT USE IN UNAPPROVED INDICATION,6
NL,VISION BLURRED,6
NL,ABSCESS,5
NL,ACUTE KIDNEY INJURY,5
NL,APATHY,5
NL,ASTHENIA,5
NL,ASTIGMATISM,5
NL,BLINDNESS TRANSIENT,5
NL,BLOOD CREATININE INCREASED,5
NL,BONE PAIN,5
NL,CHOLESTASIS,5
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
NL,CONSTIPATION,5
NL,ENDOCRINE OPHTHALMOPATHY,5
NL,EPSTEIN-BARR VIRUS INFECTION,5
NL,EYE IRRITATION,5
NL,FALL,5
NL,HYPOXIA,5
NL,JAUNDICE,5
NL,KIDNEY TRANSPLANT REJECTION,5
NL,LEUKOPENIA,5
NL,LIVER FUNCTION TEST ABNORMAL,5
NL,MYELODYSPLASTIC SYNDROME,5
NL,NEUROPATHY PERIPHERAL,5
NL,OBESITY,5
NL,OSTEONECROSIS OF JAW,5
NL,PLEURAL EFFUSION,5
NL,PORTAL HYPERTENSION,5
NL,PROSTATE CANCER,5
NL,PULMONARY ARTERIAL HYPERTENSION,5
NL,SPLENIC CANDIDIASIS,5
NL,URTICARIA,5
NL,VIRAL INFECTION,5
NL,ACUTE MYOCARDIAL INFARCTION,4
NL,ACUTE RESPIRATORY DISTRESS SYNDROME,4
NL,ADRENAL INSUFFICIENCY,4
NL,AGGRESSION,4
NL,ARTHRALGIA,4
NL,ASPARTATE AMINOTRANSFERASE INCREASED,4
NL,ATRIAL FLUTTER,4
NL,ATYPICAL HAEMOLYTIC URAEMIC SYNDROME,4
NL,CATARACT,4
NL,CELLULITIS,4
NL,CHILLS,4
NL,COLITIS,4
NL,COLOUR BLINDNESS,4
NL,CYTOMEGALOVIRUS INFECTION,4
NL,DECREASED APPETITE,4
NL,DELIRIUM,4
NL,DIFFUSE LARGE B-CELL LYMPHOMA,4
NL,DRUG HYPERSENSITIVITY,4
NL,DYSPHAGIA,4
NL,ECZEMA,4
NL,ELECTROCARDIOGRAM QT PROLONGED,4
NL,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,4
NL,ERYTHEMA,4
NL,ESCHERICHIA INFECTION,4
NL,EXPOSURE DURING PREGNANCY,4
NL,EYELID OEDEMA,4
NL,FOETAL EXPOSURE DURING PREGNANCY,4
NL,GASTROENTERITIS,4
NL,HYPERSENSITIVITY,4
NL,HYPOCALCAEMIA,4
NL,KLEBSIELLA INFECTION,4
NL,MENINGITIS,4
NL,MUCOCUTANEOUS LEISHMANIASIS,4
NL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
NL,MUSCULAR WEAKNESS,4
NL,NATURAL KILLER-CELL LEUKAEMIA,4
NL,NIGHT SWEATS,4
NL,OSTEOMYELITIS,4
NL,PERIODONTITIS,4
NL,PERIPHERAL SWELLING,4
NL,PLATELET COUNT DECREASED,4
NL,POLYARTHRITIS,4
NL,PROTEINURIA,4
NL,PSEUDOMONAS AERUGINOSA MENINGITIS,4
NL,Q FEVER,4
NL,SECOND PRIMARY MALIGNANCY,4
NL,SEIZURE,4
NL,SOFT TISSUE DISORDER,4
NL,SQUAMOUS CELL CARCINOMA OF SKIN,4
NL,STOMATITIS,4
NL,SYSTEMIC LUPUS ERYTHEMATOSUS,4
NL,URINARY RETENTION,4
NL,WEIGHT INCREASED,4
NL,WHIPPLE^S DISEASE,4
NL,ABDOMINAL PAIN UPPER,3
NL,ADENOVIRUS INFECTION,3
NL,AMNESIA,3
NL,ANGINA PECTORIS,3
NL,ARRHYTHMIA,3
NL,ASPERGILLUS INFECTION,3
NL,BACTERAEMIA,3
NL,BLADDER CANCER,3
NL,BLINDNESS,3
NL,BLISTER,3
NL,CANDIDA INFECTION,3
NL,CANDIDA PNEUMONIA,3
NL,CARDIAC ARREST,3
NL,CARDIAC DISORDER,3
NL,CARDIOMYOPATHY,3
NL,CEREBRAL ISCHAEMIA,3
NL,CEREBROVASCULAR ACCIDENT,3
NL,COLON CANCER,3
NL,CUSHINGOID,3
NL,DEPRESSED MOOD,3
NL,DEPRESSION,3
NL,DERMATITIS CONTACT,3
NL,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,3
NL,ENCEPHALOPATHY,3
NL,GASTRIC DISORDER,3
NL,GASTRIC HAEMORRHAGE,3
NL,GASTRIC ULCER,3
NL,GASTROENTERITIS VIRAL,3
NL,GRAFT VERSUS HOST DISEASE,3
NL,HAEMATOCHEZIA,3
NL,HAEMATOMA,3
NL,HEPATOSPLENIC T-CELL LYMPHOMA,3
NL,HERPES SIMPLEX HEPATITIS,3
NL,HYPERCALCAEMIA,3
NL,HYPERKALAEMIA,3
NL,HYPOACUSIS,3
NL,HYPOGAMMAGLOBULINAEMIA,3
NL,HYPOPHOSPHATAEMIA,3
NL,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,3
NL,INCORRECT DOSE ADMINISTERED,3
NL,LACTIC ACIDOSIS,3
NL,LISTERIOSIS,3
NL,LUNG ABSCESS,3
NL,LUNG NEOPLASM MALIGNANT,3
NL,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,3
NL,MALNUTRITION,3
NL,MATERNAL EXPOSURE BEFORE PREGNANCY,3
NL,MENINGITIS LISTERIA,3
NL,METASTASES TO LIVER,3
NL,NEOPLASM,3
NL,NEUTROPENIC INFECTION,3
NL,PALPITATIONS,3
NL,PARTIAL SEIZURES,3
NL,PELVIC PAIN,3
NL,PLEURISY,3
NL,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,3
NL,PRODUCT USE ISSUE,3
NL,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
NL,PROSTATIC SPECIFIC ANTIGEN INCREASED,3
NL,PULMONARY HYPERTENSION,3
NL,RASH MACULO-PAPULAR,3
NL,REBOUND EFFECT,3
NL,RESPIRATORY TRACT INFECTION,3
NL,RHEUMATOID ARTHRITIS,3
NL,SKIN EXFOLIATION,3
NL,SPEECH DISORDER,3
NL,STAPHYLOCOCCAL BACTERAEMIA,3
NL,SYNOVIAL CYST,3
NL,THERAPEUTIC RESPONSE DECREASED,3
NL,TOOTH ABSCESS,3
NL,TOXICITY TO VARIOUS AGENTS,3
NL,ABDOMINAL PAIN LOWER,2
NL,ABNORMAL FAECES,2
NL,ACUTE CORONARY SYNDROME,2
NL,ACUTE GRAFT VERSUS HOST DISEASE,2
NL,ALANINE AMINOTRANSFERASE INCREASED,2
NL,ANAPHYLACTIC REACTION,2
NL,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,2
NL,APHASIA,2
NL,ARTHRITIS,2
NL,ARTHRITIS BACTERIAL,2
NL,BILIARY COLIC,2
NL,BLADDER TRABECULATION,2
NL,BLOOD ALKALINE PHOSPHATASE INCREASED,2
NL,BLOOD GLUCOSE INCREASED,2
NL,BLOOD UREA INCREASED,2
NL,BRADYPHRENIA,2
NL,BREAST CANCER,2
NL,BRONCHIOLOALVEOLAR CARCINOMA,2
NL,CARDIOVASCULAR DISORDER,2
NL,CHOLELITHIASIS,2
NL,CIRCULATORY COLLAPSE,2
NL,COGNITIVE DISORDER,2
NL,COLECTOMY,2
NL,CONCOMITANT DISEASE PROGRESSION,2
NL,CORONARY ARTERY STENOSIS,2
NL,CRANIAL NERVE DISORDER,2
NL,CYSTITIS HAEMORRHAGIC,2
NL,DERMATITIS EXFOLIATIVE,2
NL,DEVICE RELATED INFECTION,2
NL,DISTURBANCE IN ATTENTION,2
NL,DIVERTICULITIS,2
NL,DIVERTICULUM,2
NL,DIVERTICULUM INTESTINAL HAEMORRHAGIC,2
NL,DRUG EFFECT DECREASED,2
NL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
NL,DUODENITIS,2
NL,EJECTION FRACTION DECREASED,2
NL,EMBOLISM,2
NL,ENTEROCUTANEOUS FISTULA,2
NL,EOSINOPHILIA,2
NL,EPILEPSY,2
NL,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,2
NL,FACIAL NERVE DISORDER,2
NL,FOCAL DYSCOGNITIVE SEIZURES,2
NL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
NL,GASTROINTESTINAL INFECTION,2
NL,GENERAL PHYSICAL CONDITION ABNORMAL,2
NL,GRAFT VERSUS HOST DISEASE IN SKIN,2
NL,GROIN PAIN,2
NL,HAEMATOTOXICITY,2
NL,HAEMOLYSIS,2
NL,HAEMOPTYSIS,2
NL,HEPATIC HAEMORRHAGE,2
NL,HEPATITIS E,2
NL,HEPATOSPLENIC CANDIDIASIS,2
NL,HERPES ZOSTER,2
NL,HYPERGLYCAEMIA,2
NL,HYPERHIDROSIS,2
NL,HYPOALDOSTERONISM,2
NL,HYPOKALAEMIA,2
NL,HYPOMAGNESAEMIA,2
NL,HYPOPHAGIA,2
NL,IMMUNOSUPPRESSION,2
NL,INFLUENZA LIKE ILLNESS,2
NL,INJECTION SITE REACTION,2
NL,INTESTINAL ISCHAEMIA,2
NL,LARGE INTESTINAL HAEMORRHAGE,2
NL,LETHARGY,2
NL,LIVER INJURY,2
NL,LOCALISED INFECTION,2
NL,LOSS OF CONSCIOUSNESS,2
NL,LUNG ADENOCARCINOMA,2
NL,LUNG INFILTRATION,2
NL,LUNG TRANSPLANT,2
NL,LUPUS NEPHRITIS,2
NL,LYMPHADENOPATHY,2
NL,MACULAR OEDEMA,2
NL,MATERNAL EXPOSURE DURING PREGNANCY,2
NL,MENINGITIS BACTERIAL,2
NL,MENINGITIS PNEUMOCOCCAL,2
NL,METASTASES TO CENTRAL NERVOUS SYSTEM,2
NL,METASTATIC RENAL CELL CARCINOMA,2
NL,MOUTH ULCERATION,2
NL,MUSCULOSKELETAL PAIN,2
NL,MYALGIA,2
NL,NASOPHARYNGITIS,2
NL,NEOPLASM MALIGNANT,2
NL,NERVOUS SYSTEM DISORDER,2
NL,NEUROTOXICITY,2
NL,NOROVIRUS TEST POSITIVE,2
NL,OEDEMA,2
NL,OLIGODENDROGLIOMA,2
NL,OLIGURIA,2
NL,OPPORTUNISTIC INFECTION,2
NL,OPTIC NEURITIS,2
NL,ORAL DISORDER,2
NL,ORCHITIS,2
NL,ORTHOSTATIC HYPOTENSION,2
NL,OSTEOPOROSIS,2
NL,PANCREATITIS ACUTE,2
NL,PERIPHERAL SENSORY NEUROPATHY,2
NL,PHARYNGITIS,2
NL,PLACENTA PRAEVIA HAEMORRHAGE,2
NL,PNEUMONIA ASPIRATION,2
NL,PNEUMONIA FUNGAL,2
NL,POLYNEUROPATHY,2
NL,POST PROCEDURAL HAEMORRHAGE,2
NL,PREMATURE BABY,2
NL,PREMATURE LABOUR,2
NL,PROCEDURAL HAEMORRHAGE,2
NL,PRODUCTIVE COUGH,2
NL,PSEUDOMONAL SEPSIS,2
NL,PULMONARY SEPSIS,2
NL,PULMONARY TUBERCULOSIS,2
NL,PYELONEPHRITIS,2
NL,RASH ERYTHEMATOUS,2
NL,RENAL FAILURE ACUTE,2
NL,RENAL HAEMORRHAGE,2
NL,RHINORRHOEA,2
NL,SERUM FERRITIN INCREASED,2
NL,SHOCK,2
NL,SINUSITIS,2
NL,SKIN CANCER,2
NL,SKIN REACTION,2
NL,SKIN STRIAE,2
NL,SOMNOLENCE,2
NL,SPINAL CORD COMPRESSION,2
NL,SPINAL FRACTURE,2
NL,SPLENOMEGALY,2
NL,SQUAMOUS CELL CARCINOMA OF THE TONGUE,2
NL,STAPHYLOCOCCAL INFECTION,2
NL,STAPHYLOCOCCAL SCALDED SKIN SYNDROME,2
NL,STAPHYLOCOCCAL SEPSIS,2
NL,STAPHYLOCOCCAL SKIN INFECTION,2
NL,STREPTOCOCCAL INFECTION,2
NL,SUBARACHNOID HAEMORRHAGE,2
NL,SUPRAVENTRICULAR TACHYCARDIA,2
NL,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
NL,TOOTHACHE,2
NL,TRANSPLANT REJECTION,2
NL,TUMOUR LYSIS SYNDROME,2
NL,TYPE 2 DIABETES MELLITUS,2
NL,UVEITIS,2
NL,WHITE BLOOD CELL COUNT INCREASED,2
NL,WOUND INFECTION,2
NL,ABDOMINAL DISCOMFORT,1
NL,ABDOMINAL MASS,1
NL,ABDOMINAL RIGIDITY,1
NL,ABDOMINAL SYMPTOM,1
NL,ABSCESS DRAINAGE,1
NL,ABSCESS JAW,1
NL,ADENOCARCINOMA OF COLON,1
NL,ADRENAL SUPPRESSION,1
NL,ADVERSE DRUG REACTION,1
NL,ADVERSE EVENT,1
NL,AGITATION,1
NL,AGRANULOCYTOSIS,1
NL,AMYLASE INCREASED,1
NL,AMYOTROPHIC LATERAL SCLEROSIS,1
NL,ANAL ABSCESS,1
NL,ANAL ULCER,1
NL,ANAPHYLACTIC SHOCK,1
NL,ANAPLASTIC LARGE-CELL LYMPHOMA,1
NL,ANGIOEDEMA,1
NL,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT,1
NL,ANORECTAL DISORDER,1
NL,ANURIA,1
NL,AORTIC ANEURYSM,1
NL,AORTIC CALCIFICATION,1
NL,AORTIC VALVE STENOSIS,1
NL,APHAGIA,1
NL,APRAXIA,1
NL,APTYALISM,1
NL,ARRHYTHMIA SUPRAVENTRICULAR,1
NL,ARTHRITIS REACTIVE,1
NL,ASCITES,1
NL,ASPHYXIA,1
NL,ASPIRATION,1
NL,ASPIRATION JOINT,1
NL,ATELECTASIS,1
NL,ATONIC SEIZURES,1
NL,AUTOIMMUNE THYROIDITIS,1
NL,AUTOIMMUNE UVEITIS,1
NL,B-CELL LYMPHOMA,1
NL,BACK DISORDER,1
NL,BACTERIAL SEPSIS,1
NL,BILIRUBIN CONJUGATED INCREASED,1
NL,BK VIRUS INFECTION,1
NL,BLADDER IRRITATION,1
NL,BLADDER TRANSITIONAL CELL CARCINOMA,1
NL,BLEEDING VARICOSE VEIN,1
NL,BLINDNESS UNILATERAL,1
NL,BLOOD BILIRUBIN INCREASED,1
NL,BLOOD COUNT ABNORMAL,1
NL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
NL,BLOOD GLUCOSE ABNORMAL,1
NL,BLOOD LACTATE DEHYDROGENASE DECREASED,1
NL,BLOOD LACTATE DEHYDROGENASE INCREASED,1
NL,BLOOD PRESSURE INCREASED,1
NL,BLOOD PRESSURE SYSTOLIC INCREASED,1
NL,BLOOD STEM CELL TRANSPLANT FAILURE,1
NL,BLOOD URINE PRESENT,1
NL,BONE DENSITY DECREASED,1
NL,BONE MARROW DISORDER,1
NL,BRADYCARDIA,1
NL,BRAIN OEDEMA,1
NL,BREAST CANCER METASTATIC,1
NL,BREAST CELLULITIS,1
NL,BREAST ENLARGEMENT,1
NL,BRONCHIAL ANASTOMOSIS COMPLICATION,1
NL,BRONCHIAL CARCINOMA,1
NL,BRONCHIECTASIS,1
NL,BRONCHITIS,1
NL,BRONCHOSPASM,1
NL,C-REACTIVE PROTEIN INCREASED,1
NL,CAMPYLOBACTER GASTROENTERITIS,1
NL,CANCER SURGERY,1
NL,CANDIDIASIS,1
NL,CARDIAC ASTHMA,1
NL,CARDIAC FAILURE CONGESTIVE,1
NL,CARDIO-RESPIRATORY ARREST,1
NL,CAT SCRATCH DISEASE,1
NL,CATATONIA,1
NL,CATHETER MANAGEMENT,1
NL,CATHETERISATION CARDIAC,1
NL,CELLULITIS ORBITAL,1
NL,CEREBELLAR ATAXIA,1
NL,CEREBRAL THROMBOSIS,1
NL,CEREBRAL TOXOPLASMOSIS,1
NL,CERVIX CANCER METASTATIC,1
NL,CERVIX CARCINOMA,1
NL,CHEST DISCOMFORT,1
NL,CHOKING,1
NL,CHOLECYSTITIS,1
NL,CHRONIC MYELOID LEUKAEMIA,1
NL,CHYLOTHORAX,1
NL,CLOSTRIDIAL INFECTION,1
NL,CLOSTRIDIUM COLITIS,1
NL,CLOSTRIDIUM DIFFICILE INFECTION,1
NL,COAGULATION TIME PROLONGED,1
NL,COAGULOPATHY,1
NL,COLITIS ULCERATIVE,1
NL,COLOUR BLINDNESS ACQUIRED,1
NL,COMPLEMENT FACTOR DECREASED,1
NL,COMPLICATIONS OF TRANSPLANT SURGERY,1
NL,COMPUTERISED TOMOGRAM ABNORMAL,1
NL,CONTINUOUS HAEMODIAFILTRATION,1
NL,CONTRAINDICATED PRODUCT ADMINISTERED,1
NL,CUTANEOUS LYMPHOMA,1
NL,CYANOSIS CENTRAL,1
NL,CYST,1
NL,CYST DRAINAGE,1
NL,CYSTOID MACULAR OEDEMA,1
NL,DEMENTIA,1
NL,DENTAL CARIES,1
NL,DERMATITIS,1
NL,DERMATITIS PSORIASIFORM,1
NL,DIARRHOEA HAEMORRHAGIC,1
NL,DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY,1
NL,DISORIENTATION,1
NL,DIVERTICULAR PERFORATION,1
NL,DRUG DEPENDENCE,1
NL,DRUG EFFECT INCOMPLETE,1
NL,DRUG RESISTANCE,1
NL,DRY SKIN,1
NL,DUODENAL ULCER PERFORATION,1
NL,DYSAESTHESIA,1
NL,DYSARTHRIA,1
NL,DYSLIPIDAEMIA,1
NL,DYSPHONIA,1
NL,EAR INFECTION,1
NL,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
NL,ELECTROCARDIOGRAM U WAVE PRESENT,1
NL,ELECTROENCEPHALOGRAM ABNORMAL,1
NL,END STAGE RENAL DISEASE,1
NL,ENDOCARDITIS,1
NL,ENDOCARDITIS Q FEVER,1
NL,EPISTAXIS,1
NL,ERYSIPELAS,1
NL,ESCHERICHIA BACTERAEMIA,1
NL,ESCHERICHIA SEPSIS,1
NL,ESCHERICHIA URINARY TRACT INFECTION,1
NL,EXERCISE LACK OF,1
NL,EYE COMPLICATION ASSOCIATED WITH DEVICE,1
NL,EYE PAIN,1
NL,FACE OEDEMA,1
NL,FAMILIAL MEDITERRANEAN FEVER,1
NL,FAT NECROSIS,1
NL,FEBRILE CONVULSION,1
NL,FEELING COLD,1
NL,FIBRIN D DIMER INCREASED,1
NL,FLANK PAIN,1
NL,FLUID RETENTION,1
NL,FOETAL DEATH,1
NL,FOETAL HYPOKINESIA,1
NL,FUNGAL INFECTION,1
NL,GAIT DISTURBANCE,1
NL,GASTRIC ULCER PERFORATION,1
NL,GASTRITIS,1
NL,GASTROENTERITIS CRYPTOSPORIDIAL,1
NL,GASTROENTERITIS NOROVIRUS,1
NL,GASTROENTERITIS SALMONELLA,1
NL,GASTROINTESTINAL HAEMORRHAGE,1
NL,GASTROINTESTINAL HYPOMOTILITY,1
NL,GASTROINTESTINAL PERFORATION,1
NL,GASTROINTESTINAL TOXICITY,1
NL,GASTROOESOPHAGEAL REFLUX DISEASE,1
NL,GENERALISED OEDEMA,1
NL,GENITAL HERPES ZOSTER,1
NL,GINGIVAL HYPERPLASIA,1
NL,GINGIVAL HYPERTROPHY,1
NL,GLIOBLASTOMA,1
NL,GLOMERULAR FILTRATION RATE DECREASED,1
NL,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,1
NL,GLOMERULONEPHRITIS MEMBRANOUS,1
NL,GOUT,1
NL,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
NL,GRAFT VERSUS HOST DISEASE IN INTESTINE,1
NL,GRAND MAL CONVULSION,1
NL,GROWTH RETARDATION,1
NL,GUILLAIN-BARRE SYNDROME,1
NL,HAEMATOCRIT DECREASED,1
NL,HAEMOLYTIC ANAEMIA,1
NL,HAEMORRHAGIC DIATHESIS,1
NL,HAEMORRHAGIC STROKE,1
NL,HAEMORRHOIDS,1
NL,HEARING IMPAIRED,1
NL,HEART RATE DECREASED,1
NL,HEPATIC ENZYME ABNORMAL,1
NL,HEPATIC FUNCTION ABNORMAL,1
NL,HEPATOCELLULAR CARCINOMA,1
NL,HEPATOMEGALY,1
NL,HEPATOTOXICITY,1
NL,HERPES OESOPHAGITIS,1
NL,HERPES SIMPLEX,1
NL,HERPES VIRUS INFECTION,1
NL,HERPES ZOSTER DISSEMINATED,1
NL,HISTIOCYTOSIS HAEMATOPHAGIC,1
NL,HOT FLUSH,1
NL,HUMAN BOCAVIRUS INFECTION,1
NL,HYDRONEPHROSIS,1
NL,HYPERCHOLESTEROLAEMIA,1
NL,HYPERPHOSPHATAEMIA,1
NL,HYPERTHYROIDISM,1
NL,HYPERTROPHIC CARDIOMYOPATHY,1
NL,HYPERVISCOSITY SYNDROME,1
NL,HYPOGLOSSAL NERVE PARALYSIS,1
NL,HYPOGLYCAEMIA,1
NL,HYPONATRAEMIA,1
NL,HYPOPERFUSION,1
NL,HYPOTHERMIA,1
NL,HYPOTHYROIDISM,1
NL,HYPOVOLAEMIC SHOCK,1
NL,IDIOPATHIC THROMBOCYTOPENIC PURPURA,1
NL,ILEAL FISTULA,1
NL,ILEAL STENOSIS,1
NL,ILEUS PARALYTIC,1
NL,IMMOBILISATION PROLONGED,1
NL,IMMUNE SYSTEM DISORDER,1
NL,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
NL,IMPAIRED GASTRIC EMPTYING,1
NL,IMPAIRED HEALING,1
NL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
NL,INCORRECT DOSAGE ADMINISTERED,1
NL,INCORRECT DRUG ADMINISTRATION DURATION,1
NL,INCORRECT PRODUCT STORAGE,1
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
NL,INCREASED APPETITE,1
NL,INFECTED CYST,1
NL,INFECTED SEROMA,1
NL,INFLAMMATION,1
NL,INFLAMMATORY CARCINOMA OF THE BREAST,1
NL,INFUSION SITE HAEMATOMA,1
NL,INJECTION SITE ERYTHEMA,1
NL,INJECTION SITE PAIN,1
NL,INJECTION SITE RASH,1
NL,INTENTIONAL PRODUCT MISUSE,1
NL,INTENTIONAL PRODUCT USE ISSUE,1
NL,INTENTIONAL SELF-INJURY,1
NL,INTERSTITIAL LUNG DISEASE,1
NL,INTESTINAL ADENOCARCINOMA,1
NL,INTESTINAL FISTULA,1
NL,INTESTINAL HAEMORRHAGE,1
NL,INTRAOCULAR PRESSURE INCREASED,1
NL,INVASIVE LOBULAR BREAST CARCINOMA,1
NL,ISCHAEMIC CEREBRAL INFARCTION,1
NL,ISCHAEMIC STROKE,1
NL,JOINT SWELLING,1
NL,JUVENILE IDIOPATHIC ARTHRITIS,1
NL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
NL,LARGE INTESTINAL ULCER HAEMORRHAGE,1
NL,LARGE INTESTINE BENIGN NEOPLASM,1
NL,LARYNGEAL OEDEMA,1
NL,LASER THERAPY,1
NL,LEFT VENTRICULAR DYSFUNCTION,1
NL,LEISHMANIASIS,1
NL,LENTIGO MALIGNA,1
NL,LEUKOCYTOSIS,1
NL,LIVEDO RETICULARIS,1
NL,LOCAL SWELLING,1
NL,LUNG CONSOLIDATION,1
NL,LYMPHANGIECTASIA,1
NL,LYMPHOEDEMA,1
NL,LYMPHOPROLIFERATIVE DISORDER,1
NL,MACULAR DEGENERATION,1
NL,MASS,1
NL,MEDIASTINAL SHIFT,1
NL,MELAENA,1
NL,MEMORY IMPAIRMENT,1
NL,MENINGITIS CRYPTOCOCCAL,1
NL,MENINGITIS VIRAL,1
NL,MENINGORADICULITIS,1
NL,MENORRHAGIA,1
NL,MENSTRUATION IRREGULAR,1
NL,MENTAL IMPAIRMENT,1
NL,MESENTERIC ARTERY THROMBOSIS,1
NL,METABOLIC ACIDOSIS,1
NL,METASTASES TO BONE,1
NL,METASTASES TO NECK,1
NL,METASTASES TO PLEURA,1
NL,METASTASES TO SPINE,1
NL,METASTASIS,1
NL,METASTATIC MALIGNANT MELANOMA,1
NL,METASTATIC PAIN,1
NL,MICROANGIOPATHY,1
NL,MICTURITION FREQUENCY DECREASED,1
NL,MOBILITY DECREASED,1
NL,MONOPARESIS,1
NL,MOTOR DYSFUNCTION,1
NL,MOUTH SWELLING,1
NL,MUCINOUS BREAST CARCINOMA,1
NL,MULTIPLE CONGENITAL ABNORMALITIES,1
NL,MULTIPLE FRACTURES,1
NL,MULTIPLE SCLEROSIS RELAPSE,1
NL,MUSCLE ATROPHY,1
NL,MUSCLE SPASMS,1
NL,MUSCULOSKELETAL DISORDER,1
NL,MUSCULOSKELETAL STIFFNESS,1
NL,MYASTHENIA GRAVIS,1
NL,MYCOSIS FUNGOIDES STAGE IV,1
NL,MYOPATHY,1
NL,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
NL,NAIL DISORDER,1
NL,NASAL CONGESTION,1
NL,NECK PAIN,1
NL,NEGATIVISM,1
NL,NEPHROLITHIASIS,1
NL,NEPHROTIC SYNDROME,1
NL,NEUROLOGICAL SYMPTOM,1
NL,NODULAR VASCULITIS,1
NL,NON-HODGKIN^S LYMPHOMA,1
NL,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
NL,OEDEMA GENITAL,1
NL,OEDEMA PERIPHERAL,1
NL,OESOPHAGEAL CANDIDIASIS,1
NL,OESOPHAGEAL ULCER,1
NL,OESOPHAGITIS,1
NL,ORAL FUNGAL INFECTION,1
NL,ORAL HERPES,1
NL,ORAL INFECTION,1
NL,ORAL MUCOSAL ERYTHEMA,1
NL,OSTEITIS,1
NL,OSTEOPENIA,1
NL,OTITIS MEDIA BACTERIAL,1
NL,OVARIAN DISORDER,1
NL,OVARIAN EPITHELIAL CANCER,1
NL,OXYGEN SATURATION DECREASED,1
NL,PAIN IN JAW,1
NL,PAIN MANAGEMENT,1
NL,PAIN THRESHOLD DECREASED,1
NL,PAINFUL RESPIRATION,1
NL,PALLIATIVE CARE,1
NL,PANCREATITIS,1
NL,PANCREATITIS NECROTISING,1
NL,PARAESTHESIA,1
NL,PARAINFLUENZAE VIRUS INFECTION,1
NL,PARANOIA,1
NL,PARKINSON^S DISEASE,1
NL,PCO2 DECREASED,1
NL,PEMPHIGOID,1
NL,PEMPHIGUS,1
NL,PERICARDIAL EFFUSION,1
NL,PERINEPHRIC COLLECTION,1
NL,PERIORBITAL OEDEMA,1
NL,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
NL,PERIPHERAL ARTERY OCCLUSION,1
NL,PERITONITIS,1
NL,PETECHIAE,1
NL,PHOTOPSIA,1
NL,PHOTOSENSITIVITY REACTION,1
NL,PNEUMOCOCCAL SEPSIS,1
NL,PNEUMONIA BACTERIAL,1
NL,PNEUMONIA ESCHERICHIA,1
NL,PNEUMONIA KLEBSIELLA,1
NL,PNEUMONIA PSEUDOMONAL,1
NL,PNEUMONITIS,1
NL,PNEUMOTHORAX,1
NL,POLLAKIURIA,1
NL,POLYDIPSIA,1
NL,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,1
NL,PRODUCT PRESCRIBING ISSUE,1
NL,PSORIASIS,1
NL,PSYCHOTIC DISORDER,1
NL,PULMONARY CONGESTION,1
NL,PULMONARY FIBROSIS,1
NL,PULMONARY NECROSIS,1
NL,PURPURA,1
NL,PUSTULAR PSORIASIS,1
NL,RASH,1
NL,RASH GENERALISED,1
NL,RECTAL HAEMORRHAGE,1
NL,RECTOSIGMOID CANCER,1
NL,REFRACTORY ANAEMIA WITH RINGED SIDEROBLASTS,1
NL,RENAL CANCER,1
NL,RENAL CELL CARCINOMA,1
NL,RENAL DISORDER,1
NL,RENAL FAILURE CHRONIC,1
NL,RENAL INJURY,1
NL,RENAL PAIN,1
NL,RENAL TRANSPLANT FAILURE,1
NL,RESPIRATORY DEPTH DECREASED,1
NL,RESPIRATORY TRACT CONGESTION,1
NL,RETICULOENDOTHELIAL DYSFUNCTION,1
NL,RETINAL DETACHMENT,1
NL,RETINAL TEAR,1
NL,RETINAL VEIN OCCLUSION,1
NL,RETINITIS,1
NL,RETRO-ORBITAL NEOPLASM,1
NL,RHABDOMYOLYSIS,1
NL,RHINITIS,1
NL,RIGHT VENTRICULAR DYSFUNCTION,1
NL,RIGHT VENTRICULAR HYPERTROPHY,1
NL,SARCOIDOSIS,1
NL,SCHNITZLER^S SYNDROME,1
NL,SENSORY DISTURBANCE,1
NL,SEPTIC PHLEBITIS,1
NL,SERRATIA INFECTION,1
NL,SERRATIA SEPSIS,1
NL,SIMPLEX VIRUS TEST POSITIVE,1
NL,SKIN IRRITATION,1
NL,SKIN LESION,1
NL,SKIN NEOPLASM EXCISION,1
NL,SKIN PAPILLOMA,1
NL,SLEEP APNOEA SYNDROME,1
NL,SMALL INTESTINE CARCINOMA,1
NL,SMALL INTESTINE ULCER,1
NL,SOLAR LENTIGO,1
NL,SPINAL CORD INJURY,1
NL,SPONTANEOUS HAEMATOMA,1
NL,SPUTUM PURULENT,1
NL,STAPHYLOCOCCUS TEST POSITIVE,1
NL,STEM CELL TRANSPLANT,1
NL,STENOTROPHOMONAS INFECTION,1
NL,STRABISMUS,1
NL,STREPTOCOCCUS TEST POSITIVE,1
NL,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
NL,SUICIDAL IDEATION,1
NL,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,1
NL,SUPERIOR VENA CAVA SYNDROME,1
NL,SURGICAL PROCEDURE REPEATED,1
NL,SYNOVITIS,1
NL,TACHYCARDIA,1
NL,TACHYPNOEA,1
NL,TENDONITIS,1
NL,TENOSYNOVITIS,1
NL,THERAPEUTIC RESPONSE UNEXPECTED,1
NL,THERAPY CHANGE,1
NL,THERAPY NON-RESPONDER,1
NL,THROMBOPHLEBITIS,1
NL,THROMBOSIS,1
NL,THROMBOTIC MICROANGIOPATHY,1
NL,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
NL,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
NL,TONSILLITIS,1
NL,TOXIC OPTIC NEUROPATHY,1
NL,TRANSFUSION-RELATED ACUTE LUNG INJURY,1
NL,TRANSPLANT FAILURE,1
NL,TRICHOPHYTOSIS,1
NL,TRISOMY 18,1
NL,TROPONIN T INCREASED,1
NL,TUBERCULOSIS GASTROINTESTINAL,1
NL,TUBULOINTERSTITIAL NEPHRITIS,1
NL,TUMOUR PSEUDOPROGRESSION,1
NL,UNEVALUABLE EVENT,1
NL,UPPER EXTREMITY MASS,1
NL,UREAPLASMA INFECTION,1
NL,URETERIC RUPTURE,1
NL,URETERIC STENOSIS,1
NL,URETEROLITHIASIS,1
NL,URETHRAL DISORDER,1
NL,URINARY TRACT OBSTRUCTION,1
NL,VASCULAR OCCLUSION,1
NL,VASCULITIS,1
NL,VENOOCCLUSIVE DISEASE,1
NL,VENOUS OCCLUSION,1
NL,VENTRICULAR ARRHYTHMIA,1
NL,VENTRICULAR TACHYCARDIA,1
NL,VIITH NERVE PARALYSIS,1
NL,VIOLENCE-RELATED SYMPTOM,1
NL,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
NL,VISUAL ACUITY REDUCED,1
NL,VITAMIN D DEFICIENCY,1
NL,VITREOUS FLOATERS,1
NL,WHITE BLOOD CELL COUNT DECREASED,1
NL,WOUND ABSCESS,1
NL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
NZ,FATIGUE,13
NZ,ARTHRALGIA,12
NZ,PAIN,12
NZ,DRUG INEFFECTIVE,11
NZ,MALAISE,11
NZ,DYSPNOEA,10
NZ,PYREXIA,10
NZ,FEBRILE NEUTROPENIA,9
NZ,CROHN^S DISEASE,8
NZ,MUSCULOSKELETAL STIFFNESS,8
NZ,PAIN IN EXTREMITY,8
NZ,ANAEMIA,7
NZ,ANXIETY,7
NZ,ARTHRITIS,7
NZ,FEELING ABNORMAL,7
NZ,HEADACHE,7
NZ,RESPIRATORY FAILURE,7
NZ,INTERSTITIAL LUNG DISEASE,6
NZ,MOBILITY DECREASED,6
NZ,NAUSEA,6
NZ,NEUROPATHY PERIPHERAL,6
NZ,PNEUMONIA,6
NZ,RHEUMATOID ARTHRITIS,6
NZ,VOMITING,6
NZ,COUGH,5
NZ,DIZZINESS,5
NZ,FALL,5
NZ,INFECTION,5
NZ,NEUTROPENIA,5
NZ,RASH,5
NZ,SYNCOPE,5
NZ,URTICARIA,5
NZ,ANKYLOSING SPONDYLITIS,4
NZ,ARTHROPATHY,4
NZ,BACK PAIN,4
NZ,BRONCHITIS,4
NZ,CELLULITIS,4
NZ,CHEST PAIN,4
NZ,CONDITION AGGRAVATED,4
NZ,DEPRESSION,4
NZ,MELAENA,4
NZ,OSTEOARTHRITIS,4
NZ,PRURITUS,4
NZ,TREATMENT FAILURE,4
NZ,ABDOMINAL PAIN,3
NZ,ASTHMA,3
NZ,C-REACTIVE PROTEIN INCREASED,3
NZ,CARDIAC DISORDER,3
NZ,CARPAL TUNNEL SYNDROME,3
NZ,CHILLS,3
NZ,DEATH,3
NZ,DEMYELINATION,3
NZ,DEPRESSED MOOD,3
NZ,DIARRHOEA,3
NZ,DISEASE PROGRESSION,3
NZ,EXPOSURE DURING PREGNANCY,3
NZ,GENERAL PHYSICAL HEALTH DETERIORATION,3
NZ,HAEMOGLOBIN DECREASED,3
NZ,HYPERHIDROSIS,3
NZ,HYPERTENSION,3
NZ,HYPOTENSION,3
NZ,HYPOXIA,3
NZ,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
NZ,INFLAMMATION,3
NZ,JOINT EFFUSION,3
NZ,JOINT SWELLING,3
NZ,LIVER FUNCTION TEST ABNORMAL,3
NZ,MEDICATION ERROR,3
NZ,MUCORMYCOSIS,3
NZ,MUSCULAR WEAKNESS,3
NZ,MUSCULOSKELETAL PAIN,3
NZ,MYALGIA,3
NZ,OROPHARYNGEAL PAIN,3
NZ,ORTHOSTATIC HYPOTENSION,3
NZ,PERIPHERAL SWELLING,3
NZ,PNEUMONITIS,3
NZ,POLYARTHRITIS,3
NZ,PRODUCTIVE COUGH,3
NZ,PROSTATISM,3
NZ,RESPIRATORY DISORDER,3
NZ,RESPIRATORY RATE INCREASED,3
NZ,RHEUMATIC DISORDER,3
NZ,SEPSIS,3
NZ,SUPRAVENTRICULAR TACHYCARDIA,3
NZ,THROMBOCYTOPENIA,3
NZ,VIRAL INFECTION,3
NZ,WEIGHT DECREASED,3
NZ,ABDOMINAL PAIN UPPER,2
NZ,ACTIVITIES OF DAILY LIVING IMPAIRED,2
NZ,ACUTE MYOCARDIAL INFARCTION,2
NZ,ACUTE RESPIRATORY DISTRESS SYNDROME,2
NZ,AFFECT LABILITY,2
NZ,ANGIOEDEMA,2
NZ,ARTHRODESIS,2
NZ,ASTHENIA,2
NZ,ATRIAL FIBRILLATION,2
NZ,BEDRIDDEN,2
NZ,BODY TEMPERATURE INCREASED,2
NZ,BONE DENSITY DECREASED,2
NZ,BONE MARROW FAILURE,2
NZ,CARDIAC FAILURE,2
NZ,CARDIOTOXICITY,2
NZ,CHEST DISCOMFORT,2
NZ,CONTUSION,2
NZ,CONVULSION,2
NZ,DECREASED APPETITE,2
NZ,DEPRESSED LEVEL OF CONSCIOUSNESS,2
NZ,DIABETIC FOOT INFECTION,2
NZ,DISEASE RECURRENCE,2
NZ,DRUG EFFECT DECREASED,2
NZ,EMOTIONAL DISORDER,2
NZ,ENCEPHALOPATHY,2
NZ,EYE PAIN,2
NZ,FEAR,2
NZ,FIBROMYALGIA,2
NZ,FLUSHING,2
NZ,GASTROINTESTINAL DISORDER,2
NZ,GASTROINTESTINAL HAEMORRHAGE,2
NZ,GLOMERULAR FILTRATION RATE DECREASED,2
NZ,GOUT,2
NZ,HYPERSENSITIVITY,2
NZ,HYPOMANIA,2
NZ,INCORRECT DOSE ADMINISTERED,2
NZ,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,2
NZ,INSOMNIA,2
NZ,JOINT STIFFNESS,2
NZ,LOWER RESPIRATORY TRACT INFECTION,2
NZ,LUNG INFILTRATION,2
NZ,MIGRAINE,2
NZ,MONOCYTOSIS,2
NZ,MOUTH ULCERATION,2
NZ,MUSCLE SPASMS,2
NZ,MYELODYSPLASTIC SYNDROME,2
NZ,MYOCARDIAL INFARCTION,2
NZ,NEOPLASM MALIGNANT,2
NZ,NEPHROPATHY TOXIC,2
NZ,NEUTROPHIL COUNT DECREASED,2
NZ,NEUTROPHILIA,2
NZ,OEDEMA PERIPHERAL,2
NZ,ORAL HERPES,2
NZ,OSTEONECROSIS,2
NZ,PARAESTHESIA,2
NZ,PATHOLOGICAL FRACTURE,2
NZ,PLATELET COUNT DECREASED,2
NZ,PSORIASIS,2
NZ,PULMONARY EMBOLISM,2
NZ,RASH ERYTHEMATOUS,2
NZ,SEDATION,2
NZ,SMALL INTESTINAL OBSTRUCTION,2
NZ,SPINAL FUSION SURGERY,2
NZ,SPINAL OSTEOARTHRITIS,2
NZ,STRESS,2
NZ,SUICIDAL IDEATION,2
NZ,SURGERY,2
NZ,SWELLING,2
NZ,SWELLING FACE,2
NZ,TEARFULNESS,2
NZ,TREMOR,2
NZ,UNEVALUABLE EVENT,2
NZ,URINARY TRACT INFECTION,2
NZ,UVEITIS,2
NZ,VISUAL ACUITY REDUCED,2
NZ,VISUAL IMPAIRMENT,2
NZ,WEIGHT BEARING DIFFICULTY,2
NZ,ABDOMINAL DISCOMFORT,1
NZ,ABDOMINAL HERNIA,1
NZ,ABDOMINAL INJURY,1
NZ,ABDOMINAL SEPSIS,1
NZ,ABSCESS,1
NZ,ACQUIRED CLAW TOE,1
NZ,ACUTE ABDOMEN,1
NZ,ACUTE KIDNEY INJURY,1
NZ,ADRENAL INSUFFICIENCY,1
NZ,AGITATION,1
NZ,ALANINE AMINOTRANSFERASE INCREASED,1
NZ,ALLERGY TO VACCINE,1
NZ,ANAL STENOSIS,1
NZ,ANAPHYLACTIC REACTION,1
NZ,ANGER,1
NZ,ANKLE FRACTURE,1
NZ,ANORECTAL DISORDER,1
NZ,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,1
NZ,AORTIC ANEURYSM,1
NZ,AORTIC ARTERIOSCLEROSIS,1
NZ,AORTIC DILATATION,1
NZ,APHASIA,1
NZ,APNOEA,1
NZ,ATAXIA,1
NZ,AXONAL NEUROPATHY,1
NZ,BACTERIAL SEPSIS,1
NZ,BALANCE DISORDER,1
NZ,BLOOD ALKALINE PHOSPHATASE INCREASED,1
NZ,BLOOD CREATININE INCREASED,1
NZ,BLOOD PRESSURE DECREASED,1
NZ,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
NZ,BLOOD PRESSURE INCREASED,1
NZ,BLOOD TRIGLYCERIDES INCREASED,1
NZ,BRADYCARDIA,1
NZ,BREAST CELLULITIS,1
NZ,BUNDLE BRANCH BLOCK LEFT,1
NZ,BURNING SENSATION,1
NZ,C-REACTIVE PROTEIN ABNORMAL,1
NZ,CARDIAC ARREST,1
NZ,CARDIAC FAILURE CONGESTIVE,1
NZ,CARDIOGENIC SHOCK,1
NZ,CARDIOMEGALY,1
NZ,CARDIOVASCULAR DISORDER,1
NZ,CAROTID ARTERY STENOSIS,1
NZ,CENTRAL NERVOUS SYSTEM NECROSIS,1
NZ,CEREBRAL CALCIFICATION,1
NZ,CEREBRAL THROMBOSIS,1
NZ,CEREBROVASCULAR ACCIDENT,1
NZ,CHLAMYDIAL INFECTION,1
NZ,CHOKING,1
NZ,CHOLELITHIASIS,1
NZ,CHONDROCALCINOSIS PYROPHOSPHATE,1
NZ,CHONDROPATHY,1
NZ,CHORIORETINOPATHY,1
NZ,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
NZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NZ,COLECTOMY,1
NZ,COLITIS,1
NZ,COLORECTAL CANCER,1
NZ,COLOUR BLINDNESS,1
NZ,COMA,1
NZ,CONFUSIONAL STATE,1
NZ,CONGESTIVE CARDIOMYOPATHY,1
NZ,CRYSTAL ARTHROPATHY,1
NZ,CYSTITIS HAEMORRHAGIC,1
NZ,DEAFNESS,1
NZ,DEAFNESS UNILATERAL,1
NZ,DECREASED INTEREST,1
NZ,DEEP VEIN THROMBOSIS,1
NZ,DELIRIUM,1
NZ,DELUSION,1
NZ,DERMATITIS,1
NZ,DERMATITIS PSORIASIFORM,1
NZ,DEVICE DIFFICULT TO USE,1
NZ,DIABETES MELLITUS,1
NZ,DIABETIC FOOT,1
NZ,DIFFUSE ALVEOLAR DAMAGE,1
NZ,DISORIENTATION,1
NZ,DRAIN PLACEMENT,1
NZ,DRUG DOSE OMISSION,1
NZ,DRUG EFFECT INCOMPLETE,1
NZ,DRUG HYPERSENSITIVITY,1
NZ,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
NZ,DRUG INTOLERANCE,1
NZ,DRUG SPECIFIC ANTIBODY PRESENT,1
NZ,DRUG-INDUCED LIVER INJURY,1
NZ,DRY MOUTH,1
NZ,DYSGEUSIA,1
NZ,DYSMENORRHOEA,1
NZ,DYSPEPSIA,1
NZ,DYSURIA,1
NZ,EJECTION FRACTION DECREASED,1
NZ,ELECTROCARDIOGRAM ABNORMAL,1
NZ,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
NZ,EMPHYSEMA,1
NZ,EMPYEMA,1
NZ,ENDOMETRIOSIS,1
NZ,ENTERITIS,1
NZ,ERYTHEMA,1
NZ,ESCHERICHIA URINARY TRACT INFECTION,1
NZ,EYE DISORDER,1
NZ,EYE SWELLING,1
NZ,EYELID OEDEMA,1
NZ,FACE OEDEMA,1
NZ,FEELING OF BODY TEMPERATURE CHANGE,1
NZ,FEELING OF DESPAIR,1
NZ,FEMORAL NECK FRACTURE,1
NZ,FISTULA,1
NZ,FISTULA DISCHARGE,1
NZ,FLANK PAIN,1
NZ,FLATULENCE,1
NZ,FOAMING AT MOUTH,1
NZ,FRUSTRATION,1
NZ,FRUSTRATION TOLERANCE DECREASED,1
NZ,GAIT DISTURBANCE,1
NZ,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
NZ,GASTRIC PH DECREASED,1
NZ,GASTROINTESTINAL INFLAMMATION,1
NZ,GASTROINTESTINAL OBSTRUCTION,1
NZ,GLOMERULONEPHRITIS MEMBRANOUS,1
NZ,GLOMERULONEPHRITIS PROLIFERATIVE,1
NZ,GLOMERULOSCLEROSIS,1
NZ,GLUCOSE TOLERANCE IMPAIRED,1
NZ,GOITRE,1
NZ,GRANULOCYTES ABNORMAL,1
NZ,GRIP STRENGTH DECREASED,1
NZ,GROIN PAIN,1
NZ,GROWTH RETARDATION,1
NZ,H1N1 INFLUENZA,1
NZ,HAEMATEMESIS,1
NZ,HAEMATOCRIT DECREASED,1
NZ,HAEMOGLOBIN ABNORMAL,1
NZ,HAEMOLYSIS,1
NZ,HALLUCINATION,1
NZ,HAND DEFORMITY,1
NZ,HEART RATE IRREGULAR,1
NZ,HEPATIC ENZYME INCREASED,1
NZ,HEPATIC FAILURE,1
NZ,HEPATOTOXICITY,1
NZ,HERPES ZOSTER MENINGOENCEPHALITIS,1
NZ,HIP ARTHROPLASTY,1
NZ,HYPERACUSIS,1
NZ,HYPERAMMONAEMIA,1
NZ,HYPERAMMONAEMIC ENCEPHALOPATHY,1
NZ,HYPERGLYCAEMIA,1
NZ,HYPERKALAEMIA,1
NZ,HYPERTHYROIDISM,1
NZ,HYPOAESTHESIA,1
NZ,HYPOKALAEMIA,1
NZ,HYPOPHAGIA,1
NZ,ILEOSTOMY,1
NZ,IMPAIRED HEALING,1
NZ,IMPAIRED WORK ABILITY,1
NZ,INFLUENZA LIKE ILLNESS,1
NZ,INFUSION RELATED REACTION,1
NZ,INJECTION SITE PAIN,1
NZ,INTERNAL HAEMORRHAGE,1
NZ,INTERNATIONAL NORMALISED RATIO DECREASED,1
NZ,INTERVERTEBRAL DISC DISORDER,1
NZ,INTESTINAL RESECTION,1
NZ,INTESTINAL STENOSIS,1
NZ,INTRA-ABDOMINAL HAEMORRHAGE,1
NZ,IRITIS,1
NZ,ISCHAEMIA,1
NZ,ISCHAEMIC NEUROPATHY,1
NZ,ISCHAEMIC STROKE,1
NZ,JOINT ARTHROPLASTY,1
NZ,JOINT CONTRACTURE,1
NZ,JOINT RANGE OF MOTION DECREASED,1
NZ,JUDGEMENT IMPAIRED,1
NZ,KERATOACANTHOMA,1
NZ,KNEE ARTHROPLASTY,1
NZ,LEFT VENTRICULAR DYSFUNCTION,1
NZ,LEUKOENCEPHALOPATHY,1
NZ,LIMB INJURY,1
NZ,LIP BLISTER,1
NZ,LIP EXFOLIATION,1
NZ,LIP SWELLING,1
NZ,LIVER DISORDER,1
NZ,LOCALISED INFECTION,1
NZ,LOSS OF CONSCIOUSNESS,1
NZ,LOWER LIMB FRACTURE,1
NZ,LYMPHOCELE,1
NZ,MALNUTRITION,1
NZ,MASTITIS,1
NZ,MATERNAL EXPOSURE DURING PREGNANCY,1
NZ,MENSTRUAL DISORDER,1
NZ,MENTAL DISORDER,1
NZ,MENTAL IMPAIRMENT,1
NZ,MENTAL STATUS CHANGES,1
NZ,MESOTHELIOMA,1
NZ,METASTASES TO LIVER,1
NZ,METASTASIS,1
NZ,MICTURITION URGENCY,1
NZ,MITRAL VALVE INCOMPETENCE,1
NZ,MULTI-ORGAN FAILURE,1
NZ,MULTIPLE SCLEROSIS,1
NZ,MUSCLE INJURY,1
NZ,MYELOPATHY,1
NZ,MYOCARDIAL FIBROSIS,1
NZ,MYOCARDIAL ISCHAEMIA,1
NZ,MYOSITIS,1
NZ,NECK PAIN,1
NZ,NECROSIS,1
NZ,NECROTISING FASCIITIS STAPHYLOCOCCAL,1
NZ,NECROTISING SCLERITIS,1
NZ,NEPHRITIS,1
NZ,NEPHROTIC SYNDROME,1
NZ,NERVE INJURY,1
NZ,NERVOUSNESS,1
NZ,NEUTROPENIC SEPSIS,1
NZ,NEUTROPHIL COUNT INCREASED,1
NZ,NEUTROPHIL HYPERSEGMENTED MORPHOLOGY PRESENT,1
NZ,OESOPHAGITIS CHEMICAL,1
NZ,OESOPHAGITIS ULCERATIVE,1
NZ,OPTIC NEURITIS,1
NZ,ORTHOSTATIC HYPERTENSION,1
NZ,OSTEOLYSIS,1
NZ,OSTEOMYELITIS,1
NZ,OVERDOSE,1
NZ,OVULATION PAIN,1
NZ,PALLOR,1
NZ,PARAESTHESIA ORAL,1
NZ,PHARYNGEAL OEDEMA,1
NZ,PHOTOPHOBIA,1
NZ,PHOTOPSIA,1
NZ,PHOTOSENSITIVITY REACTION,1
NZ,PLACENTA PRAEVIA,1
NZ,PLEURAL EFFUSION,1
NZ,PLEURITIC PAIN,1
NZ,PNEUMOCYSTIS JIROVECI INFECTION,1
NZ,PNEUMOCYSTIS JIROVECII INFECTION,1
NZ,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
NZ,PNEUMONIA HAEMOPHILUS,1
NZ,PNEUMONIA INFLUENZAL,1
NZ,POLYCYTHAEMIA,1
NZ,POST PROCEDURAL COMPLICATION,1
NZ,POST PROCEDURAL FEVER,1
NZ,POSTOPERATIVE WOUND COMPLICATION,1
NZ,PREMATURE DELIVERY,1
NZ,PROCEDURAL PAIN,1
NZ,PROCTALGIA,1
NZ,PRODUCT USE ISSUE,1
NZ,PSORIATIC ARTHROPATHY,1
NZ,PSYCHIATRIC SYMPTOM,1
NZ,PSYCHOTIC BEHAVIOUR,1
NZ,PSYCHOTIC DISORDER,1
NZ,PULMONARY HYPERTENSION,1
NZ,PURPURA,1
NZ,RASH MACULAR,1
NZ,RASH PRURITIC,1
NZ,RECTAL DISCHARGE,1
NZ,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
NZ,RENAL FAILURE,1
NZ,RENAL FAILURE ACUTE,1
NZ,RESPIRATORY TRACT INFECTION,1
NZ,RETCHING,1
NZ,RETINAL OEDEMA,1
NZ,RHABDOMYOLYSIS,1
NZ,RHINITIS,1
NZ,ROAD TRAFFIC ACCIDENT,1
NZ,SCAR,1
NZ,SCIATICA,1
NZ,SECONDARY ADRENOCORTICAL INSUFFICIENCY,1
NZ,SECRETION DISCHARGE,1
NZ,SEIZURE,1
NZ,SENSATION OF FOREIGN BODY,1
NZ,SINUS BRADYCARDIA,1
NZ,SINUSITIS,1
NZ,SJOGREN^S SYNDROME,1
NZ,SKIN EXFOLIATION,1
NZ,SKIN GRAFT FAILURE,1
NZ,SKIN ULCER,1
NZ,SLEEP APNOEA SYNDROME,1
NZ,SMALL BOWEL ANGIOEDEMA,1
NZ,SOFT TISSUE INJURY,1
NZ,SOFT TISSUE SWELLING,1
NZ,SPINAL FRACTURE,1
NZ,SPINAL PAIN,1
NZ,STAPHYLOCOCCAL INFECTION,1
NZ,STEROID WITHDRAWAL SYNDROME,1
NZ,STEVENS-JOHNSON SYNDROME,1
NZ,STREPTOCOCCAL INFECTION,1
NZ,STREPTOCOCCAL SEPSIS,1
NZ,STRIDOR,1
NZ,SUBACUTE ENDOCARDITIS,1
NZ,SUBARACHNOID HAEMORRHAGE,1
NZ,SUBDURAL HAEMATOMA,1
NZ,SUDDEN DEATH,1
NZ,SUFFOCATION FEELING,1
NZ,SUPERINFECTION BACTERIAL,1
NZ,SWOLLEN TONGUE,1
NZ,SYSTEMIC LUPUS ERYTHEMATOSUS,1
NZ,SYSTEMIC MASTOCYTOSIS,1
NZ,TACHYCARDIA,1
NZ,TENDON DISCOMFORT,1
NZ,TENDON DISORDER,1
NZ,TENDONITIS,1
NZ,THERAPY CESSATION,1
NZ,THROAT TIGHTNESS,1
NZ,TINNITUS,1
NZ,TORSADE DE POINTES,1
NZ,TRANSIENT ISCHAEMIC ATTACK,1
NZ,TRANSPLANT REJECTION,1
NZ,TREATMENT NONCOMPLIANCE,1
NZ,UPPER RESPIRATORY TRACT INFECTION,1
NZ,URINARY TRACT DISORDER,1
NZ,URINE OUTPUT INCREASED,1
NZ,VAGINAL HAEMORRHAGE,1
NZ,VIRAL MYOCARDITIS,1
NZ,VISION BLURRED,1
NZ,WEIGHT INCREASED,1
NZ,WEIGHT LOSS POOR,1
NZ,WHITE BLOOD CELL COUNT INCREASED,1
NZ,WOUND,1
NZ,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
NG,DIABETES MELLITUS,3
NG,MICROSPORIDIA INFECTION,3
NG,CYTOMEGALOVIRUS INFECTION,2
NG,HISTIOCYTOSIS HAEMATOPHAGIC,2
NG,DEATH,1
NG,DEEP VEIN THROMBOSIS,1
NG,DIARRHOEA,1
NG,KERATITIS,1
NG,NODULE,1
NG,PANCYTOPENIA,1
NG,PROCEDURAL HYPOTENSION,1
NG,PYREXIA,1
NG,THROMBOPHLEBITIS,1
NG,TRANSPLANT REJECTION,1
NO,HAEMATOTOXICITY,118
NO,FEBRILE NEUTROPENIA,109
NO,DISEASE PROGRESSION,33
NO,OSTEONECROSIS,23
NO,INTRACRANIAL VENOUS SINUS THROMBOSIS,19
NO,VENOOCCLUSIVE DISEASE,16
NO,DEATH,14
NO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,11
NO,CARDIAC FAILURE,9
NO,CARDIOMYOPATHY ACUTE,8
NO,INTRA-ABDOMINAL HAEMORRHAGE,8
NO,NERVOUS SYSTEM DISORDER,7
NO,PULMONARY OEDEMA,7
NO,ANAEMIA,6
NO,CARDIAC SARCOIDOSIS,6
NO,HYPOGAMMAGLOBULINAEMIA,6
NO,MUSCLE SPASMS,6
NO,PERICARDIAL EFFUSION,6
NO,THROMBOCYTOPENIA,6
NO,MEMORY IMPAIRMENT,5
NO,TOXICITY TO VARIOUS AGENTS,5
NO,TREMOR,5
NO,CYTOMEGALOVIRUS INFECTION,4
NO,HAEMATURIA,4
NO,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,4
NO,TENDERNESS,4
NO,THROMBOSIS,4
NO,BONE MARROW FAILURE,3
NO,CEREBRAL VENOUS THROMBOSIS,3
NO,DIARRHOEA,3
NO,LEUKOPENIA,3
NO,LYMPHOMA,3
NO,NEUTROPENIA,3
NO,PYREXIA,3
NO,RASH GENERALISED,3
NO,VASCULITIS,3
NO,BACK PAIN,2
NO,COMPLETED SUICIDE,2
NO,DISEASE RECURRENCE,2
NO,EVANS SYNDROME,2
NO,HAEMOLYTIC ANAEMIA,2
NO,INFECTION,2
NO,MALIGNANT NEOPLASM PROGRESSION,2
NO,MATERNAL EXPOSURE BEFORE PREGNANCY,2
NO,PNEUMONIA,2
NO,POLYNEUROPATHY,2
NO,PRODUCT USE ISSUE,2
NO,PULMONARY EMBOLISM,2
NO,RENAL FAILURE,2
NO,SECOND PRIMARY MALIGNANCY,2
NO,BACTERAEMIA,1
NO,BLINDNESS,1
NO,BLOOD BILIRUBIN INCREASED,1
NO,BLOOD LACTATE DEHYDROGENASE INCREASED,1
NO,BURSITIS,1
NO,C-REACTIVE PROTEIN INCREASED,1
NO,CARCINOID TUMOUR OF THE APPENDIX,1
NO,CARDIAC ARREST,1
NO,CHEST PAIN,1
NO,COOMBS TEST POSITIVE,1
NO,DEEP VEIN THROMBOSIS,1
NO,DIVERTICULAR FISTULA,1
NO,DIVERTICULITIS,1
NO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
NO,DYSPNOEA,1
NO,EMBOLISM,1
NO,EOSINOPHILIA,1
NO,FATIGUE,1
NO,GASTROINTESTINAL TOXICITY,1
NO,HAEMOLYSIS,1
NO,HYPERTRIGLYCERIDAEMIA,1
NO,INTERSTITIAL LUNG DISEASE,1
NO,KIDNEY INFECTION,1
NO,LYMPHOCYTIC LEUKAEMIA,1
NO,MUCOSAL INFLAMMATION,1
NO,MULTI-ORGAN FAILURE,1
NO,MYELODYSPLASTIC SYNDROME,1
NO,NEUROPATHY PERIPHERAL,1
NO,NON-HODGKIN^S LYMPHOMA,1
NO,OSTEITIS,1
NO,OSTEONECROSIS OF JAW,1
NO,PLEURAL EFFUSION,1
NO,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
NO,PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA,1
NO,PSEUDOMONAL SEPSIS,1
NO,PULMONARY HYPERTENSION,1
NO,RIGHT VENTRICULAR DYSFUNCTION,1
NO,SEPSIS,1
NO,SEPTIC SHOCK,1
NO,THERAPY RESPONDER,1
NO,TRANSIENT ISCHAEMIC ATTACK,1
NO,URINARY TRACT INFECTION,1
OM,ANAEMIA,1
OM,ARTHRITIS BACTERIAL,1
OM,ARTHRITIS INFECTIVE,1
OM,ELECTROLYTE IMBALANCE,1
OM,GENERALISED OEDEMA,1
OM,HYPERALDOSTERONISM,1
OM,HYPERSENSITIVITY,1
OM,HYPERTENSION,1
OM,NEPHROPATHY TOXIC,1
OM,PARVOVIRUS B19 INFECTION,1
OM,PSEUDOSEPSIS,1
OM,PYREXIA,1
OM,SYNOVITIS,1
PK,BONE MARROW FAILURE,6
PK,GASTROINTESTINAL DISORDER,6
PK,APHASIA,2
PK,CONFUSIONAL STATE,2
PK,RESPIRATORY FAILURE,2
PK,ACINETOBACTER BACTERAEMIA,1
PK,ACINETOBACTER INFECTION,1
PK,DEEP VEIN THROMBOSIS,1
PK,DRUG INEFFECTIVE,1
PK,EMBOLISM VENOUS,1
PK,PULMONARY EMBOLISM,1
PK,WALDENSTROM^S MACROGLOBULINAEMIA,1
PA,ASTHENIA,4
PA,HEADACHE,3
PA,DIZZINESS,2
PA,EXPOSURE DURING PREGNANCY,2
PA,HAEMOGLOBIN DECREASED,2
PA,ACNE,1
PA,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
PA,AGITATION,1
PA,ANAL ABSCESS,1
PA,ASTHMATIC CRISIS,1
PA,CHOLECYSTITIS ACUTE,1
PA,DIARRHOEA,1
PA,DISORIENTATION,1
PA,DYSPNOEA,1
PA,FACIAL PAIN,1
PA,FATIGUE,1
PA,FEBRILE NEUTROPENIA,1
PA,FLUID RETENTION,1
PA,GAIT DISTURBANCE,1
PA,HAEMOGLOBIN ABNORMAL,1
PA,HYPERSENSITIVITY,1
PA,INSOMNIA,1
PA,INTESTINAL FISTULA,1
PA,INTESTINAL STENOSIS,1
PA,LABORATORY TEST ABNORMAL,1
PA,LEUKOPENIA,1
PA,MALAISE,1
PA,MENINGITIS BACTERIAL,1
PA,MENINGITIS CRYPTOCOCCAL,1
PA,METABOLIC ACIDOSIS,1
PA,NASOPHARYNGITIS,1
PA,NAUSEA,1
PA,NECK PAIN,1
PA,PNEUMONIA,1
PA,PYREXIA,1
PA,RENAL FAILURE,1
PA,SYNCOPE,1
PA,TACHYCARDIA,1
PA,TOOTHACHE,1
PA,VOMITING,1
PA,WEIGHT DECREASED,1
PG,BREAST FEEDING,1
PG,DIARRHOEA,1
PG,EXPOSURE DURING BREAST FEEDING,1
PG,NEUTROPENIA,1
PY,MATERNAL EXPOSURE DURING PREGNANCY,2
PY,SEPTIC SHOCK,2
PY,AMERICAN TRYPANOSOMIASIS,1
PY,BONE MARROW FAILURE,1
PY,CHRONIC MYELOID LEUKAEMIA,1
PY,MALIGNANT NEOPLASM PROGRESSION,1
PY,PREGNANCY ON CONTRACEPTIVE,1
PY,PREGNANCY WITH INJECTABLE CONTRACEPTIVE,1
PY,SEPSIS,1
PY,SYSTEMIC LUPUS ERYTHEMATOSUS,1
PE,PYREXIA,7
PE,ANAEMIA,4
PE,FATIGUE,4
PE,PAIN IN EXTREMITY,4
PE,PATHOGEN RESISTANCE,4
PE,PNEUMONIA,4
PE,ALANINE AMINOTRANSFERASE INCREASED,3
PE,ASPARTATE AMINOTRANSFERASE INCREASED,3
PE,DIARRHOEA,3
PE,HEPATIC ENZYME INCREASED,3
PE,LUNG INFECTION,3
PE,PLEURAL EFFUSION,3
PE,TRICHODYSPLASIA SPINULOSA,3
PE,VOMITING,3
PE,ATRIAL FIBRILLATION,2
PE,BLOOD CREATININE INCREASED,2
PE,COUGH,2
PE,DYSPNOEA,2
PE,ERYTHEMA,2
PE,FALL,2
PE,LEUKOPENIA,2
PE,LUNG NEOPLASM MALIGNANT,2
PE,MALAISE,2
PE,NAUSEA,2
PE,NEUTROPENIA,2
PE,NO THERAPEUTIC RESPONSE,2
PE,SYSTEMIC LUPUS ERYTHEMATOSUS,2
PE,THROMBOCYTOPENIA,2
PE,ACUTE MYOCARDIAL INFARCTION,1
PE,ANGIOEDEMA,1
PE,ANKLE FRACTURE,1
PE,ARTHRALGIA,1
PE,ASPERGILLOMA,1
PE,ASTHENIA,1
PE,BACK PAIN,1
PE,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
PE,BLOOD PRESSURE DECREASED,1
PE,BRADYCARDIA,1
PE,BRONCHITIS,1
PE,BRONCHOSPASM,1
PE,BURSITIS,1
PE,CARDIO-RESPIRATORY ARREST,1
PE,CATARACT,1
PE,CEREBRAL INFARCTION,1
PE,CHEST DISCOMFORT,1
PE,CHEST INJURY,1
PE,CHILLS,1
PE,CHOKING SENSATION,1
PE,CHRONIC GASTRITIS,1
PE,CONDITION AGGRAVATED,1
PE,CORNEAL PERFORATION,1
PE,CYSTITIS RADIATION,1
PE,DEHYDRATION,1
PE,DERMATOMYOSITIS,1
PE,DISEASE RECURRENCE,1
PE,DIZZINESS,1
PE,DRUG DOSE OMISSION,1
PE,DRUG INEFFECTIVE,1
PE,DRUG RESISTANCE,1
PE,DRUG-INDUCED LIVER INJURY,1
PE,ENCEPHALITIS,1
PE,ENTERITIS,1
PE,EXPOSURE DURING PREGNANCY,1
PE,FACE OEDEMA,1
PE,FEBRILE NEUTROPENIA,1
PE,FIBROMYALGIA,1
PE,GAIT DISTURBANCE,1
PE,GASTROENTERITIS,1
PE,GASTROINTESTINAL HAEMORRHAGE,1
PE,HAEMATOTOXICITY,1
PE,HAEMOGLOBIN DECREASED,1
PE,HAND FRACTURE,1
PE,HEART RATE INCREASED,1
PE,HEPATIC CIRRHOSIS,1
PE,HEPATOMEGALY,1
PE,HERPES ZOSTER,1
PE,HIATUS HERNIA,1
PE,HYPERGLYCAEMIA,1
PE,HYPERHIDROSIS,1
PE,HYPOAESTHESIA,1
PE,HYPOALBUMINAEMIA,1
PE,HYPOGLYCAEMIA NEONATAL,1
PE,HYPOTHERMIA,1
PE,HYPOVOLAEMIC SHOCK,1
PE,IMMUNE SYSTEM DISORDER,1
PE,INCREASED UPPER AIRWAY SECRETION,1
PE,INFECTION,1
PE,INFLUENZA,1
PE,INFUSION RELATED REACTION,1
PE,INGUINAL HERNIA,1
PE,INTERMITTENT CLAUDICATION,1
PE,INTERSTITIAL LUNG DISEASE,1
PE,INTESTINAL OBSTRUCTION,1
PE,JAUNDICE NEONATAL,1
PE,JOINT INJURY,1
PE,JOINT SWELLING,1
PE,LEUKOCYTOSIS,1
PE,LIP DISCOLOURATION,1
PE,LOWER GASTROINTESTINAL HAEMORRHAGE,1
PE,LUNG CYST,1
PE,LUNG INFILTRATION,1
PE,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
PE,MENISCUS INJURY,1
PE,MULTI-ORGAN FAILURE,1
PE,MUSCULAR WEAKNESS,1
PE,MYOCARDIAL INFARCTION,1
PE,MYOPATHY,1
PE,NASOPHARYNGITIS,1
PE,NEONATAL ASPIRATION,1
PE,NEUROPATHY PERIPHERAL,1
PE,NEUTROPENIC INFECTION,1
PE,NEUTROPHILIA,1
PE,OEDEMA,1
PE,OROPHARYNGEAL CANDIDIASIS,1
PE,OSTEOMYELITIS SALMONELLA,1
PE,OXYGEN SATURATION DECREASED,1
PE,PAIN,1
PE,PALLOR,1
PE,PERIPHERAL SWELLING,1
PE,PLATELET COUNT DECREASED,1
PE,PNEUMOTHORAX,1
PE,PREMATURE BABY,1
PE,PRODUCT USE ISSUE,1
PE,PROSTATIC DISORDER,1
PE,PSEUDOMONAS INFECTION,1
PE,RASH,1
PE,RESPIRATORY DISORDER,1
PE,RESPIRATORY FAILURE,1
PE,RESPIRATORY TRACT INFECTION,1
PE,SEPTIC SHOCK,1
PE,SKIN DISCOLOURATION,1
PE,SKIN LESION,1
PE,TONGUE DISCOLOURATION,1
PE,TOXICITY TO VARIOUS AGENTS,1
PE,TRANSAMINASES INCREASED,1
PE,UPPER RESPIRATORY TRACT INFECTION,1
PE,UVEITIS,1
PE,VENTRICULAR EXTRASYSTOLES,1
PE,VIRAL INFECTION,1
PE,VISUAL ACUITY REDUCED,1
PE,WEIGHT DECREASED,1
PH,PNEUMONIA,10
PH,PYREXIA,7
PH,BACK PAIN,3
PH,BLOOD CREATININE INCREASED,3
PH,DIABETES MELLITUS,3
PH,GASTROENTERITIS,3
PH,KIDNEY TRANSPLANT REJECTION,3
PH,OEDEMA,3
PH,PLEURAL EFFUSION,3
PH,PULMONARY TUBERCULOSIS,3
PH,ACUTE HEPATIC FAILURE,2
PH,ACUTE MYOCARDIAL INFARCTION,2
PH,ANAEMIA,2
PH,BRAIN OEDEMA,2
PH,DEATH,2
PH,DIARRHOEA,2
PH,DRUG INEFFECTIVE,2
PH,DYSPHAGIA,2
PH,DYSURIA,2
PH,FOETAL EXPOSURE DURING PREGNANCY,2
PH,HAEMORRHAGE,2
PH,HEPATIC FAILURE,2
PH,INFECTION,2
PH,MELAENA,2
PH,PREMATURE BABY,2
PH,RENAL TUBULAR NECROSIS,2
PH,SEPSIS,2
PH,SEPTIC SHOCK,2
PH,TRANSPLANT REJECTION,2
PH,URINARY TRACT INFECTION,2
PH,URTICARIA,2
PH,ABDOMINAL PAIN UPPER,1
PH,ABSCESS JAW,1
PH,ACNE,1
PH,ACUTE CORONARY SYNDROME,1
PH,ACUTE RESPIRATORY FAILURE,1
PH,ADENOCARCINOMA,1
PH,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
PH,ALOPECIA,1
PH,ANURIA,1
PH,ARRHYTHMIA,1
PH,ARTERITIS,1
PH,ARTHRALGIA,1
PH,ARTHROPATHY,1
PH,BK VIRUS INFECTION,1
PH,BLADDER SQUAMOUS CELL CARCINOMA STAGE I,1
PH,BLADDER SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED,1
PH,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
PH,BLOOD CREATININE ABNORMAL,1
PH,BLOOD PRESSURE INCREASED,1
PH,BLOOD URINE PRESENT,1
PH,BONE MARROW FAILURE,1
PH,BONE MARROW INFILTRATION,1
PH,BONE SWELLING,1
PH,BRONCHOSPASM,1
PH,CARDIAC FAILURE CONGESTIVE,1
PH,CARDIAC MURMUR,1
PH,CENTRAL OBESITY,1
PH,CEREBRAL INFARCTION,1
PH,CEREBROVASCULAR ACCIDENT,1
PH,CHROMATURIA,1
PH,CHRONIC GASTRITIS,1
PH,CHRONIC MYELOID LEUKAEMIA,1
PH,COLITIS,1
PH,COOMBS TEST POSITIVE,1
PH,CREPITATIONS,1
PH,CUSHINGOID,1
PH,CUSHING^S SYNDROME,1
PH,DECREASED APPETITE,1
PH,DEHYDRATION,1
PH,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PH,DRUG RESISTANCE,1
PH,ELECTROLYTE IMBALANCE,1
PH,EOSINOPHILIA,1
PH,ESCHERICHIA URINARY TRACT INFECTION,1
PH,EXPOSURE DURING PREGNANCY,1
PH,FACE OEDEMA,1
PH,FAECALOMA,1
PH,FATIGUE,1
PH,FULL BLOOD COUNT DECREASED,1
PH,GASTRIC ULCER,1
PH,GASTROINTESTINAL HAEMORRHAGE,1
PH,GOUT,1
PH,HAEMATEMESIS,1
PH,HAEMATOCHEZIA,1
PH,HAEMATURIA,1
PH,HEADACHE,1
PH,HEART RATE INCREASED,1
PH,HELICOBACTER GASTRITIS,1
PH,HIGH TURNOVER OSTEOPATHY,1
PH,HYPERCHOLESTEROLAEMIA,1
PH,HYPERSENSITIVITY,1
PH,HYPERURICAEMIA,1
PH,HYPOAESTHESIA,1
PH,HYPOTENSION,1
PH,INFLAMMATION,1
PH,INTENTIONAL PRODUCT USE ISSUE,1
PH,IRON DEFICIENCY ANAEMIA,1
PH,JAUNDICE,1
PH,LARYNGEAL OEDEMA,1
PH,LENTICULAR OPACITIES,1
PH,LIPOHYPERTROPHY,1
PH,LOSS OF CONSCIOUSNESS,1
PH,LOW BIRTH WEIGHT BABY,1
PH,LUPUS NEPHRITIS,1
PH,LYMPHADENOPATHY,1
PH,MALIGNANT NEOPLASM PROGRESSION,1
PH,METASTASES TO BONE,1
PH,METASTASES TO LYMPH NODES,1
PH,MUCOUS MEMBRANE DISORDER,1
PH,MULTI-ORGAN FAILURE,1
PH,MYCOBACTERIUM ABSCESSUS INFECTION,1
PH,NAUSEA,1
PH,NECROSIS,1
PH,OEDEMA PERIPHERAL,1
PH,OESOPHAGITIS,1
PH,ORCHIDECTOMY,1
PH,OROPHARYNGEAL CANDIDIASIS,1
PH,OSTEOARTHRITIS,1
PH,OSTEONECROSIS OF JAW,1
PH,PAIN IN JAW,1
PH,PARAESTHESIA,1
PH,PEMPHIGOID,1
PH,PEPTIC ULCER,1
PH,PLATELET COUNT DECREASED,1
PH,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,1
PH,PREMATURE DELIVERY,1
PH,PRODUCT USE IN UNAPPROVED INDICATION,1
PH,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
PH,PROTEINURIA,1
PH,PRURITUS,1
PH,PURULENT DISCHARGE,1
PH,RASH PRURITIC,1
PH,RENAL TRANSPLANT FAILURE,1
PH,RENAL TUBULAR DISORDER,1
PH,RESPIRATORY FAILURE,1
PH,SEIZURE,1
PH,SKIN INFECTION,1
PH,SKIN NECROSIS,1
PH,SKIN STRIAE,1
PH,SQUAMOUS CELL CARCINOMA,1
PH,THROMBOCYTOPENIA,1
PH,TONSILLAR EXUDATE,1
PH,TOXICITY TO VARIOUS AGENTS,1
PH,TUBERCULOSIS,1
PH,ULCER,1
PH,URINARY TRACT INFECTION STAPHYLOCOCCAL,1
PH,URINARY TRACT OBSTRUCTION,1
PH,URINE OUTPUT DECREASED,1
PH,VIRAL INFECTION,1
PH,VIRAL MYOCARDITIS,1
PH,VOMITING,1
PH,WAIST CIRCUMFERENCE INCREASED,1
PH,WEIGHT DECREASED,1
PH,WHITE BLOOD CELL COUNT DECREASED,1
PL,NEUTROPENIA,45
PL,ANAEMIA,42
PL,DRUG INEFFECTIVE,39
PL,BASAL CELL CARCINOMA,37
PL,PANCYTOPENIA,36
PL,PNEUMONIA,35
PL,THROMBOCYTOPENIA,34
PL,LEUKOPENIA,33
PL,PYREXIA,28
PL,SQUAMOUS CELL CARCINOMA,28
PL,DIABETES MELLITUS,26
PL,VENTRICULAR REMODELLING,23
PL,DIARRHOEA,21
PL,RESPIRATORY FAILURE,20
PL,SEPSIS,20
PL,DYSLIPIDAEMIA,19
PL,ASTHENIA,18
PL,CYTOMEGALOVIRUS INFECTION,18
PL,DISEASE PROGRESSION,18
PL,DYSPNOEA,18
PL,DEATH,17
PL,INFECTION,16
PL,SEPTIC SHOCK,16
PL,URINARY TRACT INFECTION,16
PL,CANDIDA INFECTION,15
PL,HYPERTENSION,15
PL,HYPOGAMMAGLOBULINAEMIA,15
PL,PULMONARY EMBOLISM,15
PL,ASPERGILLUS INFECTION,14
PL,HERPES ZOSTER,14
PL,RENAL FAILURE,14
PL,TOXICITY TO VARIOUS AGENTS,14
PL,CARDIAC FAILURE,13
PL,CORONARY ARTERY DISEASE,13
PL,HYPERGLYCAEMIA,13
PL,MATERNAL EXPOSURE DURING PREGNANCY,13
PL,UPPER RESPIRATORY TRACT INFECTION,13
PL,ABDOMINAL PAIN,12
PL,PREMATURE BABY,12
PL,ACUTE KIDNEY INJURY,11
PL,CHRONIC KIDNEY DISEASE,11
PL,FEBRILE NEUTROPENIA,11
PL,FOETAL EXPOSURE DURING PREGNANCY,11
PL,HYPONATRAEMIA,11
PL,KLEBSIELLA INFECTION,11
PL,MULTI-ORGAN FAILURE,11
PL,NAUSEA,11
PL,TRANSPLANT REJECTION,11
PL,VOMITING,11
PL,DEEP VEIN THROMBOSIS,10
PL,LYMPHADENOPATHY,10
PL,LYMPHOPENIA,10
PL,PROTEINURIA,10
PL,ANAL PRURITUS,9
PL,BLOOD CREATININE INCREASED,9
PL,BRONCHITIS,9
PL,FATIGUE,9
PL,LEFT VENTRICULAR HYPERTROPHY,9
PL,PULMONARY OEDEMA,9
PL,RENAL DISORDER,9
PL,RENAL IMPAIRMENT,9
PL,SEIZURE,9
PL,URINARY TRACT INFECTION BACTERIAL,9
PL,ABORTION SPONTANEOUS,8
PL,ACUTE CORONARY SYNDROME,8
PL,CARDIAC ARREST,8
PL,DIASTOLIC DYSFUNCTION,8
PL,HISTIOCYTOSIS HAEMATOPHAGIC,8
PL,HYPERURICAEMIA,8
PL,MYOCARDIAL INFARCTION,8
PL,POLYNEUROPATHY,8
PL,STAPHYLOCOCCAL INFECTION,8
PL,ALANINE AMINOTRANSFERASE INCREASED,7
PL,CENTRAL NERVOUS SYSTEM LYMPHOMA,7
PL,COUGH,7
PL,DRUG INTOLERANCE,7
PL,EXPOSURE DURING PREGNANCY,7
PL,KIDNEY TRANSPLANT REJECTION,7
PL,NECROTISING HERPETIC RETINOPATHY,7
PL,STAPHYLOCOCCAL SEPSIS,7
PL,ACINETOBACTER INFECTION,6
PL,ARTHRALGIA,6
PL,ATRIAL FIBRILLATION,6
PL,BLOOD PRESSURE INCREASED,6
PL,BONE MARROW FAILURE,6
PL,C-REACTIVE PROTEIN INCREASED,6
PL,CHEST PAIN,6
PL,COMPLICATIONS OF TRANSPLANTED KIDNEY,6
PL,DECREASED APPETITE,6
PL,DRUG EFFECT INCOMPLETE,6
PL,ESCHERICHIA SEPSIS,6
PL,GENERAL PHYSICAL HEALTH DETERIORATION,6
PL,HEPATIC ENZYME INCREASED,6
PL,HYPOPROTEINAEMIA,6
PL,HYPOTENSION,6
PL,LOW BIRTH WEIGHT BABY,6
PL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,6
PL,NECROTISING GASTRITIS,6
PL,OEDEMA PERIPHERAL,6
PL,THROMBOSIS,6
PL,ALOPECIA,5
PL,ASTHMA,5
PL,BACK PAIN,5
PL,BACTERIAL INFECTION,5
PL,COAGULOPATHY,5
PL,DEHYDRATION,5
PL,DISEASE RECURRENCE,5
PL,ERYTHEMA,5
PL,ESCHERICHIA URINARY TRACT INFECTION,5
PL,EXERCISE TOLERANCE DECREASED,5
PL,FOETAL DEATH,5
PL,GASTROINTESTINAL NECROSIS,5
PL,HEPATIC CIRRHOSIS,5
PL,MORAXELLA INFECTION,5
PL,NEUROPATHY PERIPHERAL,5
PL,OEDEMA,5
PL,PLEURAL EFFUSION,5
PL,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,5
PL,PREMATURE DELIVERY,5
PL,PSEUDOMONAS INFECTION,5
PL,RESPIRATORY TRACT INFECTION,5
PL,TACHYPNOEA,5
PL,VARICELLA ZOSTER VIRUS INFECTION,5
PL,ACUTE LYMPHOCYTIC LEUKAEMIA,4
PL,AGRANULOCYTOSIS,4
PL,AUTOIMMUNE HAEMOLYTIC ANAEMIA,4
PL,CARDIOVASCULAR DISORDER,4
PL,CARDIOVASCULAR INSUFFICIENCY,4
PL,CATARACT,4
PL,DISSEMINATED INTRAVASCULAR COAGULATION,4
PL,DRUG LEVEL INCREASED,4
PL,DRUG RESISTANCE,4
PL,ELECTROLYTE IMBALANCE,4
PL,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,4
PL,FUNGAL INFECTION,4
PL,GASTROINTESTINAL HAEMORRHAGE,4
PL,GLOMERULAR FILTRATION RATE DECREASED,4
PL,HAEMOLYSIS,4
PL,HAEMORRHAGIC DIATHESIS,4
PL,HEADACHE,4
PL,HEPATIC FAILURE,4
PL,HYPERKALAEMIA,4
PL,HYPOTHYROIDISM,4
PL,INTERSTITIAL LUNG DISEASE,4
PL,ISCHAEMIC STROKE,4
PL,LACTIC ACIDOSIS,4
PL,LEUKOCYTOSIS,4
PL,METASTATIC RENAL CELL CARCINOMA,4
PL,NEUROTOXICITY,4
PL,NEUTROPHIL PELGER-HUET ANOMALY PRESENT,4
PL,OLIGURIA,4
PL,OSTEONECROSIS OF JAW,4
PL,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
PL,PRODUCT USE IN UNAPPROVED INDICATION,4
PL,PROTEUS INFECTION,4
PL,RENAL INJURY,4
PL,SMALL INTESTINAL PERFORATION,4
PL,THERAPEUTIC RESPONSE DECREASED,4
PL,THROMBOTIC MICROANGIOPATHY,4
PL,TONGUE FUNGAL INFECTION,4
PL,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,3
PL,ACUTE MYOCARDIAL INFARCTION,3
PL,ADVERSE EVENT,3
PL,AGITATION,3
PL,ANXIETY DISORDER,3
PL,ARRHYTHMIA,3
PL,ASPARTATE AMINOTRANSFERASE INCREASED,3
PL,B-CELL LYMPHOMA,3
PL,BACTERIAL SEPSIS,3
PL,BK VIRUS INFECTION,3
PL,BLOOD DISORDER,3
PL,BLOOD PRESSURE DECREASED,3
PL,BODY TEMPERATURE INCREASED,3
PL,BRADYCARDIA,3
PL,CARDIOPULMONARY FAILURE,3
PL,CATATONIA,3
PL,CHRONIC LYMPHOCYTIC LEUKAEMIA,3
PL,CIRCULATORY COLLAPSE,3
PL,CONDITION AGGRAVATED,3
PL,CONGENITAL PNEUMONIA,3
PL,DERMATITIS ATOPIC,3
PL,DYSPNOEA EXERTIONAL,3
PL,DYSURIA,3
PL,EAR INFECTION,3
PL,FUNGAEMIA,3
PL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
PL,HEPATITIS C,3
PL,HERPES VIRUS INFECTION,3
PL,HYPERBILIRUBINAEMIA,3
PL,HYPERCHOLESTEROLAEMIA,3
PL,HYPERHIDROSIS,3
PL,INTRAUTERINE INFECTION,3
PL,JAUNDICE,3
PL,LIVER DISORDER,3
PL,LIVER INJURY,3
PL,LOSS OF CONSCIOUSNESS,3
PL,LUNG TRANSPLANT REJECTION,3
PL,LYMPHOCYTOSIS,3
PL,MALAISE,3
PL,NEPHROTIC SYNDROME,3
PL,ORAL FUNGAL INFECTION,3
PL,PALPITATIONS,3
PL,PANCREATITIS ACUTE,3
PL,PARAESTHESIA,3
PL,PERITONITIS,3
PL,PLASMA CELL MYELOMA,3
PL,PLATELET COUNT DECREASED,3
PL,POSTOPERATIVE WOUND INFECTION,3
PL,PROSTATE CANCER METASTATIC,3
PL,PSYCHOMOTOR HYPERACTIVITY,3
PL,RASH,3
PL,RESPIRATORY SYNCYTIAL VIRUS INFECTION,3
PL,RICHTER^S SYNDROME,3
PL,SECOND PRIMARY MALIGNANCY,3
PL,SQUAMOUS CELL CARCINOMA OF SKIN,3
PL,STOMATITIS,3
PL,STREPTOCOCCAL INFECTION,3
PL,TACHYCARDIA,3
PL,THROMBOTIC STROKE,3
PL,ULCER,3
PL,UROSEPSIS,3
PL,URTICARIA,3
PL,VENTRICULAR HYPERTROPHY,3
PL,WEIGHT DECREASED,3
PL,ABSCESS,2
PL,ACARODERMATITIS,2
PL,ACUTE ABDOMEN,2
PL,ACUTE MONOCYTIC LEUKAEMIA,2
PL,ADAMS-STOKES SYNDROME,2
PL,ADRENAL INSUFFICIENCY,2
PL,ALTERED STATE OF CONSCIOUSNESS,2
PL,ARRHYTHMIA SUPRAVENTRICULAR,2
PL,ARTHRITIS,2
PL,AUTOIMMUNE HEPATITIS,2
PL,BETA-2 GLYCOPROTEIN ANTIBODY POSITIVE,2
PL,BLOOD TRIGLYCERIDES INCREASED,2
PL,BOWEN^S DISEASE,2
PL,BRAIN ABSCESS,2
PL,BRONCHOPNEUMONIA,2
PL,CALCIUM METABOLISM DISORDER,2
PL,CARDIAC DISORDER,2
PL,CARDIO-RESPIRATORY ARREST,2
PL,CHILLS,2
PL,CHOLELITHIASIS,2
PL,CHROMATURIA,2
PL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
PL,CLOSTRIDIUM DIFFICILE COLITIS,2
PL,CONFUSIONAL STATE,2
PL,CONGENITAL INFECTION,2
PL,CORYNEBACTERIUM INFECTION,2
PL,DYSPEPSIA,2
PL,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,2
PL,EMBOLISM VENOUS,2
PL,EPILEPSY,2
PL,ESCHERICHIA INFECTION,2
PL,EXPOSED BONE IN JAW,2
PL,FEELING HOT,2
PL,FOETAL GROWTH RESTRICTION,2
PL,GASTRITIS HAEMORRHAGIC,2
PL,GINGIVAL HYPERTROPHY,2
PL,HAEMATEMESIS,2
PL,HAEMATOCHEZIA,2
PL,HAEMOGLOBIN DECREASED,2
PL,HAEMORRHAGE,2
PL,HEART RATE INCREASED,2
PL,HEMIPARESIS,2
PL,HEPATOMEGALY,2
PL,HEPATOSPLENOMEGALY,2
PL,HIRSUTISM,2
PL,HYPERTONIA,2
PL,HYPOALBUMINAEMIA,2
PL,HYPOCHROMIC ANAEMIA,2
PL,HYPOKALAEMIA,2
PL,HYPOMAGNESAEMIA,2
PL,HYPORESPONSIVE TO STIMULI,2
PL,HYPOTONIA,2
PL,HYPOXIA,2
PL,ILEUS,2
PL,INFLAMMATION,2
PL,INFUSION RELATED REACTION,2
PL,INTRAVENTRICULAR HAEMORRHAGE,2
PL,INTUSSUSCEPTION,2
PL,KIDNEY FIBROSIS,2
PL,LIVE BIRTH,2
PL,LIVIDITY,2
PL,LOCAL SWELLING,2
PL,LOWER RESPIRATORY TRACT INFECTION,2
PL,LYMPHOCYTIC INFILTRATION,2
PL,MALIGNANT NEOPLASM PROGRESSION,2
PL,MORGANELLA INFECTION,2
PL,MOVEMENT DISORDER,2
PL,MUSCLE RIGIDITY,2
PL,MUSCULAR WEAKNESS,2
PL,NERVOUS SYSTEM DISORDER,2
PL,NEUTROPHILIA,2
PL,NIGHT SWEATS,2
PL,NO THERAPEUTIC RESPONSE,2
PL,NODULE,2
PL,OESOPHAGITIS,2
PL,OSMOTIC DEMYELINATION SYNDROME,2
PL,OTITIS MEDIA,2
PL,PAIN,2
PL,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
PL,PANCREATITIS NECROTISING,2
PL,PAPILLOMA VIRAL INFECTION,2
PL,PEPTIC ULCER HAEMORRHAGE,2
PL,PHARYNGITIS,2
PL,PHOSPHORUS METABOLISM DISORDER,2
PL,PLASMAPHERESIS,2
PL,PNEUMOCOCCAL INFECTION,2
PL,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,2
PL,POLYURIA,2
PL,PROSTATE CANCER,2
PL,PRURITUS,2
PL,PULMONARY HAEMORRHAGE,2
PL,PULMONARY HYPERTENSION,2
PL,PULMONARY TOXICITY,2
PL,PYURIA,2
PL,RALES,2
PL,RASH ERYTHEMATOUS,2
PL,RASH GENERALISED,2
PL,RENAL TUBULAR ATROPHY,2
PL,SARCOIDOSIS,2
PL,SCEDOSPORIUM INFECTION,2
PL,SINUSITIS,2
PL,SKIN LESION,2
PL,SKIN ULCER,2
PL,SPINAL PAIN,2
PL,SPLENOMEGALY,2
PL,STATUS EPILEPTICUS,2
PL,SUDDEN DEATH,2
PL,THERAPY RESPONDER,2
PL,THREATENED LABOUR,2
PL,TORTICOLLIS,2
PL,TRACHEAL STENOSIS,2
PL,TRANSPLANT DYSFUNCTION,2
PL,TREMOR,2
PL,TUBERCULOSIS,2
PL,URETERAL NECROSIS,2
PL,URINARY RETENTION,2
PL,VENOUS THROMBOSIS LIMB,2
PL,VENTRICULAR ARRHYTHMIA,2
PL,WHITE BLOOD CELL COUNT INCREASED,2
PL,ABDOMINAL PAIN UPPER,1
PL,ACIDOSIS,1
PL,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
PL,ACUTE LEFT VENTRICULAR FAILURE,1
PL,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
PL,ACUTE PSYCHOSIS,1
PL,ACUTE RESPIRATORY FAILURE,1
PL,ACUTE TONSILLITIS,1
PL,ADENOCARCINOMA OF COLON,1
PL,ADENOVIRUS INFECTION,1
PL,ADHESION,1
PL,ADJUSTMENT DISORDER WITH DEPRESSED MOOD,1
PL,ADVERSE DRUG REACTION,1
PL,AGGRESSION,1
PL,AMENORRHOEA,1
PL,AMNIOCENTESIS ABNORMAL,1
PL,AMYLASE INCREASED,1
PL,ANAEMIA MACROCYTIC,1
PL,ANAL ABSCESS,1
PL,ANAPLASTIC ASTROCYTOMA,1
PL,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,1
PL,ANGINA UNSTABLE,1
PL,APATHY,1
PL,APHTHOUS ULCER,1
PL,APPENDIX CANCER,1
PL,ASCITES,1
PL,ASPERGILLOMA,1
PL,ATRIAL FLUTTER,1
PL,ATRIAL HYPERTROPHY,1
PL,AURAL POLYP,1
PL,BACTERAEMIA,1
PL,BENIGN FAMILIAL PEMPHIGUS,1
PL,BILE DUCT STONE,1
PL,BLADDER DISORDER,1
PL,BLADDER TRANSITIONAL CELL CARCINOMA,1
PL,BLINDNESS,1
PL,BLOOD ALKALINE PHOSPHATASE INCREASED,1
PL,BLOOD BILIRUBIN INCREASED,1
PL,BLOOD CHOLESTEROL INCREASED,1
PL,BLOOD FOLLICLE STIMULATING HORMONE INCREASED,1
PL,BLOOD LACTATE DEHYDROGENASE INCREASED,1
PL,BLOOD LUTEINISING HORMONE INCREASED,1
PL,BODY MASS INDEX DECREASED,1
PL,BODY TEMPERATURE DECREASED,1
PL,BONE ABSCESS,1
PL,BONE MARROW TOXICITY,1
PL,BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC,1
PL,BURKITT^S LYMPHOMA,1
PL,CACHEXIA,1
PL,CAESAREAN SECTION,1
PL,CAMPYLOBACTER SEPSIS,1
PL,CARDIAC FAILURE CHRONIC,1
PL,CARDIAC FAILURE CONGESTIVE,1
PL,CARDIAC TAMPONADE,1
PL,CARDIOTOXICITY,1
PL,CELLULITIS,1
PL,CENTRAL OBESITY,1
PL,CEREBRAL ASPERGILLOSIS,1
PL,CEREBROVASCULAR ACCIDENT,1
PL,CEREBROVASCULAR DISORDER,1
PL,CHANGE OF BOWEL HABIT,1
PL,CHEST DISCOMFORT,1
PL,CHOLANGITIS,1
PL,CHOLESTASIS,1
PL,CHRONIC GRAFT VERSUS HOST DISEASE,1
PL,CLOSTRIDIUM DIFFICILE INFECTION,1
PL,COLITIS ULCERATIVE,1
PL,COLORECTAL CANCER,1
PL,COMPLICATIONS OF TRANSPLANT SURGERY,1
PL,COMPLICATIONS OF TRANSPLANTED LIVER,1
PL,CONJUNCTIVITIS,1
PL,CONSTIPATION,1
PL,CONVULSION,1
PL,COR PULMONALE ACUTE,1
PL,CORONARY ARTERY THROMBOSIS,1
PL,CREPITATIONS,1
PL,CUSHINGOID,1
PL,CUSHING^S SYNDROME,1
PL,CYSTITIS HAEMORRHAGIC,1
PL,CYTOGENETIC ANALYSIS ABNORMAL,1
PL,CYTOMEGALOVIRUS TEST POSITIVE,1
PL,DEAFNESS,1
PL,DEAFNESS UNILATERAL,1
PL,DECREASED IMMUNE RESPONSIVENESS,1
PL,DEFAECATION URGENCY,1
PL,DELAYED GRAFT FUNCTION,1
PL,DENTAL CARIES,1
PL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PL,DEPRESSION,1
PL,DEPRESSIVE SYMPTOM,1
PL,DERMATITIS,1
PL,DERMATITIS EXFOLIATIVE,1
PL,DEVELOPMENTAL DELAY,1
PL,DIABETIC FOOT,1
PL,DIABETIC KETOACIDOSIS,1
PL,DIARRHOEA HAEMORRHAGIC,1
PL,DIARRHOEA INFECTIOUS,1
PL,DIASTASIS RECTI ABDOMINIS,1
PL,DIPLOPIA,1
PL,DISORIENTATION,1
PL,DISTRACTIBILITY,1
PL,DIZZINESS,1
PL,DRUG DEPENDENCE,1
PL,DRUG ERUPTION,1
PL,DYSAESTHESIA,1
PL,DYSPHAGIA,1
PL,DYSPLASIA,1
PL,ECHOCARDIOGRAM ABNORMAL,1
PL,ECHOLALIA,1
PL,ECHOPRAXIA,1
PL,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
PL,EMBOLIC STROKE,1
PL,EMBOLISM,1
PL,EMBOLISM ARTERIAL,1
PL,ENCEPHALITIS,1
PL,ENDOCARDITIS,1
PL,ENDOTHELIAL DYSFUNCTION,1
PL,ENTEROBACTER INFECTION,1
PL,EOSINOPHIL COUNT,1
PL,EOSINOPHILIA,1
PL,EPIDERMODYSPLASIA VERRUCIFORMIS,1
PL,EPSTEIN-BARR VIRAEMIA,1
PL,EPSTEIN-BARR VIRUS INFECTION,1
PL,ERYSIPELAS,1
PL,ERYTHROPENIA,1
PL,ERYTHROPOIESIS ABNORMAL,1
PL,EXCORIATION,1
PL,EYE DISORDER,1
PL,FACTOR VIII INHIBITION,1
PL,FIBRIN D DIMER INCREASED,1
PL,FISTULA,1
PL,FLUID OVERLOAD,1
PL,FOETAL DISTRESS SYNDROME,1
PL,FOETAL HEART RATE DECREASED,1
PL,FOETAL HYPOKINESIA,1
PL,FOOD ALLERGY,1
PL,FUNGAL PERITONITIS,1
PL,FUNGAL SEPSIS,1
PL,FURUNCLE,1
PL,GAIT DISTURBANCE,1
PL,GASTRIC HAEMORRHAGE,1
PL,GASTRIC ULCER,1
PL,GASTRITIS,1
PL,GESTATIONAL HYPERTENSION,1
PL,GINGIVAL DISORDER,1
PL,GINGIVAL OEDEMA,1
PL,GLAUCOMA,1
PL,GLOMERULONEPHRITIS CHRONIC,1
PL,GLOMERULONEPHRITIS MINIMAL LESION,1
PL,GLOMERULOSCLEROSIS,1
PL,GOUT,1
PL,GRAFT VERSUS HOST DISEASE,1
PL,GRANULOCYTOPENIA,1
PL,GRANULOMATOSIS WITH POLYANGIITIS,1
PL,GYNAECOMASTIA,1
PL,HAEMATOMA,1
PL,HAEMATURIA,1
PL,HAEMOCHROMATOSIS,1
PL,HAEMOLYTIC ANAEMIA,1
PL,HALLUCINATION_ AUDITORY,1
PL,HEAD INJURY,1
PL,HEARING DISABILITY,1
PL,HEART RATE ABNORMAL,1
PL,HEART RATE DECREASED,1
PL,HEPATIC CANCER METASTATIC,1
PL,HEPATIC FUNCTION ABNORMAL,1
PL,HEPATITIS C ANTIBODY POSITIVE,1
PL,HEPATITIS CHOLESTATIC,1
PL,HEPATITIS TOXIC,1
PL,HERPES SIMPLEX,1
PL,HYDROCELE,1
PL,HYDRONEPHROSIS,1
PL,HYPERGAMMAGLOBULINAEMIA,1
PL,HYPERKERATOSIS,1
PL,HYPERPLASIA,1
PL,HYPERREFLEXIA,1
PL,HYPERSENSITIVITY,1
PL,HYPERTHYROIDISM,1
PL,HYPOAESTHESIA ORAL,1
PL,HYPOCALCAEMIA,1
PL,HYPOGLYCAEMIA,1
PL,HYPOKINESIA,1
PL,HYPOTONIA NEONATAL,1
PL,HYPOVOLAEMIA,1
PL,HYPOVOLAEMIC SHOCK,1
PL,ILEAL PERFORATION,1
PL,ILL-DEFINED DISORDER,1
PL,IMMUNE SYSTEM DISORDER,1
PL,IMMUNE THROMBOCYTOPENIC PURPURA,1
PL,IMMUNODEFICIENCY,1
PL,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
PL,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
PL,IMMUNOSUPPRESSION,1
PL,INAPPROPRIATE AFFECT,1
PL,INCORRECT DOSE ADMINISTERED,1
PL,INCREASED BRONCHIAL SECRETION,1
PL,INDIFFERENCE,1
PL,INTENTIONAL PRODUCT USE ISSUE,1
PL,INTERVERTEBRAL DISC DISORDER,1
PL,INTERVERTEBRAL DISC PROTRUSION,1
PL,INTESTINAL PERFORATION,1
PL,JAW FRACTURE,1
PL,JUVENILE IDIOPATHIC ARTHRITIS,1
PL,KAPOSI^S SARCOMA,1
PL,LACK OF SPONTANEOUS SPEECH,1
PL,LARGE CELL LUNG CANCER,1
PL,LARGE INTESTINAL ULCER,1
PL,LARYNGITIS,1
PL,LEFT VENTRICULAR DYSFUNCTION,1
PL,LEFT VENTRICULAR FAILURE,1
PL,LEUKAEMIA RECURRENT,1
PL,LEUKOCYTURIA,1
PL,LIPASE INCREASED,1
PL,LIVER FUNCTION TEST INCREASED,1
PL,LOCALISED OEDEMA,1
PL,LOOSE ASSOCIATIONS,1
PL,LUMBAR VERTEBRAL FRACTURE,1
PL,LUNG INFECTION,1
PL,LUNG INFILTRATION,1
PL,LUNG NEOPLASM,1
PL,LUNG NEOPLASM MALIGNANT,1
PL,LYMPHOCYTE COUNT DECREASED,1
PL,LYMPHOCYTE COUNT INCREASED,1
PL,LYMPHOMA,1
PL,LYMPHOMATOID PAPULOSIS,1
PL,LYMPHORRHOEA,1
PL,MANTLE CELL LYMPHOMA RECURRENT,1
PL,MATERNAL EXPOSURE BEFORE PREGNANCY,1
PL,MEDIASTINUM NEOPLASM,1
PL,MENSTRUAL DISORDER,1
PL,MENTAL DISORDER,1
PL,METASTASES TO BONE,1
PL,METASTASES TO LIVER,1
PL,METASTASES TO SKIN,1
PL,MICTURITION URGENCY,1
PL,MONOCYTE COUNT INCREASED,1
PL,MONOPARESIS,1
PL,MOOD ALTERED,1
PL,MUCOSAL EXFOLIATION,1
PL,MUCOSAL INFLAMMATION,1
PL,MUCOSAL ULCERATION,1
PL,MUSCLE CONTRACTIONS INVOLUNTARY,1
PL,MUSCULOSKELETAL PAIN,1
PL,MUTISM,1
PL,MYALGIA,1
PL,MYASTHENIA GRAVIS,1
PL,MYCOSIS FUNGOIDES,1
PL,MYOCARDITIS,1
PL,MYOPIA,1
PL,MYOSITIS,1
PL,NASAL NEOPLASM,1
PL,NASAL SEPTUM PERFORATION,1
PL,NEGATIVISM,1
PL,NEOPLASM,1
PL,NEOPLASM MALIGNANT,1
PL,NEOPLASM OF ORBIT,1
PL,NEOPLASM PROGRESSION,1
PL,NEPHROGENIC ANAEMIA,1
PL,NEURALGIA,1
PL,NEUROLOGICAL SYMPTOM,1
PL,NEUTROPENIC INFECTION,1
PL,NEUTROPHIL COUNT DECREASED,1
PL,NOCTURIA,1
PL,NON-HODGKIN^S LYMPHOMA,1
PL,NORMAL NEWBORN,1
PL,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
PL,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
PL,OCULAR ICTERUS,1
PL,OEDEMA MUCOSAL,1
PL,OPTIC NEURITIS,1
PL,ORAL CANDIDIASIS,1
PL,ORAL DISORDER,1
PL,ORAL MUCOSA EROSION,1
PL,OSTEITIS,1
PL,OSTEOLYSIS,1
PL,OSTEOPOROSIS,1
PL,OSTEOPOROTIC FRACTURE,1
PL,OVARIAN HYPERSTIMULATION SYNDROME,1
PL,OXYGEN SATURATION DECREASED,1
PL,PAIN IN EXTREMITY,1
PL,PAIN IN JAW,1
PL,PALLOR,1
PL,PALMAR ERYTHEMA,1
PL,PANCREATITIS,1
PL,PANNICULITIS,1
PL,PARAPARESIS,1
PL,PEMPHIGOID,1
PL,PENILE OEDEMA,1
PL,PERCUSSION TEST ABNORMAL,1
PL,PERIPHERAL ARTERY OCCLUSION,1
PL,PERIPHERAL ARTERY STENOSIS,1
PL,PERIPHERAL ISCHAEMIA,1
PL,PERIPHERAL NERVE PALSY,1
PL,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
PL,PERIPHERAL SENSORY NEUROPATHY,1
PL,PERIPHERAL SWELLING,1
PL,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
PL,PERIRENAL HAEMATOMA,1
PL,PERITONEAL DISORDER,1
PL,PERITONITIS BACTERIAL,1
PL,PERNICIOUS ANAEMIA,1
PL,PERSECUTORY DELUSION,1
PL,PHARYNGEAL DISORDER,1
PL,PLACENTAL DISORDER,1
PL,PLATELET COUNT INCREASED,1
PL,PLEOCYTOSIS,1
PL,PLEURAL MESOTHELIOMA MALIGNANT,1
PL,PLEURAL RUB,1
PL,PNEUMOCOCCAL SEPSIS,1
PL,PNEUMOCYSTIS JIROVECII INFECTION,1
PL,PNEUMONIA FUNGAL,1
PL,PNEUMONITIS,1
PL,PO2 DECREASED,1
PL,POLYP,1
PL,POST PROCEDURAL HAEMATOMA,1
PL,POSTPERICARDIOTOMY SYNDROME,1
PL,POSTURING,1
PL,PREMATURE LABOUR,1
PL,PREMATURE RUPTURE OF MEMBRANES,1
PL,PRODUCT USE ISSUE,1
PL,PRODUCTIVE COUGH,1
PL,PULMONARY ARTERIAL PRESSURE INCREASED,1
PL,PULMONARY FIBROSIS,1
PL,PULMONARY MYCOSIS,1
PL,PULMONARY VASCULAR DISORDER,1
PL,PYELOCALIECTASIS,1
PL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PL,REFRACTORY CANCER,1
PL,RENAL ABSCESS,1
PL,RENAL CANCER RECURRENT,1
PL,RENAL FAILURE ACUTE,1
PL,RENAL FAILURE CHRONIC,1
PL,RENAL MASS,1
PL,RENAL TRANSPLANT FAILURE,1
PL,RESPIRATORY ACIDOSIS,1
PL,RESPIRATORY DISORDER,1
PL,RESPIRATORY RATE INCREASED,1
PL,RESUSCITATION,1
PL,RETINAL OEDEMA,1
PL,RHEUMATOID FACTOR POSITIVE,1
PL,ROTAVIRUS INFECTION,1
PL,SCAR,1
PL,SCIATICA,1
PL,SCLERODERMA,1
PL,SCLEROSING ENCAPSULATING PERITONITIS,1
PL,SECONDARY IMMUNODEFICIENCY,1
PL,SERUM FERRITIN INCREASED,1
PL,SEZARY CELLS INCREASED,1
PL,SKIN ATROPHY,1
PL,SKIN DISCOLOURATION,1
PL,SKIN DISORDER,1
PL,SKIN EXFOLIATION,1
PL,SKIN NECROSIS,1
PL,SKIN PAPILLOMA,1
PL,SOCIAL AVOIDANT BEHAVIOUR,1
PL,SPINAL FRACTURE,1
PL,SPINAL VASCULAR DISORDER,1
PL,SPLENIC ABSCESS,1
PL,SPUTUM RETENTION,1
PL,STARING,1
PL,STATUS ASTHMATICUS,1
PL,STRIDOR,1
PL,STUPOR,1
PL,SUBCUTANEOUS ABSCESS,1
PL,SUBDURAL HAEMATOMA,1
PL,SUBILEUS,1
PL,SUPERIOR VENA CAVA SYNDROME,1
PL,SUPRAVENTRICULAR TACHYCARDIA,1
PL,SYSTEMIC LUPUS ERYTHEMATOSUS,1
PL,TACHYCARDIA PAROXYSMAL,1
PL,THERAPEUTIC RESPONSE UNEXPECTED,1
PL,THORACIC VERTEBRAL FRACTURE,1
PL,THROMBOTIC CEREBRAL INFARCTION,1
PL,THYROID DISORDER,1
PL,TONSILLAR NEOPLASM,1
PL,TOOTH ABSCESS,1
PL,TOXIC EPIDERMAL NECROLYSIS,1
PL,TOXOPLASMOSIS,1
PL,TRANSPLANT FAILURE,1
PL,TRAUMATIC HAEMATOMA,1
PL,TREATMENT FAILURE,1
PL,TRICHOPHYTOSIS,1
PL,TUMOUR LYSIS SYNDROME,1
PL,UNDERWEIGHT,1
PL,UNRESPONSIVE TO STIMULI,1
PL,URETHRAL STENOSIS,1
PL,URINARY TRACT DISORDER,1
PL,URINARY TRACT INFECTION ENTEROCOCCAL,1
PL,URINARY TRACT OBSTRUCTION,1
PL,VARICELLA VIRUS TEST POSITIVE,1
PL,VASCULITIS,1
PL,VENOUS THROMBOSIS,1
PL,VENTRICULAR EXTRASYSTOLES,1
PL,VENTRICULAR FAILURE,1
PL,VENTRICULAR SEPTAL DEFECT,1
PL,VIRAEMIA,1
PL,VIRAL HAEMORRHAGIC CYSTITIS,1
PL,VISUAL ACUITY REDUCED,1
PL,VISUAL IMPAIRMENT,1
PL,VITAL CAPACITY DECREASED,1
PL,VOLVULUS OF SMALL BOWEL,1
PL,WEIGHT INCREASED,1
PL,WHEEZING,1
PL,WHITE BLOOD CELL COUNT DECREASED,1
PL,WHITE BLOOD CELLS URINE,1
PL,WOUND ABSCESS,1
PL,YELLOW SKIN,1
PT,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,90
PT,TRANSPLANT DYSFUNCTION,74
PT,GRAFT LOSS,37
PT,COMPLICATIONS OF TRANSPLANTED KIDNEY,16
PT,CRYPTOCOCCOSIS,13
PT,KAPOSI^S SARCOMA,13
PT,EXPOSURE DURING PREGNANCY,12
PT,KIDNEY TRANSPLANT REJECTION,12
PT,PREMATURE BABY,12
PT,FOETAL EXPOSURE DURING PREGNANCY,10
PT,PRE-ECLAMPSIA,10
PT,INFLAMMATION,9
PT,LIVE BIRTH,9
PT,OESOPHAGEAL ATRESIA,9
PT,RENAL TRANSPLANT FAILURE,9
PT,TERATOGENICITY,9
PT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,6
PT,DISEASE PROGRESSION,5
PT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,5
PT,TOXICITY TO VARIOUS AGENTS,5
PT,BK VIRUS INFECTION,4
PT,DIABETES MELLITUS,4
PT,INFECTION,4
PT,TRANSPLANT REJECTION,4
PT,UROSEPSIS,4
PT,ASPERGILLUS INFECTION,3
PT,BRONCHOPULMONARY ASPERGILLOSIS,3
PT,DRUG INEFFECTIVE,3
PT,FOETAL GROWTH RESTRICTION,3
PT,HYPOTENSION,3
PT,KIDNEY FIBROSIS,3
PT,MATERNAL EXPOSURE DURING PREGNANCY,3
PT,NEUROPATHY PERIPHERAL,3
PT,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
PT,RENAL TUBULAR ATROPHY,3
PT,RESPIRATORY FAILURE,3
PT,ACIDOSIS,2
PT,ACUTE KIDNEY INJURY,2
PT,ADMINISTRATION RELATED REACTION,2
PT,ASTHENIA,2
PT,BICYTOPENIA,2
PT,BLOOD LACTATE DEHYDROGENASE INCREASED,2
PT,CARDIOVASCULAR DISORDER,2
PT,CYTOMEGALOVIRUS INFECTION,2
PT,DEATH,2
PT,DECREASED APPETITE,2
PT,DELAYED GRAFT FUNCTION,2
PT,DRUG DISPENSING ERROR,2
PT,DYSPNOEA,2
PT,EMBOLISM,2
PT,ERYTHEMA,2
PT,FEBRILE NEUTROPENIA,2
PT,HAEMATOTOXICITY,2
PT,HEPATITIS ACUTE,2
PT,HEPATITIS B,2
PT,HEPATOTOXICITY,2
PT,ISCHAEMIA,2
PT,JAUNDICE,2
PT,LEUKAEMIC INFILTRATION BRAIN,2
PT,MEDICATION ERROR,2
PT,NEOPLASM MALIGNANT,2
PT,OVERDOSE,2
PT,PEMPHIGOID,2
PT,PNEUMONIA ASPIRATION,2
PT,RENAL CELL CARCINOMA,2
PT,RENAL IMPAIRMENT,2
PT,RESPIRATORY ARREST,2
PT,RHABDOMYOLYSIS,2
PT,SEPTIC SHOCK,2
PT,SHOCK,2
PT,STRONGYLOIDIASIS,2
PT,THROMBOCYTOPENIA,2
PT,ABDOMINAL PAIN,1
PT,ABDOMINAL PAIN UPPER,1
PT,ALANINE AMINOTRANSFERASE INCREASED,1
PT,ALPORT^S SYNDROME,1
PT,ANAPHYLACTIC REACTION,1
PT,APALLIC SYNDROME,1
PT,ARTHRALGIA,1
PT,ASCITES,1
PT,ASPARTATE AMINOTRANSFERASE INCREASED,1
PT,ASTHMA,1
PT,ATROPHY,1
PT,B-CELL LYMPHOMA RECURRENT,1
PT,B-CELL LYMPHOMA REFRACTORY,1
PT,BLOOD BILIRUBIN INCREASED,1
PT,BLOOD DISORDER,1
PT,BLOOD PRESSURE DECREASED,1
PT,BONE EROSION,1
PT,BREATH SOUNDS ABNORMAL,1
PT,CEREBROVASCULAR ACCIDENT,1
PT,CHOLURIA,1
PT,CHRONIC ALLOGRAFT NEPHROPATHY,1
PT,CLEAR CELL RENAL CELL CARCINOMA,1
PT,CLONUS,1
PT,CLOSTRIDIUM DIFFICILE INFECTION,1
PT,COAGULOPATHY,1
PT,COCCYDYNIA,1
PT,COGNITIVE DISORDER,1
PT,CONSTIPATION,1
PT,CONVULSION,1
PT,COUGH,1
PT,CYSTITIS,1
PT,DEEP VEIN THROMBOSIS,1
PT,DELUSION OF GRANDEUR,1
PT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PT,DERMATITIS ALLERGIC,1
PT,DIARRHOEA,1
PT,DRUG LEVEL INCREASED,1
PT,DUODENAL PERFORATION,1
PT,DUODENAL ULCER,1
PT,ELEVATED MOOD,1
PT,ENCEPHALITIS AUTOIMMUNE,1
PT,EXTENSOR PLANTAR RESPONSE,1
PT,EYE MOVEMENT DISORDER,1
PT,EYELID OEDEMA,1
PT,FIBROSIS,1
PT,GASTROINTESTINAL CANCER METASTATIC,1
PT,GRAND MAL CONVULSION,1
PT,GRANULOMATOUS LIVER DISEASE,1
PT,HAEMATURIA,1
PT,HAEMOLYTIC URAEMIC SYNDROME,1
PT,HALLUCINATION_ VISUAL,1
PT,HENOCH-SCHONLEIN PURPURA,1
PT,HEPATIC FAILURE,1
PT,HEPATIC STEATOSIS,1
PT,HEPATITIS,1
PT,HERPES VIRUS INFECTION,1
PT,HIP FRACTURE,1
PT,HISTOPLASMOSIS DISSEMINATED,1
PT,HYPERCHOLESTEROLAEMIA,1
PT,HYPERSENSITIVITY VASCULITIS,1
PT,HYPERTENSION,1
PT,ILEAL ULCER,1
PT,INFUSION RELATED REACTION,1
PT,INJECTION SITE INFLAMMATION,1
PT,INSOMNIA,1
PT,INTENTIONAL PRODUCT USE ISSUE,1
PT,IRRITABILITY,1
PT,JC VIRUS INFECTION,1
PT,JEALOUS DELUSION,1
PT,JOINT HYPEREXTENSION,1
PT,LARGE INTESTINAL HAEMORRHAGE,1
PT,LARGE INTESTINAL ULCER,1
PT,LETHARGY,1
PT,LIP OEDEMA,1
PT,LIVER FUNCTION TEST ABNORMAL,1
PT,LUNG INFILTRATION,1
PT,MACULOPATHY,1
PT,MALAISE,1
PT,MALIGNANT NEOPLASM PROGRESSION,1
PT,MALIGNANT PLEURAL EFFUSION,1
PT,MATERNAL DRUGS AFFECTING FOETUS,1
PT,MENINGITIS CRYPTOCOCCAL,1
PT,MENINGITIS LISTERIA,1
PT,MULTI-ORGAN FAILURE,1
PT,MYOCARDIAL INFARCTION,1
PT,NEPHROPATHY TOXIC,1
PT,NEUROTOXICITY,1
PT,NEUTROPENIA,1
PT,NO ADVERSE EVENT,1
PT,NODULE,1
PT,OEDEMA,1
PT,ORGAN FAILURE,1
PT,ORGANISING PNEUMONIA,1
PT,OSTEONECROSIS,1
PT,PARAPARESIS,1
PT,PARTIAL SEIZURES,1
PT,PERIPHERAL SWELLING,1
PT,PLASMA CELL MYELOMA,1
PT,PLASMA CELL MYELOMA RECURRENT,1
PT,PLEURAL EFFUSION,1
PT,PNEUMONITIS,1
PT,POLYHYDRAMNIOS,1
PT,PORTAL FIBROSIS,1
PT,PORTAL HYPERTENSION,1
PT,PREMATURE LABOUR,1
PT,PRESSURE OF SPEECH,1
PT,PRIMARY EFFUSION LYMPHOMA,1
PT,PRODUCTIVE COUGH,1
PT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
PT,PROTEINURIA,1
PT,PSEUDOMEMBRANOUS COLITIS,1
PT,PULMONARY MASS,1
PT,PURPURA,1
PT,PYREXIA,1
PT,RASH,1
PT,RASH MACULO-PAPULAR,1
PT,RENAL FAILURE,1
PT,RENAL TUBULAR NECROSIS,1
PT,RENAL VEIN THROMBOSIS,1
PT,RESPIRATORY TRACT INFECTION,1
PT,SCEDOSPORIUM INFECTION,1
PT,SCLERODERMA,1
PT,SELF-MEDICATION,1
PT,SEPSIS,1
PT,SKIN HYPERTROPHY,1
PT,SKIN LESION,1
PT,SKIN MASS,1
PT,SOMNOLENCE,1
PT,SPONTANEOUS HAEMORRHAGE,1
PT,STRIDOR,1
PT,TRANSAMINASES INCREASED,1
PT,ULCER,1
PT,VASOGENIC CEREBRAL OEDEMA,1
PT,WEIGHT DECREASED,1
PR,INJECTION SITE PAIN,167
PR,NASOPHARYNGITIS,85
PR,PAIN,67
PR,DRUG INEFFECTIVE,66
PR,ARTHRALGIA,62
PR,HEADACHE,60
PR,PAIN IN EXTREMITY,47
PR,BURNING SENSATION,38
PR,DIARRHOEA,36
PR,FATIGUE,35
PR,DIZZINESS,29
PR,PYREXIA,27
PR,URINARY TRACT INFECTION,25
PR,ABDOMINAL PAIN,24
PR,ASTHENIA,23
PR,NAUSEA,23
PR,ASTHMA,22
PR,HYPERTENSION,22
PR,INFLAMMATION,22
PR,MALAISE,22
PR,BLOOD GLUCOSE INCREASED,21
PR,PRURITUS,21
PR,INJECTION SITE ERYTHEMA,20
PR,BRONCHITIS,19
PR,FALL,19
PR,VOMITING,19
PR,ARTHRITIS,18
PR,RASH,18
PR,HAEMOGLOBIN DECREASED,17
PR,CHEST PAIN,16
PR,INJECTION SITE PRURITUS,16
PR,RECTAL HAEMORRHAGE,16
PR,ABDOMINAL PAIN UPPER,15
PR,RHEUMATOID ARTHRITIS,15
PR,COUGH,14
PR,DYSPHONIA,14
PR,ERYTHEMA,14
PR,HYPERSENSITIVITY,14
PR,PNEUMONIA,14
PR,BACK PAIN,13
PR,GASTROINTESTINAL INFLAMMATION,13
PR,INJECTION SITE HAEMATOMA,13
PR,ANAEMIA,12
PR,CELLULITIS,12
PR,GAIT DISTURBANCE,12
PR,NASAL CONGESTION,12
PR,PERIPHERAL SWELLING,12
PR,PSORIASIS,12
PR,CHIKUNGUNYA VIRUS INFECTION,11
PR,CROHN^S DISEASE,11
PR,DEPRESSION,11
PR,JOINT SWELLING,11
PR,PHARYNGITIS,11
PR,DYSPNOEA,10
PR,INJECTION SITE SWELLING,10
PR,OROPHARYNGEAL PAIN,10
PR,ANXIETY,9
PR,BONE PAIN,9
PR,DIABETES MELLITUS,9
PR,MUSCULOSKELETAL PAIN,9
PR,OSTEOARTHRITIS,9
PR,PRODUCTIVE COUGH,9
PR,ALOPECIA,8
PR,INCORRECT DOSE ADMINISTERED,8
PR,INJECTION SITE WARMTH,8
PR,NECK PAIN,8
PR,URTICARIA,8
PR,WEIGHT DECREASED,8
PR,ABDOMINAL DISTENSION,7
PR,BACTERIAL INFECTION,7
PR,CATARACT,7
PR,COLITIS ULCERATIVE,7
PR,DEHYDRATION,7
PR,DISCOMFORT,7
PR,INSOMNIA,7
PR,INTESTINAL OBSTRUCTION,7
PR,MOBILITY DECREASED,7
PR,MYALGIA,7
PR,OROPHARYNGEAL DISCOMFORT,7
PR,SWELLING,7
PR,UNEVALUABLE EVENT,7
PR,VIRAL INFECTION,7
PR,ABDOMINAL DISCOMFORT,6
PR,BLOOD PRESSURE INCREASED,6
PR,CONSTIPATION,6
PR,CONTUSION,6
PR,DRUG EFFECT DECREASED,6
PR,FEELING HOT,6
PR,GASTRITIS,6
PR,HERPES ZOSTER,6
PR,HYPERCHOLESTEROLAEMIA,6
PR,INFECTION,6
PR,INFLUENZA,6
PR,INJECTION SITE BRUISING,6
PR,MUSCLE SPASMS,6
PR,RASH MACULAR,6
PR,RESPIRATORY TRACT CONGESTION,6
PR,CARDIAC DISORDER,5
PR,CHILLS,5
PR,DECREASED APPETITE,5
PR,DERMATITIS ALLERGIC,5
PR,DRUG DOSE OMISSION,5
PR,DRUG PRESCRIBING ERROR,5
PR,HAEMORRHAGE,5
PR,HYPOAESTHESIA,5
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
PR,INJECTION SITE HAEMORRHAGE,5
PR,INJECTION SITE RASH,5
PR,INTERVERTEBRAL DISC PROTRUSION,5
PR,PALPITATIONS,5
PR,PROCEDURAL PAIN,5
PR,PRURITUS GENERALISED,5
PR,SOMNOLENCE,5
PR,SYNCOPE,5
PR,TACHYCARDIA,5
PR,TREMOR,5
PR,VAGINAL HAEMORRHAGE,5
PR,ABSCESS,4
PR,ABSCESS LIMB,4
PR,BLOOD CHOLESTEROL INCREASED,4
PR,CARDIAC MURMUR,4
PR,CHEST DISCOMFORT,4
PR,CHOLELITHIASIS,4
PR,COLITIS,4
PR,CONDITION AGGRAVATED,4
PR,DRUG EFFECT INCOMPLETE,4
PR,DRY EYE,4
PR,DYSPHAGIA,4
PR,DYSURIA,4
PR,EAR PAIN,4
PR,FEELING ABNORMAL,4
PR,FIBROMYALGIA,4
PR,GASTROINTESTINAL HAEMORRHAGE,4
PR,HAEMATOMA,4
PR,HYPERHIDROSIS,4
PR,INJECTION SITE HYPERSENSITIVITY,4
PR,KNEE ARTHROPLASTY,4
PR,LIMB DISCOMFORT,4
PR,MENISCUS INJURY,4
PR,MIGRAINE,4
PR,NEPHROLITHIASIS,4
PR,OXYGEN SATURATION DECREASED,4
PR,PHLEBITIS,4
PR,RESPIRATORY ARREST,4
PR,SPINAL DISORDER,4
PR,SURGERY,4
PR,VISION BLURRED,4
PR,VISUAL IMPAIRMENT,4
PR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,4
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
PR,BLINDNESS,3
PR,BLISTER,3
PR,BREAST ABSCESS,3
PR,BREAST MASS,3
PR,DEATH,3
PR,DERMATITIS,3
PR,DEVICE ISSUE,3
PR,DRUG ADMINISTRATION ERROR,3
PR,DRUG HYPERSENSITIVITY,3
PR,DRY MOUTH,3
PR,EPISTAXIS,3
PR,EXOSTOSIS,3
PR,EXPOSURE DURING PREGNANCY,3
PR,EYE HAEMORRHAGE,3
PR,EYE PAIN,3
PR,FLATULENCE,3
PR,FLUID RETENTION,3
PR,GASTRIC DISORDER,3
PR,GASTROINTESTINAL PAIN,3
PR,HAEMATOCHEZIA,3
PR,HEART RATE DECREASED,3
PR,HEPATIC ENZYME INCREASED,3
PR,HYPOTENSION,3
PR,INJECTION SITE DISCOLOURATION,3
PR,INJECTION SITE DISCOMFORT,3
PR,INJECTION SITE INFLAMMATION,3
PR,INJECTION SITE MASS,3
PR,INJECTION SITE REACTION,3
PR,INJURY ASSOCIATED WITH DEVICE,3
PR,LARYNGITIS,3
PR,LIMB INJURY,3
PR,LOCAL SWELLING,3
PR,NEOPLASM MALIGNANT,3
PR,OSTEONECROSIS,3
PR,PARAESTHESIA,3
PR,PLATELET COUNT DECREASED,3
PR,PROCTALGIA,3
PR,PRURITUS ALLERGIC,3
PR,SEIZURE,3
PR,SEPSIS,3
PR,SINUSITIS,3
PR,SKIN DISCOLOURATION,3
PR,SKIN ULCER,3
PR,SMALL INTESTINAL OBSTRUCTION,3
PR,SPINAL OSTEOARTHRITIS,3
PR,SWELLING FACE,3
PR,SYSTEMIC LUPUS ERYTHEMATOSUS,3
PR,THROMBOPHLEBITIS,3
PR,URINARY TRACT INFECTION BACTERIAL,3
PR,WHITE BLOOD CELL COUNT DECREASED,3
PR,ADVERSE DRUG REACTION,2
PR,AMNESIA,2
PR,ANAL FISTULA,2
PR,ANGINA PECTORIS,2
PR,APPENDICITIS,2
PR,ARTHROPATHY,2
PR,ASPHYXIA,2
PR,BACK INJURY,2
PR,BEDRIDDEN,2
PR,BLOOD IRON DECREASED,2
PR,BLOOD POTASSIUM DECREASED,2
PR,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
PR,BREAST CANCER FEMALE,2
PR,BRONCHITIS CHRONIC,2
PR,BURSITIS,2
PR,CARDIOMEGALY,2
PR,CEREBROVASCULAR ACCIDENT,2
PR,CHOLECYSTITIS,2
PR,CORONARY ARTERY DISEASE,2
PR,DEPRESSED MOOD,2
PR,DIABETES MELLITUS INADEQUATE CONTROL,2
PR,DRY SKIN,2
PR,DYSGEUSIA,2
PR,DYSPEPSIA,2
PR,EAR INFECTION,2
PR,EYE DISORDER,2
PR,EYE INFLAMMATION,2
PR,EYE IRRITATION,2
PR,FEMUR FRACTURE,2
PR,FINGER DEFORMITY,2
PR,GALLBLADDER OPERATION,2
PR,GASTRIC ULCER,2
PR,GASTROINTESTINAL DISORDER,2
PR,GRIP STRENGTH DECREASED,2
PR,HAEMORRHOIDS,2
PR,HEART RATE INCREASED,2
PR,HEART RATE IRREGULAR,2
PR,HIP FRACTURE,2
PR,HOSPITALISATION,2
PR,HYPOPHAGIA,2
PR,IMMUNODEFICIENCY,2
PR,IMPAIRED HEALING,2
PR,INFECTED BITES,2
PR,INJECTION SITE CELLULITIS,2
PR,INJECTION SITE INDURATION,2
PR,INJECTION SITE OEDEMA,2
PR,INJECTION SITE PAPULE,2
PR,INJECTION SITE URTICARIA,2
PR,INTERVERTEBRAL DISC DISORDER,2
PR,INTESTINAL PERFORATION,2
PR,INTRADUCTAL PAPILLOMA OF BREAST,2
PR,JOINT STIFFNESS,2
PR,LACERATION,2
PR,LARGE INTESTINAL OBSTRUCTION,2
PR,LOSS OF CONSCIOUSNESS,2
PR,LUMBAR SPINAL STENOSIS,2
PR,LUNG DISORDER,2
PR,LYMPHOMA,2
PR,MENSTRUATION IRREGULAR,2
PR,MULTIPLE SCLEROSIS,2
PR,MUSCULOSKELETAL DISCOMFORT,2
PR,MUSCULOSKELETAL DISORDER,2
PR,MUSCULOSKELETAL STIFFNESS,2
PR,MYOCARDIAL INFARCTION,2
PR,NERVE COMPRESSION,2
PR,NERVOUSNESS,2
PR,NEUROPATHY PERIPHERAL,2
PR,NODULE,2
PR,ORAL FUNGAL INFECTION,2
PR,OSTEOPOROSIS,2
PR,PAIN OF SKIN,2
PR,PANCREATITIS,2
PR,PELVIC PAIN,2
PR,PLEURITIC PAIN,2
PR,POLYP,2
PR,POST PROCEDURAL INFECTION,2
PR,POSTOPERATIVE WOUND INFECTION,2
PR,PRE-ECLAMPSIA,2
PR,PRODUCT QUALITY ISSUE,2
PR,PULMONARY FIBROSIS,2
PR,RASH GENERALISED,2
PR,RENAL CANCER,2
PR,RENAL DISORDER,2
PR,RENAL FAILURE,2
PR,RESPIRATORY DISORDER,2
PR,RESPIRATORY TRACT INFECTION,2
PR,RHINORRHOEA,2
PR,RIB FRACTURE,2
PR,SECRETION DISCHARGE,2
PR,SKIN CANCER,2
PR,SLEEP APNOEA SYNDROME,2
PR,SLEEP DISORDER,2
PR,STRESS,2
PR,SYNOVIAL CYST,2
PR,THROMBOCYTOPENIA,2
PR,THYROID DISORDER,2
PR,THYROID MASS,2
PR,TINNITUS,2
PR,VENOUS OCCLUSION,2
PR,WEIGHT INCREASED,2
PR,WOUND,2
PR,ABASIA,1
PR,ABDOMINAL ABSCESS,1
PR,ABDOMINAL HERNIA,1
PR,ABNORMAL LOSS OF WEIGHT,1
PR,ABORTION SPONTANEOUS,1
PR,ACINETOBACTER INFECTION,1
PR,ACNE,1
PR,ACUTE HEPATIC FAILURE,1
PR,ACUTE LEUKAEMIA,1
PR,ADENOMA BENIGN,1
PR,ADNEXA UTERI PAIN,1
PR,ADULT T-CELL LYMPHOMA/LEUKAEMIA,1
PR,ADVERSE EVENT,1
PR,ADVERSE REACTION,1
PR,ALANINE AMINOTRANSFERASE INCREASED,1
PR,ANAL ABSCESS,1
PR,ANAL HAEMORRHAGE,1
PR,ANAL INFLAMMATION,1
PR,ANAL PRURITUS,1
PR,ANAL ULCER,1
PR,ANAPHYLACTIC REACTION,1
PR,ANKLE FRACTURE,1
PR,ANORECTAL DISCOMFORT,1
PR,ANTIPHOSPHOLIPID SYNDROME,1
PR,APHASIA,1
PR,APHTHOUS ULCER,1
PR,APPENDICEAL MUCOCOELE,1
PR,ARTERIAL OCCLUSIVE DISEASE,1
PR,ARTERIOSCLEROSIS,1
PR,ASPARTATE AMINOTRANSFERASE INCREASED,1
PR,ATELECTASIS,1
PR,AXILLARY MASS,1
PR,AXILLARY PAIN,1
PR,BACTERAEMIA,1
PR,BACTERIAL TEST,1
PR,BALANCE DISORDER,1
PR,BENIGN RENAL NEOPLASM,1
PR,BLAST CELL CRISIS,1
PR,BLOOD ALBUMIN DECREASED,1
PR,BLOOD CHOLESTEROL,1
PR,BLOOD DISORDER,1
PR,BLOOD OESTROGEN DECREASED,1
PR,BLOOD POTASSIUM INCREASED,1
PR,BLOOD PRESSURE DECREASED,1
PR,BLOOD PROLACTIN INCREASED,1
PR,BLOOD TEST ABNORMAL,1
PR,BOWEL MOVEMENT IRREGULARITY,1
PR,BRAIN OPERATION,1
PR,BREAST CANCER,1
PR,BREAST CYST,1
PR,BREAST DISORDER,1
PR,BREAST DISORDER FEMALE,1
PR,BRONCHOSPASM,1
PR,C-REACTIVE PROTEIN INCREASED,1
PR,CALCINOSIS,1
PR,CARDIO-RESPIRATORY ARREST,1
PR,CARDIOVASCULAR DISORDER,1
PR,CARPAL TUNNEL SYNDROME,1
PR,CARTILAGE INJURY,1
PR,CENTRAL NERVOUS SYSTEM LESION,1
PR,CEREBRAL DISORDER,1
PR,CEREBRAL INFARCTION,1
PR,CEREBRAL THROMBOSIS,1
PR,CERUMEN IMPACTION,1
PR,CERVICAL POLYP,1
PR,CHEST X-RAY ABNORMAL,1
PR,CHOLECYSTITIS ACUTE,1
PR,CLOSTRIDIUM DIFFICILE SEPSIS,1
PR,COAGULOPATHY,1
PR,COLON OPERATION,1
PR,CORONARY ARTERY OCCLUSION,1
PR,DEAFNESS BILATERAL,1
PR,DEAFNESS UNILATERAL,1
PR,DEMENTIA ALZHEIMER^S TYPE,1
PR,DERMATITIS INFECTED,1
PR,DEVICE MALFUNCTION,1
PR,DIAPHRAGMALGIA,1
PR,DIARRHOEA HAEMORRHAGIC,1
PR,DIPLOPIA,1
PR,DISEASE COMPLICATION,1
PR,DISLOCATION OF VERTEBRA,1
PR,DISORIENTATION,1
PR,DISTAL INTESTINAL OBSTRUCTION SYNDROME,1
PR,DIVERTICULITIS,1
PR,DIVERTICULUM,1
PR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
PR,DRUG INTOLERANCE,1
PR,DRUG RESISTANCE,1
PR,DRUG THERAPY,1
PR,DRY THROAT,1
PR,DYSMENORRHOEA,1
PR,EAR CANAL STENOSIS,1
PR,EAR DISORDER,1
PR,ELBOW DEFORMITY,1
PR,ENDOMETRIAL THICKENING,1
PR,ENTERITIS,1
PR,ENTEROCOCCAL INFECTION,1
PR,ESCHERICHIA URINARY TRACT INFECTION,1
PR,ESSENTIAL HYPERTENSION,1
PR,EYE ALLERGY,1
PR,EYE SWELLING,1
PR,EYELID PTOSIS,1
PR,FACE INJURY,1
PR,FACE OEDEMA,1
PR,FAECES SOFT,1
PR,FEAR,1
PR,FEBRILE NEUTROPENIA,1
PR,FEEDING DISORDER,1
PR,FEELING OF DESPAIR,1
PR,FLANK PAIN,1
PR,FOOD CRAVING,1
PR,FOOD INTOLERANCE,1
PR,FUNGAL INFECTION,1
PR,GALLBLADDER PERFORATION,1
PR,GANGRENE,1
PR,GASTRIC FISTULA,1
PR,GASTRIC INFECTION,1
PR,GASTROINTESTINAL COMPLICATION ASSOCIATED WITH DEVICE,1
PR,GASTROINTESTINAL MOTILITY DISORDER,1
PR,GASTROINTESTINAL TRACT IRRITATION,1
PR,GASTROOESOPHAGEAL REFLUX DISEASE,1
PR,GENERALISED OEDEMA,1
PR,GENITAL RASH,1
PR,GINGIVAL PAIN,1
PR,GLOBULINS DECREASED,1
PR,GLUCOSE TOLERANCE IMPAIRED,1
PR,GRANULOMATOSIS WITH POLYANGIITIS,1
PR,HAEMATOCRIT,1
PR,HAEMATURIA,1
PR,HAEMOGLOBIN,1
PR,HAEMOPTYSIS,1
PR,HAEMORRHOIDAL HAEMORRHAGE,1
PR,HALLUCINATION,1
PR,HAND DEFORMITY,1
PR,HEAD DISCOMFORT,1
PR,HEARING IMPAIRED,1
PR,HEPATIC PAIN,1
PR,HEPATIC STEATOSIS,1
PR,HIATUS HERNIA,1
PR,HIDRADENITIS,1
PR,HIP ARTHROPLASTY,1
PR,HYPERAESTHESIA,1
PR,HYPERBILIRUBINAEMIA,1
PR,HYPERCHLORHYDRIA,1
PR,HYPERKERATOSIS,1
PR,HYPERTRIGLYCERIDAEMIA,1
PR,HYPOCOAGULABLE STATE,1
PR,HYPOGLYCAEMIA,1
PR,IMMUNE SYSTEM DISORDER,1
PR,IMMUNOSUPPRESSION,1
PR,INCORRECT DOSE ADMINISTERED BY DEVICE,1
PR,INCREASED UPPER AIRWAY SECRETION,1
PR,INFECTED SKIN ULCER,1
PR,INFECTIOUS MONONUCLEOSIS,1
PR,INGROWING NAIL,1
PR,INGUINAL HERNIA,1
PR,INJECTION SITE ABSCESS,1
PR,INJECTION SITE INJURY,1
PR,INJECTION SITE ULCER,1
PR,INJURY,1
PR,INTERNAL HAEMORRHAGE,1
PR,INTESTINAL HAEMORRHAGE,1
PR,INTESTINAL OPERATION,1
PR,INTESTINAL STENOSIS,1
PR,INTESTINAL ULCER,1
PR,INTRACRANIAL ANEURYSM,1
PR,IRRITABLE BOWEL SYNDROME,1
PR,JOINT ABSCESS,1
PR,JOINT DESTRUCTION,1
PR,JOINT EFFUSION,1
PR,JOINT INJURY,1
PR,KIDNEY INFECTION,1
PR,KLEBSIELLA INFECTION,1
PR,KNEE OPERATION,1
PR,LIGAMENT INJURY,1
PR,LIGHT CHAIN ANALYSIS INCREASED,1
PR,LIMB DEFORMITY,1
PR,LIP NEOPLASM,1
PR,LIP SWELLING,1
PR,LIPOMA,1
PR,LOCALISED INFECTION,1
PR,LOOSE TOOTH,1
PR,LOW TURNOVER OSTEOPATHY,1
PR,LOWER LIMB FRACTURE,1
PR,LUNG INFECTION,1
PR,LUNG NEOPLASM,1
PR,LUPUS-LIKE SYNDROME,1
PR,LYMPHADENITIS,1
PR,LYMPHOCYTE COUNT INCREASED,1
PR,MAJOR DEPRESSION,1
PR,MALABSORPTION,1
PR,MALNUTRITION,1
PR,MASS,1
PR,MEDICAL DEVICE SITE PAIN,1
PR,MEMORY IMPAIRMENT,1
PR,MENOPAUSE,1
PR,MENORRHAGIA,1
PR,MENTAL DISORDER,1
PR,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,1
PR,MIDDLE EAR EFFUSION,1
PR,MITRAL VALVE PROLAPSE,1
PR,MONOCLONAL IMMUNOGLOBULIN PRESENT,1
PR,MONOPLEGIA,1
PR,MOOD ALTERED,1
PR,MOUTH HAEMORRHAGE,1
PR,MOUTH SWELLING,1
PR,MOUTH ULCERATION,1
PR,MUCOSAL DISCOLOURATION,1
PR,MUCOSAL DRYNESS,1
PR,MUCOUS MEMBRANE DISORDER,1
PR,MULTIPLE SCLEROSIS RELAPSE,1
PR,MUSCLE ATROPHY,1
PR,MUSCULAR WEAKNESS,1
PR,MYASTHENIA GRAVIS,1
PR,MYCOPLASMA INFECTION,1
PR,NAIL DISORDER,1
PR,NEURALGIA,1
PR,NIGHT SWEATS,1
PR,OCCULT BLOOD POSITIVE,1
PR,OEDEMA,1
PR,OEDEMA PERIPHERAL,1
PR,ORAL CANDIDIASIS,1
PR,ORAL INFECTION,1
PR,ORAL SURGERY,1
PR,ORGANISING PNEUMONIA,1
PR,OSTEOPENIA,1
PR,OTORRHOEA,1
PR,OVARIAN CYST,1
PR,OVERDOSE,1
PR,PAIN IN JAW,1
PR,PAINFUL DEFAECATION,1
PR,PALLOR,1
PR,PANCYTOPENIA,1
PR,PELVIC ABSCESS,1
PR,PERIPROSTHETIC FRACTURE,1
PR,PERITONITIS,1
PR,PHARYNGEAL ERYTHEMA,1
PR,PLANTAR FASCIITIS,1
PR,PLEURAL EFFUSION,1
PR,POST PROCEDURAL CELLULITIS,1
PR,PRE-EXISTING CONDITION IMPROVED,1
PR,PRODUCT USE IN UNAPPROVED INDICATION,1
PR,PRODUCT USE ISSUE,1
PR,PROTEIN TOTAL ABNORMAL,1
PR,PROTEIN TOTAL INCREASED,1
PR,PTERYGIUM,1
PR,PULMONARY FUNCTION TEST DECREASED,1
PR,PULMONARY GRANULOMA,1
PR,PULMONARY MASS,1
PR,PULMONARY PAIN,1
PR,PYODERMA GANGRENOSUM,1
PR,RALES,1
PR,RASH PAPULAR,1
PR,RASH PRURITIC,1
PR,RECTAL DISCHARGE,1
PR,RECTAL TENESMUS,1
PR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PR,RED CELL DISTRIBUTION WIDTH,1
PR,RENAL CYST,1
PR,RENAL PAIN,1
PR,RESPIRATORY FAILURE,1
PR,RETINOPATHY,1
PR,RHONCHI,1
PR,ROAD TRAFFIC ACCIDENT,1
PR,ROSACEA,1
PR,SCAR,1
PR,SCIATICA,1
PR,SCRATCH,1
PR,SENSORY DISTURBANCE,1
PR,SKIN ABRASION,1
PR,SKIN EXFOLIATION,1
PR,SKIN IRRITATION,1
PR,SKIN MASS,1
PR,SKIN PLAQUE,1
PR,SKIN REACTION,1
PR,SMALL INTESTINAL STENOSIS,1
PR,SNEEZING,1
PR,SPINAL COMPRESSION FRACTURE,1
PR,STAPHYLOCOCCAL INFECTION,1
PR,SUBCUTANEOUS ABSCESS,1
PR,SUICIDAL IDEATION,1
PR,SUICIDE THREAT,1
PR,TAKAYASU^S ARTERITIS,1
PR,THERAPEUTIC RESPONSE SHORTENED,1
PR,THERAPEUTIC RESPONSE UNEXPECTED,1
PR,THERMAL BURN,1
PR,THROAT IRRITATION,1
PR,THROMBOSIS,1
PR,THYROID CANCER,1
PR,TONGUE DISCOLOURATION,1
PR,TONGUE DISORDER,1
PR,TONSILLITIS,1
PR,TOOTHACHE,1
PR,TRACHEAL OEDEMA,1
PR,TRACHEAL STENOSIS,1
PR,TRANSFUSION RELATED COMPLICATION,1
PR,TRAUMATIC HAEMATOMA,1
PR,TREATMENT FAILURE,1
PR,TREATMENT NONCOMPLIANCE,1
PR,TUMOUR EXCISION,1
PR,TYMPANIC MEMBRANE PERFORATION,1
PR,UMBILICAL CORD ABNORMALITY,1
PR,UPPER LIMB FRACTURE,1
PR,UPPER RESPIRATORY FUNGAL INFECTION,1
PR,UPPER RESPIRATORY TRACT INFECTION,1
PR,UTERINE DISORDER,1
PR,UTERINE HAEMORRHAGE,1
PR,UTERINE LEIOMYOMA,1
PR,UVEITIS,1
PR,VAGINAL CANCER,1
PR,VENOUS PRESSURE JUGULAR INCREASED,1
PR,VERTIGO,1
PR,VESTIBULAR NEURONITIS,1
PR,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
PR,VITAMIN D DECREASED,1
PR,VITAMIN D DEFICIENCY,1
PR,WHITE BLOOD CELL COUNT INCREASED,1
PR,WISDOM TEETH REMOVAL,1
QA,MUCORMYCOSIS,6
QA,DEEP VEIN THROMBOSIS,2
QA,DIABETES MELLITUS,2
QA,ESCHERICHIA INFECTION,2
QA,ORGANISING PNEUMONIA,2
QA,PANCYTOPENIA,2
QA,PNEUMOCYSTIS JIROVECII INFECTION,2
QA,PSEUDOMONAS INFECTION,2
QA,ACANTHOSIS NIGRICANS,1
QA,DIARRHOEA,1
QA,HYPERGLYCAEMIA,1
QA,INSULIN RESISTANCE,1
QA,MUCOSAL INFLAMMATION,1
QA,PAIN IN EXTREMITY,1
QA,PORTAL VEIN THROMBOSIS,1
QA,THORACOTOMY,1
RE,BRONCHIECTASIS,3
RE,NEUTROPENIA,2
RO,KAPOSI^S SARCOMA,14
RO,ACUTE MYOCARDIAL INFARCTION,10
RO,ANAEMIA,8
RO,DRUG INEFFECTIVE,8
RO,BREAST CANCER,7
RO,BRONCHIAL CARCINOMA,6
RO,CERVIX CARCINOMA,6
RO,DYSPNOEA,6
RO,LUNG NEOPLASM MALIGNANT,6
RO,PYREXIA,6
RO,VOMITING,6
RO,ASTHENIA,5
RO,DRUG INTOLERANCE,5
RO,FATIGUE,5
RO,GASTROINTESTINAL HAEMORRHAGE,5
RO,NAUSEA,5
RO,PALLOR,5
RO,PANCYTOPENIA,5
RO,TREATMENT NONCOMPLIANCE,5
RO,VASCULAR STENT THROMBOSIS,5
RO,ACINETOBACTER INFECTION,4
RO,ANGINA PECTORIS,4
RO,BLOOD CHOLESTEROL INCREASED,4
RO,CARDIAC ARREST,4
RO,CORONARY ARTERY DISEASE,4
RO,HAEMOGLOBIN DECREASED,4
RO,HEART RATE INCREASED,4
RO,HYPERTENSION,4
RO,HYPOKALAEMIA,4
RO,HYPOPROTEINAEMIA,4
RO,INTENTIONAL DOSE OMISSION,4
RO,OXYGEN SATURATION DECREASED,4
RO,PLATELET COUNT DECREASED,4
RO,PNEUMONIA,4
RO,RHEUMATOID ARTHRITIS,4
RO,UTERINE CANCER,4
RO,ABDOMINAL PAIN,3
RO,ANGINA UNSTABLE,3
RO,DECREASED APPETITE,3
RO,DIABETES MELLITUS,3
RO,DYSLIPIDAEMIA,3
RO,HAEMATEMESIS,3
RO,HEPATITIS B,3
RO,INTENTIONAL PRODUCT MISUSE,3
RO,MYOCARDIAL INFARCTION,3
RO,NEUTROPENIA,3
RO,OEDEMA PERIPHERAL,3
RO,PLEURAL EFFUSION,3
RO,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,3
RO,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
RO,SEPSIS,3
RO,SHOCK HAEMORRHAGIC,3
RO,STRONGYLOIDIASIS,3
RO,UPPER GASTROINTESTINAL HAEMORRHAGE,3
RO,ACUTE TONSILLITIS,2
RO,ALKALOSIS,2
RO,APLASIA,2
RO,BLOOD UREA INCREASED,2
RO,BONE MARROW FAILURE,2
RO,BONE PAIN,2
RO,CARDIO-RESPIRATORY ARREST,2
RO,CATARACT,2
RO,CHOLESTASIS,2
RO,COMA,2
RO,CONDITION AGGRAVATED,2
RO,CUSHING^S SYNDROME,2
RO,CYSTITIS KLEBSIELLA,2
RO,DIARRHOEA,2
RO,DISSEMINATED INTRAVASCULAR COAGULATION,2
RO,DIZZINESS,2
RO,EJECTION FRACTION DECREASED,2
RO,GENERAL PHYSICAL HEALTH DETERIORATION,2
RO,GENERALISED OEDEMA,2
RO,HEPATOCELLULAR INJURY,2
RO,HERPES ZOSTER,2
RO,HYPERURICAEMIA,2
RO,HYPOALBUMINAEMIA,2
RO,HYPOGLYCAEMIA,2
RO,ILEUS PARALYTIC,2
RO,KLEBSIELLA INFECTION,2
RO,LEUKOPENIA,2
RO,LUNG ABSCESS,2
RO,LUNG INFECTION,2
RO,OLIGURIA,2
RO,OSTEOPOROSIS,2
RO,PROTEINURIA,2
RO,RENAL CELL CARCINOMA,2
RO,SKIN TOXICITY,2
RO,SYSTEMIC CANDIDA,2
RO,THROMBOCYTOPENIA,2
RO,WEIGHT DECREASED,2
RO,ABDOMINAL INFECTION,1
RO,ABDOMINAL PAIN UPPER,1
RO,ABORTION SPONTANEOUS,1
RO,ACCIDENTAL OVERDOSE,1
RO,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
RO,ACUTE LUNG INJURY,1
RO,ACUTE RESPIRATORY FAILURE,1
RO,ADULT T-CELL LYMPHOMA/LEUKAEMIA,1
RO,ALANINE AMINOTRANSFERASE INCREASED,1
RO,ANXIETY,1
RO,ARTHRALGIA,1
RO,ASPARTATE AMINOTRANSFERASE INCREASED,1
RO,ATRIAL FIBRILLATION,1
RO,B PRECURSOR TYPE ACUTE LEUKAEMIA,1
RO,BACK PAIN,1
RO,BLADDER NEOPLASM,1
RO,BLADDER TRANSITIONAL CELL CARCINOMA,1
RO,BLOOD ALBUMIN DECREASED,1
RO,BLOOD CHLORIDE DECREASED,1
RO,BLOOD GLUCOSE DECREASED,1
RO,BLOOD IMMUNOGLOBULIN A INCREASED,1
RO,BLOOD IMMUNOGLOBULIN G INCREASED,1
RO,BLOOD IMMUNOGLOBULIN M INCREASED,1
RO,BLOOD IRON INCREASED,1
RO,BLOOD LACTATE DEHYDROGENASE INCREASED,1
RO,BONE MARROW TOXICITY,1
RO,BRONCHOPNEUMOPATHY,1
RO,BUNDLE BRANCH BLOCK RIGHT,1
RO,CARDIAC FAILURE,1
RO,CARDIAC FAILURE CONGESTIVE,1
RO,CARDIOPULMONARY FAILURE,1
RO,CARDIOTOXICITY,1
RO,CELLULITIS,1
RO,CEREBROVASCULAR ACCIDENT,1
RO,CHEST PAIN,1
RO,CHILLS,1
RO,CHOKING SENSATION,1
RO,CHORIORETINOPATHY,1
RO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
RO,CONFUSIONAL STATE,1
RO,CONJUNCTIVAL HYPERAEMIA,1
RO,COORDINATION ABNORMAL,1
RO,CORNEAL REFLEX DECREASED,1
RO,COUGH,1
RO,CYANOSIS,1
RO,DEATH,1
RO,DEEP VEIN THROMBOSIS,1
RO,DEHYDRATION,1
RO,DIPLOPIA,1
RO,DISEASE PROGRESSION,1
RO,DRUG EFFECT INCOMPLETE,1
RO,DRUG-INDUCED LIVER INJURY,1
RO,DUODENITIS,1
RO,ENCEPHALOPATHY,1
RO,ENTERITIS,1
RO,EOSINOPHIL PERCENTAGE INCREASED,1
RO,ERYTHEMA MULTIFORME,1
RO,EXPOSURE DURING PREGNANCY,1
RO,EYE HAEMORRHAGE,1
RO,EYELID PTOSIS,1
RO,FAECES SOFT,1
RO,FALL,1
RO,GASTRIC CANCER,1
RO,GASTRITIS,1
RO,GASTRITIS EROSIVE,1
RO,GASTROINTESTINAL DISORDER,1
RO,GENERALISED TONIC-CLONIC SEIZURE,1
RO,HALLUCINATION_ VISUAL,1
RO,HEMIPLEGIA,1
RO,HEPATIC CIRRHOSIS,1
RO,HEPATITIS D,1
RO,HEPATOMEGALY,1
RO,HIATUS HERNIA,1
RO,HUMAN T-CELL LYMPHOTROPIC VIRUS INFECTION,1
RO,HYPERAEMIA,1
RO,HYPERGLYCAEMIA,1
RO,HYPERHIDROSIS,1
RO,HYPERREFLEXIA,1
RO,HYPERSENSITIVITY,1
RO,HYPOCHOLESTEROLAEMIA,1
RO,HYPOCOMPLEMENTAEMIA,1
RO,HYPOTENSION,1
RO,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
RO,INCISION SITE INFLAMMATION,1
RO,INFECTIVE MYOSITIS,1
RO,INFLAMMATION,1
RO,INTERVERTEBRAL DISCITIS,1
RO,IRIDOCYCLITIS,1
RO,JAUNDICE,1
RO,LACERATION,1
RO,LOSS OF CONSCIOUSNESS,1
RO,LUPUS-LIKE SYNDROME,1
RO,LYMPHADENOPATHY,1
RO,LYMPHOCELE,1
RO,LYMPHOCYTE COUNT INCREASED,1
RO,LYMPHOCYTE PERCENTAGE INCREASED,1
RO,LYMPHOCYTIC INFILTRATION,1
RO,MALAISE,1
RO,MALIGNANT NEOPLASM PROGRESSION,1
RO,MANIA,1
RO,MENTAL STATUS CHANGES,1
RO,MULTI-ORGAN FAILURE,1
RO,MYALGIA,1
RO,MYOPATHY,1
RO,NASOPHARYNGITIS,1
RO,NEPHROTIC SYNDROME,1
RO,NEUROPATHY PERIPHERAL,1
RO,NO THERAPEUTIC RESPONSE,1
RO,NON-HODGKIN^S LYMPHOMA,1
RO,OESOPHAGITIS,1
RO,ORTHOSTATIC HYPOTENSION,1
RO,OSTEOARTHRITIS,1
RO,OSTEOPOROTIC FRACTURE,1
RO,OVERDOSE,1
RO,PALPITATIONS,1
RO,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
RO,PLEURISY,1
RO,PNEUMOTHORAX,1
RO,POLYSEROSITIS,1
RO,PRODUCT USE IN UNAPPROVED INDICATION,1
RO,PRODUCT USE ISSUE,1
RO,PROLACTIN-PRODUCING PITUITARY TUMOUR,1
RO,PROSTATE CANCER METASTATIC,1
RO,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
RO,PRURITUS,1
RO,PSEUDOMONAS INFECTION,1
RO,PSYCHOMOTOR HYPERACTIVITY,1
RO,PULMONARY EMBOLISM,1
RO,PULMONARY FIBROSIS,1
RO,PULMONARY MICROEMBOLI,1
RO,PULMONARY TUBERCULOSIS,1
RO,PULSE ABNORMAL,1
RO,PUPILLARY DISORDER,1
RO,PUPILLARY REFLEX IMPAIRED,1
RO,PYRAMIDAL TRACT SYNDROME,1
RO,RASH ERYTHEMATOUS,1
RO,RECTAL HAEMORRHAGE,1
RO,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
RO,RENAL CANCER,1
RO,RENAL FAILURE,1
RO,RESPIRATORY ARREST,1
RO,SCLERODERMA RENAL CRISIS,1
RO,SELF-MEDICATION,1
RO,SKIN DISCOLOURATION,1
RO,SKIN LESION,1
RO,SKIN ULCER,1
RO,SLOW SPEECH,1
RO,SOMNOLENCE,1
RO,SPEECH DISORDER,1
RO,SPLENOMEGALY,1
RO,STOMATITIS HAEMORRHAGIC,1
RO,SUBARACHNOID HAEMORRHAGE,1
RO,SUBCUTANEOUS ABSCESS,1
RO,SUDDEN DEATH,1
RO,SUPERINFECTION,1
RO,SUPRAVENTRICULAR TACHYCARDIA,1
RO,SYSTEMIC LUPUS ERYTHEMATOSUS,1
RO,TACHYARRHYTHMIA,1
RO,TACHYCARDIA,1
RO,THERAPEUTIC PRODUCT INEFFECTIVE,1
RO,THYMOL TURBIDITY TEST INCREASED,1
RO,TOOTH ABSCESS,1
RO,TOXICITY TO VARIOUS AGENTS,1
RO,TRACHEOBRONCHITIS,1
RO,TUBULOINTERSTITIAL NEPHRITIS,1
RO,ULCERATIVE KERATITIS,1
RO,UNEVALUABLE EVENT,1
RO,UNRESPONSIVE TO STIMULI,1
RO,URETERIC CANCER,1
RO,URETHRAL CANCER,1
RO,URINARY RETENTION,1
RO,URINARY TRACT INFECTION,1
RO,UROBILINOGEN URINE INCREASED,1
RO,URTICARIA,1
RO,VASCULAR STENT RESTENOSIS,1
RO,VENOUS THROMBOSIS,1
RO,VENTRICULAR FIBRILLATION,1
RO,VERTIGO,1
RO,VISUAL ACUITY REDUCED,1
RO,WHITE BLOOD CELL COUNT INCREASED,1
RU,FOETAL EXPOSURE DURING PREGNANCY,20
RU,PREMATURE BABY,16
RU,PNEUMONIA,10
RU,NEONATAL PNEUMONIA,6
RU,NEONATAL RESPIRATORY DISTRESS SYNDROME,6
RU,VENA CAVA THROMBOSIS,5
RU,ASTHENIA,4
RU,BRONCHOPULMONARY ASPERGILLOSIS,4
RU,MATERNAL EXPOSURE DURING PREGNANCY,4
RU,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
RU,RESPIRATORY DISTRESS,4
RU,RESPIRATORY FAILURE,4
RU,TOXICITY TO VARIOUS AGENTS,4
RU,ABDOMINAL PAIN UPPER,3
RU,HEADACHE,3
RU,PANCYTOPENIA,3
RU,SUPERIOR SAGITTAL SINUS THROMBOSIS,3
RU,ATRIAL FIBRILLATION,2
RU,BODY TEMPERATURE INCREASED,2
RU,CARDIOMYOPATHY,2
RU,DEMYELINATION,2
RU,EXPOSURE DURING PREGNANCY,2
RU,HYPOAESTHESIA,2
RU,LEFT ATRIAL DILATATION,2
RU,NEUROLOGICAL SYMPTOM,2
RU,PRODUCT USE ISSUE,2
RU,REFRACTORY CANCER,2
RU,RENAL FAILURE,2
RU,ABORTION,1
RU,ACUTE KIDNEY INJURY,1
RU,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
RU,ACUTE MYOCARDIAL INFARCTION,1
RU,ANGIOEDEMA,1
RU,AORTIC VALVE INCOMPETENCE,1
RU,ARRHYTHMIA SUPRAVENTRICULAR,1
RU,ARTHRALGIA,1
RU,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
RU,AZOTAEMIA,1
RU,B-CELL LYMPHOMA RECURRENT,1
RU,BACTERIAL TEST,1
RU,BASAL CELL CARCINOMA,1
RU,BLOOD PRESSURE INCREASED,1
RU,BLOOD UREA INCREASED,1
RU,BONE MARROW TOXICITY,1
RU,BRAIN OEDEMA,1
RU,BUNDLE BRANCH BLOCK LEFT,1
RU,BUNDLE BRANCH BLOCK RIGHT,1
RU,CARDIAC FAILURE ACUTE,1
RU,CARDIOTOXICITY,1
RU,CELLULITIS GANGRENOUS,1
RU,CEREBROVASCULAR DISORDER,1
RU,CHILLS,1
RU,CONDITION AGGRAVATED,1
RU,CONFUSIONAL STATE,1
RU,CORONARY ARTERY DISEASE,1
RU,CYANOSIS,1
RU,DEATH NEONATAL,1
RU,DELIRIUM,1
RU,DIFFUSE LARGE B-CELL LYMPHOMA,1
RU,DILATATION VENTRICULAR,1
RU,DRUG EFFECT DECREASED,1
RU,DRUG INEFFECTIVE,1
RU,ELECTROCARDIOGRAM QT PROLONGED,1
RU,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
RU,EPILEPSY,1
RU,ERYTHEMA,1
RU,GASTROINTESTINAL INFECTION,1
RU,GLOMERULAR FILTRATION RATE DECREASED,1
RU,HAEMATOTOXICITY,1
RU,HAEMORRHAGE,1
RU,HALLUCINATION,1
RU,HEART VALVE INCOMPETENCE,1
RU,HEMIPARESIS,1
RU,HEPATIC ENZYME INCREASED,1
RU,HEPATOTOXICITY,1
RU,HYPERGLYCAEMIA,1
RU,HYPERTENSION,1
RU,HYPOKALAEMIA,1
RU,INFECTION,1
RU,LEFT VENTRICULAR DYSFUNCTION,1
RU,LEUKAEMOID REACTION,1
RU,MENTAL DISORDER,1
RU,MITRAL VALVE INCOMPETENCE,1
RU,MYELOPROLIFERATIVE DISORDER,1
RU,NAUSEA,1
RU,NEPHROPATHY TOXIC,1
RU,OEDEMA PERIPHERAL,1
RU,OSTEONECROSIS,1
RU,PAIN,1
RU,PLATELET COUNT DECREASED,1
RU,PREMATURE LABOUR,1
RU,PROCTITIS INFECTIOUS,1
RU,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
RU,PSORIASIS,1
RU,PSORIATIC ARTHROPATHY,1
RU,PULMONARY OEDEMA,1
RU,PYELONEPHRITIS,1
RU,PYREXIA,1
RU,RASH,1
RU,RECTAL CANCER,1
RU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
RU,RENAL FAILURE ACUTE,1
RU,RESPIRATORY TRACT INFECTION,1
RU,RESPIRATORY TRACT INFECTION VIRAL,1
RU,SINUS ARRHYTHMIA,1
RU,SUBARACHNOID HAEMORRHAGE,1
RU,SUBDURAL HAEMATOMA,1
RU,SUDDEN DEATH,1
RU,SUPRAVENTRICULAR EXTRASYSTOLES,1
RU,TACHYCARDIA,1
RU,THROMBOSIS,1
RU,TOXIC ENCEPHALOPATHY,1
RU,TRICUSPID VALVE INCOMPETENCE,1
RU,URINARY TRACT INFECTION,1
RU,VARICELLA,1
RU,VENOUS THROMBOSIS LIMB,1
RU,VENOUS THROMBOSIS NEONATAL,1
RU,VENTRICULAR EXTRASYSTOLES,1
RU,VIRAL INFECTION,1
RU,VOMITING,1
RU,WHITE BLOOD CELL COUNT INCREASED,1
SA,NEUTROPENIA,5
SA,BACTERIAL INFECTION,4
SA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,4
SA,CYTOPENIA,3
SA,PRODUCT USE IN UNAPPROVED INDICATION,3
SA,TOXICITY TO VARIOUS AGENTS,3
SA,CLOSTRIDIUM DIFFICILE INFECTION,2
SA,CYTOMEGALOVIRUS INFECTION,2
SA,EXPOSURE DURING PREGNANCY,2
SA,FEBRILE NEUTROPENIA,2
SA,FOETAL DEATH,2
SA,HYPERGLYCAEMIA,2
SA,MUCOSAL INFLAMMATION,2
SA,OLIGOHYDRAMNIOS,2
SA,PLEURITIC PAIN,2
SA,PYREXIA,2
SA,RENAL MASS,2
SA,SEIZURE,2
SA,SEPTIC SHOCK,2
SA,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
SA,ACUTE MYELOID LEUKAEMIA,1
SA,ACUTE MYOCARDIAL INFARCTION,1
SA,ANASTOMOTIC STENOSIS,1
SA,ANGIOSARCOMA METASTATIC,1
SA,ARTHRITIS,1
SA,BENIGN INTRACRANIAL HYPERTENSION,1
SA,BILE DUCT STENOSIS,1
SA,BILIARY TRACT INFECTION,1
SA,BRUCELLOSIS,1
SA,COLONIC PSEUDO-OBSTRUCTION,1
SA,CONDITION AGGRAVATED,1
SA,CYTOMEGALOVIRUS TEST POSITIVE,1
SA,DRUG INEFFECTIVE,1
SA,FATIGUE,1
SA,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
SA,FUNGAL INFECTION,1
SA,GLOMERULONEPHRITIS MEMBRANOUS,1
SA,GRANULOMA,1
SA,HAEMOPTYSIS,1
SA,HAEMORRHAGE INTRACRANIAL,1
SA,HEPATIC ARTERY STENOSIS,1
SA,HEPATIC ARTERY THROMBOSIS,1
SA,HERPES ZOSTER,1
SA,HYPOCHROMIC ANAEMIA,1
SA,INFECTION,1
SA,JUGULAR VEIN THROMBOSIS,1
SA,LEUKAEMIA RECURRENT,1
SA,LEUKAEMIC INFILTRATION EXTRAMEDULLARY,1
SA,METASTASES TO CENTRAL NERVOUS SYSTEM,1
SA,METASTASES TO LUNG,1
SA,METASTASES TO MENINGES,1
SA,OPTIC NEUROPATHY,1
SA,ORGANISING PNEUMONIA,1
SA,PANCREATITIS,1
SA,PANCYTOPENIA,1
SA,PLACENTAL DISORDER,1
SA,PNEUMONIA CYTOMEGALOVIRAL,1
SA,POST PROCEDURAL BILE LEAK,1
SA,PROTEINURIA,1
SA,PULMONARY ALVEOLAR HAEMORRHAGE,1
SA,RENAL FAILURE,1
SA,RESPIRATORY FAILURE,1
SA,RETINAL HAEMORRHAGE,1
SA,RETINOIC ACID SYNDROME,1
SA,RHEUMATIC DISORDER,1
SA,SARCOIDOSIS,1
SA,TREATMENT NONCOMPLIANCE,1
SA,TUBERCULOSIS,1
SA,TUMOUR LYSIS SYNDROME,1
SA,VIRAL INFECTION,1
SA,WEIGHT INCREASED,1
SA,WHITE BLOOD CELL COUNT DECREASED,1
SN,PANCYTOPENIA,5
SN,RETROPERITONEAL HAEMATOMA,5
SN,DRUG RESISTANCE,4
SN,HEPATIC FAILURE,3
SN,SCLERODERMA RENAL CRISIS,3
SN,CARDIAC FAILURE CONGESTIVE,2
SN,FOETOR HEPATICUS,2
SN,GENERALISED TONIC-CLONIC SEIZURE,2
SN,HAEMATEMESIS,2
SN,RETINOPATHY HYPERTENSIVE,2
SN,SUBDURAL HAEMATOMA,2
SN,VARICES OESOPHAGEAL,2
SN,ABDOMINAL PAIN,1
SN,COMA,1
SN,DRUG INEFFECTIVE,1
SN,EXTRAPYRAMIDAL DISORDER,1
SN,MALIGNANT HYPERTENSION,1
SN,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
SN,PORTAL HYPERTENSIVE GASTROPATHY,1
SN,THROMBOCYTOPENIA,1
RS,BLOOD CREATININE INCREASED,4
RS,HYPOMAGNESAEMIA,4
RS,METABOLIC ACIDOSIS,4
RS,RENAL FAILURE,4
RS,ACUTE RESPIRATORY FAILURE,3
RS,DEHYDRATION,3
RS,DISEASE RECURRENCE,3
RS,HYPERTENSION,3
RS,OEDEMA PERIPHERAL,3
RS,PNEUMONIA,3
RS,RESPIRATORY FAILURE,3
RS,SEPTIC SHOCK,3
RS,THROMBOCYTOPENIA,3
RS,ANAEMIA,2
RS,ASPERGILLUS INFECTION,2
RS,ASTHENIA,2
RS,CUSHING^S SYNDROME,2
RS,DISEASE PROGRESSION,2
RS,DRUG LEVEL INCREASED,2
RS,ENCEPHALITIS,2
RS,GASTROINTESTINAL HAEMORRHAGE,2
RS,HEPATOSPLENOMEGALY,2
RS,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
RS,NEUTROPENIA,2
RS,NOCARDIOSIS,2
RS,PNEUMOPERITONEUM,2
RS,PROTEINURIA,2
RS,PSEUDOMONAS INFECTION,2
RS,PYREXIA,2
RS,SEPSIS,2
RS,SUBILEUS,2
RS,ACUTE MYELOID LEUKAEMIA,1
RS,AGRANULOCYTOSIS,1
RS,ARTHROPATHY,1
RS,AZOTAEMIA,1
RS,BONE DENSITY DECREASED,1
RS,BRAIN ABSCESS,1
RS,BRONCHITIS,1
RS,BRONCHOPULMONARY ASPERGILLOSIS,1
RS,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
RS,CONDITION AGGRAVATED,1
RS,DIPLOPIA,1
RS,DRUG RESISTANCE,1
RS,EFFUSION,1
RS,EPILEPSY,1
RS,EPSTEIN-BARR VIRUS INFECTION,1
RS,ESCHERICHIA URINARY TRACT INFECTION,1
RS,EYELID PTOSIS,1
RS,FALL,1
RS,FATIGUE,1
RS,FEBRILE NEUTROPENIA,1
RS,FEMUR FRACTURE,1
RS,GENERAL PHYSICAL HEALTH DETERIORATION,1
RS,GLOMERULONEPHRITIS,1
RS,GLOMERULONEPHRITIS PROLIFERATIVE,1
RS,HAEMATURIA,1
RS,HEADACHE,1
RS,HEPATIC LESION,1
RS,HODGKIN^S DISEASE NODULAR SCLEROSIS,1
RS,HYDRONEPHROSIS,1
RS,HYPERFERRITINAEMIA,1
RS,HYPERTRIGLYCERIDAEMIA,1
RS,HYPOGAMMAGLOBULINAEMIA,1
RS,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
RS,INFLAMMATORY MARKER INCREASED,1
RS,INTERNATIONAL NORMALISED RATIO INCREASED,1
RS,LEUKOPENIA,1
RS,LIMB INJURY,1
RS,LIMBIC ENCEPHALITIS,1
RS,MELAENA,1
RS,METASTASES TO CENTRAL NERVOUS SYSTEM,1
RS,NAUSEA,1
RS,NEOPLASM,1
RS,NEPHROPATHY TOXIC,1
RS,OVERDOSE,1
RS,PANCYTOPENIA,1
RS,PERIHEPATIC ABSCESS,1
RS,PNEUMONIA BACTERIAL,1
RS,PNEUMONITIS,1
RS,PROSTATE CANCER,1
RS,PULMONARY EMBOLISM,1
RS,PULMONARY VENOUS THROMBOSIS,1
RS,PYELONEPHRITIS,1
RS,RENAL ATROPHY,1
RS,RIB FRACTURE,1
RS,SKIN LESION,1
RS,SPINAL COMPRESSION FRACTURE,1
RS,STAPHYLOCOCCAL SEPSIS,1
RS,THROMBOPHLEBITIS,1
RS,TRANSAMINASES INCREASED,1
RS,TRAUMATIC HAEMOTHORAX,1
RS,TREATMENT FAILURE,1
RS,WOUND INFECTION,1
SL,ABDOMINAL DISCOMFORT,1
SL,ACCIDENT,1
SL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
SL,ANXIETY,1
SL,ARTHRALGIA,1
SL,ARTHRITIS,1
SL,ASTHENIA,1
SL,BONE PAIN,1
SL,BRAIN NEOPLASM,1
SL,BURNOUT SYNDROME,1
SL,CEREBRAL DISORDER,1
SL,CHILLS,1
SL,DEPRESSION,1
SL,DISABILITY,1
SL,DRUG HYPERSENSITIVITY,1
SL,DYSPNOEA,1
SL,EMOTIONAL DISTRESS,1
SL,FALL,1
SL,FATIGUE,1
SL,FEELING ABNORMAL,1
SL,FLATULENCE,1
SL,HEAD INJURY,1
SL,HYPERHIDROSIS,1
SL,INFECTION,1
SL,INSOMNIA,1
SL,INTENTIONAL PRODUCT MISUSE,1
SL,IRRITABILITY,1
SL,JOINT SWELLING,1
SL,LOSS OF CONSCIOUSNESS,1
SL,LOSS OF EMPLOYMENT,1
SL,MALAISE,1
SL,MENTAL FATIGUE,1
SL,MOBILITY DECREASED,1
SL,MUSCLE DISORDER,1
SL,MUSCULAR WEAKNESS,1
SL,MUSCULOSKELETAL PAIN,1
SL,NAUSEA,1
SL,NERVE INJURY,1
SL,PAIN,1
SL,PAIN IN EXTREMITY,1
SL,PARAESTHESIA,1
SL,PERICARDITIS,1
SL,PERIPHERAL SWELLING,1
SL,PRODUCTIVE COUGH,1
SL,PRURITUS,1
SL,PYREXIA,1
SL,SEXUAL ABUSE,1
SL,SKIN ATROPHY,1
SL,SKIN DISCOLOURATION,1
SL,SKIN DISORDER,1
SL,STRESS,1
SL,SWELLING,1
SL,UNDERDOSE,1
SL,URINARY INCONTINENCE,1
SL,URTICARIA,1
SL,VOMITING,1
SL,WALKING AID USER,1
SL,WHITE BLOOD CELL COUNT DECREASED,1
SL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
SG,PNEUMONIA CYTOMEGALOVIRAL,4
SG,CYTOMEGALOVIRUS CHORIORETINITIS,3
SG,CYTOMEGALOVIRUS INFECTION,3
SG,ADVERSE DRUG REACTION,1
SG,BLOOD PRESSURE INCREASED,1
SG,CHEST DISCOMFORT,1
SG,CORONARY ARTERY THROMBOSIS,1
SG,DEATH,1
SG,DIABETES MELLITUS,1
SG,DISEASE RECURRENCE,1
SG,DYSPNOEA,1
SG,EATING DISORDER,1
SG,EPIGASTRIC DISCOMFORT,1
SG,GASTROINTESTINAL PERFORATION,1
SG,HAEMOLYTIC URAEMIC SYNDROME,1
SG,HEPATITIS E,1
SG,HIRSUTISM,1
SG,HISTOPLASMOSIS DISSEMINATED,1
SG,ILEITIS,1
SG,INFLUENZA,1
SG,LEUKOPENIA,1
SG,MALAISE,1
SG,ORTHOSTATIC HYPOTENSION,1
SG,PRODUCT USE ISSUE,1
SG,RASH,1
SG,RETINITIS,1
SG,STEVENS-JOHNSON SYNDROME,1
SG,SYNCOPE,1
SG,TENOSYNOVITIS,1
SG,TOXIC EPIDERMAL NECROLYSIS,1
SG,WEIGHT INCREASED,1
SK,PLASMA CELL MYELOMA,5
SK,THROMBOCYTOPENIA,5
SK,DRUG INEFFECTIVE,4
SK,FATIGUE,4
SK,ACUTE MYOCARDIAL INFARCTION,3
SK,ANGINA PECTORIS,3
SK,ASTHENIA,3
SK,DISEASE PROGRESSION,3
SK,PULMONARY EMBOLISM,3
SK,SINUSITIS,3
SK,STOMATITIS,3
SK,ALOPECIA,2
SK,CEREBROVASCULAR ACCIDENT,2
SK,CONSTIPATION,2
SK,DEATH,2
SK,FEBRILE NEUTROPENIA,2
SK,GASTROINTESTINAL DISORDER,2
SK,HEPATIC ENZYME INCREASED,2
SK,HYPERTENSION,2
SK,INFECTION,2
SK,MALIGNANT NEOPLASM PROGRESSION,2
SK,NEPHROPATHY TOXIC,2
SK,NEUTROPENIA,2
SK,PNEUMONIA,2
SK,PNEUMONIA BACTERIAL,2
SK,RENAL FAILURE,2
SK,WEIGHT DECREASED,2
SK,ABORTION SPONTANEOUS,1
SK,ACUTE KIDNEY INJURY,1
SK,ANAEMIA,1
SK,APPENDICITIS PERFORATED,1
SK,ASTHMA,1
SK,BLOOD ALKALINE PHOSPHATASE ABNORMAL,1
SK,BLOOD PRESSURE INCREASED,1
SK,BONE PAIN,1
SK,BRAIN STEM SYNDROME,1
SK,BREAST CANCER,1
SK,BRONCHITIS,1
SK,BRONCHOPNEUMONIA,1
SK,BRONCHOPULMONARY ASPERGILLOSIS,1
SK,CALCINOSIS,1
SK,CARDIAC ARREST,1
SK,CARDIAC FAILURE CONGESTIVE,1
SK,CARDIOPULMONARY FAILURE,1
SK,CATABOLIC STATE,1
SK,CHOLECYSTITIS,1
SK,CHRONIC SINUSITIS,1
SK,COLITIS ULCERATIVE,1
SK,CONDITION AGGRAVATED,1
SK,DECREASED APPETITE,1
SK,DEEP VEIN THROMBOSIS,1
SK,DEPRESSION,1
SK,DERMATITIS ALLERGIC,1
SK,DERMATOMYOSITIS,1
SK,DIARRHOEA,1
SK,DIVERTICULITIS,1
SK,DRUG EFFECT INCOMPLETE,1
SK,DYSGEUSIA,1
SK,ECZEMA,1
SK,EMPYEMA,1
SK,ENDOCARDITIS,1
SK,ERYTHEMA,1
SK,ERYTHEMA ANNULARE,1
SK,FALL,1
SK,FLUID OVERLOAD,1
SK,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SK,GASTROENTERITIS,1
SK,GINGIVAL BLEEDING,1
SK,GINGIVAL HYPERTROPHY,1
SK,HEADACHE,1
SK,HEPATORENAL SYNDROME,1
SK,HICCUPS,1
SK,HYPERGLYCAEMIA,1
SK,HYPERTRICHOSIS,1
SK,HYPOACUSIS,1
SK,HYPOALBUMINAEMIA,1
SK,HYPOPROTEINAEMIA,1
SK,HYPOTENSION,1
SK,ILEUS,1
SK,ILEUS PARALYTIC,1
SK,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
SK,INFLUENZA,1
SK,INFUSION SITE PAPULE,1
SK,INSOMNIA,1
SK,JC VIRUS INFECTION,1
SK,JEJUNAL PERFORATION,1
SK,LARYNGEAL SQUAMOUS CELL CARCINOMA,1
SK,LIPOATROPHY,1
SK,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III,1
SK,LYME DISEASE,1
SK,MULTI-ORGAN FAILURE,1
SK,MUSCLE SPASMS,1
SK,MYASTHENIA GRAVIS,1
SK,MYOCARDIAL INFARCTION,1
SK,NERVOUS SYSTEM DISORDER,1
SK,NEUROPATHY PERIPHERAL,1
SK,NEUROTOXICITY,1
SK,NO THERAPEUTIC RESPONSE,1
SK,OPTIC NEURITIS,1
SK,ORAL DISCOMFORT,1
SK,OSTEONECROSIS,1
SK,PALPITATIONS,1
SK,PANCREATITIS,1
SK,PANCREATITIS ACUTE,1
SK,PANCYTOPENIA,1
SK,PLASMA CELL MYELOMA RECURRENT,1
SK,PLEURAL EFFUSION,1
SK,PNEUMONIA KLEBSIELLA,1
SK,POLYNEUROPATHY,1
SK,PREGNANCY,1
SK,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
SK,PULMONARY FIBROSIS,1
SK,PULMONARY TOXICITY,1
SK,PYELONEPHRITIS,1
SK,SKULL FRACTURE,1
SK,SPINAL DISORDER,1
SK,SUBDURAL HAEMATOMA,1
SK,SUFFOCATION FEELING,1
SK,TACHYCARDIA,1
SK,THROMBOCYTOPENIC PURPURA,1
SK,THROMBOSIS,1
SK,TOXICITY TO VARIOUS AGENTS,1
SK,TREATMENT FAILURE,1
SK,TYPE 2 DIABETES MELLITUS,1
SK,URINARY TRACT INFECTION,1
SK,VERTEBRAL LESION,1
SK,VERTEBROPLASTY,1
SI,NEUTROPENIA,4
SI,BACTERIAL SEPSIS,1
SI,DRUG EFFECT DECREASED,1
SI,FEBRILE NEUTROPENIA,1
SI,HAEMOGLOBIN DECREASED,1
SI,HAEMORRHAGE,1
SI,HEPATORENAL SYNDROME,1
SI,INFLAMMATORY MARKER INCREASED,1
SI,LYMPHOMA,1
SI,NEUROPATHY PERIPHERAL,1
SI,PETECHIAE,1
SI,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
SI,PURPURA,1
SI,SEPSIS,1
SI,SHOCK,1
ZA,RENAL FAILURE,11
ZA,SEPSIS,11
ZA,HYPOKALAEMIA,9
ZA,DEATH,8
ZA,PNEUMONIA,8
ZA,NEUTROPENIC SEPSIS,7
ZA,VOMITING,7
ZA,ASTHENIA,6
ZA,ATRIAL FIBRILLATION,6
ZA,DRUG INEFFECTIVE,6
ZA,NEUTROPENIA,6
ZA,RESPIRATORY DISTRESS,6
ZA,ACUTE KIDNEY INJURY,5
ZA,ANAEMIA,5
ZA,ARTHRALGIA,5
ZA,CHEST PAIN,5
ZA,CONFUSIONAL STATE,5
ZA,DEEP VEIN THROMBOSIS,5
ZA,DIABETES MELLITUS,5
ZA,DIARRHOEA,5
ZA,GASTROINTESTINAL HAEMORRHAGE,5
ZA,MALAISE,5
ZA,NAUSEA,5
ZA,PNEUMOCYSTIS JIROVECII PNEUMONIA,5
ZA,PRURITUS,5
ZA,PULMONARY EMBOLISM,5
ZA,PYREXIA,5
ZA,RHEUMATOID ARTHRITIS,5
ZA,SEIZURE,5
ZA,ABDOMINAL PAIN,4
ZA,COUGH,4
ZA,DRUG RESISTANCE,4
ZA,DYSPNOEA,4
ZA,FATIGUE,4
ZA,JOINT TUBERCULOSIS,4
ZA,MULTI-ORGAN FAILURE,4
ZA,PRODUCT USE IN UNAPPROVED INDICATION,4
ZA,SEPTIC SHOCK,4
ZA,TUBERCULOSIS,4
ZA,BACK PAIN,3
ZA,CARDIAC ARREST,3
ZA,COMA,3
ZA,DEPRESSION,3
ZA,DIZZINESS,3
ZA,ELECTROLYTE IMBALANCE,3
ZA,FEBRILE NEUTROPENIA,3
ZA,GAIT DISTURBANCE,3
ZA,GASTROENTERITIS,3
ZA,HEADACHE,3
ZA,HYPERTENSION,3
ZA,HYPOTENSION,3
ZA,IMMUNOSUPPRESSION,3
ZA,LEUKOPENIA,3
ZA,LOWER RESPIRATORY TRACT INFECTION,3
ZA,MYOCARDIAL INFARCTION,3
ZA,PAIN,3
ZA,PAIN IN EXTREMITY,3
ZA,PNEUMONITIS,3
ZA,RASH,3
ZA,RENAL IMPAIRMENT,3
ZA,SOMNOLENCE,3
ZA,ACUTE MYOCARDIAL INFARCTION,2
ZA,ADVERSE DRUG REACTION,2
ZA,ALTERNARIA INFECTION,2
ZA,APHASIA,2
ZA,ARRHYTHMIA,2
ZA,ASTHMA,2
ZA,BLOOD CREATININE INCREASED,2
ZA,BLOOD SODIUM DECREASED,2
ZA,BONE LOSS,2
ZA,BRONCHOSPASM,2
ZA,CENTRAL NERVOUS SYSTEM LYMPHOMA,2
ZA,CHEST DISCOMFORT,2
ZA,COLITIS ULCERATIVE,2
ZA,CYTOMEGALOVIRUS INFECTION,2
ZA,DIABETIC ULCER,2
ZA,DISSEMINATED INTRAVASCULAR COAGULATION,2
ZA,ECZEMA,2
ZA,EXPOSURE DURING PREGNANCY,2
ZA,FALL,2
ZA,GENERAL PHYSICAL HEALTH DETERIORATION,2
ZA,HAEMATOCHEZIA,2
ZA,HAEMATOMA INFECTION,2
ZA,HEMIPARESIS,2
ZA,HEPATIC ENZYME INCREASED,2
ZA,HISTIOCYTOSIS HAEMATOPHAGIC,2
ZA,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,2
ZA,INCORRECT DRUG ADMINISTRATION DURATION,2
ZA,INFECTION,2
ZA,JOINT ANKYLOSIS,2
ZA,JOINT DESTRUCTION,2
ZA,LIVER TRANSPLANT REJECTION,2
ZA,LYMPHOPENIA,2
ZA,MICROSPORIDIA INFECTION,2
ZA,MOUTH ULCERATION,2
ZA,MULTIPLE-DRUG RESISTANCE,2
ZA,MUSCULOSKELETAL STIFFNESS,2
ZA,MYALGIA,2
ZA,NEPHROLITHIASIS,2
ZA,ORGANISING PNEUMONIA,2
ZA,OROPHARYNGEAL PAIN,2
ZA,PANCYTOPENIA,2
ZA,PEPTIC ULCER,2
ZA,PERIPHERAL SWELLING,2
ZA,PSYCHOTIC DISORDER,2
ZA,PULMONARY TUBERCULOSIS,2
ZA,RASH ERYTHEMATOUS,2
ZA,RASH PRURITIC,2
ZA,RESPIRATORY FAILURE,2
ZA,SKIN NECROSIS,2
ZA,SPINAL OSTEOARTHRITIS,2
ZA,SYSTEMIC LUPUS ERYTHEMATOSUS,2
ZA,TACHYCARDIA,2
ZA,THROMBOCYTOPENIA,2
ZA,TRANSPLANT REJECTION,2
ZA,URINARY TRACT INFECTION,2
ZA,WEIGHT BEARING DIFFICULTY,2
ZA,ABASIA,1
ZA,ABORTION SPONTANEOUS,1
ZA,ABSCESS LIMB,1
ZA,ACCIDENTAL OVERDOSE,1
ZA,ACTIVITIES OF DAILY LIVING IMPAIRED,1
ZA,ACUTE ABDOMEN,1
ZA,ACUTE RESPIRATORY DISTRESS SYNDROME,1
ZA,ADENOCARCINOMA OF COLON,1
ZA,ANAEMIA MACROCYTIC,1
ZA,ANOGENITAL WARTS,1
ZA,AORTIC STENOSIS,1
ZA,APATHY,1
ZA,APHONIA,1
ZA,ARTHRITIS,1
ZA,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
ZA,BALANCE DISORDER,1
ZA,BAND SENSATION,1
ZA,BENIGN HEPATIC NEOPLASM,1
ZA,BIOPSY,1
ZA,BLOOD GLUCOSE INCREASED,1
ZA,BLOOD IMMUNOGLOBULIN E INCREASED,1
ZA,BLOOD PRESSURE FLUCTUATION,1
ZA,BONE PAIN,1
ZA,BRAIN NEOPLASM,1
ZA,BREAST CANCER,1
ZA,BRONCHITIS,1
ZA,BRONCHOPNEUMONIA,1
ZA,BURSITIS INFECTIVE,1
ZA,C-REACTIVE PROTEIN INCREASED,1
ZA,CARDIAC DISORDER,1
ZA,CARDIAC FAILURE,1
ZA,CARDIAC VALVE DISEASE,1
ZA,CARDIOPULMONARY FAILURE,1
ZA,CEREBELLAR SYNDROME,1
ZA,CEREBRAL INFARCTION,1
ZA,CEREBRAL ISCHAEMIA,1
ZA,CEREBRAL THROMBOSIS,1
ZA,CERVICAL RADICULOPATHY,1
ZA,CHOLECYSTITIS,1
ZA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
ZA,CLOSTRIDIUM DIFFICILE COLITIS,1
ZA,CLOSTRIDIUM DIFFICILE INFECTION,1
ZA,COLITIS,1
ZA,COLORECTAL CANCER METASTATIC,1
ZA,CONDITION AGGRAVATED,1
ZA,CONGENITAL OESOPHAGEAL ANOMALY,1
ZA,CONVULSION,1
ZA,CSF TEST ABNORMAL,1
ZA,CUSHINGOID,1
ZA,DECREASED APPETITE,1
ZA,DEFORMITY,1
ZA,DEHYDRATION,1
ZA,DELIRIUM,1
ZA,DEMENTIA,1
ZA,DEMYELINATION,1
ZA,DEPRESSED LEVEL OF CONSCIOUSNESS,1
ZA,DERMATITIS ALLERGIC,1
ZA,DIARRHOEA HAEMORRHAGIC,1
ZA,DIFFUSE LARGE B-CELL LYMPHOMA,1
ZA,DISEASE PROGRESSION,1
ZA,DISORIENTATION,1
ZA,DRUG EFFECT DECREASED,1
ZA,DRUG HYPERSENSITIVITY,1
ZA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
ZA,DYSARTHRIA,1
ZA,DYSPEPSIA,1
ZA,EAR DISORDER,1
ZA,EAR PAIN,1
ZA,EPILEPSY,1
ZA,ESCHERICHIA INFECTION,1
ZA,ESCHERICHIA SEPSIS,1
ZA,EYE SWELLING,1
ZA,FACIAL PARALYSIS,1
ZA,FEELING HOT,1
ZA,FOETAL EXPOSURE TIMING UNSPECIFIED,1
ZA,FOOD ALLERGY,1
ZA,GASTRIC OPERATION,1
ZA,GASTRIC ULCER,1
ZA,GASTRIC VOLVULUS,1
ZA,GASTRITIS,1
ZA,GASTROINTESTINAL POLYP HAEMORRHAGE,1
ZA,GASTROOESOPHAGEAL REFLUX DISEASE,1
ZA,HAEMATEMESIS,1
ZA,HAEMOGLOBIN DECREASED,1
ZA,HAEMOLYSIS,1
ZA,HAEMOPTYSIS,1
ZA,HAEMORRHAGE,1
ZA,HAEMORRHAGE IN PREGNANCY,1
ZA,HAEMORRHOIDS,1
ZA,HALLUCINATION,1
ZA,HEART RATE IRREGULAR,1
ZA,HEART TRANSPLANT REJECTION,1
ZA,HEPATIC FAILURE,1
ZA,HEPATIC FUNCTION ABNORMAL,1
ZA,HEPATIC NECROSIS,1
ZA,HEPATITIS,1
ZA,HERNIA,1
ZA,HIP ARTHROPLASTY,1
ZA,HIP FRACTURE,1
ZA,HIV TEST POSITIVE,1
ZA,HOSPITALISATION,1
ZA,HYDROCEPHALUS,1
ZA,HYPERGLYCAEMIA,1
ZA,HYPERHIDROSIS,1
ZA,HYPERKALAEMIA,1
ZA,HYPERTENSIVE EMERGENCY,1
ZA,HYPOACUSIS,1
ZA,HYPOAESTHESIA ORAL,1
ZA,HYPOCALCAEMIA,1
ZA,HYPONATRAEMIA,1
ZA,HYPOPHAGIA,1
ZA,ILL-DEFINED DISORDER,1
ZA,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS,1
ZA,IMMUNE THROMBOCYTOPENIC PURPURA,1
ZA,IMMUNOGLOBULINS DECREASED,1
ZA,IMPAIRED HEALING,1
ZA,IMPAIRED WORK ABILITY,1
ZA,INCORRECT STORAGE OF DRUG,1
ZA,INFECTED SKIN ULCER,1
ZA,INFECTIVE EXACERBATION OF BRONCHIECTASIS,1
ZA,INFLAMMATION,1
ZA,INFLAMMATORY MARKER INCREASED,1
ZA,INFLUENZA,1
ZA,INJECTION SITE MASS,1
ZA,INJECTION SITE PAIN,1
ZA,INJECTION SITE PRURITUS,1
ZA,INTENTION TREMOR,1
ZA,INTERSTITIAL LUNG DISEASE,1
ZA,INTERVERTEBRAL DISC DEGENERATION,1
ZA,INTRACRANIAL PRESSURE INCREASED,1
ZA,INTRAOCULAR PRESSURE INCREASED,1
ZA,IRON DEFICIENCY ANAEMIA,1
ZA,JAUNDICE,1
ZA,JOINT LOCK,1
ZA,JOINT SWELLING,1
ZA,KLEBSIELLA INFECTION,1
ZA,KLEBSIELLA SEPSIS,1
ZA,KNEE ARTHROPLASTY,1
ZA,LARGE INTESTINE PERFORATION,1
ZA,LIP SWELLING,1
ZA,LIVIDITY,1
ZA,LOW BIRTH WEIGHT BABY,1
ZA,LOWER GASTROINTESTINAL HAEMORRHAGE,1
ZA,LUMBAR SPINAL STENOSIS,1
ZA,LUNG DISORDER,1
ZA,LUPUS-LIKE SYNDROME,1
ZA,LYMPHOCYTE COUNT DECREASED,1
ZA,LYMPHOMA,1
ZA,MALIGNANT NEOPLASM PROGRESSION,1
ZA,MATERNAL EXPOSURE DURING PREGNANCY,1
ZA,MENINGIOMA,1
ZA,MENINGITIS CRYPTOCOCCAL,1
ZA,MENINGITIS TUBERCULOUS,1
ZA,MENTAL IMPAIRMENT,1
ZA,MICTURITION DISORDER,1
ZA,MIOSIS,1
ZA,MOOD SWINGS,1
ZA,MULTIPLE SCLEROSIS RELAPSE,1
ZA,MUSCLE HAEMORRHAGE,1
ZA,MUSCLE SPASMS,1
ZA,MYELITIS,1
ZA,MYOSITIS,1
ZA,NEPHROTIC SYNDROME,1
ZA,NERVE ROOT COMPRESSION,1
ZA,NERVOUSNESS,1
ZA,NEUROPSYCHIATRIC SYNDROME,1
ZA,NEUTROPHIL COUNT INCREASED,1
ZA,NEUTROPHILIA,1
ZA,NIGHT SWEATS,1
ZA,NO THERAPEUTIC RESPONSE,1
ZA,NON-HODGKIN^S LYMPHOMA,1
ZA,NOSOCOMIAL INFECTION,1
ZA,ORAL HERPES,1
ZA,OSTEONECROSIS,1
ZA,OSTEOPENIA,1
ZA,PANCREATIC CARCINOMA,1
ZA,PANCREATITIS NECROTISING,1
ZA,PAPILLOEDEMA,1
ZA,PARALYSIS,1
ZA,PARAPLEGIA,1
ZA,PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA,1
ZA,PERICARDIAL EFFUSION,1
ZA,PERICARDITIS,1
ZA,PERIPHERAL ISCHAEMIA,1
ZA,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
ZA,PHAEHYPHOMYCOSIS,1
ZA,PHARYNGITIS,1
ZA,PLATELET COUNT INCREASED,1
ZA,PLEURAL EFFUSION,1
ZA,PLEURITIC PAIN,1
ZA,PNEUMONIA ASPIRATION,1
ZA,PNEUMONIA CRYPTOCOCCAL,1
ZA,PNEUMONIA CYTOMEGALOVIRAL,1
ZA,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
ZA,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
ZA,PREMATURE BABY,1
ZA,PREMATURE DELIVERY,1
ZA,PRODUCT QUALITY ISSUE,1
ZA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
ZA,PSYCHOGENIC SEIZURE,1
ZA,PULMONARY HYPERTENSION,1
ZA,PYELONEPHRITIS,1
ZA,PYELONEPHRITIS ACUTE,1
ZA,RASH PAPULAR,1
ZA,RECTAL HAEMORRHAGE,1
ZA,RENAL CELL CARCINOMA,1
ZA,RENAL FAILURE ACUTE,1
ZA,RESPIRATORY TRACT INFECTION,1
ZA,RETINAL DETACHMENT,1
ZA,RETROVIRAL INFECTION,1
ZA,RHABDOMYOLYSIS,1
ZA,RHEUMATOID FACTOR INCREASED,1
ZA,RHINITIS,1
ZA,ROTATOR CUFF SYNDROME,1
ZA,RUSSELL^S VIPER VENOM TIME ABNORMAL,1
ZA,SCIATICA,1
ZA,SENILE DEMENTIA,1
ZA,SHOCK,1
ZA,SHOULDER OPERATION,1
ZA,SINUS TACHYCARDIA,1
ZA,SJOGREN^S SYNDROME,1
ZA,SKIN INFECTION,1
ZA,SKIN ULCER,1
ZA,SPEECH DISORDER,1
ZA,SPINAL CORD HAEMORRHAGE,1
ZA,STAPHYLOCOCCUS TEST POSITIVE,1
ZA,STEVENS-JOHNSON SYNDROME,1
ZA,SWOLLEN TONGUE,1
ZA,SYNOVIAL CYST,1
ZA,TACHYPNOEA,1
ZA,TAKAYASU^S ARTERITIS,1
ZA,TERMINAL STATE,1
ZA,THALAMIC INFARCTION,1
ZA,THERAPEUTIC RESPONSE SHORTENED,1
ZA,THROAT IRRITATION,1
ZA,THROMBECTOMY,1
ZA,THROMBOSIS,1
ZA,THYROID FUNCTION TEST ABNORMAL,1
ZA,TONSILLITIS,1
ZA,TOXICITY TO VARIOUS AGENTS,1
ZA,TREATMENT FAILURE,1
ZA,TREATMENT NONCOMPLIANCE,1
ZA,TREMOR,1
ZA,TUBERCULIN TEST POSITIVE,1
ZA,TUMOUR LYSIS SYNDROME,1
ZA,UNEVALUABLE EVENT,1
ZA,UPPER RESPIRATORY TRACT INFECTION,1
ZA,URETHRAL FISTULA,1
ZA,URINARY RETENTION,1
ZA,URINARY TRACT INFECTION BACTERIAL,1
ZA,UROSEPSIS,1
ZA,URTICARIA,1
ZA,VAGINAL DISCHARGE,1
ZA,VASCULITIS,1
ZA,VERTEBRAL LESION,1
ZA,WEIGHT DECREASED,1
ZA,WEIGHT INCREASED,1
ZA,WHITE BLOOD CELL COUNT DECREASED,1
ZA,WHITE BLOOD CELL COUNT INCREASED,1
ZA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
ES,PYREXIA,99
ES,ANAEMIA,86
ES,PNEUMONIA,78
ES,NEUTROPENIA,75
ES,CONDITION AGGRAVATED,66
ES,THROMBOCYTOPENIA,62
ES,TOXICITY TO VARIOUS AGENTS,60
ES,FEBRILE NEUTROPENIA,55
ES,DRUG INEFFECTIVE,52
ES,PANCYTOPENIA,51
ES,ASTHENIA,44
ES,SEPTIC SHOCK,43
ES,SEPSIS,39
ES,DIARRHOEA,38
ES,DISEASE RECURRENCE,38
ES,RESPIRATORY FAILURE,35
ES,MUCOSAL INFLAMMATION,34
ES,FATIGUE,33
ES,INFECTION,33
ES,VOMITING,33
ES,URINARY TRACT INFECTION,32
ES,CYTOMEGALOVIRUS INFECTION,31
ES,DEATH,31
ES,HEADACHE,29
ES,DISEASE PROGRESSION,27
ES,ERYTHEMA,27
ES,DIZZINESS,26
ES,DYSPNOEA,26
ES,RENAL IMPAIRMENT,26
ES,NAUSEA,25
ES,PRODUCT USE IN UNAPPROVED INDICATION,25
ES,SOMNOLENCE,25
ES,DISORIENTATION,24
ES,LEUKOPENIA,24
ES,TRANSAMINASES INCREASED,24
ES,CARDIAC FAILURE,23
ES,RASH,23
ES,RESPIRATORY TRACT INFECTION,23
ES,NEUROPATHY PERIPHERAL,22
ES,DECREASED APPETITE,21
ES,EUPHORIC MOOD,20
ES,ATRIAL FIBRILLATION,19
ES,NEPHROTIC SYNDROME,19
ES,PLEURAL EFFUSION,19
ES,RENAL FAILURE,19
ES,STUPOR,19
ES,ERYTHRODERMIC PSORIASIS,18
ES,PAIN IN EXTREMITY,18
ES,TOXIC SKIN ERUPTION,18
ES,BACTERAEMIA,17
ES,CONSTIPATION,17
ES,GAIT DISTURBANCE,17
ES,HYPOTENSION,17
ES,C-REACTIVE PROTEIN INCREASED,16
ES,DRUG DEPENDENCE,16
ES,GENERAL PHYSICAL HEALTH DETERIORATION,16
ES,HAEMATOTOXICITY,16
ES,HEPATOTOXICITY,16
ES,INFLAMMATION,16
ES,INJECTION SITE ERYTHEMA,16
ES,PAIN,16
ES,PARAESTHESIA,16
ES,BONE MARROW FAILURE,15
ES,CONFUSIONAL STATE,15
ES,NEUROTOXICITY,15
ES,RHEUMATOID ARTHRITIS,15
ES,TRANSPLANT REJECTION,15
ES,WEIGHT DECREASED,15
ES,CARDIOTOXICITY,14
ES,INTERSTITIAL LUNG DISEASE,14
ES,POLYMYALGIA RHEUMATICA,14
ES,PRODUCT USE ISSUE,14
ES,ABDOMINAL PAIN,13
ES,ACUTE MYELOID LEUKAEMIA,13
ES,ARTHRALGIA,13
ES,BACK PAIN,13
ES,COUGH,13
ES,DEEP VEIN THROMBOSIS,13
ES,FALL,13
ES,FOETAL EXPOSURE DURING PREGNANCY,13
ES,GASTROINTESTINAL HAEMORRHAGE,13
ES,HEPATIC FAILURE,13
ES,MULTIPLE ORGAN DYSFUNCTION SYNDROME,13
ES,STAPHYLOCOCCAL INFECTION,13
ES,ACUTE KIDNEY INJURY,12
ES,ACUTE MYOCARDIAL INFARCTION,12
ES,BLOOD STEM CELL HARVEST FAILURE,12
ES,BONE PAIN,12
ES,HYPONATRAEMIA,12
ES,LIVER DISORDER,12
ES,MULTI-ORGAN FAILURE,12
ES,MYELODYSPLASTIC SYNDROME,12
ES,PULMONARY EMBOLISM,12
ES,TREMOR,12
ES,URTICARIA,12
ES,ACUTE RESPIRATORY FAILURE,11
ES,ASPERGILLUS INFECTION,11
ES,ATYPICAL FEMUR FRACTURE,11
ES,HYPERGLYCAEMIA,11
ES,INJECTION SITE PAIN,11
ES,MYOCARDIAL INFARCTION,11
ES,PERIPHERAL SWELLING,11
ES,PNEUMONITIS,11
ES,RED BLOOD CELL SEDIMENTATION RATE INCREASED,11
ES,SKIN ULCER,11
ES,CHEILITIS,10
ES,DEPRESSION,10
ES,DRUG INTOLERANCE,10
ES,FACTOR XIII DEFICIENCY,10
ES,GASTROINTESTINAL DISORDER,10
ES,HAEMORRHAGE,10
ES,HERPES ZOSTER,10
ES,HISTIOCYTOSIS HAEMATOPHAGIC,10
ES,INJECTION SITE PRURITUS,10
ES,OEDEMA,10
ES,OEDEMA PERIPHERAL,10
ES,OVERDOSE,10
ES,PALPITATIONS,10
ES,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,10
ES,TUBERCULOSIS,10
ES,ASTHMA,9
ES,BRONCHITIS,9
ES,BRONCHOPULMONARY ASPERGILLOSIS,9
ES,CHEST PAIN,9
ES,DIABETES MELLITUS,9
ES,GASTROINTESTINAL TOXICITY,9
ES,HYPOAESTHESIA,9
ES,HYPOKALAEMIA,9
ES,ILEUS PARALYTIC,9
ES,INFLUENZA,9
ES,LYMPHOPENIA,9
ES,MALAISE,9
ES,MYALGIA,9
ES,PERIPHERAL SENSORY NEUROPATHY,9
ES,PLASMA CELL MYELOMA,9
ES,RENAL FAILURE ACUTE,9
ES,RENAL TUBULAR NECROSIS,9
ES,RESPIRATORY DISTRESS,9
ES,SCROTAL ULCER,9
ES,SINUSITIS,9
ES,SKIN LESION,9
ES,ACANTHAMOEBA INFECTION,8
ES,ACUTE LYMPHOCYTIC LEUKAEMIA,8
ES,BURSITIS,8
ES,CANDIDA INFECTION,8
ES,CHRONIC HEPATITIS,8
ES,COLITIS ULCERATIVE,8
ES,FACE OEDEMA,8
ES,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,8
ES,HEPATITIS E,8
ES,LYMPHADENOPATHY,8
ES,MATERNAL EXPOSURE DURING PREGNANCY,8
ES,PANCREATITIS ACUTE,8
ES,PORTAL HYPERTENSION,8
ES,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,8
ES,PREMATURE BABY,8
ES,PSEUDOMONAS INFECTION,8
ES,SEDATION,8
ES,SYNCOPE,8
ES,VARICES OESOPHAGEAL,8
ES,ACUTE RESPIRATORY DISTRESS SYNDROME,7
ES,ADRENOCORTICAL INSUFFICIENCY ACUTE,7
ES,CARDIAC ARREST,7
ES,CELLULITIS,7
ES,CEREBROVASCULAR ACCIDENT,7
ES,COLITIS,7
ES,DRUG EFFECT INCOMPLETE,7
ES,DYSPHAGIA,7
ES,ENCEPHALOPATHY,7
ES,FLANK PAIN,7
ES,HAEMOGLOBIN DECREASED,7
ES,HYPERTENSION,7
ES,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
ES,ISCHAEMIC STROKE,7
ES,LARGE INTESTINAL ULCER,7
ES,LOW BIRTH WEIGHT BABY,7
ES,MOBILITY DECREASED,7
ES,NASAL POLYPS,7
ES,NERVOUS SYSTEM DISORDER,7
ES,ORAL HERPES,7
ES,PARVOVIRUS B19 INFECTION,7
ES,PNEUMOCYSTIS JIROVECII PNEUMONIA,7
ES,SKIN EXFOLIATION,7
ES,TOXIC EPIDERMAL NECROLYSIS,7
ES,URINARY RETENTION,7
ES,VISCERAL LEISHMANIASIS,7
ES,ABDOMINAL PAIN UPPER,6
ES,ARTHRITIS,6
ES,CHILLS,6
ES,COAGULOPATHY,6
ES,GASTRIC HAEMORRHAGE,6
ES,GLOMERULONEPHROPATHY,6
ES,HYPERBILIRUBINAEMIA,6
ES,ILL-DEFINED DISORDER,6
ES,INJECTION SITE HAEMATOMA,6
ES,INTESTINAL OBSTRUCTION,6
ES,KAPOSI^S SARCOMA,6
ES,LOSS OF CONSCIOUSNESS,6
ES,MALNUTRITION,6
ES,MOUTH ULCERATION,6
ES,MUSCULAR WEAKNESS,6
ES,MUSCULOSKELETAL PAIN,6
ES,NEOPLASM PROGRESSION,6
ES,NORMOCHROMIC NORMOCYTIC ANAEMIA,6
ES,PRURITUS,6
ES,PSORIASIS,6
ES,PULMONARY FIBROSIS,6
ES,SQUAMOUS CELL CARCINOMA,6
ES,THERAPEUTIC RESPONSE DECREASED,6
ES,ALOPECIA,5
ES,ARRHYTHMIA,5
ES,BREAST CANCER,5
ES,BRONCHOSPASM,5
ES,CACHEXIA,5
ES,CARDIAC DISORDER,5
ES,COMA,5
ES,CUSHINGOID,5
ES,CYSTITIS HAEMORRHAGIC,5
ES,DEAFNESS NEUROSENSORY,5
ES,DEVICE RELATED INFECTION,5
ES,DISCOMFORT,5
ES,DRUG HYPERSENSITIVITY,5
ES,DRUG RESISTANCE,5
ES,ELECTROLYTE IMBALANCE,5
ES,EMBOLISM,5
ES,EOSINOPHILIA,5
ES,EPISTAXIS,5
ES,GASTROENTERITIS,5
ES,GRAFT VERSUS HOST DISEASE,5
ES,HAEMATOMA,5
ES,HEMIPARESIS,5
ES,HEPATITIS,5
ES,HYPERTRIGLYCERIDAEMIA,5
ES,HYPOGLYCAEMIA,5
ES,INJECTION SITE MASS,5
ES,INJECTION SITE REACTION,5
ES,IRIDOCYCLITIS,5
ES,JOINT SWELLING,5
ES,LISTERIOSIS,5
ES,LUNG INFECTION,5
ES,LUNG INFILTRATION,5
ES,MEDICATION ERROR,5
ES,METASTASES TO BONE,5
ES,NEPHROPATHY TOXIC,5
ES,NEUROLOGICAL DECOMPENSATION,5
ES,ORAL CANDIDIASIS,5
ES,PERITONITIS,5
ES,PROTEUS INFECTION,5
ES,PULMONARY ARTERIAL HYPERTENSION,5
ES,RHINITIS ALLERGIC,5
ES,SLEEP APNOEA SYNDROME,5
ES,STRONGYLOIDIASIS,5
ES,SYSTEMIC MYCOSIS,5
ES,TACHYCARDIA,5
ES,TUBULOINTERSTITIAL NEPHRITIS,5
ES,UPPER RESPIRATORY TRACT INFECTION,5
ES,WEIGHT INCREASED,5
ES,ABDOMINAL DISCOMFORT,4
ES,ABDOMINAL DISTENSION,4
ES,ACUTE POLYNEUROPATHY,4
ES,ADENOVIRUS INFECTION,4
ES,ADVERSE DRUG REACTION,4
ES,AGRANULOCYTOSIS,4
ES,APHTHOUS ULCER,4
ES,ARTHRITIS BACTERIAL,4
ES,ARTHROPATHY,4
ES,ASPIRATION,4
ES,BARTTER^S SYNDROME,4
ES,BASAL CELL CARCINOMA,4
ES,BONE MARROW TOXICITY,4
ES,BRAIN ABSCESS,4
ES,CARDIO-RESPIRATORY ARREST,4
ES,CHEST DISCOMFORT,4
ES,CHOLECYSTITIS,4
ES,CHOLESTASIS,4
ES,CHORIORETINOPATHY,4
ES,CHOROIDITIS,4
ES,CROHN^S DISEASE,4
ES,CUSHING^S SYNDROME,4
ES,CYTOMEGALOVIRUS MUCOCUTANEOUS ULCER,4
ES,DEAFNESS,4
ES,DEHYDRATION,4
ES,DIVERTICULITIS,4
ES,DRUG ADMINISTRATION ERROR,4
ES,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
ES,ENTEROCOCCAL INFECTION,4
ES,ESCHERICHIA URINARY TRACT INFECTION,4
ES,FAECALOMA,4
ES,FOETAL GROWTH RESTRICTION,4
ES,GENERALISED OEDEMA,4
ES,GUILLAIN-BARRE SYNDROME,4
ES,HAEMATURIA,4
ES,HAEMOLYTIC ANAEMIA,4
ES,HAEMOPTYSIS,4
ES,HEPATIC ENCEPHALOPATHY,4
ES,HEPATITIS C,4
ES,HYPERTRICHOSIS,4
ES,HYPOCALCAEMIA,4
ES,HYPOMAGNESAEMIA,4
ES,INCORRECT DOSE ADMINISTERED,4
ES,INFUSION RELATED REACTION,4
ES,INJECTION SITE HAEMORRHAGE,4
ES,INTESTINAL ISCHAEMIA,4
ES,INTESTINAL PERFORATION,4
ES,KIDNEY TRANSPLANT REJECTION,4
ES,LOWER RESPIRATORY TRACT INFECTION,4
ES,LUNG NEOPLASM MALIGNANT,4
ES,MALIGNANT NEOPLASM PROGRESSION,4
ES,MENINGITIS ASEPTIC,4
ES,METABOLIC ACIDOSIS,4
ES,NO THERAPEUTIC RESPONSE,4
ES,NON-HODGKIN^S LYMPHOMA,4
ES,OSTEONECROSIS OF JAW,4
ES,PALMAR ERYTHEMA,4
ES,PLATELET COUNT DECREASED,4
ES,PREMATURE DELIVERY,4
ES,PROSTATE CANCER,4
ES,PROTEINURIA,4
ES,PSORIATIC ARTHROPATHY,4
ES,PSYCHOTIC SYMPTOM,4
ES,PULMONARY HYPERTENSION,4
ES,PULMONARY OEDEMA,4
ES,REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS,4
ES,RENAL DISORDER,4
ES,SALMONELLOSIS,4
ES,SPEECH DISORDER,4
ES,SPINAL FRACTURE,4
ES,STOMATITIS,4
ES,STREPTOCOCCAL INFECTION,4
ES,SUDDEN DEATH,4
ES,SWELLING FACE,4
ES,THROMBOTIC MICROANGIOPATHY,4
ES,VENTRICULAR TACHYCARDIA,4
ES,ACUTE PULMONARY OEDEMA,3
ES,ADVERSE EVENT,3
ES,ALTERNARIA INFECTION,3
ES,ANXIETY,3
ES,APHASIA,3
ES,APLASIA PURE RED CELL,3
ES,ATELECTASIS,3
ES,ATRIOVENTRICULAR BLOCK,3
ES,AUTOIMMUNE HAEMOLYTIC ANAEMIA,3
ES,B-CELL LYMPHOMA RECURRENT,3
ES,BILE DUCT STENOSIS,3
ES,BLOOD CREATININE INCREASED,3
ES,BLOOD LACTATE DEHYDROGENASE INCREASED,3
ES,BLOOD PRESSURE DECREASED,3
ES,BLOOD PRESSURE INCREASED,3
ES,BLOOD URIC ACID INCREASED,3
ES,BONE DISORDER,3
ES,BRONCHIAL OEDEMA,3
ES,BRONCHIECTASIS,3
ES,CASTLEMAN^S DISEASE,3
ES,CEREBRAL HAEMORRHAGE,3
ES,CEREBRAL TOXOPLASMOSIS,3
ES,CHOLECYSTITIS ACUTE,3
ES,CHOLELITHIASIS,3
ES,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
ES,COLON CANCER,3
ES,COLORECTAL CANCER,3
ES,CONGENITAL CARDIOVASCULAR ANOMALY,3
ES,CONVULSION,3
ES,CYTOMEGALOVIRUS TEST POSITIVE,3
ES,CYTOPENIA,3
ES,DECREASED IMMUNE RESPONSIVENESS,3
ES,DEMODICIDOSIS,3
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,3
ES,DERMATITIS PSORIASIFORM,3
ES,DISSEMINATED TUBERCULOSIS,3
ES,DRUG LEVEL INCREASED,3
ES,DYSLIPIDAEMIA,3
ES,ENCEPHALITIS,3
ES,ENCEPHALITIS AUTOIMMUNE,3
ES,ENCEPHALITIS VIRAL,3
ES,ENTERITIS,3
ES,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,3
ES,ERYTHEMA MULTIFORME,3
ES,ESCHERICHIA BACTERAEMIA,3
ES,FLUID RETENTION,3
ES,FOOT DEFORMITY,3
ES,FRACTURE DELAYED UNION,3
ES,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,3
ES,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
ES,GENERALISED TONIC-CLONIC SEIZURE,3
ES,GINGIVAL HYPERTROPHY,3
ES,GLOMERULONEPHRITIS MINIMAL LESION,3
ES,GRAND MAL CONVULSION,3
ES,HAEMODYNAMIC INSTABILITY,3
ES,HAEMORRHAGIC DISORDER,3
ES,HALLUCINATION_ VISUAL,3
ES,HEPATIC ENZYME INCREASED,3
ES,HEPATITIS B,3
ES,HEPATITIS B REACTIVATION,3
ES,HEPATITIS CHOLESTATIC,3
ES,HERPES SIMPLEX ENCEPHALITIS,3
ES,HYPERHIDROSIS,3
ES,HYPERKALAEMIA,3
ES,HYPERTENSIVE CRISIS,3
ES,HYPOPROTEINAEMIA,3
ES,HYPOTONIA,3
ES,HYPOTONY OF EYE,3
ES,IMMUNODEFICIENCY,3
ES,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,3
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
ES,INJECTION SITE WARMTH,3
ES,KIDNEY FIBROSIS,3
ES,KLEBSIELLA INFECTION,3
ES,LACRIMATION INCREASED,3
ES,LUPUS NEPHRITIS,3
ES,LYMPHOCYTOSIS,3
ES,MALIGNANT MELANOMA,3
ES,METABOLIC DISORDER,3
ES,METABOLIC ENCEPHALOPATHY,3
ES,MOVEMENT DISORDER,3
ES,MUCOCUTANEOUS LEISHMANIASIS,3
ES,MUSCLE HAEMORRHAGE,3
ES,NASAL CONGESTION,3
ES,NASOPHARYNGITIS,3
ES,NECROTISING FASCIITIS,3
ES,NEOPLASM,3
ES,NON-CARDIAC CHEST PAIN,3
ES,NORMETANEPHRINE URINE INCREASED,3
ES,OBSTRUCTIVE UROPATHY,3
ES,ORTHOPNOEA,3
ES,OSTEONECROSIS,3
ES,PANCREATITIS,3
ES,PAPILLOEDEMA,3
ES,PAPILLOMA VIRAL INFECTION,3
ES,PARTIAL SEIZURES,3
ES,PERICARDITIS,3
ES,PETECHIAE,3
ES,PHLEBITIS,3
ES,PIGMENTATION DISORDER,3
ES,PLEOCYTOSIS,3
ES,POLYNEUROPATHY,3
ES,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,3
ES,POSTOPERATIVE WOUND INFECTION,3
ES,PRODUCTIVE COUGH,3
ES,PROSTATE CANCER METASTATIC,3
ES,PSEUDOMONAL SEPSIS,3
ES,PULMONARY ARTERY THROMBOSIS,3
ES,RASH MACULO-PAPULAR,3
ES,RASH MORBILLIFORM,3
ES,RASH PRURITIC,3
ES,RECTAL HAEMORRHAGE,3
ES,REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA,3
ES,RETCHING,3
ES,SCIATICA,3
ES,SERRATIA INFECTION,3
ES,SKIN INFECTION,3
ES,SPINAL COMPRESSION FRACTURE,3
ES,SPINAL CORD COMPRESSION,3
ES,STAPHYLOCOCCAL BACTERAEMIA,3
ES,SWELLING,3
ES,THALAMIC INFARCTION,3
ES,THERAPY NON-RESPONDER,3
ES,THROAT IRRITATION,3
ES,TRANSIENT ISCHAEMIC ATTACK,3
ES,TREATMENT NONCOMPLIANCE,3
ES,TYPE 2 LEPRA REACTION,3
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,3
ES,URINARY TRACT INFECTION ENTEROCOCCAL,3
ES,VENTRICULAR FIBRILLATION,3
ES,VISION BLURRED,3
ES,ABASIA,2
ES,ABDOMINAL PAIN LOWER,2
ES,ABORTION SPONTANEOUS,2
ES,ABSCESS,2
ES,ACCIDENTAL OVERDOSE,2
ES,ACQUIRED TRACHEO-OESOPHAGEAL FISTULA,2
ES,ACUTE HEPATIC FAILURE,2
ES,ACUTE PSYCHOSIS,2
ES,ADRENAL INSUFFICIENCY,2
ES,ALANINE AMINOTRANSFERASE ABNORMAL,2
ES,ANAL FISSURE,2
ES,ANAPHYLACTIC REACTION,2
ES,ANGINA PECTORIS,2
ES,ANGIOEDEMA,2
ES,ANURIA,2
ES,AORTIC VALVE INCOMPETENCE,2
ES,AREFLEXIA,2
ES,ARRHYTHMIA SUPRAVENTRICULAR,2
ES,ARTERIAL THROMBOSIS,2
ES,ARTHRITIS INFECTIVE,2
ES,ASPARTATE AMINOTRANSFERASE ABNORMAL,2
ES,ASPARTATE AMINOTRANSFERASE INCREASED,2
ES,ASPIRATION BRONCHIAL,2
ES,ATRIAL FLUTTER,2
ES,B-CELL LYMPHOMA,2
ES,BACTERIAL INFECTION,2
ES,BACTERIAL PYELONEPHRITIS,2
ES,BENIGN INTRACRANIAL HYPERTENSION,2
ES,BENIGN PROSTATIC HYPERPLASIA,2
ES,BILE DUCT STONE,2
ES,BILIARY ANASTOMOSIS,2
ES,BK VIRUS INFECTION,2
ES,BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0,2
ES,BLINDNESS,2
ES,BLISTER,2
ES,BLOOD CATECHOLAMINES INCREASED,2
ES,BLOOD CHOLESTEROL INCREASED,2
ES,BLOOD GLUCOSE ABNORMAL,2
ES,BLOOD GLUCOSE INCREASED,2
ES,BLOOD POTASSIUM DECREASED,2
ES,BLOOD PRESSURE ABNORMAL,2
ES,BODY TEMPERATURE INCREASED,2
ES,BONE INFARCTION,2
ES,CARDIAC FAILURE CONGESTIVE,2
ES,CARDIAC VALVE VEGETATION,2
ES,CARDIOGENIC SHOCK,2
ES,CARDIOVASCULAR DISORDER,2
ES,CAT SCRATCH DISEASE,2
ES,CATARRH,2
ES,CELLULITIS STREPTOCOCCAL,2
ES,CEREBRAL INFARCTION,2
ES,CERVICAL DYSPLASIA,2
ES,CERVIX CARCINOMA,2
ES,CHEMICAL PERITONITIS,2
ES,CHOLANGIOCARCINOMA,2
ES,CHRONIC KIDNEY DISEASE,2
ES,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
ES,CHRONIC RESPIRATORY FAILURE,2
ES,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,2
ES,CLAUDICATION OF JAW MUSCLES,2
ES,COGNITIVE DISORDER,2
ES,CONJUNCTIVAL HAEMORRHAGE,2
ES,CORONARY ARTERY DISEASE,2
ES,COXSACKIE VIRUS TEST POSITIVE,2
ES,CUTANEOUS LUPUS ERYTHEMATOSUS,2
ES,CYTOMEGALOVIRUS CHORIORETINITIS,2
ES,CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION,2
ES,DELAYED GRAFT FUNCTION,2
ES,DEMYELINATION,2
ES,DERMATOMYOSITIS,2
ES,DIFFUSE LARGE B-CELL LYMPHOMA,2
ES,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
ES,DRUG ERUPTION,2
ES,DRUG LEVEL DECREASED,2
ES,DRY MOUTH,2
ES,DUODENAL NEOPLASM,2
ES,DYSARTHRIA,2
ES,DYSPNOEA EXERTIONAL,2
ES,EJECTION FRACTION DECREASED,2
ES,ELECTROCARDIOGRAM ABNORMAL,2
ES,ELECTROCARDIOGRAM QT PROLONGED,2
ES,ENCEPHALITIS CYTOMEGALOVIRUS,2
ES,ENCEPHALOMALACIA,2
ES,END STAGE RENAL DISEASE,2
ES,ENDOCARDITIS,2
ES,ENDOMETRIAL ADENOCARCINOMA,2
ES,EPIGLOTTITIS,2
ES,EPILEPSY,2
ES,EPSTEIN-BARR VIRAEMIA,2
ES,EPSTEIN-BARR VIRUS INFECTION,2
ES,ESCHERICHIA INFECTION,2
ES,ESCHERICHIA SEPSIS,2
ES,EXPOSURE DURING PREGNANCY,2
ES,EXTRAVASATION,2
ES,EYELID OEDEMA,2
ES,FACTOR XIII INHIBITION,2
ES,FALSE POSITIVE INVESTIGATION RESULT,2
ES,FAT TISSUE INCREASED,2
ES,FEAR OF INJECTION,2
ES,FEELING ABNORMAL,2
ES,FEELING HOT,2
ES,GALLBLADDER DISORDER,2
ES,GASTRITIS,2
ES,GASTROENTERITIS SALMONELLA,2
ES,GLOMERULONEPHRITIS PROLIFERATIVE,2
ES,GROIN PAIN,2
ES,GROWTH RETARDATION,2
ES,HAEMATEMESIS,2
ES,HAEMATOCHEZIA,2
ES,HAEMOGLOBIN ABNORMAL,2
ES,HAEMOLYSIS,2
ES,HAEMOTHORAX,2
ES,HELLP SYNDROME,2
ES,HEPATIC FUNCTION ABNORMAL,2
ES,HEPATITIS ACUTE,2
ES,HEPATOCELLULAR CARCINOMA,2
ES,HERPES SIMPLEX,2
ES,HERPES VIRUS INFECTION,2
ES,HIP FRACTURE,2
ES,HOSPITALISATION,2
ES,HYPERAMMONAEMIA,2
ES,HYPERCHOLESTEROLAEMIA,2
ES,HYPERSENSITIVITY,2
ES,HYPERSENSITIVITY VASCULITIS,2
ES,HYPERTHYROIDISM,2
ES,HYPERURICAEMIA,2
ES,HYPOGAMMAGLOBULINAEMIA,2
ES,HYPOVOLAEMIC SHOCK,2
ES,ILEUS SPASTIC,2
ES,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
ES,IMMUNOSUPPRESSION,2
ES,IMPAIRED HEALING,2
ES,INJECTION SITE INFLAMMATION,2
ES,INJECTION SITE SWELLING,2
ES,INJECTION SITE URTICARIA,2
ES,INSOMNIA,2
ES,INTENTIONAL PRODUCT USE ISSUE,2
ES,INTERNATIONAL NORMALISED RATIO INCREASED,2
ES,INTERVERTEBRAL DISC DEGENERATION,2
ES,IRON DEFICIENCY,2
ES,LEFT VENTRICULAR DYSFUNCTION,2
ES,LETHARGY,2
ES,LIPASE INCREASED,2
ES,LIVER FUNCTION TEST ABNORMAL,2
ES,LIVER GRAFT LOSS,2
ES,LOCALISED INFECTION,2
ES,LOCKED-IN SYNDROME,2
ES,LUNG ADENOCARCINOMA METASTATIC,2
ES,LUNG DISORDER,2
ES,LUPUS-LIKE SYNDROME,2
ES,LYMPHOCELE,2
ES,LYMPHOMA,2
ES,MALIGNANT HYPERTENSION,2
ES,MANIA,2
ES,MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL,2
ES,METASTASES TO SPINE,2
ES,MITRAL VALVE INCOMPETENCE,2
ES,MUSCLE ABSCESS,2
ES,MUSCULOSKELETAL STIFFNESS,2
ES,MYCOBACTERIUM FORTUITUM INFECTION,2
ES,MYOCARDITIS,2
ES,MYOCLONUS,2
ES,MYOPATHY,2
ES,NAIL DISORDER,2
ES,NEOPLASM RECURRENCE,2
ES,NEPHROPATHY,2
ES,NEUTROPENIC SEPSIS,2
ES,NEUTROPHILIA,2
ES,NO ADVERSE EVENT,2
ES,NON-HODGKIN^S LYMPHOMA RECURRENT,2
ES,NON-SMALL CELL LUNG CANCER,2
ES,NUTRITIONAL CONDITION ABNORMAL,2
ES,ODYNOPHAGIA,2
ES,OESOPHAGEAL ADENOCARCINOMA,2
ES,OESOPHAGEAL CANDIDIASIS,2
ES,OESOPHAGEAL CARCINOMA,2
ES,OESOPHAGEAL DISORDER,2
ES,OPPORTUNISTIC INFECTION,2
ES,OPTIC ISCHAEMIC NEUROPATHY,2
ES,OSTEOPOROSIS,2
ES,OXYGEN SATURATION DECREASED,2
ES,PALLOR,2
ES,PARADOXICAL DRUG REACTION,2
ES,PARAINFLUENZAE VIRUS INFECTION,2
ES,PELVIC INFLAMMATORY DISEASE,2
ES,PERIPHERAL ISCHAEMIA,2
ES,PERIPHERAL SENSORIMOTOR NEUROPATHY,2
ES,PERIVASCULAR DERMATITIS,2
ES,PITYRIASIS ROSEA,2
ES,PLASMABLASTIC LYMPHOMA,2
ES,PNEUMONIA ASPIRATION,2
ES,PNEUMONIA BACTERIAL,2
ES,PNEUMONIA NECROTISING,2
ES,PNEUMONIA STREPTOCOCCAL,2
ES,POLYARTHRITIS,2
ES,POOR QUALITY SLEEP,2
ES,PORTAL VEIN THROMBOSIS,2
ES,PORTOPULMONARY HYPERTENSION,2
ES,POST PROCEDURAL COMPLICATION,2
ES,POST PROCEDURAL HAEMORRHAGE,2
ES,PRE-ECLAMPSIA,2
ES,PRERENAL FAILURE,2
ES,PROSTATE CANCER RECURRENT,2
ES,PROTEIN TOTAL DECREASED,2
ES,PRURIGO,2
ES,PRURITUS GENERALISED,2
ES,PSEUDOMONAS TEST POSITIVE,2
ES,PSYCHOMOTOR HYPERACTIVITY,2
ES,PULMONARY HAEMORRHAGE,2
ES,PULMONARY MASS,2
ES,PULMONARY SEPSIS,2
ES,PULMONARY TOXICITY,2
ES,PURPURA,2
ES,PUSTULAR PSORIASIS,2
ES,PYELONEPHRITIS,2
ES,PYELONEPHRITIS ACUTE,2
ES,RASH ERYTHEMATOUS,2
ES,RAYNAUD^S PHENOMENON,2
ES,RECTAL CANCER,2
ES,RENAL TRANSPLANT FAILURE,2
ES,RENAL TUBULAR ACIDOSIS,2
ES,RETROVIRAL REBOUND SYNDROME,2
ES,RHABDOMYOLYSIS,2
ES,RHEUMATOID FACTOR DECREASED,2
ES,RHINORRHOEA,2
ES,SCEDOSPORIUM INFECTION,2
ES,SECOND PRIMARY MALIGNANCY,2
ES,SKIN MASS,2
ES,SKIN PAPILLOMA,2
ES,SKIN REACTION,2
ES,SMALL CELL LUNG CANCER,2
ES,SOFT TISSUE INFECTION,2
ES,SPLENOMEGALY,2
ES,SQUAMOUS CELL CARCINOMA OF LUNG,2
ES,SUBARACHNOID HAEMORRHAGE,2
ES,SUBDURAL HAEMATOMA,2
ES,SUBILEUS,2
ES,SUICIDAL IDEATION,2
ES,SUPERINFECTION,2
ES,SUPERINFECTION BACTERIAL,2
ES,SUPRAVENTRICULAR TACHYCARDIA,2
ES,SYSTEMIC CANDIDA,2
ES,SYSTEMIC LUPUS ERYTHEMATOSUS,2
ES,THERAPEUTIC RESPONSE UNEXPECTED,2
ES,THROMBOSIS,2
ES,TOXIC ENCEPHALOPATHY,2
ES,TRANSITIONAL CELL CARCINOMA,2
ES,TRANSPLANT DYSFUNCTION,2
ES,TRANSPLANT FAILURE,2
ES,TREATMENT FAILURE,2
ES,TUMOUR LYSIS SYNDROME,2
ES,UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE,2
ES,URINARY INCONTINENCE,2
ES,URINARY TRACT INFECTION BACTERIAL,2
ES,UROSEPSIS,2
ES,UVEITIS,2
ES,VARICELLA ZOSTER VIRUS INFECTION,2
ES,VARICOSE VEIN,2
ES,VENOOCCLUSIVE LIVER DISEASE,2
ES,VENOUS THROMBOSIS,2
ES,VIRAL HAEMORRHAGIC CYSTITIS,2
ES,VIRAL LOAD INCREASED,2
ES,VISUAL IMPAIRMENT,2
ES,VITRITIS,2
ES,WHEEZING,2
ES,WOUND DEHISCENCE,2
ES,ABDOMINAL ABSCESS,1
ES,ABDOMINAL LYMPHADENOPATHY,1
ES,ABDOMINAL SEPSIS,1
ES,ABDOMINAL WALL ABSCESS,1
ES,ABDOMINAL WALL HAEMATOMA,1
ES,ACANTHOSIS NIGRICANS,1
ES,ACCIDENT,1
ES,ACTIVITIES OF DAILY LIVING IMPAIRED,1
ES,ACUTE CORONARY SYNDROME,1
ES,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
ES,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,1
ES,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
ES,ACUTE INTERSTITIAL PNEUMONITIS,1
ES,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
ES,ACUTE MOTOR-SENSORY AXONAL NEUROPATHY,1
ES,ACUTE ON CHRONIC LIVER FAILURE,1
ES,ADENOCARCINOMA OF COLON,1
ES,ADENOVIRUS TEST POSITIVE,1
ES,ADRENAL DISORDER,1
ES,AGGRESSION,1
ES,AIR EMBOLISM,1
ES,ALANINE AMINOTRANSFERASE INCREASED,1
ES,ALTERED STATE OF CONSCIOUSNESS,1
ES,AMENORRHOEA,1
ES,AMMONIA INCREASED,1
ES,AMNESIA,1
ES,AMYLASE INCREASED,1
ES,AMYOTROPHY,1
ES,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
ES,ANAEMIA MACROCYTIC,1
ES,ANAL ULCER,1
ES,ANASTOMOTIC LEAK,1
ES,ANGINA UNSTABLE,1
ES,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,1
ES,ANTICOAGULATION DRUG LEVEL ABNORMAL,1
ES,ANTIPHOSPHOLIPID ANTIBODIES,1
ES,AORTIC ANEURYSM,1
ES,AORTIC STENOSIS,1
ES,APATHY,1
ES,APGAR SCORE LOW,1
ES,AQUEOUS HUMOUR LEAKAGE,1
ES,ARTERIAL STENOSIS,1
ES,ARTERIOVENOUS FISTULA MATURATION FAILURE,1
ES,ARTERIOVENOUS FISTULA SITE INFECTION,1
ES,ARTERIOVENOUS FISTULA THROMBOSIS,1
ES,ASCITES,1
ES,ASTHENOPIA,1
ES,ATAXIA,1
ES,ATRIOVENTRICULAR BLOCK COMPLETE,1
ES,ATYPICAL MYCOBACTERIAL INFECTION,1
ES,AUTOIMMUNE DISORDER,1
ES,AUTOIMMUNE THYROIDITIS,1
ES,AUTOINFLAMMATORY DISEASE,1
ES,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
ES,BACILLUS BACTERAEMIA,1
ES,BACTERASCITES,1
ES,BACTERIAL SEPSIS,1
ES,BALANCE DISORDER,1
ES,BEHCET^S SYNDROME,1
ES,BENIGN NEOPLASM,1
ES,BEZOAR,1
ES,BILIARY TRACT INFECTION,1
ES,BIOPSY HEART ABNORMAL,1
ES,BLINDNESS CORTICAL,1
ES,BLINDNESS UNILATERAL,1
ES,BLOOD ALBUMIN DECREASED,1
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,1
ES,BLOOD BILIRUBIN ABNORMAL,1
ES,BLOOD BILIRUBIN DECREASED,1
ES,BLOOD BILIRUBIN INCREASED,1
ES,BLOOD CALCIUM DECREASED,1
ES,BLOOD CHOLESTEROL DECREASED,1
ES,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
ES,BLOOD DISORDER,1
ES,BLOOD FOLATE DECREASED,1
ES,BLOOD GLUCOSE DECREASED,1
ES,BLOOD IMMUNOGLOBULIN G INCREASED,1
ES,BLOOD INSULIN ABNORMAL,1
ES,BLOOD TRIGLYCERIDES ABNORMAL,1
ES,BLOOD TRIGLYCERIDES INCREASED,1
ES,BLOOD UREA INCREASED,1
ES,BODY HEIGHT BELOW NORMAL,1
ES,BONE LOSS,1
ES,BONE MARROW TRANSPLANT REJECTION,1
ES,BRADYCARDIA,1
ES,BRADYPHRENIA,1
ES,BRAIN HYPOXIA,1
ES,BRAIN OEDEMA,1
ES,BREAST CANCER METASTATIC,1
ES,BREAST CYST,1
ES,BRONCHOPNEUMONIA,1
ES,BURKITT^S LYMPHOMA RECURRENT,1
ES,BURNS SECOND DEGREE,1
ES,BURSITIS INFECTIVE,1
ES,CAECITIS,1
ES,CALCIUM DEFICIENCY,1
ES,CAMPYLOBACTER GASTROENTERITIS,1
ES,CAMPYLOBACTER INFECTION,1
ES,CANDIDA PNEUMONIA,1
ES,CARDIAC FAILURE ACUTE,1
ES,CARDIAC FAILURE CHRONIC,1
ES,CARDIAC PACEMAKER INSERTION,1
ES,CARDIAC VALVE DISEASE,1
ES,CARDIOACTIVE DRUG LEVEL INCREASED,1
ES,CARTILAGE INJURY,1
ES,CATARACT,1
ES,CATARACT SUBCAPSULAR,1
ES,CATHETER SITE ERYTHEMA,1
ES,CATHETER SITE PAIN,1
ES,CATHETER SITE SWELLING,1
ES,CAVERNOUS SINUS THROMBOSIS,1
ES,CELL-MEDIATED IMMUNE DEFICIENCY,1
ES,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,1
ES,CENTRAL NERVOUS SYSTEM LESION,1
ES,CEREBRAL ISCHAEMIA,1
ES,CERVIX CARCINOMA STAGE 0,1
ES,CHEST X-RAY ABNORMAL,1
ES,CHOKING,1
ES,CHOLANGITIS ACUTE,1
ES,CHOLECYSTITIS CHRONIC,1
ES,CHOLECYSTITIS INFECTIVE,1
ES,CHONDROPATHY,1
ES,CHORIORETINITIS,1
ES,CHROMATURIA,1
ES,CHRONIC RESPIRATORY DISEASE,1
ES,CLOSTRIDIAL SEPSIS,1
ES,CLOSTRIDIUM DIFFICILE COLITIS,1
ES,CLOSTRIDIUM DIFFICILE INFECTION,1
ES,COAGULATION FACTOR DEFICIENCY,1
ES,COLECTOMY,1
ES,COMPLETED SUICIDE,1
ES,COMPLICATIONS OF TRANSPLANTED HEART,1
ES,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
ES,CONTUSION,1
ES,CORNEAL INFILTRATES,1
ES,COSTOCHONDRITIS,1
ES,CRITICAL ILLNESS POLYNEUROPATHY,1
ES,CRYPTOCOCCOSIS,1
ES,CUTANEOUS SARCOIDOSIS,1
ES,CUTANEOUS VASCULITIS,1
ES,CYANOSIS,1
ES,CYSTADENOCARCINOMA OVARY,1
ES,CYSTOCELE,1
ES,CYSTOID MACULAR OEDEMA,1
ES,CYTOMEGALOVIRUS COLITIS,1
ES,CYTOMEGALOVIRUS GASTROENTERITIS,1
ES,CYTOMEGALOVIRUS OESOPHAGITIS,1
ES,CYTOMEGALOVIRUS SYNDROME,1
ES,CYTOMEGALOVIRUS VIRAEMIA,1
ES,DECREASED ACTIVITY,1
ES,DEPRESSED MOOD,1
ES,DERMATITIS,1
ES,DERMATITIS ATOPIC,1
ES,DERMATITIS CONTACT,1
ES,DERMATITIS EXFOLIATIVE,1
ES,DEVICE DISLOCATION,1
ES,DIABETES MELLITUS INADEQUATE CONTROL,1
ES,DIABETIC FOOT,1
ES,DIABETIC HYPERGLYCAEMIC COMA,1
ES,DIABETIC NEUROPATHIC ULCER,1
ES,DIFFUSE ALOPECIA,1
ES,DILATATION ATRIAL,1
ES,DILATATION VENTRICULAR,1
ES,DISSEMINATED CYTOMEGALOVIRAL INFECTION,1
ES,DISSEMINATED INTRAVASCULAR COAGULATION,1
ES,DIVERTICULAR PERFORATION,1
ES,DIVERTICULITIS MECKEL^S,1
ES,DIVERTICULUM,1
ES,DIZZINESS POSTURAL,1
ES,DROWNING,1
ES,DRUG DOSE TITRATION NOT PERFORMED,1
ES,DRUG EFFECT DECREASED,1
ES,DRUG LEVEL BELOW THERAPEUTIC,1
ES,DRUG LEVEL FLUCTUATING,1
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
ES,DRUG SPECIFIC ANTIBODY,1
ES,DRUG-DISEASE INTERACTION,1
ES,DRUG-INDUCED LIVER INJURY,1
ES,DRY SKIN,1
ES,DUCTUS ARTERIOSUS PREMATURE CLOSURE,1
ES,DUODENAL ULCER,1
ES,DYSAESTHESIA,1
ES,DYSGEUSIA,1
ES,DYSPEPSIA,1
ES,DYSPHONIA,1
ES,DYSPNOEA PAROXYSMAL NOCTURNAL,1
ES,DYSTONIA,1
ES,DYSURIA,1
ES,EAR INFECTION,1
ES,EAR PAIN,1
ES,EAR SWELLING,1
ES,ECZEMA,1
ES,EMBOLISM VENOUS,1
ES,EMOTIONAL DISTRESS,1
ES,EMPHYSEMA,1
ES,ENCEPHALITIS BRAIN STEM,1
ES,ENDOPHTHALMITIS,1
ES,ENGRAFT FAILURE,1
ES,ENTEROCOCCAL BACTERAEMIA,1
ES,ENTEROCOLITIS,1
ES,ENTEROVIRUS INFECTION,1
ES,EPIDERMODYSPLASIA VERRUCIFORMIS,1
ES,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,1
ES,EPSTEIN-BARR VIRUS TEST POSITIVE,1
ES,EROSIVE DUODENITIS,1
ES,ERYTHEMA INFECTIOSUM,1
ES,ERYTHEMA NODOSUM,1
ES,EXPOSURE VIA BODY FLUID,1
ES,EYE DISORDER,1
ES,EYE INFECTION,1
ES,EYE MOVEMENT DISORDER,1
ES,EYELID PTOSIS,1
ES,FASCIITIS,1
ES,FEAR,1
ES,FEEDING DISORDER,1
ES,FEMALE GENITAL TRACT FISTULA,1
ES,FIBRINOLYSIS,1
ES,FISTULA,1
ES,FISTULA DISCHARGE,1
ES,FIXED ERUPTION,1
ES,FOETAL DEATH,1
ES,FOLLICULITIS,1
ES,FOOD INTOLERANCE,1
ES,FOOT FRACTURE,1
ES,FRACTURE,1
ES,FUNGAL INFECTION,1
ES,FUNGAL SEPSIS,1
ES,FUSARIUM INFECTION,1
ES,GALLBLADDER PERFORATION,1
ES,GASTRIC DISORDER,1
ES,GASTRIC POLYPS,1
ES,GASTRIC ULCER,1
ES,GASTRIC ULCER HAEMORRHAGE,1
ES,GASTRITIS HAEMORRHAGIC,1
ES,GASTROINTESTINAL HYPOMOTILITY,1
ES,GASTROINTESTINAL INFLAMMATION,1
ES,GASTROINTESTINAL NECROSIS,1
ES,GASTROINTESTINAL ULCER HAEMORRHAGE,1
ES,GASTROOESOPHAGEAL REFLUX DISEASE,1
ES,GAZE PALSY,1
ES,GENERALISED ERYTHEMA,1
ES,GENITAL TRACT INFLAMMATION,1
ES,GIARDIASIS,1
ES,GINGIVITIS,1
ES,GLIOBLASTOMA MULTIFORME,1
ES,GLOSSITIS,1
ES,GLOSSOPHARYNGEAL NERVE PARALYSIS,1
ES,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
ES,GOUTY ARTHRITIS,1
ES,GRAFT DYSFUNCTION,1
ES,GRAFT INFECTION,1
ES,GRAFT LOSS,1
ES,GRANULOMATOSIS WITH POLYANGIITIS,1
ES,GYNAECOMASTIA,1
ES,H1N1 INFLUENZA,1
ES,HAEMARTHROSIS,1
ES,HAEMATOCRIT DECREASED,1
ES,HAEMATOPOIETIC STEM CELL MOBILISATION,1
ES,HAEMOPHILUS INFECTION,1
ES,HAEMORRHAGE INTRACRANIAL,1
ES,HAEMORRHOIDS,1
ES,HALLUCINATION,1
ES,HALLUCINATION_ AUDITORY,1
ES,HAND DEFORMITY,1
ES,HEART RATE INCREASED,1
ES,HELICOBACTER INFECTION,1
ES,HEMIPLEGIA,1
ES,HEPATITIS C VIRUS TEST POSITIVE,1
SE,ANAEMIA,8
SE,HEADACHE,7
SE,ABNORMAL FAECES,6
SE,ALOPECIA,6
SE,APHASIA,6
SE,CHROMATURIA,6
SE,DRY MOUTH,6
SE,DYSPNOEA,6
SE,EAR INFECTION,6
SE,FLUSHING,6
SE,GASTROINTESTINAL MOTILITY DISORDER,6
SE,HEART RATE INCREASED,6
SE,LIP SWELLING,6
SE,MUSCULOSKELETAL DISCOMFORT,6
SE,ORAL DISCOMFORT,6
SE,RED BLOOD CELL COUNT DECREASED,6
SE,SOMATIC DELUSION,6
SE,SWOLLEN TONGUE,6
SE,URINE ODOUR ABNORMAL,6
SE,WEIGHT DECREASED,6
SE,WHITE BLOOD CELL COUNT DECREASED,6
SE,BLOOD CREATININE INCREASED,5
SE,C-REACTIVE PROTEIN INCREASED,5
SE,HYPOTENSION,5
SE,SEPSIS,5
SE,THROMBOCYTOPENIA,5
SE,BACK PAIN,4
SE,NEUTROPENIA,4
SE,PERIPHERAL SWELLING,4
SE,PYREXIA,4
SE,TUMOUR FLARE,4
SE,APLASTIC ANAEMIA,3
SE,DEATH,3
SE,DEEP VEIN THROMBOSIS,3
SE,MUSCLE SPASMS,3
SE,PAIN IN EXTREMITY,3
SE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,3
SE,ABDOMINAL PAIN,2
SE,ABDOMINAL PAIN UPPER,2
SE,ADVERSE DRUG REACTION,2
SE,AGRANULOCYTOSIS,2
SE,BK VIRUS INFECTION,2
SE,COLITIS ULCERATIVE,2
SE,DRUG INEFFECTIVE,2
SE,DYSARTHRIA,2
SE,DYSPHAGIA,2
SE,FATIGUE,2
SE,FEBRILE NEUTROPENIA,2
SE,GAIT DISTURBANCE,2
SE,GENERAL PHYSICAL HEALTH DETERIORATION,2
SE,HEPATIC FAILURE,2
SE,HISTIOCYTOSIS HAEMATOPHAGIC,2
SE,HYPONATRAEMIA,2
SE,INTERSTITIAL LUNG DISEASE,2
SE,KIDNEY TRANSPLANT REJECTION,2
SE,LEUKOPENIA,2
SE,MEMORY IMPAIRMENT,2
SE,MULTI-ORGAN FAILURE,2
SE,NEUTROPENIC SEPSIS,2
SE,PANCYTOPENIA,2
SE,PNEUMONIA,2
SE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
SE,SENSORY DISTURBANCE,2
SE,STAPHYLOCOCCAL SEPSIS,2
SE,ABORTION SPONTANEOUS,1
SE,ACUTE MYELOID LEUKAEMIA,1
SE,ACUTE MYOCARDIAL INFARCTION,1
SE,ANGER,1
SE,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED,1
SE,AORTIC ANEURYSM,1
SE,ARTHRALGIA,1
SE,ARTHRITIS,1
SE,ASTHENIA,1
SE,ATAXIA,1
SE,ATRIAL FIBRILLATION,1
SE,ATRIAL FLUTTER,1
SE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
SE,BACTERIAL INFECTION,1
SE,BALANCE DISORDER,1
SE,BLADDER CANCER,1
SE,BLOOD DISORDER,1
SE,BLOOD LACTATE DEHYDROGENASE INCREASED,1
SE,BLOOD POTASSIUM INCREASED,1
SE,CEREBRAL ISCHAEMIA,1
SE,CHOLESTASIS,1
SE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
SE,CIRCULATORY COLLAPSE,1
SE,COAGULOPATHY,1
SE,COLOSTOMY,1
SE,CONFUSIONAL STATE,1
SE,CONJUNCTIVITIS,1
SE,CUSHINGOID,1
SE,CYTOMEGALOVIRUS INFECTION,1
SE,CYTOPENIA,1
SE,DERMATITIS EXFOLIATIVE,1
SE,DIPLOPIA,1
SE,DISEASE PROGRESSION,1
SE,DISTURBANCE IN ATTENTION,1
SE,DIZZINESS,1
SE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
SE,DRY SKIN,1
SE,DYSKINESIA,1
SE,DYSSTASIA,1
SE,DYSURIA,1
SE,ERYTHEMA,1
SE,EXTENSOR PLANTAR RESPONSE,1
SE,GAIT INABILITY,1
SE,GASTROINTESTINAL CANCER METASTATIC,1
SE,GENERAL PHYSICAL CONDITION ABNORMAL,1
SE,HAEMOGLOBIN ABNORMAL,1
SE,HAEMOGLOBIN DECREASED,1
SE,HEART RATE IRREGULAR,1
SE,HEMIPARESIS,1
SE,HEPATIC ENZYME INCREASED,1
SE,HEPATITIS B,1
SE,HEPATITIS FULMINANT,1
SE,HEPATITIS VIRAL,1
SE,HEPATOTOXICITY,1
SE,HYPERGLYCAEMIA,1
SE,HYPERKALAEMIA,1
SE,HYPERTRIGLYCERIDAEMIA,1
SE,ILEUS,1
SE,INFECTIVE ANEURYSM,1
SE,INFLUENZA,1
SE,IRON DEFICIENCY,1
SE,IRRITABILITY,1
SE,JC VIRUS INFECTION,1
SE,JOINT STIFFNESS,1
SE,JOINT SWELLING,1
SE,KLEBSIELLA INFECTION,1
SE,LACRIMATION DISORDER,1
SE,LACTIC ACIDOSIS,1
SE,LISTERIA SEPSIS,1
SE,MELAENA,1
SE,MENINGITIS,1
SE,METABOLIC ACIDOSIS,1
SE,MOTOR DYSFUNCTION,1
SE,MUSCULAR WEAKNESS,1
SE,MUSCULOSKELETAL STIFFNESS,1
SE,MYELODYSPLASTIC SYNDROME,1
SE,MYOCARDIAL ISCHAEMIA,1
SE,MYOSITIS,1
SE,NAUSEA,1
SE,NECK PAIN,1
SE,NEOPLASM MALIGNANT,1
SE,NEUROLOGICAL DECOMPENSATION,1
SE,NEUROLOGICAL SYMPTOM,1
SE,NO THERAPEUTIC RESPONSE,1
SE,NYSTAGMUS,1
SE,OESOPHAGITIS,1
SE,OROPHARYNGEAL PAIN,1
SE,OSTEONECROSIS OF JAW,1
SE,OVERDOSE,1
SE,PARAESTHESIA,1
SE,PLASMA CELL MYELOMA,1
SE,PNEUMOCOCCAL INFECTION,1
SE,PNEUMONIA LEGIONELLA,1
SE,PNEUMONITIS,1
SE,POLYARTHRITIS,1
SE,PRODUCT USE IN UNAPPROVED INDICATION,1
SE,PRODUCT USE ISSUE,1
SE,PRURITUS,1
SE,QUADRIPARESIS,1
SE,RASH,1
SE,RASH PRURITIC,1
SE,RECTAL STENOSIS,1
SE,RENAL FAILURE,1
SE,RESPIRATORY FAILURE,1
SE,RESPIRATORY TRACT INFECTION,1
SE,RHEUMATOID ARTHRITIS,1
SE,SALIVARY GLAND ENLARGEMENT,1
SE,SEPTIC EMBOLUS,1
SE,SERUM FERRITIN INCREASED,1
SE,SMALL INTESTINAL PERFORATION,1
SE,SPEECH DISORDER,1
SE,SPONDYLITIS,1
SE,SUBCUTANEOUS ABSCESS,1
SE,SYNCOPE,1
SE,THROMBOSIS,1
SE,TOXICITY TO VARIOUS AGENTS,1
SE,UPPER RESPIRATORY TRACT INFECTION,1
SE,URINARY INCONTINENCE,1
SE,URINARY RETENTION,1
SE,VANISHING BILE DUCT SYNDROME,1
SE,VENTRICULAR ARRHYTHMIA,1
SE,VERTIGO,1
SE,VIRAL SEPSIS,1
SE,VOMITING,1
SE,WHITE MATTER LESION,1
CH,PYREXIA,34
CH,THROMBOCYTOPENIA,34
CH,DIARRHOEA,25
CH,EXPOSURE DURING PREGNANCY,23
CH,DYSPNOEA,22
CH,PNEUMONIA,22
CH,AGRANULOCYTOSIS,20
CH,DRUG INEFFECTIVE,20
CH,PNEUMOCYSTIS JIROVECII PNEUMONIA,20
CH,ACUTE KIDNEY INJURY,19
CH,LYMPHOPENIA,18
CH,ANAEMIA,17
CH,NEUTROPENIA,17
CH,RENAL FAILURE,17
CH,ACUTE RESPIRATORY DISTRESS SYNDROME,16
CH,HYPERKALAEMIA,16
CH,VOMITING,16
CH,CARDIAC ARREST,15
CH,CARDIAC FAILURE,15
CH,FEBRILE NEUTROPENIA,15
CH,HYPERTENSION,15
CH,LIVER INJURY,15
CH,CONFUSIONAL STATE,13
CH,GENERAL PHYSICAL HEALTH DETERIORATION,13
CH,DISEASE PROGRESSION,12
CH,HAEMATURIA,12
CH,LEUKOPENIA,12
CH,NAUSEA,12
CH,PULMONARY EMBOLISM,12
CH,RENAL FAILURE ACUTE,12
CH,RESPIRATORY FAILURE,12
CH,SEPSIS,12
CH,ASTHENIA,11
CH,POLYNEUROPATHY,11
CH,HEADACHE,10
CH,PAIN IN EXTREMITY,10
CH,PLEURAL EFFUSION,10
CH,PREMATURE BABY,10
CH,TACHYCARDIA,10
CH,TORSADE DE POINTES,10
CH,VENTRICULAR FIBRILLATION,10
CH,ARTHRALGIA,9
CH,CONDITION AGGRAVATED,9
CH,HEPATOCELLULAR INJURY,9
CH,HYPOKALAEMIA,9
CH,HYPOTENSION,9
CH,OEDEMA PERIPHERAL,9
CH,PANCYTOPENIA,9
CH,PNEUMONIA CYTOMEGALOVIRAL,9
CH,WEIGHT INCREASED,9
CH,ALTERED STATE OF CONSCIOUSNESS,8
CH,BRONCHOPULMONARY ASPERGILLOSIS,8
CH,CHRONIC KIDNEY DISEASE,8
CH,DIZZINESS,8
CH,EPILEPSY,8
CH,FATIGUE,8
CH,GAIT DISTURBANCE,8
CH,HYPONATRAEMIA,8
CH,RASH MACULO-PAPULAR,8
CH,TREMOR,8
CH,BRADYCARDIA,7
CH,DEATH,7
CH,DRUG ADMINISTRATION ERROR,7
CH,DYSPHONIA,7
CH,ENCEPHALOPATHY,7
CH,GASTROINTESTINAL HAEMORRHAGE,7
CH,MATERNAL EXPOSURE DURING PREGNANCY,7
CH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,7
CH,MYELODYSPLASTIC SYNDROME,7
CH,RHABDOMYOLYSIS,7
CH,SYNCOPE,7
CH,ACCIDENTAL OVERDOSE,6
CH,ATRIAL FIBRILLATION,6
CH,BLOOD CREATININE INCREASED,6
CH,COLITIS,6
CH,DEHYDRATION,6
CH,DIABETES MELLITUS,6
CH,FOETAL EXPOSURE DURING PREGNANCY,6
CH,FOETAL GROWTH RESTRICTION,6
CH,HAEMOLYTIC ANAEMIA,6
CH,HYPOAESTHESIA,6
CH,INFECTION,6
CH,INTERSTITIAL LUNG DISEASE,6
CH,METABOLIC ACIDOSIS,6
CH,PAIN,6
CH,PRESCRIBED OVERDOSE,6
CH,RASH,6
CH,RASH ERYTHEMATOUS,6
CH,RHINITIS,6
CH,SEPTIC SHOCK,6
CH,SPEECH DISORDER,6
CH,TOXIC EPIDERMAL NECROLYSIS,6
CH,TOXICITY TO VARIOUS AGENTS,6
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,6
CH,VENTRICULAR TACHYCARDIA,6
CH,VISCERAL LEISHMANIASIS,6
CH,VULVAL CANCER STAGE 0,6
CH,WITHDRAWAL SYNDROME,6
CH,ABORTION SPONTANEOUS,5
CH,CLOSTRIDIUM DIFFICILE COLITIS,5
CH,DEPRESSED LEVEL OF CONSCIOUSNESS,5
CH,DRUG-INDUCED LIVER INJURY,5
CH,ELECTROCARDIOGRAM QT PROLONGED,5
CH,ERYTHEMA,5
CH,HAEMORRHAGE,5
CH,HEMIPARESIS,5
CH,HISTIOCYTOSIS HAEMATOPHAGIC,5
CH,HYPERAMMONAEMIA,5
CH,HYPERHIDROSIS,5
CH,HYPOCALCAEMIA,5
CH,INCORRECT DOSE ADMINISTERED,5
CH,INTENTIONAL OVERDOSE,5
CH,KAPOSI^S SARCOMA,5
CH,LOSS OF CONSCIOUSNESS,5
CH,MALIGNANT NEOPLASM PROGRESSION,5
CH,MOUTH ULCERATION,5
CH,MYALGIA,5
CH,RENAL IMPAIRMENT,5
CH,RESPIRATORY DISTRESS,5
CH,STAPHYLOCOCCAL SEPSIS,5
CH,SUICIDE ATTEMPT,5
CH,TACHYPNOEA,5
CH,UNDERDOSE,5
CH,URINARY TRACT INFECTION,5
CH,VISUAL IMPAIRMENT,5
CH,ABORTION INDUCED,4
CH,ACUTE MYELOID LEUKAEMIA,4
CH,AGITATION,4
CH,BACTERAEMIA,4
CH,BACTERIAL INFECTION,4
CH,BRONCHOPNEUMONIA,4
CH,CASTLEMAN^S DISEASE,4
CH,CEREBROVASCULAR ACCIDENT,4
CH,CHILLS,4
CH,CHOLESTASIS,4
CH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
CH,COUGH,4
CH,CYTOMEGALOVIRUS INFECTION,4
CH,DECREASED APPETITE,4
CH,DEPRESSION,4
CH,DIFFUSE LARGE B-CELL LYMPHOMA,4
CH,DRUG INTOLERANCE,4
CH,DRUG WITHDRAWAL SYNDROME,4
CH,EYELID OEDEMA,4
CH,FALL,4
CH,GASTRITIS,4
CH,HAEMATOMA,4
CH,HAEMOGLOBIN DECREASED,4
CH,HAEMOLYTIC URAEMIC SYNDROME,4
CH,HEPATIC ENZYME INCREASED,4
CH,HYPERSENSITIVITY VASCULITIS,4
CH,HYPOALDOSTERONISM,4
CH,INFUSION RELATED REACTION,4
CH,INTERNATIONAL NORMALISED RATIO INCREASED,4
CH,LONG QT SYNDROME,4
CH,MELAENA,4
CH,METASTASES TO LUNG,4
CH,MUSCLE CONTRACTIONS INVOLUNTARY,4
CH,MUSCULAR WEAKNESS,4
CH,MYDRIASIS,4
CH,MYOPATHY,4
CH,PANCREATITIS,4
CH,PAPILLOEDEMA,4
CH,PSEUDOMONAS INFECTION,4
CH,RASH GENERALISED,4
CH,SEROTONIN SYNDROME,4
CH,SOMNOLENCE,4
CH,TRANSPLANT REJECTION,4
CH,ABDOMINAL PAIN,3
CH,ABDOMINAL PAIN UPPER,3
CH,ACUTE RESPIRATORY FAILURE,3
CH,AGGRESSION,3
CH,ANGINA PECTORIS,3
CH,ASTHMA,3
CH,B-LYMPHOCYTE ABNORMALITIES,3
CH,B-LYMPHOCYTE COUNT DECREASED,3
CH,BACK PAIN,3
CH,BLISTER,3
CH,BRONCHITIS,3
CH,CALCIPHYLAXIS,3
CH,CHOLESTATIC LIVER INJURY,3
CH,CHOREA,3
CH,CHRONIC GRAFT VERSUS HOST DISEASE,3
CH,COAGULOPATHY,3
CH,CONJUNCTIVITIS,3
CH,CONSTIPATION,3
CH,DELIRIUM,3
CH,DISORIENTATION,3
CH,DISSEMINATED INTRAVASCULAR COAGULATION,3
CH,DRUG LEVEL INCREASED,3
CH,DRUG RESISTANCE,3
CH,DYSPHAGIA,3
CH,ELECTROLYTE IMBALANCE,3
CH,ENCEPHALITIS,3
CH,EPISTAXIS,3
CH,FACE OEDEMA,3
CH,FEMUR FRACTURE,3
CH,FOETAL DEATH,3
CH,GASTROENTERITIS ESCHERICHIA COLI,3
CH,GASTROINTESTINAL DISORDER,3
CH,GASTROOESOPHAGEAL REFLUX DISEASE,3
CH,GENERALISED OEDEMA,3
CH,GLYCOSURIA,3
CH,HAEMOLYSIS,3
CH,HAEMOPTYSIS,3
CH,HAEMORRHAGIC ANAEMIA,3
CH,HEMIPLEGIA,3
CH,HERPES ZOSTER,3
CH,HYDROCELE,3
CH,HYPERGLYCAEMIA,3
CH,HYPERREFLEXIA,3
CH,HYPOALBUMINAEMIA,3
CH,HYPOXIA,3
CH,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,3
CH,IMPAIRED HEALING,3
CH,INFLUENZA LIKE ILLNESS,3
CH,INTESTINAL TRANSIT TIME DECREASED,3
CH,LEFT VENTRICULAR DYSFUNCTION,3
CH,LUNG DISORDER,3
CH,METAPNEUMOVIRUS INFECTION,3
CH,MIXED LIVER INJURY,3
CH,NEOPLASM PROGRESSION,3
CH,NERVOUSNESS,3
CH,OBLITERATIVE BRONCHIOLITIS,3
CH,ODYNOPHAGIA,3
CH,OEDEMA,3
CH,OSTEONECROSIS OF JAW,3
CH,PEMPHIGOID,3
CH,PLASMA CELL MYELOMA,3
CH,PRODUCT USE ISSUE,3
CH,PROSTATE CANCER,3
CH,PULMONARY OEDEMA,3
CH,RASH MACULAR,3
CH,RHODOCOCCUS INFECTION,3
CH,SEIZURE,3
CH,SKIN DISCOLOURATION,3
CH,SKIN LESION,3
CH,SQUAMOUS CELL CARCINOMA,3
CH,SQUAMOUS CELL CARCINOMA OF THE VAGINA,3
CH,STAPHYLOCOCCAL INFECTION,3
CH,STATUS EPILEPTICUS,3
CH,STEVENS-JOHNSON SYNDROME,3
CH,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,3
CH,UROSEPSIS,3
CH,WEIGHT DECREASED,3
CH,ABORTION SPONTANEOUS COMPLICATED,2
CH,ALVEOLITIS ALLERGIC,2
CH,AMERICAN TRYPANOSOMIASIS,2
CH,ANGIOPATHY,2
CH,ANORECTAL CELLULITIS,2
CH,ANURIA,2
CH,AORTIC STENOSIS,2
CH,APHTHOUS STOMATITIS,2
CH,APLASTIC ANAEMIA,2
CH,ARTHRITIS BACTERIAL,2
CH,BACTERIAL DISEASE CARRIER,2
CH,BALANCE DISORDER,2
CH,BARRETT^S OESOPHAGUS,2
CH,BASAL CELL CARCINOMA,2
CH,BLOOD LACTATE DEHYDROGENASE INCREASED,2
CH,BLOOD PRESSURE DECREASED,2
CH,BLOOD PRESSURE INCREASED,2
CH,BLOOD UREA INCREASED,2
CH,BONE MARROW FAILURE,2
CH,BURNING FEET SYNDROME,2
CH,CAESAREAN SECTION,2
CH,CAMPYLOBACTER GASTROENTERITIS,2
CH,CARDIO-RESPIRATORY ARREST,2
CH,CARDIOMEGALY,2
CH,CARDIOTOXICITY,2
CH,CATHETER PLACEMENT,2
CH,CELLULITIS,2
CH,CEREBRAL HAEMORRHAGE,2
CH,CEREBRAL ISCHAEMIA,2
CH,CHEST PAIN,2
CH,CHOLECYSTITIS,2
CH,CIRCULATORY COLLAPSE,2
CH,CLONUS,2
CH,COGNITIVE DISORDER,2
CH,COLITIS ULCERATIVE,2
CH,COMA,2
CH,CONGENITAL NOSE MALFORMATION,2
CH,CONGESTIVE CARDIOMYOPATHY,2
CH,CROHN^S DISEASE,2
CH,CUSHINGOID,2
CH,CUSHING^S SYNDROME,2
CH,DEVICE RELATED INFECTION,2
CH,DIVERTICULITIS,2
CH,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
CH,DRUG LEVEL DECREASED,2
CH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CH,DUODENAL ULCER,2
CH,DUODENAL ULCER HAEMORRHAGE,2
CH,DYSKINESIA,2
CH,EMPHYSEMA,2
CH,ENANTHEMA,2
CH,ERYSIPELAS,2
CH,ESCHERICHIA SEPSIS,2
CH,ESCHERICHIA TEST POSITIVE,2
CH,ESCHERICHIA URINARY TRACT INFECTION,2
CH,EWING^S SARCOMA,2
CH,EXFOLIATIVE RASH,2
CH,EXOMPHALOS,2
CH,EYE DISORDER,2
CH,FEMORAL NECK FRACTURE,2
CH,FLUID OVERLOAD,2
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
CH,GASTRIC ULCER,2
CH,GLOMERULONEPHRITIS,2
CH,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,2
CH,GRANULOMATOSIS WITH POLYANGIITIS,2
CH,GRANULOMATOUS LIVER DISEASE,2
CH,GROWTH RETARDATION,2
CH,HAEMATOCHEZIA,2
CH,HAEMODIALYSIS,2
CH,HAEMOGLOBIN URINE PRESENT,2
CH,HAEMORRHAGIC STROKE,2
CH,HEPATITIS,2
CH,HEPATITIS CHOLESTATIC,2
CH,HEPATOTOXICITY,2
CH,HUMAN HERPESVIRUS 8 INFECTION,2
CH,HYPERBILIRUBINAEMIA,2
CH,HYPERCALCAEMIA,2
CH,HYPERTELORISM OF ORBIT,2
CH,HYPERTHERMIA,2
CH,HYPERTHYROIDISM,2
CH,HYPERTONIA,2
CH,HYPOGLYCAEMIA NEONATAL,2
CH,HYPOVOLAEMIC SHOCK,2
CH,IMMUNE SYSTEM DISORDER,2
CH,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
CH,INFLAMMATION,2
CH,INTRACRANIAL PRESSURE INCREASED,2
CH,JAUNDICE CHOLESTATIC,2
CH,LACTIC ACIDOSIS,2
CH,LOGORRHOEA,2
CH,LYMPHADENOPATHY,2
CH,MALAISE,2
CH,MALNUTRITION,2
CH,MEDICATION MONITORING ERROR,2
CH,METASTASES TO LYMPH NODES,2
CH,MUCOSAL INFLAMMATION,2
CH,MUSCLE RIGIDITY,2
CH,MUSCLE SPASMS,2
CH,MYOCARDIAL INFARCTION,2
CH,MYOPATHY TOXIC,2
CH,NEUROLEPTIC MALIGNANT SYNDROME,2
CH,NEUROTOXICITY,2
CH,NEUTROPENIC COLITIS,2
CH,NEUTROPHIL COUNT DECREASED,2
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
CH,ORCHITIS,2
CH,ORGANISING PNEUMONIA,2
CH,OROPHARYNGEAL PAIN,2
CH,OSTEOPOROSIS,2
CH,OVERDOSE,2
CH,OXYGEN SATURATION DECREASED,2
CH,PANCREATITIS ACUTE,2
CH,PAPILLOMA VIRAL INFECTION,2
CH,PARAESTHESIA,2
CH,PARESIS,2
CH,PERIORBITAL OEDEMA,2
CH,PNEUMOMEDIASTINUM,2
CH,PNEUMONIA STAPHYLOCOCCAL,2
CH,POLYARTHRITIS,2
CH,POTENTIATING DRUG INTERACTION,2
CH,PRE-ECLAMPSIA,2
CH,PREGNANCY,2
CH,PROCTITIS,2
CH,PROSTATITIS,2
CH,PRURITUS,2
CH,PSYCHOMOTOR HYPERACTIVITY,2
CH,PULMONARY HAEMORRHAGE,2
CH,PULMONARY HYPERTENSION,2
CH,PULMONARY TUBERCULOSIS,2
CH,PYELOCALIECTASIS,2
CH,PYELONEPHRITIS,2
CH,RASH PRURITIC,2
CH,RASH PUSTULAR,2
CH,RECTAL HAEMORRHAGE,2
CH,RENAL FAILURE CHRONIC,2
CH,RHEUMATOID ARTHRITIS,2
CH,SALMONELLOSIS,2
CH,SCRATCH,2
CH,SECONDARY IMMUNODEFICIENCY,2
CH,SHOCK HAEMORRHAGIC,2
CH,SINUS BRADYCARDIA,2
CH,SKIN ATROPHY,2
CH,SKIN PLAQUE,2
CH,SKIN TEST POSITIVE,2
CH,SKIN TOXICITY,2
CH,SLEEP DISORDER,2
CH,SQUAMOUS CELL CARCINOMA OF THE CERVIX,2
CH,SUBARACHNOID HAEMORRHAGE,2
CH,SUPRAVENTRICULAR TACHYARRHYTHMIA,2
CH,SWELLING FACE,2
CH,SYSTEMIC LUPUS ERYTHEMATOSUS,2
CH,SYSTOLIC HYPERTENSION,2
CH,TENDON RUPTURE,2
CH,TENSION HEADACHE,2
CH,TOOTH ABSCESS,2
CH,TRANSITIONAL CELL CARCINOMA,2
CH,TRICHOPHYTIC GRANULOMA,2
CH,TUBERCULOSIS,2
CH,UNINTENDED PREGNANCY,2
CH,URINARY INCONTINENCE,2
CH,URTICARIA,2
CH,VASCULITIC RASH,2
CH,VASCULITIS,2
CH,VERTIGO,2
CH,VITAMIN B12 DEFICIENCY,2
CH,WHEEZING,2
CH,YAWNING,2
CH,ZYGOMYCOSIS,2
CH,ABASIA,1
CH,ABDOMINAL DISTENSION,1
CH,ABDOMINAL TENDERNESS,1
CH,ABDOMINAL WOUND DEHISCENCE,1
CH,ABSCESS,1
CH,ACCOMMODATION DISORDER,1
CH,ACNE,1
CH,ACQUIRED HAEMOPHILIA WITH ANTI FVIII_ XI_ OR XIII,1
CH,ACTINIC KERATOSIS,1
CH,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
CH,ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
CH,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
CH,ACUTE GRAFT VERSUS HOST DISEASE,1
CH,ACUTE HEPATIC FAILURE,1
CH,ACUTE INTERSTITIAL PNEUMONITIS,1
CH,ACUTE LYMPHOCYTIC LEUKAEMIA,1
CH,ACUTE MYOCARDIAL INFARCTION,1
CH,ACUTE PRERENAL FAILURE,1
CH,ADENOCARCINOMA GASTRIC,1
CH,ADENOVIRUS INFECTION,1
CH,ADRENAL INSUFFICIENCY,1
CH,ADVERSE DRUG REACTION,1
CH,ADVERSE EVENT,1
CH,AFFECT LABILITY,1
CH,ALANINE AMINOTRANSFERASE INCREASED,1
CH,ALBUMINURIA,1
CH,ALCOHOLIC PANCREATITIS,1
CH,ALLERGIC GRANULOMATOUS ANGIITIS,1
CH,ALOPECIA,1
CH,AMYLASE INCREASED,1
CH,AMYLOIDOSIS,1
CH,ANAEMIA NEONATAL,1
CH,ANAPHYLACTOID REACTION,1
CH,ANGIOEDEMA,1
CH,ANGIOSARCOMA METASTATIC,1
CH,ANTIBODY TEST POSITIVE,1
CH,ANXIETY,1
CH,APHASIA,1
CH,APLASIA PURE RED CELL,1
CH,APOPTOSIS,1
CH,APOPTOTIC COLONOPATHY,1
CH,APPLICATION SITE HAEMORRHAGE,1
CH,ARRHYTHMIA,1
CH,ARTERIAL OCCLUSIVE DISEASE,1
CH,ARTHRITIS,1
CH,ARTHRITIS INFECTIVE,1
CH,ASCITES,1
CH,ASPARTATE AMINOTRANSFERASE INCREASED,1
CH,ASPERGILLUS INFECTION,1
CH,ASPIRATION,1
CH,ASPIRATION BRONCHIAL,1
CH,ASPIRATION PLEURAL CAVITY,1
CH,ATAXIA,1
CH,ATELECTASIS,1
CH,ATRIOVENTRICULAR BLOCK COMPLETE,1
CH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
CH,ATYPICAL PNEUMONIA,1
CH,B-CELL LYMPHOMA,1
CH,B-CELL LYMPHOMA RECURRENT,1
CH,BACTERIAL TEST POSITIVE,1
CH,BILE DUCT STONE,1
CH,BILIARY DILATATION,1
CH,BIOPSY LIVER ABNORMAL,1
CH,BLADDER TRANSITIONAL CELL CARCINOMA,1
CH,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CH,BLOOD ELECTROLYTES ABNORMAL,1
CH,BLOOD ETHANOL INCREASED,1
CH,BLOOD GROWTH HORMONE INCREASED,1
CH,BLOOD POTASSIUM INCREASED,1
CH,BLOOD PROLACTIN INCREASED,1
CH,BONE DENSITY DECREASED,1
CH,BONE MARROW TOXICITY,1
CH,BOWEN^S DISEASE,1
CH,BRAIN ABSCESS,1
CH,BRONCHIAL HAEMORRHAGE,1
CH,BRONCHIAL OEDEMA,1
CH,BRONCHIECTASIS,1
CH,BRONCHITIS BACTERIAL,1
CH,BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC,1
CH,BRONCHOSPASM,1
CH,BRONCHOSTENOSIS,1
CH,BUNDLE BRANCH BLOCK LEFT,1
CH,BURSITIS,1
CH,C-REACTIVE PROTEIN INCREASED,1
CH,CANDIDA INFECTION,1
CH,CAPILLARY DISORDER,1
CH,CARDIAC DISORDER,1
CH,CARDIAC FAILURE ACUTE,1
CH,CARDIAC MURMUR,1
CH,CARDIAC TAMPONADE,1
CH,CARDIOGENIC SHOCK,1
CH,CARDIOMYOPATHY,1
CH,CARDIOPULMONARY FAILURE,1
CH,CARDIOVASCULAR DISORDER,1
CH,CATARACT,1
CH,CELLULITIS PHARYNGEAL,1
CH,CENTRAL OBESITY,1
CH,CEREBELLAR SYNDROME,1
CH,CEREBRAL HAEMATOMA,1
CH,CERVICAL CONISATION,1
CH,CERVICITIS HUMAN PAPILLOMA VIRUS,1
CH,CERVIX CARCINOMA,1
CH,CHAPPED LIPS,1
CH,CHEST DISCOMFORT,1
CH,CHOLANGIOCARCINOMA,1
CH,CHOLANGITIS,1
CH,CHOLECYSTITIS ACUTE,1
CH,CLAVICLE FRACTURE,1
CH,CLOSTRIDIAL INFECTION,1
CH,CNS VENTRICULITIS,1
CH,COGWHEEL RIGIDITY,1
CH,COLITIS ISCHAEMIC,1
CH,COMPLICATIONS OF TRANSPLANTED LUNG,1
CH,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
CH,CONGENITAL HAND MALFORMATION,1
CH,CONGENITAL MEGACOLON,1
CH,CONVULSION,1
CH,CORONA VIRUS INFECTION,1
CH,CORONARY ARTERY DISEASE,1
CH,CREATININE RENAL CLEARANCE DECREASED,1
CH,CREUTZFELDT-JAKOB DISEASE,1
CH,CROSS INFECTION,1
CH,CRYPTOCOCCAL CUTANEOUS INFECTION,1
CH,CUTANEOUS SPOROTRICHOSIS,1
CH,CUTANEOUS TUBERCULOSIS,1
CH,CYTOMEGALOVIRUS CHORIORETINITIS,1
CH,CYTOMEGALOVIRUS GASTROENTERITIS,1
CH,CYTOMEGALOVIRUS VIRAEMIA,1
CH,DANDRUFF,1
CH,DELAYED PUBERTY,1
CH,DEMYELINATING POLYNEUROPATHY,1
CH,DEVICE DEPENDENCE,1
CH,DEVICE RELATED SEPSIS,1
CH,DIFFUSE ALVEOLAR DAMAGE,1
CH,DILATATION ATRIAL,1
CH,DISSEMINATED CRYPTOCOCCOSIS,1
CH,DISSEMINATED TUBERCULOSIS,1
CH,DRUG DOSE OMISSION,1
CH,DRUG DOSE TITRATION NOT PERFORMED,1
CH,DRUG EFFECT INCOMPLETE,1
CH,DRUG ERUPTION,1
CH,DRY EYE,1
CH,DRY MOUTH,1
CH,DRY SKIN,1
CH,DUODENITIS,1
CH,DYSARTHRIA,1
CH,DYSLIPIDAEMIA,1
CH,DYSMETRIA,1
CH,DYSMORPHISM,1
CH,DYSSTASIA,1
CH,EAR MALFORMATION,1
CH,ECZEMA ASTEATOTIC,1
CH,ELECTROCARDIOGRAM QT INTERVAL ABNORMAL,1
CH,EMBOLIC STROKE,1
CH,ENCEPHALITIS VIRAL,1
CH,END STAGE RENAL DISEASE,1
CH,ENDOCARDITIS STAPHYLOCOCCAL,1
CH,ENDOMETRITIS,1
CH,ENTEROBACTER SEPSIS,1
CH,ENTEROCOCCAL SEPSIS,1
CH,ENTEROCOCCUS TEST POSITIVE,1
CH,ENZYME INHIBITION,1
CH,EOSINOPHILIC PNEUMONIA,1
CH,EPIDIDYMITIS,1
CH,EPSTEIN-BARR VIRUS INFECTION,1
CH,ESCHERICHIA INFECTION,1
CH,ESSENTIAL HYPERTENSION,1
CH,EXERCISE TOLERANCE DECREASED,1
CH,EXPOSURE VIA FATHER,1
CH,EXTRADURAL ABSCESS,1
CH,EXTRAPYRAMIDAL DISORDER,1
CH,EXTREMITY NECROSIS,1
CH,EYE MOVEMENT DISORDER,1
CH,FAECAL VOMITING,1
CH,FAECES DISCOLOURED,1
CH,FANCONI SYNDROME,1
CH,FANCONI SYNDROME ACQUIRED,1
CH,FEELING ABNORMAL,1
CH,FEELING COLD,1
CH,FEELING OF BODY TEMPERATURE CHANGE,1
CH,FIBROSIS,1
CH,FINGER DEFORMITY,1
CH,FLANK PAIN,1
CH,FOLATE DEFICIENCY,1
CH,FOOD ALLERGY,1
CH,FORMICATION,1
CH,GALLBLADDER DISORDER,1
CH,GASTRIC ULCER PERFORATION,1
CH,GASTROENTERITIS,1
CH,GASTROENTERITIS SALMONELLA,1
CH,GASTROENTERITIS VIRAL,1
CH,GASTROINTESTINAL ANASTOMOTIC LEAK,1
CH,GASTROINTESTINAL ULCER,1
CH,GINGIVAL EROSION,1
CH,GLOMERULAR FILTRATION RATE DECREASED,1
CH,GLOSSITIS,1
CH,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
CH,GRAFT LOSS,1
CH,GRAFT THROMBOSIS,1
CH,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
CH,GRAFT VERSUS HOST DISEASE IN LUNG,1
CH,GRANULOMA,1
CH,GROIN PAIN,1
CH,HAEMATEMESIS,1
CH,HAEMATOMA INFECTION,1
CH,HAEMODYNAMIC INSTABILITY,1
CH,HAEMOFILTRATION,1
CH,HAEMORRHAGE INTRACRANIAL,1
CH,HALLUCINATION_ VISUAL,1
CH,HEART TRANSPLANT REJECTION,1
CH,HENOCH-SCHONLEIN PURPURA NEPHRITIS,1
CH,HEPARIN-INDUCED THROMBOCYTOPENIA,1
CH,HEPATIC ARTERY THROMBOSIS,1
CH,HEPATIC FAILURE,1
CH,HEPATIC FUNCTION ABNORMAL,1
CH,HEPATIC INFILTRATION EOSINOPHILIC,1
CH,HEPATIC LESION,1
CH,HEPATIC NEOPLASM,1
CH,HEPATITIS B,1
CH,HEPATITIS FULMINANT,1
CH,HEPATITIS VIRAL,1
CH,HEPATOSPLENIC T-CELL LYMPHOMA,1
CH,HEPATOSPLENOMEGALY,1
CH,HILAR LYMPHADENOPATHY,1
CH,HIP FRACTURE,1
CH,HIRSUTISM,1
CH,HODGKIN^S DISEASE NODULAR SCLEROSIS STAGE II,1
CH,HODGKIN^S DISEASE RECURRENT,1
CH,HODGKIN^S DISEASE STAGE II,1
CH,HOT FLUSH,1
CH,HYDROCEPHALUS,1
CH,HYPERCOAGULATION,1
CH,HYPERFERRITINAEMIA,1
CH,HYPERPHOSPHATAEMIA,1
CH,HYPERVENTILATION,1
CH,HYPOCHROMIC ANAEMIA,1
CH,HYPOGAMMAGLOBULINAEMIA,1
CH,HYPOMAGNESAEMIA,1
CH,HYPOPERFUSION,1
CH,HYPOPHOSPHATAEMIA,1
CH,HYPOPHYSITIS,1
CH,HYPOREFLEXIA,1
CH,HYPOTHYROIDISM,1
CH,HYPOTONIA,1
CH,HYPOVOLAEMIA,1
CH,ILEUS,1
CH,IMMUNE-MEDIATED ADVERSE REACTION,1
CH,IMMUNOLOGY TEST ABNORMAL,1
CH,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
CH,IMMUNOSUPPRESSION,1
CH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CH,INCORRECT DRUG DOSAGE FORM ADMINISTERED,1
CH,INFECTIOUS COLITIS,1
CH,INFLAMMATORY BOWEL DISEASE,1
CH,INFLUENZA,1
CH,INHIBITORY DRUG INTERACTION,1
CH,INJECTION SITE ERYTHEMA,1
CH,INJECTION SITE INDURATION,1
CH,INJECTION SITE INFLAMMATION,1
CH,INJECTION SITE MASS,1
CH,INJECTION SITE PAIN,1
CH,INSOMNIA,1
CH,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
CH,INTESTINAL ISCHAEMIA,1
CH,INTESTINAL OBSTRUCTION,1
CH,INTESTINAL ULCER,1
CH,INTRA-ABDOMINAL HAEMATOMA,1
CH,INTRA-ABDOMINAL HAEMORRHAGE,1
CH,ISCHAEMIC STROKE,1
CH,JOINT RANGE OF MOTION DECREASED,1
CH,JOINT SWELLING,1
CH,KERATINISING SQUAMOUS CELL CARCINOMA OF NASOPHARYNX,1
CH,KLEBSIELLA BACTERAEMIA,1
CH,KLEBSIELLA INFECTION,1
CH,LACRIMATION INCREASED,1
CH,LARGE INTESTINE PERFORATION,1
CH,LARYNGEAL ULCERATION,1
CH,LEFT VENTRICULAR FAILURE,1
CH,LETHARGY,1
CH,LEUKOCYTOSIS,1
CH,LEWIS-SUMNER SYNDROME,1
CH,LIP DRY,1
CH,LIPASE INCREASED,1
CH,LIPODYSTROPHY ACQUIRED,1
CH,LIVER DISORDER,1
CH,LIVER FUNCTION TEST ABNORMAL,1
CH,LIVER FUNCTION TEST INCREASED,1
CH,LIVER TRANSPLANT,1
CH,LOCALISED OEDEMA,1
CH,LOW SET EARS,1
CH,LUNG INFECTION,1
CH,LUNG INFILTRATION,1
CH,LUNG TRANSPLANT REJECTION,1
CH,LUPUS ENCEPHALITIS,1
CH,LYMPH NODE HAEMORRHAGE,1
CH,LYMPHADENOPATHY MEDIASTINAL,1
CH,LYMPHANGIOSIS CARCINOMATOSA,1
CH,LYMPHOCYTOSIS,1
CH,MACULAR DEGENERATION,1
CH,MANTLE CELL LYMPHOMA,1
CH,MEDIASTINAL MASS,1
CH,MENINGITIS CRYPTOCOCCAL,1
CH,MENINGITIS HERPES,1
CH,MESENTERIC ARTERY THROMBOSIS,1
CH,METABOLIC ALKALOSIS,1
CH,METASTASES TO ABDOMINAL CAVITY,1
CH,METASTASES TO BONE,1
CH,METASTASES TO LIVER,1
CH,METASTASES TO PERITONEUM,1
CH,METASTASES TO PLEURA,1
CH,METASTASIS,1
CH,METASTATIC MALIGNANT MELANOMA,1
CH,MIGRAINE WITHOUT AURA,1
CH,MIOSIS,1
CH,MITRAL VALVE INCOMPETENCE,1
CH,MONOCLONAL GAMMOPATHY,1
CH,MULTI-ORGAN FAILURE,1
CH,MUSCLE ATROPHY,1
CH,MUSCLE CONTRACTURE,1
CH,MYELITIS,1
CH,MYOCARDITIS,1
CH,NASAL SEPTUM PERFORATION,1
CH,NASOPHARYNGITIS,1
CH,NECK PAIN,1
CH,NEPHROSCLEROSIS,1
CH,NERVOUS SYSTEM DISORDER,1
CH,NEURALGIA,1
CH,NEUROLOGICAL SYMPTOM,1
CH,NEUROPATHY PERIPHERAL,1
CH,NEUTROPENIC SEPSIS,1
CH,NEUTROPHILIA,1
CH,NIGHT SWEATS,1
CH,NO ADVERSE EVENT,1
CH,NOCTURIA,1
CH,NON-CARDIAC CHEST PAIN,1
CH,NOSOCOMIAL INFECTION,1
CH,OBESITY,1
CH,OESOPHAGEAL CANDIDIASIS,1
CH,OESOPHAGEAL FISTULA,1
CH,OESOPHAGITIS,1
CH,OPHTHALMIC HERPES ZOSTER,1
CH,ORAL DISCOMFORT,1
CH,ORAL FUNGAL INFECTION,1
CH,OSTEITIS,1
CH,OSTEONECROSIS,1
CH,PALPITATIONS,1
CH,PANCREATIC FISTULA,1
CH,PANCREATIC NEOPLASM,1
CH,PANNICULITIS,1
CH,PAPULE,1
CH,PARAINFLUENZAE VIRUS INFECTION,1
CH,PARANEOPLASTIC PEMPHIGUS,1
CH,PAROTITIS,1
CH,PATHOLOGICAL FRACTURE,1
CH,PERICARDITIS,1
CH,PERINEAL ABSCESS,1
CH,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CH,PERIPHERAL COLDNESS,1
CH,PERIPHERAL NERVE PARESIS,1
CH,PERIPHERAL SENSORY NEUROPATHY,1
CH,PERIPHERAL SWELLING,1
CH,PERITONITIS BACTERIAL,1
CH,PERITONSILLAR ABSCESS,1
CH,PETECHIAE,1
CH,PHARYNGITIS BACTERIAL,1
CH,PLATELET COUNT ABNORMAL,1
CH,PLATELET COUNT DECREASED,1
CH,PNEUMOCYSTIS JIROVECII INFECTION,1
CH,PNEUMONIA BACTERIAL,1
CH,PNEUMONIA CRYPTOCOCCAL,1
CH,PNEUMONIA ESCHERICHIA,1
CH,PNEUMONIA HAEMOPHILUS,1
CH,PNEUMONIA LEGIONELLA,1
CH,PNEUMONIA NECROTISING,1
CH,PNEUMONIA STREPTOCOCCAL,1
CH,PNEUMONIA VIRAL,1
CH,PNEUMONITIS,1
CH,POLLAKIURIA,1
CH,POST PROCEDURAL BILE LEAK,1
CH,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
CH,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
CH,PREMATURE DELIVERY,1
CH,PREMATURE LABOUR,1
CH,PREMATURE RUPTURE OF MEMBRANES,1
CH,PROCEDURAL PAIN,1
CH,PRODUCT QUALITY ISSUE,1
CH,PRODUCT STORAGE ERROR,1
CH,PRODUCT USE IN UNAPPROVED INDICATION,1
CH,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
CH,PROLACTINOMA,1
CH,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
CH,PROTEINURIA,1
CH,PRURITUS GENERALISED,1
CH,PRURITUS GENITAL,1
CH,PSEUDOMONAL SEPSIS,1
CH,PSORIASIS,1
CH,PSYCHOMOTOR RETARDATION,1
CH,PSYCHOMOTOR SKILLS IMPAIRED,1
CH,PSYCHOTIC DISORDER,1
CH,PULMONARY ALVEOLAR HAEMORRHAGE,1
CH,PULMONARY FIBROSIS,1
CH,PULMONARY FUNCTION TEST DECREASED,1
CH,PULMONARY SEPSIS,1
CH,PULMONARY TOXICITY,1
CH,PULMONARY VENOUS THROMBOSIS,1
CH,PUNCTATE KERATITIS,1
CH,PUPILS UNEQUAL,1
CH,PUSTULAR PSORIASIS,1
CH,RADICULITIS,1
CH,RASH PAPULAR,1
CH,RASH SCARLATINIFORM,1
CH,REBOUND EFFECT,1
CH,RECTAL PERFORATION,1
CH,RED BLOOD CELL COUNT DECREASED,1
CH,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
CH,REFRACTORY CANCER,1
CH,RENAL INJURY,1
CH,RENAL ISCHAEMIA,1
CH,RENAL TUBULAR NECROSIS,1
CH,RESPIRATORY ARREST,1
CH,RESPIRATORY SYNCYTIAL VIRUS INFECTION,1
CH,RESPIRATORY TRACT INFECTION,1
CH,RETINAL VEIN THROMBOSIS,1
CH,RETROGRADE AMNESIA,1
CH,RETROPERITONEAL HAEMATOMA,1
CH,RETROPERITONEAL LYMPHADENOPATHY,1
CH,RETROPERITONEAL NEOPLASM METASTATIC,1
CH,RIGHT VENTRICULAR FAILURE,1
CH,ROTATOR CUFF SYNDROME,1
CH,SALIVARY HYPERSECRETION,1
CH,SALMONELLA BACTERAEMIA,1
CH,SCAR,1
CH,SCLERITIS,1
CH,SCROTAL INFECTION,1
CH,SEDATION,1
CH,SENSATION OF FOREIGN BODY,1
CH,SENSORY DISTURBANCE,1
CH,SEPSIS SYNDROME,1
CH,SERUM SICKNESS,1
CH,SIALOADENITIS,1
CH,SINUS TACHYCARDIA,1
CH,SINUSITIS,1
CH,SKIN EXFOLIATION,1
CH,SKIN INFECTION,1
CH,SKIN NECROSIS,1
CH,SKIN REACTION,1
CH,SKIN STRIAE,1
CH,SKIN ULCER,1
CH,SKIN WOUND,1
CH,SMALL FOR DATES BABY,1
CH,SOFT TISSUE INFECTION,1
CH,SPINAL CORD ABSCESS,1
CH,SPINAL FRACTURE,1
CH,SPINAL FUSION SURGERY,1
CH,SPLENOMEGALY,1
CH,SPONTANEOUS HAEMATOMA,1
CH,SPOROTRICHOSIS,1
CH,SQUAMOUS CELL CARCINOMA OF SKIN,1
CH,STAPHYLOCOCCUS TEST POSITIVE,1
CH,STILLBIRTH,1
CH,STOMATOCYTES PRESENT,1
CH,SUBCUTANEOUS HAEMATOMA,1
CH,SUPRAVENTRICULAR EXTRASYSTOLES,1
CH,TALIPES,1
CH,THERAPEUTIC RESPONSE DECREASED,1
CH,THERAPY NON-RESPONDER,1
CH,THINKING ABNORMAL,1
CH,THORACIC VERTEBRAL FRACTURE,1
CH,THROMBOCYTOPENIC PURPURA,1
CH,THROMBOTIC STROKE,1
CH,TOOTH DISORDER,1
CH,TOOTH EROSION,1
CH,TOXIC NEUROPATHY,1
CH,TOXIC SKIN ERUPTION,1
CH,TRACHEOBRONCHITIS,1
CH,TRANSAMINASES INCREASED,1
CH,TRANSFUSION,1
CH,TREATMENT FAILURE,1
CH,TRIGEMINAL NEURALGIA,1
CH,TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM,1
CH,TUBERCULOSIS OF GENITOURINARY SYSTEM,1
CH,TUBULOINTERSTITIAL NEPHRITIS,1
CH,TUMOUR EMBOLISM,1
CH,TUMOUR LYSIS SYNDROME,1
CH,TUMOUR PAIN,1
CH,TYPE I HYPERSENSITIVITY,1
CH,TYPE IV HYPERSENSITIVITY REACTION,1
CH,ULCER,1
CH,ULTRASOUND ABDOMEN ABNORMAL,1
CH,UNRESPONSIVE TO STIMULI,1
CH,UPPER RESPIRATORY TRACT INFECTION,1
CH,UTERINE HAEMATOMA,1
CH,VARICELLA,1
CH,VASCULITIS CEREBRAL,1
CH,VENOUS THROMBOSIS,1
CH,VENTRICULAR HYPOKINESIA,1
CH,VIRAL INFECTION,1
CH,VISION BLURRED,1
CH,VISUAL ACUITY REDUCED,1
CH,VITAMIN D DEFICIENCY,1
CH,VOCAL CORD DISORDER,1
CH,VULVAL CANCER,1
CH,VULVOVAGINAL CANDIDIASIS,1
CH,WHITE BLOOD CELL COUNT DECREASED,1
CH,WOUND DEHISCENCE,1
TW,DEATH,26
TW,CELLULITIS,6
TW,PYREXIA,6
TW,HEPATITIS B,5
TW,LEUKOPENIA,5
TW,CYTOMEGALOVIRUS INFECTION,4
TW,FUNGAL INFECTION,4
TW,LYMPHADENOPATHY,4
TW,FOLLICULITIS,3
TW,COUGH,2
TW,DRUG HYPERSENSITIVITY,2
TW,DYSPNOEA,2
TW,FEBRILE NEUTROPENIA,2
TW,HEPATIC FAILURE,2
TW,HEPATITIS,2
TW,INFECTION,2
TW,PLEURAL EFFUSION,2
TW,PNEUMONIA,2
TW,PNEUMONITIS,2
TW,PRODUCT USE IN UNAPPROVED INDICATION,2
TW,THROMBOCYTOPENIA,2
TW,ABDOMINAL DISTENSION,1
TW,ABDOMINAL PAIN UPPER,1
TW,ABDOMINAL WALL ABSCESS,1
TW,ACUTE HEPATITIS B,1
TW,ACUTE RESPIRATORY DISTRESS SYNDROME,1
TW,ADVERSE EVENT,1
TW,ALANINE AMINOTRANSFERASE INCREASED,1
TW,ALTERED STATE OF CONSCIOUSNESS,1
TW,ARTHROPOD BITE,1
TW,ASTHENIA,1
TW,BLOOD CREATININE INCREASED,1
TW,BLOOD UREA INCREASED,1
TW,C-REACTIVE PROTEIN INCREASED,1
TW,CARDIAC ARREST,1
TW,CEREBRAL ARTERY OCCLUSION,1
TW,CONDITION AGGRAVATED,1
TW,CONTUSION,1
TW,CONVULSION,1
TW,DECREASED APPETITE,1
TW,DIABETES MELLITUS,1
TW,DIFFUSE LARGE B-CELL LYMPHOMA,1
TW,DISEASE PROGRESSION,1
TW,DISSEMINATED INTRAVASCULAR COAGULATION,1
TW,DRUG EFFECT INCOMPLETE,1
TW,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
TW,DYSURIA,1
TW,EMOTIONAL DISTRESS,1
TW,ENTEROCOLITIS INFECTIOUS,1
TW,EPSTEIN-BARR VIRUS INFECTION,1
TW,FEMUR FRACTURE,1
TW,FOETAL EXPOSURE DURING PREGNANCY,1
TW,GASTRIC ULCER,1
TW,GASTROINTESTINAL HAEMORRHAGE,1
TW,GASTROOESOPHAGEAL REFLUX DISEASE,1
TW,GLAUCOMA,1
TW,HEAD INJURY,1
TW,HEPATIC FUNCTION ABNORMAL,1
TW,HEPATITIS B REACTIVATION,1
TW,HEPATITIS C,1
TW,HEPATOTOXICITY,1
TW,HIP FRACTURE,1
TW,HYPERKALAEMIA,1
TW,HYPOAESTHESIA,1
TW,HYPOKALAEMIA,1
TW,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
TW,INFLAMMATION,1
TW,INJECTION SITE ULCER,1
TW,INTESTINAL FISTULA,1
TW,INVASIVE DUCTAL BREAST CARCINOMA,1
TW,KNEE ARTHROPLASTY,1
TW,LOSS OF CONSCIOUSNESS,1
TW,LOW BIRTH WEIGHT BABY,1
TW,LUNG INFECTION,1
TW,LUNG NEOPLASM MALIGNANT,1
TW,LUPUS-LIKE SYNDROME,1
TW,MANTLE CELL LYMPHOMA,1
TW,MOVEMENT DISORDER,1
TW,MUSCULAR WEAKNESS,1
TW,MYCOBACTERIUM TEST POSITIVE,1
TW,NASOPHARYNGITIS,1
TW,NEUTROPENIA,1
TW,OSTEOARTHRITIS,1
TW,OVERDOSE,1
TW,PALPITATIONS,1
TW,PANCREATITIS,1
TW,PANCYTOPENIA,1
TW,PAPILLARY THYROID CANCER,1
TW,PERITONEAL CLOUDY EFFLUENT,1
TW,PNEUMONIA LEGIONELLA,1
TW,POLYARTHRITIS,1
TW,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
TW,RENAL IMPAIRMENT,1
TW,RESPIRATORY FAILURE,1
TW,ROAD TRAFFIC ACCIDENT,1
TW,SEPTIC SHOCK,1
TW,STOMATITIS,1
TW,SUBARACHNOID HAEMORRHAGE,1
TW,SUPERINFECTION,1
TW,THERAPEUTIC RESPONSE DECREASED,1
TW,TRANSPLANT REJECTION,1
TW,TUMOUR LYSIS SYNDROME,1
TW,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TW,WOUND,1
TW,WOUND COMPLICATION,1
TH,NEUTROPENIA,7
TH,FEBRILE NEUTROPENIA,5
TH,PNEUMONIA,5
TH,SEPSIS,4
TH,SEPTIC SHOCK,4
TH,THROMBOCYTOPENIA,4
TH,PYREXIA,3
TH,ADENOVIRAL HAEMORRHAGIC CYSTITIS,2
TH,CYTOMEGALOVIRUS CHORIORETINITIS,2
TH,DEATH,2
TH,DIARRHOEA INFECTIOUS,2
TH,HYPOKALAEMIA,2
TH,INFECTION,2
TH,PROTEINURIA,2
TH,ACUTE GRAFT VERSUS HOST DISEASE,1
TH,ACUTE RESPIRATORY DISTRESS SYNDROME,1
TH,ANAEMIA,1
TH,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT,1
TH,ASYMPTOMATIC BACTERIURIA,1
TH,BACTERIAL SEPSIS,1
TH,BLOOD LACTATE DEHYDROGENASE INCREASED,1
TH,BONE MARROW DISORDER,1
TH,BRONCHOSPASM,1
TH,CEREBROVASCULAR ACCIDENT,1
TH,CYSTITIS HAEMORRHAGIC,1
TH,CYTOMEGALOVIRUS INFECTION,1
TH,DECREASED APPETITE,1
TH,DECUBITUS ULCER,1
TH,DIARRHOEA,1
TH,DRUG ERUPTION,1
TH,DRUG HYPERSENSITIVITY,1
TH,DYSPNOEA EXERTIONAL,1
TH,ENTEROCOLITIS FUNGAL,1
TH,FATIGUE,1
TH,GASTRITIS,1
TH,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
TH,HAEMATEMESIS,1
TH,HAEMATOTOXICITY,1
TH,HAEMATURIA,1
TH,HAEMORRHOIDS,1
TH,HEPATITIS,1
TH,MALIGNANT NEOPLASM PROGRESSION,1
TH,MALNUTRITION,1
TH,MYALGIA,1
TH,MYOCARDIAL INFARCTION,1
TH,OESOPHAGEAL CANDIDIASIS,1
TH,ORAL CANDIDIASIS,1
TH,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT,1
TH,PULMONARY SEPSIS,1
TH,PULMONARY TUBERCULOSIS,1
TH,RASH ERYTHEMATOUS,1
TH,RENAL FAILURE ACUTE,1
TH,RENAL INJURY,1
TH,SPINAL OSTEOARTHRITIS,1
TH,SYSTEMIC CANDIDA,1
TH,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TG,ISCHAEMIC STROKE,1
TG,MOTOR DYSFUNCTION,1
TN,KAPOSI^S SARCOMA,8
TN,RENAL FAILURE,7
TN,DEATH,6
TN,DRUG INEFFECTIVE,6
TN,SEPSIS,6
TN,GLOMERULONEPHRITIS MINIMAL LESION,4
TN,PANCYTOPENIA,4
TN,PANNICULITIS,4
TN,PNEUMOCYSTIS JIROVECII INFECTION,4
TN,RENAL IMPAIRMENT,4
TN,RESPIRATORY DISTRESS,4
TN,SEPTIC SHOCK,4
TN,TUBULOINTERSTITIAL NEPHRITIS,4
TN,ASPERGILLUS INFECTION,3
TN,BLASTOMYCOSIS,3
TN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
TN,FUNGAL INFECTION,3
TN,HYPERLIPIDAEMIA,3
TN,LEISHMANIASIS,3
TN,MENINGITIS CRYPTOCOCCAL,3
TN,MUCOSAL INFLAMMATION,3
TN,ALANINE AMINOTRANSFERASE INCREASED,2
TN,ARTHRITIS BACTERIAL,2
TN,ASPARTATE AMINOTRANSFERASE INCREASED,2
TN,ASTHENIA,2
TN,BLOOD CREATININE INCREASED,2
TN,BONE MARROW FAILURE,2
TN,CUTANEOUS LEISHMANIASIS,2
TN,DIARRHOEA,2
TN,DRUG LEVEL ABOVE THERAPEUTIC,2
TN,FEBRILE NEUTROPENIA,2
TN,HEPATOTOXICITY,2
TN,HYPOXIA,2
TN,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
TN,NEPHROTIC SYNDROME,2
TN,NEUTROPENIA,2
TN,PIGMENTATION DISORDER,2
TN,PNEUMONIA,2
TN,POLYCYTHAEMIA,2
TN,PYREXIA,2
TN,RENAL TRANSPLANT FAILURE,2
TN,SHOCK,2
TN,SHOCK HAEMORRHAGIC,2
TN,T-CELL LYMPHOMA,2
TN,TUBERCULOSIS,2
TN,URINARY TRACT INFECTION,2
TN,VENOUS THROMBOSIS,2
TN,ABDOMINAL DISTENSION,1
TN,ABDOMINAL PAIN,1
TN,ACIDOSIS,1
TN,ADVERSE EVENT,1
TN,ANAEMIA,1
TN,ARRHYTHMIA,1
TN,AUTOIMMUNE HEPATITIS,1
TN,BONE MARROW TOXICITY,1
TN,CARDIOMYOPATHY,1
TN,CARDIOVASCULAR DISORDER,1
TN,COLITIS,1
TN,CYTOMEGALOVIRUS INFECTION,1
TN,DEHYDRATION,1
TN,DISORIENTATION,1
TN,DISSEMINATED INTRAVASCULAR COAGULATION,1
TN,DRUG INTOLERANCE,1
TN,DRUG LEVEL INCREASED,1
TN,DYSPNOEA EXERTIONAL,1
TN,EMBOLISM,1
TN,ESCHERICHIA INFECTION,1
TN,FATIGUE,1
TN,FOOD POISONING,1
TN,GASTRIC DISORDER,1
TN,GASTRIC HAEMORRHAGE,1
TN,GASTROINTESTINAL DISORDER,1
TN,GASTROINTESTINAL TOXICITY,1
TN,GENERAL PHYSICAL HEALTH DETERIORATION,1
TN,GRAFT COMPLICATION,1
TN,HAEMATOTOXICITY,1
TN,HEPATIC FAILURE,1
TN,HEPATITIS,1
TN,HERPES ZOSTER,1
TN,HUMAN HERPESVIRUS 8 INFECTION,1
TN,HYPERCALCAEMIA,1
TN,HYPOKALAEMIA,1
TN,HYPONATRAEMIA,1
TN,HYPOTENSION,1
TN,INFLAMMATORY BOWEL DISEASE,1
TN,INTERCOSTAL NEURALGIA,1
TN,JUGULAR VEIN THROMBOSIS,1
TN,KIDNEY TRANSPLANT REJECTION,1
TN,LACTIC ACIDOSIS,1
TN,LYMPH NODE TUBERCULOSIS,1
TN,MENINGITIS,1
TN,METABOLIC ACIDOSIS,1
TN,MYALGIA,1
TN,NECK PAIN,1
TN,NEOPLASM PROGRESSION,1
TN,NEPHROPATHY TOXIC,1
TN,NEUROTOXICITY,1
TN,NOCARDIOSIS,1
TN,OEDEMA PERIPHERAL,1
TN,OESOPHAGEAL VARICES HAEMORRHAGE,1
TN,PAIN IN EXTREMITY,1
TN,PLASMA CELL MYELOMA RECURRENT,1
TN,PLATELET COUNT INCREASED,1
TN,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
TN,PRODUCT USE IN UNAPPROVED INDICATION,1
TN,PROTEINURIA,1
TN,PULMONARY EMBOLISM,1
TN,PULMONARY TUBERCULOSIS,1
TN,PUSTULAR PSORIASIS,1
TN,REMISSION NOT ACHIEVED,1
TN,SECOND PRIMARY MALIGNANCY,1
TN,SENSATION OF BLOOD FLOW,1
TN,SKIN TOXICITY,1
TN,SWELLING FACE,1
TN,SYSTEMIC CANDIDA,1
TN,SYSTEMIC LUPUS ERYTHEMATOSUS,1
TN,TACHYCARDIA,1
TN,TRANSPLANT REJECTION,1
TN,VENTRICULAR EXTRASYSTOLES,1
TN,VOMITING,1
TN,ZYGOMYCOSIS,1
TR,FEBRILE NEUTROPENIA,11
TR,OXALOSIS,11
TR,HAEMOLYTIC ANAEMIA,9
TR,TUBULOINTERSTITIAL NEPHRITIS,8
TR,FOETAL EXPOSURE DURING PREGNANCY,7
TR,INTERSTITIAL LUNG DISEASE,7
TR,ARTERIOSPASM CORONARY,6
TR,ESCHERICHIA URINARY TRACT INFECTION,6
TR,INFECTION,6
TR,INTESTINAL PERFORATION,6
TR,NEUTROPENIA,6
TR,PREMATURE BABY,6
TR,SKIN NECROSIS,6
TR,ACUTE MYOCARDIAL INFARCTION,5
TR,CORONARY ARTERY DISEASE,5
TR,CYTOMEGALOVIRUS INFECTION,5
TR,MALIGNANT NEOPLASM PROGRESSION,5
TR,MATERNAL EXPOSURE DURING PREGNANCY,5
TR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,5
TR,PRODUCT USE IN UNAPPROVED INDICATION,5
TR,RESPIRATORY FAILURE,5
TR,TOXICITY TO VARIOUS AGENTS,5
TR,HEPATITIS TOXIC,4
TR,HYPERCALCIURIA,4
TR,JAUNDICE,4
TR,LEUKOPENIA,4
TR,NEPHROCALCINOSIS,4
TR,PREMATURE DELIVERY,4
TR,URINE CALCIUM/CREATININE RATIO INCREASED,4
TR,ACUTE KIDNEY INJURY,3
TR,BENIGN NEOPLASM OF THYROID GLAND,3
TR,BK VIRUS INFECTION,3
TR,CHEST PAIN,3
TR,DIFFUSE LARGE B-CELL LYMPHOMA,3
TR,HEADACHE,3
TR,HYPERGLYCAEMIA,3
TR,INVASIVE DUCTAL BREAST CARCINOMA,3
TR,MUCOSAL INFLAMMATION,3
TR,NAUSEA,3
TR,PNEUMONIA,3
TR,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,3
TR,SEPSIS,3
TR,THROMBOCYTOPENIA,3
TR,URINARY TRACT INFECTION,3
TR,ALANINE AMINOTRANSFERASE INCREASED,2
TR,ANGIOPATHY,2
TR,ATRIAL THROMBOSIS,2
TR,BLINDNESS,2
TR,CYTOMEGALOVIRUS NEPHRITIS,2
TR,DEEP VEIN THROMBOSIS,2
TR,DIARRHOEA,2
TR,DISEASE PROGRESSION,2
TR,DRUG INEFFECTIVE,2
TR,EXPOSURE DURING PREGNANCY,2
TR,FATIGUE,2
TR,FEMUR FRACTURE,2
TR,FIBROSARCOMA,2
TR,GENERALISED TONIC-CLONIC SEIZURE,2
TR,INCORRECT DOSE ADMINISTERED,2
TR,KIDNEY FIBROSIS,2
TR,LEUKOENCEPHALOPATHY,2
TR,MENINGIOMA,2
TR,OSTEONECROSIS OF JAW,2
TR,PAIN,2
TR,PANCYTOPENIA,2
TR,PAPILLARY THYROID CANCER,2
TR,PATHOGEN RESISTANCE,2
TR,PERIPHERAL NERVE SHEATH TUMOUR MALIGNANT,2
TR,PERIPHERAL SENSORY NEUROPATHY,2
TR,PLEURAL EFFUSION,2
TR,PNEUMONIA ASPIRATION,2
TR,PYREXIA,2
TR,TERATOGENICITY,2
TR,THROMBOSIS,2
TR,THYROID ADENOMA,2
TR,TREATMENT FAILURE,2
TR,TREMOR,2
TR,TUMOUR LYSIS SYNDROME,2
TR,URINARY RETENTION,2
TR,VISION BLURRED,2
TR,ABDOMINAL DISTENSION,1
TR,ABDOMINAL PAIN,1
TR,ABDOMINAL WALL HAEMATOMA,1
TR,ABORTION INDUCED,1
TR,ABORTION SPONTANEOUS,1
TR,ABSCESS,1
TR,ABSCESS JAW,1
TR,ACCIDENTAL OVERDOSE,1
TR,ACNE,1
TR,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,1
TR,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
TR,ACUTE LYMPHOCYTIC LEUKAEMIA,1
TR,ACUTE MOTOR AXONAL NEUROPATHY,1
TR,ACUTE POLYNEUROPATHY,1
TR,ADENOVIRUS INFECTION,1
TR,ANAEMIA,1
TR,ASCITES,1
TR,ASPARTATE AMINOTRANSFERASE INCREASED,1
TR,ASTHMA,1
TR,AUTONOMIC NEUROPATHY,1
TR,B-CELL LYMPHOMA,1
TR,BACTERIAL INFECTION,1
TR,BILE DUCT OBSTRUCTION,1
TR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
TR,BLOOD BILIRUBIN INCREASED,1
TR,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
TR,BLOOD CREATININE INCREASED,1
TR,BRONCHOPULMONARY ASPERGILLOSIS,1
TR,BURKITT^S LYMPHOMA,1
TR,CARDIAC FAILURE CONGESTIVE,1
TR,CARDIOVASCULAR DISORDER,1
TR,CELLULITIS,1
TR,CHEMICAL PERITONITIS,1
TR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
TR,COLITIS,1
TR,CONJUNCTIVITIS,1
TR,CORONARY OSTIAL STENOSIS,1
TR,CYSTITIS HAEMORRHAGIC,1
TR,DEATH,1
TR,DECREASED APPETITE,1
TR,DEHYDRATION,1
TR,DRUG LEVEL INCREASED,1
TR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
TR,ENCEPHALOPATHY,1
TR,ENTEROBACTER PNEUMONIA,1
TR,ESCHERICHIA INFECTION,1
TR,GASTROINTESTINAL DISORDER,1
TR,GENERAL PHYSICAL HEALTH DETERIORATION,1
TR,GRAFT VERSUS HOST DISEASE,1
TR,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
TR,HAEMATOMA,1
TR,HAEMOGLOBIN DECREASED,1
TR,HAEMORRHAGE,1
TR,HEPATIC LESION,1
TR,HEPATIC NECROSIS,1
TR,HEPATITIS C,1
TR,HEPATITIS CHOLESTATIC,1
TR,HODGKIN^S DISEASE,1
TR,HODGKIN^S DISEASE RECURRENT,1
TR,HYPERURICAEMIA,1
TR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
TR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
TR,INSOMNIA,1
TR,KAPOSI^S SARCOMA,1
TR,LARGE INTESTINE PERFORATION,1
TR,LIVER ABSCESS,1
TR,LIVER TRANSPLANT REJECTION,1
TR,LYMPHADENOPATHY,1
TR,LYMPHOPENIA,1
TR,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
TR,MICTURITION FREQUENCY DECREASED,1
TR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
TR,NEOPLASM PROGRESSION,1
TR,NEOPLASM RECURRENCE,1
TR,NEUROPATHY PERIPHERAL,1
TR,OEDEMA PERIPHERAL,1
TR,ORGAN FAILURE,1
TR,ORTHOSTATIC HYPOTENSION,1
TR,OVERDOSE,1
TR,PANCREATIC PSEUDOCYST,1
TR,PANCREATITIS NECROTISING,1
TR,PERITONEAL NEOPLASM,1
TR,PLASMA CELL MYELOMA,1
TR,PLEURITIC PAIN,1
TR,PNEUMOTHORAX,1
TR,POLYNEUROPATHY,1
TR,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
TR,PRODUCT USE ISSUE,1
TR,PULMONARY SEPSIS,1
TR,RASH ERYTHEMATOUS,1
TR,RASH MACULO-PAPULAR,1
TR,RENAL FAILURE,1
TR,RICHTER^S SYNDROME,1
TR,SEPTIC SHOCK,1
TR,SKIN LESION,1
TR,SOMATIC DELUSION,1
TR,SPLENIC NECROSIS,1
TR,SPLENOMEGALY,1
TR,SQUAMOUS CELL CARCINOMA OF THE CERVIX,1
TR,STEM CELL TRANSPLANT,1
TR,STOMATITIS,1
TR,SYSTOLIC DYSFUNCTION,1
TR,THERAPY PARTIAL RESPONDER,1
TR,TRANSAMINASES INCREASED,1
TR,TRANSURETHRAL PROSTATECTOMY,1
TR,TRISMUS,1
TR,TUBERCULOSIS LIVER,1
TR,URINARY TRACT INFECTION ENTEROCOCCAL,1
TR,VAGINAL DISCHARGE,1
TR,VARICELLA ZOSTER VIRUS INFECTION,1
TR,VOMITING,1
TR,WEIGHT DECREASED,1
UG,DEATH,3
UG,OEDEMA PERIPHERAL,2
UG,NEPHROPATHY TOXIC,1
UG,PROTEIN URINE PRESENT,1
UG,PROTEINURIA,1
UG,PYURIA,1
UG,RED BLOOD CELLS URINE,1
UA,ATRIAL FIBRILLATION,4
UA,CARDIAC FAILURE,4
UA,ASTHENIA,3
UA,HEPATITIS TOXIC,3
UA,NEUROTOXICITY,3
UA,PERIPHERAL SENSORY NEUROPATHY,3
UA,ANAEMIA,2
UA,ANGINA PECTORIS,2
UA,CARDIOTOXICITY,2
UA,DYSPNOEA,2
UA,FEBRILE NEUTROPENIA,2
UA,NEUTROPENIA,2
UA,PALPITATIONS,2
UA,PERIPHERAL SENSORIMOTOR NEUROPATHY,2
UA,POLYNEUROPATHY,2
UA,PRODUCT USE IN UNAPPROVED INDICATION,2
UA,THROMBOCYTOPENIA,2
UA,ARRHYTHMIA,1
UA,CARDIOMYOPATHY,1
UA,DECREASED APPETITE,1
UA,FATIGUE,1
UA,GAIT DISTURBANCE,1
UA,GASTROINTESTINAL DISORDER,1
UA,HAEMATOTOXICITY,1
UA,HEART INJURY,1
UA,HEPATITIS B,1
UA,HEPATITIS E,1
UA,HEPATOTOXICITY,1
UA,HYPERTENSION,1
UA,LEUKOPENIA,1
UA,LUNG DISORDER,1
UA,LYMPHADENOPATHY,1
UA,LYMPHADENOPATHY MEDIASTINAL,1
UA,MOOD SWINGS,1
UA,MUCOSAL INFLAMMATION,1
UA,NAUSEA,1
UA,NEUROPATHY PERIPHERAL,1
UA,NEUROSIS,1
UA,NON-HODGKIN^S LYMPHOMA,1
UA,PHLEBITIS,1
UA,PULMONARY OEDEMA,1
UA,PYELONEPHRITIS CHRONIC,1
UA,SENSORY DISTURBANCE,1
UA,TRANSAMINASES INCREASED,1
UA,TREMOR,1
UA,VOMITING,1
AE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
AE,ASTHENIA,1
AE,BLOOD CREATININE INCREASED,1
AE,BLOOD UREA INCREASED,1
AE,DIARRHOEA,1
AE,PNEUMONIA,1
AE,PROSTATE CANCER METASTATIC,1
AE,STRONGYLOIDIASIS,1
AE,VOMITING,1
GB,INFECTION,33
GB,INFUSION RELATED REACTION,31
GB,NEUTROPENIA,28
GB,PNEUMONIA,27
GB,FEBRILE NEUTROPENIA,25
GB,NEUTROPENIC SEPSIS,24
GB,DYSPNOEA,23
GB,LOWER RESPIRATORY TRACT INFECTION,22
GB,DIARRHOEA,21
GB,RESPIRATORY FAILURE,19
GB,MALAISE,18
GB,FATIGUE,17
GB,PYREXIA,17
GB,CONSTIPATION,16
GB,HEADACHE,16
GB,ANAEMIA,15
GB,ATRIAL FIBRILLATION,15
GB,DEATH,14
GB,SEPSIS,14
GB,URINARY TRACT INFECTION,14
GB,VOMITING,14
GB,ABDOMINAL PAIN,13
GB,NAUSEA,13
GB,RASH,13
GB,BACK PAIN,12
GB,ACUTE KIDNEY INJURY,11
GB,ARTHRALGIA,11
GB,NECK PAIN,10
GB,SOMNOLENCE,10
GB,COUGH,9
GB,INFLUENZA LIKE ILLNESS,9
GB,INSOMNIA,9
GB,MALIGNANT NEOPLASM PROGRESSION,9
GB,MUSCULOSKELETAL PAIN,9
GB,PRODUCT USE ISSUE,9
GB,PULMONARY EMBOLISM,9
GB,TACHYCARDIA,9
GB,ACCIDENTAL OVERDOSE,8
GB,AGITATION,8
GB,ASTHMA,8
GB,BLOOD GLUCOSE ABNORMAL,8
GB,CONDITION AGGRAVATED,8
GB,DIZZINESS,8
GB,EXPOSURE DURING PREGNANCY,8
GB,HERPES ZOSTER,8
GB,HODGKIN^S DISEASE,8
GB,PALPITATIONS,8
GB,SWOLLEN TONGUE,8
GB,ASTHENIA,7
GB,C-REACTIVE PROTEIN INCREASED,7
GB,CHEST PAIN,7
GB,DRUG INEFFECTIVE,7
GB,FLUSHING,7
GB,JOINT SWELLING,7
GB,LIVER FUNCTION TEST ABNORMAL,7
GB,NEUROPATHY PERIPHERAL,7
GB,OEDEMA PERIPHERAL,7
GB,RENAL FAILURE ACUTE,7
GB,URINARY RETENTION,7
GB,CASTLEMAN^S DISEASE,6
GB,DISEASE PROGRESSION,6
GB,EYE PRURITUS,6
GB,HYPERKALAEMIA,6
GB,HYPOXIA,6
GB,OBSTRUCTIVE AIRWAYS DISORDER,6
GB,OSTEONECROSIS,6
GB,PAIN,6
GB,RESPIRATORY TRACT INFECTION,6
GB,WITHDRAWAL SYNDROME,6
GB,ABDOMINAL TENDERNESS,5
GB,ABORTION SPONTANEOUS,5
GB,ACUTE MYELOID LEUKAEMIA,5
GB,ATRIOVENTRICULAR BLOCK COMPLETE,5
GB,COLITIS,5
GB,CONFUSIONAL STATE,5
GB,DRUG DOSE OMISSION,5
GB,DRUG INTOLERANCE,5
GB,HYPERTENSION,5
GB,HYPOTENSION,5
GB,METAPNEUMOVIRUS INFECTION,5
GB,NON-HODGKIN^S LYMPHOMA,5
GB,PAIN IN EXTREMITY,5
GB,PERIPHERAL SWELLING,5
GB,PLATELET COUNT DECREASED,5
GB,PLEURAL EFFUSION,5
GB,PLEURITIC PAIN,5
GB,PNEUMONITIS,5
GB,PRESYNCOPE,5
GB,PRURITUS,5
GB,RESTLESSNESS,5
GB,SLE ARTHRITIS,5
GB,TEARFULNESS,5
GB,WHITE BLOOD CELL COUNT DECREASED,5
GB,ADVERSE DRUG REACTION,4
GB,ANAPHYLACTOID REACTION,4
GB,BLOOD CREATININE INCREASED,4
GB,CELLULITIS,4
GB,CHILLS,4
GB,CONGENITAL ANOMALY,4
GB,CONTUSION,4
GB,DEPRESSION,4
GB,DYSGEUSIA,4
GB,FALL,4
GB,GASTRIC ULCER,4
GB,GASTROINTESTINAL DISORDER,4
GB,INCORRECT DOSE ADMINISTERED,4
GB,LUNG INFECTION,4
GB,NEUTROPHIL COUNT DECREASED,4
GB,PARAESTHESIA,4
GB,SKIN ULCER,4
GB,SYNCOPE,4
GB,THERAPEUTIC RESPONSE DECREASED,4
GB,WEIGHT DECREASED,4
GB,ABDOMINAL DISCOMFORT,3
GB,ACUTE RESPIRATORY DISTRESS SYNDROME,3
GB,ANAPHYLACTIC REACTION,3
GB,BRADYCARDIA,3
GB,CARDIAC ARREST,3
GB,CARDIAC DISORDER,3
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
GB,CYTOMEGALOVIRUS INFECTION,3
GB,DISTURBANCE IN ATTENTION,3
GB,DRUG HYPERSENSITIVITY,3
GB,DRY MOUTH,3
GB,EAR INFECTION,3
GB,HEPATITIS,3
GB,LETHARGY,3
GB,MEMORY IMPAIRMENT,3
GB,MONOCLONAL IMMUNOGLOBULIN PRESENT,3
GB,MUSCULAR WEAKNESS,3
GB,MYOCARDIAL INFARCTION,3
GB,NERVOUS SYSTEM DISORDER,3
GB,PLASMA CELL MYELOMA,3
GB,PRODUCT USE IN UNAPPROVED INDICATION,3
GB,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
GB,PULMONARY CAVITATION,3
GB,PULMONARY FIBROSIS,3
GB,RENAL FAILURE,3
GB,RESPIRATORY DISORDER,3
GB,RHEUMATOID ARTHRITIS,3
GB,SKIN DISCOLOURATION,3
GB,SWELLING FACE,3
GB,UPPER RESPIRATORY TRACT INFECTION,3
GB,ABDOMINAL DISTENSION,2
GB,ACUTE LYMPHOCYTIC LEUKAEMIA,2
GB,AGEUSIA,2
GB,ALVEOLITIS ALLERGIC,2
GB,AMNESIA,2
GB,ANAPHYLACTIC SHOCK,2
GB,ANGINA PECTORIS,2
GB,B-CELL LYMPHOMA,2
GB,BLADDER TRANSITIONAL CELL CARCINOMA,2
GB,BLOOD GLUCOSE INCREASED,2
GB,BLOOD PRESSURE DECREASED,2
GB,BODY TEMPERATURE INCREASED,2
GB,BRONCHIECTASIS,2
GB,COLD SWEAT,2
GB,CONTRAINDICATED DRUG ADMINISTERED,2
GB,CYANOSIS,2
GB,DEHYDRATION,2
GB,DRUG EFFECT DECREASED,2
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
GB,DYSKINESIA,2
GB,EJECTION FRACTION DECREASED,2
GB,EMBOLISM,2
GB,ENTEROVIRUS INFECTION,2
GB,ERYTHEMA,2
GB,EXERCISE TOLERANCE DECREASED,2
GB,EYE CONTUSION,2
GB,FACE OEDEMA,2
GB,FACIAL SPASM,2
GB,FEELING HOT,2
GB,GASTROINTESTINAL HAEMORRHAGE,2
GB,GASTROINTESTINAL STOMA COMPLICATION,2
GB,GINGIVAL BLEEDING,2
GB,GINGIVAL PAIN,2
GB,HAEMOGLOBIN DECREASED,2
GB,HEAD INJURY,2
GB,HYPERHIDROSIS,2
GB,HYPERSENSITIVITY,2
GB,HYPERTENSIVE EMERGENCY,2
GB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
GB,INFECTION REACTIVATION,2
GB,INJECTION SITE ERYTHEMA,2
GB,INJECTION SITE REACTION,2
GB,INTESTINAL OBSTRUCTION,2
GB,LIVER TRANSPLANT REJECTION,2
GB,LOSS OF CONSCIOUSNESS,2
GB,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I,2
GB,LYMPHOMA,2
GB,MENTAL IMPAIRMENT,2
GB,METASTATIC MALIGNANT MELANOMA,2
GB,MUSCLE SPASMS,2
GB,MYALGIA,2
GB,MYCOBACTERIUM CHELONAE INFECTION,2
GB,MYCOSIS FUNGOIDES STAGE IV,2
GB,NIGHT SWEATS,2
GB,OBLITERATIVE BRONCHIOLITIS,2
GB,OSTEOPOROSIS,2
GB,OVERDOSE,2
GB,PANCREATITIS,2
GB,PANCYTOPENIA,2
GB,PARAESTHESIA ORAL,2
GB,PNEUMATOSIS INTESTINALIS,2
GB,PNEUMOPERITONEUM,2
GB,PNEUMOTHORAX,2
GB,POST HERPETIC NEURALGIA,2
GB,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
GB,PSEUDOMONAS INFECTION,2
GB,RASH PRURITIC,2
GB,RESPIRATORY ARREST,2
GB,SEPTIC SHOCK,2
GB,SKIN EXFOLIATION,2
GB,SKIN INFECTION,2
GB,SKIN LESION,2
GB,SMALL INTESTINAL OBSTRUCTION,2
GB,SPUTUM PURULENT,2
GB,SQUAMOUS CELL CARCINOMA OF SKIN,2
GB,STAPHYLOCOCCAL INFECTION,2
GB,TAKAYASU^S ARTERITIS,2
GB,THROMBOCYTOPENIA,2
GB,THROMBOSIS,2
GB,TOXICITY TO VARIOUS AGENTS,2
GB,TRANSITIONAL CELL CANCER OF RENAL PELVIS AND URETER METASTATIC,2
GB,TROPONIN INCREASED,2
GB,VAGINAL DYSPLASIA,2
GB,VENOUS THROMBOSIS,2
GB,VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION,2
GB,WHEEZING,2
GB,WOUND HAEMORRHAGE,2
GB,ABASIA,1
GB,ABNORMAL BEHAVIOUR,1
GB,ACUTE CORONARY SYNDROME,1
GB,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
GB,ACUTE MYOCARDIAL INFARCTION,1
GB,ADRENAL SUPPRESSION,1
GB,ADVERSE EVENT,1
GB,ALOPECIA,1
GB,AMYLASE ABNORMAL,1
GB,ANKLE FRACTURE,1
GB,ANURIA,1
GB,ANXIETY,1
GB,AORTIC STENOSIS,1
GB,APNOEA,1
GB,ARRHYTHMIA,1
GB,ATAXIA,1
GB,ATRIOVENTRICULAR BLOCK,1
GB,BACTERIAL PAROTITIS,1
GB,BALANCE DISORDER,1
GB,BARRETT^S OESOPHAGUS,1
GB,BILE DUCT OBSTRUCTION,1
GB,BLISTER,1
GB,BLOOD DISORDER,1
GB,BLOOD PRESSURE INCREASED,1
GB,BLOOD TEST ABNORMAL,1
GB,BONE MARROW DISORDER,1
GB,BONE MARROW FAILURE,1
GB,BONE MARROW TRANSPLANT REJECTION,1
GB,BONE PAIN,1
GB,BRONCHOPNEUMONIA,1
GB,BRONCHOPULMONARY ASPERGILLOSIS,1
GB,CAPILLARY LEAK SYNDROME,1
GB,CARDIAC FAILURE,1
GB,CATARACT,1
GB,CEREBELLAR SYNDROME,1
GB,CEREBRAL HAEMORRHAGE,1
GB,CEREBROVASCULAR DISORDER,1
GB,CHEST DISCOMFORT,1
GB,CHRONIC KIDNEY DISEASE,1
GB,CIRCULATORY COLLAPSE,1
GB,COMA SCALE ABNORMAL,1
GB,CROHN^S DISEASE,1
GB,CULTURE POSITIVE,1
GB,CYTOMEGALOVIRUS VIRAEMIA,1
GB,DECREASED APPETITE,1
GB,DEEP VEIN THROMBOSIS,1
GB,DELIRIUM,1
GB,DEPRESSED MOOD,1
GB,DEPRESSION SUICIDAL,1
GB,DEVICE RELATED INFECTION,1
GB,DIARRHOEA HAEMORRHAGIC,1
GB,DIFFUSE ALVEOLAR DAMAGE,1
GB,DIFFUSE LARGE B-CELL LYMPHOMA,1
GB,DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY,1
GB,DISORIENTATION,1
GB,DIVERTICULUM,1
GB,DRUG DISPENSING ERROR,1
GB,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
GB,DRUG LEVEL BELOW THERAPEUTIC,1
GB,DRY EYE,1
GB,DRY SKIN,1
GB,DYSPEPSIA,1
GB,DYSPNOEA EXERTIONAL,1
GB,ECZEMA,1
GB,ELECTROCARDIOGRAM T WAVE INVERSION,1
GB,EMOTIONAL DISORDER,1
GB,EMOTIONAL DISTRESS,1
GB,EMPYEMA,1
GB,ENDOMETRIAL CANCER,1
GB,ENTEROBACTER INFECTION,1
GB,ENTEROCOCCAL INFECTION,1
GB,EOSINOPHIL COUNT INCREASED,1
GB,EOSINOPHILIA,1
GB,EPSTEIN-BARR VIRAEMIA,1
GB,FAECAL VOLUME INCREASED,1
GB,FEELING ABNORMAL,1
GB,FEELING COLD,1
GB,FEMUR FRACTURE,1
GB,FIBROSIS,1
GB,FINE MOTOR SKILL DYSFUNCTION,1
GB,FOCAL DYSCOGNITIVE SEIZURES,1
GB,FOETAL EXPOSURE DURING PREGNANCY,1
GB,FOLLICLE CENTRE LYMPHOMA_ FOLLICULAR GRADE I_ II_ III REFRACTORY,1
GB,GAIT DISTURBANCE,1
GB,GASTROINTESTINAL INFECTION,1
GB,GASTROOESOPHAGEAL REFLUX DISEASE,1
GB,GENITAL PAIN,1
GB,GINGIVAL ABSCESS,1
GB,GINGIVAL DISORDER,1
GB,GINGIVAL SWELLING,1
GB,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,1
GB,GOUT,1
GB,HAEMOLYTIC URAEMIC SYNDROME,1
GB,HAEMORRHAGE,1
GB,HAEMORRHAGE INTRACRANIAL,1
GB,HAIR TEXTURE ABNORMAL,1
GB,HANGOVER,1
GB,HEPATIC ENZYME ABNORMAL,1
GB,HEPATIC FUNCTION ABNORMAL,1
GB,HEPATIC LESION,1
GB,HEPATIC NECROSIS,1
GB,HEPATOMEGALY,1
GB,HEPATOSPLENIC T-CELL LYMPHOMA,1
GB,HERPES OESOPHAGITIS,1
GB,HERPES ZOSTER OTICUS,1
GB,HISTIOCYTOSIS HAEMATOPHAGIC,1
GB,HODGKIN^S DISEASE REFRACTORY,1
GB,HOT FLUSH,1
GB,HYDRONEPHROSIS,1
GB,HYPERAESTHESIA,1
GB,HYPERCALCAEMIA,1
GB,HYPERTENSIVE CRISIS,1
GB,HYPERTHYROIDISM,1
GB,HYPOGAMMAGLOBULINAEMIA,1
GB,HYPOKALAEMIA,1
GB,HYPOKINESIA,1
GB,HYPONATRAEMIA,1
GB,HYPOPHOSPHATAEMIA,1
GB,HYPOPROTEINAEMIA,1
GB,ILEAL STENOSIS,1
GB,ILEOSTOMY CLOSURE,1
GB,ILL-DEFINED DISORDER,1
GB,IMPAIRED HEALING,1
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
GB,INFERTILITY,1
GB,INFESTATION,1
GB,INFUSION SITE REACTION,1
GB,INTELLECTUAL DISABILITY,1
GB,INTERSTITIAL LUNG DISEASE,1
GB,INTERVERTEBRAL DISC OPERATION,1
GB,INTERVERTEBRAL DISCITIS,1
GB,INTESTINAL ISCHAEMIA,1
GB,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
GB,IRITIS,1
GB,JUVENILE IDIOPATHIC ARTHRITIS,1
GB,LEFT VENTRICULAR DYSFUNCTION,1
GB,LEUKAEMIA RECURRENT,1
GB,LEUKOCYTOSIS,1
GB,LEUKOPENIA,1
GB,LIP SWELLING,1
GB,LIVER DISORDER,1
GB,LOW BIRTH WEIGHT BABY,1
GB,LOWER LIMB FRACTURE,1
GB,LUMBAR VERTEBRAL FRACTURE,1
GB,LUNG ADENOCARCINOMA,1
GB,LUNG ADENOCARCINOMA STAGE IV,1
GB,LUNG CONSOLIDATION,1
GB,LUNG DISORDER,1
GB,LUNG TRANSPLANT REJECTION,1
GB,LYMPHOPROLIFERATIVE DISORDER,1
GB,MACULAR HOLE,1
GB,MATERNAL EXPOSURE DURING PREGNANCY,1
GB,MEDIASTINITIS,1
GB,MEDICATION ERROR,1
GB,MENINGITIS VIRAL,1
GB,METASTASES TO ADRENALS,1
GB,METASTASES TO LIVER,1
GB,METASTASES TO LUNG,1
GB,METASTATIC NEOPLASM,1
GB,MICTURITION DISORDER,1
GB,MOBILITY DECREASED,1
GB,MONOCYTOSIS,1
GB,MOUTH ULCERATION,1
GB,MUCOSAL INFLAMMATION,1
GB,MUSCLE ATROPHY,1
GB,MUSCLE TIGHTNESS,1
GB,MUSCULOSKELETAL CHEST PAIN,1
GB,MYELOPATHY,1
GB,MYOCARDIAL ISCHAEMIA,1
GB,MYOPATHY,1
GB,NAIL DISORDER,1
GB,NASOPHARYNGITIS,1
GB,NEOPLASM,1
GB,NEURALGIA,1
GB,NEUTROPENIC INFECTION,1
GB,NEUTROPHIL COUNT INCREASED,1
GB,NO THERAPEUTIC RESPONSE,1
GB,NON-CARDIAC CHEST PAIN,1
GB,NORMAL NEWBORN,1
GB,OESOPHAGEAL CARCINOMA,1
GB,OESOPHAGEAL STENOSIS,1
GB,ORTHOSTATIC HYPOTENSION,1
GB,OSTEOPENIA,1
GB,OXYGEN SATURATION DECREASED,1
GB,PAPILLOEDEMA,1
GB,PARANOIA,1
GB,PEAK EXPIRATORY FLOW RATE DECREASED,1
GB,PERIPHERAL ISCHAEMIA,1
GB,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
GB,PETECHIAE,1
GB,PHLEBITIS,1
GB,PLASMACYTOMA,1
GB,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
GB,PNEUMONIA BACTERIAL,1
GB,PNEUMONIA FUNGAL,1
GB,POLLAKIURIA,1
GB,PREMATURE BABY,1
GB,PREMATURE DELIVERY,1
GB,PREMATURE LABOUR,1
GB,PRODUCT QUALITY ISSUE,1
GB,PRODUCT USED FOR UNKNOWN INDICATION,1
GB,PRODUCTIVE COUGH,1
GB,PROSTATE CANCER,1
GB,PROSTATE CANCER METASTATIC,1
GB,PROTEUS SYNDROME,1
GB,PRURITUS GENERALISED,1
GB,PSORIASIS,1
GB,PULMONARY AIR LEAKAGE,1
GB,PULMONARY HAEMORRHAGE,1
GB,QUADRANTANOPIA,1
GB,RALES,1
GB,RASH ERYTHEMATOUS,1
GB,RASH MACULAR,1
GB,RASH MACULO-PAPULAR,1
GB,RASH PAPULAR,1
GB,RAYNAUD^S PHENOMENON,1
GB,RECURRENT CANCER,1
GB,RED MAN SYNDROME,1
GB,RENAL FAILURE CHRONIC,1
GB,RENAL IMPAIRMENT,1
GB,RESPIRATORY DISTRESS,1
GB,RESPIRATORY TRACT INFECTION BACTERIAL,1
GB,RESPIRATORY TRACT INFECTION FUNGAL,1
GB,RETINAL DETACHMENT,1
GB,RHINITIS,1
GB,SALIVARY GLAND CALCULUS,1
GB,SEBACEOUS GLAND DISORDER,1
GB,SEIZURE,1
GB,SENSORY DISTURBANCE,1
GB,SIALOADENITIS,1
GB,SINUS PAIN,1
GB,SJOGREN^S SYNDROME,1
GB,SKIN DISORDER,1
GB,SKIN TIGHTNESS,1
GB,SKIN WARM,1
GB,SPEECH DISORDER,1
GB,SPINAL COLUMN STENOSIS,1
GB,SPINAL COMPRESSION FRACTURE,1
GB,SPINAL FRACTURE,1
GB,STAPHYLOCOCCAL ABSCESS,1
GB,STAPHYLOCOCCUS TEST POSITIVE,1
GB,STRONGYLOIDIASIS,1
GB,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
GB,SUBCUTANEOUS EMPHYSEMA,1
GB,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
GB,SURGERY,1
GB,TENDERNESS,1
GB,TENSION HEADACHE,1
GB,THIRST,1
GB,THORACIC VERTEBRAL FRACTURE,1
GB,THROAT TIGHTNESS,1
GB,THROMBOPHLEBITIS,1
GB,TOXIC EPIDERMAL NECROLYSIS,1
GB,TREATMENT NONCOMPLIANCE,1
GB,TROPONIN NORMAL,1
GB,TUMOUR LYSIS SYNDROME,1
GB,TYPE I HYPERSENSITIVITY,1
GB,ULCERATED HAEMANGIOMA,1
GB,URINE OUTPUT DECREASED,1
GB,URTICARIA,1
GB,VASCULAR ACCESS COMPLICATION,1
GB,VEIN DISORDER,1
GB,VERTIGO,1
GB,VIITH NERVE PARALYSIS,1
GB,VIRAL INFECTION,1
GB,VISION BLURRED,1
GB,VISUAL IMPAIRMENT,1
GB,VITREOUS ADHESIONS,1
GB,WHITE BLOOD CELL COUNT INCREASED,1
US,DRUG INEFFECTIVE,7151
US,FATIGUE,5893
US,DYSPNOEA,5003
US,NAUSEA,4586
US,PAIN,4546
US,ARTHRALGIA,4340
US,DIARRHOEA,4169
US,HEADACHE,4157
US,PNEUMONIA,3293
US,INJECTION SITE PAIN,3071
US,PAIN IN EXTREMITY,2859
US,ASTHENIA,2800
US,MALAISE,2792
US,DIZZINESS,2663
US,PYREXIA,2576
US,DEATH,2573
US,COUGH,2536
US,VOMITING,2471
US,RASH,2372
US,FALL,2327
US,DRUG DOSE OMISSION,2239
US,BACK PAIN,2133
US,WEIGHT DECREASED,2020
US,RHEUMATOID ARTHRITIS,2018
US,WEIGHT INCREASED,1774
US,ABDOMINAL PAIN,1707
US,PERIPHERAL SWELLING,1681
US,INSOMNIA,1616
US,SINUSITIS,1602
US,CONDITION AGGRAVATED,1576
US,DECREASED APPETITE,1570
US,PRURITUS,1570
US,NASOPHARYNGITIS,1530
US,ANAEMIA,1520
US,GAIT DISTURBANCE,1505
US,JOINT SWELLING,1484
US,URINARY TRACT INFECTION,1465
US,ANXIETY,1453
US,CHEST PAIN,1451
US,FEELING ABNORMAL,1369
US,HYPERTENSION,1358
US,BRONCHITIS,1347
US,DEPRESSION,1341
US,MUSCLE SPASMS,1293
US,DRUG HYPERSENSITIVITY,1258
US,INJECTION SITE BRUISING,1258
US,CONSTIPATION,1231
US,ABDOMINAL PAIN UPPER,1226
US,CROHN^S DISEASE,1218
US,HYPOAESTHESIA,1188
US,INJECTION SITE ERYTHEMA,1164
US,DEHYDRATION,1156
US,ASTHMA,1127
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1123
US,MYALGIA,1122
US,CONTUSION,1118
US,OEDEMA PERIPHERAL,1112
US,INFECTION,1109
US,ALOPECIA,1092
US,BLOOD GLUCOSE INCREASED,1086
US,ABDOMINAL DISCOMFORT,1027
US,SEPSIS,1019
US,INCORRECT DOSE ADMINISTERED,990
US,ARTHRITIS,987
US,MUSCULAR WEAKNESS,987
US,URTICARIA,982
US,PARAESTHESIA,969
US,HYPERSENSITIVITY,951
US,HYPOTENSION,943
US,ERYTHEMA,938
US,OROPHARYNGEAL PAIN,920
US,INFLUENZA,918
US,CHILLS,905
US,TREMOR,901
US,MUSCULOSKELETAL PAIN,867
US,MUSCULOSKELETAL STIFFNESS,840
US,PRODUCT USE ISSUE,840
US,NEUROPATHY PERIPHERAL,834
US,SWELLING,829
US,BLOOD PRESSURE INCREASED,814
US,PULMONARY EMBOLISM,808
US,VISION BLURRED,805
US,ATRIAL FIBRILLATION,780
US,CHEST DISCOMFORT,758
US,GASTROOESOPHAGEAL REFLUX DISEASE,758
US,UPPER RESPIRATORY TRACT INFECTION,757
US,GASTROINTESTINAL HAEMORRHAGE,755
US,HAEMOGLOBIN DECREASED,744
US,CONFUSIONAL STATE,742
US,MEMORY IMPAIRMENT,729
US,INJECTION SITE PRURITUS,720
US,DRUG EFFECT DECREASED,719
US,DEEP VEIN THROMBOSIS,717
US,INJECTION SITE HAEMORRHAGE,717
US,PLATELET COUNT DECREASED,717
US,OSTEOARTHRITIS,716
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,714
US,RESPIRATORY FAILURE,712
US,HERPES ZOSTER,709
US,DRUG EFFECT INCOMPLETE,703
US,ABDOMINAL DISTENSION,692
US,SOMNOLENCE,685
US,CARDIAC FAILURE CONGESTIVE,681
US,OSTEOPOROSIS,680
US,HYPERHIDROSIS,672
US,ACUTE KIDNEY INJURY,671
US,PRODUCT QUALITY ISSUE,652
US,CEREBROVASCULAR ACCIDENT,644
US,THROMBOCYTOPENIA,643
US,CELLULITIS,638
US,DYSPHAGIA,628
US,WHEEZING,627
US,DYSPEPSIA,626
US,DIABETES MELLITUS,623
US,COLITIS ULCERATIVE,622
US,RENAL FAILURE,620
US,INFLUENZA LIKE ILLNESS,619
US,LOCAL SWELLING,618
US,MYOCARDIAL INFARCTION,613
US,RHINORRHOEA,598
US,INJECTION SITE SWELLING,592
US,VISUAL IMPAIRMENT,591
US,MOBILITY DECREASED,587
US,SWELLING FACE,584
US,INJECTION SITE REACTION,583
US,CATARACT,582
US,HEART RATE INCREASED,578
US,DISEASE PROGRESSION,563
US,PSORIASIS,563
US,FEBRILE NEUTROPENIA,556
US,NASAL CONGESTION,556
US,MIGRAINE,553
US,MALIGNANT NEOPLASM PROGRESSION,552
US,NEUTROPENIA,547
US,PRODUCTIVE COUGH,547
US,UNEVALUABLE EVENT,547
US,PALPITATIONS,543
US,WHITE BLOOD CELL COUNT DECREASED,542
US,NECK PAIN,539
US,OEDEMA,539
US,EPISTAXIS,536
US,DYSPHONIA,527
US,PLEURAL EFFUSION,522
US,THROMBOSIS,522
US,BONE PAIN,520
US,INJURY,516
US,DRY MOUTH,511
US,FLUID RETENTION,498
US,ARTHROPATHY,493
US,HAEMORRHAGE,491
US,FLUSHING,489
US,HOSPITALISATION,488
US,LOSS OF CONSCIOUSNESS,487
US,SYNCOPE,481
US,BALANCE DISORDER,479
US,TOXICITY TO VARIOUS AGENTS,472
US,DEVICE MALFUNCTION,468
US,STAPHYLOCOCCAL INFECTION,466
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,463
US,HAEMATOCHEZIA,453
US,CLOSTRIDIUM DIFFICILE INFECTION,445
US,STOMATITIS,445
US,PANCYTOPENIA,439
US,ADVERSE DRUG REACTION,435
US,DYSGEUSIA,434
US,INFUSION RELATED REACTION,434
US,INTENTIONAL PRODUCT MISUSE,434
US,PRODUCT USE IN UNAPPROVED INDICATION,428
US,THERAPEUTIC RESPONSE DECREASED,428
US,BLOOD CREATININE INCREASED,426
US,DEVICE ISSUE,423
US,BURNING SENSATION,416
US,COLITIS,416
US,HOT FLUSH,416
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,416
US,TACHYCARDIA,413
US,LUNG DISORDER,412
US,RASH PRURITIC,410
US,SEPTIC SHOCK,405
US,DRY SKIN,403
US,HYPOXIA,403
US,STRESS,401
US,DYSPNOEA EXERTIONAL,395
US,THERAPEUTIC RESPONSE UNEXPECTED,394
US,SEIZURE,390
US,LYMPHADENOPATHY,382
US,INFLAMMATION,381
US,BLISTER,377
US,JOINT STIFFNESS,377
US,RECTAL HAEMORRHAGE,377
US,OXYGEN SATURATION DECREASED,376
US,BONE DISORDER,374
US,GASTROINTESTINAL DISORDER,373
US,LUNG INFECTION,371
US,NEPHROLITHIASIS,370
US,ADVERSE EVENT,368
US,HEPATIC ENZYME INCREASED,368
US,WHITE BLOOD CELL COUNT INCREASED,359
US,IMPAIRED HEALING,356
US,FUNGAL INFECTION,355
US,CARDIAC DISORDER,352
US,FEELING HOT,352
US,SYSTEMIC LUPUS ERYTHEMATOSUS,348
US,GENERAL PHYSICAL HEALTH DETERIORATION,342
US,DRUG INTOLERANCE,337
US,INJECTION SITE RASH,336
US,EMOTIONAL DISTRESS,333
US,SKIN DISCOLOURATION,333
US,FLATULENCE,332
US,INTERVERTEBRAL DISC PROTRUSION,332
US,NIGHT SWEATS,331
US,PAIN IN JAW,328
US,PULMONARY OEDEMA,322
US,PLASMA CELL MYELOMA,321
US,POLLAKIURIA,320
US,UNDERDOSE,320
US,INTESTINAL OBSTRUCTION,319
US,NERVOUSNESS,319
US,HYPOKALAEMIA,316
US,SLEEP DISORDER,315
US,AMNESIA,314
US,RENAL IMPAIRMENT,313
US,OSTEOPENIA,311
US,LETHARGY,310
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,310
US,MULTIPLE SCLEROSIS RELAPSE,306
US,SKIN EXFOLIATION,302
US,ANAPHYLACTIC REACTION,299
US,MENTAL STATUS CHANGES,297
US,VIRAL INFECTION,297
US,CARDIAC ARREST,296
US,DIVERTICULITIS,295
US,LEUKOPENIA,295
US,RIB FRACTURE,293
US,CYSTITIS,292
US,ABASIA,291
US,BLOOD POTASSIUM DECREASED,291
US,HYPERGLYCAEMIA,290
US,CANDIDA INFECTION,287
US,THROAT IRRITATION,287
US,DYSURIA,286
US,OVERDOSE,283
US,ACUTE RESPIRATORY FAILURE,280
US,BLOOD CHOLESTEROL INCREASED,279
US,ROTATOR CUFF SYNDROME,278
US,FOOT FRACTURE,277
US,TREATMENT FAILURE,271
US,LOCALISED INFECTION,270
US,HAEMATURIA,268
US,INTERVERTEBRAL DISC DEGENERATION,266
US,RASH ERYTHEMATOUS,266
US,OSTEONECROSIS OF JAW,265
US,PANCREATITIS,264
US,ACTIVITIES OF DAILY LIVING IMPAIRED,262
US,SPINAL OSTEOARTHRITIS,261
US,GOUT,260
US,RENAL FAILURE ACUTE,260
US,EXPOSURE DURING PREGNANCY,259
US,FREQUENT BOWEL MOVEMENTS,259
US,BLOOD PRESSURE DECREASED,258
US,HAEMOPTYSIS,258
US,PSORIATIC ARTHROPATHY,258
US,PULMONARY MASS,258
US,SKIN LESION,256
US,DRY EYE,253
US,PULMONARY HYPERTENSION,253
US,INJECTION SITE URTICARIA,252
US,HIP FRACTURE,251
US,FIBROMYALGIA,250
US,GASTRIC DISORDER,250
US,EYE SWELLING,248
US,OSTEOMYELITIS,248
US,LACERATION,247
US,SKIN ULCER,247
US,FEMUR FRACTURE,244
US,VERTIGO,243
US,CARDIAC FAILURE,242
US,SINUS DISORDER,241
US,ACNE,240
US,RASH GENERALISED,240
US,ALANINE AMINOTRANSFERASE INCREASED,238
US,INCREASED TENDENCY TO BRUISE,238
US,WOUND,238
US,SURGERY,237
US,LIMB DISCOMFORT,236
US,SPINAL FRACTURE,235
US,PNEUMONITIS,234
US,RESPIRATORY DISTRESS,233
US,RESPIRATORY TRACT INFECTION,233
US,GASTRITIS,232
US,ORAL PAIN,232
US,RENAL DISORDER,232
US,RESPIRATORY TRACT CONGESTION,231
US,EAR INFECTION,229
US,INTENTIONAL PRODUCT USE ISSUE,229
US,INTERSTITIAL LUNG DISEASE,229
US,EYE PAIN,228
US,SLEEP APNOEA SYNDROME,226
US,VITAMIN D DEFICIENCY,225
US,ATELECTASIS,222
US,CHOLELITHIASIS,222
US,HAEMORRHOIDS,222
US,HYPONATRAEMIA,222
US,HYPOTHYROIDISM,219
US,TENDON RUPTURE,219
US,SPEECH DISORDER,218
US,ASPARTATE AMINOTRANSFERASE INCREASED,217
US,DISCOMFORT,216
US,LEUKOCYTOSIS,216
US,ROAD TRAFFIC ACCIDENT,216
US,TINNITUS,216
US,ACUTE MYELOID LEUKAEMIA,215
US,INJECTION SITE WARMTH,213
US,RASH MACULAR,213
US,JOINT INJURY,212
US,NO ADVERSE EVENT,212
US,VISUAL ACUITY REDUCED,211
US,SMALL INTESTINAL OBSTRUCTION,210
US,HIATUS HERNIA,209
US,TOOTH DISORDER,209
US,HALLUCINATION,208
US,DEPRESSED MOOD,207
US,SKIN DISORDER,207
US,LIVER FUNCTION TEST ABNORMAL,206
US,UPPER LIMB FRACTURE,206
US,URINARY INCONTINENCE,205
US,DRUG ADMINISTRATION ERROR,202
US,HYPOPHAGIA,202
US,RASH PAPULAR,201
US,EAR PAIN,200
US,OCULAR HYPERAEMIA,200
US,LIMB INJURY,199
US,SINUS CONGESTION,198
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,197
US,PULMONARY FIBROSIS,196
US,NODULE,194
US,RED BLOOD CELL COUNT DECREASED,194
US,DYSSTASIA,193
US,GASTROENTERITIS VIRAL,192
US,CORONARY ARTERY DISEASE,191
US,JOINT RANGE OF MOTION DECREASED,191
US,PNEUMOTHORAX,191
US,TREATMENT NONCOMPLIANCE,191
US,EYE DISORDER,190
US,HYPERSOMNIA,189
US,KIDNEY INFECTION,189
US,PRURITUS GENERALISED,189
US,RESPIRATORY DISORDER,189
US,MUSCULOSKELETAL CHEST PAIN,188
US,PERICARDIAL EFFUSION,187
US,SUICIDAL IDEATION,187
US,LIP SWELLING,186
US,AGITATION,185
US,HYPOACUSIS,185
US,LUNG NEOPLASM MALIGNANT,185
US,MUSCULOSKELETAL DISCOMFORT,185
US,TRANSIENT ISCHAEMIC ATTACK,185
US,BLOOD GLUCOSE DECREASED,183
US,BURSITIS,183
US,ILL-DEFINED DISORDER,183
US,NEURALGIA,183
US,OSTEONECROSIS,183
US,FLUID OVERLOAD,182
US,LUNG INFILTRATION,182
US,CONVULSION,181
US,ORAL CANDIDIASIS,181
US,PHARYNGEAL OEDEMA,181
US,TRANSPLANT REJECTION,180
US,BLINDNESS,179
US,MYELODYSPLASTIC SYNDROME,179
US,THROAT TIGHTNESS,177
US,ARRHYTHMIA,173
US,HAEMATOCRIT DECREASED,173
US,ADRENAL INSUFFICIENCY,172
US,DISTURBANCE IN ATTENTION,172
US,TOOTHACHE,172
US,FOETAL EXPOSURE DURING PREGNANCY,171
US,SPINAL COMPRESSION FRACTURE,171
US,BODY HEIGHT DECREASED,170
US,TENDONITIS,170
US,CLOSTRIDIUM DIFFICILE COLITIS,169
US,URINARY RETENTION,169
US,CHRONIC KIDNEY DISEASE,168
US,FOOT DEFORMITY,168
US,THERAPY CESSATION,168
US,TOOTH INFECTION,168
US,IMMUNE SYSTEM DISORDER,167
US,LACRIMATION INCREASED,167
US,CARPAL TUNNEL SYNDROME,163
US,DENTAL CARIES,163
US,HEAD INJURY,163
US,LABORATORY TEST ABNORMAL,163
US,PANIC ATTACK,163
US,SPINAL COLUMN STENOSIS,162
US,HYPERKALAEMIA,161
US,INJECTION SITE MASS,161
US,IRRITABILITY,161
US,SKIN CANCER,161
US,CARDIOMEGALY,160
US,GLAUCOMA,160
US,METASTASES TO BONE,160
US,HAEMATOMA,159
US,MASS,159
US,TYPE 2 DIABETES MELLITUS,159
US,INCORRECT PRODUCT STORAGE,158
US,KNEE ARTHROPLASTY,158
US,DEAFNESS,157
US,MUSCULOSKELETAL DISORDER,157
US,BACTERAEMIA,156
US,NEOPLASM MALIGNANT,156
US,SWOLLEN TONGUE,156
US,BLOOD URINE PRESENT,154
US,EXOSTOSIS,154
US,FEELING COLD,154
US,COGNITIVE DISORDER,153
US,FULL BLOOD COUNT DECREASED,153
US,TOOTH ABSCESS,153
US,MULTIPLE FRACTURES,152
US,TENDERNESS,152
US,ANKLE FRACTURE,151
US,NEUTROPHIL COUNT DECREASED,151
US,BASAL CELL CARCINOMA,150
US,COAGULOPATHY,150
US,HYPERLIPIDAEMIA,150
US,SNEEZING,150
US,ASCITES,149
US,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,149
US,ABSCESS,148
US,AGEUSIA,148
US,IRRITABLE BOWEL SYNDROME,148
US,LIVER DISORDER,148
US,MUCOSAL INFLAMMATION,148
US,CYTOMEGALOVIRUS INFECTION,147
US,DISORIENTATION,147
US,INTERNATIONAL NORMALISED RATIO INCREASED,147
US,SCIATICA,147
US,CARDIOMYOPATHY,145
US,EMPHYSEMA,145
US,EYE IRRITATION,144
US,SPUTUM DISCOLOURED,143
US,MEDICATION ERROR,142
US,MOUTH ULCERATION,142
US,DIPLOPIA,141
US,ANHEDONIA,140
US,BACK DISORDER,140
US,MATERNAL EXPOSURE DURING PREGNANCY,139
US,PROSTATE CANCER,139
US,BREAST CANCER,138
US,PULMONARY ARTERIAL HYPERTENSION,138
US,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,137
US,LOWER LIMB FRACTURE,136
US,MENTAL DISORDER,136
US,DYSARTHRIA,135
US,MOVEMENT DISORDER,135
US,RETCHING,134
US,SCAR,134
US,UPPER-AIRWAY COUGH SYNDROME,133
US,ENCEPHALOPATHY,132
US,FEELING JITTERY,132
US,APHASIA,131
US,NOCARDIOSIS,131
US,PRE-EXISTING CONDITION IMPROVED,131
US,DELIRIUM,130
US,MULTIPLE ORGAN DYSFUNCTION SYNDROME,130
US,LYMPHOMA,129
US,ANGINA PECTORIS,128
US,BLOOD PRESSURE ABNORMAL,128
US,FAECES DISCOLOURED,128
US,INTESTINAL PERFORATION,128
US,JOINT EFFUSION,128
US,POOR QUALITY SLEEP,128
US,INJECTION SITE DISCOLOURATION,127
US,PULMONARY CONGESTION,127
US,RED BLOOD CELL SEDIMENTATION RATE INCREASED,127
US,ACCIDENTAL EXPOSURE TO PRODUCT,126
US,BACTERIAL INFECTION,126
US,BLOOD BILIRUBIN INCREASED,126
US,CYST,126
US,GALLBLADDER DISORDER,126
US,GASTRIC ULCER,126
US,IMMUNOSUPPRESSION,125
US,MALNUTRITION,125
US,SEASONAL ALLERGY,125
US,TOOTH FRACTURE,125
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,124
US,DEVICE RELATED INFECTION,123
US,INCREASED APPETITE,123
US,LOWER RESPIRATORY TRACT INFECTION,123
US,NERVE COMPRESSION,123
US,ORAL HERPES,123
US,BLOOD COUNT ABNORMAL,122
US,CHROMATURIA,122
US,GLOSSODYNIA,122
US,SQUAMOUS CELL CARCINOMA,122
US,ACUTE RESPIRATORY DISTRESS SYNDROME,121
US,MOOD SWINGS,121
US,MULTIPLE SCLEROSIS,121
US,TRANSAMINASES INCREASED,121
US,ECZEMA,120
US,HERNIA,120
US,PHARYNGITIS STREPTOCOCCAL,120
US,PRESYNCOPE,120
US,CRYING,119
US,DIVERTICULUM,119
US,DYSKINESIA,119
US,ECCHYMOSIS,119
US,LIVER FUNCTION TEST INCREASED,119
US,MITRAL VALVE INCOMPETENCE,119
US,SCOLIOSIS,119
US,THYROID DISORDER,119
US,ACUTE MYOCARDIAL INFARCTION,118
US,DISEASE RECURRENCE,118
US,HEART RATE IRREGULAR,118
US,IMMUNODEFICIENCY,118
US,NERVOUS SYSTEM DISORDER,118
US,VAGINAL HAEMORRHAGE,118
US,HEPATIC STEATOSIS,117
US,KIDNEY TRANSPLANT REJECTION,117
US,PROCEDURAL PAIN,117
US,RENAL CYST,117
US,THERAPY NON-RESPONDER,117
US,TRANSFUSION,117
US,BLOOD SODIUM DECREASED,116
US,HYPERCALCAEMIA,116
US,LARGE INTESTINE POLYP,116
US,PNEUMOCYSTIS JIROVECII PNEUMONIA,116
US,BLOOD UREA INCREASED,115
US,EYE PRURITUS,115
US,JOINT DISLOCATION,115
US,BLOOD ALKALINE PHOSPHATASE INCREASED,114
US,EATING DISORDER,114
US,FEAR,114
US,LIGAMENT SPRAIN,114
US,MENISCUS INJURY,114
US,MULTI-ORGAN FAILURE,114
US,ABDOMINAL PAIN LOWER,113
US,CHOKING,112
US,DRUG PRESCRIBING ERROR,112
US,FLANK PAIN,112
US,INCORRECT DRUG ADMINISTRATION DURATION,112
US,LARYNGITIS,112
US,RESTLESSNESS,112
US,UPPER GASTROINTESTINAL HAEMORRHAGE,112
US,CEREBRAL HAEMORRHAGE,111
US,HEART RATE DECREASED,111
US,NEPHROGENIC SYSTEMIC FIBROSIS,111
US,WRIST FRACTURE,111
US,DERMATITIS,110
US,DIARRHOEA HAEMORRHAGIC,110
US,NO THERAPEUTIC RESPONSE,110
US,SPLENOMEGALY,110
US,ANGIOEDEMA,109
US,PHOTOPHOBIA,109
US,SECOND PRIMARY MALIGNANCY,109
US,SKIN INFECTION,109
US,ABORTION SPONTANEOUS,108
US,HAEMORRHAGIC ANAEMIA,108
US,HEAD DISCOMFORT,108
US,RESTLESS LEGS SYNDROME,108
US,TOOTH LOSS,108
US,APHONIA,107
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,107
US,CORONARY ARTERY OCCLUSION,106
US,RENAL FAILURE CHRONIC,106
US,SINUS TACHYCARDIA,106
US,SKIN BURNING SENSATION,106
US,BONE LESION,105
US,DEMENTIA,105
US,DISABILITY,105
US,FISTULA,105
US,ASPERGILLUS INFECTION,104
US,BONE DENSITY DECREASED,104
US,HYPOGLYCAEMIA,104
US,BEDRIDDEN,103
US,CUSHINGOID,103
US,GASTROENTERITIS,103
US,INFLAMMATORY BOWEL DISEASE,103
US,MOOD ALTERED,103
US,MUSCLE TIGHTNESS,103
US,PAIN OF SKIN,103
US,SYNOVITIS,103
US,FACIAL PAIN,102
US,GROIN PAIN,102
US,PREGNANCY,102
US,VITAMIN D DECREASED,102
US,CARDIO-RESPIRATORY ARREST,101
US,DEFORMITY,101
US,FEEDING DISORDER,101
US,HEPATIC FAILURE,101
US,SKIN ATROPHY,101
US,ABNORMAL BEHAVIOUR,100
US,EXPIRED PRODUCT ADMINISTERED,100
US,GRAFT VERSUS HOST DISEASE,100
US,HIP ARTHROPLASTY,100
US,LUPUS-LIKE SYNDROME,100
US,PHOTOSENSITIVITY REACTION,100
US,BK VIRUS INFECTION,99
US,HYPOCALCAEMIA,99
US,INJECTION SITE INDURATION,99
US,IRON DEFICIENCY ANAEMIA,99
US,LYMPHOCYTE COUNT DECREASED,99
US,POST PROCEDURAL COMPLICATION,99
US,UROSEPSIS,99
US,BLOOD GLUCOSE ABNORMAL,98
US,COMPRESSION FRACTURE,98
US,EJECTION FRACTION DECREASED,98
US,DRUG RESISTANCE,97
US,MUSCLE STRAIN,97
US,MYOPATHY,97
US,PELVIC FRACTURE,97
US,WOUND INFECTION,97
US,METABOLIC ACIDOSIS,96
US,NEOPLASM PROGRESSION,96
US,PLATELET COUNT INCREASED,96
US,SINUS HEADACHE,96
US,BLOOD TRIGLYCERIDES INCREASED,95
US,CHOLECYSTECTOMY,95
US,DECUBITUS ULCER,95
US,EAR DISCOMFORT,95
US,HEPATITIS C,95
US,TRICUSPID VALVE INCOMPETENCE,95
US,ABNORMAL LOSS OF WEIGHT,94
US,OBESITY,94
US,PANCREATITIS ACUTE,94
US,SJOGREN^S SYNDROME,94
US,BRADYCARDIA,93
US,C-REACTIVE PROTEIN INCREASED,93
US,DRUG-INDUCED LIVER INJURY,93
US,FURUNCLE,93
US,MALABSORPTION,93
US,NOCTURIA,93
US,PREMATURE BABY,93
US,UNRESPONSIVE TO STIMULI,93
US,BLOOD CALCIUM DECREASED,92
US,BODY TEMPERATURE INCREASED,92
US,BONE MARROW FAILURE,92
US,HAEMORRHAGE INTRACRANIAL,92
US,SPINAL DISORDER,92
US,BLOOD LACTATE DEHYDROGENASE INCREASED,91
US,CYTOMEGALOVIRUS VIRAEMIA,91
US,DIFFUSE LARGE B-CELL LYMPHOMA,91
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,91
US,MUSCLE ATROPHY,91
US,INJECTION SITE EXTRAVASATION,90
US,LOWER GASTROINTESTINAL HAEMORRHAGE,90
US,NERVE INJURY,90
US,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,90
US,PROTEINURIA,90
US,RENAL TUBULAR NECROSIS,90
US,SPINAL PAIN,90
US,BONE LOSS,89
US,EMOTIONAL DISORDER,89
US,HEMIPARESIS,89
US,JAUNDICE,89
US,BLOOD IRON DECREASED,88
US,CONJUNCTIVITIS,88
US,EXTRA DOSE ADMINISTERED,88
US,GASTROINTESTINAL INFLAMMATION,88
US,INJECTION SITE PAPULE,88
US,PHARYNGITIS,88
US,SARCOIDOSIS,88
US,TOOTH EXTRACTION,88
US,ULCER,88
US,ANGER,87
US,DRUG DISPENSING ERROR,87
US,EXPOSED BONE IN JAW,87
US,EYE INFECTION,86
US,PALLOR,86
US,PNEUMONIA ASPIRATION,86
US,BRONCHOPULMONARY ASPERGILLOSIS,85
US,HAND DEFORMITY,85
US,INTERNAL HAEMORRHAGE,85
US,SECRETION DISCHARGE,85
US,SKIN HAEMORRHAGE,85
US,MELAENA,84
US,MUSCLE TWITCHING,84
US,PATHOLOGICAL FRACTURE,84
US,PETECHIAE,84
US,PROSTATE CANCER METASTATIC,84
US,BLOOD MAGNESIUM DECREASED,83
US,BRONCHOSPASM,83
US,ERUCTATION,83
US,EYE HAEMORRHAGE,83
US,MALIGNANT MELANOMA,83
US,RASH MACULO-PAPULAR,83
US,SCAB,83
US,SQUAMOUS CELL CARCINOMA OF SKIN,83
US,VASCULITIS,83
US,CENTRAL NERVOUS SYSTEM LESION,82
US,COMA,82
US,DERMATITIS CONTACT,82
US,HYPERCHOLESTEROLAEMIA,82
US,INTRAMEDULLARY ROD INSERTION,82
US,PARAESTHESIA ORAL,82
US,PLEURISY,82
US,PSEUDOMONAS INFECTION,82
US,THINKING ABNORMAL,82
US,GASTROINTESTINAL INFECTION,81
US,INJURY ASSOCIATED WITH DEVICE,81
US,MENTAL IMPAIRMENT,81
US,MICTURITION URGENCY,81
US,PELVIC PAIN,81
US,PULMONARY THROMBOSIS,81
US,TUBULOINTERSTITIAL NEPHRITIS,81
US,FAILURE TO THRIVE,80
US,GINGIVAL PAIN,80
US,HYPOAESTHESIA ORAL,80
US,TENDON DISORDER,80
US,ARTERIOSCLEROSIS,79
US,BLOOD POTASSIUM INCREASED,79
US,STRESS FRACTURE,79
US,SYNOVIAL CYST,79
US,WEIGHT FLUCTUATION,79
US,GINGIVAL BLEEDING,78
US,IMPAIRED WORK ABILITY,78
US,LYMPHOPENIA,78
US,ORAL DISCOMFORT,78
US,RESPIRATORY ARREST,78
US,THIRST,78
US,WALKING AID USER,78
US,CARDIAC MURMUR,77
US,HAEMOLYSIS,77
US,HEPATITIS,77
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,77
US,SENSORY DISTURBANCE,77
US,ANKYLOSING SPONDYLITIS,76
US,CARDIOVASCULAR DISORDER,76
US,LARGE INTESTINE PERFORATION,76
US,OESOPHAGITIS,76
US,ORAL DISORDER,76
US,PSYCHOMOTOR HYPERACTIVITY,76
US,AORTIC ARTERIOSCLEROSIS,75
US,BACK INJURY,75
US,BLOOD PRESSURE FLUCTUATION,75
US,COMPLETED SUICIDE,75
US,DEVICE FAILURE,75
US,HISTIOCYTOSIS HAEMATOPHAGIC,75
US,HYPOMAGNESAEMIA,75
US,METASTASES TO LIVER,75
US,NEPHROPATHY TOXIC,75
US,OSTEOSCLEROSIS,75
US,PERIPHERAL COLDNESS,75
US,ABDOMINAL ABSCESS,74
US,FRACTURE,74
US,GENERALISED OEDEMA,74
US,INCREASED UPPER AIRWAY SECRETION,74
US,JOINT CREPITATION,74
US,NIGHTMARE,74
US,ORAL MUCOSAL BLISTERING,74
US,PERITONITIS,74
US,TUMOUR LYSIS SYNDROME,74
US,ARTHROPOD BITE,73
US,AUTOIMMUNE DISORDER,73
US,CHRONIC SINUSITIS,73
US,HYPOKINESIA,73
US,OSTEOLYSIS,73
US,AORTIC ANEURYSM,72
US,BLINDNESS UNILATERAL,72
US,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,72
US,GASTROINTESTINAL PAIN,72
US,ILEUS,72
US,MACULAR DEGENERATION,72
US,DEVICE DISLOCATION,71
US,DEVICE USE ERROR,71
US,DRUG EFFECT DELAYED,71
US,FACE OEDEMA,71
US,HEPATIC CIRRHOSIS,71
US,LOW TURNOVER OSTEOPATHY,71
US,MUCORMYCOSIS,71
US,PSYCHOTIC DISORDER,71
US,SUBDURAL HAEMATOMA,71
US,DRUG WITHDRAWAL SYNDROME,70
US,GRIP STRENGTH DECREASED,70
US,HAND FRACTURE,70
US,HYDRONEPHROSIS,70
US,HYPOGAMMAGLOBULINAEMIA,70
US,INTENTIONAL DRUG MISUSE,70
US,INTRAOCULAR PRESSURE INCREASED,70
US,LUMBAR SPINAL STENOSIS,70
US,SUPRAVENTRICULAR TACHYCARDIA,70
US,ATAXIA,69
US,EYELID OEDEMA,69
US,PROCTALGIA,69
US,PULMONARY HAEMORRHAGE,69
US,ACUTE HEPATIC FAILURE,68
US,CALCIUM DEFICIENCY,68
US,DECREASED INTEREST,68
US,MIDDLE INSOMNIA,68
US,ORTHOSTATIC HYPOTENSION,68
US,PREMATURE DELIVERY,68
US,RHABDOMYOLYSIS,68
US,SCRATCH,68
US,AUTOIMMUNE HEPATITIS,67
US,BLOOD CALCIUM INCREASED,67
US,BLOOD TEST ABNORMAL,67
US,CYTOPENIA,67
US,FINGER DEFORMITY,67
US,GAIT INABILITY,67
US,INGUINAL HERNIA,67
US,PARANASAL SINUS HYPERSECRETION,67
US,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,67
US,PURULENT DISCHARGE,67
US,AGGRESSION,66
US,ARTERIOSCLEROSIS CORONARY ARTERY,66
US,ARTHRITIS BACTERIAL,66
US,ASPIRATION,66
US,BRONCHIECTASIS,66
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,66
US,DRUG SPECIFIC ANTIBODY PRESENT,66
US,HAEMATEMESIS,66
US,HISTOPLASMOSIS,66
US,INTERVERTEBRAL DISC DISORDER,66
US,INTESTINAL STENOSIS,66
US,MENORRHAGIA,66
US,VITREOUS FLOATERS,66
US,COLON CANCER,65
US,GENERALISED TONIC-CLONIC SEIZURE,65
US,HEPATOMEGALY,65
US,POST PROCEDURAL INFECTION,65
US,RASH PUSTULAR,65
US,SKIN MASS,65
US,STAPHYLOCOCCAL BACTERAEMIA,65
US,TACHYPNOEA,65
US,TEMPERATURE INTOLERANCE,65
US,TUBERCULOSIS,65
US,EPSTEIN-BARR VIRUS INFECTION,64
US,KYPHOSIS,64
US,SKIN FISSURES,64
US,ABDOMINAL HERNIA,63
US,BLADDER DISORDER,63
US,BREAST PAIN,63
US,CHOLECYSTITIS,63
US,COLD SWEAT,63
US,HISTOPLASMOSIS DISSEMINATED,63
US,IMPAIRED DRIVING ABILITY,63
US,IMPAIRED GASTRIC EMPTYING,63
US,LYMPHOEDEMA,63
US,MULTIPLE ALLERGIES,63
US,ORGANISING PNEUMONIA,63
US,PAPULE,63
US,PERONEAL NERVE PALSY,63
US,RHINITIS ALLERGIC,63
US,RIGHT VENTRICULAR FAILURE,63
US,VENTRICULAR TACHYCARDIA,63
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,62
US,CATARACT OPERATION,62
US,DEFAECATION URGENCY,62
US,DRY THROAT,62
US,EYE DISCHARGE,62
US,FIBULA FRACTURE,62
US,HYPOVOLAEMIA,62
US,ONYCHOMYCOSIS,62
US,POLYMYALGIA RHEUMATICA,62
US,QUALITY OF LIFE DECREASED,62
US,SPINAL OPERATION,62
US,STEVENS-JOHNSON SYNDROME,62
US,WITHDRAWAL SYNDROME,62
US,BREATH SOUNDS ABNORMAL,61
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,61
US,INCONTINENCE,61
US,PNEUMONIA BACTERIAL,61
US,STRONGYLOIDIASIS,61
US,ARTHRITIS INFECTIVE,60
US,CONCUSSION,60
US,EMBOLISM,60
US,GOITRE,60
US,METASTASES TO SPINE,60
US,PERIPHERAL VASCULAR DISORDER,60
US,PLATELET COUNT ABNORMAL,60
US,PRESCRIBED OVERDOSE,60
US,PULMONARY FUNCTION TEST DECREASED,60
US,TIBIA FRACTURE,60
US,ENTERITIS,59
US,ESCHERICHIA URINARY TRACT INFECTION,59
US,GINGIVITIS,59
US,GLUCOSE TOLERANCE IMPAIRED,59
US,NEUROTOXICITY,59
US,POLYP,59
US,URINE OUTPUT DECREASED,59
US,ATRIAL FLUTTER,58
US,BLOOD ALBUMIN DECREASED,58
US,ESCHERICHIA INFECTION,58
US,HEARING IMPAIRED,58
US,HERPES SIMPLEX,58
US,HUNGER,58
US,HYPERKERATOSIS,58
US,INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS,58
US,MOUTH HAEMORRHAGE,58
US,RALES,58
US,SKIN ABRASION,58
US,ABDOMINAL ADHESIONS,57
US,ACCIDENTAL OVERDOSE,57
US,AORTIC CALCIFICATION,57
US,CARDIOGENIC SHOCK,57
US,ESSENTIAL HYPERTENSION,57
US,HYPERTHYROIDISM,57
US,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,57
US,LEFT VENTRICULAR HYPERTROPHY,57
US,LOOSE TOOTH,57
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,57
US,PYELONEPHRITIS,57
US,SHOCK,57
US,SKIN WARM,57
US,SUNBURN,57
US,TRANSPLANT FAILURE,57
US,BLOOD DISORDER,56
US,DIABETIC KETOACIDOSIS,56
US,DIVERTICULAR PERFORATION,56
US,DRUG DEPENDENCE,56
US,IDIOPATHIC PULMONARY FIBROSIS,56
US,PRODUCT SUBSTITUTION ISSUE,56
US,SKIN IRRITATION,56
US,ATYPICAL PNEUMONIA,55
US,BLOOD GLUCOSE FLUCTUATION,55
US,CEREBRAL INFARCTION,55
US,DIVERTICULUM INTESTINAL,55
US,EOSINOPHILIA,55
US,FAECAL INCONTINENCE,55
US,FEAR OF INJECTION,55
US,FOOT OPERATION,55
US,INTERVERTEBRAL DISC SPACE NARROWING,55
US,LACTIC ACIDOSIS,55
US,LIGAMENT RUPTURE,55
US,OVARIAN CYST,55
US,POOR QUALITY DRUG ADMINISTERED,55
US,SENSITIVITY OF TEETH,55
US,DIALYSIS,54
US,ERECTILE DYSFUNCTION,54
US,HAEMOLYTIC ANAEMIA,54
US,ISCHAEMIC STROKE,54
US,LIPASE INCREASED,54
US,MANIA,54
US,PARANASAL SINUS DISCOMFORT,54
US,RENAL TRANSPLANT,54
US,TENDON INJURY,54
US,VERTEBRAL FORAMINAL STENOSIS,54
US,ABSCESS INTESTINAL,53
US,END STAGE RENAL DISEASE,53
US,EYE INFLAMMATION,53
US,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,53
US,METASTASES TO LUNG,53
US,PRODUCT STORAGE ERROR,53
US,UVEITIS,53
US,ABNORMAL DREAMS,52
US,BREAST MASS,52
US,INJECTION SITE VESICLES,52
US,NON-CARDIAC CHEST PAIN,52
US,OBSTRUCTIVE AIRWAYS DISORDER,52
US,RENAL PAIN,52
US,SLUGGISHNESS,52
US,STREPTOCOCCAL INFECTION,52
US,THROMBOPHLEBITIS SUPERFICIAL,52
US,WOUND COMPLICATION,52
US,ABDOMINAL TENDERNESS,51
US,ADVERSE REACTION,51
US,HYSTERECTOMY,51
US,INJECTION SITE DISCOMFORT,51
US,INJECTION SITE NODULE,51
US,OSTEITIS,51
US,RHINITIS,51
US,SPINAL CORD COMPRESSION,51
US,SPONDYLOLISTHESIS,51
US,SUBARACHNOID HAEMORRHAGE,51
US,AORTIC STENOSIS,50
US,COLECTOMY,50
US,ELECTROLYTE IMBALANCE,50
US,GLOMERULAR FILTRATION RATE DECREASED,50
US,HAEMOGLOBIN ABNORMAL,50
US,HALLUCINATION_ VISUAL,50
US,LUMBAR VERTEBRAL FRACTURE,50
US,NAIL DISORDER,50
US,ONYCHOCLASIS,50
US,OPTIC NEURITIS,50
US,PHYSICAL DISABILITY,50
US,POSTOPERATIVE WOUND INFECTION,50
US,PROCEDURAL COMPLICATION,50
US,PULMONARY ALVEOLAR HAEMORRHAGE,50
US,SEDATION,50
US,ANAL FISTULA,49
US,ANAL INCONTINENCE,49
US,AORTIC VALVE INCOMPETENCE,49
US,DERMATITIS ALLERGIC,49
US,DIZZINESS POSTURAL,49
US,DRUG LEVEL INCREASED,49
US,FUNGAL SKIN INFECTION,49
US,HUMERUS FRACTURE,49
US,LEFT VENTRICULAR DYSFUNCTION,49
US,MOTOR DYSFUNCTION,49
US,ORTHOPNOEA,49
US,PERIPHERAL SENSORY NEUROPATHY,49
US,UMBILICAL HERNIA,49
US,VARICELLA ZOSTER VIRUS INFECTION,49
US,ANAPHYLACTIC SHOCK,48
US,APHAGIA,48
US,CEREBRAL ATROPHY,48
US,ENERGY INCREASED,48
US,ENTEROCOCCAL INFECTION,48
US,HAEMORRHAGIC DIATHESIS,48
UM,ABDOMINAL PAIN,1
UM,ARTHRALGIA,1
UM,GAIT DISTURBANCE,1
UM,GAIT INABILITY,1
UM,HAEMATOCHEZIA,1
UM,HAEMOGLOBIN DECREASED,1
UM,HAEMOLYTIC URAEMIC SYNDROME,1
UM,INFECTION,1
UM,INJECTION SITE REACTION,1
UM,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
UM,MUSCLE SPASMS,1
UM,MYALGIA,1
UM,OXYGEN SATURATION DECREASED,1
UM,PAIN IN EXTREMITY,1
UM,PULMONARY FIBROSIS,1
UM,SKIN DISCOLOURATION,1
UM,STAPHYLOCOCCAL INFECTION,1
UM,TENDON RUPTURE,1
UM,TENDONITIS,1
UM,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
UM,VASCULAR PAIN,1
UY,DRUG INEFFECTIVE,2
UY,FATIGUE,2
UY,NECROTISING FASCIITIS STREPTOCOCCAL,2
UY,PYREXIA,2
UY,SEPSIS,2
UY,SEPTIC SHOCK,2
UY,ADJUSTMENT DISORDER WITH DEPRESSED MOOD,1
UY,ANOGENITAL WARTS,1
UY,ASTHENIA,1
UY,ATRIOVENTRICULAR BLOCK,1
UY,BONE PAIN,1
UY,CARDIO-RESPIRATORY ARREST,1
UY,CYST,1
UY,DISSEMINATED TUBERCULOSIS,1
UY,EMOTIONAL DISORDER,1
UY,EPISTAXIS,1
UY,HAEMOGLOBIN DECREASED,1
UY,HEADACHE,1
UY,HISTOPLASMOSIS,1
UY,LARYNGEAL OEDEMA,1
UY,LOSS OF CONSCIOUSNESS,1
UY,LYMPHADENOPATHY,1
UY,LYMPHANGITIS,1
UY,MORGANELLA INFECTION,1
UY,MUSCULOSKELETAL STIFFNESS,1
UY,PANCYTOPENIA,1
UY,PANNICULITIS,1
UY,PAPILLOMA VIRAL INFECTION,1
UY,PSYCHIATRIC SYMPTOM,1
UY,SKIN DISORDER,1
UY,THROMBOCYTOPENIA,1
UY,WHITE BLOOD CELL COUNT DECREASED,1
VE,PRODUCT USE ISSUE,4
VE,TUBERCULIN TEST POSITIVE,4
VE,ARTHRALGIA,3
VE,ASTHMA,3
VE,ASTHMATIC CRISIS,3
VE,PAIN,3
VE,SEIZURE,3
VE,ANXIETY,2
VE,ASPHYXIA,2
VE,BLOOD CREATININE INCREASED,2
VE,BRONCHITIS,2
VE,CARDIAC DISORDER,2
VE,CHIKUNGUNYA VIRUS INFECTION,2
VE,DRUG INTOLERANCE,2
VE,FATIGUE,2
VE,GAIT DISTURBANCE,2
VE,HAEMOGLOBIN DECREASED,2
VE,HEPATIC ENZYME INCREASED,2
VE,HYPERSENSITIVITY,2
VE,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
VE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
VE,INFECTION PARASITIC,2
VE,INSOMNIA,2
VE,MALAISE,2
VE,PNEUMONIA,2
VE,PYREXIA,2
VE,RENAL HAEMORRHAGE,2
VE,THROMBOSIS,2
VE,TRANSAMINASES INCREASED,2
VE,URINARY TRACT INFECTION,2
VE,ABDOMINAL PAIN UPPER,1
VE,ABORTION,1
VE,ACCIDENT,1
VE,ACROMEGALY,1
VE,ALOPECIA,1
VE,ANAL FISTULA,1
VE,ANGINA PECTORIS,1
VE,ARTHROPATHY,1
VE,BEDRIDDEN,1
VE,BENIGN NEOPLASM OF THYROID GLAND,1
VE,BLOOD DISORDER,1
VE,BLOOD GLUCOSE DECREASED,1
VE,BLUE TOE SYNDROME,1
VE,BONE PAIN,1
VE,CARDIAC FAILURE,1
VE,CEREBRAL PALSY,1
VE,CERVIX CARCINOMA,1
VE,CHOLELITHIASIS,1
VE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
VE,COLITIS,1
VE,DEATH,1
VE,DECREASED APPETITE,1
VE,DEEP VEIN THROMBOSIS,1
VE,DEHYDRATION,1
VE,DEPRESSION,1
VE,DERMATITIS,1
VE,DEVICE MATERIAL ISSUE,1
VE,DISCOMFORT,1
VE,DISEASE PROGRESSION,1
VE,DISEASE RECURRENCE,1
VE,DIZZINESS,1
VE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
VE,DRUG PRESCRIBING ERROR,1
VE,DRUG-INDUCED LIVER INJURY,1
VE,DRY SKIN,1
VE,DYSPNOEA,1
VE,EAR NEOPLASM MALIGNANT,1
VE,ESCHERICHIA TEST POSITIVE,1
VE,EXPOSURE DURING PREGNANCY,1
VE,FALL,1
VE,FEBRILE NEUTROPENIA,1
VE,FEELING ABNORMAL,1
VE,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
VE,GASTRITIS,1
VE,GENERAL PHYSICAL HEALTH DETERIORATION,1
VE,GENERALISED OEDEMA,1
VE,GLOBULINS INCREASED,1
VE,GOITRE,1
VE,GRAFT LOSS,1
VE,HAEMATOLOGY TEST ABNORMAL,1
VE,HAEMATOTOXICITY,1
VE,HAEMOTHORAX,1
VE,HAND FRACTURE,1
VE,HEPATOTOXICITY,1
VE,HERNIAL EVENTRATION,1
VE,HIGH RISK PREGNANCY,1
VE,HYPERTENSION,1
VE,HYPOGLYCAEMIA,1
VE,HYPOSTHENURIA,1
VE,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
VE,INFECTION,1
VE,INSULIN-LIKE GROWTH FACTOR INCREASED,1
VE,INTRACRANIAL PRESSURE INCREASED,1
VE,JOINT SWELLING,1
VE,KIDNEY ENLARGEMENT,1
VE,KIDNEY TRANSPLANT REJECTION,1
VE,LABORATORY TEST ABNORMAL,1
VE,LAZINESS,1
VE,LIVER DISORDER,1
VE,LUNG NEOPLASM,1
VE,MALNUTRITION,1
VE,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
VE,MENINGITIS,1
VE,MICROCEPHALY,1
VE,MOUTH ULCERATION,1
VE,MUSCULOSKELETAL DISCOMFORT,1
VE,MYOCARDIAL INFARCTION,1
VE,NASAL OBSTRUCTION,1
VE,NEAR DROWNING,1
VE,NEOPLASM,1
VE,NEOPLASM MALIGNANT,1
VE,NEPHROTIC SYNDROME,1
VE,NEUTROPENIA,1
VE,NON-HODGKIN^S LYMPHOMA,1
VE,NON-HODGKIN^S LYMPHOMA RECURRENT,1
VE,OPPORTUNISTIC INFECTION,1
VE,OPTIC NEURITIS,1
VE,PANCREATIC DISORDER,1
VE,PAPILLOEDEMA,1
VE,PITUITARY TUMOUR,1
VE,PLACENTA PRAEVIA,1
VE,POSTOPERATIVE WOUND INFECTION,1
VE,PRODUCTIVE COUGH,1
VE,PSYCHOMOTOR RETARDATION,1
VE,RASH,1
VE,RECTAL ABSCESS,1
VE,RECTAL CANCER,1
VE,RENAL DISORDER,1
VE,RESPIRATORY ARREST,1
VE,RESTLESSNESS,1
VE,RHINORRHOEA,1
VE,SEPSIS,1
VE,SKIN DISCOLOURATION,1
VE,SKIN EXFOLIATION,1
VE,SYNCOPE,1
VE,THERAPY NON-RESPONDER,1
VE,TUBERCULOSIS,1
VE,UMBILICAL HERNIA,1
VE,URETHRAL DISORDER,1
VE,URINE OUTPUT INCREASED,1
VE,UTERINE DISORDER,1
VE,UTERINE HAEMORRHAGE,1
VE,UTERINE LEIOMYOMA,1
VE,VIRAL INFECTION,1
VE,VOMITING,1
VE,WEIGHT INCREASED,1
VE,WOUND,1
VN,NEUTROPENIA,5
VN,FATIGUE,4
VN,WHITE BLOOD CELL COUNT DECREASED,3
VN,ALANINE AMINOTRANSFERASE INCREASED,2
VN,ANAEMIA,2
VN,ASPARTATE AMINOTRANSFERASE INCREASED,2
VN,FEBRILE NEUTROPENIA,2
VN,INFUSION RELATED REACTION,2
VN,PLATELET COUNT DECREASED,2
VN,PYREXIA,2
VN,THROMBOCYTOPENIA,2
VN,TRANSAMINASES INCREASED,2
VN,VOMITING,2
VN,ABDOMINAL DISTENSION,1
VN,ABDOMINAL PAIN,1
VN,ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED,1
VN,ACUTE KIDNEY INJURY,1
VN,ALOPECIA,1
VN,ASTHENIA,1
VN,ATRIAL FIBRILLATION,1
VN,BLOOD BILIRUBIN INCREASED,1
VN,BLOOD CREATININE INCREASED,1
VN,BLOOD LACTATE DEHYDROGENASE INCREASED,1
VN,COAGULATION FACTOR IX LEVEL INCREASED,1
VN,COMPLICATIONS OF TRANSPLANT SURGERY,1
VN,COUGH,1
VN,DEATH,1
VN,DECREASED APPETITE,1
VN,DEEP VEIN THROMBOSIS,1
VN,DIARRHOEA,1
VN,EXTRAVASATION,1
VN,GRANULOCYTE COUNT DECREASED,1
VN,HAEMATOTOXICITY,1
VN,HEADACHE,1
VN,HEPATITIS B,1
VN,HYPOAESTHESIA,1
VN,HYPONATRAEMIA,1
VN,INFLAMMATION,1
VN,INTERVERTEBRAL DISC PROTRUSION,1
VN,LOCAL SWELLING,1
VN,LUNG INFECTION,1
VN,LYMPHOMA TRANSFORMATION,1
VN,MALIGNANT PLEURAL EFFUSION,1
VN,MUCOSAL ULCERATION,1
VN,MYOCARDIAL ISCHAEMIA,1
VN,NAUSEA,1
VN,OEDEMA PERIPHERAL,1
VN,PANCREAS INFECTION,1
VN,PANCREATITIS,1
VN,PELVIC PAIN,1
VN,PELVIC VENOUS THROMBOSIS,1
VN,PLASMINOGEN ACTIVATOR INHIBITOR INCREASED,1
VN,PLEURAL EFFUSION,1
VN,PNEUMONITIS,1
VN,PRURITUS,1
VN,RED BLOOD CELL COUNT DECREASED,1
VN,RENAL VEIN THROMBOSIS,1
VN,RESPIRATORY FAILURE,1
VN,SINUSITIS,1
VN,THERAPY RESPONDER,1
VN,URETERITIS,1
VN,VENTRICULAR TACHYCARDIA,1
VN,WEIGHT DECREASED,1
